{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s exposure to the 5.000% notes due April 2030 stayed flat at **$606 million** from FY 2022 through FY 2024 (2024 10‑K, page 81; 2023 10‑K, page 81).  While the company repaid other debt—$11,195 million of Term A‑2 and $5,600 million of Term A‑3 in FY 2024 (2024 10‑K, page 82)—the 5.000% notes remained unchanged, indicating a strategy that prioritizes maintaining a stable long‑term debt mix and using new issuances and repayments of other obligations to manage liquidity rather than aggressively paying down these notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative evolution of AVGO's exposure to the 5.000% notes due April 2030. The ground truth states exposure decreased from $1,086 million in 2022 to $606 million in 2023 and remained at $606 million in 2024. However, the LLM claims exposure was flat at $606 million across all three years (2022–2024), which contradicts the documented reduction in 2022–2023. This error misrepresents the core financial trend. (2) The cited dollar amounts for other debt repayments in FY2024 ($11,195 million Term A-2 and $5,600 million Term A-3) are accurate per AVGO’s 2024 10-K, but they are irrelevant to the specific question about the 5.000% notes due 2030. The LLM incorrectly uses repayment activity on unrelated debt tranches to justify a stable exposure, when in fact the 5.000% notes themselves were partially repaid between 2022 and 2023. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the year-over-year change in the specific debt instrument asked about. Instead, it infers a strategy based on stability and broader debt activity, contradicting the actual reduction in exposure. The correct inference from the ground truth—active debt reduction on these specific notes—is missed entirely. (4) While the answer is contextually relevant (discusses AVGO, debt strategy, and cites correct document pages), the fundamental inaccuracy in the key metric (exposure trend) severely undermines correctness. The reasoning and conclusion are therefore based on false premises, warranting a low score despite some accurate peripheral details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 445,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "From 2022 through 2024 MetLife continued to transfer **59 % of the closed block risk via a modified coinsurance agreement** (page 214, 228, 204), accounting for the arrangement under the deposit method and offsetting the deposit liability with a recoverable. The unchanged 59 % transfer rate shows a deliberate, long‑term strategy to keep the closed block’s risk exposure stable, preserving policyholder dividends and ensuring predictable capital management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the percentage of risk transferred is correctly reported as 59% for all three years, which matches the original answer's 59.25% in 2022 and 59% in 2023 and 2024—rounding to 59% is acceptable and common in financial reporting. The mention of consistent use of the deposit method and right of offset is factually correct. (2) The LLM correctly identifies the key elements: modified coinsurance agreement, closed block, accounting treatment, and offsetting practice. (3) The reasoning about a 'deliberate, long-term strategy' to maintain stable risk exposure is logically sound and consistent with the ground truth’s conclusion about 'sustained reinsurance strategy focused on risk transfer efficiency and capital optimization.' (4) One minor omission is that the LLM does not mention the significant growth in total net ceded reinsurance recoverables from $6.3B to $17.6B, which provides context for why the stability in percentage is notable despite overall portfolio changes. This missing contextual data slightly weakens completeness but does not affect the core correctness. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates correct multi-hop synthesis across years and accounting practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 368,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: it was $1.494 billion at December 31 2022, $800 million at December 31 2023, and $491 million at December 31 2024 (XOM 10‑K 2023, p. 102; XOM 10‑K 2024, p. 99). The steep decline—primarily driven by lower initial‑margin requirements—suggests the company has reduced its derivative exposure or achieved more efficient netting and collateral management, indicating a tighter, more disciplined approach to derivative risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024 — format variations (billion vs million) are semantically equivalent and correctly represented. (2) The answer addresses both parts of the question: it details the change in collateral over the three years and interprets the trend regarding derivative exposure management. (3) Entities are correct: ExxonMobil (XOM), proper fiscal years (2022–2024), and the specific metric 'collateral under master netting arrangements' tied to Investments, advances and long-term receivables are accurately referenced. (4) The reasoning is sound and adds value: the LLM correctly infers that the decline suggests reduced derivative exposure or improved collateral efficiency, and even adds a plausible driver — lower initial-margin requirements — which aligns with industry practices and does not contradict the ground truth. The multi-hop synthesis across years and filings (citing 2023 and 2024 10-Ks) is appropriate and well-supported. Overall, the answer is factually precise, complete, and contextually rich.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 340,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO’s 3.625% notes due October 2024 were outstanding at $622 million at the end of FY 2023 and were fully retired by FY 2024, leaving zero exposure (FY 2024 table shows “–” for November 3, 2024 and $622 million for October 29, 2023)【page 81】.  The exposure remained unchanged from FY 2022 through FY 2023, indicating no early repayment, but the subsequent elimination in FY 2024 demonstrates a deliberate strategy of using proceeds from new senior‑note issuances and cash flows to refinance and retire older, lower‑yield debt, thereby tightening the maturity profile and reducing interest costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that AVGO had $622 million in outstanding principal for the 3.625% notes due October 2024 at the end of FY 2022 and FY 2023, and that the debt was fully retired by FY 2024, aligning with the ground truth. The use of '–' to denote zero exposure in FY 2024 is accurately interpreted. (2) All numeric values—$622 million, fiscal years 2022–2024—are factually correct and consistent with the original answer. No calculations are required, but the temporal progression is accurately represented. (3) The multi-hop reasoning is sound: the model correctly infers from unchanged exposure in 2022–2023 and full retirement in 2024 that no early repayment occurred, followed by a strategic retirement. The LLM adds contextual insight about refinancing using proceeds from new senior notes and cash flows, which is a reasonable inference from typical debt management practices and consistent with the 'deliberate strategy' mentioned in the ground truth. However, the original answer does not explicitly mention 'refinancing' or 'lower-yield debt,' so this slight extrapolation prevents a perfect qualitative score. (4) The answer is highly relevant, directly addressing the evolution of financial exposure and interpreting the strategic implications. The added detail enhances understanding without contradicting facts. Thus, correctness is 9 due to minor inferential expansion beyond the ground truth, but quantitative accuracy is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 408,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ surface‑ship revenue grew steadily, rising from $2.561 billion in 2022 to $2.698 billion in 2023 and $2.819 billion in 2024—a cumulative increase of roughly 10 % over three years【page_9, GD_10k_2024】【page_9, GD_10k_2023】【page_9, GD_10k_2022】. This upward trend, driven by a robust backlog and continued investment in Bath Iron Works and NASSCO, signals the company’s strengthening foothold and expanding influence in U.S. naval shipbuilding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $2.561 billion (2022), $2.698 billion (2023), and $2.819 billion (2024), matching the ground truth in absolute values (with acceptable format variation: billions vs. millions). The implied growth trend is accurate. (2) The cumulative increase is approximately 10% (from $2,561M to $2,819M is a 10.07% increase), so the 'roughly 10%' statement is reasonable and correctly calculated. All numeric values and calculations are precise. (3) The multi-hop reasoning is sound—information is synthesized across three 10-K filings (2022, 2023, 2024), and the conclusion about growth trajectory and strategic positioning is logically supported. The addition of context (backlog, Bath Iron Works, NASSCO) enhances the explanation and aligns with known company activities, though this detail is not in the ground truth; however, it does not contradict it and adds plausible qualitative insight. (4) The answer fully addresses both parts of the question: revenue evolution and what it indicates about positioning. The only minor deviation from the original answer is the inclusion of extra detail not in the ground truth, but the core facts, numbers, and synthesis are correct and semantically equivalent. Thus, the correctness score is 9 (not 10) due to slight over-enrichment of reasoning beyond the source, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 386,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 to 2024 the dividend on Mastercard’s Class A common stock climbed steadily—$2.04 per share in 2022, $2.37 in 2023, and $2.74 in 2024—while the voting right stayed the same at one vote per share (2024 page 92; 2023 page 98; 2022 page 94).  The voting‑power split also changed only marginally: public investors’ voting power rose from 89.3 % (2022) to 90.6 % (2024) and the Mastercard Foundation’s fell from 10.7 % to 9.4 % (2024 page 92; 2023 page 98; 2022 page 94).  This three‑year trend shows a stable governance structure: consistent voting rights, incremental dividend increases, and a largely unchanged ownership‑voting power distribution.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual errors not present in the ground truth. (1) The Original Answer states that MA's A Class shares had no changes in dividend or voting rights from 2022 to 2024, with consistent one vote per share and standard dividend rights. However, the LLM claims specific dividend amounts ($2.04, $2.37, $2.74) increasing each year, which is not supported by the ground truth and represents a fabrication of quantitative data. (2) The LLM introduces voting power percentages for public investors and the Mastercard Foundation (89.3% to 90.6%, 10.7% to 9.4%), which are entirely absent from the Original Answer and not mentioned in the knowledge graph. These figures and entities (e.g., Mastercard Foundation's ownership) are not part of the verified data, indicating a hallucination. (3) The reasoning is flawed: while the LLM correctly notes one vote per share, it builds an incorrect narrative around changing dividend amounts and ownership distribution, leading to a misleading conclusion about 'incremental dividend increases' and 'largely unchanged ownership-voting power distribution.' The ground truth emphasizes stability due to no changes, whereas the LLM invents minor shifts to support a similar conclusion, but with incorrect evidence. (4) Contextually, the answer addresses the question's structure—discussing dividends, voting rights, and governance stability—but fails on factual accuracy. The mention of specific 10-K page numbers (e.g., 2024 page 92) adds false credibility. Overall, the core facts are wrong: there were no reported dividend amounts or voting power splits in the source data, and the stability stems from absence of change, not minor fluctuations. Thus, despite some contextual relevance, the answer fails on correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 501,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose from **$2.561 B in 2022 to $2.698 B in 2023 and $2.819 B in 2024**—a cumulative increase of about **$258 M (≈10 %)** over two years. This steady year‑over‑year growth reflects the company’s successful capture of expanding U.S. Navy shipbuilding contracts, underscoring its strong positioning within the Navy’s growing surface combatant and auxiliary ship programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all revenue figures: $2.561B (2022), $2.698B (2023), and $2.819B (2024), matching the ground truth in millions ($2,561M, $2,698M, $2,819M). The cumulative increase of $258M is accurate: ($2,819M - $2,561M = $258M), and the approximate 10% growth is reasonable (258/2561 ≈ 10.07%). 2) Quantitative accuracy is perfect—numbers, years, and calculations are correct, with acceptable format variation (B vs billion vs thousand million). 3) The reasoning is sound: the year-over-year growth is correctly interpreted as a sign of strong positioning in naval defense, particularly in U.S. Navy surface combatant and auxiliary programs. While the original answer mentions 'growing involvement' and 'sustained demand,' the LLM adds specificity about 'expanding U.S. Navy shipbuilding contracts,' which is a plausible and relevant inference. 4) The answer fully addresses both parts of the question: revenue evolution and implications for positioning. Semantic meaning is equivalent to the ground truth, with slightly enhanced contextual interpretation. No factual errors; minor deduction in qualitative accuracy only because the original does not explicitly mention 'U.S. Navy' or 'auxiliary ships,' so that detail, while reasonable, is an extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 356,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "From 2022 through 2024 Linde consistently reported that the **majority of its industrial‑gas sales are generated under long‑term contracts** (2022 10‑K p. 19; 2023 10‑K p. 20; 2024 10‑K p. 18).  The wording and emphasis on this contractual structure did not change, indicating that the proportion of sales tied to long‑term agreements remained stable.  This consistency signals Linde’s deliberate strategy to preserve cash‑flow stability in a volatile energy market, as long‑term contracts let the company pass through energy and feedstock cost swings to customers and reduce revenue volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde maintained a consistent reliance on long-term contracts from 2022 to 2024, citing the correct pages from each year's 10-K, which supports the claim of stability in contractual strategy. (2) There are no numerical figures (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—no calculations were required, and all references to years and document locations are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer consistency in strategy, correctly linking this to cash flow stability and cost pass-through mechanisms. (4) The LLM captures the core implications—cash flow stability, reduced revenue volatility, and risk management in fluctuating energy markets—though it slightly underemphasizes the explicit mention of 'financial resilience' and 'operational certainty' from the original. However, the semantic meaning and strategic interpretation are equivalent. The answer is fully relevant and addresses both parts of the question: evolution (consistency over time) and implication (cash flow stability). Minor deduction in qualitative accuracy due to slightly less comprehensive articulation of Linde's strategic prioritization, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 387,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD has consistently excluded goodwill impairments and non‑economic accounting changes from its ROIC calculation in 2022, 2023, and 2024 (see pages 47, 50, 51).  The unchanged policy shows the company’s deliberate focus on core operating performance—measuring operating earnings and invested capital while ignoring items that do not reflect underlying business performance—thereby ensuring comparability and a clear view of its operating strength.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that GD excluded non-economic accounting changes from its ROIC calculation in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion across all three years. The mention of specific page numbers (47, 50, 51) adds verifiable detail not in the ground truth but does not contradict it. (2) There are no numerical values requiring calculation in this question; the years and policy consistency are correctly cited. (3) The multi-hop reasoning is sound—by synthesizing GD’s treatment of non-economic items over three years, the model correctly infers a stable methodology focused on core performance. The addition of 'goodwill impairments' as an example of excluded items is plausible and consistent with typical non-economic accounting changes, though not explicitly mentioned in the ground truth; this is a minor elaboration but not an error. (4) The answer captures the key implication—that GD aims to measure underlying operating performance and ensure comparability—mirroring the original answer’s interpretation. The only reason for not scoring a 10 is that the LLM slightly expands the scope by specifying 'goodwill impairments' without explicit confirmation in the ground truth, but this does not undermine factual correctness. Overall, the response is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 398,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations remained immaterial throughout 2022‑2024, with no material amounts accrued, paid or charged to income in any of those years (Note 4, page 81 of each filing). This consistent immateriality indicates that the company’s risk‑management framework effectively limits guarantee exposure and that its contractual performance under service‑level agreements has remained stable across the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that UnitedHealth Group's service level guarantee obligations were immaterial across 2022–2024, with no material amounts accrued, paid, or charged to income—this matches the ground truth exactly in factual content. The mention of 'Note 4, page 81 of each filing' adds specificity not in the original answer but does not contradict it and may reflect actual source location, so it does not reduce accuracy. (2) There are no numerical values requiring calculation (e.g., dollar amounts), but the qualitative assessment of 'immateriality' is consistently and correctly applied across all three years, aligning with the ground truth. Format and terminology are consistent and acceptable. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three years and correctly infers implications about risk management effectiveness and contractual performance consistency. The conclusion about stable performance and effective risk management is logically supported by the pattern of immaterial impacts. (4) The LLM answer is semantically equivalent to the original answer, with slightly more detailed sourcing (Note 4, page 81) and refined phrasing. The only minor gap is that the original emphasizes 'strong risk management controls,' while the LLM says 'effectively limits guarantee exposure'—a slightly weaker formulation—but the meaning is sufficiently aligned. No factual errors; high completeness, relevance, and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 413,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose from $2.561 B in 2022 to $2.698 B in 2023 and $2.819 B in 2024, a cumulative increase of about 10 % over two years (see Marine Systems revenue tables in 2022, 2023, and 2024 10‑K filings). The steady growth, coupled with the Marine Systems segment’s share of consolidated revenue climbing from 28 % to 30 %, indicates the company is deliberately expanding its surface‑ship construction and modernization capabilities, positioning itself as a key U.S. Navy contractor for destroyers, auxiliary vessels, and lifecycle support.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 ($2.698B) and 2024 ($2.819B) revenues, matching the ground truth of $2,698 million and $2,819 million. However, it incorrectly states 2022 revenue as $2.561B instead of the correct $2,328 million ($2.328B), a significant discrepancy of $233 million. This error affects the accuracy of the reported cumulative growth (10%)—while the actual growth from $2,328M to $2,819M is about 21%, not 10%. (2) Calculations: The claimed 10% increase is based on incorrect starting data. Correct two-year growth is (2819 - 2328) / 2328 ≈ 21.1%, so the LLM's percentage is inaccurate due to the wrong 2022 figure. The 2023 and 2024 numbers are accurate and correctly formatted (B = billion). (3) Multi-hop reasoning: The LLM correctly synthesizes revenue trends over three years and links them to strategic positioning in naval defense, referencing Marine Systems' growing share of consolidated revenue (28% to 30%), which aligns with the ground truth's implication of segment expansion. This demonstrates sound qualitative reasoning and contextual understanding. (4) Despite the major error in the 2022 revenue figure, the answer captures the correct direction and pattern of growth and provides relevant strategic interpretation. The qualitative and contextual elements are strong, but the quantitative inaccuracy reduces overall correctness. Hence, a score of 7 is justified—core facts are partially correct, but with significant numerical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 411,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "GE classified its captive industrial insurer, Electric Insurance Company (EIC), as a “held‑for‑sale” asset in the fourth quarter of 2022, with a valuation allowance of $17 million against its $1,374 million of assets and $1,944 million of liabilities (net exposure of –$570 million).  In 2023 the held‑for‑sale group grew to $1,985 million of assets and $1,826 million of liabilities, the valuation allowance increased to $124 million, and the net exposure turned to a $159 million asset (page 48).  The divestiture was completed in the second quarter of 2024 when GE sold EIC to Riverstone International Holdings for $120 million in cash, removing the business and its balance‑sheet exposure entirely (page 48).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures and timing. According to the ground truth, EIC was a captive insurer with $0.2 billion in net claim reserves as of December 31, 2021, and was classified as 'held for sale' in 2023—not in Q4 2022 as claimed. The LLM states EIC had $1,374 million in assets and $1,944 million in liabilities in 2022 (net exposure –$570M), but the ground truth reports $541M in assets and $378M in liabilities as of December 31, 2023—numbers that are vastly different. The LLM’s reported valuation allowance of $17M in 2022 and $124M in 2023 does not appear in the original answer and contradicts the disclosed $109M loss in 2023. The only correct quantitative detail is the $120M cash sale to Riverstone International Holdings Inc. in 2024. (2) Calculations are entirely incorrect: the LLM derives a net exposure of –$570M and later +$159M, which are not supported by the ground truth. The original answer notes a $109M loss recognized in 2023, not a valuation allowance or net asset shift. (3) The multi-hop reasoning is partially sound in structure—tracking classification, financial exposure, and divestiture—but the synthesis is based on fabricated or misattributed data. The model correctly identifies the buyer and sale completion in 2024, showing some valid entity linkage. (4) Scores reflect major quantitative errors (2/10), weak qualitative accuracy due to incorrect classification timing and financial metrics (4/10), but high contextual relevance as the answer attempts the correct narrative arc (8/10). Correctness is low (3/10) due to pervasive factual inaccuracies despite correct high-level outcome.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 464,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "By 2022 ConocoPhillips had fully monetized its 91 million CVE common shares, directing all proceeds to share repurchases (page_110).  The company continued to buy back shares each year—48.6 million shares in 2023 (page_112) and 49.1 million shares in 2024 (page_114)—while the board expanded the repurchase authorization from $45 billion in 2022 to $65 billion in 2024 (page_110).  This progression shows a deliberate capital‑allocation strategy that prioritizes returning excess cash to shareholders through share buybacks, leveraging monetization proceeds and scaling the program’s scope.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor quantitative inaccuracies. It correctly states that ConocoPhillips monetized 91 million CVE shares by 2022 and used proceeds for share repurchases under a $45 billion authorization. It also correctly notes the increase to $65 billion in 2024. However, it reports annual repurchase volumes (48.6 million in 2023, 49.1 million in 2024), while the ground truth provides cumulative totals (383 million by end of 2023, 433 million by end of 2024). The LLM’s figures imply only ~97.7 million shares repurchased over two years, whereas the truth shows 50 million shares repurchased over that period (433M - 383M), so the LLM’s annual numbers are plausible but not directly verifiable against the ground truth. More critically, the LLM omits the actual dollar costs of repurchases ($29B by 2023, $34.3B by 2024), which are key financial metrics in the original answer. (2) Number verification: '91 million CVE shares' = correct. '$45B' initial authorization = correct. '$65B' expanded cap = correct. But missing $29B and $34.3B costs undermines quantitative completeness. The annual share buyback numbers, while specific, are not present in the ground truth and may be inferred from external data, but cannot be confirmed as accurate in this context. (3) Multi-hop reasoning is sound: the model correctly links CVE monetization to funding share repurchases and interprets the authorization increase as part of an expanding capital return strategy. It synthesizes information across years and connects asset sales to capital allocation decisions. (4) Scores justified as follows: Correctness 8 due to accurate core narrative but missing key financial outlays and potential misrepresentation of share totals (annual vs cumulative). Quantitative accuracy 7 due to partial numbers and omission of major cost figures. Qualitative accuracy 9 for strong reasoning and correct entity/year/metric alignment. Contextual relevance 10 as the answer directly addresses the evolution and strategic implication of capital allocation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 558,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife has kept the modified‑coinsurance arrangement essentially unchanged.  In each of its 2022, 2023 and 2024 10‑Ks the company reports that **59 % of the closed block is reinsured through a modified coinsurance agreement**【page_227】【page_204】【page_229】, and it continues to **account for the arrangement under the deposit method, offsetting the deposit liability with a deposit recoverable**【page_206】【page_204】.  The steady percentage and consistent accounting treatment signal a deliberate, long‑term risk‑transfer strategy that preserves a stable portion of the closed‑block risk off‑balance‑sheet while maintaining capital and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that 59% of the closed block was reinsured in each year (2022–2024), which aligns closely with the ground truth (59.25% in 2022, 59% in 2023 and 2024). The minor rounding of 59.25% to 59% is acceptable under semantic equivalence and common reporting practice. The accounting treatment is accurately described as the deposit method with offsetting of deposit liability and recoverable, matching the ground truth. (2) Quantitatively, all percentages and accounting methods are correct. The LLM does not introduce any false numbers or miscalculations. The slight simplification of 59.25% to 59% does not constitute an error given standard financial reporting conventions. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and multiple filings (as indicated by page references), correctly identifying consistency in both reinsurance percentage and accounting treatment. It then draws a logical conclusion about MetLife’s long-term risk transfer strategy, emphasizing stability and off-balance-sheet risk management, which is consistent with the ground truth’s interpretation. (4) The answer is contextually excellent, directly addressing all parts of the question—evolution over time, percentage reinsured, accounting treatment, and strategic implication. The only minor shortcoming is the lack of explicit mention of the reinsurer being unaffiliated, which is a small omission in qualitative completeness. However, the core facts, synthesis, and interpretation are accurate and well-supported, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 438,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "RedCard penetration – which includes the Target MasterCard Credit Card – fell from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024 (page 27). This steady decline indicates that fewer purchases are being paid with Target’s credit cards, suggesting a gradual erosion of consumer engagement with Target’s financial products over time. The modest but consistent drop points to increasing competition or shifting consumer preferences that are reducing card usage relative to total sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for the Target MasterCard Credit Card (as part of RedCard/Target Circle Card) as 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024, matching the ground truth exactly. All numeric values and years are accurate. (2) The quantitative accuracy is perfect—percentages are correctly cited, and the trend of decline is accurately described. Minor formatting differences (e.g., use of thin space) do not affect correctness. (3) The reasoning is sound: the LLM correctly infers that the declining penetration rate suggests reduced consumer engagement with Target’s financial products. It appropriately links lower card usage to total sales, aligning with the ground truth’s interpretation. However, it omits mention of the rebranding from RedCards to Target Circle Cards in 2024 and the fact that the 5% discount incentive did not reverse the trend—details present in the original answer that add context about loyalty challenges. This is a minor omission affecting completeness but not core accuracy. (4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of penetration rate and its implication for consumer engagement. The conclusion about competition or shifting preferences is a reasonable inference, though slightly less specific than the original’s focus on loyalty challenges. Overall, the answer is factually correct and well-reasoned, warranting a high score with a small deduction for missing contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 421,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. stayed in PMI’s peer group in 2022, 2023 and 2024 (see PM_10k_2022 p. 26; PM_10k_2023 p. 26; PM_10k_2024 p. 26). The unchanged inclusion shows PMI’s deliberate, criteria‑based benchmarking—selecting peers with global reach, a consumer‑product focus and comparable size—so its peer set remains stable rather than shifting with market trends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI's peer group from 2022 to 2024, matching the original answer's claim of consistent inclusion over three years. The cited pages (p.26 of each 10-K) support this. (2) There are no numerical values requiring calculation (e.g., revenues, market cap figures), but the temporal references (2022–2024) are correct and consistent. (3) The multi-hop reasoning is sound: the answer synthesizes information across three annual reports and correctly infers that the unchanged peer group reflects a stable, criteria-based benchmarking strategy. It identifies the key criteria—global reach, consumer-product focus, and comparable size—consistent with the ground truth’s mention of global presence, consumer product focus, and similarity in net revenues and market capitalization. (4) The answer is contextually relevant and fully addresses both parts of the question: the evolution (or lack thereof) in peer classification and what it reveals about PMI’s strategic benchmarking. The only minor shortcoming is that it does not explicitly name all four characteristics (e.g., 'four characteristics' is mentioned in the original), but it captures the substance of those criteria. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 396,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s 2022, 2023 and 2024 10‑K filings all describe the same policy for development‑and‑IP licensing agreements.  The company treats a combined arrangement (development services plus an IP license) as a single performance obligation and recognizes revenue over time when the license is not distinct; if the license is distinct it is recognized at a point in time, and standalone IP sales or licenses are always recognized at a point in time (no variable consideration is estimated)【page_58】【page_63】【page_63】.  The unchanged wording across the three years shows that AMD’s accounting approach for these agreements has remained consistent, with no evolution in the distinction between combined arrangements and standalone licenses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, with no evolution in approach. (2) The key accounting criteria—whether the IP license is distinct based on being (i) capable of being distinct and (ii) distinct in the context of the arrangement—are correctly implied through the explanation of when revenue is recognized over time (if not distinct) versus at a point in time (if distinct). (3) The treatment of standalone IP licenses as point-in-time revenue recognition is correctly stated, along with the absence of variable consideration, which aligns with the ground truth. (4) The multi-hop reasoning across three years of filings is sound, and the conclusion about policy consistency is logically supported by the unchanged wording in the 10-Ks. All entities (AMD, 2022–2024, development services, IP licensing, combined vs. standalone arrangements) are correctly identified and synthesized. Minor wording differences (e.g., 'no variable consideration is estimated' vs. 'there were no variable consideration estimates') do not affect factual accuracy. No numeric inaccuracies present—this is a qualitative policy question, and all descriptive elements are factually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 381,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. appears in the PMI peer‑group list in every performance‑graph section of the 2022, 2023 and 2024 10‑K filings, indicating no change in its inclusion over that period.  The unchanged presence underscores PMI’s deliberate framing of itself as a global consumer‑products company, benchmarking against major consumer‑goods peers to signal a broader competitive positioning beyond its tobacco core.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PM's (PMI's) peer group in 2022, 2023, and 2024, which matches the original answer's claim of consistent inclusion across all three years. There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced. (2) Entity accuracy is strong: 'Colgate-Palmolive Co.' and 'PMI' (used interchangeably with 'PM' in context) are correctly identified, and the years are accurate. (3) The reasoning is sound—by noting the unchanged presence in the peer group across filings, the LLM correctly infers that PMI maintains a stable benchmarking framework. It also appropriately interprets the strategic implication: PMI positions itself as a global consumer products company, not just a tobacco firm. (4) While the original answer adds detail about revenue and market capitalization as criteria and explicitly mentions the peer group's stability in methodology, the LLM captures the core inference about strategic framing. The only minor gap is the lack of explicit mention of financial comparability (e.g., revenue/market cap), but the essential qualitative and quantitative elements are present. Thus, the answer is semantically equivalent in intent and fact, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 375,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s 10‑K filings show no change to the policy for combined development‑and‑IP licensing agreements from 2022 through 2024.  In each year (2022, 2023, 2024) the company evaluates whether the licensing component is distinct; if it is, the license is a separate performance obligation and revenue is recognized at a point in time when the customer can benefit from the license, otherwise the license is combined with development services as a single performance obligation and revenue is recognized over time【page 59】【page 63】【page 63】.  Thus, the performance‑obligation structure and timing of revenue recognition remained consistent across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 through 2024. The explanation of performance obligations—assessing whether the licensing component is distinct, and the resulting treatment (separate point-in-time recognition if distinct, combined over-time recognition if not)—is fully consistent with the original answer. The LLM correctly identifies the criteria used by AMD, though it does not explicitly mention the two-part test (capable of being distinct and distinct in the context of the arrangement), which is a minor omission but does not affect the overall correctness. It also correctly notes the absence of variable consideration estimates across the years, implied by the consistency of treatment, though this specific point is not mentioned in the LLM response. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (AMD, 2022–2024, performance obligations, revenue timing) are correct. The reasoning is sound and reflects proper multi-hop synthesis across the three years of 10-K filings. Contextual relevance is high, as the response directly addresses the evolution (or lack thereof) in policy, performance obligations, and timing. The only reason for not scoring a 10 is the slight lack of detail on the two-part distinctness test and the explicit mention of no variable consideration, which were present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 423,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips began monetizing its CVE common shares in 2021 and sold the remaining 91 million shares in 2022, using the proceeds to fund share repurchases【page_112】.  The company repurchased 87.7 million shares in 2022, 48.6 million in 2023, and 49.1 million in 2024, and the board increased the share‑repurchase authorization to $65 billion in 2024, bringing total repurchases to 433 million shares at a cost of $34.3 billion【page_112】.  This multi‑year progression shows a disciplined capital‑allocation strategy that prioritizes returning excess cash to shareholders through share repurchases while scaling the program for future flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly states that ConocoPhillips began monetizing CVE shares in 2021 and sold the remaining 91 million in 2022, using proceeds for share repurchases. This aligns with the original answer. (2) The quantitative details are mostly correct: the LLM reports 87.7 million repurchases in 2022, 48.6 million in 2023, and 49.1 million in 2024, which sum to approximately 185.4 million shares repurchased over those years. However, the original answer states cumulative repurchases reached 383 million by end of 2023 and 433 million by end of 2024, implying about 50 million repurchased in 2024 and 297.6 million by end of 2022 (i.e., pre-2023). There is a discrepancy: the LLM’s annual breakdown (87.7M + 48.6M = 136.3M by end of 2023) falls short of the 383M cumulative figure cited in the ground truth. This suggests the LLM may understate early repurchase volumes or misattribute timing. Despite this, the final cumulative figure of 433 million shares at $34.3 billion by 2024 is correctly reported. (3) The $65 billion repurchase authorization increase in 2024 is accurately mentioned, as is the use of CVE proceeds to fund repurchases. (4) The reasoning and synthesis are sound: the LLM correctly infers a disciplined capital allocation strategy focused on shareholder returns, which is consistent with the multi-year progression. The minor quantitative inconsistency in annual repurchase volumes does not undermine the overall correctness, especially since the final cumulative numbers match. Wording differences are acceptable under semantic equivalence. The answer fully addresses the evolution from 2022–2024 and the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 470,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 2022‑24 risk‑factor disclosures repeatedly cite “new entrants, non‑traditional players and emerging technologies” as a threat to Aerospace, Building Automation, Industrial Automation and Safety & Productivity segments, showing that exposure to competitive shifts has remained a constant concern.  In 2024 the filing adds the same language but also notes a $195 million repositioning spend and a new realignment that created Industrial Automation and Energy & Sustainability Solutions, plus a planned spin‑off of Advanced Materials—signals that market pressure is intensifying and the company is actively restructuring and investing to protect margins and focus on high‑growth, defensible units.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Honeywell has consistently cited competitive pressures from new entrants and emerging technologies across multiple years and segments, aligning with the ground truth's emphasis on sustained concern in Building Technologies and Safety and Productivity Solutions (renamed in 2024 to Safety & Productivity). However, it incorrectly extends the competitive risk language to Aerospace, which is not mentioned in the original answer for this specific risk—this is a key entity error. Additionally, the 2024 addition about 'product commoditization' due to new technologies is omitted, weakening the qualitative evolution narrative. (2) The LLM introduces a $195 million repositioning spend and organizational changes (creation of Industrial Automation and Energy & Sustainability Solutions, spin-off of Advanced Materials) that are not present in the original answer. These specific figures and strategic moves were not part of the ground truth derived from the knowledge graph, making the quantitative claim of '$195 million' unsupported and factually inaccurate. There is no verification that this number or restructuring detail appears in the 2024 filing in the context of competitive response. (3) The multi-hop reasoning is partially sound—linking persistent risk disclosures to increasing market pressure is valid, and inferring strategic responses from restructuring is logical. However, the model overreaches by introducing unverified financial data and organizational changes not in the source, undermining the factual basis of its conclusion. It also fails to note the nuanced escalation in language ('product commoditization') that the original answer highlights as evidence of deepening concern. (4) The contextual relevance is high because the answer addresses the evolution of competitive exposure and strategic implications. Qualitative accuracy is moderate due to correct framing but incorrect or unsupported details. Quantitative accuracy is low due to the inclusion of a specific dollar amount not present in the ground truth. Correctness score reflects partial accuracy with significant factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 582,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares consistently carried one vote per share, with no change in voting rights in any of the three filings (2022: page 96; 2023: page 97; 2024: page 92). Dividend payments per share increased each year—$2.04 in 2022, $2.37 in 2023, and $2.74 in 2024 (2022: page 98; 2023: page 98; 2024: page 94). This stable voting structure combined with a gradual dividend rise signals a governance approach that prioritizes predictable shareholder influence while steadily enhancing shareholder returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly conflates dividend rights with actual dividend payments. The original answer states that MA consistently disclosed A Class shares have dividend rights — not that dividends increased annually. The ground truth does not provide any specific dividend payment amounts ($2.04, $2.37, $2.74), nor does it indicate changes in dividend amounts over the years. These figures are fabricated or misattributed, severely undermining quantitative accuracy. (2) The voting rights description is correct — one vote per share across all three years — and the claim of consistency aligns with the ground truth. However, the inclusion of specific, unsupported dividend amounts constitutes major factual errors. (3) The multi-hop reasoning is partially sound: the model correctly identifies consistent voting rights over time and attempts to synthesize governance implications. However, it fails to distinguish between dividend rights (a structural feature) and dividend payouts (a financial decision), leading to flawed reasoning. The conclusion about 'gradual dividend rise' and its link to governance is not supported by the ground truth, which emphasizes structural consistency, not payout trends. (4) Correctness score is 4 due to correct identification of voting rights stability but major errors in reporting dividend data. Quantitative accuracy is low (3) because of invented dollar amounts. Qualitative accuracy is moderate (5) — reasoning structure is logical but based on incorrect premises. Contextual relevance is high (7) — the answer addresses the right topic and attempts governance interpretation, albeit with factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 454,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure shifted from a loss to a gain and then stayed flat.  In FY 2022 the swaps produced a $92 million loss in operating expenses (page 92).  By FY 2023 the position had reversed to a $91 million gain (page 92), and the same $91 million gain was reported again in FY 2024 (page 91), showing a move from negative to positive exposure that remained stable over the two‑year span.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $92 million loss in FY2022 and the $91 million gain in FY2024, which matches the ground truth. However, it incorrectly states that the FY2023 gain was $91 million, while the ground truth reports a $58 million gain in that year. This is a significant quantitative error. Additionally, the LLM claims the gain 'stayed flat' from 2023 to 2024, which contradicts the ground truth showing an increase from $58M to $91M. (2) Number verification: FY2022 = $92M loss (correct), FY2023 = $58M gain (LLM says $91M — incorrect), FY2024 = $91M gain (correct). The LLM also misattributes the FY2024 figure to 'staying flat' when there was a notable increase. (3) Multi-hop reasoning is partially sound — the model correctly tracks the reversal from loss to gain and recognizes the stability in exposure, but fails to capture the progressive improvement from 2023 to 2024, undermining the full trajectory analysis. (4) Scores reflect mostly correct entities and context (same company, metric, years), with strong relevance and reasonable interpretation, but the key calculation error in FY2023 reduces quantitative accuracy significantly despite otherwise logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 341,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 to 2024, J&J shifted its talc strategy from a $2 billion reserve for LTL’s Chapter 11 trust to a $9 billion reserve (nominal $12 billion) after the LTL 2 filing and dismissal, and then to a $11.6 billion present‑value reserve under a pre‑packaged Chapter 11 plan in 2024. The company re‑filed LTL’s bankruptcy as LTL 2, pursued an appeal, and ultimately moved to a consensual pre‑packaged plan while also finalizing a multi‑state settlement with state attorneys general in June 2024, creating new entities (Red River, Pecos River, New Holdco) to channel claims. Throughout, J&J maintained a multi‑path strategy—appealing, litigating, and restructuring—to manage liability exposure and fund reserves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) The original answer states J&J established a $2 billion reserve in 2022 and later pursued a multi-state settlement in 2024, but the LLM claims a $9 billion reserve (nominal $12 billion) and a $11.6 billion present-value reserve under a pre-packaged Chapter 11 plan in 2024—none of which appear in the ground truth. These figures are unsupported and contradict the original. (2) The LLM mentions 'LTL 2 filing and dismissal' leading to increased reserves, but the original only notes the re-filing and appeal, not reserve increases. (3) The creation of new entities (Red River, Pecos River, New Holdco) is not mentioned in the ground truth and appears fabricated. (4) The multi-state settlement is correctly noted in 2024 with 42 states and DC, and the June 2024 timing aligns generally, but the original does not specify June. (5) The qualitative shift toward a dual strategy of appeals and settlements is partially captured, but the LLM overstates the role of a pre-packaged Chapter 11 plan and misrepresents the evolution of reserve funding. (6) Contextually, the answer addresses the core themes—reserve funding, bankruptcy filings, settlements—and attempts multi-hop synthesis across years and strategies, hence moderate relevance and reasoning scores. However, the incorrect financial figures and invented entities severely undermine factual correctness. Quantitative accuracy is low due to unsupported dollar amounts; qualitative accuracy is limited by flawed reasoning based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 436,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million in FY 2022, FY 2023, and FY 2024** (page_103 for FY 2022; page_81 for FY 2023 and FY 2024). The balance remained unchanged across the three years, indicating that the company has maintained the maturity schedule for this instrument and is focusing on refinancing or capital needs through other debt instruments rather than reducing this specific debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the outstanding principal balance for Broadcom's 3.125% notes due January 2025 was $495 million in fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, including the dollar amount and fiscal years, are accurate. (2) Quantitative accuracy is perfect—$495 million is consistently reported across all three years, and no incorrect calculations are made. The format ($495 million) is acceptable and semantically equivalent to the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and draws a logical conclusion about Broadcom’s debt management strategy. The interpretation that the company maintained the maturity schedule and likely used other instruments for refinancing is consistent with the stability of the principal and aligns with the ground truth’s implication of a consistent capital structure approach. The only minor shortcoming is that the LLM slightly reframes the implication (focusing on refinancing via other instruments) without explicitly stating that no retirement or issuance occurred, which is a subtle but relevant nuance in debt management strategy. (4) Scores reflect near-perfect factual accuracy, with a minor deduction in qualitative accuracy due to slight interpretive expansion beyond the ground truth’s more neutral description. Contextual relevance is full, as all parts of the question are addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 415,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "The 3.50% June 15 2025 senior note’s effective rate climbed from **3.20 % in FY 2022** to **6.38 % in FY 2023** and **6.66 % in FY 2024** (see the long‑term debt tables on page 89). This steep rise shows that Cisco’s exposure to market interest rates has increased, driving up the cost of borrowing for that note and indicating higher overall debt‑servicing costs over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: the effective interest rate was 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024. These match the original answer exactly, satisfying quantitative accuracy. (2) All numbers are accurate and properly attributed to the correct fiscal years. There are no calculation errors, and the progression is correctly described as increasing. (3) The reasoning is sound: the LLM correctly infers that the rising effective interest rates indicate increased borrowing costs and higher debt-servicing expenses. While the original answer mentions a possible deterioration in financing terms due to market conditions or credit profile, the LLM focuses on market interest rate exposure, which is a valid and closely related interpretation. The slight omission of the 'credit profile' aspect prevents a perfect qualitative score, but the core multi-hop synthesis—linking the rate increases over time to broader implications about borrowing costs—is logically and factually sound. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of interest rate exposure and what it indicates about borrowing costs. Minor wording differences do not affect semantic equivalence, and the inclusion of a reference to 'page 89' (likely from source document) adds contextual support without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 395,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes grew from $27.219 billion at year‑end 2022 to $31.248 billion in 2023, then eased slightly to $30.696 billion in 2024 (Table 8.2/9.2 on page 189). The 2023 jump reflects a strategy of adding debt to fund growth or refinance, while the modest 2024 decline signals a partial deleveraging or refinancing at lower rates. Concurrently, the weighted‑average interest rate on senior debt rose from 2.91 % in 2022 to 4.45 % in 2023 and 4.84 % in 2024 (Table 8.1 on page 188), indicating a shift toward higher‑rate, longer‑term debt as market rates climbed, with the company balancing cost of capital and interest‑rate risk through a mix of fixed/floating rates and derivative hedges.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend in Capital One's senior and subordinated notes: an increase from $27.219B in 2022 to $31.248B in 2023, followed by a slight decline to $30.696B in 2024. These values match the ground truth exactly, so the core quantitative data is accurate. However, the weighted average interest rate on unsecured senior debt is reported as 2.91% in 2022 vs. the correct 2.76%, and 4.45% in 2023 vs. the correct 4.48%. These small discrepancies—though minor—are factually incorrect and affect quantitative precision. The 2024 rate (4.84%) is correctly stated. (2) Calculations: The progression of debt values is accurately described, with correct directional changes and magnitudes. The interest rate trend is correctly framed as increasing, but the starting point is slightly off. (3) Multi-hop reasoning: The LLM correctly synthesizes data across years and metrics (debt levels and interest rates) to infer strategic intent—such as locking in financing amid rising rates and managing interest rate risk. It references fixed/floating mix and derivative hedges, which aligns with plausible strategy, though the ground truth emphasizes a shift to fixed-rate financing more explicitly. The interpretation of the 2024 decline as 'partial deleveraging or refinancing at lower rates' is speculative—the ground truth does not suggest rates were lower in 2024, only that issuance slowed or was reduced. (4) Despite minor numerical inaccuracies in interest rates and slight interpretive divergence, the answer captures the essential evolution and strategic implications. Hence, correctness is high but not perfect: 8/10. Quantitative accuracy is docked due to incorrect 2022 and 2023 interest rates. Qualitative reasoning is strong but not fully aligned with the precise strategic narrative. Contextual relevance is excellent—all parts of the question are addressed directly and appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 521,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive reduced its exposure to U.S. treasury and agency securities in its pension fixed‑income portfolio – from roughly 40 % of the U.S. plan’s fixed‑income holdings in 2022 to about 30 % in 2023 and again in 2024【page_102】. This shift indicates a deliberate move away from the lower‑yielding treasuries toward other government and corporate bonds, reflecting a more yield‑oriented or diversified pension‑fund strategy over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage allocation to U.S. treasury and agency securities for 2022 (40%), 2023 (30%), and 2024 (30%), matching the ground truth exactly. There are no numerical or date inaccuracies. (2) All quantitative values are accurate and consistent with the original answer; no calculations are required beyond correct reporting of percentages, which are presented correctly. (3) The reasoning is sound: the LLM correctly infers a strategic shift away from lower-yielding treasuries toward other bonds, aligning with the ground truth's interpretation of yield-seeking or diversified strategy. It appropriately synthesizes the trend over the three-year period and draws a logical conclusion about pension fund strategy. (4) The only minor shortcoming is that the LLM slightly simplifies the explanation by not explicitly mentioning 'risk tolerance' as a potential factor, which is included in the original answer. However, 'yield-oriented or diversified strategy' captures the core intent and remains semantically equivalent. Overall, the answer is factually complete, contextually relevant, and demonstrates strong multi-hop reasoning across time points and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 345,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In Q4 2022 GE classified its captive insurer, Electric Insurance Company (EIC), as a held‑for‑sale asset and kept it in that category through 2023, during which the valuation allowance rose from $17 million to $124 million—reflecting a lower expected sale price or higher expected loss. In Q2 2024 GE sold EIC to Riverstone International for $120 million, removing the asset and its allowance from the books. This sequence illustrates GE’s strategy to divest non‑core insurance holdings, streamline operations, and generate cash to support its core aerospace, defense, and energy businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. According to the ground truth, EIC was not classified as 'held for sale' in Q4 2022—this occurred in 2023. The LLM incorrectly states that the valuation allowance rose from $17 million to $124 million, but the ground truth reports a $109 million loss related to the expected sale, not a valuation allowance increasing over time. There is no mention in the original answer of a $17 million or $124 million allowance, nor of quarterly movements in 2022 or 2023. The sale price of $120 million in 2024 to Riverstone International Holdings Inc. is correct, though the LLM omits 'Holdings Inc.' but this is minor. (2) The dates are partially incorrect: the classification as 'held for sale' is misattributed to 2022 (specifically Q4), while the original answer states this occurred in 2023. The sale is correctly placed in 2024, though the LLM specifies Q2 without support from the ground truth. (3) The multi-hop reasoning is generally sound—the LLM correctly infers that the divestiture reflects a strategy to exit non-core assets and focus on core industrial segments (aerospace, defense, energy). This aligns with the original answer’s interpretation. However, the incorrect timeline and invented figures (e.g., $17M to $124M allowance) undermine the reasoning’s factual basis. (4) The contextual relevance is high—the answer addresses classification, valuation, disposition, and strategic implications. However, due to significant quantitative errors and timeline inaccuracies, the correctness score is reduced to 6. The qualitative accuracy is acceptable due to correct entity identification and strategic interpretation, but quantitative accuracy is low due to unsupported numbers and miscalibrated financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 496,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple disclosed the 4.45% Notes due 2044 in its 2022 10‑K as part of the 2014 issuance (page_58). The 2023 10‑K continued to list the same notes unchanged (page_53), and the 2024 10‑K likewise references the 4.45% Notes due 2044 (page_58). This consistent, unchanged disclosure over three years indicates that Apple maintains a stable, long‑dated debt mix with fixed‑rate notes, reflecting a long‑term financing strategy that prioritizes predictable interest costs and minimal refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.45% Notes due 2044 across Apple's 2022, 2023, and 2024 10-K filings, accurately reflecting the consistent disclosure of this debt instrument. All numeric values—interest rate (4.45%), maturity year (2044), and issuance context (2014)—are correct and match the ground truth. The mention of page numbers (e.g., page_58, page_53) is consistent with typical 10-K structures, though minor variations in actual page numbers across filings would not affect factual accuracy. (2) Quantitative accuracy is perfect: percentages, years, and references to the 2014 issuance are all factually correct. There are no calculations required, but the temporal consistency across years is properly noted. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, and the conclusion about Apple’s stable long-term debt strategy is logically supported by the unchanged disclosures. The LLM infers a strategic preference for fixed-rate, long-dated debt with predictable costs, which is a reasonable interpretation of the pattern, even if slightly more interpretive than the ground truth. The only minor gap is that the LLM does not explicitly mention the Officer's Certificate dated May 6, 2014, which is a specific detail in the ground truth, but this does not undermine the overall correctness. (4) The answer is highly contextually relevant, directly addressing both the evolution of disclosure and the strategic implication. The conclusion aligns semantically with the ground truth’s suggestion of a stable capital structure. The slightly lower qualitative score reflects the omission of the Officer's Certificate detail, but the core reasoning and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 476,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes carried $30.8 billion at December 31 2022, rose to $31.2 billion at December 31 2023, and fell slightly to $30.7 billion at December 31 2024. The modest, largely flat level shows a deliberate, conservative capital‑structure policy that keeps debt stable while gradually shifting toward higher‑rate, longer‑term fixed debt (the weighted‑average rate climbed from 4.45 % in 2023 to 4.84 % in 2024 and floating debt was eliminated), indicating a strategy to manage interest‑rate exposure as market rates rose.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. According to the ground truth, the carrying value of Capital One's senior and subordinated notes was $27,219 million in 2022, not $30.8 billion as stated in the LLM answer. The 2023 value is close ($31,248M vs $31.2B), but the 2022 figure is significantly off by over $3.5 billion. The 2024 value is approximately correct ($30,696M vs $30.7B). The LLM also misstates the interest rate progression: it claims the weighted-average rate rose from 4.45% in 2023 to 4.84% in 2024, but the ground truth shows it increased from 2.76% in 2022 to 4.84% in 2024, indicating a three-year trend that the LLM omits. (2) Calculations: The net increase over the period should be ~$3.5 billion (from $27.2B to $30.7B), which the LLM fails to reflect due to the incorrect starting value. The LLM implies near-flat movement, which misrepresents the actual growth trajectory. (3) Multi-hop reasoning: While the LLM correctly infers a strategic shift toward fixed-rate, longer-term debt and links it to interest rate risk management, it bases this on incomplete and partially incorrect data. The elimination of floating debt and move to fixed is consistent with the ground truth, but the reasoning is anchored in inaccurate year-over-year comparisons. (4) The contextual relevance is high because the answer addresses both the evolution of debt and the strategic implications. However, the correctness score is reduced to 6 due to significant quantitative errors in early-year values and interest rate history, despite capturing the general direction and qualitative strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 452,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "In 2022, the 10‑K did not provide a detailed description of Frame.io in the pages supplied. The 2023 filing (page 12) positioned Frame.io as a cloud‑native creative‑collaboration platform that is integrated with Premiere Pro and After Effects, emphasizing real‑time upload, review, and frame‑accurate commenting. By 2024, the platform’s integration broadened to Photoshop, Lightroom and Workfront, and Frame.io was positioned as a core component of Adobe GenStudio, further embedding it across the Creative Cloud ecosystem (page 12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely matches the ground truth in terms of the evolution of Frame.io's positioning and integration within Adobe's ecosystem across 2022–2024. (1) It correctly notes that Frame.io was not described in detail in the 2022 10-K (consistent with the ground truth that it was only listed as a trademark, implying recognition but not detailed positioning). In 2023, the LLM accurately identifies Frame.io as a 'cloud-native creative collaboration platform' with integration into Premiere Pro and After Effects, and highlights key features like real-time upload, review, and frame-accurate commenting—matching the original answer. In 2024, it correctly states expanded integration into Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio, reflecting deeper ecosystem embedding. (2) There are no numeric values, dates, or calculations to verify, so quantitative accuracy is unaffected. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly tracking the progression from minimal mention to core integration. The only minor omission is not explicitly stating that Frame.io was a registered trademark in 2022 (though the absence of detailed description implies this), which slightly affects completeness. (4) The answer is contextually highly relevant, directly addressing the question’s focus on positioning and integration across time. Wording differs slightly but maintains semantic equivalence. Overall, this is a highly accurate, well-reasoned response with only a minor detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 433,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated disclosure of the 4.550% Notes due April 5, 2049 (see Supplemental Indenture 4.16 in the 2022 10‑K page 82, the 2023 10‑K page 75, and the 2024 10‑K page 75) shows that the company is deliberately keeping a long‑term debt instrument with a moderate coupon in its capital structure.  By maintaining this 2049‑maturity note, Lowe’s locks in financing costs and spreads its debt maturities well into the 2040s, reducing refinancing risk and supporting a stable, long‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.550% Notes due April 5, 2049, and their consistent disclosure in the 2022, 2023, and 2024 10-K filings, which matches the ground truth. All numeric values—interest rate (4.550%), maturity date (April 5, 2049)—are accurate and consistently reported. The citation of specific filing pages (2022 10-K p.82, 2023 p.75, 2024 p.75) adds precision and aligns with expected transparency, though exact page numbers were not part of the ground truth; however, this does not detract from accuracy. (2) Quantitative accuracy is perfect: percentages and dates are correct, and no calculations were required. (3) The reasoning correctly infers that maintaining this long-dated debt reflects a strategic choice to lock in financing costs, reduce refinancing risk, and stabilize the long-term debt profile—this aligns with the ground truth’s emphasis on stability and lack of early redemption or restructuring. The LLM does not explicitly mention the absence of disclosures about modifications or repayments (a minor omission), but it captures the core implication of consistency across filings. (4) The answer is highly contextually relevant, directly addressing both long-term capital structure strategy and debt maturity profile management. It synthesizes multi-hop information by recognizing the significance of repeated disclosure over three years and linking it to strategic financial management. The only reason for not scoring a 10 is the slight lack of emphasis on the absence of active refinancing or restructuring actions, which is a nuanced but important point in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 448,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million** at the end of fiscal 2022, and the balance remained unchanged at **$495 million** in both fiscal 2023 and fiscal 2024. This steady figure shows that the company has neither issued additional amounts nor redeemed any principal on this note, indicating a conservative debt‑management approach that keeps the maturity profile stable and avoids unnecessary refinancing or redemption costs for this specific instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Broadcom's outstanding principal balance for its 3.125% notes due January 2025 was $495 million in fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values (amount, interest rate, maturity date) are accurate. (2) The dollar amount ($495 million) is consistently reported across all three years with no discrepancies; format is clear and equivalent to the ground truth. No calculations were required beyond recognition of stability, which is correctly interpreted. (3) The reasoning is sound: the LLM correctly infers that the unchanged balance indicates no repayments or new issuances, and draws a logical conclusion about Broadcom’s debt management strategy—specifically, maintaining a stable maturity profile and avoiding refinancing costs. This aligns with and expands upon the ground truth’s interpretation without introducing inaccuracies. (4) All parts of the question are addressed: the evolution of the balance over time (stable), and what it indicates about debt management (strategic stability, conservative approach). Entities (AVGO, 3.125% notes, January 2025 maturity) and fiscal years are correctly identified. Semantic meaning is equivalent to the original answer, with slightly different but equally valid phrasing (e.g., 'conservative debt-management approach' vs 'deliberate strategy'). Scores are maximized across all categories due to full factual accuracy, correct synthesis, and relevant, logical interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 419,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In the 2022 10‑K, IBM disclosed the 0.950% Notes due 2025 only in the notes to the consolidated financial statements, referencing the instrument definitions in Exhibit 4.1/4.2 to Form 8‑K (pages 28‑32【page_28】【page_29】【page_30】【page_31】【page_32】). The 2023 10‑K continued to reference the same instrument definitions but did not list the notes in the securities registration list (page 20【page_20】). By the 2024 10‑K, IBM had moved to explicitly list the 0.950% Notes due 2025 as a registered security under Section 12(b) and again referenced the instrument definitions (pages 1, 20【page_1】【page_20】), reflecting a more transparent and comprehensive disclosure of its debt obligations and a clearer presentation of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: IBM disclosed the 0.950% Notes due 2025 in 2022 via incorporation by reference from the May 2017 Form 8-K (Exhibits 4.1/4.2), reiterated this in 2023, and in 2024 began listing the notes as a registered security under Section 12(b) on the NYSE under ticker IBM25B. The LLM correctly identifies the evolution in disclosure depth and registration status. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and years of filing (2022–2024)—are all accurate. Page references are included and consistent with source formatting. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports and correctly infers increasing transparency. The only minor omission is that the 2024 listing on the New York Stock Exchange under ticker IBM25B is not explicitly mentioned, though the registration under Section 12(b) implies it. This slightly reduces qualitative accuracy but does not undermine the core correctness. (4) The answer is contextually excellent—directly addresses the evolution of treatment and disclosure and draws a reasonable conclusion about capital structure strategy emphasizing transparency. Wording differs from the original but maintains semantic equivalence. Overall, a very strong response with only a slight gap in completeness regarding the ticker symbol and exchange listing detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 401,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "In each of BNY Mellon’s 2022, 2023 and 2024 Form 10‑K filings, the principal‑accountant section states that **KPMG LLP’s PCAOB firm identification number is 185**【page_14】【page_14】【page_14】. The identical number appears in all three years, showing that the firm’s PCAOB registration number has remained unchanged across the 2022‑24 filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that KPMG LLP's PCAOB firm identification number is 185 in all three years—2022, 2023, and 2024—confirming consistency across filings. (2) The numeric value '185' is correct and consistent with the original answer; no calculations are required, but the repetition across years is correctly noted. (3) The reasoning is sound: the model correctly synthesizes the information across three annual filings and concludes that the number has remained unchanged, demonstrating proper multi-hop logic. (4) The answer is contextually relevant, directly addressing each part of the question—identification number, years, and consistency—while citing the relevant section (principal-accountant) and even providing document page references. Minor wording differences (e.g., mentioning BNY Mellon’s filings) do not detract from factual accuracy, as the focus remains on KPMG LLP’s disclosed PCAOB number. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 296,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One increased its fixed‑unsecured senior debt from $19.975 bn in 2022 to $27.168 bn in 2023 and then slightly reduced to $26.930 bn in 2024 (Table 8.1 2022, Table 8.1 2023, Table 9.1 2024).  The interest‑rate range rose from 0.80–4.25 % (avg 2.91 %) in 2022 to 0.80–7.62 % (avg 4.45 %) in 2023 and 1.65–7.62 % (avg 4.84 %) in 2024, while maturities shifted from 2022‑2032 to 2024‑2034 and then to 2025‑2035.  This evolution shows Capital One’s strategy to lock in low rates early in the cycle, then as Fed tightening accelerated, it increased the weighted‑average rate and pushed maturities further out to mitigate refinancing risk amid rising rates and inflation.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy in the 2023 Fixed Unsecured Senior Debt value. The LLM states $27.168 billion for 2023, while the ground truth does not provide a 2023 figure—only 2022 ($19,975 million) and 2024 ($26,930 million). Since the ground truth skips 2023, the LLM may have pulled a correct value from an external source, but its inclusion introduces a data point not confirmed by the ground truth, creating uncertainty. The 2024 value ($26.930 billion) matches exactly. (2) Interest rates: The LLM reports a 2022 average of 2.91%, which matches. For 2024, it correctly reports 4.84%. However, it introduces a 2023 average of 4.45%, which is not in the ground truth. While plausible, this interpolated value lacks verification. The rate ranges (e.g., 0.80–7.62%) are likely accurate but not confirmed in the ground truth, which only provides weighted averages. (3) The reasoning and multi-hop synthesis are strong: the LLM correctly infers a strategic shift toward longer-term debt with extended maturities (2022–2032 to 2025–2035), aligning with the ground truth’s implication of locking in fixed rates amid rising macro rates. It correctly contextualizes this within Fed tightening and inflation, showing sound qualitative understanding. (4) Contextual relevance is excellent—the answer directly addresses the evolution of issuance, interest rates, and capital structure strategy in response to macro conditions. The core facts (directional increase in debt and rates, strategic rationale) are correct, but unverified intermediate values (2023 debt and rate) reduce quantitative precision. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 465,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s 10‑K notes show the same revenue‑recognition framework for development‑plus‑IP licensing deals in 2022, 2023 and 2024.  In each year the company evaluates whether the license component is distinct; if it is, revenue is recognized at a point in time when the customer can benefit, otherwise the development services and license are combined and revenue is recognized over time (2022 p. 59; 2023 p. 63; 2024 p. 63).  The unchanged methodology signals a deliberate, disciplined strategy that treats IP licensing as a clear, separate performance obligation, underscoring AMD’s long‑term focus on predictable, risk‑controlled monetization of its intellectual property.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that AMD maintained a consistent revenue recognition methodology from 2022 to 2024 for development and IP licensing agreements, accurately describing the evaluation of whether the license component is distinct and the resulting revenue recognition treatment (point in time vs. over time). The citations to the 10-K pages (2022 p.59, 2023 p.63, 2024 p.63) support the claim of consistency, though these specific page numbers are not in the ground truth, they do not contradict it and add verifiability. The LLM correctly infers that the unchanged approach reflects a disciplined, long-term strategy focused on predictable and risk-controlled IP monetization, which is a valid interpretation of the stability in policy. The only minor shortcoming is that the LLM omits the explicit mention of 'no variable consideration estimates'—a detail included in the original answer—which slightly reduces completeness but does not affect the core correctness. All entities (AMD, years, IP licensing, revenue recognition) are accurate, and the reasoning across years is sound. The answer is semantically equivalent to the ground truth in substance, with only slight differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 356,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes increased from $30.8 billion at year‑end 2022 to $31.2 billion in 2023, then fell to $30.7 billion in 2024 (Table 8.1, 2023 & 2022 p. 186; Table 9.1, 2024 p. 188). This flat trajectory shows a deliberate strategy to keep long‑term debt near a target level while refinancing maturing notes. The weighted‑average interest rate rose from 2.91 % in 2022 to 4.84 % in 2024 (Table 8.1 p. 186; Table 9.1 p. 188), indicating a shift toward longer‑dated, higher‑rate debt as market rates climbed, allowing the firm to lock in rates and manage interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the reported dollar amounts for senior and subordinated notes. According to the ground truth, the correct values are $27,219 million in 2022, $31,248 million in 2023, and $30,696 million in 2024. The LLM reports $30.8 billion (i.e., $30,800 million) in 2022, $31.2 billion ($31,200 million) in 2023, and $30.7 billion ($30,700 million) in 2024. While the 2023 and 2024 figures are close, the 2022 figure is significantly off—by over $3.5 billion—indicating a failure to accurately extract the starting value. This is a critical error in quantitative accuracy. (2) The interest rate progression is correctly reported: 2.91% in 2022 and 4.84% in 2024, though the LLM omits the intermediate 2023 rate of 4.45%, which weakens the multi-year trend analysis. However, the overall upward trend is correctly captured. (3) The LLM correctly infers the strategic intent behind the capital structure changes—locking in higher fixed rates amid rising interest rates—and identifies the shift toward higher-cost debt. However, it completely omits the key detail about the reduction and elimination of floating unsecured senior debt ($1,709M to $349M to $0), which is a major component of the strategy described in the ground truth. This omission limits completeness and qualitative depth. (4) Despite these issues, the answer remains contextually relevant and provides a reasonable interpretation of the trend, with mostly correct terminology and logical reasoning. The conclusion about managing interest rate risk is valid and aligned with the evidence. The score reflects mostly correct reasoning with significant but not fatal data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 463,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$24.1 B at a 4.45 % weighted‑average rate in 2022** (Table 8.1, page 178) to **$27.2 B at 4.45 % in 2023** (same table).  In 2024 the carrying value fell slightly to **$26.9 B, but the weighted‑average rate climbed to 4.84 %** (Table 9.1, page 188).  The modest expansion followed by a small reduction, coupled with the rate increase, indicates the company is keeping its debt base relatively stable while refinancing at higher rates to manage maturity and cost in a tightening rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that Capital One's fixed unsecured senior debt was $24.1B at a 4.45% interest rate in 2022, but the ground truth reports a carrying value of $19,975 million ($19.975B) and a rate of 2.91% in 2022. This is a major error in both dollar amount and interest rate. The 2023 figures are closer—the LLM reports $27.2B at 4.45%, while the truth is $27,168 million ($27.168B) at 4.45%, which is acceptable with rounding. The 2024 value of $26.9B at 4.84% aligns well with the true $26,930 million and 4.84%, so those are accurate. (2) Calculations and comparisons are partially correct: the slight decrease from 2023 to 2024 is correctly noted, but the starting point (2022) is wrong, undermining trend analysis. The LLM incorrectly implies the rate was already 4.45% in 2022, when it actually rose from 2.91% to 4.45%—a significant increase that the model fails to capture. (3) Multi-hop reasoning is present but flawed: the model attempts to synthesize data across years and draw strategic conclusions, but due to incorrect baseline data, the reasoning is compromised. The conclusion about refinancing in a tightening environment is plausible and contextually relevant, but it's based on incorrect inputs. (4) The qualitative assessment is reasonable—entities (COF, fixed unsecured senior debt, years) are correct, and the answer addresses all parts of the question. However, the core financial data for 2022 is so inaccurate that the overall correctness is significantly reduced. The contextual relevance is high because the structure and intent match the question, and the 2023–2024 trend is well interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 461,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy on revenue recognition for development‑plus‑IP arrangements and for pure IP licenses did not change between 2022 and 2024.  In each filing the company states that a combined development‑and‑IP contract is treated as a single or multiple performance obligation; if the IP license is not distinct it is bundled with the development services and revenue is recognized over time, but if the license is distinct revenue is recognized at a point in time when the customer can benefit from it.  Stand‑alone IP‑sale or licensing agreements are always treated as a single performance obligation and revenue is recognized at a point in time when the customer has the ability to benefit from the license【page_59】【page_63】【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that AMD’s revenue recognition policy for development and IP licensing agreements remained unchanged from 2022 to 2024. The explanation of combined arrangements—where non-distinct licenses are bundled with development services and revenue is recognized over time, while distinct licenses are recognized at a point in time—is consistent with the original answer. The treatment of standalone IP licenses as single performance obligations recognized at a point in time is also correct. The LLM accurately captures the absence of variable consideration (implied stability in policy) and correctly identifies the consistent application across years. The only minor limitation is that the LLM does not explicitly mention the absence of variable consideration estimates, which is a small but relevant detail in the ground truth. However, this does not detract significantly from the overall correctness. All entities (AMD, development services, IP licenses, performance obligations), years (2022–2024), and accounting concepts are accurately used. The reasoning is sound, demonstrating proper synthesis across the multi-year filings. Quantitative elements (though no specific dollar amounts or percentages are involved) are handled correctly in terms of policy consistency over time. The citations (e.g., page_59) suggest grounding in source documents. Semantic equivalence is strong, and the answer fully addresses the evolution (or lack thereof) in policy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 424,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "From 2022 to 2024, COF’s short‑term borrowings fell from **$883 million** in 2022 to **$538 million** in 2023 and then rose modestly to **$562 million** in 2024, while long‑term debt stayed at **$49.3 billion** in 2022–23 and declined to **$44.99 billion** in 2024. The three‑year trend shows a deliberate reduction in overall debt—especially long‑term debt—paired with a low, relatively stable short‑term borrowing base, indicating a strategy to lower interest costs and manage rate exposure. COF’s weighted‑average long‑term debt rates hovered around 4.8–5.7 % and the firm actively uses interest‑rate swaps to hedge against rate volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both short-term borrowings and long-term debt figures. According to the ground truth, total debt (short-term + long-term) was $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports long-term debt alone as $49.3B in 2022–2023, which already exceeds the total debt in the ground truth. Additionally, the LLM states short-term borrowings were $883M in 2022, but this does not align with the implied short-term portion from the ground truth (total debt minus long-term debt is not provided directly, but the LLM’s breakdown is inconsistent with the total trend). The LLM also incorrectly claims long-term debt was flat between 2022 and 2023 at $49.3B, whereas the ground truth shows an increase in total debt from $43.086B to $48.715B, implying a rise in long-term or short-term obligations. The 2024 decline to $44.99B is close to the ground truth total of $45.551B but still inaccurate and misattributed. (2) Interest rate figures are also incorrect: the LLM states rates hovered around 4.8–5.7%, but the ground truth shows a precise rise from 2.76% (2022) to 4.48% (2023) to 4.84% (2024). The LLM overstates the starting rate and range. (3) The reasoning is flawed: the LLM concludes a 'deliberate reduction in overall debt' starting in 2022, but the ground truth shows an increase from 2022 to 2023 before a partial decline in 2024. Thus, the multi-hop synthesis fails—COF initially expanded debt during rising rates, which the LLM misses entirely. The mention of interest-rate swaps is extraneous and not supported in the original answer. (4) While the LLM attempts to interpret strategy and rate exposure, its conclusions are based on incorrect data, leading to a misleading narrative. The contextual relevance is moderate because it addresses the right question framework (debt evolution and strategy), but factual errors severely undermine correctness. Minor format flexibility is allowed, but numerical discrepancies are too large to overlook. Hence, low scores on quantitative and qualitative accuracy, with a correctness score of 3 due to partial alignment in 2024 directionality but major errors in magnitude, timing, and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 599,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy on revenue recognition for development‑plus‑IP licensing agreements did not change between FY 2022, FY 2023 and FY 2024.  The company continues to evaluate whether the licensing component is distinct; if it is not distinct, the combined arrangement is treated as a single performance obligation and revenue is recognized over time, whereas if it is distinct the license is treated as a separate obligation and revenue is recognized at a point in time.  Stand‑alone IP licensing arrangements are always recognized at a point in time, with no variable‑consideration estimates.  (See the “Development and intellectual property licensing agreements” note on pages 59 (2022), 63 (2023) and 63 (2024).)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy for development and IP licensing agreements remained unchanged from 2022 to 2024, which aligns with the ground truth assertion of 'no material change' and 'consistent policy.' (2) The treatment of combined arrangements—evaluating whether the licensing component is distinct, leading to either a single performance obligation (revenue over time) or separate obligations (revenue at a point in time)—is accurately described, matching the original answer's explanation for all three years. (3) The LLM correctly identifies that standalone IP licenses result in point-in-time recognition and that no variable consideration estimates are applied, which is consistent with the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three years and between combined vs. standalone arrangements. (5) The citation of specific footnote locations (pages 59, 63, 63) adds precision and supports the claim of consistency. There are no factual errors, omissions, or misinterpretations. All entities (AMD, development agreements, IP licensing, performance obligations) are correctly identified and contextualized. Minor wording differences (e.g., 'did not change' vs. 'maintained a consistent policy') do not affect meaning. The answer fully addresses the evolution (or lack thereof), performance obligations, and the distinction between combined and standalone arrangements as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 434,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The repeated inclusion of the “Certificate of Designations of Series B Convertible Participating Preferred Stock” as an exhibit in Visa’s 2022, 2023, and 2024 10‑K filings (Exhibit 4.5 in 2022, Exhibit 4.4 in 2023 and 2024) shows that the instrument remains outstanding and has not been retired or replaced. This consistency signals that the Series B preferred stock continues to play a stable, ongoing role in Visa’s capital structure, providing a persistent source of capital and conversion rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the exhibit numbers (4.5 in 2022, 4.4 in 2023 and 2024) and the implication of continuity are accurately reported. Although the LLM does not explicitly mention the June 21, 2016 filing date—which is a minor omission—it correctly infers stability from the consistent inclusion of the certificate across years. (2) The reasoning is sound: the model correctly interprets repeated disclosure as evidence of an unmodified, ongoing instrument in Visa’s capital structure. (3) The multi-hop synthesis across three years of filings is logically handled, and the conclusion about stability and ongoing relevance is well-supported. (4) While the LLM omits the specific 2016 filing date and does not note the 'static' nature as explicitly as the original answer, it captures the core meaning—unchanged terms and continued relevance—thus achieving semantic equivalence on the main point. The answer is contextually excellent, directly addressing the question about stability and relevance. The only reason for not scoring a 10 is the omission of the original filing date, which is a factual detail present in the ground truth and contributes to the completeness of the explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 359,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "Pratt & Whitney’s ownership stake in the IAE collaboration has been steady, with a net program‑share interest of 57 % in IAE and 51 % in IAE LLC through 2022‑2024 (Note 17, page 101).  The carrying amounts of the consolidated variable‑interest entities grew from $8.4 B in 2022 to $10.2 B in 2023 and $11.4 B in 2024, while liabilities rose from $9.2 B to $13.1 B and $13.7 B respectively (page 101 for 2023/2022 and page 102 for 2024/2023).  This unchanged stake combined with expanding carrying amounts indicates Pratt & Whitney’s stable, primary‑beneficiary position and deepening economic exposure in the V2500 engine program.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key percentages. It states Pratt & Whitney has a '51% in IAE LLC' and a '57% net program-share interest', but the ground truth specifies a consistent 61% program share interest, 49.5% ownership interest, and 57% net program share interest after sub-collaborator participation. The 51% figure for IAE LLC is not mentioned in the ground truth and contradicts the 49.5% ownership interest. While the 57% net program share is correct, the conflation of entities (IAE vs IAE LLC) and incorrect ownership percentage undermines quantitative accuracy. (2) The carrying amounts and liabilities cited ($8.4B, $10.2B, etc.) are not part of the original answer and were likely pulled from unrelated financial statements. While such data may exist in filings, they are not relevant to the question about stake evolution or strategic positioning in the V2500 program, and their inclusion misrepresents the basis for concluding 'deepening economic exposure'. The ground truth emphasizes stability, not increasing exposure. (3) The multi-hop reasoning is flawed: the model infers 'deepening economic exposure' from rising carrying amounts of variable-interest entities, but this does not align with the ground truth, which concludes no change in strategic positioning due to stable stakes. The model fails to synthesize the correct ownership and program share data across years and introduces irrelevant financial metrics to support an incorrect interpretation. (4) Despite these issues, the answer is contextually relevant—addressing the right collaboration (IAE), the correct subsidiary (Pratt & Whitney), and the V2500 engine program—and correctly notes stability in the 57% net program share. However, major factual errors in ownership percentages and misinterpretation of financial data reduce correctness significantly. The conclusion contradicts the ground truth’s emphasis on unchanged strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 532,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic’s 10‑K filings for 2022, 2023 and 2024 all reference the same Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan (Exhibit 10.3) – see page 117 for 2022 and page 115 for 2023 and 2024. This unchanged use indicates a deliberate preference for a stable, long‑term incentive structure for directors, emphasizing continuity and long‑term alignment over frequent plan revisions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Medtronic used the same Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across fiscal years 2022, 2023, and 2024, and correctly infers that this reflects a stable, long-term director compensation strategy. However, there is a critical error in the exhibit number and page references. The ground truth states that the agreement was listed as Exhibit 10.41 in 2022 and Exhibit 10.52 in both 2023 and 2024, whereas the LLM incorrectly claims it was Exhibit 10.3 in all three years and cites page numbers (117, 115) not mentioned in the original answer. These inaccuracies affect quantitative and factual precision. (2) The fiscal years are correct, and the core financial/structural detail—the continued use of the 2008 plan—is accurate. However, the exhibit numbers are factually wrong, which matters for document traceability. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistency of the agreement across three years and draws a logical conclusion about long-term strategy. It captures the contrast between stability in director compensation versus potential changes in other plans, though it omits mention of the 2013 plan updates noted in the ground truth, slightly weakening completeness. (4) The answer is contextually relevant and semantically close to the original, with strong qualitative reasoning. The correctness score is 7 because key facts (plan name, consistency, strategic implication) are correct, but exhibit details are inaccurate, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 441,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin uses variable‑interest‑rate swaps to convert fixed‑rate borrowings into variable‑rate debt as a fair‑value hedge against changes in the debt’s fair value.  The aggregate notional amount of outstanding interest‑rate swaps was $1.3 billion at December 31 2022, 2023 and 2024 (page 95; page 52), showing a steady level of hedging activity and a consistent interest‑rate‑risk management approach over that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that the notional amount of interest rate swaps was $1.3 billion in 2022, 2023, and 2024, which directly contradicts the ground truth stating $500 million in 2022, rising to $1.3 billion in 2023 and remaining there in 2024. This error misrepresents the evolution of LMT's swap usage. (2) Quantitative accuracy is severely compromised: the $1.3 billion figure is incorrectly applied to 2022, missing the tripling in exposure from $500M to $1.3B. The calculation of a 160% increase (from $500M to $1.3B) is omitted, and the key progression is erased. (3) The reasoning is flawed: the LLM concludes a 'steady level of hedging activity' and 'consistent approach', while the ground truth identifies a strategic shift followed by stabilization. This misinterprets the intent behind the data. The multi-hop synthesis fails because it does not connect the increasing notional amounts to a strategic evolution in risk management. (4) Contextual relevance is moderate—the answer discusses the correct company (LMT), correct financial instrument (variable interest rate swaps), and correct time frame, and correctly identifies the purpose of the swaps as fair-value hedges. However, due to the incorrect data and resulting flawed interpretation, the overall correctness is low. Minor note: citation of page numbers is extraneous and not part of the required answer, but not factually damaging.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 405,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s 10‑K filings for 2022, 2023 and 2024 all state that “stockholders may only remove directors for cause” (2022, page 44; 2023, page 27; 2024, page 27), with no change in wording or scope over the three years. This unwavering consistency signals a deliberate, long‑term strategy to safeguard board stability and deter hostile takeover attempts by making director removal difficult without a material cause.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie's governance provision allowing director removal only for cause remained unchanged from 2022 to 2024, citing the correct language and page numbers across all three 10-K filings. There are no numeric inaccuracies—dates, years, and document locations are correct. (2) Quantitative accuracy is perfect: the years (2022–2024), page numbers (44, 27, 27), and consistent wording are all correctly reported. (3) The reasoning is sound: the model correctly infers that the lack of change over three years reflects a deliberate strategy to maintain board stability and deter hostile takeovers, which is a valid interpretation supported by the original answer. It captures the multi-hop element by synthesizing the consistent provision across years and drawing a strategic conclusion. (4) While the LLM answer is highly accurate, it omits mention of other related anti-takeover provisions noted in the ground truth—specifically staggered boards and supermajority voting—which provide additional context for AbbVie’s governance posture. This minor omission slightly reduces completeness and depth of qualitative analysis, but does not undermine the core correctness. Overall, the answer is semantically equivalent and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 378,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market‑fund and time‑deposit holdings fell from **$21 million in 2022 to $10 million in 2023 and remained at $10 million in 2024**【page 79】【page 84】.  This decline, set against a backdrop of fluctuating cash balances (from $9,201 million in 2022 to $12,814 million in 2023 and $5,524 million in 2024【page 110】【page 79】【page 84】), indicates a shift toward keeping more cash on hand or investing in other short‑term instruments, reflecting a conservative liquidity strategy that prioritizes immediate liquidity over marketable securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the allocation to money market funds and time deposits and the cash balances. According to the ground truth, AbbVie's allocation increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. The LLM incorrectly states it fell from $21 million in 2022 to $10 million in 2023, which reverses the actual trend for 2022–2023. Additionally, the LLM reports cash balances of $9,201 million in 2022 and $12,814 million in 2023, but the ground truth shows $8,449 million in 2022 and $9,201 million in 2023. The 2024 cash balance ($5,524 million) is correctly reported. (2) These numerical inaccuracies severely undermine the quantitative accuracy. The LLM also fails to note the increase in low-risk instrument allocation in 2023, instead portraying a continuous decline, which distorts the interpretation. (3) The reasoning is flawed due to incorrect data inputs—claiming a 'decline' from 2022 to 2023 when there was actually an increase breaks the multi-hop synthesis required to assess strategic shifts. The conclusion about a 'conservative liquidity strategy' may seem plausible but is based on false premises. (4) While the answer attempts to address the question’s components—allocation trend and liquidity strategy interpretation—the severe factual and numerical errors result in a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but accuracy is critically compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 424,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s 10‑K filings show that the provision allowing stockholders to remove directors **only for cause** has been unchanged from 2022 through 2024 (2022: page 46; 2023: page 27; 2024: page 27).  The unchanged language—part of the amended and restated certificate of incorporation and bylaws and Delaware law—underscores a deliberate, long‑term strategy to keep the board insulated from shareholder pressure and to deter hostile takeovers by requiring a cause‑based removal process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie maintained the 'removal only for cause' provision from 2022 to 2024, which matches the original answer's claim of consistency across all three years. The page numbers cited (2022: p.46; 2023: p.27; 2024: p.27) are specific and plausible, though not directly verifiable from the ground truth, but do not contradict it. (2) There are no numerical values requiring calculation, so quantitative accuracy pertains to correct referencing of years and document locations—these are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance provisions across three years of 10-K filings and infers strategic intent regarding anti-takeover defenses. It correctly identifies the provision as part of the certificate of incorporation and bylaws under Delaware law, adding contextual depth. (4) The answer conveys semantic equivalence to the original: while it omits the explicit phrase 'strategic continuity' or 'activist interventions,' it captures the core idea of deterring hostile takeovers and insulating the board, which is the central inference in the ground truth. The only minor shortcoming is slightly less elaboration on the broader set of governance mechanisms, but the key point about long-term strategy is clearly conveyed. Hence, the answer is highly accurate with negligible omissions, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 410,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "In 2022 Intel introduced PowerVia as a breakthrough backside‑power technology slated for the upcoming Intel 20A node. By 2023 the company described PowerVia as a unique industry‑first implementation that eliminates front‑side power routing and optimizes signal transmission on the 20A node (page 14). In 2024 Intel shifted the commercial focus to the Intel 18A node, positioning PowerVia as a key feature to improve performance‑per‑watt and density scaling (page 10). This evolution shows Intel’s strategy to make backside power delivery a core differentiator, moving PowerVia from a future concept to a commercialized technology that reduces routing complexity and boosts performance in advanced nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel's future roadmap, positioned in 2023 for Intel 20A as a solution to eliminate front-side power routing and optimize signal transmission, and then shifted in 2024 to Intel 18A with a focus on performance-per-watt and scaling. These details match the original answer. (2) Quantitative accuracy is perfect: years (2022, 2023, 2024), process nodes (Intel 20A, Intel 18A), and the 2025 high-volume manufacturing timeline (implied in original, not contradicted in LLM) are correctly referenced. No numerical errors. (3) Multi-hop reasoning is sound: the LLM synthesizes the evolution across three years and interprets the strategic implications—shifting from concept to commercialization and differentiation—consistent with the original. The only minor gap is that the LLM does not explicitly mention the strategic implication of 'external foundry offerings,' which is part of the original's conclusion about Intel's refined roadmap. This omission slightly affects completeness but does not distort the overall meaning. (4) Semantic equivalence is strong: the LLM conveys the same progression and strategic intent using different but equivalent phrasing (e.g., 'core differentiator' vs 'prioritization of practical implementation'). Contextual relevance is excellent as it directly addresses the evolution and strategic implications of PowerVia.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 410,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility assumption rose from 23.04 % in fiscal 2022 to 24.05 % in 2023 and further to 24.29 % in 2024 (see the assumptions table on page 82 for 2024‑23 and page 83 for 2022). This gradual upward trend—despite a small dip in 2023—shows that the company is actively adjusting its option‑pricing model to reflect higher market volatility, indicating a cautious, data‑driven approach to valuing non‑qualified stock options.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It reports specific percentages (23.04%, 24.05%, 24.29%) for expected volatility in 2022, 2023, and 2024, but the ground truth does not provide any numerical values for volatility assumptions—instead, it describes a methodological shift in how MDT determines expected volatility. There is no mention in the original answer of these exact percentages, nor of a 'small dip in 2023'—in fact, the reported numbers show a consistent increase, contradicting the claim of a dip. Thus, the quantitative claims are unsupported and likely fabricated. (2) The cited pages (82, 83) and precise decimal percentages suggest spurious precision, with no alignment to the ground truth, which focuses on methodology, not numerical inputs. (3) The multi-hop reasoning is flawed: the question asks about the evolution of assumptions in the Black-Scholes model, specifically regarding volatility inputs, and the correct answer involves a shift from historical-only to a blend of historical and implied volatility. The LLM completely misses this key conceptual evolution and instead invents a trend in numerical volatility values. It fails to mention the use of implied volatility from market-traded options in 2023 and 2024, which is the central point of the original answer. (4) While the LLM attempts to interpret the trend ('cautious, data-driven approach'), this conclusion is based on false premises. The contextual relevance is moderate because it addresses MDT’s volatility assumptions in the Black-Scholes model over time, but the factual foundation is incorrect, leading to a misleading interpretation. The answer substitutes methodological insight with invented numerical trends, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 489,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In 2022 Intel introduced PowerVia as a future “back‑side power delivery” breakthrough for upcoming nodes (Intel 20A) 【page_7】. By 2023 it was positioned as a key performance‑per‑watt technology for the Intel 20A node, expected to deliver up to 15 % improvement 【page_14】. In 2024 PowerVia was described as the first high‑volume commercial implementation in the Intel 18A process (and again noted for Intel 20A), underscoring its central role in Intel’s advanced roadmap for backside power delivery and efficiency in next‑generation chips 【page_10】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are accurate: the 15% performance-per-watt improvement and the correct timeline (2022 introduction, 2023 reaffirmation, 2024 update) match the original answer. (2) The entity names—PowerVia, Intel 20A, Intel 18A—are correctly identified, and the technology is accurately described as a backside power delivery solution. (3) The reasoning is mostly sound: the LLM correctly tracks PowerVia’s continuity across Intel 20A and Intel 18A. However, it misses a key strategic shift noted in the ground truth: the cancellation of Intel 20A’s productization in favor of Intel 18A. While the LLM mentions PowerVia in both nodes, it does not explicitly state that Intel 20A was canceled, which is a significant strategic update. Instead, it says PowerVia was implemented in Intel 18A 'and again noted for Intel 20A,' which could imply both nodes are still in production, creating a minor inaccuracy in strategic interpretation. (4) Despite this omission, the core message—that PowerVia remains central to Intel’s roadmap—is correctly conveyed, and the answer is contextually relevant and well-supported by the timeline and technical details. The missing detail reduces completeness and qualitative accuracy slightly, but not enough to undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 379,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024 the Black‑Scholes assumptions for MDT’s non‑qualified options shifted from a 23.04 % volatility, 0.90 % risk‑free rate, 1.95 % dividend yield and 6‑year expected life to 24.29 % volatility, 4.16 % risk‑free rate, 3.18 % dividend yield and 6.1‑year expected life. The modest rise in volatility, coupled with the larger uptick in the risk‑free rate and dividend yield, shows the company is updating its model to reflect higher market rates and slightly higher market risk, while the slight increase in expected life suggests a more conservative view of how long employees will hold options before exercising. This progression indicates MDT is dynamically adjusting its volatility and exercise‑behavior assumptions to align with evolving market conditions and a slightly longer anticipated exercise horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that the key evolution in MDT's Black-Scholes assumptions from 2022 to 2024 was the incorporation of implied volatility (in addition to historical volatility) starting in 2023, which continued in 2024. However, the LLM answer fabricates specific numerical values (e.g., 23.04% volatility, 0.90% risk-free rate, 6-year expected life) that are not present in the original answer and are not supported by the knowledge graph. These numbers are entirely absent from the ground truth, making the quantitative claims baseless. (2) There is no verification of calculations because the numbers themselves are invented. The original answer does not provide any specific percentages or durations; instead, it describes a methodological shift in volatility estimation. The LLM incorrectly presents precise metrics as if they were disclosed, failing the quantitative accuracy test. (3) The multi-hop reasoning is flawed. While the LLM attempts to interpret trends (e.g., rising risk-free rates, longer expected life), it does so based on fabricated data rather than the actual qualitative shift in methodology (use of implied volatility). The reasoning about employee exercise behavior (6.1-year expected life) is speculative and unsupported by the original answer, which does not mention changes in expected life. (4) Contextual relevance is moderate because the LLM addresses the right topic—evolution of Black-Scholes assumptions at MDT—and attempts to discuss volatility, risk-free rates, dividends, and exercise behavior. However, it misses the central point: the integration of market-implied volatility as a more sophisticated, market-informed approach. Instead, it invents a narrative around numerical changes that do not appear in the ground truth. The conclusion about aligning with market conditions is partially aligned with the spirit of the original answer but is derived from false premises. Thus, while the direction of interpretation is somewhat relevant, the factual foundation is entirely incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 575,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "The collateral that ExxonMobil reports within the “Other assets, including intangibles – net” line fell from **$1.494 billion in 2022 to $491 million in 2024** – a decline of roughly $1.0 billion. This steep reduction indicates the company has tightened its derivative exposure, likely through more efficient netting, lower margin requirements or a smaller volume of derivative positions, thereby improving liquidity and risk management.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall decline in collateral from $1,494 million in 2022 to $491 million in 2024, which matches the ground truth. However, it omits the intermediate 2023 value of $800 million, which is a notable omission for a multi-year trend analysis. While the final drop is accurate, the absence of the 2023 data point reduces completeness and precision in tracking the year-by-year trend. (2) The numbers used for 2022 and 2024 are factually correct and correctly formatted ($1.494 billion = $1,494 million; $491 million is consistent). The stated decline of 'roughly $1.0 billion' is approximately correct (actual difference: $1,494M - $491M = $1,003M), so the calculation is sound. (3) The reasoning about reduced derivative exposure, efficient netting, and improved risk management is logically consistent with the trend and aligns semantically with the ground truth interpretation involving strategic exposure reduction and margin management. However, the LLM does not mention possible external factors like lower commodity market volatility or shifts in hedging strategy, which were included in the original answer and add depth to the interpretation. (4) Despite missing the 2023 data point, the core quantitative facts and qualitative interpretation are substantially correct. The answer remains contextually relevant and provides a reasonable explanation. The correctness score is 8 due to the omission of a key intermediate data point in a multi-hop, multi-year trend question, which affects completeness but not the overall directional accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 439,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra Energy’s fair value of options – primarily gas remained roughly $100 million in assets and liabilities each year from 2022 through 2024, with 2023 reporting $100 m/$97 m and 2024 reporting $100 m/$102 m【page_82】【page_86】.  Implied volatility assumptions stayed around 50 % (20–233 % in 2023, 15–150 % in 2024) while implied correlation assumptions rose from about 57 % in 2023 to 99 % in 2024, signalling a shift toward more conservative, higher‑correlation risk parameters【page_82】【page_86】.  This evolution shows the company is maintaining a steady gas‑derivative exposure while tightening its volatility and correlation assumptions to better manage market risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NextEra Energy's fair value of 'Options - primarily gas' was $356M in assets and $347M in liabilities in 2022, not around $100M as stated in the LLM answer. The LLM incorrectly claims the fair value was roughly $100M each year, but in reality, there was a sharp decline from over $350M in 2022 to $100M in 2023. This misrepresents the trend entirely. Additionally, the implied volatility values are wrong: the ground truth shows a weighted average of 36% in 2022, rising to 50% in 2023 and 52% in 2024, while the LLM reports ranges (20–233%, 15–150%) instead of weighted averages and omits the correct 2022 figure. (2) The calculation and comparison of financial values are incorrect. The LLM fails to capture the substantial reduction in fair value from 2022 to 2023, which is a key part of the trend. The volatility assumptions are misrepresented with incorrect ranges and missing 2022 data. (3) The multi-hop reasoning is flawed. The LLM does not correctly synthesize the evolution across years, especially the significant drop in fair value between 2022 and 2023. It also introduces 'implied correlation assumptions' (57% to 99%), which are not mentioned in the original answer and are irrelevant to the question about volatility and fair value. This suggests confusion or hallucination. (4) The contextual relevance is moderate because the answer addresses the general topic of risk positioning in gas derivatives, but due to severe quantitative and qualitative errors, the conclusion about 'steady exposure' is incorrect—the company actually reduced its exposure significantly. The reasoning about 'tightening volatility and correlation assumptions' is unsupported by the ground truth, which only discusses increasing implied volatility, indicating higher, not lower, perceived risk. Overall, the answer is mostly incorrect with major factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 533,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 35A has remained unchanged: a face amount of $750,000 and an annual debt service of $19,875, with a 30‑year maturity (07/15/30). The consistency of these terms indicates that the company is maintaining a stable, low‑interest long‑term debt instrument rather than expanding or restructuring it, reflecting a conservative, predictable debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the face amount ($750,000) and annual debt service ($19,875) for Unsecured Notes - 35A across 2022–2024, matching the ground truth exactly. It accurately notes the stability of these figures, confirming no changes occurred over the period. The maturity date (07/15/30) is an additional detail not in the original answer but does not contradict it and may reflect supplementary accurate data from the filing. 2) All numeric values are correct and consistently reported. No calculations were required, but the synthesis of stable figures across years is accurate. Format variations (e.g., $750,000 vs $750,000) are consistent and acceptable. 3) The reasoning correctly infers that the unchanged terms reflect a stable, predictable debt strategy. The LLM characterizes this as a 'conservative, predictable debt-management strategy,' which is semantically equivalent to the original conclusion about prioritizing predictability in debt servicing. The only minor gap is that the original emphasizes 'no new issuances or repayments,' while the LLM focuses on low interest and lack of restructuring—slightly different framing but logically consistent. 4) The answer fully addresses all parts of the question: evolution over time (stable), face amount, annual debt service, and implications for long-term strategy. The added maturity date enhances context without introducing error. Overall, the answer is factually complete, quantitatively precise, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to nuanced emphasis differences in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 448,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments has consistently framed analog and embedded‑processing as its core business across 2022, 2023 and 2024 (2022 10‑K p.18; 2023 10‑K p.18; 2024 10‑K p.18). Embedded‑processing revenue rose from $3.26 bn in 2022 to $3.37 bn in 2023 before falling to $2.53 bn in 2024 (2022 10‑K p.20; 2023 10‑K p.20; 2024 10‑K p.20), reflecting market‑driven shifts while the company maintained its strategic emphasis. This steady, albeit fluctuating, focus on embedded‑processing—paired with its analog strength—underscores TI’s long‑term positioning as a diversified, high‑margin semiconductor provider that can sustain robust cash flow and resilience amid cyclical demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, there is no mention of specific revenue figures for embedded processing products in any year, nor any indication of a drop to $2.53B in 2024. These numbers are not present in the original answer derived from the knowledge graph and appear to be fabricated or misattributed. The ground truth emphasizes consistent strategic language across years, not revenue fluctuations. (2) The cited revenue numbers ($3.26B, $3.37B, $2.53B) cannot be verified against the ground truth and contradict the qualitative emphasis on stability and continuity in strategic focus. If such revenue changes were true, they would undermine the narrative of consistent strategic emphasis unless contextualized appropriately—which the model attempts with 'market-driven shifts'—but without grounding in the source data, this introduces factual error. (3) Qualitatively, the LLM correctly identifies that Texas Instruments maintained a consistent strategic emphasis on embedded processing alongside analog products across the three years, which aligns with the ground truth’s assertion of stable, long-term positioning. It also correctly infers that this supports resilience and cash flow, which is consistent with the original answer’s conclusion about free cash flow and competitive differentiation. The multi-hop reasoning—linking strategic emphasis over time to long-term industry positioning—is sound and relevant. (4) Contextually, the answer is well-framed and addresses both parts of the question: evolution of strategy (as stability) and long-term implications. However, the inclusion of unsupported numerical data severely undermines factual correctness, warranting a moderate score. While the overall direction is reasonable, the incorrect figures lead to a misleading impression of performance trends, which were not part of the original insight. Thus, correctness is partially compromised despite strong qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 547,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "In 2022, CMCSA offered shared‑data plans only as part of bundled broadband services, giving customers the choice of unlimited, shared, or per‑gigabyte usage (CMCSA 10‑K 2022, page 6). By 2024 the company expanded the wireless offering to include prepaid unlimited data plans under the NOW brand while still bundling wireless with broadband, and it kept the same unlimited/shared/per‑GB options plus interest‑free financing for devices (CMCSA 10‑K 2024, page 6). Thus, the strategy evolved from a limited bundled approach to a broader, more flexible plan and payment structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that CMCSA offered shared data plans as part of bundled broadband services from 2022 to 2024, with options including unlimited, shared, and per-gigabyte plans. It correctly notes the 2024 expansion with the introduction of prepaid unlimited data plans under the NOW brand. The mention of interest-free device financing (referred to as 'financing options over 24 months' in the original) is consistent in intent, though the original does not explicitly mention 'interest-free'—this is a minor addition not contradicted by the source. (2) There are no numerical values requiring calculation, and all dates (2022, 2024) are used correctly. (3) The multi-hop reasoning across years is sound: the answer correctly synthesizes the continuity of shared data plans and the strategic expansion in 2024. However, it omits explicit mention of 2023, which the original includes to show consistency in plan structure across all three years—this is a minor gap in completeness. (4) The answer is contextually relevant and addresses both parts of the question: positioning within bundled offerings and evolution of payment/plan options. The conclusion about a shift to a 'broader, more flexible' structure is supported. The omission of 2023 and slight rewording of financing terms prevent a perfect score, but core facts and evolution are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 397,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose from **$51.4 billion** at year‑end 2022 to **$60.4 billion** in 2023 and **$71.4 billion** in 2024 (see the Stockholders’ Equity tables on pages 73, 73, and 70/68). The steady increase—$9.0 billion in 2023 and $11.0 billion in 2024—shows that the company has been consistently using excess cash to buy back shares. This trend signals a capital‑allocation policy that prioritizes shareholder returns through share repurchases, likely to support the share price and earnings per share rather than allocating cash to dividends or other investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2022 value: it reports $51.4 billion, while the ground truth is $(36,658) million (i.e., $36.7 billion). This is a material discrepancy of ~$14.7 billion. The 2023 and 2024 values are correct: $60.4 billion matches $(60,429) million and $71.4 billion matches $(71,431) million (with acceptable rounding). (2) Calculations: The LLM claims a $9.0 billion increase in 2023 (from $51.4B to $60.4B), but the actual increase from 2022 to 2023 should be $23.7 billion ($36.7B to $60.4B). Similarly, the $11.0 billion increase from 2023 to 2024 is correct. Thus, the year-over-year change for 2024 is accurate, but the 2023 change is wrong due to the incorrect base. (3) Multi-hop reasoning: The model correctly identifies the trend across three years and synthesizes the implication about capital allocation—specifically, prioritizing share buybacks to return value to shareholders. This reasoning is sound and aligns with the ground truth. The mention of supporting EPS and share price adds context not in the original but is a reasonable inference. (4) Entity and time period accuracy: Company (Mastercard), metric (Class A Treasury Stock), and years (2022–2024) are all correct. The answer is contextually complete and relevant, addressing both the evolution and strategic implication. However, the major numerical error in the 2022 figure reduces confidence in the quantitative accuracy, warranting a score of 6 for that dimension. Overall correctness is reduced to 7 due to this key error, though the trend direction and strategic interpretation remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 448,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "Repair and other services revenue fell from $1,169 million in 2022 to $1,132 million in 2024, a decline of about $37 million (≈3 %). The slight drop, with no growth in 2023, shows the service segment has been relatively flat or slightly contracting, indicating it is not a major growth driver for General Dynamics during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 revenue ($1,169 million) and the 2024 revenue ($1,132 million), matching the ground truth. However, it skips the 2023 value ($1,132 million), which was explicitly mentioned in the original answer and is relevant for showing the year-over-year trend. While the final drop from 2022 to 2024 is accurately stated as $37 million and approximately 3%, the percentage is slightly rounded down—the exact decline is (37/1,169) ≈ 3.16%, which rounds to 3.2% as in the original. (2) The calculation of the dollar difference is correct: 1,169 - 1,132 = 37 million. The percentage is acceptably close but not exact—this minor inaccuracy prevents a perfect quantitative score. (3) The reasoning is sound: the LLM correctly infers that the lack of growth and slight decline suggests the service segment is not a growth driver, aligning with the original conclusion of stagnation or contraction. However, it fails to explicitly note that revenue remained flat from 2023 to 2024, missing a key detail in the multi-hop trend analysis. (4) Despite the omission of the 2023 data point and slight rounding of the percentage, the LLM captures the core trend and implication. The answer is contextually complete and relevant, with only minor gaps in completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 366,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "In 2022 and 2023 CVS’s consolidated RMBS portfolio had a fair value of $614 million and an unrealized loss of $60 million (page 150 for 2022; page 149 and 148 for 2023).  In 2024 the fair value reported for RMBS in the separate‑account balance sheet fell to $71 million (page 160), implying a much larger unrealized loss relative to amortized cost and a sharp reduction in exposure.  This multi‑year trend shows CVS is actively trimming its RMBS holdings and managing interest‑rate risk, positioning itself more conservatively in this asset class.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error: it states that in both 2022 and 2023, CVS had a fair value of $614 million in RMBS. However, the ground truth shows that in 2022, the fair value was $629 million (with $10 million in unrealized losses), and only in 2023 did the fair value drop to $614 million (with unrealized losses increasing to $60 million). The LLM incorrectly merges the 2022 and 2023 fair values, misrepresenting the trajectory. Additionally, the LLM omits the 2022 unrealized loss figure of $10 million entirely. In 2024, the LLM correctly reports the $71 million fair value. (2) Calculations: The LLM does not perform any explicit calculations, but the misstatement of 2022 fair value as $614M (same as 2023) distorts the year-over-year trend. The correct trajectory is a drop from $629M → $614M → $71M, not $614M in both 2022 and 2023. (3) Multi-hop reasoning: The LLM correctly identifies the overall de-risking trend and interprets the sharp drop in 2024 as a strategic reduction in exposure. It also correctly infers conservative risk positioning, aligning with the ground truth's conclusion of a deliberate de-risking strategy. The reasoning about managing interest-rate risk is a reasonable inference, though not explicitly stated in the original. (4) Justification for scores: Correctness is 7 because the core trend (declining exposure, increasing losses, then sharp reduction) is captured, but key numbers are wrong. Quantitative accuracy is 6 due to the incorrect 2022 fair value and omission of 2022 unrealized losses. Qualitative accuracy is 8 because the logic and synthesis across years are sound despite numerical inaccuracies. Contextual relevance is 10 as the answer directly addresses the question’s focus on evolution and risk positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 490,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Linde’s on‑site contracts for atmospheric gases have remained long‑term, total‑requirement agreements with minimum purchase commitments and price‑escalation clauses, and the variable pricing components tied to price indices have stayed constrained (see 2022 page 97 and 2024 page 87).  The share of on‑site sales fell from about 27 % of total sales in 2022 to roughly 23 % in 2024, indicating a modest shift toward merchant and packaged gas sales, but the core contractual structure and pricing mechanisms for atmospheric gases did not materially change (2024 page 89).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements about Linde's long-term on-site contracts, including minimum purchase commitments, price escalation clauses, and constrained variable pricing tied to indices, which aligns partially with the ground truth. However, it introduces a significant inaccuracy: the claim that on-site sales fell from 27% to 23% of total sales between 2022 and 2024. This quantitative detail is not present in the original answer (ground truth) and cannot be verified from the provided knowledge graph data, making it potentially fabricated or misattributed. Additionally, the LLM fails to mention the key evolution in 2023 when Linde first clarified the fluctuation of pricing with indices and the presence of variable consideration—this is a critical multi-hop point showing progression in disclosure transparency. The 2024 reinforcement of the practical expedient under ASC 606 for revenue recognition aligned with invoicing rights is also omitted, weakening the qualitative analysis of how contractual structures evolved in terms of accounting and reporting. While the core structure description is consistent and contextually relevant, the answer lacks the nuanced evolution across the three years, especially the increasing emphasis on transparency and ASC 606 compliance. The reasoning is partially sound but misses the synthesis across 2022–2024 disclosures regarding pricing mechanism clarity. Thus, while some factual elements are correct, the absence of key developments and introduction of unverified percentages reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 429,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net fair value of forward gas contracts rose from **$160 million in 2022** (assets $191 m – liabilities $31 m) to **$300 million in 2023** (assets $377 m – liabilities $77 m), then fell to **$250 million in 2024** (assets $296 m – liabilities $46 m). The 3‑year swing—expanding exposure in 2023 and trimming it in 2024—indicates an active hedging strategy that increases coverage when market conditions or cost forecasts warrant more protection and then reduces it as outlook or risk appetite shifts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values from the ground truth: net exposure of $160M in 2022 ($191M assets - $31M liabilities), $300M in 2023 ($377M - $77M), and $250M in 2024 ($296M - $46M). All figures match exactly, with only formatting differences (e.g., 'm' vs 'million'), which are acceptable. (2) Calculations are accurate: 191-31=160, 377-77=300, 296-46=250 — all correct. (3) The multi-hop reasoning is sound: the model synthesizes data across three years, identifies the trend (increase then decrease), and infers strategic intent — aligning with the ground truth's interpretation of shifting risk positioning. (4) The qualitative analysis is strong: while wording differs slightly (e.g., 'active hedging strategy' vs 'strategic shift'), the semantic meaning is equivalent — both describe intentional adjustments in exposure based on market conditions. All parts of the question are addressed: evolution over time and implications for risk positioning. Thus, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 294,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "AVGO consistently positioned industrial fiber optics as a core element of its industrial portfolio across 2022, 2023, and 2024, listing it as a key offering under the “Industrial” end markets of factory automation, renewable energy, and automotive electronics alongside other industrial components such as optocouplers and sensors [page_5 (2022), page_5 (2023), page_5 (2024)]. The narrative in each filing—page 8 of the 2022 10‑K and page 6 of the 2023 and 2024 10‑Ks—continues to describe fiber‑optic components as part of the broader industrial and telecom markets, underscoring a steady emphasis on industrial applications [page_8, page_6]. No significant shift in positioning or application focus is evident across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. It correctly identifies that AVGO consistently positioned Industrial Fiber Optics as a core part of its industrial portfolio across 2022–2024, with stable application markets including factory automation, renewable energy, and automotive electronics. It accurately notes the co-location of Industrial Fiber Optics with optocouplers, sensors, and other industrial components in the product portfolio. The mention of consistent narrative placement in the 10-K filings (page 8 in 2022, page 6 in 2023 and 2024) aligns with the source structure, though the original answer does not include page numbers—this addition does not detract from accuracy and may reflect actual document layout. There is no quantitative data (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is scored as 10 by default. The reasoning is sound, demonstrating multi-hop synthesis across three years of filings. The only minor shortcoming is that the LLM omits specific mentions of 'motion encoders' (2023) and 'Ethernet ICs' (2024) as co-located products, and slightly generalizes the 2022 applications (e.g., 'medical systems, defense, aerospace') under broader terms. However, the central conclusion—that there was no significant shift in positioning—is fully supported. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 413,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 31B carried a fixed 3.25 % interest rate and a face amount of $750,000, with an annual debt service of $24,375 thousand (≈$24.4 million) and a maturity of 11/30/26 in all three filings【page_50】【page_50】【page_51】.  The unchanged terms show that Simon has kept this long‑term, low‑cost note on a stable, fixed‑rate basis, underscoring a conservative debt strategy that prioritizes predictable cash‑flow obligations and minimal refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a critical error in the face amount: it states '$750,000' instead of the correct '$750,000,000' as per the ground truth. This is a significant quantitative mistake—off by three orders of magnitude—though the annual debt service is correctly reported as $24,375,000 (expressed as $24,375 thousand, which is equivalent and acceptable). The interest rate (3.25%) and maturity date (11/30/26) are accurately reported and consistent across years. (2) The calculation of annual debt service is implied to be correct: 3.25% of $750 million = $24,375,000. However, because the face amount is misrepresented as $750,000, the implied calculation would be incorrect if taken literally (3.25% of $750,000 = $24,375), suggesting the model may have confused thousands with millions. This undermines quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies that the terms remained unchanged from 2022 to 2024 and synthesizes this into a conclusion about SPG’s conservative long-term debt strategy, emphasizing stability and low refinancing risk. This aligns with the ground truth’s interpretation. (4) Despite the major error in face amount, the overall reasoning and qualitative insights are strong, and the answer addresses both parts of the question—evolution of obligations and strategic implications. The contextual relevance is high, and the use of citations (e.g., page references) adds credibility. The correctness score is reduced primarily due to the face amount error, which is a material financial inaccuracy, but not completely invalidating given that other key figures (debt service, rate) are correct in value and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 473,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and to **$76 million in 2024** (see each year’s 10‑K). This modest upward trend shows the company is maintaining a steady, slightly growing investment in employee retirement benefits, reflecting a consistent commitment to these plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These values are factually accurate and properly attributed to the respective years. (2) The quantitative accuracy is perfect—no calculation errors or misstatements. While the LLM does not explicitly compute the total percentage increase (8.6%), it correctly describes the trend as 'modest upward' and 'slightly growing,' which aligns with the 8.6% increase from $70M to $76M. The omission of the exact percentage is a minor gap but does not detract significantly from the correctness. (3) The multi-hop reasoning is sound: the model synthesizes data across three years from the 10-K filings and draws a reasonable conclusion about the company's commitment to retirement benefits. The term 'steady, slightly growing investment' semantically matches the ground truth's 'steady and slightly growing commitment.' (4) All entities—Texas Instruments, U.S. defined contribution plans, and the years 2022–2024—are correctly identified. The answer fully addresses both parts of the question: the evolution of expenses and the interpretation of the trend. The only minor shortcoming is the lack of explicit percentage calculation, but the qualitative assessment remains accurate. Thus, the answer is highly correct with only a slight omission in numerical detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 405,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in 2022, 2023 and 2024.  The same wording appears in each year’s discussion of ROIC, indicating that the company treats these items as non‑reflective of operating performance.  This consistency shows a deliberate, transparent performance‑evaluation methodology that isolates core operating results and ensures comparability across periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of methodological stability across those years. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited, and the treatment of non-economic items is accurately described. (3) The multi-hop reasoning is sound—by observing consistent exclusion across three years, the model correctly infers a stable, disciplined performance evaluation methodology focused on core operations. (4) The LLM adds value by noting the 'same wording' across years and emphasizing transparency and comparability, which are logically supported implications and enhance the explanation without introducing error. All aspects of the question—evolution over time and implications for performance evaluation—are addressed with factual accuracy and strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 296,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "Separate‑Accounts assets fell from **$3.313 billion** at December 31 2022 to **$3.204 billion** at December 31 2023, then rose to **$3.311 billion** at December 31 2024 (page 157 for 2022‑23; page 108 for 2024). The modest dip followed by a rebound to near‑2022 levels indicates that CVS has kept a relatively stable asset base for its long‑term insurance products, reflecting a steady investment positioning rather than a significant erosion or shift in those holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. The ground truth states that CVS's Separate Accounts Assets were $5,087 million in 2022, $3,250 million in 2023, and $3,311 million in 2024. However, the LLM reports $3.313 billion (i.e., $3,313 million) in 2022, $3.204 billion ($3,204 million) in 2023, and $3.311 billion in 2024. This misstates the 2022 value by over $1.7 billion and the 2023 value by ~$46 million, which is a major quantitative error. (2) The calculation of trend is therefore flawed: the ground truth shows a sharp 36.5% decline from 2022 to 2023, indicating a significant strategic or market-driven reduction, but the LLM describes only a 'modest dip' due to much smaller reported changes. This leads to an incorrect qualitative interpretation. (3) The multi-hop reasoning fails because the LLM did not correctly extract or synthesize the actual figures across years, leading to a conclusion opposite to the ground truth: stabilization near 2022 levels vs. a major drop followed by slight recovery. (4) While the LLM attempts to address both parts of the question (evolution and implication), the severe numerical inaccuracies undermine both completeness and reasoning. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is unsound. Minor note: citing page numbers adds apparent sourcing but does not compensate for incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 404,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. (originally dated Oct 22 2012) was amended in 2022 with a Third Amendment (filed as Exhibit (10)JJ to the Oct 29 2022 10‑Q) and further modified in 2023 by a Letter Agreement (filed as Exhibit 10.21.4 to the Apr 29 2023 10‑Q) (page 75). The 2024 10‑K incorporates the base agreement and these two post‑2022 amendments as exhibits, marking key contractual milestones in the program’s evolution (pages 69‑75).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that a 'Third Amendment' was filed in 2022 and a 'Letter Agreement' in 2023, which contradicts the ground truth: the most recent amendment by 2024 was the second amendment dated November 19, 2019. There is no mention in the ground truth of amendments in 2022 or 2023. (2) The LLM cites specific exhibits (Exhibit (10)JJ to the Oct 29, 2022 10-Q and Exhibit 10.21.4 to the Apr 29, 2023 10-Q) and page numbers (e.g., pages 69–75), which are not supported by the original answer and appear fabricated or misattributed. (3) The multi-hop reasoning is flawed: instead of correctly tracing the evolution as sustained with formal amendments up to 2019, the model invents post-2022 developments, failing to align with the documented timeline. (4) While the base agreement date (Oct 22, 2012) is correctly referenced, the core evolution narrative is incorrect. The ground truth emphasizes continuity and references only up to the second amendment (2019), whereas the LLM introduces unsupported amendments. Thus, despite addressing the general topic and citing document types appropriately, the answer is factually wrong on key dates and events, leading to a low correctness score. Contextual relevance is moderate because it discusses the right companies and document types, but accuracy is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 390,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In 2022 Linde presented rare gases simply as a co‑product of its atmospheric‑gas manufacturing, noting that they were part of the same cryogenic air‑separation process that produced oxygen, nitrogen and argon (page 94). By 2024 the company positioned rare‑gas production as a differentiated, patented capability, emphasizing its leadership in non‑cryogenic air‑separation technologies that enable higher purity and lower‑cost rare‑gas output (page 4). Linde also highlighted that this technology is integrated with its engineering and distribution platforms—leveraging shared air‑separation processes and the on‑site, merchant and packaged gas channels to deliver rare gases alongside other industrial gases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Linde's evolution from 2022 to 2024: in 2022, rare gases were presented as co-products of air separation (cryogenic process), and by 2024, Linde emphasized technological differentiation through non-cryogenic methods like VPSA and membrane separation. The mention of integration with on-site, merchant, and packaged channels matches the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes Linde’s shift from a product-centric to a technology-driven strategy, correctly linking rare gas production to proprietary technologies and distribution integration. It references specific technologies (non-cryogenic air separation) and business integration points, though it omits minor details such as 'long-term contracts with price escalation clauses' in 2023 and the explicit mention of krypton, neon, and xenon. (4) Despite these small omissions, the core facts, timeline, and strategic evolution are accurately conveyed with strong semantic equivalence. The answer is fully relevant to the question about production evolution, technological differentiation, and integration with other product lines. A score of 9 is justified due to high accuracy with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 404,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell sharply over the three‑year period: it was $1.494 billion at year‑end 2022, dropped to $800 million in 2023, and fell further to $491 million in 2024【page_102】【page_99】.  The decline reflects a shrinking exposure to derivative positions that are tied to advances to equity companies, indicating that the company has reduced its derivative activity or tightened its netting and margin strategy for those relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024 — matching the ground truth exactly with acceptable format variation. 2) Quantitatively, all figures are accurate and correctly attributed to the respective years; no calculations were required beyond recognition of the trend, which is correctly described as a decline. 3) The multi-hop reasoning is sound: the answer links collateral under master netting arrangements to derivative exposure tied to equity company advances, and infers reduced exposure, which aligns with the ground truth’s interpretation of de-risking or portfolio optimization. The LLM uses slightly different phrasing — 'reduced derivative activity or tightened netting and margin strategy' — which is a plausible and reasonable interpretation, though not identical to 'strategic reduction' or 'de-risking/optimization' in the original. This constitutes a minor difference in nuance but does not undermine factual correctness. 4) All entities (ExxonMobil, collateral under master netting arrangements, equity company advances, derivative liabilities) are correctly identified and contextually relevant. The answer fully addresses both parts of the question: the evolution over time and the implication for exposure. The inclusion of citation markers 【page_102】【page_99】 suggests proper grounding. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high score with only a slight deduction in qualitative accuracy due to less precise characterization of the strategic rationale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 448,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s long‑term contract coverage rose from about **92 % of its net generating capacity in 2022** (2022 10‑K, p. 19) to **94 % in 2023** (2023 10‑K, p. 19) and remained at that level in 2024 (2024 10‑K, p. 19). This steady, high‑level coverage demonstrates a deliberate risk‑mitigation strategy that locks in revenue and reduces exposure to spot‑market volatility in increasingly competitive electricity markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages and years are correct: 92% in 2022, 94% in 2023, and 94% in 2024, with proper citation of the respective 10-K filings. There are no calculation or numerical errors. (2) The answer addresses the evolution of NEER's reliance on long-term bilateral contracts across the three years, fulfilling the multi-part temporal comparison. (3) The reasoning correctly infers that the trend reflects a risk-mitigation strategy focused on revenue stability and reduced exposure to spot-market volatility, which is consistent with the original answer's interpretation. (4) The only minor omission is that the LLM does not mention the use of shorter-term bilateral contracts as a hedge when long-term agreements are absent—a detail included in the ground truth that adds nuance to the risk management strategy. However, this does not undermine the core correctness of the response. The answer is semantically equivalent in conveying the main trend and strategic implication. Entity names (NEER), time periods (2022–2024), and financial concepts (long-term bilateral contracts, spot-market volatility) are accurate and appropriately used.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 344,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal balance of $495 million at the end of fiscal 2022 (page 103), which remained unchanged at $495 million at the end of fiscal 2023 and again at $495 million at the end of fiscal 2024 (page 81). This shows that AVGO has not repaid or refinanced this instrument, reflecting a strategy of keeping the debt mix stable while managing overall leverage through other debt instruments or cash flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: the $495 million figure is consistently reported for all three fiscal years, and the maturity date (January 2025) is correct. Format is consistent and clear. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years from what would be multiple filings. The conclusion that AVGO maintained a stable debt balance is correct. However, the LLM states the company 'has not repaid or refinanced this instrument,' which slightly overreaches: the data shows no principal reduction, but refinancing could still occur near maturity. The original answer more accurately suggests AVGO 'may be planning to refinance or use cash reserves,' which is a more cautious and precise interpretation. (4) Despite this minor interpretive difference, the LLM answer is factually correct, complete, and highly relevant. The core insight about stable debt management is valid, and all key elements of the question are addressed with high fidelity. Thus, correctness is docked slightly to 9 for a small leap in interpretation, but all other scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 381,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 37B stayed unchanged: the interest rate remained 2.25 %, the face amount stayed at $700,000, and the maturity date stayed on January 15, 2032. This lack of change shows Simon Property Group’s preference for a stable, low‑cost long‑term debt profile, keeping predictable debt‑service obligations and avoiding refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the interest rate (2.25%) and maturity date (January 15, 2032), which match the ground truth. However, it incorrectly states the face amount as $700,000 instead of $700,000,000—a critical error that significantly understates the value by a factor of 1,000. This mistake undermines the quantitative accuracy. 2) The numbers for interest rate and maturity date are correct, but the face amount is off by three orders of magnitude. While formatting variations are acceptable (e.g., $700M vs $700,000,000), $700,000 is not equivalent and represents a factual error. 3) The reasoning about Simon Property Group’s long-term debt strategy—emphasizing stability, predictable obligations, and avoidance of refinancing risk—is logically sound and aligns with the ground truth interpretation. The synthesis across the three years showing no change is correctly interpreted. 4) Despite strong qualitative reasoning and contextual relevance, the severe quantitative error in the face amount prevents a higher correctness score. The answer is semantically close but factually flawed in a material financial metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 320,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "Texas Industries’ Melaka, Malaysia site remained an analog‑only manufacturing facility throughout the 2022‑24 period (2022: “Melaka, Malaysia ** – Analog”; 2023: “Melaka, Malaysia † – Analog”; 2024: “Melaka, Malaysia * – Analog”)【page_16】【page_16】【page_16】.  The footnote designation changed from ** to † to * (all indicating a leased/owned portion), but the product focus did not shift to embedded processing.  This three‑year consistency shows TI’s continued emphasis on analog products at Melaka, with no expansion into embedded processing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Texas Instruments' Melaka, Malaysia site remained focused exclusively on analog products from 2022 to 2024, with no expansion into embedded processing—this matches the ground truth. The core factual content is accurate: the site maintained an analog-only footprint throughout the three-year period. (2) There are no numeric values requiring calculation (e.g., financial figures or percentages), but the years (2022, 2023, 2024) are correctly referenced and aligned with the original answer. The use of footnote symbols (**, †, *) is consistent with formatting variations in source documents and does not affect factual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the unchanged product focus indicates a strategic emphasis on analog. The conclusion about 'continued emphasis on analog products' aligns with the ground truth's interpretation of 'targeted investment in analog capabilities.' (4) The only minor deviation is the company name: the LLM refers to 'Texas Industries' instead of 'Texas Instruments (TXN)', which is a factual error in entity naming, though the ticker is not used and context makes clear it refers to TI. This slightly affects qualitative accuracy but does not undermine the overall correctness. Wording differs but maintains semantic equivalence. Thus, the answer is highly accurate, complete, and contextually relevant, meriting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 416,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s real‑time payment infrastructure grew from 12 markets in 2022 to 13 markets in 2023 and 2024 (2022 page 11; 2023 page 11; 2024 page 11).  Over the same period the company maintained a multi‑layered security program—adding an enterprise‑resilience program, insurance coverage, regular testing, dedicated security operations, fusion and intelligence centers, and the use of tokenization, fraud‑scoring and technical standards—to protect the expanding global network (2022 page 12; 2023 page 12; 2024 page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of real-time payment infrastructure from 12 markets in 2022 to 13 in 2023, which aligns with the ground truth. However, it incorrectly states that the number remained at 13 in 2024, omitting the critical evolution in 2024—Mastercard's expansion into China via a joint venture and the need to scale security for domestic transaction processing there. This is a significant omission in the evolution of the security approach. (2) Quantitatively, the market counts (12 in 2022, 13 in 2023) are accurate and properly cited. The claim about 13 markets in 2024 is not factually wrong per se but is incomplete, as it fails to reflect the qualitative leap in market complexity with China's inclusion. No calculations are involved, so numerical accuracy is acceptable. (3) The multi-hop reasoning is partially sound: the model connects security measures across years and references consistent elements like tokenization, fraud scoring, and technical standards. However, it fails to synthesize the key 2024 development—integration of third-party risks and public-private partnerships in response to China's market entry and cross-border real-time payment threats—thus missing a core aspect of the security evolution. (4) Contextual relevance is high because the answer addresses the expansion of real-time payments and links it to security enhancements. But the lack of mention of China’s role in driving security changes in 2024 and the deeper integration of ecosystem-wide risk management reduces qualitative accuracy. The answer provides general security program details but does not fully capture the adaptive, multi-layered evolution in response to specific infrastructural changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 474,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics produced **449 new LAVs for the Canadian Army in 2022** (page 10, 2022 10‑K), **360 new LAVs in 2023** (page 11, 2023 10‑K), and **399 new LAVs in 2024** (page 10, 2024 10‑K). The dip from 2022 to 2023 followed by a rebound in 2024 shows the company is fine‑tuning its production schedule while still maintaining a strong, ongoing commitment to the Canadian LAV program, underscoring its strategic focus on sustaining and expanding that market segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported production volumes. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM incorrectly states 449 units in 2022, 360 in 2023, and 399 in 2024—reversing the trend. This misrepresentation fundamentally undermines the answer’s correctness. (2) The numbers are all mismatched to the years: 2022 should be 360 (not 449), 2023 should be 399 (not 360), and 2024 should be 449 (not 399). These are not formatting differences but outright inversions of the data, leading to incorrect calculations and comparisons. (3) The reasoning is flawed due to incorrect data synthesis: the LLM claims a 'dip' from 2022 to 2023, but in reality, there was a consistent increase each year. The conclusion about 'fine-tuning production' contradicts the ground truth, which indicates a consistent and growing strategic emphasis. The multi-hop synthesis across years fails because the temporal sequence is reversed. (4) While the answer addresses the right entities (General Dynamics, LAVs, Canadian Army) and attempts to interpret strategic focus, the severe quantitative inaccuracies lead to an incorrect narrative. Contextual relevance is moderate because the topic and structure align with the question, but factual correctness is critically compromised. Correctness and quantitative accuracy are low due to reversed time-series data; qualitative accuracy suffers from invalid reasoning based on wrong numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 423,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS’s target allocation to hedge‑fund limited‑partnership investments in its pension plan rose from **3 % in 2022** to **4 % in 2024** (up from 3 % in 2023 as well)【page_174】【page_169】. This modest 1‑percentage‑point increase over three years signals a deliberate shift toward higher‑risk, higher‑return assets, reflecting a more active and diversified pension‑fund strategy aimed at improving expected returns while still maintaining overall portfolio balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and type of data. The original answer reports absolute dollar allocations ($214M, $225M, $252M), while the LLM reports target allocation percentages (3%, 3%, 4%), which are different metrics. There is no mention of dollar amounts in the LLM response, and the percentages do not align with the ground truth data. The claimed '3% in 2022' and '4% in 2024' are unsupported by the ground truth, which does not provide percentage allocations. (2) The quantitative values are entirely inaccurate: the LLM invents percentage figures not present in the original answer, and no calculation from the dollar amounts in the original would yield these percentages without additional data (e.g., total pension assets), which are not provided or referenced. The '1-percentage-point increase' and '4% in 2024' are therefore unfounded. (3) The multi-hop reasoning fails because the LLM misrepresents the nature of the data (percentages vs. absolute dollar investments) and draws conclusions about strategy based on fabricated metrics. The original answer’s conclusion about a 'gradual upward trend' and 'consistent strategic approach' is reasonable given the 17.8% growth in dollar terms, but the LLM’s claim of a 'deliberate shift toward higher-risk, higher-return assets' is speculative and based on incorrect data. (4) Contextual relevance is moderate because the LLM addresses the general topic of CVS’s pension fund strategy and time frame, but the factual foundation is wrong, undermining the analysis. The citations to 'page_174' and 'page_169' suggest document grounding, but the data does not match the verified truth. Overall, the answer is mostly incorrect due to fundamental data mismatch.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 477,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration rate fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page_27】. This gradual decline suggests that while the card remains widely used, its share of total purchases is shrinking relative to overall sales growth, indicating a modest slowdown in consumer adoption or engagement as other payment methods or sales channels expand.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rate for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports the 2024 penetration rate as 18.6%, which is incorrect—the ground truth value is 17.8%. This discrepancy affects the quantitative accuracy significantly. (2) The calculation of the trend (declining penetration) is directionally correct, but the magnitude of the drop from 2023 to 2024 is understated (0.8 percentage points vs. actual 2.0 points), leading to an inaccurate portrayal of the trend's severity. (3) The reasoning about consumer adoption and engagement is partially sound—correctly attributing the decline to slower adoption relative to overall sales growth—but misses the key insight from the ground truth that RedCard sales increased in absolute terms while being outpaced by total sales, diluting penetration. It also omits mention of the continued 5% discount incentive and possible factors like competition or reduced sensitivity to discounts. (4) Despite the incorrect 2024 figure, the answer addresses both parts of the question—trend evolution and implications—and provides a reasonable interpretation, earning moderate scores in qualitative accuracy and high relevance. The primary failure is factual inaccuracy in a critical numeric value, limiting correctness to partial credit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 377,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "NextEra’s fair‑value exposure for FPL Cost Recovery Clauses rose sharply from a net $1 million in 2022 (observable $(5) + unobservable $7) to $38 million in 2023 (observable $4 + unobservable $34) and remained at $38 million in 2024. The composition shifted markedly: observable inputs jumped from $4 to $38 million (31 + 6 + 1) while unobservable inputs stayed roughly flat at $34 million, indicating a move toward more observable inputs【page_55】【page_54】【page_56】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both numbers and years. According to the ground truth, the total fair value was $1M in 2022, $12M in 2023, and $38M in 2024. However, the LLM incorrectly states that the value rose to $38M in 2023 and remained flat in 2024, completely omitting the correct 2023 value of $12M. Additionally, the LLM misrepresents the 2022 inputs: it claims unobservable inputs were $7M, but the truth is +$6M (with observable at -$5M). In 2023, the LLM skips the actual breakdown (-$12M observable, +$24M unobservable) and instead jumps to 2024-level inputs. The claim that 'observable inputs jumped from $4 to $38M' is baseless—the observable input was negative in 2022 and 2023, only turning positive in 2024 at $4M. (2) Calculations are fundamentally flawed: the LLM suggests a jump from $4M to $38M in observable inputs, but no such values exist in the data. It also incorrectly asserts unobservable inputs were flat at $34M, when they increased from $6M to $24M to $34M. (3) Multi-hop reasoning fails: the model does not correctly track the evolution across three years, conflates 2023 and 2024 data, and misattributes input shifts. It incorrectly infers a shift toward observable inputs, while the truth shows growing reliance on unobservable inputs over time, especially from 2022 to 2023. (4) Despite these issues, the answer is contextually relevant—it addresses fair value exposure, FPL Cost Recovery Clauses, and input types—and cites pages, suggesting some grounding in the document. However, the severe quantitative and qualitative inaccuracies severely undermine correctness, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 454,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike has maintained a strong competitive edge over Anta from 2022 through 2024, consistently emphasizing product innovation with technologies such as Flyknit, FlyEase, and React that continue to drive performance and sustainability (2024 page_6). Its brand‑engagement strategy remains centered on digital experiences, athlete endorsements, and direct‑to‑consumer channels, with a modest shift toward more digital commerce and fewer physical stores (2024 page_8; 2024 page_6; 2022 page_6). These sustained emphases underscore Nike’s continued advantage over Anta in both innovation and consumer engagement (2024 page_8).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but lacks the full evolution of NKE's strategic shift relative to Anta, particularly in the progression of innovation emphasis from 2022 to 2024. (1) Correct elements: The LLM correctly identifies NKE’s sustained focus on product innovation (e.g., Flyknit, FlyEase, React), digital engagement, athlete endorsements, and DTC channels. It accurately reflects NKE's competitive stance over Anta and cites appropriate document pages. There are no incorrect numbers, dates, or entities—quantitative accuracy is perfect. (2) Quantitative accuracy: No explicit numerical data (e.g., revenue, percentages) are present in either answer, so no discrepancies exist. The years 2022–2024 are correctly referenced. (3) Multi-hop reasoning: The LLM synthesizes information across years and correctly identifies Anta as a competitor and NKE’s innovation and engagement strategies. However, it omits the nuanced shift in priority: in 2022, performance and reliability were emphasized over innovation, but by 2023–2024, 'innovation and development' became the leading differentiator—a key strategic evolution highlighted in the ground truth but missing in the LLM response. (4) The answer is contextually relevant and well-structured, but the absence of this progression weakens the qualitative accuracy. While the conclusion of NKE’s advantage is valid, the explanation lacks the depth of strategic repositioning over time, which is central to the question. Hence, correctness and qualitative accuracy are reduced accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 432,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "From 2022 through 2024 the equity‑compensation tables show no shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan.  In 2022 the “available for future issuance” column lists only the 2009 LTIP, 2014 ESPP and 2018 Director Plan (page 63), in 2023 it lists the same three plans (page 61), and in 2024 it lists the 2024 LTIP, 2014 ESPP and 2018 Director Plan (page 59).  This steady absence of future‑issuance capacity indicates that TI is no longer allocating new shares under the 2003 plan and is effectively phasing it out, using it only for existing awards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the status of the 2003 Director Compensation Plan in 2022. According to the original answer, the 2003 plan was still active in 2022 with shares being issued under it, while the LLM claims no shares were available for future issuance as early as 2022. However, the LLM correctly observes that the plan does not appear in the 'available for future issuance' tables in 2022–2024, which supports the conclusion that TI was phasing it out. The key financial and structural details—correct plans listed for each year (2009 LTIP, 2014 ESPP, 2018 Director Plan in 2022–2023; 2024 LTIP replacing 2009 LTIP in 2024)—are accurate and properly cited by page number, demonstrating strong quantitative and entity accuracy. The reasoning is sound: the absence of the 2003 plan from future issuance tables across three years supports the conclusion that it is being phased out. The LLM correctly infers that the plan is only used for existing awards, which matches the ground truth. However, it underrepresents the plan’s residual activity in 2022, missing the nuance that it was still referenced as active with new grants at that time. This omission slightly weakens the qualitative accuracy but does not invalidate the overall trend analysis. The answer is highly contextually relevant and synthesizes multi-hop evidence (cross-year plan availability) effectively. Minor deduction from full score due to incomplete representation of 2022 status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 422,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "CMCSA’s advertising business already offered technology, tools, data‑driven services and marketplace solutions in 2022 (page 6, 2022). By 2023 it expanded this ecosystem by launching the NOW TV service, adding the Xumo Stream Box (formerly Flex) and integrating advanced search and voice‑activated remote control into its X1 and Sky Q platforms, thereby deepening its data‑driven advertising capabilities (page 6, 2023). In 2024 the company further enhanced its technology stack with DOCSIS 4.0 to deliver multigigabit symmetrical broadband speeds and continued to broaden marketplace solutions for advertisers (page 7, 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity identification and reasoning, leading to a moderate correctness score. (1) Correct elements include the general timeline of CMCSA's advertising evolution from 2022 to 2024 and the mention of expanding data-driven services. The 2022 baseline is accurately described as offering technology, tools, and data-driven services. (2) Quantitative accuracy is high—there are no numeric values to verify, and dates (2022–2024) are correctly used. (3) However, the qualitative accuracy suffers due to incorrect or unsupported enhancements: launching NOW TV, Xumo Stream Box, DOCSIS 4.0, and voice-activated remotes are not mentioned in the ground truth as part of advertising-specific technology enhancements. These may be product launches but are not explicitly tied to advertising tools or marketplace solutions in the provided truth. The ground truth emphasizes cloud-based platforms, integrated search across content sources, and strengthened third-party representation agreements—none of which are mentioned in the LLM answer. Instead, the LLM conflates broader platform developments with advertising-specific enhancements. (4) Contextual relevance is fair because the answer stays within the domain of CMCSA’s tech evolution, but it fails to accurately synthesize the multi-hop requirement of linking specific advertising technology improvements across years. The core of the question—evolution of data-driven *advertising* services—is not fully or correctly addressed, resulting in a score of 5 for correctness and qualitative accuracy despite correct timing and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 449,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities (CMBS) exposure has shrunk markedly.  At December 31 2022 the company held $1,018 million of CMBS with $98 million in unrealized losses; by December 31 2023 the fair value fell to $975 million and unrealized losses dropped to $2 million (2023 10‑K, pp. 148‑149).  In 2024 the CMBS fair value in the consolidated balance sheet is only $3 million (Separate Accounts, p. 160) with virtually no unrealized losses, indicating a deliberate move to a lower‑risk, more conservative position in this asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS held $574 million in CMBS with $12 million in unrealized losses in 2022, but the LLM claims $1,018 million and $98 million, respectively. In 2023, the ground truth reports CMBS fair value dropped to $675 million with unrealized losses increasing to $100 million, whereas the LLM states $975 million and only $2 million in losses—both values are incorrect. For 2024, the LLM correctly identifies a near-elimination of exposure ($3M vs. ground truth $6M), which is directionally close but still quantitatively off. (2) Calculations and comparisons are therefore flawed: the trend of rising unrealized losses in 2023 (from $12M to $100M) is reversed in the LLM answer (from $98M to $2M), completely misrepresenting the risk trajectory. (3) While the LLM attempts multi-hop reasoning across years and draws a conclusion about de-risking—which aligns with the ground truth’s interpretation—the underlying synthesis is based on incorrect data from the filings, undermining the validity of the conclusion. The model references specific pages (e.g., 148–149, p.160), suggesting document access, but reports values inconsistent with the ground truth derived from those sources. (4) Despite incorrect numbers, the answer remains contextually relevant by addressing all parts of the question—evolution over time, fair value, unrealized losses, and risk positioning—and reaches a qualitatively plausible conclusion (de-risking), though supported by false premises. Hence, low quantitative accuracy severely limits correctness, but structure and intent are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 459,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings for 2022 (page 5), 2023 (page 6), and 2024 (page 6) all list a “merchandise and other discounts” benefit for employees, but none of the documents disclose a specific discount rate or dollar value. Because the scope of the benefit remains the same and no change in value is reported, the filings suggest Target keeps a stable, predictable discount as part of its broader employee‑compensation strategy rather than frequently adjusting it.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually correct in stating that Target's 10-K filings from 2022 to 2024 consistently list 'merchandise and other discounts' as an employee benefit and that no specific discount rate or dollar value is disclosed—this aligns with the ground truth. Thus, quantitative accuracy is perfect: no incorrect numbers or dates are presented. However, the answer fails to capture the key qualitative evolution described in the original answer: the changing context and framing of merchandise discounts within an expanding benefits ecosystem. The ground truth emphasizes a strategic shift—from core compensation (2022) to inclusion in a broader package with financial wellness (2023) and holistic well-being (2024)—which the LLM answer omits entirely. Instead, it concludes that the benefit is 'stable' and 'predictable,' which, while not false, misses the nuanced progression in how Target presents its benefits strategy. This reflects a failure in multi-hop reasoning: the model did not synthesize the evolving narrative across years about benefit enhancements beyond discounts. As such, while contextually relevant and factually neutral, the answer lacks the depth and interpretive accuracy required by the question, which asked what the progression suggests about strategy. The LLM provides a simplistic stability narrative instead of the correct strategic evolution toward holistic well-being.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 387,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "From 2022 to 2024, Linde consistently listed cultural challenges as a key integration risk (page_12). The 2024 filing added an explicit reference to integration across different cultures and languages in foreign acquisitions (page_10), underscoring a heightened focus on cross‑cultural integration. This evolution signals a strategic emphasis on proactive cultural alignment to mitigate cross‑border integration risks and preserve synergies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Linde consistently highlighted cultural challenges as a key integration risk from 2022 to 2024 and that the 2024 filing emphasized integration across cultures and languages in foreign acquisitions. The dates and entities (Linde, 2022–2024) are correct, and there are no numerical inaccuracies, earning a perfect score on quantitative accuracy. Contextual relevance is high, as the response directly addresses the evolution of cultural risk emphasis and links it to cross-border integration strategy. However, the qualitative accuracy is slightly lower because the LLM omits key nuances present in the ground truth: it does not mention the 2023 shift linking cultural challenges to global regulatory and compliance risks, nor does it capture the 2024 framing of cultural integration in terms of financial impact and synergy realization. While the LLM correctly infers a strategic shift toward proactive alignment, it fails to fully synthesize the multi-hop progression—particularly the intermediate 2023 development and the increasing linkage to financial outcomes—resulting in a partially complete rather than comprehensive answer. Thus, the correctness score is 7 to reflect accurate core facts but missing depth in the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 359,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.494 billion in 2022 to $491 million in 2024** – a decline of about **$1.0 billion**. This drop indicates the company has reduced the amount of derivative exposure that requires initial‑margin collateral or has improved its netting efficiency, suggesting more effective management of its derivative risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key data points: $1.494 billion in 2022 and $491 million in 2024, matching the ground truth. However, it omits the intermediate 2023 value of $800 million, which is part of the full trend. While not strictly necessary to answer the overall change, its absence reduces completeness in showing the consistent year-over-year decline. The calculation of a ~$1.0 billion decrease is accurate ($1,494M - $491M = $1,003M). (2) Number formats are acceptable ($1.494 billion = $1,494 million), and the final 2024 figure is correctly stated. The omission of the 2023 data point is a minor quantitative gap but does not invalidate the overall trend. (3) The reasoning is sound: the decline is correctly interpreted as indicating reduced derivative exposure or improved netting efficiency, which aligns with the ground truth's interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' The model successfully synthesizes the multi-hop concept of collateral trends over time and infers appropriate implications about risk management. (4) Scores reflect high accuracy in all dimensions: near-perfect quantitative reporting, strong qualitative reasoning, and full contextual relevance. The only deduction is a minor one on correctness and quantitative accuracy due to the missing 2023 data point, which was part of the original trend description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 395,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "AVGO’s 2022 10‑K described the Security Insights Platform as a mainframe‑focused tool that “quickly interprets and assesses security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis, with the data available for use with in‑house SIEM tools”【page_11】. The 2023 filing repeats the same wording, showing no change in positioning or capabilities【page_11】. In 2024 the description is identical, but the platform is now explicitly referenced as part of the broader “Enterprise Security” portfolio, underscoring its role in an integrated cyber‑defense strategy while still offering the same risk‑identification, remediation, and SIEM‑integration features【page_10】. Thus, the platform’s core functions and external‑tool integration remained constant, with only a clearer alignment to the company’s overall cybersecurity framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, descriptions, and entity references (AVGO, Security Insights Platform, SIEM integration), and correctly cites consistent core functionality across years, which aligns with the ground truth. The quantitative and entity accuracy is perfect: years (2022–2024), platform name, and integration with in-house SIEM tools are correctly reported. However, the LLM underrepresents the evolution in 2024 by stating the description is 'identical' and that there was 'no change' in positioning, which contradicts the ground truth’s emphasis on a more strategic contextualization within an expanded software suite (Cybersecurity, AIOps, DevOps) and a broader role in enterprise security and compliance. While the LLM notes alignment with the 'Enterprise Security' portfolio in 2024, it misses the deeper integration and strategic expansion beyond just labeling. This omission downplays the platform’s evolved role in broader cybersecurity strategies, particularly its contextualization within a more comprehensive suite. The reasoning is sound in tracking continuity but incomplete in capturing the qualitative shift in strategic positioning. The answer remains contextually relevant and captures the core thread of integration and remediation, but lacks full completeness on the evolution of strategic alignment as required by the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 384,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 32B has stayed unchanged: the face value remains $750,000 and the coupon rate is 3.38 % with a maturity of June 15 2027 (see 2022 page 50, 2023 page 50, and 2024 page 51).  The unchanged terms show that the company is keeping this long‑term, fixed‑rate debt stable rather than refinancing or altering its exposure, underscoring a conservative, low‑cost debt‑management approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the interest rate (3.38%), maturity date (June 15, 2027), and the fact that the terms remained unchanged from 2022 to 2024. It also accurately captures the strategic implication of maintaining stable, fixed-rate debt as part of a conservative debt management approach. However, there is a critical error in the face value: the LLM states '$750,000' instead of the correct '$750,000,000' as stated in the ground truth. This is a three-order-of-magnitude error and significantly impacts quantitative accuracy.\n\n2) Quantitative verification: The interest rate (3.38%) and maturity date (June 15, 2027) are correct. The face value is incorrect — $750,000 vs $750,000,000. This is not a formatting issue but a factual error. The references to page numbers across years are plausible but not verifiable without source documents; however, they do not compensate for the numerical inaccuracy.\n\n3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years (2022–2024), confirms no changes in terms, and infers a consistent long-term debt strategy. The conclusion about conservative debt management aligns with the ground truth’s interpretation of a 'stable long-term debt strategy.'\n\n4) Despite strong qualitative reasoning and contextual relevance, the face value error severely undermines factual correctness. A score of 7 is justified because the core strategic interpretation is accurate and most non-numeric elements are correct, but the magnitude of the dollar amount error prevents a higher score. Quantitative accuracy is penalized heavily (score 4) due to the incorrect face value, while qualitative and contextual aspects remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 465,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022‑2024 the filings show that Lumen has steadily expanded its fiber‑to‑the‑premises network, adding fiber‑based service in more of Comcast’s footprint and offering higher‑speed plans that surpass traditional DSL.  The competitive threat has therefore grown as Lumen’s fiber rollout brings multigigabit options into many of Comcast’s markets.  While the documents note that competitors—including Lumen—may bundle broadband with voice or TV services, they do not provide specific details on Lumen’s bundling strategy; the primary concern remains the incremental fiber coverage and the higher‑speed packages it can now deliver.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of the evolving competitive threat from Lumen to CMCSA (Comcast) from 2022 to 2024. It correctly identifies the key trend: Lumen's ongoing fiber-to-the-premises (FTTP) expansion, which increases competitive pressure by enabling higher-speed broadband (including multigigabit) in Comcast's markets. The answer accurately reflects that fiber deployment is a central element of Lumen’s competitive strategy, consistent across the three years. However, the LLM slightly underrepresents the original answer’s emphasis on service bundling. While the LLM acknowledges that bundling (e.g., broadband with voice or TV) is noted among competitors generally, it states there is no specific detail on Lumen’s bundling strategy. In contrast, the original answer explicitly states that Lumen emphasized bundled offerings as part of its core strategy in each year, particularly as fiber deployment enabled more competitive packages. This omission is not a factual error but a reduction in completeness regarding Lumen’s strategic focus. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), as no specific figures are misstated. The reasoning is sound and reflects multi-hop synthesis across years and strategies, though the bundling aspect could have been more confidently asserted based on the source trend. Contextual relevance is excellent—the response directly addresses the question’s focus on fiber expansion and bundling over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 421,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded payment‑card penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024 (RedCard/Target Circle Card penetration)【page_27】. The steady decline indicates that fewer customers are adopting the cards, suggesting the loyalty‑driven payment strategy is becoming less effective at driving card usage and incremental sales【page_27】【page_29】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rate for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports 18.6% for 2024, whereas the original answer states 17.8%, which is a significant numerical discrepancy. This error affects the quantitative accuracy. (2) The calculation of the trend as a 'steady decline' is logically sound given the decreasing percentages, but the specific 2024 figure is incorrect, undermining full factual precision. The cited source (page_27) may contain the wrong data point or reflect a different metric (e.g., RedCard/Target Circle Card penetration), which does not align with the ground truth. (3) The multi-hop reasoning is appropriate—the model synthesizes penetration rates over three years and infers a trend about the effectiveness of Target's loyalty strategy. The conclusion that the strategy is becoming less effective is consistent with the downward trend and supported by the context, even if the magnitude of the 2024 drop is overstated. (4) The answer is contextually relevant and addresses both parts of the question: the evolution of penetration rates and the implication for Target’s strategy. Despite the incorrect 2024 value, the overall direction and interpretation remain plausible, warranting a moderate correctness score. Minor flexibility is allowed for referencing specific card names (RedCard/Target Circle), but the core metric must align with ground truth, which it does not in the final year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 413,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron’s presence in the Republic of Congo moved from ownership to divestiture between 2022 and 2024.  In 2022 the company held a 31.5 % non‑operated working interest in the offshore Haute Mer permit area and a 15.75 % interest in the Congo portion of the Lianzi field (2022 10‑K, p. 31).  By 2024 Chevron announced the sale of both interests—31.5 % in Haute Mer and 15.75 % in Lianzi—effective January 2025, signaling a strategic pullback from the region and a reduction in capital commitment there (2024 10‑K, p. 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron held a 31.5% nonoperated interest in Haute Mer and 15.75% in Lianzi in 2022, and announced the sale of both assets by 2024. These percentages match the original answer exactly. The mention of the 2024 10-K and effective date of January 2025 adds precision. (2) Quantitative accuracy is perfect—percentages and timeframes are correct, and no erroneous calculations were made. (3) The reasoning is sound: the LLM correctly infers a strategic pullback from asset divestiture, consistent with the original answer’s conclusion about portfolio realignment. The only minor omission is that the $0.7 billion investment in African offshore projects (including Congo) in 2023 is not mentioned, which slightly reduces completeness in showing the intermediate phase of continued investment before exit. However, this does not undermine the core narrative of evolution from presence to divestiture. (4) Contextual relevance is excellent—the response directly addresses asset ownership, investment implications, and strategic positioning over the 2022–2024 period. Wording differs but semantic meaning matches. Thus, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 365,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NEE’s net short gas‑option position grew from (1,307 MMBtu) in 2022 to (1,452 MMBtu) in 2023, then eased to (1,131 MMBtu) in 2024 (see Notional Volumes tables, pages 85 and 87).  The net fair value of gas options stayed essentially flat at a slight liability of about $2 million in both 2023 and 2024, while the weighted‑average implied volatility remained at 52 % (see Options‑primarily‑gas tables, pages 85 and 86).  This stability in fair value and implied volatility indicates that NEE’s hedging strategy kept the market‑perceived risk level unchanged even as the notional exposure contracted.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that in 2022, NextEra Energy had $356M in assets and $347M in liabilities for gas-related options, but the LLM claims a net liability of only ~$2M in 2023 and 2024 with no mention of 2022 values. The LLM introduces notional volumes (e.g., 1,307 MMBtu) not present in the original answer, suggesting a confusion between notional exposure and fair value. The fair value drop from $356M to $100M in assets from 2022 to 2023 is completely omitted. Additionally, implied volatility is reported as 52% in both 2023 and 2024 by the LLM, but the ground truth shows 50% in 2023 and 52% in 2024, with a significant increase from 36% in 2022—this trend is misrepresented. (2) Completeness: The LLM fails to address the evolution from 2022 to 2023 in fair value and volatility, which is central to the question. It skips 2022 data entirely and misrepresents the stability of fair value when in fact there was a major reduction. (3) Entity Accuracy: While the company (NextEra Energy/NEE) and topic (gas options) are correct, the metrics used (notional volume, net fair value of $2M) do not align with the ground truth’s focus on gross fair value of assets/liabilities and implied volatility trends. (4) Reasoning: The conclusion that 'hedging strategy kept market-perceived risk level unchanged' contradicts the ground truth, which shows a sharp de-risking (reduced exposure) amid rising volatility expectations—indicating increased caution, not stability. The LLM’s reasoning is based on incorrect data and thus flawed. (5) Semantic Equivalence: The core narrative—reduction in exposure followed by stabilization while volatility rose—is entirely missing and replaced with a false narrative of stable fair value and constant volatility. Despite referencing correct document sections, the extracted facts are factually inconsistent with the ground truth. Minor relevance is retained by discussing gas options and time trends, but the substance is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 555,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike’s 10‑K filings show a consistent treatment of FlyEase: it is listed among the company’s suite of technologies in both the 2022 and 2024 reports, appearing in the “Product Research, Design and Development” section as part of the broader “proliferation of technologies” (see 2022 page 6 and 2024 page 6).  The unchanged mention indicates that FlyEase remains an integrated, but not headline, element of Nike’s innovation portfolio—used to enhance product performance and accessibility rather than serving as a flagship technology.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually consistent in mentioning FlyEase's presence in Nike's 10-K filings for 2022 and 2024 and correctly locates it in the 'Product Research, Design and Development' section. There are no numeric inaccuracies, so quantitative accuracy is high. However, the answer incorrectly interprets the evolution of FlyEase: it claims the mention is 'unchanged' between 2022 and 2024, which contradicts the ground truth that shows a clear progression—from initial introduction in 2022, to expanded integration in 2023, to established core technology status in 2024. The LLM fails to acknowledge any development across the years, particularly omitting any mention of 2023, which breaks the multi-hop reasoning required to assess the evolution. This omission leads to an incorrect conclusion that FlyEase remains a 'not headline' element, whereas the ground truth indicates it became a foundational part of Nike’s innovation strategy. While the answer is relevant and based on plausible sections of the 10-K, it lacks the necessary synthesis across all three years and misrepresents the trajectory of FlyEase’s strategic importance. Thus, while contextually relevant and quantitatively sound, the qualitative reasoning and overall correctness are significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 355,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 35A stayed unchanged: a $750 000 face amount, a 2.65 % interest rate, and a maturity of July 15 2030 (page_50 for 2022 & 2023, page_51 for 2024). This constancy shows the company is pursuing a conservative long‑term debt strategy that relies on stable, low‑cost, fixed‑rate financing rather than frequent refinancing or restructuring of existing notes (page_50, page_51).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the face amount ($750,000), interest rate (2.65%), maturity date (07/15/30), and the consistency across 2022–2024 are accurately reported. Minor formatting differences (e.g., 'July 15 2030' vs '07/15/30', spacing in numbers) do not affect factual correctness. (2) Quantitative elements are fully accurate—no calculations were required beyond recognizing consistency, which was correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesized data across three years and correctly inferred that the lack of change indicates a stable debt strategy. The conclusion about a 'conservative long-term debt strategy' and reliance on 'stable, low-cost, fixed-rate financing' is a reasonable interpretation of the consistent terms, even if the original answer used slightly different phrasing ('steady approach'). (4) The answer is contextually complete and directly addresses both parts of the question: the evolution (no change) and what it reveals about SPG's strategy. The only minor shortcoming is that the original answer explicitly mentions annual debt service ($19,875), which the LLM omits. While this is a factual detail present in the ground truth, its absence does not undermine the core correctness or interpretation, warranting a 9 instead of a 10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 390,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across 2022, 2023 and 2024 Texas Instruments’ MD&A (pages 18–20 of each filing) repeatedly frames embedded‑processing as a core pillar of its business model, stressing its importance in industrial and automotive markets alongside analog products. Segment results show embedded‑processing revenue grew modestly from $3.26 B in 2022 to $3.37 B in 2023, then fell to $2.53 B in 2024, yet the company continues to highlight the segment as a key source of high‑margin cash flow. This consistent emphasis signals that TI’s long‑term growth strategy hinges on leveraging its manufacturing and channel advantages in analog and embedded‑processing products to maximize free‑cash‑flow‑per‑share and deliver sustainable shareholder value.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing across 2022–2024 and links it to free cash flow per share and long-term shareholder value, which aligns with the ground truth. However, the revenue figures provided—$3.26B in 2022, $3.37B in 2023, and $2.53B in 2024—are factually incorrect and not supported by the ground truth, which does not mention specific revenue numbers for embedded processing. These numbers appear fabricated or misattributed, severely undermining quantitative accuracy. (2) There is no verification in the ground truth for any revenue amounts or trends (growth then decline), so the inclusion of precise dollar figures constitutes a major factual error. The drop to $2.53B in 2024 is particularly problematic as it implies a significant decline not mentioned in the original answer. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the strategic narrative across years and connects embedded processing to TI’s competitive advantages and capital allocation strategy. It also appropriately references the MD&A sections and industrial/automotive focus, which are contextually relevant. However, the introduction of false quantitative data undermines the reasoning, suggesting a failure to distinguish between qualitative assertions and unsupported numerical claims. (4) Despite the serious quantitative inaccuracies, the qualitative narrative about TI’s long-term strategy centered on high-margin, scalable embedded processing products driving free cash flow per share is consistent with the ground truth. The answer remains contextually relevant and captures the core strategic intent, but the made-up figures significantly reduce overall correctness. Hence, correctness_score is 5 (partially correct but major errors), quantitative_accuracy is 3 (severe number errors), qualitative_accuracy is 7 (core logic sound but flawed by false data), and contextual_relevance is 9 (highly relevant to the question's intent).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 549,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "In 2022, Marvel was not a top‑level tile on Disney+; by 2023 Disney+ had elevated Marvel to a top‑level tile alongside Disney, Pixar, Star Wars and National Geographic (page_7), and by 2024 Marvel remained a key intangible asset, with its trademarks listed among the indefinite‑lived intangibles (page_114). This evolution shows Disney’s strategy of monetizing high‑value IP to attract and retain subscribers, thereby justifying investment in and amortization of intangible assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel was an indefinite-lived intangible asset in 2022 and 2024, and became a top-level tile on Disney+ by 2023. The mention of page_7 and page_114 suggests source grounding, though not required for scoring. (2) There are no numeric values (e.g., subscriber counts) in the LLM answer, but the original answer includes 123 million subscribers as of September 28, 2024. This omission is notable but not critical, as the LLM focuses on the strategic evolution rather than specific subscriber metrics. All other dates and classifications (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years and platforms—linking Marvel’s financial classification as an intangible asset with its strategic UI placement on Disney+. It infers Disney’s intent to monetize IP for subscriber growth, which is consistent with the original answer’s conclusion. (4) The answer is contextually relevant and captures the core evolution: from passive asset to active engagement driver. The only minor shortcoming is the lack of explicit mention of ESPN+'s planned tile launch in fiscal 2025, which adds depth to the strategic pattern. However, the central focus on Marvel is fully addressed. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness and qualitative accuracy, 10 for quantitative accuracy (no errors where numbers are used) and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 422,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife continued to reinsure 59 % of its closed block under a modified‑coinsurance agreement each year from 2022 through 2024.  The net ceded reinsurance recoverables linked to that agreement grew markedly, rising from $6.1 billion at December 31 2022 to $16.7 billion at December 31 2023 and to $17.6 billion at December 31 2024, reflecting the expanding scope of the modified‑coinsurance arrangement.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both percentages and dollar amounts compared to the ground truth. (1) Quantitatively: The percentage of the closed block reinsured was 59.25% in 2022, not 59%, and only stabilized at 59% in 2023 and 2024—this minor change is misrepresented as constant. More critically, the reinsurance recoverable balances are wildly incorrect: the ground truth reports $3.6B (2022), $4.4B (2023), and $4.2B (2024), whereas the LLM claims $6.1B, $16.7B, and $17.6B—over four times higher by 2024. These figures do not match any variation of 'unsecured' or 'net ceded' balances in the source data. (2) The answer fails to note the slight decrease in percentage from 2022 to 2023 or the decline in exposure in 2024, instead implying steady growth in the agreement’s scope. (3) Qualitatively, the reasoning is flawed: the conclusion that the arrangement expanded is unsupported and contradicts the stable percentage and only modest fluctuation in recoverables. The model appears to have either accessed incorrect data or misinterpreted the metric (e.g., confusing 'net ceded' with 'unsecured recoverable'). (4) Contextually, the answer addresses the right topic—evolution of modified coinsurance—and covers the correct time frame and entities (MetLife, closed block, modified coinsurance), so relevance is moderate. However, due to severe numerical errors and incorrect synthesis, the overall correctness is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 400,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s residential mortgage‑backed‑security (RMBS) portfolio fell from $721 million in 2022 to $614 million in 2023 (a decline of $107 million)【page_149】, and the fair value of RMBS held in its separate accounts rose to $71 million in 2024 from $51 million in 2023【page_160】. This 3‑year trend shows a cautious, risk‑averse stance: the company is trimming duration exposure while keeping high‑quality, agency‑guaranteed RMBS in separate accounts to preserve liquidity and meet regulatory capital requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS investment increased from $629M in 2022 to $614M in 2023, then dropped sharply to $71M in 2024. However, the LLM claims it fell from $721M in 2022 to $614M in 2023, which contradicts both the direction and magnitude in the first year. The 2024 value is cited as $71M, which matches the ground truth, but the LLM incorrectly frames this as an increase from $51M in 2023 (no such figure exists in the ground truth). (2) Calculations are flawed: the LLM reports a $107M decline from 2022 to 2023, but this is based on incorrect starting figures. The ground truth shows a slight decrease from $629M to $614M (a $15M drop), not $107M. Furthermore, the LLM introduces 'separate accounts' and 'fair value' language not present in the original answer, misrepresenting the nature of the portfolio shift. (3) Multi-hop reasoning is unsound: the LLM fails to recognize the strategic pivot implied by high exposure followed by de-risking, instead portraying a consistent risk-averse stance, which contradicts the rising unrealized losses (from $10M to $60M) in 2022–2023 that indicate increasing risk. The conclusion about preserving liquidity and meeting regulatory requirements is speculative and not supported in the ground truth. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the evolution of RMBS holdings and attempts to interpret strategic positioning—hence a moderate score on relevance. However, due to major errors in numbers, direction of change, and interpretation, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 453,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife continued to re‑insure 59 % of the closed block through a modified coinsurance agreement in both 2022 and 2024, and it has consistently accounted for the arrangement under the deposit method, offsetting the deposit liability against a deposit recoverable (2022 p. 214; 2024 p. 204). The deposit‑asset balance grew from roughly $1.8 billion in 2022 to $4.6 billion in 2024 (with $5.1 billion in 2023) (2024 p. 206; 2023 p. 229; 2022 p. 216).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions. While it correctly identifies the use of a modified coinsurance agreement and the deposit method accounting treatment, it incorrectly states that 59% was reinsured in both 2022 and 2024, omitting the precise 59.25% figure for 2022 and failing to mention 2023 at all. The ground truth specifies that the percentage was 59.25% in 2022 and 59% in both 2023 and 2024, so the LLM oversimplifies and misrepresents the evolution by implying consistency without acknowledging the slight change. (2) The dollar amounts cited ($1.8B, $4.6B, $5.1B) are not present in the original answer and were introduced without grounding in the provided truth; these figures may be factually correct in external context but are not part of the ground truth knowledge and thus constitute factual hallucinations. The original answer does not mention deposit-asset balances at all, so including them misaligns with the requested information. (3) The multi-hop reasoning is partially sound—linking accounting treatment across years—but fails to fully synthesize the evolution across all three years as required. It skips 2023 entirely in the narrative and mischaracterizes the stability of the percentage. (4) The qualitative accuracy is moderate because the core concept of consistent accounting under the deposit method with offsetting is correct. Contextual relevance is high since the response addresses reinsurance percentage and accounting treatment, though it adds irrelevant details about asset balances. Due to significant quantitative inaccuracies and omission of key details, the correctness score is 6—partially correct but with notable flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 464,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NEE’s net notional volume of forward gas contracts was **(1,307) MMBtu** at 2022, rose to **(1,452) MMBtu** in 2023, and fell to **(1,131) MMBtu** in 2024 (all figures from page 87). The decline in 2024 relative to the 2023 peak indicates the company is trimming its net‑short exposure to natural‑gas price risk, suggesting a more conservative or balanced hedging stance in the gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative data. It reports net notional volume in MMBtu (million British thermal units), while the ground truth refers to net exposure in dollar amounts ($ millions). The values cited—(1,307), (1,452), and (1,131) MMBtu—are not equivalent to the actual financial exposures of $160M, $300M, and $250M. There is no indication in the original answer that these MMBtu figures correspond to the dollar values, and no conversion or context is provided. (2) The numbers are entirely mismatched: for example, net exposure increased from $160M to $300M from 2022 to 2023 in the ground truth, but the LLM claims a decline in net notional volume from 2022 to 2023 (from -1,307 to -1,452 MMBtu, interpreted as short positions), which contradicts the financial trend. The 2024 decline is real in both cases, but the LLM bases it on volume, not financial exposure. (3) The reasoning is partially sound in interpreting a decline as a more conservative stance, which aligns with the original conclusion, but the multi-hop synthesis fails because it uses a different metric (physical volume vs. financial exposure). The model does not reference assets and liabilities or compute net exposure as the difference between them, missing the financial risk dimension entirely. (4) While the answer addresses the question's structure and attempts trend analysis and interpretation, it does so using an incorrect metric, leading to a fundamentally flawed response. The contextual relevance is moderate because it discusses the right company and topic and draws a plausible conclusion, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 455,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "AVGO’s 2022 filing described industrial fiber optics as a versatile component used across industrial automation, power‑generation, medical, defense, aerospace and automotive subsystems, and noted its integration with motion encoders and Ethernet ICs (page 7, page 10). The 2023 filing broadened the industrial markets to explicitly include renewable‑energy applications while keeping the same integration emphasis (page 5), and the 2024 filing maintained that positioning, reinforcing the product’s role in high‑speed data and sensor connectivity across an even wider array of industrial and automotive use cases (page 5).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022–2024), entities (AVGO, Industrial Fiber Optics, motion encoders, Ethernet ICs), and general application areas (industrial automation, automotive, medical, defense, renewable energy). It correctly notes the continuity in integration with motion encoders and Ethernet ICs and the expansion into renewable energy by 2023. However, it lacks depth in capturing the *evolution* of integration as emphasized in the original answer. Specifically, the 2024 shift toward explicit linkage with Ethernet PHYs, switch ICs, and camera microcontrollers—indicating a move toward networked and vision-based systems—is not mentioned. The LLM answer generalizes the 2024 positioning as 'reinforcing the product’s role in high-speed data and sensor connectivity' without highlighting the strategic pivot to more intelligent, integrated systems. While no numbers are incorrect (quantitative accuracy is perfect), the qualitative reasoning is partially incomplete in synthesizing the multi-hop progression across years. The answer remains contextually relevant and captures the core trajectory but misses nuanced strategic shifts in 2024. Hence, correctness is reduced to 7 for missing key details in the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 358,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock has remained unchanged through FY 2022‑FY 2024.  The cumulative dividend obligation stayed at $0.10 per share, payable annually on May 31, and the preferred shares—fully issued to Sojitz America at $1 par and redeemable at par for $0.3 million—continued to be the sole preferred class with no new issuances or structural changes.  Consequently, the dividend and stock‑structure obligations were stable across the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial implications of Nike's relationship with Sojitz America through redeemable preferred stock from FY2022 to FY2024. (1) All key facts are correct: the annual dividend obligation is accurately stated as $0.10 per share, the total par value (and redemption amount) is correctly noted as $0.3 million, and the stock structure remained unchanged. The date of dividend payment (May 31) is an additional detail not in the original answer but does not contradict it and may reflect deeper filing insight. (2) Quantitative accuracy is perfect: all dollar amounts, share terms, and dividend figures match the ground truth. Format variations (e.g., $0.3 million vs $0.3M) are acceptable and correctly interpreted. (3) Reasoning is sound: the LLM correctly infers stability in both dividend obligations and stock structure across the three fiscal years, synthesizing consistent terms over time. It correctly identifies Sojitz America as the sole holder and emphasizes the absence of new issuances or changes. (4) The only minor omission is that the LLM does not mention the dividend priority—i.e., that preferred dividends must be paid before common dividends—which is a notable qualitative aspect of the financial relationship emphasized in the original answer. Additionally, the point about Sojitz America not exercising its redemption option, while not strictly necessary, adds context to the stability claim. These omissions prevent a perfect 10 on qualitative accuracy, but the core multi-hop synthesis (stable structure + consistent obligations over time) is correctly executed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 482,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "From 2022 through 2024, the Unsecured Notes – 31B has remained unchanged: it has a face amount of $750 000, an interest rate of 3.25 %, and a maturity of 11/30/26 in each filing【page_50】【page_50】【page_51】. This stability shows that SPG treats the note as a fixed‑rate, long‑term debt instrument and has not sought to refinance or extend its terms, reflecting a conservative, predictable long‑term financing strategy for this debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the unsecured debt amount ($750,000), interest rate (3.25%), maturity date (November 30, 2026), and the stability across 2022–2024. These match the ground truth exactly, with acceptable formatting variations (e.g., '750 000' vs. '$750,000'). (2) Quantitative accuracy is perfect—no calculation errors, and all numbers/dates are correct. The maturity date is accurately rendered as 11/30/26, equivalent to November 30, 2026. (3) The reasoning is sound: the model correctly infers that the lack of change in this instrument indicates a conservative, predictable long-term financing strategy. It acknowledges broader portfolio changes implicitly by focusing on the stability of this specific note. However, it omits mention of other portfolio activities (e.g., retirement of other notes, issuance of Unsecured Notes - 41A in 2024), which were included in the ground truth for context. This minor omission slightly weakens the qualitative completeness of the multi-hop synthesis but does not affect the core correctness. (4) The answer is contextually fully relevant, directly addressing both parts of the question—evolution over time and strategic implication. The conclusion about SPG’s financing strategy is logically supported. A score of 9 is justified due to full factual and quantitative accuracy, with only a slight reduction in qualitative accuracy due to missing contextual nuance about broader debt portfolio changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 411,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "TI common stock held in U.S. defined‑contribution plans declined from $940 million (6 million shares) in 2022 to $873 million (5 million shares) in 2023 and to $852 million (5 million shares) in 2024. The downward trend reflects both a fall in the company’s share price and a reduction in share holdings, indicating that employees are selling or limiting their exposure to TI stock in retirement plans, likely in response to weaker stock performance or a desire to diversify.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the dollar values of TI common stock held in U.S. defined contribution plans for all three years—$940 million in 2022, $873 million in 2023, and $852 million in 2024—matching the ground truth exactly. It also adds share quantities (6M, 5M, 5M), which are not in the original answer but do not contradict it and may reflect additional data; their inclusion does not reduce accuracy. (2) All numeric values and trends (declining balances) are accurate. The year-over-year decreases are correctly implied: a $67M drop from 2022 to 2023 and $21M from 2023 to 2024. No calculation errors. (3) The reasoning correctly identifies the declining trend and attributes it to both falling share price and reduced holdings, which aligns with and expands upon the original answer’s suggestion of employee behavior shifts and the 2016 freeze. The LLM infers employee selling or reduced exposure due to performance or diversification, which is a reasonable interpretation consistent with the ground truth. However, it omits explicit mention of the 2016 freeze on new contributions, a key contextual factor noted in the original answer, slightly weakening the completeness of the causal explanation. (4) Despite this minor omission, the LLM captures the core trend and provides a plausible, well-reasoned analysis. The answer is semantically equivalent in intent and mostly in content, with excellent quantitative accuracy and high qualitative reasoning. Hence, a correctness score of 9 is warranted—excellent but not perfect due to missing one key structural reason (the 2016 freeze).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 443,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "From the 2022 10‑K (page 5) to the 2024 10‑K (page 16), Disney’s workforce grew from about 220,000 employees to roughly 233,000, with U.S. staff rising from 166,000 to 171,000 and international staff from 54,000 to 62,000. The proportion of seasonal workers increased modestly from 7 % to 8 % of the global workforce. Throughout this period, a significant number of employees—especially in theme‑park, production and cruise operations—continued to be covered by collective‑bargaining agreements, and employees outside the U.S. remained represented by works councils, trade unions or other employee associations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: total workforce increased from 220,000 to 233,000; U.S. employees grew from 166,000 to 171,000; international employees rose from 54,000 to 62,000; and seasonal workforce percentage increased from 7% to 8%. These figures are consistent with the original answer, and no calculation errors are present. (2) The answer is complete, addressing all parts of the question: total employees, U.S. vs. international distribution, seasonal workforce percentages, and employee representation. (3) Entity accuracy is correct—The Walt Disney Company is properly identified, and the time frame (2022 to 2024) is accurately referenced with appropriate context from the 10-K filings. (4) The reasoning is sound and reflects proper multi-hop synthesis across years and workforce categories. The mention of collective bargaining agreements and employee associations (e.g., works councils, trade unions) for theme park, production, and cruise staff aligns with the original answer’s emphasis on ongoing representation. (5) The semantic meaning is equivalent to the ground truth, with slightly enhanced detail (e.g., specifying cruise operations and works councils) that adds value without introducing inaccuracies. Wording differences do not affect factual correctness. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 393,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in 2022, 2023, and 2024.  The 10‑K disclosures for each year state that ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance.”  This steady approach shows the company’s intent to measure core operating performance and capital efficiency by isolating the returns generated by actual business activity from accounting adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion across all three years. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years, the model correctly infers a stable methodology and links it to GD’s intent to measure core performance. (4) The LLM adds contextual detail (e.g., mentioning goodwill impairments and quoting 10-K language) that enhances accuracy without introducing error. The conclusion about isolating business activity from accounting adjustments aligns perfectly with the original answer’s emphasis on economic performance over accounting volatility. All aspects—factual, qualitative, and contextual—are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 285,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "Linde’s 2022 10‑K did not discuss rare‑gas production at all, focusing instead on atmospheric and process gases (page_94). By 2024, the company explicitly notes that krypton, neon and xenon are produced as co‑products of its air‑separation plants and that it is a market leader in non‑cryogenic separation technology (page_4). This shift shows Linde is now positioning rare gases as a strategic extension of its core technology, giving it a reliable, cost‑efficient supply that strengthens its competitive edge in the industrial gas market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy by claiming that Linde’s 2022 10-K 'did not discuss rare-gas production at all.' This contradicts the ground truth, which states that in 2022, Linde explicitly included rare gases (krypton, neon, xenon) as part of its industrial gases portfolio produced via cryogenic air separation. The 2023 filing further reinforced this by positioning rare gases as core atmospheric gases. The LLM incorrectly omits any mention of the 2023 filing, breaking the multi-hop evolution from 2022 to 2024. However, the 2024 claim — that Linde identified itself as a market leader in non-cryogenic air separation technologies — is accurate and aligns with the ground truth. (2) There are no numerical values in the response, so quantitative accuracy is not applicable; no dates or financial figures are misstated, hence a score of 10. (3) The multi-hop reasoning is flawed because the model fails to acknowledge the continuity in rare gas production across all three years, instead creating a false dichotomy between 2022 and 2024. It misses the strategic progression through 2023, which is critical for showing evolution. The conclusion about competitive advantage is partially valid but oversimplified, lacking mention of specific technologies like VPSA and membrane separation cited in the ground truth. (4) Contextual relevance is high because the answer addresses Linde's strategy and competitive advantage in industrial gases, but the omission of key intermediate data and incorrect characterization of 2022 content reduces its overall correctness. The answer captures part of the truth but fails on full synthesis across the time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 463,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s reliance on long‑term bilateral contracts grew from roughly 92 % of its net generating capacity in 2022 (NEE_10k_2022, p. 19) to about 94 % in 2023 (NEE_10k_2023, p. 18) and remained at that level in 2024 (NEE_10k_2024, p. 18). This steady increase and plateau demonstrate a deliberate risk‑management strategy that prioritizes revenue certainty and hedges against price volatility in a highly volatile energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts for 2022 (92%), 2023 (94%), and 2024 (94%), matching the ground truth exactly. These values are accurately cited with correct document references (NEE_10k_2022, NEE_10k_2023, NEE_10k_2024), confirming quantitative accuracy. (2) All numbers and time periods are correct, with no calculation errors. The trend description — 'grew from roughly 92%... to about 94%... and remained at that level' — accurately reflects the slight increase and stabilization observed in the data. (3) The reasoning is sound: the LLM correctly infers that this trend indicates a deliberate risk-management strategy focused on revenue certainty and protection against price volatility. It aligns with the ground truth’s interpretation of risk mitigation in a volatile market. However, the LLM omits mention of 'non-qualifying hedges' as part of NEER's broader risk management approach, which is a minor but relevant detail in the full strategic picture. This omission prevents a perfect qualitative score. (4) The answer is contextually complete and highly relevant, addressing both the evolution of contract reliance and its implication for risk management. The slight increase and plateau are correctly interpreted as strategic. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth, with only a minor gap in completeness regarding hedging instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 417,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "The 3.125% notes due January 2025 had an outstanding principal balance of **$495 million at the end of FY 2022, FY 2023, and FY 2024** (shown in the debt schedule on page 81 of the 2023 and 2024 10‑Ks and on the FY 2022 10‑K).  The balance remained flat over this period, indicating that AVGO has chosen to keep this long‑term debt unchanged, focusing its debt‑management activity on other instruments (e.g., issuing new senior notes and repaying term loans) while preserving the maturity profile of the 3.125% notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million for the 3.125% notes due January 2025 is accurately reported for fiscal years 2022, 2023, and 2024. The dollar amount, percentage rate, and maturity date are all correct, with acceptable formatting (e.g., $495 million). (2) The answer is complete, addressing both parts of the question: the evolution of the balance (unchanged over three years) and the implication for AVGO's debt management strategy. (3) Entity accuracy is perfect: AVGO is correctly identified, the fiscal years are accurate, and the specific debt instrument is properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the lack of change in principal indicates no retirement or refinancing of this instrument, and it contextualizes this within broader debt management activities (e.g., issuing new notes, repaying term loans), which aligns with the qualitative insight in the ground truth. The mention of specific 10-K pages adds verifiability. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., referencing specific filings) that enhances rather than distorts accuracy. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 365,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "SPG’s Unsecured Notes – 37B has remained unchanged over the three reporting periods: the face amount stayed at **$700,000** and the maturity date remained **January 15, 2032** in 2022 (page 50), 2023 (page 50), and 2024 (page 51). This stability shows that the company has not altered or refinanced this instrument, reflecting a long‑term debt strategy that values a predictable, fixed‑maturity profile rather than frequent restructuring.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the face amount of $700,000 is correctly reported for all three years (2022–2024), and the maturity date of January 15, 2032 (formatted as 01/15/32 in the original) is correctly stated. Minor formatting differences (e.g., 'January 15, 2032' vs '01/15/32') are acceptable and do not affect factual accuracy. (2) Quantitative accuracy is perfect: no calculations are required beyond consistency checks, and the values match exactly across years. (3) The multi-hop reasoning is sound—information is synthesized across three years and filings (referencing specific pages), demonstrating that the note remained unchanged over time. (4) The conclusion about SPG’s long-term debt strategy—emphasizing stability, lack of refinancing, and a predictable maturity profile—aligns with and appropriately interprets the data. The answer addresses all parts of the question: evolution over time (face amount and maturity), and strategic implication. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 312,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has remained an **analog‑only** manufacturing location throughout the three reporting years.  In each 10‑K the property table lists Melaka under the “Analog” column only and leaves the “Embedded Processing” column blank, with no change in product‑line involvement from 2022 to 2024【page 16】【page 18】【page 18】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site remained exclusively focused on analog operations from 2022 to 2024, with no involvement in embedded processing—matching the original answer's key claim of consistent, specialized analog-only operations. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the absence of change over time is properly noted. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings (citing page references for each), confirming consistent categorization under 'Analog' and exclusion from 'Embedded Processing'. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in operational footprint and product line involvement. Minor stylistic differences (e.g., 'analog-only' vs 'exclusively under analog operations') do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 309,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "In fiscal 2022 Disney’s Content Sales/Licensing segment did not list post‑production services from Industrial Light & Magic (ILM) as a separate revenue line – the segment was described only in terms of TV/VOD, theatrical and home‑entertainment distribution. By fiscal 2023 and again in fiscal 2024 the segment’s description was updated to explicitly include “post‑production services through Industrial Light & Magic and Skywalker Sound” as a distinct revenue source, indicating a shift toward more granular reporting of that business within the segment【page_12】【page_7】【page_7】.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly states that in fiscal 2022, Industrial Light & Magic (ILM) was *not* listed as part of the Content Sales/Licensing segment, when the original answer confirms it *was* explicitly included. Conversely, the LLM claims that ILM was *added* in fiscal 2023 and 2024 as a newly explicit revenue source, which reverses the actual timeline. This inversion of the factual sequence severely undermines the answer's correctness. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is neutral—no calculations are involved, but the dates (2022, 2023, 2024) are correctly referenced in terms of fiscal years. (3) The multi-hop reasoning is flawed: the LLM fails to trace the *evolution* of ILM’s role correctly. Instead of identifying a strategic repositioning within a shifting content model (e.g., alignment with DTC-first strategy), it fabricates a change in reporting granularity that contradicts the source. (4) Contextual relevance is moderate because the answer addresses the right segment and entity (ILM in Content Sales/Licensing) and attempts to describe changes over time, but the core narrative is factually backward. The original answer describes a stable inclusion of ILM with evolving strategic framing, while the LLM describes a sudden disclosure of ILM as a new reporting line, which is incorrect. Thus, despite using relevant keywords and structure, the answer misrepresents the key evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 433,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method income from operating joint ventures fell from **$51 million in 2022 to $38 million in 2023** (page 247) but then surged to **$175 million in 2024** (page 224). The sharp rebound in 2024 indicates that the company’s insurance‑underwriting joint ventures recovered and performed strongly, improving profitability after a weaker 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the reported financial figures. According to the ground truth, MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. However, the LLM reports $51 million (2022), $38 million (2023), and $175 million (2024), which are all significantly off—both in magnitude and trend. These numbers are not within acceptable rounding or formatting variations and represent a complete mismatch. (2) The quantitative accuracy is very low: all three annual values are incorrect, and the implied year-over-year changes (e.g., a drop to $38M then rise to $175M) do not match the actual sharp drop to $151M and strong rebound to $988M. The LLM’s calculation of a 'sharp rebound' to $175M misrepresents the scale of recovery. (3) While the LLM attempts multi-hop reasoning by identifying a decline followed by a rebound, the underlying data synthesis is flawed—likely drawing from incorrect sources or misreading the filing. The qualitative assessment of recovery in 2024 aligns loosely with the ground truth trend, but the reasoning is based on incorrect data. (4) Contextual relevance is moderate: the answer addresses the right metric (equity-method income from joint ventures) and time frame (2022–2024), and interprets the trend directionally (decline then recovery), but the severe numerical inaccuracies undermine the conclusion. The mention of specific document pages suggests source grounding, but the data extracted is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 424,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "In 2022 General Dynamics produced 449 LAVs for the Canadian Army (page_10, 2022); production fell to 360 in 2023 (page_11, 2023); and rebounded to 399 in 2024 (page_11, 2024). The rebound after a dip demonstrates that the LAV platform remains a key export and modernization asset, underscoring its strategic importance as a market‑leading light‑armored vehicle in the company’s defense portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported production volumes and their chronological order. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023, and then to 449 in 2024. However, the LLM incorrectly states that 449 units were produced in 2022, 360 in 2023, and 399 in 2024—reversing the trend and misrepresenting the data. This inversion of the time series fundamentally undermines the answer's correctness. (2) The numbers themselves (360, 399, 449) are present but assigned to the wrong years, leading to incorrect year-over-year comparisons and invalidating any derived conclusions about growth or decline. Calculations or trends based on these misaligned figures are therefore erroneous. (3) The multi-hop reasoning fails because the model did not correctly synthesize the temporal progression across years. While it attempts to interpret strategic importance, the flawed data leads to an incorrect narrative of a 'dip and rebound' rather than a consistent upward trajectory, which is central to the original conclusion about increasing strategic importance. (4) Despite the incorrect numbers and trend, the LLM does address both parts of the question—production evolution and strategic significance—and uses appropriate context (e.g., export relevance, modernization asset), earning partial credit for contextual relevance. However, due to major quantitative and qualitative inaccuracies, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 416,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan increased its hedge‑fund limited‑partnership exposure from **$214 million in 2022** (page 166, 2022 10‑K) to **$252 million in 2023** (page 173, 2023 10‑K) and to **$280 million in 2024** (page 167, 2024 10‑K). The steady rise reflects a deliberate tilt toward hedge funds, consistent with the plan’s target allocation of roughly 4 % in hedge funds and a strategy to diversify risk while pursuing higher expected returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for hedge fund exposure. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM incorrectly states $252M in 2023 and $280M in 2024, which are both factually wrong. The 2022 figure is correct. (2) The quantitative inaccuracies are severe: the 2023 value is overstated by $27M (from $225M to $252M), and 2024 is overstated by $28M (from $252M to $280M). These are not minor rounding differences but material misstatements. Additionally, the LLM cites page numbers and filings, which may appear credible but contradict the verified ground truth data. (3) The reasoning and synthesis are partially sound—the conclusion about a 'deliberate tilt toward hedge funds' aligns with the upward trend—but because the underlying data is incorrect, the multi-hop inference is based on false premises. The mention of a '4% target allocation' is not present in the original answer and introduces unverified detail. (4) The contextual relevance is fair because the answer addresses the evolution of exposure and interprets the trend in strategic terms, which matches the question's intent. However, due to major numerical inaccuracies, the correctness score is low. Quantitative accuracy is severely compromised, qualitative accuracy is moderate due to correct directional interpretation but incorrect specifics, and contextual relevance is acceptable due to proper framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 415,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Sorriso has remained a principal global and regional trademark in Colgate‑Palmolive’s 10‑K filings for 2022, 2023 and 2024, underscoring its continued integration into the company’s global Oral, Personal and Home Care portfolio【page_79】.  The brand is part of the Oral Care segment, which accounted for 43 % of worldwide net sales in 2024, 42 % in 2023 and 43 % in 2022, indicating no significant repositioning or integration changes over the three years【page_79】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that Sorriso remained a principal global and regional trademark across 2022, 2023, and 2024, which matches the original answer's claim about its consistent presence in Colgate-Palmolive’s portfolio. (2) The percentages for Oral Care segment net sales (43%, 42%, 43% across the three years) are factually correct and support the conclusion of stable integration, though this specific data was not in the original answer—it is consistent with the broader context and enhances the response without introducing error. (3) The multi-hop reasoning is sound: the LLM synthesizes trademark status over three years and links it to segment performance, correctly inferring no significant repositioning. (4) While the original answer emphasizes Sorriso’s role in regional market penetration and diversified engagement, the LLM captures the essence of strategic continuity, even if slightly less detailed in qualitative nuance. The mention of page_79 adds sourcing credibility. No factual inaccuracies; minor deduction in qualitative accuracy only because the LLM does not explicitly note Sorriso’s positioning alongside Colgate and Palmolive as a strategic signal, but the core conclusion of stable integration is correct. All entities, years, and metrics are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 375,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s operating‑joint‑venture exposure fell from **$51 million in 2022 to $38 million in 2023**, then surged to **$175 million in 2024**. This three‑year swing signals a strategic shift toward greater equity‑method exposure in operating joint ventures, indicating the company is prioritizing these higher‑return, diversified investments to strengthen its overall equity‑method portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, MetLife's financial exposure decreased from $77M in 2022 to $51M in 2023 to $38M in 2024. The LLM incorrectly states exposure was $51M in 2022, $38M in 2023, and then falsely claims a surge to $175M in 2024—this is the opposite of the actual trend. (2) All numerical values are wrong except for $38M in 2024, which appears in both answers but is misattributed to the wrong year in the LLM response (it is listed as 2023 in LLM, but should be 2024). The $77M figure for 2022 is completely omitted and replaced with an incorrect $51M. The claim of a surge to $175M in 2024 has no basis in the ground truth. (3) The multi-hop reasoning is fundamentally flawed: instead of identifying a consistent decline indicating reduced strategic emphasis, the LLM infers a strategic increase in equity-method investments, which contradicts the evidence. The synthesis across years is incorrect, and the conclusion is the opposite of what the data supports. (4) The contextual relevance is partially maintained because the answer addresses financial exposure to joint ventures and attempts to interpret strategic positioning, but due to severe factual and logical errors, the overall correctness score is very low. Quantitative accuracy is extremely poor (score 1), qualitative reasoning is invalid (score 1), and while the topic is relevant, the answer misrepresents the trend (contextual relevance score 3).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 416,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "From 2022 to 2024 Chevron’s stake in Angola LNG Limited stayed at 36.4 % (2022 10‑K, page 78; 2024 10‑K, page 14). In 2024 the company broadened its operational footprint by adding frontier acreage (Blocks 49 and 50) and a 31 % non‑operated working interest in the New Gas Consortium Project, whose Quiluma and Maboqueiro fields will feed gas to the Soyo LNG plant, and it also holds a 31 % interest in a PSA for Block 14/23, thereby deepening its integration with upstream gas development in Angola.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states Chevron's 36.4% stake in Angola LNG Limited, consistent across 2022 and 2024, and accurately notes the 31% non-operated working interest in the New Gas Consortium (NGC) Project, including the Quiluma and Maboqueiro fields feeding into the Soyo LNG plant. These quantitative details match the ground truth exactly. (2) All numbers, percentages, and project names (Blocks 49/50, Block 14/23, NGC) are factually correct and align with the original answer and underlying data. The citation of 10-K pages adds precision. (3) However, the LLM answer misses the evolution of Chevron’s operational role over time—specifically, the shift from a 'passive equity investor' in 2022 to more integrated operations by 2024. While it mentions expanded acreage and interests, it does not convey the strategic narrative of evolving integration, which is central to the question. The original answer emphasizes a multi-year shift in operational posture, which the LLM answer omits in favor of listing new assets. (4) The answer is contextually strong and factually precise on numbers and entities, but lacks the qualitative synthesis of Chevron’s changing role over time, which is a key part of the multi-hop reasoning required. Thus, while quantitatively accurate and relevant, it falls short on fully capturing the strategic evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 386,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO had $622 million of 3.625% notes due October 2024 outstanding at the end of FY 2023 (and, having been issued in April 2019, the same amount was also outstanding at FY 2022)【page_81】. By the end of FY 2024 the company had retired the notes, reducing exposure to zero【page_81】. This progression shows a proactive debt‑management strategy that actively refines the maturity profile—repaying or refinancing maturing debt before its due date to keep the debt structure favorable and mitigate refinancing risk【page_81】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $622 million outstanding amount for the 3.625% notes due October 2024 is accurately reported for both 2022 and 2023, with complete retirement by 2024—consistent with the original answer. The fiscal years and maturity date (October 2024) are correctly referenced. (2) The answer correctly infers that the amount remained unchanged from 2022 to 2023 based on the note issuance date (April 2019) and absence of repayment activity before 2024, which aligns with the ground truth. (3) The multi-hop reasoning is sound: it synthesizes data across fiscal years and interprets the retirement of debt by 2024, even if not explicitly stated in every filing, using disclosure absence as evidence—this is a valid analytical approach supported by SEC reporting norms. (4) The qualitative interpretation about AVGO’s proactive debt management strategy—refining maturity profile, mitigating refinancing risk through repayment or refinancing—is semantically equivalent to the ground truth’s conclusion. The use of terms like 'proactive debt-management strategy' and 'refines the maturity profile' accurately reflects the strategic implication. All parts of the question are addressed: evolution over 2022–2024 and strategic interpretation. Minor wording differences (e.g., 'refines' vs 'refinancing') do not affect factual equivalence. No errors in entities, numbers, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 402,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The interest expense on Unsecured Notes – 35B was $28,500 thousand in 2022 (page 50), 2023 (page 51), and 2024 (page 51) – the same 3.80 % rate on a $750,000 face amount each year.  The unchanged expense shows that SPG’s financing cost for this instrument has been stable over the period, with no increase in interest burden.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the interest expense of $28,500 thousand (i.e., $28.5 million) is accurately reported for all three years—2022, 2023, and 2024—consistent with the original answer. The additional detail about the 3.80% interest rate on a $750,000 thousand ($750 million) face amount is factually sound and provides useful context, as 3.80% of $750,000,000 equals $28,500,000, confirming the accuracy of the expense figure. (2) The answer is complete, addressing both parts of the question: the evolution of interest expense (stable across years) and what the trend suggests (stable financing costs due to fixed-rate structure, implied by unchanged expense). (3) Entity accuracy is correct: SPG is the company, 'Unsecured Notes - 35B' is the instrument, and the years 2022–2024 are properly referenced. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: the model inferred that constant dollar expense over time implies a fixed interest rate, which aligns with financial logic and the conclusion in the ground truth. The inclusion of source pages (50, 51) adds traceability, though not required. (5) Semantic equivalence is strong: while the LLM provides slightly more detail (rate, face value), the core message—that interest expense remained unchanged, indicating stable financing costs—is identical to the original. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 405,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "Disney’s DTC strategy shifted from a high‑cost, growth‑oriented model in 2022—when it announced an ad‑supported Disney+ service, new pricing and cost realignment to counter rising programming costs and competition (page 27)—to a more structured, cost‑containing approach in 2023, with the reorganization of DMED into Entertainment and Sports, trimming of content on DTC platforms, and the launch of ESPN+ as a flagship streaming service amid intensified competition (pages 22, 28). By 2024, Disney continued to invest in DTC but focused on cost containment, re‑organization, and expanding its ad‑supported Disney+ and ESPN+ offerings, while managing higher content costs and a crowded streaming market (pages 28, 51).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall evolution of Disney's DTC strategy from 2022 to 2024 and correctly identifies key strategic shifts, such as the introduction of ad-supported tiers, cost containment, reorganization, and rising programming costs. There are no numeric inaccuracies—no specific dollar amounts or percentages are stated in the LLM answer that contradict the ground truth (e.g., the $12.25 billion in unused bank facilities is not mentioned but not denied). However, the LLM omits several key elements from the original answer that affect completeness and qualitative accuracy: (1) it does not mention Disney’s acknowledgment in 2022 of negative or low returns and uncertain business prospects, which is a critical part of the cautious investment stance; (2) it fails to reference the expectation that subscription and ad revenues would offset declining linear affiliate fees, a core financial rationale in 2023; (3) it does not include the point about programming distributors demanding terms that reduce revenue growth, such as bundling DTC services with fewer linear networks, which is a significant competitive and strategic shift in 2024. While the LLM captures the general trajectory—increased investment amid rising costs and competition—it synthesizes less of the financial uncertainty and revenue transition dynamics that are central to the multi-hop reasoning required. The answer is contextually relevant and well-structured, citing page numbers plausibly, and maintains semantic alignment on the strategic moves (e.g., ESPN+ expansion, cost trimming). However, the omission of key financial and strategic nuances reduces the qualitative accuracy. Quantitative accuracy is scored highly because no numbers are misstated—only omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 488,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew sharply in 2023, rising from $1.8 billion of deposit assets and $1.4 billion of deposit liabilities in 2022 (the same level reported for 2021 and 2020) to $5.1 billion and $1.3 billion in 2023, before easing slightly to $4.6 billion and $1.2 billion in 2024【page_216】【page_206】. The 2023 risk‑transfer deal with Global Atlantic created $10.3 billion of deposit receivables and a $770 million net cost recorded as deposit liabilities, driving the 2023 increase【page_206】. The deposit method continued to be applied to reinsurance agreements that do not expose MetLife to a reasonable possibility of a significant insurance‑risk loss.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 deposit assets ($1.8B) and liabilities ($1.4B), the 2024 figures ($4.6B assets, $1.2B liabilities), and the $10.3B reinsurance recoverables from the Global Atlantic transaction. However, it incorrectly states that deposit assets rose to $5.1B in 2023, while the ground truth does not report 2023 interim balances and instead notes a jump to $4.6B by end-of-2024. The $5.1B figure is unsupported and contradicts the trajectory implied in the original answer. Additionally, the claim of a $770M net cost recorded as deposit liabilities is not present in the ground truth, which reports liabilities declining to $1.2B by 2024 without mentioning such a cost. (2) Quantitative inaccuracies include the fabricated $5.1B 2023 asset value and the erroneous $770M liability adjustment. The correct 2023 data should reflect a significant increase due to the $10.3B receivable, but the original answer does not specify 2023 year-end balances—only 2024. Thus, the LLM introduces unsupported precision. (3) The multi-hop reasoning is mostly sound: it connects the Global Atlantic transaction to the increase in deposit method usage and correctly contextualizes the accounting policy. However, it misrepresents the timing and magnitude of balance changes, failing to reflect the 'post-transaction rebalancing' described in the original answer. (4) Despite the numerical inaccuracies, the LLM captures the strategic shift in 2023 and the recalibration by 2024, correctly citing sources and maintaining semantic alignment on the overall trend. Hence, correctness is reduced due to significant quantitative errors, but qualitative and contextual accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 466,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s commercial mortgage‑backed‑security (CMBS) holdings declined over the three‑year period: the fair value of CMBS in the overall portfolio fell from **$1.172 billion in 2022 to $1.066 billion in 2023** (see 2023 and 2022 tables on page 147), and the fair value of CMBS held in Separate Accounts dropped from **$6 million in 2023 to $3 million in 2024** (page 160). This downward trend indicates a deliberate shift away from CMBS, suggesting the company is trimming exposure to this asset class—likely in response to market volatility or a preference for lower‑risk, more liquid investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and then dropped to $3 million in 2024. However, the LLM claims $1.172 billion in 2022 and $1.066 billion in 2023, which are more than double the correct values. Additionally, the LLM introduces a distinction between 'overall portfolio' and 'Separate Accounts' not present in the original answer or implied by the question, misrepresenting the data source and structure. The only correct number is the $3 million in 2024. (2) Calculations and comparisons are therefore incorrect: the claimed decrease from $1.172B to $1.066B is a modest drop, whereas the actual trajectory includes a spike in 2023 followed by a near-total divestment in 2024. The LLM misses the increase from 2022 to 2023 entirely. (3) The multi-hop reasoning is partially sound in that it identifies a downward trend from 2023 to 2024 and infers a strategic reduction in exposure, which aligns with the ground truth's conclusion about de-risking. However, it fails to capture the full three-year evolution—specifically the increase in 2023—which is critical to understanding the strategic shift occurring only after that year. (4) The contextual relevance is fair because the answer addresses the evolution and strategic implication, but the severe numerical inaccuracies undermine correctness. The qualitative reasoning is somewhat logical but based on incorrect data. Thus, the correctness score is low due to major factual errors, despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 448,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "The “hello” brand has been listed as a principal global and regional trademark in each of the 2022, 2023 and 2024 10‑K filings (2022 page 79; 2023 page 79; 2024 page 79), showing that the company continues to protect and promote the brand.  The brand remains positioned within the Oral, Personal and Home Care segment, which accounted for 43 % of net sales in 2022 and 2024 and 42 % in 2023 (2024 page 79; 2023 page 79; 2022 page 79), indicating a stable strategic emphasis with no significant shift in positioning across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 'hello' brand is consistently listed as a principal trademark in the 2022, 2023, and 2024 10-K filings on page 79 of each, confirming its ongoing inclusion in Colgate-Palmolive’s trademark disclosures. The percentages of net sales for the Oral, Personal and Home Care segment (43% in 2022 and 2024, 42% in 2023) are accurately reported and correctly cited to page 79 of the respective filings. These numbers match the expected data and show no calculation errors. (2) The entity identification is correct—Colgate-Palmolive, the 'hello' brand, the relevant time frame (2022–2024), and the correct business segment are all properly referenced. (3) The multi-hop reasoning is sound: the model synthesizes trademark disclosure data across three years and integrates it with segment-level financial performance to infer stable strategic positioning. This demonstrates appropriate cross-year and cross-metric analysis. (4) While the original answer emphasizes the brand’s role in diversification and consumer engagement strategies, the LLM answer reaches a semantically equivalent conclusion by noting 'no significant shift in positioning' and 'stable strategic emphasis.' The only minor gap is the lack of explicit mention of the brand’s alignment with core categories like oral care and personal hygiene, which is implied but not stated. However, this does not detract from the overall correctness. The answer is contextually precise, directly addressing the evolution of the brand’s portfolio positioning through trademark disclosures and strategic emphasis. Minor deduction from 10 to 9 due to slightly less elaboration on strategic intent, but all key facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 486,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s reinsurance accounting has shifted toward the deposit method, which is used for agreements that do not expose the company to a significant insurance‑risk.  In 2022 the company applied the deposit method to a modified‑coinsurance arrangement covering 59.25 % of the closed block (page 214).  Deposit assets grew from $1.8 billion in 2021 to $5.1 billion at year‑end 2023, while deposit liabilities remained roughly $1.3 billion (page 206).  In 2024 the deposit‑method balances eased slightly to $4.6 billion in assets and $1.2 billion in liabilities, indicating a modest contraction or rebalancing of such agreements while still maintaining a strategy of risk transfer with collateral (page 206).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the overall trend of increasing use of the deposit method and correctly identifies the shift in accounting strategy. It notes the decline in 2024 deposit assets and liabilities, aligning with the ground truth. However, there are key quantitative inaccuracies: it states deposit assets grew from $1.8 billion in 2021 (not 2022) to $5.1 billion in 2023, while the ground truth reports $1.8 billion in 2022 and $4.6 billion in 2024 (with no 2023 asset figure provided in the original answer). The LLM incorrectly cites $5.1 billion in 2023 assets, which is both a misstatement of the amount and the year. Additionally, the ground truth does not mention the 59.25% closed block arrangement or page numbers, suggesting the LLM may have pulled details from a real filing but introduced specifics not in the ground truth, potentially overfitting to source material not part of the evaluation.\n\n2) Quantitative accuracy is compromised: the $1.8 billion asset figure is attributed to 2021 instead of 2022, and the $5.1 billion figure for 2023 is inconsistent with the ground truth’s $4.6 billion in 2024. While the 2024 figures ($4.6B assets, $1.2B liabilities) are correct, the trajectory is misrepresented. Liabilities are stated as 'roughly $1.3 billion' in 2023, but the ground truth does not provide a 2023 liability figure—only 2022 ($1.4B) and 2024 ($1.2B). This introduces unsupported interpolation.\n\n3) The reasoning is logically sound: the LLM infers a strategic shift toward reinsurance structures with limited risk transfer and interprets the 2024 dip as a rebalancing, which is a reasonable conclusion. It correctly links the deposit method to lack of significant insurance risk and notes balance sheet implications. However, it misses the explicit connection to the Global Atlantic transaction mentioned in the ground truth, which is a key driver of the 2024 increase.\n\n4) The answer is contextually relevant and addresses both the evolution of accounting practice and what the trend reveals about strategy and risk. Despite incorrect intermediate numbers, the overall narrative of increased reliance on deposit-method reinsurance followed by slight contraction is plausible. The score is reduced primarily due to factual inaccuracies in timing and amounts, which affect the reliability of the financial trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 625,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "NEE’s special‑use‑fund exposure rose from $4.4 billion in 2022 to $8.7 billion in 2023 and $9.8 billion in 2024, with the assets reported as other assets and measured at fair value; the fair‑value disclosures show carrying amounts essentially equal to estimated fair values, indicating little change in valuation. Collateral exposure tied to credit‑risk‑related derivative features fell from about $7.4 billion in 2022 to $4.7 billion in 2023, and the amount of collateral posted (cash and letters of credit) dropped from roughly $4.6 billion to $2.3 billion, reflecting a lower potential collateral requirement. The 2024 collateral posting requirements are not disclosed in the provided pages, but the balance‑sheet presentation of special use funds remains as other assets with fair‑value measurement.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024, but the LLM incorrectly states $8.7 billion in 2023 (close) and omits the 2022 value entirely, instead citing $4.4 billion in 2022, which does not appear in the ground truth. The ground truth does not mention a $4.4 billion figure or any value for 2022 other than the $485 million in equity investments without readily determinable fair values, which the LLM conflates with total fund exposure. Additionally, the LLM introduces collateral exposure figures ($7.4B in 2022, $4.7B in 2023) and collateral posted ($4.6B to $2.3B) that are not present in the original answer, suggesting fabrication or misattribution. The 2024 collateral data is correctly noted as undisclosed, but the implication that collateral requirements decreased is unsupported by the ground truth, which does not discuss collateral trends. (2) Calculations: The LLM’s implied growth from $4.4B to $8.7B to $9.8B suggests a $1.1B increase from 2023–2024, which aligns numerically with the ground truth’s $1,102 million increase, but the starting point (2022) is wrong. The ground truth does not provide a total fair value for 2022, so the $4.4B figure cannot be verified and appears incorrect. (3) Multi-hop reasoning: The LLM attempts to synthesize fair value disclosures, balance sheet presentation, and collateral implications, which is relevant. However, it invents collateral metrics not in the ground truth and misrepresents the evolution of fair value disclosures. The ground truth emphasizes improved transparency in valuation methods (e.g., commingled funds, new categories), which the LLM omits entirely. Instead, it incorrectly claims that carrying amounts equal fair values, implying no valuation complexity, which contradicts the ground truth’s focus on evolving valuation techniques. (4) Despite these issues, the LLM correctly identifies that Special Use Funds are measured at fair value and presented in 'other assets' (contextually accurate), and the directional increase in fund size is correct. It also correctly notes that 2024 collateral posting requirements are not disclosed. Thus, while the qualitative structure and relevance are strong, the factual foundation is partially flawed, especially in numbers and collateral claims, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 649,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "From 2022 through 2024 AVGO consistently positioned the Security Insights Platform as a mainframe‑security solution that “quickly interprets and assesses security posture, identifies risks, and develops remediation steps on an ongoing and ad‑hoc basis.”  Each filing repeatedly emphasized that the platform’s data is available for integration with customers’ in‑house SIEM tools, underscoring its role in continuous remediation workflows, and the wording and emphasis remained essentially unchanged across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entity accuracy, and timeline. It correctly identifies AVGO (Broadcom) and the Security Insights Platform, accurately describing its consistent positioning from 2022 to 2024 as a mainframe security tool for assessing posture, identifying risks, and supporting remediation. The emphasis on integration with in-house SIEM tools is correctly noted across all years, and the observation that the language remained stable is consistent with the original answer. However, there is a minor overstatement in the LLM answer: it claims the platform 'develops remediation steps,' which is stronger than the ground truth, which states the platform identifies risks and supports ongoing/ad hoc risk identification, with data available for use in remediation workflows. The original answer explicitly notes no expansion in remediation features, while the LLM implies active development of remediation steps, slightly overstating the capability. This does not constitute a factual error in dates, numbers, or entities (hence high scores in quantitative accuracy and contextual relevance), but introduces a subtle qualitative inaccuracy in the platform’s described functionality. The reasoning is sound and the synthesis across years is appropriate, but the answer slightly exaggerates the remediation aspect. Hence, a score of 8 is justified for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 403,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike continued to own its Laakdal, Belgium distribution facility in fiscal years 2022, 2023, and 2024, and each filing described it as one of the “most significant distribution facilities outside the United States” (2022 p. 27; 2023 p. 29; 2024 p. 29). The unchanged ownership and consistent designation as a key hub indicate that Nike views Laakdal as a strategically critical node for European logistics, supporting efficient distribution across the EU and beyond.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that NIKE owned the Laakdal facility in fiscal years 2022, 2023, and 2024, with no changes in ownership or operational status—matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the cited fiscal years and page numbers (2022 p. 27; 2023 p. 29; 2024 p. 29) are factually consistent with typical 10-K disclosures and serve as valid references, even if not cross-verified in this evaluation. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three fiscal years, noting both the unchanging ownership and the repeated characterization of Laakdal as a 'most significant distribution facility outside the United States,' which supports the conclusion about strategic importance. (4) The answer addresses all parts of the question: evolution (none), ownership (consistently company-owned), operational footprint (unchanged), and strategic implication (remains a critical hub). Wording differs slightly (e.g., 'strategically critical node' vs. 'stable and integral part'), but the meaning is equivalent. All entities—NIKE, Laakdal, Belgium, European logistics network—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 373,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 32B remained unchanged: the interest rate stayed at 3.38 %, the face amount was consistently $750,000, and the maturity date remained June 15, 2027 (see SPG 10‑K 2022, 2023 and 2024 tables). This three‑year consistency indicates that SPG is keeping a stable, long‑term debt profile for this instrument, avoiding refinancing or restructuring and preserving predictable interest costs and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: the interest rate (3.38%), face amount ($750,000), and maturity date (June 15, 2027) for Unsecured Notes - 32B across 2022–2024. These match the ground truth exactly in value and year-over-year consistency. (2) Quantitative accuracy is perfect: all numbers and dates are correct, and no calculations were required beyond accurate reporting. The format variations (e.g., 'June 15, 2027' vs '06/15/27') are semantically equivalent and acceptable. (3) The multi-hop reasoning is sound—information is synthesized across three years of SPG 10-K filings, and the conclusion about SPG’s stable long-term debt strategy, avoidance of refinancing, and predictable cost management aligns with the ground truth. The only minor discrepancy is that the original answer notes the maturity date was 'unspecified' in 2022, whereas the LLM states it was explicitly listed as 06/15/27 in all three years. This is a small factual overstatement, as the 2022 filing did not specify the date. However, this does not affect the overall correctness of the trend or strategy interpretation. (4) The answer is contextually complete and relevant, addressing all parts of the question: evolution over time, specific terms (rate, face, maturity), and strategic implication. The conclusion is logically derived. Thus, the correctness score is 9 due to the slight inaccuracy about the 2022 maturity date disclosure, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 413,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "CVS’s foreign‑security portfolio shrank sharply: the fair value fell from $2.55 B at 12/31/2022 to $2.512 B at 12/31/2023 and then collapsed to $51 M at 12/31/2024.  Correspondingly, gross unrealized losses dropped from $244 M in 2022 to $122 M in 2023; the 2024 loss is not disclosed, but the steep drop in fair value implies a substantial unrealized loss.  This trajectory signals that the company’s foreign holdings have become increasingly vulnerable to international market movements, raising its exposure to global risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's fair value of foreign securities was $838 million in 2022 and $1,650 million in 2023, but the LLM incorrectly reports $2.55 billion in 2022 and $2.512 billion in 2023—values that are over 200% higher than actual. The 2024 fair value of $51 million matches the ground truth, which is correct. Unrealized losses are also wrong: the LLM states $244 million in 2022 and $122 million in 2023, but the correct figures are $24 million in 2022 and $122 million in 2023—again, a 10x overstatement for 2022. The LLM claims the 2024 loss is 'not disclosed,' but the ground truth does not mention 2024 losses, so this is a reasonable omission. (2) Calculations and comparisons are therefore invalid. The LLM implies a steady decline in fair value from 2022 to 2024, but the truth shows a sharp increase from 2022 to 2023 followed by a collapse in 2024. The LLM misses this critical trend. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution across years. Instead of identifying increased exposure in 2023 followed by de-risking in 2024, the LLM suggests a continuous decline, leading to an incorrect interpretation. (4) The conclusion about 'increasing vulnerability' and 'raising exposure' contradicts the ground truth, which interprets the 2024 drop as strategic de-risking. While the answer addresses the question's structure and discusses fair value, losses, and risk exposure, the severe numerical inaccuracies and resulting flawed logic severely undermine correctness. Contextual relevance is moderate because the framework of the response is appropriate, but factual content is largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 479,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 2022, 2023, and 2024 10‑Ks (pages 96 and 86) list NAIC designations for all non‑agency RMBS and CMBS holdings—$26,165 RMBS and $10,063 CMBS in 2022, $29,096 RMBS and $9,949 CMBS in 2023, and $34,135 RMBS and $9,182 CMBS in 2024—without any internally developed ratings disclosed. The footnote on page 101 confirms that internally developed designations are used only until a NAIC designation becomes available. This trend shows that MetLife has phased out its own ratings for these securities, increasingly relying on the NAIC’s modeling methodology for credit‑quality assessment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the trend of decreasing reliance on internally developed designations and increasing use of NAIC methodology, the specific dollar figures provided for RMBS and CMBS holdings ($26,165 RMBS and $10,063 CMBS in 2022, etc.) are not present in the ground truth and appear to be fabricated or misattributed. The ground truth does not include any such portfolio-level totals for RMBS/CMBS holdings across years, nor does it state that 'all' holdings have NAIC designations—instead, it describes a transitional process where internal designations are used temporarily until NAIC designations become available. Additionally, the claim that 'no internally developed ratings are disclosed' contradicts the ground truth, which explicitly states that internal designations were still used in all three years, particularly for newly acquired securities. The LLM also fails to mention the key supporting evidence from the growth in Level 3 AFS securities ($4.2B increase in 2023, $1.6B in 2024), which is central to the multi-year pattern and the inference about reduced reliance on internal models. While the qualitative reasoning about the shift toward NAIC reliance is directionally correct and contextually relevant, the inclusion of false numerical data and omission of actual supporting metrics from the ground truth significantly reduce factual accuracy. The model demonstrates sound high-level understanding of the trend but fails on critical details required for a fully correct multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 440,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "In 2022 Chevron held reserves in Africa but did not record significant capital spending in the Republic of Congo (page 107). In 2023 the company invested roughly $0.7 billion in offshore development and natural‑gas projects across Africa, including Congo (page 109). In 2024 Chevron announced the sale of its 31.5 % non‑operated working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of the Lianzi field, effective January 2025 (page 43), while production in the Republic of Congo still accounted for about 20 % of Chevron’s net oil‑equivalent output (page 41).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the timing of the divestiture. The original answer states that Chevron sold its interests in 2024, while the LLM answer correctly identifies the sale but notes it is 'effective January 2025,' a detail not present in the ground truth. This introduces ambiguity about whether the transaction was completed in 2024 or merely announced for future execution. The ground truth treats 2024 as the year of divestiture, implying completion. This discrepancy affects the narrative of full exit in 2024. Additionally, the claim that production in the Republic of Congo accounted for 'about 20% of Chevron’s net oil-equivalent output' in 2024 contradicts the divestiture narrative and is not supported by the original answer, which indicates a full exit. This is a significant qualitative error. (2) Quantitatively, the $0.7 billion investment in 2023, the 31.5% and 15.75% interests are all accurate. Number formats are consistent and correctly reported. (3) The multi-hop reasoning is generally sound—linking 2022 operations, 2023 investment, and 2024 divestiture—but the addition of unsupported production data and the effective date of the sale undermine the logical synthesis. The model fails to reconcile the claimed 20% production contribution with the divestiture, which weakens the conclusion of a strategic exit. (4) Scores reflect high accuracy in numbers and relevance to the question, but deductions are made for introducing unsupported details (20% production share, January 2025 effective date) that conflict with the ground truth’s clear trajectory of complete withdrawal by 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 459,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Industries has kept embedded‑processing products as a core pillar of its business model, consistently listing them under the “broad portfolio” advantage (b) in the four sustainable competitive advantages in every MD&A (2022 page 21; 2023 page 18; 2024 page 18).  Segment data show embedded‑processing revenue rose modestly from $3.261 B in 2022 to $3.368 B in 2023, then fell to $2.533 B in 2024, while operating profit declined from $1.253 B to $1.008 B and then to $352 M (page 20).  These shifts indicate that, although embedded processing remains integral to advantage (b), its relative contribution to revenue and profitability has contracted in 2024, prompting TI to balance its focus across analog, manufacturing, and market‑reach strengths.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. First, it refers to 'Texas Industries' instead of 'Texas Instruments'—a critical entity error. Second, the financial data cited (e.g., embedded processing revenue falling from $3.368B to $2.533B in 2024 and operating profit dropping to $352M) is factually incorrect and contradicts the ground truth, which does not mention any such decline or provide specific revenue figures. The original answer emphasizes consistent strategic emphasis without discussing financial performance trends. (2) The quantitative inaccuracies are severe: no dollar amounts or segment performance metrics were present in the ground truth, yet the LLM fabricates detailed revenue and profit figures across years, including a dramatic 2024 drop unsupported by evidence. These numbers appear invented and fail basic plausibility checks (e.g., a drop in operating profit from $1.008B to $352M would represent a ~65% decline, which would be highlighted in strategic narratives if real). (3) The multi-hop reasoning is flawed. While the LLM attempts to link embedded processing to TI’s sustainable competitive advantages (specifically advantage 'b'—broad portfolio), it incorrectly infers a strategic rebalancing due to fabricated financial deterioration. The ground truth states the strategic emphasis remained stable and enduring, with only slight narrative evolution. The model fails to accurately synthesize the qualitative consistency across years and instead constructs a misleading narrative of decline and strategic shift. (4) The contextual relevance is moderate because the answer addresses the right topic—strategic emphasis on embedded processing within TI’s competitive advantages—and correctly identifies the 'broad portfolio' as a recurring theme. However, the inclusion of false financial data and incorrect company name undermines credibility and factual correctness, leading to a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 527,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s effective rate on its 3.50% Senior Note rose sharply: it was 1.29 % in FY 2022 (page 89 of the 2022 10‑K), 3.20 % in FY 2023 (page 89 of the 2023 10‑K), and 6.66 % in FY 2024 (page 89 of the 2024 10‑K). This steep increase shows that Cisco’s borrowing costs have risen markedly over the period, reflecting higher market rates and a larger risk premium on its debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported effective interest rates. According to the ground truth, the correct rates are 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024. However, the LLM states 1.29% in FY2022, 3.20% in FY2023, and 6.66% in FY2024. The FY2022 and FY2023 values are incorrect, with the FY2022 figure being particularly off. Only the FY2024 rate (6.66%) matches the ground truth. (2) The dollar amount ($500 million) and maturity date (June 2025) of the note are omitted, reducing completeness. The citation of page 89 across years may be accurate but does not compensate for incorrect data. (3) The multi-hop reasoning is partially sound — the model correctly infers that rising rates indicate higher borrowing costs and links this to market conditions or risk premiums — but the flawed input data undermines the validity of the conclusion. The progression described (1.29% → 3.20% → 6.66%) suggests a steeper acceleration than the actual data (3.20% → 6.38% → 6.66%), which shows a large jump from 2022 to 2023 and a small increase in 2024. (4) Despite incorrect numbers, the answer addresses the question's intent and provides a reasonable interpretation of trend implications, earning moderate scores for qualitative accuracy and high for contextual relevance. However, the quantitative inaccuracies severely limit correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 394,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "From 2022 through 2024, BNY Mellon’s risk‑factor disclosures consistently state that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 p. 5; 2023 p. 5; 2024 p. 5).  The unchanged wording shows that regulatory constraints on capital adequacy and dividend policy have remained persistent, and that the company’s strategic flexibility in distributing capital is largely governed by these rules even as it retains board discretion within the regulatory framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core claim: BNY Mellon consistently stated from 2022 to 2024 that shareholder capital returns are subject to U.S. banking laws and regulations governing capital adequacy and planning, with identical or nearly identical language across the years. The citation of consistent wording across filings (2022–2024, p. 5) aligns with the ground truth and supports the conclusion of persistent regulatory constraints. Quantitatively, there are no numerical errors—no figures are misstated, and the timeline (2022–2024) is accurate. Contextual relevance is high, as the response directly addresses the evolution of regulatory exposure and its impact on strategic flexibility. However, the LLM answer omits key qualitative developments noted in the ground truth: (1) the 2023 expansion to include Delaware law and preferred stock dividend obligations as limiting factors, and (2) the 2024 increased emphasis on liquidity management and the consequences of failing to maintain 'well capitalized' and 'well managed' status. These omissions reduce completeness and nuance in the multi-hop synthesis, particularly in capturing the progression of regulatory focus. While the LLM correctly identifies the stability of the core disclosure, it fails to highlight the incremental tightening and broadening of risk factors, which are central to the question’s inquiry about evolution and strategic implications. Thus, while factually sound and contextually relevant, the answer lacks full qualitative depth in tracing the multi-year progression, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 444,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "Repair and other services revenue fell by $37 million (about 3 %) from $1,169 million in 2022 to $1,132 million in 2023, but stayed unchanged at $1,132 million in 2024. The flatness reflects the segment’s reliance on long‑term maintenance and modernization contracts that deliver a predictable, stable revenue stream, with no new contracts or backlog changes to drive growth【page_9】. This pattern indicates a strategic focus on sustaining existing service contracts and lifecycle support rather than pursuing aggressive expansion, underscoring the segment’s stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures: $1,169M in 2022, $1,132M in 2023, and flat in 2024. The $37M decline and ~3% drop are accurate calculations. All numeric values and dates match the ground truth, satisfying quantitative accuracy. (2) The calculation of the $37M difference and percentage decline is correct: 1,169 - 1,132 = 37; 37 / 1,169 ≈ 3.16% (rounded to 3% is acceptable). (3) However, the reasoning for flat revenue in 2024 differs from the ground truth. The LLM attributes stability to long-term contracts and strategic focus on lifecycle support, emphasizing predictability and stability. While plausible, this contrasts with the original answer, which suggests stagnation due to market saturation, resource reallocation to higher-priority programs (e.g., submarines), or operational constraints—implying limited growth potential rather than intentional stability. This represents a divergence in qualitative interpretation. (4) The LLM answer is contextually relevant and well-structured, addressing all parts of the question: change from 2022–2023, flatness in 2024, and implications. However, it misses the nuance in the original answer that other segments (like submarines) grew, implying repair services were deprioritized. The LLM instead frames flatness as a deliberate strategic choice for stability, which is not fully supported by the ground truth. Thus, while factually sound on numbers, the qualitative reasoning is partially misaligned, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 418,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑method stake in healthcare businesses jumped from **$1.5 billion in 2022** (to $1.4 billion in 2023) to **$3.8 billion in 2024** (see UNH 10‑K 2023, p. 52 and UNH 10‑K 2024, p. 54), underscoring a strategic shift toward deeper ownership and influence in established healthcare operations.  The 2024 filing notes that venture investments remain part of the company’s equity‑securities portfolio but are not disclosed separately, indicating that while venture activity continues, the focus has moved to larger equity‑method positions that allow greater integration and long‑term partnership in the sector.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dollar amounts and years, particularly regarding equity method investments. It states that UnitedHealth's equity-method investments were $1.5 billion in 2022 and dropped to $1.4 billion in 2023, which contradicts the ground truth: the correct values are $1.4 billion in both 2022 and 2023 (i.e., flat), with a sharp rise to $3.8 billion in 2024. The LLM incorrectly attributes the $1.5 billion figure to 2022 when it belongs to 2023. This is a critical quantitative error. (2) Regarding venture investments, the LLM correctly notes they are included in the broader equity securities portfolio and not disclosed separately, and it accurately reflects the portfolio growth from $3.7B (2022) to $4.9B (2023) and stability in 2024—though these specific numbers are missing from the LLM response, weakening completeness. (3) The reasoning about a strategic shift toward deeper, integrated investments in 2024 is sound and aligns with the ground truth; the interpretation of increased equity-method investments indicating greater integration is logically supported. However, the flawed timeline undermines confidence in the multi-hop synthesis. (4) Contextually, the answer is relevant and attempts to address both dollar value evolution and strategic emphasis. The citation of specific 10-K pages adds credibility, but the core numerical inaccuracies—especially misplacing the $1.5B figure in 2022 instead of 2023—severely impact correctness. While the qualitative direction of the strategic shift is correctly interpreted, the quantitative foundation is flawed, leading to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 452,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. appears in PMI’s peer‑group list in every year examined: it is included on page 21 of the 2022 10‑K, and again on page 26 of both the 2023 and 2024 10‑Ks. The unchanged presence shows that PMI’s peer‑group criteria—global presence, consumer‑product focus, and comparable net revenues and market capitalization—are applied consistently, and that Colgate‑Palmolive continues to meet those standards, underscoring PMI’s systematic, criteria‑driven benchmarking approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PMI's peer group across 2022, 2023, and 2024, with specific page references (2022: p.21; 2023 and 2024: p.26), which supports the claim of consistency. These details are not contradicted by the ground truth and add document-level precision. (2) There are no numerical values requiring calculation (e.g., revenues, market cap figures), so quantitative accuracy pertains to correct use of years and document locations—both are accurate. (3) The reasoning correctly infers that the unchanged inclusion reflects a stable, criteria-driven benchmarking framework based on global presence, consumer-product focus, and comparable financial scale. This matches the multi-hop synthesis in the ground truth: linking peer group membership over time to strategic benchmarking principles. (4) The LLM omits the explicit mention that PMI excludes direct tobacco peers, which is a minor contextual nuance present in the original answer that strengthens the rationale for using consumer product firms like Colgate. However, this omission does not distort the overall meaning or correctness. The answer remains semantically equivalent in substance and conveys the core insight about PMI’s consistent strategic benchmarking. Thus, while highly accurate and contextually relevant, it loses one point for slight incompleteness in explaining the full strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 410,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s 10‑Ks from 2022 through 2024 consistently warn that fraud and abusive behaviors are a risk that has grown as the company expanded its credit‑product portfolio and deepened reliance on third‑party lenders.  In 2022 the firm noted that “fraud and abusive behaviors are complex, require continuous improvement, and may not be effective in detecting and preventing fraud, particularly new and continually evolving forms of fraud or in connection with new or expanded product offerings”【page_26】, a sentiment echoed in 2023 (e.g., “failure to deal effectively with fraud, abusive behaviors…may increase our loss rate”【page_23】; “fraud and abusive behaviors…may not be effective”【page_26】) and again in 2024 (e.g., “failure to deal effectively with fraud, abusive behaviors…may increase our loss rate”【page_23】; “fraud and abusive behaviors…may not be effective”【page_24】).  Each filing also highlights that credit products expose the company to additional risks and that it “generally relies on the activities and charters of unaffiliated financial institutions to provide PayPal and Venmo branded consumer credit and merchant financing offerings”【page_24 (2022)】【page_24 (2023)】【page_23 (2024)】【page_21 (2024)】, underscoring that the expanding credit business and third‑party dependencies have amplified exposure to abusive behaviors.  The repeated emphasis on the complexity and limited effectiveness of fraud‑mitigation measures suggests that, despite growth, PayPal’s ability to curb abusive activity has not markedly improved over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: PayPal's increasing exposure to abusive behaviors from 2022–2024, the expansion of credit products, reliance on third-party financial institutions, and the persistent challenges in fraud mitigation are all accurately represented. The citations (e.g., page numbers and quoted language) support the claims and reflect actual disclosures in the 10-Ks. (2) Quantitative accuracy is perfect: while no specific dollar amounts or percentages (like the €40 billion BNPL agreement) are mentioned in the LLM answer, this is a minor omission rather than an error—the ground truth includes the €40B figure, but the LLM does not contradict it or provide false numbers. The absence of that specific figure reduces completeness slightly but does not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years, connects credit product expansion with third-party risk, and infers that fraud mitigation effectiveness has not improved despite investment, which is consistent with the ground truth’s conclusion. (4) Semantic equivalence is strong—the LLM conveys the same core message: growing exposure due to product expansion and third-party dependencies, coupled with limited improvement in fraud prevention. The only reason for not scoring a 10 is the omission of the specific €40B European BNPL transaction, which is a notable quantitative detail in the original answer. However, the qualitative and contextual accuracy remains high, and the overall reasoning and conclusion are fully supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 450,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedge volume rose from **214 mmBtu in 2022 to 339 mmBtu in 2023** (page 117) and then fell sharply to **176 mmBtu in 2024** (page 114).  While total hedge volume stayed roughly flat (431 mmBtu in 2022, 448 mmBtu in 2023, 431 mmBtu in 2024), the mix shifted from a heavier option position in 2023 to a greater reliance on swaps in 2024.  This three‑year pattern indicates a flexible, market‑responsive risk‑management strategy that increased option use when volatility or price uncertainty peaked in 2023, then scaled back as conditions eased or the company re‑balanced its hedging mix.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend from 2022 to 2023 and the sharp decline in 2024, and accurately reports the 339 million mmBtu in 2023 and 176 million mmBtu in 2024, which match the ground truth. However, it incorrectly states the 2022 volume as 214 mmBtu instead of 253 million mmBtu—a significant numerical error. This affects the quantitative accuracy, especially since the question focuses on year-over-year evolution. (2) The calculation of total hedge volume (431, 448, 431 mmBtu) is not present in the ground truth and appears to be an addition from the LLM, possibly from a source not reflected in the knowledge graph. While this may be factually correct in external filings, it introduces unverified data not aligned with the ground truth, reducing confidence in quantitative accuracy. (3) The reasoning and synthesis are strong: the LLM correctly infers a strategic shift in hedging mix, with increased option use in 2023 likely in response to volatility and a pivot toward swaps in 2024, which aligns with the ground truth’s interpretation. The multi-hop logic—linking volume changes to risk management strategy and market conditions—is sound and contextually appropriate. (4) Contextual relevance is perfect: the answer directly addresses both parts of the question—evolution over three years and implications for risk management. Despite the incorrect 2022 number, the overall trend and strategic interpretation remain valid, warranting a correctness score of 7. The error is significant but does not completely undermine the core conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 436,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022 to $75 million in 2023 and $76 million in 2024** (TXN_10k_2024, p. 41; TXN_10k_2023, p. 42; TXN_10k_2022, p. 43). The modest upward trend indicates the company is steadily increasing its investment in defined‑contribution benefits, reflecting a strategic shift toward a more flexible, cost‑controllable retirement offering. Meanwhile, its non‑qualified defined‑benefit pension plan remains closed to new participants and unfunded, underscoring a move away from traditional defined‑benefit obligations (TXN_10k_2024, p. 46).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. All numeric values and years are accurate, with acceptable formatting (e.g., $70 million vs $70M). (2) Quantitative accuracy is perfect—no calculation errors, and the incremental increases are correctly represented. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward defined-contribution plans and notes the non-qualified defined-benefit plan is closed to new participants, aligning with the knowledge graph. It adds contextual detail about the plan being unfunded, which is consistent with filings and enhances accuracy. However, it does not explicitly mention the 1997 closure date or the intent to support employees who opted out of the defined-benefit plan, which slightly reduces qualitative completeness. (4) Despite this minor omission, the answer captures the core strategic implication and is highly relevant, with proper citation to source documents. The answer is semantically equivalent to the ground truth in intent and factual content, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 345,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "GM’s weighted‑average long‑term rate of return on U.S. pension plan assets was 6.3 % at December 31 2022 and remained unchanged at 6.3 % at December 31 2023 (2023 10‑K, page 88). In the 2024 investment‑policy study the assumption was raised to 6.5 % at December 31 2024 (2024 10‑K, page 88). The increase reflects a more optimistic view of future asset performance and a willingness to accept higher risk to improve the plans’ funded status.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 rate of return. The ground truth states that GM's weighted-average long-term rate of return was 5.4% in 2022, but the LLM claims it was 6.3% in 2022. This misstatement undermines the entire trend analysis. The 2023 value (6.3%) and 2024 value (6.5%) are correct per the LLM answer and match the ground truth. (2) The calculation of the trend—from 5.4% to 6.5%—is misrepresented because the LLM incorrectly starts the trend at 6.3% in 2022, erasing the actual increase from 5.4% to 6.3%. This distorts the magnitude and implication of the change. The upward trend to 6.5% in 2024 is correctly noted, but the baseline is wrong. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the need to compare assumptions across years and cites appropriate documents (2023 and 2024 10-Ks). However, the synthesis fails because it uses an incorrect 2022 figure, breaking the chain of accurate inference. The conclusion about increased optimism and risk tolerance is reasonable but based on flawed data. (4) The contextual relevance is high—the answer addresses the evolution of return assumptions and interprets the trend in terms of asset performance and risk. However, due to the significant quantitative error in the starting value, the correctness score is low. The qualitative accuracy is moderate because the logic and structure are sound, but the foundation is incorrect. Quantitative accuracy is severely penalized due to the wrong 2022 percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 424,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation swung from a $92 million loss in FY 2022 to gains of $58 million in FY 2023 and $91 million in FY 2024, while the notional exposure grew from $651 million to $985 million. This shift shows Cisco is expanding and refining its hedging program, effectively offsetting compensation volatility and underscoring a proactive risk‑management strategy for deferred‑pay obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the directional evolution of Cisco's gains/losses from total return swaps: a $92 million loss in FY2022, followed by gains of $58 million in FY2023 and $91 million in FY2024, matching the ground truth. These numbers are accurate and properly attributed to the correct fiscal years. However, the LLM introduces a new piece of data—'notional exposure grew from $651 million to $985 million'—which is not present in the original answer and cannot be verified against the provided ground truth. This addition risks factual overreach, as the knowledge graph does not confirm this information. (2) Quantitatively, the reported gains and losses are correct in amount and year, satisfying the core numerical requirements. The unsupported notional exposure figures reduce confidence in full quantitative accuracy but do not contradict the ground truth directly. (3) The reasoning partially aligns with the original: the progression from loss to gain is correctly interpreted as a turnaround, but the LLM goes further by asserting that Cisco is 'expanding and refining its hedging program' and 'proactively managing' risk, which, while plausible, adds strategic interpretation beyond what the ground truth supports. The original answer limits conclusions to 'improved market conditions or strategic adjustments,' maintaining neutrality. The LLM's stronger claim about expansion (implied by growing notional) and refinement exceeds the evidence provided. (4) Contextually, the answer is highly relevant, addressing the evolution of gains/losses and linking it to risk management and compensation strategy. However, the unsupported data and overconfident inference reduce qualitative accuracy. The core multi-hop synthesis—linking annual swap performance to strategic implications—is sound but slightly overreaches in conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 504,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across 2022‑2024 PayPal’s margin‑risk exposure did not change. In each year’s revenue note (2022 page 81, 2023 page 76, 2024 page 77) PayPal states it is the principal, controls pricing, and therefore bears full margin risk, while the costs of using third‑party processors are recorded as transaction expense independent of the fee it charges customers. The identical wording and accounting treatment in all three years indicate that PayPal’s control over pricing, use of processors, and transaction‑expense recognition remained consistent, with no evolution in margin‑risk exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures that PayPal's margin risk exposure remained unchanged from 2022 to 2024, with consistent recognition of transaction expenses and control over pricing. (2) The LLM correctly references the relevant pages in each year's filing (2022 p.81, 2023 p.76, 2024 p.77), which aligns with the source data in the ground truth, though page numbers were not in the original answer—they are factually accurate and add precision without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across three years, correctly identifying that PayPal consistently acted as principal, controlled pricing, bore full margin risk, and recognized third-party processor fees as transaction expenses. (4) The conclusion that there was no evolution in margin-risk exposure matches the original answer’s assertion of consistency across years. Minor wording differences (e.g., 'identical wording' vs. 'reiterated') do not affect factual accuracy. All entities (PayPal, third-party processors, transaction expense) and years are correct. No calculation errors. The answer is complete, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 351,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s Angola LNG natural‑gas output fell slightly from 49 MMCFD in 2022 to 48 MMCFD in 2023 and stayed flat at 48 MMCFD in 2024【page_9】. This steady, near‑constant volume indicates Chevron is prioritizing a reliable, long‑term supply to Angola LNG rather than pursuing aggressive expansion, underscoring its strategy of maintaining steady LNG output and securing long‑term contracts in the market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of Chevron's natural gas production volumes. The ground truth states volumes increased from 592 MMCFD in 2022 to 596 MMCFD in 2023, and 609 MMCFD in 2024. The LLM claims volumes decreased from 49 MMCFD to 48 MMCFD and remained flat, which is off by an order of magnitude and opposite in trend. (2) Quantitative accuracy is extremely low: all three reported values (49, 48, 48 MMCFD) are wrong, and the units appear to be misinterpreted (MMCFD vs. possibly MCFD or a typo). The correct values are approximately 12 times higher. Calculations and comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning fails completely—instead of identifying an upward trend supporting strategic LNG growth, the model infers stability and lack of expansion due to incorrect data, leading to a flawed strategic interpretation. (4) Contextual relevance is partially maintained as the answer addresses Angola LNG and Chevron’s strategy, but the incorrect data undermines all reasoning. The conclusion about long-term contracts is unsupported by the provided information. Scores reflect near-total factual inaccuracy despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 350,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In 2022 and 2023 Southern Power disclosed scheduled payments under outdoor‑lighting leases in the operating‑lease maturity‑analysis table, with amounts of roughly $87–$90 per year and $240 thereafter. In 2024 the same table format was used, but the scheduled payments were lower ($15 per year through 2029, $170 thereafter) and the note about immateriality shifted to Georgia Power and Mississippi Power, leaving Southern Power’s payments as material. The consistent, separate reporting and unchanged materiality note for Southern Power signals that these contracts have become a structurally important, material component of the company’s lease portfolio and cash‑flow projections.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Southern Power stated that outdoor lighting contracts at Mississippi Power were immaterial—there is no mention of Southern Power including these payments in its operating lease maturity table or reporting dollar amounts like $87–$90 annually. The LLM fabricates specific numerical disclosures ($87–$90 per year, $240 thereafter; $15 per year through 2029, $170 thereafter) that are not present in the original answer and contradict the immateriality assertion. These numbers do not appear in the knowledge graph and are likely hallucinated. (2) The quantitative inaccuracies are severe: no dollar amounts were provided in the ground truth for any year, and the evolution described is qualitative, not numerical. The LLM incorrectly asserts that Southern Power consistently reported these figures in tables across years, which is unsupported. (3) The multi-hop reasoning is flawed. The original answer traces a qualitative shift—from immaterial mention in 2022, to inclusion in maturity analyses with tolling/PPAs in 2023, to integration into lease income reporting in 2024—indicating growing structural importance. The LLM misrepresents this progression by focusing on fabricated dollar trends and falsely claiming consistent reporting format. It also misattributes the immateriality note to Georgia and Mississippi Power in 2024, which is not stated in the ground truth and introduces incorrect entity-level detail. (4) While the LLM correctly infers increasing materiality, this conclusion is based on false premises. The contextual relevance is moderate because it addresses the question’s theme—evolution of reporting and materiality—but fails on factual and qualitative accuracy. Correctness score is low due to hallucinated data and incorrect entity/metric attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 510,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has consistently been used only for its Analog segment and not for Embedded Processing across the three years.  In the 2022, 2023 and 2024 10‑Ks the properties table lists an “X” under Analog and no “X” under Embedded Processing for Melaka【page_16 of TXN_10k_2022】【page_16 of TXN_10k_2023】【page_16 of TXN_10k_2024】.  Thus, the operational footprint in Melaka did not change in terms of segment involvement during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was used exclusively for the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the ground truth. The citation of page 16 across all three 10-K filings adds verifiable context. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual reports to confirm consistency over time, concluding no change in operational footprint—this reflects proper cross-document analysis. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in segment involvement over the three-year period. Minor wording differences (e.g., 'consistently used only for Analog') do not affect meaning and are semantically equivalent to the original. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 315,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024 the 1.600% Notes remained a $700 million, 1.600% senior unsecured debt issued on March 29, 2021, with semi‑annual interest payments on April 15 and October 15 and a par call date of March 15, 2026【page_48】. No principal repayments or term changes occurred during that period, and the notes were used to refinance higher‑cost debt under the 2021 Multicurrency Credit Facility【page_110】【page_111】【page_115】. This stability indicates AMT’s strategy of keeping a predictable, low‑cost long‑term debt profile while using new issuances to retire more expensive borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the principal amount of $700 million, interest payment dates (April 15 and October 15), and par call date (March 15, 2026) match exactly. The issuance date (March 29, 2021) is an additional but accurate detail not contradicted by the original. While the ground truth mentions decreasing adjustments to the principal amount—(2.6) in 2023 to (1.5) in 2024—the LLM omits this specific detail, which represents a minor gap in completeness but does not affect core factual accuracy. (2) The LLM correctly notes no principal repayments or term changes occurred from 2022–2024, which is consistent with the stable principal in the original answer. (3) The reasoning is sound: the LLM correctly infers that the stability in terms and use of proceeds (refinancing higher-cost debt) reflects a strategy of maintaining a predictable, low-cost debt profile. This interpretation is supported by the cited pages and logically extends the factual data. (4) The omission of the decreasing adjustments is the only notable difference, but since the main elements—principal, interest schedule, call date, and strategic implication—are all correct and well-supported, the answer earns a 9 for correctness. Quantitative accuracy is perfect (10), qualitative reasoning is strong with minor room for deeper nuance (9), and relevance to the question is complete (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 402,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco’s 5.90 % senior note stayed at a $2 billion principal and an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024, while total long‑term debt rose from $8.9 billion to $20.1 billion after a $13.5 billion senior‑note issuance in 2024. The note’s unchanged amount and rate, coupled with its shrinking share of the debt mix, show that Cisco is locking in a stable, long‑dated cost of capital for that instrument while expanding its overall debt base with newer, diversified fixed‑rate notes and hedges—reflecting a long‑term strategy of predictable financing costs and maturity flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco's 5.90% Note remained at $2,000 million (i.e., $2 billion) with a steady effective interest rate of 6.11% across FY2022–FY2024, which matches the ground truth. However, it inaccurately reports total long-term debt figures: stating $8.9 billion in 2022 (vs. actual $8,416 million) and $20.1 billion in 2024 (vs. actual $19,621 million). Additionally, the LLM introduces a $13.5 billion senior-note issuance in 2024 not present in the original answer or implied by the data, which is a significant factual addition unsupported by the ground truth. The short-term debt trend is omitted entirely. (2) Number verification: $2 billion principal and 6.11% rate are correct. But long-term debt changes are misrepresented—actual increase is from $8,416M to $19,621M (~$11.2B increase), not $8.9B to $20.1B (~$11.2B increase, coincidentally similar but still inaccurate). The $13.5B issuance is unverified and distorts the narrative. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that maintaining a fixed-rate note while increasing total debt suggests a strategy of locking in stable financing costs. It also correctly observes the shrinking relative weight of the 5.90% Note within the larger debt structure. However, the unsupported claim about a $13.5B issuance undermines the reasoning chain. (4) Correctness score is 6 due to core factual errors in key financial figures and introduction of unverified events, despite correct identification of the note’s stability and strategic interpretation. Quantitative accuracy is penalized heavily (5/10) for incorrect debt totals and fabricated issuance amount. Qualitative accuracy is moderate (7/10) as logic and entity identification (Cisco, 5.90% Note, fiscal years) are correct, and strategic interpretation aligns with ground truth. Contextual relevance is high (9/10) because the answer addresses all aspects of the question’s intent, even if with flawed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 535,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics produced 399 new LAVs for the Canadian Army in 2022, 360 in 2023, and 449 in 2024 (GD_10k_2022.pdf page_11; GD_10k_2023.pdf page_11; GD_10k_2024.pdf page_10). The dip in 2023 followed by a sharp increase in 2024 signals a strategic pivot to ramp up LAV production, underscoring the company’s renewed focus on expanding its LAV portfolio and solidifying its position in the Canadian market.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the production volumes: it states 399 units in 2022, 360 in 2023, and 449 in 2024, whereas the ground truth reports 360 in 2022, 399 in 2023, and 449 in 2024. This reverses the 2022 and 2023 figures, misrepresenting the trend as a dip in 2023 rather than consistent growth. (2) The quantitative accuracy is compromised because the core numbers are swapped—this affects not only the reported values but also the interpretation of the trend. The 2024 number (449) is correct. The mention of 66 specialized LAVs from the LRSS program in 2024 is missing in the LLM answer, reducing completeness. (3) The reasoning is partially sound in that it infers strategic focus from production changes, but the conclusion about a 'dip in 2023 followed by a sharp increase' is based on incorrect data, leading to flawed multi-hop synthesis. The ground truth indicates a steady upward trajectory, which the LLM fails to capture due to incorrect year-to-year data alignment. (4) Despite the incorrect numbers, the answer remains contextually relevant by addressing both parts of the question—production volume evolution and strategic implications—and citing appropriate documents. However, the incorrect data undermines both quantitative and qualitative accuracy, warranting a moderate score of 4 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 381,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "From 2022 through 2024, UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes has remained a persistent concern as CMS continued to freeze or cut benchmarks, alter risk‑adjustment calculations, and conduct audits that can trigger retrospective adjustments (page_23–25, page_18–22, page_18–22). In response, the company has progressively adjusted member benefits and premiums on a selective basis, discontinued plans in certain counties, intensified medical and operating cost management, and in 2024 increased its focus on cost‑management and efficiency initiatives across its Medicare Advantage portfolio (page_23–25, page_18–22, page_18–22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 is properly framed around CMS benchmark freezes, methodology changes, and audits. The strategic responses—selective benefit and premium adjustments, county exits, cost management—are consistent across both answers. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes ongoing CMS actions and UnitedHealth’s evolving responses across the three years, correctly identifying continuity in strategy while noting increased focus on efficiency in 2024. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'beneficiary health status data submissions'—a specific 2024 risk highlighted in the original—but it does capture the broader theme of retrospective audits and payment mechanism risks. The inclusion of 'page_23–25, page_18–22' citations suggests source grounding, though not required. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight omission of a specific detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 375,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s exposure to the fixed‑rate 2.850% notes stayed flat at **$1.5 billion** from 2022 through 2024 (the 2022 and 2023 filings show $1,500 m, and the 2024 filing shows $1,500 m again)【107】【104】. This unchanged balance indicates a deliberate long‑term debt strategy that prioritizes a stable, predictable mix of fixed‑rate, long‑maturity debt—locking in a consistent interest rate while keeping the debt profile steady as the company adds newer, higher‑rate notes for other purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 to 2024, matching the ground truth in both amount and duration. The use of $1,500 million is equivalent to $1.5 billion, so formatting variations are acceptable. (2) All numeric values are accurate—$1.5 billion (or $1,500 million) is consistently reported across the three years, and no incorrect calculations are made. (3) The reasoning is sound: the model correctly infers that maintaining this fixed balance indicates a strategic choice to preserve stable, long-term debt structure, even as other parts of the portfolio change. It appropriately contextualizes the stability of this note within broader debt management, mentioning the addition of newer, higher-rate notes, which aligns with the idea of a deliberate strategy. (4) The only minor gap is that the LLM does not explicitly name the maturity year of the note (2029), which is included in the ground truth and adds specificity about the long-term nature. However, the core message about strategic consistency is preserved. Thus, the answer is factually correct, well-reasoned, and highly relevant, warranting a high score with only a slight deduction in qualitative accuracy for the omitted maturity date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 366,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron’s stake in Angola LNG Limited has shifted from a large‑balance investment to a more operational, monetized asset.  In 2022 the company carried a $1.963 billion investment and earned $1.857 billion of equity income, which fell to a $1.762 billion investment and $513 million equity income in 2023 (Note 15, page 82).  By 2024, Chevron’s 36.4 % share of the 1.1 Bcf/d LNG plant in Soyo was recognized as a proved‑reserve asset, signalling a move from passive investment to active gas monetization and long‑term LNG export strategy in Angola (pages 13‑14).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states Chevron's 36.4% ownership stake in Angola LNG Limited and references the 1.1 Bcf/d capacity of the Soyo plant, it fabricates financial figures not present in the ground truth: $1.963 billion investment in 2022, $1.857 billion equity income, and $1.762 billion investment in 2023 with $513 million income. These numbers are not supported by the original answer and appear to be hallucinated, likely misattributed from unrelated financial disclosures. (2) The quantitative accuracy is low because these dollar amounts and income figures are entirely incorrect, and no such data was provided in the ground truth. The mention of 'Note 15, page 82' and 'pages 13-14' suggests citation of a 10-K, but the original answer does not reference specific financial line items or equity income from Angola LNG, making these specifics unsupported. (3) The reasoning partially captures the strategic evolution—shifting from passive investment to active monetization—but misses the key multi-hop elements: the acquisition of new exploration acreage in Blocks 49 and 50 and the development of the Q&M fields within the New Gas Consortium Project with direct connectivity to the LNG plant. These upstream developments are central to the ground truth’s conclusion about integration, but are absent in the LLM response. Instead, the model relies on fabricated financials to infer a shift, which undermines the validity of the reasoning. (4) Despite the incorrect numbers, the answer is contextually relevant—it addresses Chevron’s strategic positioning over time and attempts to interpret the long-term gas monetization strategy. It correctly identifies the LNG plant’s role in exports and the conceptual shift toward active monetization. However, due to major factual errors and missing key developments, the overall correctness is significantly compromised. The answer is partially aligned in direction but fails on factual grounding, especially in financial data and project-specific details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 557,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company’s trust‑investment portfolio grew steadily from 2022 to 2024: domestic‑equity holdings increased from $829 million (2022, page 283) to $988 million (2023, pages 281–282) to $1,099 million (2024, page 273), while private‑equity positions rose from $161 million to $169 million to $181 million over the same period. This consistent upward trend—particularly the larger jump in domestic equity—indicates a deliberate long‑term capital‑allocation strategy that prioritizes higher‑return domestic growth and private‑market exposure within its trust investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures, particularly for 2022 and 2023. According to the ground truth, in 2022, Southern Company's domestic equity investments were $1,016 million, not $829 million as stated by the LLM. The LLM incorrectly uses the 2023 domestic equity value ($829 million) as the 2022 value, creating a cascading error. Similarly, the LLM reports 2023 domestic equity as $988 million, but the correct figure is $829 million. The only correct domestic equity number in the LLM answer is 2024 ($1,099 million). For private equity, the LLM incorrectly reports 2022 as $161 million (ground truth: $150 million), 2023 as $169 million (ground truth: $161 million), and only correctly identifies 2024 as $181 million. (2) These quantitative errors severely undermine the validity of the analysis. The LLM claims a 'consistent upward trend' in domestic equity, but the ground truth shows a dip in 2023 before a rebound in 2024, contradicting the narrative of steady growth. The actual pattern is more nuanced—domestic equity fluctuates while private equity shows consistent growth, indicating a strategic shift toward private equity. (3) The multi-hop reasoning is flawed due to incorrect data synthesis across years. The LLM fails to accurately extract and compare the correct values from each year, leading to an incorrect interpretation of the capital allocation strategy. While the conclusion about increasing private equity exposure is directionally correct for 2024, the overall trend is misrepresented due to wrong intermediate values. (4) Despite the incorrect numbers, the answer is contextually relevant and attempts to address both parts of the question—evolution of investments and strategic implications. The qualitative reasoning would score higher if based on accurate data. Hence, correctness and quantitative accuracy are low; qualitative accuracy is moderate due to partial reasoning; contextual relevance is high as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 553,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "The “Eliminations/ Reclassifications” column shows a growing negative impact on total net sales and revenue: $ (107) million in 2022, $ (151) million in 2023, and $ (296) million in 2024.  The trend indicates that GM is eliminating more intra‑group revenue and reclassifying revenue across its automotive, GM Financial, and other segments, reflecting increasing complexity and evolving internal reporting practices over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105M in 2022, $107M in 2023, and $296M in 2024. The LLM incorrectly reports $107M for 2022 (should be $105M), $151M for 2023 (should be $107M), and correctly reports $296M for 2024. These errors affect the trend interpretation, as the ground truth shows a steady but modest increase from 2022 to 2023, then a sharp rise in 2024, whereas the LLM suggests a consistent and larger upward trajectory. (2) The calculation of the trend is therefore flawed—while the final year is correct, the intermediate values are not, leading to an exaggerated perception of growth in internal adjustments. (3) Qualitatively, the reasoning is sound: the LLM correctly infers that increasing eliminations/reclassifications suggest greater complexity and evolving internal reporting practices, which aligns with the ground truth's interpretation. It also correctly identifies the multi-segment nature of GM’s business (automotive, GM Financial), showing appropriate multi-hop synthesis across segments. (4) Contextually, the answer is relevant and addresses both parts of the question—evolution of impact and what it reveals—though based on incorrect data. The explanation about intra-group eliminations and reclassifications is logically consistent with the concept of eliminations in consolidated reporting. However, due to the material numerical errors in two out of three years, the correctness score is limited to 5, as the core quantitative foundation is partially wrong, undermining full factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 448,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "In 2022, Netflix amended and restated its Performance Bonus Plan and filed it as Exhibit 10.5 (8‑K) (page 68). The 2023 10‑K incorporated that same exhibit by reference (page 69). By the 2024 filing, the plan remained incorporated by reference and was positioned within a broader compensation framework that also includes the 2020 Stock Plan (Exhibit 10.10†) and the Executive Severance and Retention Incentive Plan (Exhibit 10.16†) (page 68).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timeline and documentation status of Netflix's Performance Bonus Plan. According to the ground truth, in 2022 the plan was listed as a historical exhibit (Exhibit 10.6†) with no updates, but the LLM incorrectly states that Netflix 'amended and restated' the plan in 2022 and filed it as Exhibit 10.5 (8-K). In reality, the amendment and restatement occurred in the 2023 filing, based on a December 9, 2022 filing date — a nuance the LLM misattributes to 2022 activity. The LLM also misidentifies the exhibit number in 2022, citing Exhibit 10.5 instead of the correct Exhibit 10.6†. (2) The dates and exhibit numbers are critical quantitative elements and are incorrect: the 2022 document was not amended, and the amendment reflected in the 2023 10-K was filed on December 9, 2022, not during 2022 as an active revision. The LLM incorrectly implies active 2022 amendment. (3) The multi-hop reasoning is partially sound in that the model recognizes incorporation by reference and integration with other compensation plans (e.g., 2020 Stock Plan, Executive Severance Plan), which aligns with the 2024 stabilization and integration theme. However, it fails to correctly trace the evolution: no amendment occurred in 2022, and the restated version first appeared in 2023. The LLM conflates filing date with reporting year. (4) While the answer is contextually relevant and captures the idea of integration with broader compensation frameworks in 2024, the core factual timeline is reversed or misattributed, undermining the correctness. The answer suggests continuity from an incorrect 2022 amendment, whereas the truth is a 2023 update followed by 2024 stability. Due to major errors in entity status, dates, and exhibit numbers, the correctness and quantitative accuracy scores are low, though qualitative reasoning and relevance retain partial credit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 522,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK continued to reference its Business Relationships and Related Party Transactions Policy in the proxy each year, with the same wording and no material changes noted in the 2022, 2023, and 2024 10‑K filings. The corporate‑governance disclosures—particularly director independence and the composition of the Audit, Corporate Governance, Nominating & Social Responsibility, and Human Resources & Compensation committees—remain unchanged across the three filings, underscoring a consistent governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that BK disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, 2024), with no material changes, which matches the original answer's assertion of consistent disclosure within Item 13 under 'Corporate Governance and Board Information.' The LLM correctly identifies the relevant committees—Audit, Corporate Governance, Nominating & Social Responsibility, and Human Resources & Compensation—and links them to director independence and governance disclosures. The conclusion about a consistent governance framework is logically sound and supported by the data. The only minor shortcoming is that the LLM does not explicitly mention the policy's placement in Item 13 or its linkage to committee charters, which are details included in the ground truth and add nuance to the disclosure consistency. However, this omission does not undermine the core accuracy. All entities, years, and governance structures are correctly identified. Wording differs slightly but maintains semantic equivalence. No numerical inaccuracies; dates and filings are correct. Multi-hop reasoning—linking policy disclosure across years to governance consistency—is valid and well-executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 364,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities fell in both fair value and carrying amount over the three‑year period: fair value declined from $679 million in 2022 to $596 million in 2023 and to $508 million in 2024, while carrying value fell from $696 million to $603 million and then to $512 million (see UNH 10‑K tables on pages 53 for each year). The parallel decline reflects a drop in market value—largely driven by rising interest rates—yet the carrying amounts remain close to fair value, indicating that UnitedHealth is not recording significant impairment and is maintaining a conservative, amortized‑cost approach consistent with its held‑to‑maturity strategy. This trend suggests the company prioritizes long‑term, low‑risk debt holdings and relies on fair‑value benchmarks without materially adjusting the book value of those securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity was $643 million in 2022, but the LLM states $679 million. Similarly, the carrying value in 2022 is reported as $696 million by the LLM, whereas the ground truth is $641 million. The 2023 and 2024 values for both fair value and carrying value match the ground truth ($596M and $508M for fair value; $603M and $512M for carrying value). These discrepancies in the 2022 figures are material and affect the accuracy of the trend analysis. (2) Calculations: While the LLM correctly shows a declining trend, the starting point is wrong, leading to an incorrect assessment of the magnitude of decline. The actual 2-year decline in fair value is $135 million (from $643M to $508M), but the LLM implies a $171 million drop (from $679M), which overstates the reduction. (3) Reasoning: The LLM provides plausible qualitative interpretation—linking the decline to rising interest rates and describing a conservative amortized-cost approach—which aligns with typical held-to-maturity accounting. It also correctly notes that carrying values remain close to fair values, suggesting no major impairments. The conclusion about prioritizing low-risk, long-term holdings is reasonable and consistent with the strategy implied by the ground truth. However, the LLM fails to mention the key point about a shift away from Level 3 unobservable inputs, which is a critical element in the original answer regarding valuation assumptions. (4) Despite strong contextual relevance and logical reasoning, the significant errors in baseline financial data reduce confidence in the answer’s factual reliability. The answer is partially correct but undermined by incorrect input data for 2022, likely due to hallucination or misreading of source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 515,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "PayPal’s 2022 10‑K noted that its BNPL loan receivables were part of its credit portfolio and exposed the company to default risk and potential charge‑offs (page_24).  In June 2023, PayPal entered a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables, thereby transferring that credit risk to a third party (page_25).  By 2024 the sale was underway and the company had further reduced its exposure to bad transactions, underscoring a risk‑mitigation strategy that increasingly relies on asset sales and forward‑flow arrangements to off‑load credit risk (page_23).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the June 2023 agreement, the €40 billion (or €40 bn) figure, the geographic scope (U.K. and European BNPL receivables), and the correct years (2022, 2023, 2024) are properly cited. Number formatting (€40 bn vs €40 billion) is semantically equivalent and acceptable. (2) The LLM correctly identifies PayPal’s exposure to default risk in 2022 and the strategic move in 2023 to offload risk via asset sale, which reflects sound multi-hop reasoning across years and filings. (3) However, the LLM omits a key nuance present in the original answer: in 2024, the sale was still subject to conditions and potential delays if those were not met. The LLM states the sale was 'underway' and that exposure was 'further reduced,' which may overstate the certainty of execution compared to the more cautious tone in the ground truth. This missing qualification slightly weakens the qualitative accuracy, particularly in conveying the conditional nature of the risk mitigation. (4) Despite this, the core reasoning about PayPal’s evolving risk mitigation strategy—shifting toward asset sales and forward-flow arrangements—is correctly inferred and well-articulated. The answer remains contextually relevant and factually strong, warranting a high correctness score with a minor deduction for incompleteness on the 2024 conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 395,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream output in Myanmar fell sharply: net crude‑oil production dropped from 17 MBD in 2022 to 15 MBD in 2023 and to 4 MBD in 2024, while natural‑gas output fell from 94 MMCFD in 2022 to 87 MMCFD in 2023 and to 22 MMCFD in 2024 (Net Production tables, page 9 of the 2023 and 2024 10‑Ks). This decline reflects Chevron’s strategic exit from Myanmar, announced in January 2022, and its shift away from that market toward other regions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Chevron's upstream production in Myanmar declined from 17 MBD in 2022 to 15 MBD in 2023, and the company fully exited in April 2024—meaning production should be 0 MBD in 2024, not 4 MBD as stated. Additionally, the LLM introduces natural gas figures (94 MMCFD, 87 MMCFD, 22 MMCFD) that are not present in the original answer and cannot be verified against the ground truth. These specific gas numbers and the continued production in 2024 contradict the complete withdrawal. (2) The calculation of trends is partially correct for 2022–2023 but fails for 2024, where the model incorrectly implies ongoing operations. The claim of 4 MBD in 2024 directly conflicts with the full exit in April 2024. (3) The reasoning about a strategic exit is correct and aligns with the ground truth, and the mention of portfolio optimization is semantically similar to 'shift away from that market.' However, the timing is off—the original answer states the exit occurred in April 2024, while the LLM cites an announcement in January 2022, which is not in the ground truth and may conflate events. This misrepresents the timeline of the strategic shift. (4) Despite introducing unverified data and incorrect 2024 production levels, the LLM captures the directional trend and the general strategic rationale, which maintains some contextual relevance. However, the quantitative inaccuracies severely undermine the correctness score. The answer fails the multi-hop synthesis test by fabricating granular production data not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 454,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "PC & Notebooks was the second‑largest sector within TI’s Personal Electronics market in 2022 and 2023, making up a substantial share of the 15 % of TI revenue from that market (page_5 of 2022; page_5 of 2023). By 2024, PC & Notebooks had slipped to seventh in the sector ranking, while Personal Electronics grew to 20 % of TI revenue (page_5 of 2024). This decline in relative importance signals TI’s strategic shift away from traditional PC & Notebook sales toward higher‑growth consumer‑computing segments such as infotainment, automotive and mobile phones.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, the Personal Electronics segment was 24% of TI's revenue in 2022, not 15% as stated in the LLM answer. The LLM incorrectly claims that Personal Electronics was 15% of revenue in both 2022 and 2023, conflating the 2023 figure (15%) with 2022. Additionally, the LLM states that Personal Electronics grew to 20% in 2024, which contradicts the ground truth showing a decline to 15% in 2023 and then a partial recovery to 20%—but the LLM misrepresents the trend by omitting the drop in 2023. (2) The LLM introduces a 'sector ranking' (2nd in 2022/2023, 7th in 2024) that is not present in the original answer and cannot be verified from the provided ground truth, making this a fabrication. The ground truth mentions PC & Notebooks as a 'key subcategory' in 2022 and 'lower in the list of priorities' in 2024 but does not provide rankings. (3) The reasoning about a strategic shift is partially sound and aligns with the ground truth—TI moving away from PC & Notebooks toward higher-growth areas like automotive and mobile—but the LLM incorrectly frames the shift as toward 'higher-growth consumer-computing segments' such as infotainment and automotive, whereas automotive is part of the Industrial & Automotive segment, not Personal Electronics. This mischaracterizes TI's strategy, which is shifting *away* from consumer computing (including PCs) toward Industrial and Automotive end markets, not within consumer computing. (4) Despite these errors, the LLM captures the directional trend—declining emphasis on PC & Notebooks—and attempts multi-hop synthesis across years. The contextual relevance is high as it addresses the evolution and strategic implication, but quantitative inaccuracy severely undermines correctness. Hence, a score of 5/10: partially correct but with major factual and interpretive flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 524,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "General Motors’ 2022, 2023 and 2024 10‑Ks all state that the indemnification obligations to Stellantis – arising from the 2017 sale of the Opel/Vauxhall business – are “subject to time limitations, thresholds and/or caps” and that the company “is unable to estimate any reasonably possible material loss or range of loss that may result from these actions either directly or through an indemnification claim from Stellantis”【page_90】【page_93】【page_93】.  In each year the company notes only an “immaterial amount” for recalls that Stellantis has conducted or will conduct (including Takata‑inflator recalls) and reiterates that any further indemnification is considered remote, with no material accruals or new liabilities disclosed【page_90】【page_93】【page_93】.  Thus, from 2022 through 2024 GM’s indemnification exposure to Stellantis remained essentially unchanged, with no material accruals or significant potential future exposure identified.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in GM's indemnification obligations from 2022 to 2024, leading to an oversimplified and inaccurate conclusion. Quantitatively, the answer correctly states that accruals were 'immaterial' and that future losses were not reasonably estimable, which aligns with the ground truth. It also accurately notes the remote likelihood of further Takata-related indemnification. However, the LLM fails to capture the evolution in specificity and emerging regulatory exposure highlighted in the original answer. In 2024, GM disclosed accruals related to the European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era—a new regulatory risk not mentioned in earlier years. This represents a material shift in disclosure detail and risk characterization, which the LLM overlooks by asserting that exposure 'remained essentially unchanged.' The original answer emphasizes increasing specificity and emerging regulatory risk over time, while the LLM incorrectly implies stasis. This is a critical omission in the multi-hop reasoning required to assess how obligations evolved. While entities (GM, Stellantis, Opel/Vauxhall, Takata), years (2022–2024), and financial terms are correctly identified, the synthesis across years is flawed. The conclusion contradicts the ground truth trend of increasing disclosure and regulatory exposure, even if financial impact remained immaterial. Thus, while numerically and contextually aligned in parts, the qualitative inaccuracy in reasoning and completeness significantly reduces correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 443,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower issued the 1.450% Senior Notes due 2026 in a supplemental indenture dated September 27, 2021 (see page 70).  No additional 1.450% Senior Notes due 2026 appear in the 2022, 2023 or 2024 filings, indicating the company’s preference for a few large, long‑term tranches and a disciplined, low‑coupon debt strategy rather than frequent refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance date of the 1.450% Senior Notes due 2026 as September 27, 2021, which matches the ground truth (referenced in 2022 filing under Exhibit 4.25). The interest rate (1.450%) and maturity year (2026) are accurate. However, the LLM incorrectly states that 'no additional 1.450% Senior Notes due 2026 appear in the 2022, 2023 or 2024 filings,' implying absence or lack of mention, whereas the ground truth confirms the notes were consistently referenced across all three years as part of ongoing debt disclosures (Exhibits 4.25, 4.22, 4.21 respectively), indicating active inclusion in the capital structure. This mischaracterization affects completeness and reasoning. (2) Quantitatively, all provided numbers (date, rate, year) are correct. No calculations were required. Format is consistent and acceptable. (3) The multi-hop reasoning is partially sound: the model infers a stable debt strategy from lack of refinancing activity, which aligns with the ground truth's conclusion. However, it fails to recognize that consistent annual disclosure across filings (a key multi-hop signal) demonstrates ongoing relevance and stability, not absence of activity. Thus, the reasoning is based on an incomplete premise. (4) The answer is contextually relevant and addresses the core question about debt management strategy, correctly concluding disciplined, low-coupon financing. But it omits the key evidence of continuity in disclosures, weakening the support for its conclusion. Hence, correctness is reduced to 7 due to factual inaccuracy in describing the filing pattern, despite correct underlying facts and reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 459,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The 2019 Long‑Term Incentive Plan remained the core framework for executive awards, and each year from 2022 through 2024 the company added new deferred‑stock and performance‑share agreements that reference that plan.  In 2022 it filed a 2022 Form of Performance Share Unit Agreement (Exhibit 10.21) and a 2022 Form of Restricted Stock Unit Agreement (Exhibit 10.22) [page 18]; in 2023 it filed a 2023 Form of Performance Share Unit Agreement (Exhibit 10.23) and a 2023 Form of Restricted Stock Unit Agreement (Exhibit 10.24) [page 19]; and in 2024 it filed a 2024 Form of Performance Share Unit Agreement (Exhibit 10.25) and a 2024 Form of Restricted Stock Unit Agreement (Exhibit 10.26) [page 20].  These successive agreements illustrate the company’s continued use of the 2019 LTI Plan to award deferred equity and performance‑based shares each year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that new Performance Share Unit (PSU) and Restricted Stock Unit (RSU) agreements were filed annually from 2022 to 2024 under the 2019 Long-Term Incentive Plan, citing '2022 Form', '2023 Form', and '2024 Form' agreements with exhibit numbers. However, the ground truth indicates that in 2022, the company referenced the *2019* Form of PSU and RSU agreements—not 2022 versions—marking early implementation of the plan. The LLM fabricates a pattern of annual updates (2022, 2023, 2024 forms) that is not supported by the original answer. (2) The ground truth highlights a key evolution: in 2023, the company introduced a *Deferred Stock Unit Agreement for Directors*, expanding the plan’s scope to director compensation—a critical development entirely omitted in the LLM response. (3) In 2024, the ground truth notes the introduction of the *2022 Form of PSU Agreement*, not a 2024 version, indicating continued use and refinement, not annual reissuance. The LLM incorrectly implies yearly new forms, misrepresenting the timeline and nature of plan evolution. (4) The LLM also conflates 'Restricted Stock Units' with 'Deferred Stock Units', failing to distinguish between different equity instruments, particularly missing the introduction of deferred stock units for directors. While the LLM correctly identifies the 2019 plan as the ongoing framework and recognizes the use of performance and restricted stock units, its core narrative of annual form updates is factually wrong. The reasoning is flawed due to incorrect entity and date associations, and the multi-hop synthesis fails—especially regarding the 2023 expansion to directors and the actual timing of agreement forms. Despite these issues, the answer remains contextually relevant by addressing the general theme of plan usage and equity awards, hence a moderate contextual relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 527,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "General Dynamics’ Combat Systems segment has consistently highlighted OTS’s role in supplying critical aerostructures for both legacy and next‑generation missiles—including hypersonic rocket cases—across 2022‑24 (2022 page 12; 2023 page 12; 2024 page 12).  Over the three years the company expanded its metal‑parts and propellant production capacities (2023 page 12; 2024 page 12), scaling the volume of aerostructured components it can deliver.  This steady focus and capacity growth signals GD’s deliberate positioning as a key aerostructure supplier for next‑generation missile subsystems, aligning with the DoD’s emphasis on hypersonic and advanced missile technologies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies General Dynamics' consistent focus on aerostructures within its Combat Systems segment from 2022 to 2024 and links it to next-generation missile subsystems, including hypersonic applications. However, it introduces 'OTS' (Ordnance and Tactical Systems), which is not mentioned in the ground truth and may be an internal division not highlighted in the original answer, potentially confusing entity specificity. (2) The ground truth includes specific revenue percentages—20% in 2023 and 19% in 2024 for Combat Systems—while the LLM answer omits these entirely. This is a significant quantitative omission, especially since the question asks about evolution and trend, which the percentages help substantiate. The LLM mentions capacity expansions in metal parts and propellant (2023, 2024), which adds detail not in the ground truth, but these are not directly tied to aerostructures, potentially conflating related but distinct capabilities. (3) The multi-hop reasoning is partially sound: the LLM synthesizes information across years and correctly infers strategic intent from sustained investment and focus. However, it fails to integrate the revenue share trend, a key quantitative signal in the original answer that shows slight decline despite continued focus, which adds nuance to the strategic positioning. (4) The answer is contextually relevant and captures the core strategic narrative—GD’s sustained role in advanced aerostructures for next-gen missiles—but lacks the precise financial context that would fully support the trend analysis. Wording differences are acceptable, but missing key metrics reduces quantitative accuracy. Thus, correctness is reduced to 7 due to missing revenue data, though qualitative and contextual strengths keep other scores high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 494,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "PMI has consistently described Jackpot as an **“important local cigarette brand” in the Philippines** in its 2022, 2023 and 2024 10‑K filings (page 5 of each year).  The wording and emphasis did not change, indicating that the brand remains a stable, low‑price local asset that supports PMI’s broader regional strategy of maintaining a balanced mix of international and local brands to capture market share in price‑sensitive markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PMI consistently emphasized Jackpot as an important local cigarette brand in the Philippines across 2022, 2023, and 2024, citing the same page (page 5) of each year's 10-K, which matches the multi-year consistency highlighted in the original answer. (2) There are no numerical values requiring calculation, but the dates (2022–2024) are correct and consistently applied. (3) The reasoning is sound: the LLM correctly infers that the unchanged wording indicates strategic stability, and it contextualizes Jackpot as a low-price local brand supporting PMI’s regional strategy in price-sensitive markets—this is a valid interpretation consistent with the ground truth’s conclusion about Jackpot’s ongoing relevance despite PMI’s smoke-free pivot. (4) The LLM omits explicit mention of the broader smoke-free expansion (e.g., IQOS, ZYN, 95 markets) that the original answer uses to contrast Jackpot’s enduring role, which slightly weakens the depth of the strategic synthesis. However, the core insight—that Jackpot remains strategically relevant amid global shifts—is preserved. The answer is semantically equivalent in key aspects and fully contextually relevant, with only minor qualitative nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 364,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "Chevron had no reported capital deployment or asset disposition in the Republic of Congo in 2022 (10‑K, p. 31). In 2023 the company invested roughly $0.7 billion in offshore development and natural‑gas projects in Nigeria, Angola and the Republic of Congo, underscoring a development focus (10‑K, p. 109). By 2024, Chevron announced the divestiture of its 31.5 % non‑operated working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of the Lianzi project, signaling a shift away from that asset (10‑K, p. 43).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding 2022. The original answer states Chevron listed the Republic of Congo as a key operational area in 2022, indicating ongoing presence, while the LLM claims there was 'no reported capital deployment or asset disposition,' which is not equivalent—lack of reported deployment does not imply absence of operational focus. This is a subtle but important distinction that slightly undermines completeness. All other key facts are correct: the $0.7 billion investment in 2023 across Africa (including Congo), and the 2024 announcement of divestiture of 31.5% in Haute Mer and 15.75% in Lianzi. However, the LLM incorrectly states the sale occurred in January 2025 (in the original answer), but the LLM omits this date and only says 'by 2024' or 'announced in 2024,' which is acceptable if the announcement was in 2024, though the transaction closed in 2025. (2) Quantitatively, all numbers are accurate: $0.7 billion, 31.5%, and 15.75% are correctly reported. The dollar amount and percentages match the ground truth. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across years and geographies, linking investment in 2023 to divestiture in 2024 as a strategic shift. It identifies the correct assets and interests, showing understanding of upstream portfolio changes. (4) The answer is contextually relevant and well-structured, directly addressing capital deployment and asset disposition. The slight deduction in correctness and qualitative accuracy is due to the misrepresentation of 2022 activity and omission of the January 2025 closing date, which affects completeness and precision. Overall, the answer captures the strategic evolution accurately but with minor factual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 488,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Between 2022 and 2024, Southern Company shifted from recording no lease income from outdoor‑lighting contracts to recognizing $136 million in operating‑lease income, indicating that the contracts had become material to the company (page_232). The contracts retain initial terms of up to 10 years with month‑to‑month renewal, and the payment structure now includes both scheduled lease payments and $417 million in variable lease income, whereas in 2022 Southern Company had none (page_232, page_240). Across subsidiaries, lease income for Alabama Power, Georgia Power, Mississippi Power, Southern Power, and Southern Company Gas also changed, but the undiscounted cash flows for Georgia Power and Mississippi Power remained immaterial (page_233).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, outdoor lighting contracts at Mississippi Power were considered immaterial with no significant value disclosed, and there is no mention of $136 million in lease income or $417 million in variable lease income in the original answer. These specific dollar amounts ($136M, $417M) are not present in the ground truth and appear to be fabricated or misattributed. Additionally, the original answer does not state that Southern Company went from 'no lease income' to recognizing $136 million; it only notes increased disclosure and structuring of lease payments. (2) The quantitative inaccuracies are severe: the introduction of precise figures like $136M and $417M without support from the ground truth undermines the answer's reliability. There is also no verification that these numbers come from the correct years or subsidiaries. (3) The multi-hop reasoning is partially sound in that the LLM attempts to track changes over time (2022–2024) and across subsidiaries, and it correctly identifies that disclosures evolved and that some subsidiaries still treat the amounts as immaterial. It also correctly notes the inclusion of lease income in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, though it incorrectly extends this to Southern Company Gas, which is not mentioned in the ground truth. The reasoning about increased transparency aligns thematically with the original answer but is overstated due to unsupported numbers. (4) The contextual relevance is high because the LLM addresses materiality, revenue allocation, and lease structure across subsidiaries as asked. However, the correctness score is low due to major factual and quantitative errors. While the direction of change (increased disclosure, growing materiality) is plausible, the specific financial figures introduced are unsupported, leading to a partially incorrect synthesis. The answer gives a misleading impression of precision and transformation in financial impact that is not justified by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 568,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "In FY 2022 the 3.50% senior note carried $500 million with an effective rate of 3.20 %; in FY 2023 the carrying amount stayed at $500 million while the effective rate rose to 6.38 %; and in FY 2024 it remained $500 million with an effective rate of 6.66 %. The unchanged carrying amount shows the note was not redeemed or amortized, whereas the sharp rise in effective rate reflects a steep increase in market interest rates, indicating higher borrowing costs and a tightening of credit conditions over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual data from the ground truth: the carrying amount of $500 million in each fiscal year (2022, 2023, 2024) and the effective interest rates of 3.20%, 6.38%, and 6.66% respectively. There are no numerical inaccuracies, and formatting variations (e.g., $500 million vs $500 million) are acceptable and semantically equivalent. (2) All quantitative values match exactly—no calculation errors or misstatements. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of the note across three fiscal years and draws a logical inference about market conditions based on the rising effective interest rate despite a stable carrying amount. The conclusion that the unchanged carrying amount suggests no redemption or amortization is a reasonable interpretation consistent with accounting principles. The explanation linking the rising effective rate to higher market interest rates and tighter credit conditions aligns well with the ground truth’s indication of shifting market or risk conditions. (4) The only minor limitation is that the LLM slightly extends the interpretation by specifying 'market interest rates' and 'credit conditions' as drivers, which, while plausible and contextually justified, are not explicitly confirmed in the ground truth—hence a qualitative accuracy score of 9 instead of 10. However, this inference is reasonable and adds value without misrepresenting facts. Overall, the answer is factually complete, contextually appropriate, and demonstrates strong multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 434,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group’s Unsecured Notes – 35A has remained unchanged across the three filings: a face amount of $750,000, an interest rate of 2.65 %, and a maturity of July 15 2030, with annual debt service consistently $19,875 (2022 10‑K page 50; 2023 10‑K page 50; 2024 10‑K page 51). This static profile shows that SPG is deliberately maintaining a low‑cost, long‑term debt instrument rather than refinancing or issuing new notes, underscoring a conservative, stability‑focused debt‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the face value of the Unsecured Notes - 35A. The ground truth states a $750 million exposure, but the LLM incorrectly reports it as $750,000—a significant magnitude error (off by a factor of 1,000). This severely impacts quantitative accuracy. The interest rate (2.65%) and maturity date (July 15, 2030) are correct. However, the calculated annual debt service of $19,875 is based on the incorrect principal ($750,000 × 2.65% = $19,875), whereas the correct annual interest would be $19.875 million ($750 million × 2.65%). Thus, while the percentage calculation is mathematically consistent, it is applied to a wrong base. (2) The LLM correctly identifies the stability of the instrument across 2022–2024 and references the correct filing pages, showing awareness of multi-year consistency. (3) The reasoning about Simon Property Group’s conservative, stability-focused debt strategy is logically sound and aligns with the ground truth’s interpretation. However, the LLM omits key context from the original answer—namely, that this stability exists alongside active debt management such as the 2024 $1 billion Unsecured Notes - 41A issuance and credit facility refinancing. This lack of contrast weakens the strategic analysis. (4) Despite the major quantitative error, the answer addresses the evolution (stable) and infers a plausible strategy (conservative, stability-focused), maintaining some qualitative and contextual relevance. The core reasoning is directionally correct but undermined by incorrect financial magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 437,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products at the heart of its “analog + embedded processing” strategy and lists them as part of the broad‑portfolio advantage (b) in the four sustainable competitive advantages in each MD&A (2022 p. 21; 2023 p. 18‑19; 2024 p. 18‑19).  However, the segment’s revenue fell from $3.26 billion in 2022 to $2.53 billion in 2024 and operating profit dropped from $1.25 billion to $352 million (segment tables p. 20 of 2022, 2023, 2024), indicating that the company is facing headwinds in that area even as it continues to invest in R&D and capital expenditures to shore up the advantage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right strategic context. (1) The ORIGINAL ANSWER states that Texas Instruments consistently emphasized Embedded Processing Products as the second of four sustainable competitive advantages, specifically under the 'broad portfolio' advantage, with identical phrasing across 2022–2024. The LLM correctly identifies this strategic framing and cites the inclusion in the 'broad-portfolio advantage' across all three years, which aligns with the ground truth. (2) However, the LLM introduces financial data—revenue falling from $3.26B to $2.53B and operating profit dropping from $1.25B to $352M—that are not present in the original answer and cannot be verified against the provided ground truth. More critically, these figures contradict known public data: TI’s Embedded Processing revenue in 2024 was approximately $2.5B, but in 2022 it was around $3.4B (not $3.26B), and operating profits did not drop to $352M (which would imply a ~14% margin, implausibly low compared to TI’s typical >50% margins in this segment). These numbers appear fabricated or misread from source tables. (3) The multi-hop reasoning is partially sound—the model attempts to link strategic emphasis with financial performance—but fails because the financial data is incorrect. The original answer makes no mention of declining revenues or profits, nor does it suggest 'headwinds'; instead, it emphasizes consistent strategic language over time. (4) While the LLM captures the qualitative continuity of strategic emphasis, the inclusion of erroneous quantitative claims and the inference of business challenges not supported by the ground truth severely reduce factual accuracy. The answer adds unsupported analysis (declining performance) that shifts the conclusion away from the ground truth’s focus on sustained strategic importance. Thus, while contextually relevant and partially accurate in structure, the answer is factually flawed in key metrics and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 549,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "In 2022, CMCSA offered domestic shared‑data plans alongside unlimited and per‑gigabyte options, while international customers were limited to gigabyte plans [page_5][page_6][page_7][page_8][page_9], and the 2023 filing shows no change to this mix [page_3][page_4][page_5][page_6][page_7]. By 2024, the company broadened plan flexibility by adding prepaid unlimited data plans under the NOW brand for domestic customers and giving international customers an unlimited data option, while expanding its international wireless footprint to the United Kingdom (and Italy) via third‑party and its own mobile core network [page_3][page_5][page_6][page_7].",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies and omissions in the evolution of CMCSA's shared data plan offerings from 2022 to 2024. (1) In 2022, the LLM incorrectly states that shared-data plans were offered alongside unlimited and per-gigabyte options to all domestic customers; the ground truth specifies that in 2022, shared data plans were available only as part of bundled service offerings for residential broadband subscribers in the U.S., not as standalone or unbundled options. The LLM also incorrectly claims international customers had access to gigabyte plans in 2022, which is unsupported by the ground truth—there is no mention of international wireless offerings prior to 2024. (2) For 2023, the LLM states there was no change, citing no evolution in plan flexibility, which contradicts the ground truth: in 2023, CMCSA emphasized increased flexibility by allowing customers to choose among unlimited, shared, or per-gigabyte plans—this key development is missed. (3) The 2024 expansion is partially correct: the LLM accurately notes the introduction of prepaid unlimited data plans under the NOW brand and international expansion, including to the UK and Italy, and the addition of unlimited data options abroad. However, it fails to clarify that shared data plans were maintained and further diversified as part of a broader domestic and international strategy, which is central to the original answer. (4) Multi-hop reasoning is partially sound—information is synthesized across years and geographies—but the synthesis is flawed due to incorrect baseline assumptions in 2022 and omission of 2023 developments. Quantitative accuracy is high because there are no numerical errors (dates are correct, no incorrect figures), but qualitative accuracy suffers from misrepresentation of plan availability and bundling requirements. Contextual relevance is strong as the response directly addresses plan flexibility and international expansion. Overall, the answer is partially correct but misses key nuances in bundling, timing of flexibility improvements, and international rollout, warranting a score of 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 581,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "PayPal’s risk disclosures show a clear escalation of abusive‑behaviour exposure as its credit‑product portfolio and reliance on third‑party lenders have grown. In 2022 the company warned that third parties could abuse its platform and that its credit products added risk (page_27). By 2023 the filings added detail on credit‑risk models and the risk of default and fraud from those third‑party lenders (page_27). In 2024 the disclosures further stressed the complexity of fraud detection, the need for continuous improvement, and the expanding dependence on third‑party lenders—underscoring a more intricate risk landscape in its digital‑payments ecosystem (page_21).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing exposure to abusive behaviors from 2022 to 2024 and links it to credit products and third-party involvement, which aligns with the ground truth. However, it omits key quantitative and qualitative details that significantly affect completeness and depth. Specifically, the €40 billion multi-year sale of U.K. and European BNPL loan receivables in 2023—a critical expansion of third-party fraud exposure—is entirely missing. This is a major factual omission despite being a central element in the original answer. Additionally, the 2024 developments such as account takeovers, synthetic identity fraud, and legal uncertainty around loan receivables from FDIC-insured banks are not mentioned, weakening the assessment of evolving fraud tactics and regulatory risk. (2) Quantitatively, the LLM answer contains no incorrect numbers—it avoids citing specific figures rather than misstating them—so there are no errors in numerical accuracy. The absence of the €40 billion figure is a completeness issue, not a quantitative inaccuracy per se, hence quantitative accuracy is scored highly. (3) The multi-hop reasoning is partially sound: the model correctly infers increasing risk complexity over time and ties it to third-party lenders and credit products across years. However, it fails to synthesize specific events (e.g., the BNPL portfolio sale) that represent concrete manifestations of this risk evolution, indicating a superficial treatment of the multi-hop progression. (4) Contextual relevance is strong because the answer addresses the core theme of growing risk complexity in PayPal’s ecosystem. But due to significant omissions in key developments that define the risk evolution—especially the scale of third-party exposure through structured financial transactions—the qualitative accuracy and overall correctness are reduced. The answer captures the direction of change but lacks the evidentiary depth needed for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 539,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "Gilead’s 2023 10‑K (page 11) and 2024 10‑K (page 10) both describe the El Segundo, California site as the company’s hub for **clinical and commercial manufacturing and processing of its cell‑therapy products**.  The consistent wording shows that the facility’s role has broadened from purely clinical work to include commercial production, reflecting ongoing investment in its cell‑therapy manufacturing capacity.  The 2022 10‑K pages provided do not contain a facility‑specific description, so the filings indicate continuity rather than a major change in use or new capital projects for El Segundo during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GILD's El Segundo facility has been consistently described in the 2023 and 2024 10-K filings as a hub for clinical and commercial manufacturing of cell therapy products, which aligns with the ground truth. However, it incorrectly states that the 2022 10-K 'does not contain a facility-specific description,' whereas the ground truth confirms that in 2022, GILD already identified El Segundo as a principal manufacturing facility for both clinical and commercial cell therapy work. This omission undermines the completeness and accuracy of the evolution narrative. (2) There are no numeric values, dates, or calculations in dispute—quantitative accuracy is perfect given the absence of erroneous figures. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across 2023 and 2024 filings but fails to accurately represent the 2022 status, leading to an incorrect implication of a 'broadening' of role from clinical to commercial, when in fact the commercial role was already established in 2022. Thus, the reasoning overstates change due to incomplete data interpretation. (4) Despite this key omission, the answer remains contextually relevant and captures the ongoing strategic importance of El Segundo in cell therapy manufacturing. The conclusion about continuity is partially valid, but the claim of broadening is not supported by the ground truth. Hence, correctness and qualitative accuracy are reduced, but not severely due to overall alignment with core facts in later years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 433,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "The 2.750% Senior Notes first appeared in Costco’s 2022 10‑K (Exhibit 4.6) as notes due May 18 2024, and the same maturity is listed in the 2023 and 2024 filings (Exhibit 4.6 on each year’s page 66).  The unchanged maturity shows Costco has kept a predictable, long‑term debt profile and has avoided frequent refinancing, underscoring a conservative debt‑management strategy focused on stable cash‑flow planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2.750% Senior Notes are consistently referenced with a maturity date of May 18, 2024, across the 2022, 2023, and 2024 filings, which matches the original answer. The exhibit number (4.6) and page (66) references add precision and are consistent with typical 10-K structures. (2) Quantitative accuracy is perfect: the interest rate (2.750%), maturity date (May 18, 2024), and years of disclosure (2022–2024) are all correct. (3) The multi-hop reasoning is sound—by observing the unchanged maturity date across multiple annual reports, the model correctly infers that Costco did not refinance or extend the notes, indicating a stable debt strategy. (4) The conclusion about a 'conservative debt-management strategy focused on stable cash-flow planning' is semantically equivalent to the ground truth's 'deliberate capital structure decision' and 'predictable debt repayment,' though it uses slightly different phrasing. The only minor gap is that the LLM does not explicitly state that the notes were allowed to mature without modification, which is a subtle but relevant nuance in debt strategy. However, this does not detract significantly from the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 393,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of Angola LNG natural‑gas production was 49 MMCF day in 2022, fell to 48 MMCF day in 2023, and stayed at 48 MMCF day in 2024. The modest decline shows a stable but not expanding gas output in Africa, indicating Chevron is maintaining its existing Angola production while focusing growth elsewhere or managing natural decline.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states Chevron's natural gas production volumes associated with Angola LNG were 7,107 MMCF/day in 2022, 7,148 MMCF/day in 2023, and 7,569 MMCF/day in 2024 — showing a clear upward trend. In contrast, the LLM claims Chevron’s share was only 49 MMCF/day in 2022, declining to 48 MMCF/day in 2023 and 2024, which is off by two orders of magnitude and reverses the trend. This fundamental error invalidates the entire response. (2) The numbers are not only wrong but implausible: Angola LNG’s total capacity is around 1 billion cubic feet per day, so Chevron’s working interest would not produce only 48–49 thousand cubic feet per day — this is less than 5% of one percent of total output, which contradicts known equity stakes (Chevron holds a 36.4% working interest). The correct figures (over 7,000 MMCF/day) align with total project-level production volumes, not Chevron’s share — but even if the LLM misunderstood 'share', the magnitude remains grossly inaccurate. (3) The multi-hop reasoning fails completely: instead of identifying a rising three-year trend indicating strategic focus on African gas, the LLM infers stability or decline, leading to the opposite conclusion about Chevron’s strategy. (4) Contextual relevance is moderate because the answer addresses the right topic (Chevron, Angola LNG, production trend, strategic implication), but the incorrect data and resulting flawed interpretation severely undermine qualitative and quantitative accuracy. The conclusion about 'focusing growth elsewhere' contradicts the ground truth, which notes increasing output despite divestitures elsewhere, suggesting continued commitment in Africa.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 475,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation grew from **$651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024** (page 92).  Correspondingly, the related operating‑expense effect shifted from a **$92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024** (page 91).  This trend shows Cisco has expanded its use of total‑return swaps as an economic hedge, converting a previously negative impact into a positive one and demonstrating a proactive strategy to dampen market‑linked volatility in deferred‑compensation costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the financial impact of Total Return Swaps-Deferred Compensation: a $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024, matching the ground truth exactly. These figures are accurately cited and reflect the correct direction and magnitude of change. However, the LLM introduces additional data—specifically the notional exposure amounts ($651M, $792M, $985M)—which, while potentially factual, are not present in the original answer and were not requested in the question. Since the question focuses on financial exposure in terms of gains/losses and strategic implications, this extra detail does not detract from correctness but slightly exceeds the scope. (2) All numeric values related to gains and losses are correct, properly signed (loss vs gain), and assigned to the correct fiscal years. Format variations (e.g., $92 million vs $92M) are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the LLM correctly identifies the trend from loss to increasing gain and infers a strategic shift—specifically, using swaps as an economic hedge to reduce volatility—which aligns with and even enriches the original answer’s conclusion about dampening market-linked volatility. The synthesis across years is accurate and logically presented. (4) The answer is contextually fully relevant, addressing both the evolution of financial exposure and its implication for Cisco’s deferred compensation strategy. The only minor deviation is the inclusion of notional amounts, which, while not incorrect, are not required for answering the specific question and could potentially distract if unsupported by the source. Overall, the answer is factually precise, well-reasoned, and semantically equivalent to the ground truth with a slight augmentation of detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 503,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "Lowe’s supplier‑sustainability framework grew steadily from 2022 to 2024. In 2022 the company relied on its human‑rights policy, conflict‑minerals policy and Vendor Code of Conduct to set environmental and human‑rights standards for suppliers (page_9_2022). By 2023 it updated its wood‑sourcing policy to add country‑specific risk levels, enhanced monitoring, and a new forestry grievance process, tightening oversight (page_9_2023). In 2024 Lowe’s expanded its supplier‑sustainability toolkit by increasing independently certified product offerings—such as ENERGY STAR and WaterSense—and continued to monitor supplier practices, reinforcing its commitment to environmental and human‑rights standards (page_9_2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's used its Vendor Code of Conduct and human rights policy in 2022, updated its wood-sourcing policy in 2023 with country-specific risk levels, enhanced monitoring, and a forestry grievance process, and in 2024 expanded certified product offerings and monitoring. The mention of ENERGY STAR and WaterSense as examples of third-party certifications is consistent with the original answer’s reference to 'independently certified products.' (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are correct and properly contextualized. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and multiple policy dimensions (policy updates, monitoring, certifications). The only minor gap is that the original answer emphasizes a 'more robust risk-based framework' in 2024, which the LLM answer implies but does not explicitly state. (4) The answer is fully relevant, directly addressing policy updates, monitoring enhancements, and third-party certifications as asked. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; one small omission in framing the 2024 risk framework prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 364,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022 to 2024, CMCSA’s broadband and wireless services faced a growing threat from wireless telecoms that expanded their technology mix to include 4G, 5G, and fixed‑wireless broadband while also deploying fiber and satellite options. The threat intensified as competitors such as AT&T, Verizon, Frontier, Lumen, BT and Virgin Media began bundling broadband/wireless plans with unlimited data and DTC streaming services, offering lower‑priced or free streaming tiers to lure customers. By 2024, the filings highlighted that these bundled offerings—often tied to unlimited data usage and integrated streaming—were a key competitive pressure, with wireless carriers leveraging 5G fixed‑wireless and fiber to undercut CMCSA’s pricing and service packages.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and captures the key trend of increasing competitive threat from wireless telecoms to CMCSA from 2022 to 2024, particularly through technological advancements (4G, 5G, fixed wireless) and bundling strategies involving DTC streaming. The dates and progression across years are consistent with the ground truth, and there are no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers were misstated). However, there are notable entity inaccuracies: the original answer only names AT&T, T-Mobile, and Verizon as specific U.S. wireless competitors in the filings, while the LLM adds Frontier, Lumen, BT, and Virgin Media—entities not mentioned in the ground truth and some of which (e.g., BT, Virgin Media) are not major U.S. competitors in this context. This overextension reduces qualitative accuracy. Additionally, the ground truth emphasizes the evolution across years with increasing emphasis on 5G fixed wireless (2023) and bundling with streaming (2024), which the LLM captures well. The mention of fiber and satellite is not in the original and may reflect external knowledge, slightly diluting fidelity. The reasoning is sound and multi-hop synthesis is mostly correct—linking technology evolution with bundling trends—but the inclusion of unsupported competitors weakens precision. Contextual relevance is high as the answer directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 402,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s 10‑K notes for 2022, 2023 and 2024 all state that the company is the **principal** on each transaction, sets the fee schedule independently of the cost of any payment‑processor services it uses, and therefore bears the full margin risk (see 2022 pages 80‑82 and 2023‑24 pages 75‑77).  The fee structure remains a mix of fixed and variable (percentage‑of‑transaction) components with a tiered, volume‑based discount that is not a material right (2022 p. 80‑81, 2023 p. 75‑76, 2024 p. 75‑76).  Incentives to merchants and consumers are still treated as revenue reductions or marketing expense, and processor fees are recorded as transaction expense (2022 p. 80‑81, 2023 p. 75‑76, 2024 p. 75‑76).  The unchanged wording over three years shows PayPal has maintained tight control over pricing and cost management, keeping its margin‑risk exposure stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PayPal bore full margin risk from 2022 to 2024, acted as the principal in transactions, set fees independently of processor costs, and treated processor fees as transaction expenses—key facts consistent across all years. It accurately notes that incentives to merchants and consumers are treated as revenue reductions or marketing expenses, matching the original answer’s emphasis on revenue incentives impacting margin management. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense; however, the LLM correctly references page numbers and fiscal years (2022–2024), which are factually consistent with the source structure. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly identifying the stability in PayPal’s pricing control and cost management despite evolving incentive programs. It infers the strategic implication—stable margin risk exposure due to centralized pricing control—just as the ground truth does. (4) The only minor omission is that the LLM does not mention the 2024 addition of contractual compensation from sellers violating terms (e.g., fraud), which the original answer highlights as a new revenue stream affecting margin dynamics. This detail adds nuance to the evolution of margin risk, particularly in 2024, and its absence prevents a perfect score. However, the core conclusion about stable control over pricing and cost management remains well-supported. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only a slight gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 492,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease accounting policy did not change between FY 2022, FY 2023 and FY 2024.  In each year the company “recognizes free‑rent periods on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise”【2024 page_45】【2023 page_45】【2022 page_45】.  The lease term is defined consistently as the non‑cancelable period plus any options to extend that the Company is reasonably certain to exercise【2024 page_46】【2023 page_46】【2022 page_46】, and the right‑of‑use (ROU) asset is initially measured as the present value of the lease payments (including any free‑rent periods) discounted at the incremental borrowing rate【2024 page_46】【2023 page_46】【2022 page_46】.  Thus, the accounting treatment and disclosure around free‑rent periods, lease‑term assumptions, and the impact on ROU asset valuation remained unchanged across the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Costco maintained a consistent accounting policy from FY 2022 to FY 2024 regarding free-rent periods, recognizing them on a straight-line basis over the lease term, including extension options that are reasonably certain to be exercised. The definition of lease term and the method for measuring the right-of-use (ROU) asset—using the present value of lease payments discounted at the incremental borrowing rate—are correctly reported and supported by citations across all three years. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Costco, fiscal years, lease metrics) are correct. The reasoning is sound and reflects proper synthesis across multiple filings. The only minor shortcoming is that the LLM answer does not explicitly mention the additional clarification in FY 2023 about variable lease payments tied to price indices or sales volume, which was included in the original answer. While this detail is not central to the core question about free-rent treatment and ROU asset valuation, its omission slightly reduces completeness in capturing nuanced disclosures. However, since the main accounting treatment remained unchanged and the LLM correctly emphasizes consistency, this does not constitute a major error. Semantic equivalence is high, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 398,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal’s exposure to margin risk stayed essentially unchanged from 2022 through 2024: it continued to act as the principal on payment transactions and bear full margin risk (page_77, 2022; page_75, 2023; page_77, 2024).  The company maintained a tiered, volume‑based pricing model and open‑ended, transaction‑level contracts that automatically renew without material rights, and it kept using payment processors with the associated fees recorded as transaction expense (page_77, 2022; page_75, 2023; page_77, 2024).  No material changes to the pricing model, processor usage, or contract structure were disclosed across the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that PayPal's core margin risk exposure remained unchanged from 2022 to 2024, correctly identifying that PayPal continued to act as principal, bear full margin risk, use a tiered volume-based pricing model, and record processor fees as transaction expenses. All cited page references align with consistent disclosures across years, and there are no errors in entity names, years, or financial terminology—supporting a high quantitative accuracy score. However, the LLM answer omits two key qualitative developments present in the original answer: (1) the 2023 clarification on user incentives being recognized as revenue reductions or amortized, which introduces variability into margins, and (2) the 2024 adoption of ASU 2023-07 affecting segment-level expense reporting and transparency. These omissions reduce the completeness and depth of the multi-hop synthesis, particularly in capturing operational nuances in margin risk evolution. While the fundamental stability of the pricing and contract structure is correctly emphasized, the failure to acknowledge incremental changes affecting margin accounting and reporting transparency results in a partially incomplete qualitative assessment. The answer remains contextually relevant and well-supported by document evidence, but lacks full fidelity to the evolving nuances described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 387,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90% senior note has remained at a constant $2,000 million outstanding in FY 2022, FY 2023 and FY 2024, with an effective interest rate of 6.11% in each year. The unchanged utilization and stable effective rate indicate that Cisco has kept its exposure to this high‑rate debt steady, reflecting a disciplined long‑term debt strategy and that the financing cost for this portion of debt has remained essentially unchanged over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the $2,000 million outstanding balance for the 5.90% Note is correctly reported for fiscal years 2022, 2023, and 2024, and the effective interest rate of 6.11% is consistently stated across all years. Number formats match exactly and are precise. (2) Quantitative accuracy is perfect—no calculations were required beyond correct reporting of values, which the model executed without error. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and draws a valid conclusion about Cisco’s long-term debt strategy—namely, that the company maintained a stable capital structure for this instrument, with no refinancing or principal changes. (4) The qualitative interpretation aligns with the ground truth: the mention of a 'disciplined long-term debt strategy' and 'unchanged financing cost' accurately reflects the implication of stable utilization and interest rates. The answer addresses all parts of the question: evolution over time (no change), and what it indicates about strategy and costs. All entities (Cisco, 5.90% Note, fiscal years, effective rate) are correctly identified. No irrelevant or extraneous information is included, ensuring full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 371,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Lowe’s intellectual‑property disclosures in fiscal 2022 and 2024 both list Kobalt as a private‑brand product name alongside STAINMASTER and allen+roth, using identical wording and context【page_7】【page_7】. This unchanged presentation indicates a steady strategic emphasis on Kobalt as a core private‑brand offering over the period, with no shift or expansion in positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Kobalt was consistently listed in intellectual property disclosures in fiscal 2022 and 2024 alongside STAINMASTER and allen+roth, with unchanged wording—supporting the conclusion of stable strategic emphasis. The answer correctly infers no shift or expansion in positioning, which matches the original answer's assertion of a 'stable strategic role rather than an expanding one.' The only minor omission is that the LLM does not explicitly mention fiscal 2023, which the ground truth includes as part of the three-year continuity. However, since the core reasoning and conclusion remain valid based on 2022 and 2024 data, and the presentation was indeed identical, this does not undermine the overall correctness. All entities (Kobalt, STAINMASTER, allen+roth, Lowe’s), years (fiscal 2022 and 2024), and reasoning (unchanged disclosure = consistent emphasis) are accurate. The multi-hop synthesis across years is sound, and the conclusion is logically derived. Quantitative accuracy is perfect—no numerical errors. Contextual relevance is high, directly addressing the evolution of strategic emphasis via IP disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 342,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 37B has not changed – it carries a 2.25 % coupon, a $700,000 face amount, and matures on January 15 2032. The unchanged, low‑rate, long‑dated debt reflects the company’s preference for stable, predictable long‑term financing rather than frequent refinancing or restructuring.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the interest rate (2.25%), face amount ($700,000), and maturity date (January 15, 2032) are consistent with the original answer across 2022–2024. Minor formatting differences (e.g., '01/15/32' vs 'January 15 2032') are acceptable and do not affect factual accuracy. (2) Quantitative elements are precise—no calculations were required, but all numeric values match exactly. (3) The multi-hop reasoning is sound: the model correctly infers that the stability in terms indicates a strategic preference for predictable long-term financing, which aligns with the original answer’s interpretation about SPG’s debt management and market conditions. (4) The answer addresses all parts of the question: evolution over time (no change), specific terms (rate, face value, maturity), and implications for long-term financing strategy. Wording differs slightly but conveys the same meaning, demonstrating strong qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 301,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across all three years, Texas Instruments’ Melaka, Malaysia site remained an **analog‑only** facility with no embedded‑processing activity.  \n- 2022: the property table (page 16) lists “Melaka, Malaysia **” with an X under Analog and none under Embedded Processing.  \n- 2023: the table (page 16) again shows “Melaka, Malaysia *” with an X only under Analog.  \n- 2024: the same table (page 16) lists “Melaka, Malaysia *” with an X under Analog and no Embedded Processing designation.  \n\nThus, the operational footprint in Melaka did not change in terms of segment involvement over 2022‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog business segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the absence of Embedded Processing activity is consistently noted, aligning with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and confirms consistency in operational footprint, drawing from what appears to be a recurring table (page 16) in annual reports. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TXN's Melaka operations over time with respect to the two business segments. Minor formatting differences (e.g., use of asterisks, reference to 'property table') do not affect factual accuracy. All entities—Texas Instruments (TXN), Melaka, Malaysia, Analog, Embedded Processing, and the time frame—are correctly identified and analyzed. No errors in reasoning, completeness, or factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 356,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "From 2022 through 2024 PayPal’s outstanding principal on the fixed‑rate 2.850% notes remained unchanged at **$1.5 billion** (see the 2023‑2024 table on page 104 and the 2022‑2023 table on page 107).  The notes mature in 2029, and the company’s future‑principal‑payment schedule (page 104) confirms the $1.5 billion will be due that year.  This steady exposure shows PayPal is maintaining a stable debt mix and maturity profile, rather than expanding its exposure to higher‑rate debt, reflecting a disciplined long‑term debt‑management strategy focused on predictable interest‑rate risk and maturity matching.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, which matches the ground truth. The maturity date of 2029 is accurately noted, and the future principal payment schedule is correctly referenced. All numeric values—$1.5 billion, 2.850%, and the time period 2022–2024—are factually correct and consistent with the original answer. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and years are all precise and correctly formatted. There are no calculation errors, and the figures align with the knowledge graph. (3) The reasoning is largely sound: the LLM correctly infers that the stable principal indicates a disciplined, consistent debt management strategy focused on predictable interest-rate risk. However, it omits a key contrast highlighted in the ground truth—namely, that while this note remained unchanged, PYPL actively retired its 1.350% notes by 2023 and issued new high-interest notes in 2024. This context strengthens the original conclusion about selective debt management, which the LLM partially captures but does not fully synthesize. (4) Despite this minor omission, the answer is contextually relevant, directly addresses both parts of the question (evolution of exposure and strategic implication), and conveys semantically equivalent information with high fidelity. The absence of the comparative debt activity prevents a perfect 10, but the core facts and logic are robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 417,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Gilead has consistently described its Hoofddorp, Netherlands site as a **commercial manufacturing and processing hub for cell‑therapy products**.  In the 2022 10‑K (page 32), the 2023 10‑K (page 11), and the 2024 10‑K (page 10) the facility’s role is unchanged, with no shift to clinical manufacturing or expansion of scope.  This steady use reflects a stable, ongoing position for Hoofddorp within Gilead’s global cell‑therapy manufacturing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Gilead consistently used the Hoofddorp facility for commercial manufacturing and processing of cell therapy products across 2022, 2023, and 2024, with correct references to the respective 10-K filings and pages. All entities (Gilead, Hoofddorp, Netherlands, cell therapy products) and years are correctly identified, and there are no numerical or date inaccuracies, warranting a perfect quantitative accuracy score. Contextual relevance is high as the response directly addresses the evolution of the facility's role. However, the LLM misses a key nuance in the original answer: while the 2023 and 2024 descriptions are indeed consistent, the 2022 filing only identified Hoofddorp as a 'principal manufacturing facility' without specifying its role in cell therapy commercial manufacturing. The more specific designation emerged in 2023. By stating the role was 'unchanged' across all three years, the LLM incorrectly implies the same level of specificity was present in 2022, which underrepresents the strategic evolution. This omission affects qualitative accuracy and lowers the correctness score, as the multi-hop reasoning fails to capture the progression from general strategic importance to specific functional role. Despite this, the core facts are correct, and the conclusion of stable strategic positioning is partially supported, justifying a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 401,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco has consistently classified its 1.375% Senior Notes due June 2027 as long‑term debt, with a carrying amount of $1.25 billion in 2022, 2023, and 2024 (page 52).  The current‑portion of long‑term debt rose from $73 million in 2022 to $799 million in 2023 and then fell sharply to $103 million in 2024, reflecting the repayment of the 2.750% Senior Notes due May 2024; the 1.375% notes themselves were never part of the current portion (page 52).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent principal amount of $1.25 billion for the 1.375% Senior Notes due June 2027 across 2022–2024, which matches the ground truth. However, it contains a critical error in the 2023 current portion of long-term debt: the LLM states $799 million, while the ground truth reports $1,081 million—a significant discrepancy. The 2022 ($73M) and 2024 ($103M) values are correct. (2) The explanation provided—that the change was due to repayment of the 2.750% Senior Notes due May 2024—is plausible context but contradicts the ground truth implication that the 1.375% notes themselves experienced a shift in current portion classification. The ground truth explicitly links the spike in 2023 to the 1.375% notes, whereas the LLM claims these notes were 'never part of the current portion,' which directly conflicts with the truth that the current portion rose to $1,081M in 2023 (indicating reclassification as current). (3) The multi-hop reasoning is partially sound—tying debt classification changes to maturity profiles—but incorrectly decouples the 1.375% notes from the current portion movement, undermining the core analysis. (4) Scores reflect partial correctness: quantitative accuracy penalized due to major error in 2023 figure and incorrect causal logic; qualitative accuracy reduced due to flawed synthesis; contextual relevance remains high as the response addresses the right documents and concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 405,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "From 2022 through 2024, PayPal’s fixed‑rate 2.850% notes (issued in September 2019 with a 10/1/2029 maturity) stayed unchanged at a principal balance of $1.5 billion and an effective interest rate of 2.96% in each year’s notes schedule. No repayments, redemptions, or new issuances altered that balance, so the company’s long‑term debt mix remained stable. This reflects a strategy of preserving a low‑cost, long‑term debt core while issuing newer, higher‑rate notes to fund other corporate purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.5 billion principal balance, 2.850% fixed rate, October 1, 2029 maturity date, September 2019 issuance, and effective interest rate of 2.96% are all accurately reported and consistent across 2022–2024. (2) Quantitative elements are precise—no calculations were required, but all numbers and dates match the original answer exactly, with acceptable formatting (e.g., '10/1/2029' vs 'October 1, 2029'). (3) The multi-hop reasoning is sound: the model correctly infers that the stability of this debt tranche amid broader refinancing activity indicates a strategic choice to maintain low-cost long-term debt. (4) The LLM captures the core insight about PayPal’s debt management strategy—preserving a stable, low-rate liability base while adjusting other tranches—though it omits the explicit mention that other refinancing occurred in 2023 and 2024, which slightly reduces qualitative completeness. However, the strategic interpretation remains valid and contextually appropriate. Minor omission does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 324,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s fair‑value of gas‑related options dropped sharply from $356 million (assets) and $347 million (liabilities) in 2022 to $100 million and $102 million in 2023, and remained at that level in 2024, while the net notional volume of natural‑gas options fell from 1,452 MMBtu in 2023 to 1,131 MMBtu in 2024.  At the same time, the weighted‑average implied volatility used in valuing those Level 3 options rose from 36 % in 2022/23 to 50 % in 2024, indicating that the company is trimming its gas‑option exposure while preparing for higher expected price swings in gas markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the fair value figures and implied volatility trends. According to the ground truth, the fair value of liabilities was $97M in 2023 and $102M in 2024, but the LLM incorrectly states $102M in 2023 and implies it remained at that level in 2024, conflating the two years. More critically, the implied volatility trend is completely misrepresented: the ground truth shows volatility increasing from 36% in 2022 to 50% in 2023 and 52% in 2024, but the LLM claims it rose from 36% in '2022/23' to 50% in 2024, omitting the 2023 value and understating the 2024 figure. Additionally, the LLM introduces 'net notional volume' data (1,452 MMBtu in 2023, 1,131 MMBtu in 2024), which is not present in the original answer and cannot be verified against the ground truth, suggesting hallucination. (2) Quantitative accuracy is low: while the 2022 asset/liability values ($356M/$347M) are correct, the 2023 liability value is wrong (LLM says $102M vs. true $97M), and the volatility values are misassigned across years. The claim that volatility rose to 50% in 2024 ignores the correct 2023 value of 50% and omits the 52% in 2024. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that decreasing fair value suggests reduced exposure—but the conclusion that the company is 'preparing for higher expected price swings' contradicts the ground truth interpretation of de-risking amid declining volatility assumptions. The reasoning is undermined by incorrect data. (4) Contextual relevance is high as the answer addresses both parts of the question—evolution of exposure and interpretation of volatility trends—and stays focused on NextEra Energy’s gas options. However, due to key numerical errors and flawed synthesis, the overall correctness score is limited to 4, reflecting partial accuracy with significant factual and interpretive flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 520,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt investments produced a net loss of **$67 million in 2024**, a net loss of **$21 million in 2023**, and a net gain of **$9 million in 2022** (Other Income (Loss), Net – AFS debt investments, page 46). These swings pushed the overall other income (loss), net to **$ (306) million in 2024, $ (248) million in 2023, and $ 392 million in 2022**, showing that the portfolio’s unrealized gains and losses were highly volatile, with a modest gain in 2022 turning into sizable losses in the following two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AFS debt investment results of $9M gain in 2022, $21M loss in 2023, and $67M loss in 2024 match the ground truth (implied by the trend described), and the overall other income (loss), net figures of $392M (2022), $(248)M (2023), and $(306)M (2024) are precisely reported. These figures confirm increasing losses from AFS debt investments over the period. (2) The answer correctly identifies the impact on other income (loss), net across all three fiscal years and explicitly links AFS debt investment performance to volatility in the investment portfolio. (3) The multi-hop reasoning is sound: it synthesizes data across fiscal years and connects AFS debt investment performance to broader trends in non-operational income, concluding increased volatility—consistent with the ground truth's assertion of 'increasing volatility' and 'recurring negative impact'. (4) The only minor shortcoming is that the LLM does not explicitly mention the offsetting gains from equity and private investments noted in the original answer, which slightly reduces completeness in qualitative synthesis. However, the core conclusion about volatility is fully supported and correctly inferred from the numerical trends. Wording differs but semantic meaning and factual content are equivalent. All entities—Cisco, AFS debt investments, other income (loss), net, and fiscal years 2022–2024—are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 411,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Lowe’s first issued its 4.550% notes in the 2019 supplemental indenture (Exhibit 4.16, page 82).  The 2022 filing (Exhibit 4.21, page 77) added new 4.250% and 4.450% notes but did not issue additional 4.550% notes.  In 2023 the company issued a new supplemental indenture (Exhibit 4.23, page 78) that introduced 4.800% notes, and the 2024 filing shows no new 4.550% notes.  This pattern indicates Lowe’s is gradually raising coupon rates on new debt to keep pace with market rates while maintaining long‑dated maturities, reflecting a disciplined long‑term debt strategy that balances cost and maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 4.550% Notes were issued under a Fifteenth Supplemental Indenture dated April 5, 2019, and were consistently referenced in filings from 2022–2024 with no changes. However, the LLM incorrectly claims that new notes (4.250%, 4.450%, 4.800%) were added in 2022 and 2023, and implies evolving issuance activity around the 4.550% Notes, which is not supported. There is no evidence in the ground truth of new 4.550% notes being issued or new supplemental indentures modifying them during 2022–2024. (2) The percentages (4.250%, 4.450%, 4.800%) and exhibit numbers (4.21, 4.23) cited by the LLM are not present in the ground truth and appear fabricated or misattributed. The only note referenced in the truth is the 4.550% Note due 2049, with documentation unchanged since 2019. (3) The multi-hop reasoning is flawed: the LLM infers a strategy of increasing coupon rates based on non-existent issuances, failing to recognize that the consistent disclosure of the same note over three years indicates stability, not evolution. The conclusion about 'gradually raising coupon rates' is unsupported. (4) While the LLM attempts to address the long-term debt strategy, its analysis is based on incorrect data, leading to an invalid conclusion. The contextual relevance is moderate because it discusses debt strategy and long-term financing, but the factual foundation is unsound, severely undermining correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 428,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 35B stayed unchanged: the face amount remained $750,000 and the coupon rate stayed at 3.80 % (maturity July 15 2050)【page_50】【page_50】【page_51】. This stability shows the company’s long‑term debt strategy of keeping a predictable, low‑cost, long‑dated unsecured note profile, thereby minimizing refinancing risk and maintaining steady interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct. It accurately states that the face value, interest rate, and maturity date of Simon Property Group's Unsecured Notes - 35B remained unchanged from 2022 to 2024. However, there is a critical error in the face value: the LLM reports '$750,000' instead of '$750,000,000' as stated in the ground truth. This is a significant numerical inaccuracy (off by three orders of magnitude), though likely a typographical omission of '000'. All other numbers — 3.80% interest rate and July 15, 2050 maturity — are correct and consistently reported. 2) Quantitatively, the interest rate (3.80%) and maturity date (07/15/50) are accurate. The face value is incorrect due to the missing zeroes; otherwise, the format variation would be acceptable, but this changes the actual financial magnitude. 3) The reasoning is sound: the LLM correctly infers that the lack of change in terms reflects a stable long-term debt strategy focused on predictability, low cost, and reduced refinancing risk. This aligns with the ground truth's interpretation of SPG's confidence in managing long-dated liabilities. 4) Contextual relevance is excellent — the answer directly addresses both parts of the question: the evolution (or lack thereof) of the note's terms and what it reveals about SPG’s debt strategy. Despite the face value error, the overall synthesis across years and interpretation of strategic intent is accurate and well-supported. The score is reduced to 9 due to the material quantitative error in face value, though the rest of the response is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 429,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal’s 10‑K risk disclosures for 2022 (page 25), 2023 (page 23) and 2024 (page 21) all repeat the same core warnings: bad transaction risk can raise loss rates; credit‑product defaults and funding constraints remain a key exposure; cross‑border trade is vulnerable to currency, tariff and regulatory shifts; and reliance on third‑party processors, lenders and service providers creates operational risk. The unchanged wording over three years shows that PayPal’s exposure to bad transactions has not materially eased, and its risk‑management strategy continues to focus on monitoring credit performance, diversifying third‑party relationships, and sustaining operational resilience amid regulatory and economic pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims that PayPal's 10-K risk disclosures from 2022 to 2024 'repeat the same core warnings' with 'unchanged wording,' which directly contradicts the ground truth: there was a significant strategic shift in 2023 when PayPal entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables—a key quantitative and strategic detail entirely missing from the LLM response. This omission undermines the entire analysis of risk evolution. (2) No numeric values from the ground truth (e.g., €40 billion asset sale, references to Synchrony Bank, 'valid-when-made' doctrine) are mentioned or verified; instead, the LLM falsely implies stagnation. There are no calculations in the LLM answer, but it fails to report any specific figures that were present in the original. (3) The multi-hop reasoning is flawed: the question asks how exposure evolved and what that reveals about risk strategy. The ground truth shows a clear shift from internal risk absorption to external mitigation via asset sales and legal planning. The LLM instead concludes that risk exposure 'has not materially eased' and strategy remains static, which misrepresents the trend. (4) While the LLM correctly identifies general risk categories (credit products, cross-border trade, third-party dependencies), it fails to capture the dynamic changes over time, especially the 2023 strategic move to offload credit risk—rendering the answer contextually relevant but factually and analytically deficient. The answer reflects surface-level repetition rather than synthesis across years, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 460,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco’s competitive stance versus BJ’s remained consistent, with the company continuing to list BJ’s as a key competitor in its competition disclosures across 2022‑2024 (2022 page_7; 2023 page_8; 2024 page_9). However, the emphasis on private‑label differentiation evolved: in 2022 the company spoke generally of private‑label merchandise (2022 page_5), whereas by 2023 and 2024 it highlighted Kirkland Signature as a high‑quality, lower‑price brand that drives margin and member loyalty and that the firm expects to increase its sales penetration (2023 page_7; 2024 page_8). This shift underscores a sharpened focus on Kirkland Signature as a key differentiator against BJ’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in its central claim about a strategic 'evolution' or 'shift' in emphasis on Kirkland Signature from 2022 to 2024. The ground truth states that Costco's messaging around Kirkland Signature remained stable and consistent across the period, with no significant change in strategy. However, the LLM asserts that there was a 'sharpened focus' and an 'evolved' emphasis, particularly noting that in 2022 Costco spoke only 'generally of private-label merchandise' while in 2023 and 2024 it specifically highlighted Kirkland Signature. This characterization of a strategic shift is not supported by the original answer, which emphasizes consistency in messaging. While the LLM correctly identifies that Kirkland Signature was presented as high-quality, lower-priced, margin-enhancing, and loyalty-driving in later years, the inference of a strategic evolution contradicts the stability emphasized in the ground truth. There are no errors in quantitative details (no specific numbers, but years and page references are plausible and internally consistent), so quantitative accuracy is high. The reasoning is logically structured but based on a misinterpretation of the degree of change, undermining the qualitative accuracy. The answer is contextually relevant and addresses the question's focus on competitive positioning and private-label differentiation. Thus, the correctness score is moderate due to a significant error in the core interpretation of strategic continuity vs. change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 423,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "NextEra’s fair‑value of gas forward contracts dropped sharply over the three years: assets fell from $1.452 billion in 2022 to $377 million in 2023 and $296 million in 2024, while liabilities declined from $77 million to $77 million and then to $46 million. The net exposure therefore shrank from roughly $1.38 billion in 2022 to $300 million in 2023 and $250 million in 2024, indicating a deliberate move toward a more conservative natural‑gas risk posture and a smaller hedge footprint.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NextEra Energy's gas forward contract assets increased from $191 million in 2022 to $296 million in 2024, with a peak of $377 million in 2023. However, the LLM claims assets started at $1.452 billion in 2022, which is over 7.5 times higher than the correct value. Similarly, the ground truth shows liabilities rising from $31 million to $46 million, but the LLM incorrectly states they were $77 million in both 2022 and 2023 before dropping to $46 million in 2024. These errors fundamentally misrepresent the company's exposure. (2) Calculations are also incorrect: the LLM computes net exposure as shrinking from $1.38 billion to $250 million, but using correct figures, net exposure actually increased from $160 million ($191M - $31M) in 2022 to $250 million ($296M - $46M) in 2024, indicating growing, not shrinking, net asset exposure. The spike in 2023 net exposure was $346 million ($377M - $31M), not $300 million as claimed. (3) The multi-hop reasoning is flawed: while the LLM attempts to synthesize trends across years, it does so on entirely incorrect base data. The conclusion that the company adopted a 'more conservative risk posture' contradicts the ground truth, which indicates a strategic expansion in gas market participation and rising market risk. (4) Despite these issues, the answer is contextually relevant—it addresses the right company, time frame, and type of financial instrument, and attempts to interpret risk positioning. However, due to severe quantitative and qualitative inaccuracies, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 453,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure fell sharply from $2.56 billion in 2022 to $251 million in 2023, and the company had no forward swaps on its books in 2024 (the fair‑value measurement table shows zero). This decline reflects a shift from a large cash‑flow hedge on forecasted debt issuances to a smaller, more targeted hedge and ultimately to a different hedging instrument—fixed‑to‑floating swaps as fair‑value hedges—as market conditions and the company’s debt‑issuance profile evolved, indicating a more flexible interest‑rate risk‑management strategy. (page_61, page_54, page_46)",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 forward interest rate swap value, claiming $2.56 billion, which is not supported by the ground truth. The original answer states that in 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges and their impact on income over 2019–2021, but does not provide a specific dollar amount for 2022. The $2.56 billion figure is therefore incorrect and unsupported, likely a hallucination or misattribution. The 2023 value of $251 million is correct and matches the ground truth. The 2024 position of zero swaps is also correct, as confirmed by the absence of forward swaps in the 2024 disclosures. (2) The calculation of a 'decline' from $2.56B to $251M to $0 is based on a false premise due to the incorrect 2022 figure. While the direction of reduction is consistent with the ground truth, the magnitude is not. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the progression from active use in 2022, a reduced position in 2023, and no position in 2024, and infers a strategic shift in hedging instruments. It adds contextual insight about a shift to fixed-to-floating swaps as fair-value hedges, which aligns with plausible strategy evolution and may be supported by the cited pages, though not explicitly confirmed in the ground truth. However, the reasoning is undermined by the fabricated 2022 number. (4) The contextual relevance is high—the answer addresses the evolution over time and interprets strategic implications. Qualitative accuracy is moderate because the narrative logic is coherent and entity identification (Lowe's, years, derivative types) is correct, but the incorrect quantitative foundation reduces overall reliability. Correctness score is 6 due to one major quantitative error offset by otherwise accurate trajectory and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 512,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 to 2024, CMCSA kept expanding its fiber‑to‑the‑premises network, adding symmetrical speeds up to 10 Gbps for residential customers and up to 100 Gbps for business, while rolling out 2 Gbps downstream speeds on its HFC network in 2022 and deploying DOCSIS 4.0 in 2023 to deliver multigigabit symmetrical speeds【2024 page_7】【2024 page_6】. These upgrades enabled CMCSA to offer higher‑speed broadband packages in markets where Lumen is also building fiber, thereby strengthening its competitive position in overlapping service areas【2024 page_8】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in focus and factual alignment. (1) The original answer emphasizes Lumen's fiber expansion as a competitive threat to CMCSA, with CMCSA identifying Lumen as a key competitor due to overlapping fiber builds. In contrast, the LLM answer focuses almost entirely on CMCSA's own network upgrades (e.g., 10 Gbps residential, 100 Gbps business, DOCSIS 4.0) without confirming that Lumen was a growing fiber competitor in overlapping markets — the core of the question. (2) Quantitatively, the LLM introduces specific speed figures (10 Gbps, 100 Gbps, 2 Gbps) and technology rollouts (DOCSIS 4.0 in 2023) with citation tags, but these details are absent from the ground truth and cannot be verified as directly responsive to the competitive evolution with Lumen. While such upgrades may be factually present in CMCSA’s 2024 filing, they are presented here as competitive responses without establishing Lumen’s actions as the driver, which weakens factual alignment. (3) The multi-hop reasoning is flawed: the question asks how CMCSA’s positioning *against Lumen* evolved, requiring synthesis of both companies’ actions over time. The LLM fails to describe Lumen’s competitive moves beyond implying they were building fiber, and omits the key point that Lumen was consistently named as a top competitor across all three years. (4) Contextual relevance is high because the answer discusses fiber expansion in overlapping markets and competitive positioning, but it substitutes CMCSA’s initiatives for the required comparative analysis, missing the essence of the competitive dynamic. Thus, while some context and terminology are accurate, the answer does not reflect the ground truth’s emphasis on Lumen’s rising competitive role, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 497,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "From 2022 to 2024 PayPal sharpened its “one‑click” checkout promise by weaving consumer‑credit products more tightly into the payment flow—adding buy‑now‑pay‑later and installment options that can be chosen at checkout (2022 page 8; 2024 page 8) and expanding the markets where those products are available.  The company also broadened its global reach, now serving roughly 200 markets with 150 currencies for payments, 56 for withdrawals and 24 for balances (2024 page 5‑6), up from the 150‑currency, 56‑withdrawal, 24‑balance framework noted in 2022.  Finally, PayPal moved from a primarily online focus to a full omnichannel offering, adding in‑person POS tools such as Zettle by PayPal, card readers and unbranded processing via Braintree and PayPal Complete Payments (2024 page 7‑8).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly identifies PayPal's evolution from 2022 to 2024 in enhancing seamless checkout through credit integration, global currency support, and omnichannel solutions. (2) Quantitatively, it states 'roughly 200 markets with 150 currencies for payments, 56 for withdrawals and 24 for balances' in 2024, which matches the ground truth of ~150 currencies (note: '200 markets' is a reasonable interpretation of global reach, as the original does not specify market count but refers to 'over 100 currencies' in 2022 expanding to ~150). The LLM correctly notes consistency in withdrawal and balance currencies across years. Minor point: original says 'over 100' in 2022, while LLM says '150-currency... framework noted in 2022' — this is a small inaccuracy, as 150 currencies were reached by 2023–2024, not 2022. (3) Multi-hop reasoning is sound: synthesizes evolution across years, integrates credit offerings (BNPL, installment plans), links to omnichannel via Zettle, Braintree, and PayPal Complete Payments, and contextualizes global expansion. (4) Semantic equivalence is strong — uses different phrasing (e.g., 'weaving consumer-credit products') but captures the strategic shift toward financial integration and merchant enablement. Only minor quantitative overstatement on 2022 currency count prevents a perfect 10. Contextual relevance is excellent, addressing all three dimensions of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 406,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target Debit Card penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024 (RedCard penetration in 2022–2023, Target Circle Card penetration in 2024)【page_27】【page_29】. This downward trend indicates a shrinking share of purchases made with the card, suggesting its incremental sales‑driving influence is weakening over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains incorrect numeric values for 2023 and 2024. According to the ground truth, the penetration rate was 18.6% in 2023 and 17.8% in 2024, but the LLM states 19.8% in 2023 and 18.6% in 2024. This is a significant quantitative error, especially since the trend interpretation depends on accurate year-over-year changes. The 2022 figure (20.5%) is correct. (2) The calculation of the trend is affected: the actual decline from 2022 to 2024 is 2.7 percentage points (20.5% → 17.8%), while the LLM implies a 1.9-point drop (20.5% → 18.6%), understating the severity of the decline. (3) The reasoning and synthesis are otherwise sound—the LLM correctly infers that declining penetration suggests a weakening role in driving incremental sales, which aligns with the ground truth’s interpretation. It also appropriately references RedCard and Target Circle Card as part of the evolution in metrics, showing correct entity identification and contextual understanding. (4) Contextual relevance is high, as the answer addresses both parts of the question: the trend over time and its implication for sales. However, due to the incorrect intermediate and final percentages, the quantitative accuracy is low, pulling down the overall correctness score despite strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 370,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed between 2022 and 2024.  The company still evaluates whether the license is distinct; if it is, revenue is recognized at a point in time when the customer can benefit, and if it is not, the license is combined with the development services and revenue is recognized over time.  Stand‑alone licensing arrangements are always recognized at a point in time, and no variable‑consideration estimates are applied to either type of agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures AMD's consistent revenue recognition approach from 2022 to 2024: distinguishing between distinct and non-distinct licenses, recognizing revenue at a point in time for standalone licenses, and over time when combined with development services. The statement that the policy 'has not changed' matches the original answer's emphasis on consistency across years. All entities (AMD, development and IP licensing, standalone vs. combined arrangements) and time periods (2022–2024) are correctly identified. There are no numeric figures in the question or answer, so quantitative accuracy is scored as 10 by default. The only minor shortcoming is that the LLM answer omits the nuance mentioned in the original about the lack of disclosed quantitative metrics, which slightly affects completeness and reasoning depth—hence a 9 on qualitative accuracy and correctness. However, this does not detract from the core factual accuracy. The answer is fully contextually relevant and synthesizes the correct multi-hop logic: linking license distinctness to timing of revenue recognition across multiple years and agreement types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 340,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "FlyEase has remained a consistent pillar of Nike’s innovation strategy.  In each of the FY 2022, FY 2023 and FY 2024 10‑K filings, the technology is listed alongside other core innovations—Air, Zoom, Flyknit, React, etc.—in the Product Research, Design and Development section, underscoring its ongoing role as a key, integrated technology rather than a one‑off or niche offering (2022 10‑K, page 6; 2023 10‑K, page 6; 2024 10‑K, page 6).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually consistent in terms of entity and date accuracy—FlyEase is correctly identified as part of Nike's innovation portfolio across fiscal years 2022–2024, and the citations to the 10-K filings (pages, sections) are plausible. Quantitatively, there are no numerical claims to verify, so no errors exist in that regard (score 10). However, the core of the question asks about the *evolution* of FlyEase’s strategic positioning, which the LLM fails to address. The ground truth describes a clear progression: from emerging (2022) to established (2023) to mature/core (2024). In contrast, the LLM claims FlyEase was consistently listed among core innovations in all three years, implying no evolution—this contradicts the documented shift from 'new innovation' to 'mature technology'. This misrepresents the multi-hop progression and misses the key nuance of FlyEase’s maturation. While the answer is relevant and correctly identifies the technology and context, it lacks the dynamic analysis required, resulting in a qualitative accuracy score of 4 and a correctness score of 4 due to the significant omission of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 324,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "AMT’s 1.250% Notes have been steadily reduced: the outstanding principal fell from roughly $558.7 million in 2022 (558.7 = 551.9 + 6.8 million, per the 2023 table) to $551.9 million in 2023 (page 111) and to $517.7 million in 2024 (page 115). This downward trend indicates a deliberate debt‑reduction strategy, with the company repaying or redeeming the notes to lower interest costs and improve its maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the 2022 principal amount. The ground truth states $609.1 million in 2022, but the LLM incorrectly calculates and reports $558.7 million, derived from an erroneous sum of $551.9M + $6.8M. This calculation is unsupported by the context and contradicts the ground truth. The 2023 ($551.9M) and 2024 ($517.7M) figures are correct. (2) The quantitative inaccuracy in the 2022 value undermines the trend analysis, despite the correct directionality (downward). The model introduces a fabricated calculation not present in the original data. (3) The reasoning about a deliberate debt-reduction strategy is logically sound and aligns with the ground truth's interpretation of a managed amortization or repurchase strategy. The mention of improving maturity profile and reducing interest costs is a reasonable inference, though the original answer also notes stable interest payment terms and maturity date (February 2033), which the LLM omits. (4) The contextual relevance is high as the answer addresses the trend and its implications. However, the major numerical error in the starting principal significantly reduces factual correctness, warranting a score of 6—partially correct with significant factual flaws. Qualitative reasoning is mostly sound, hence 7; quantitative accuracy is low due to the incorrect 2022 figure, scoring 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 386,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2040 were valued at $870 million in FY 2023 and $851 million in FY 2024, a modest decline that left the carrying amount unchanged at $1.0 billion and the effective interest rate steady at 3.54% (page 67; page 72). The notes are classified as Level 2 debt securities and are carried at amortized cost, with no redemption or amortization during this period. This steady valuation and treatment demonstrate NVIDIA’s long‑term debt strategy of maintaining a stable, low‑coupon, long‑maturity debt profile to support growth while preserving liquidity and predictable interest expense.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in FY 2022, $851 million in FY 2023, and $1,000 million in FY 2024. However, the LLM incorrectly states the FY 2023 value as $870 million and assigns the $851 million figure to FY 2024, which is factually wrong. Additionally, the LLM omits the FY 2022 valuation entirely, failing to capture the full multi-year trajectory requested in the question. (2) The carrying amount of $1.0 billion and effective interest rate of 3.54% in FY 2024 are correctly reported and align with the ground truth. The classification as Level 2 debt securities and carrying at amortized cost (not fair value) is a relevant qualitative point that adds context, though this nuance was not in the original answer. However, the core financial figures—especially the misattribution of $851 million to FY 2024 instead of FY 2023—are factually incorrect. (3) The reasoning about NVIDIA’s long-term debt strategy—maintaining stable, low-coupon, long-maturity debt—is logically sound and consistent with the ground truth’s interpretation. The synthesis of strategy from valuation trends shows adequate multi-hop reasoning, but it is based on flawed data inputs, undermining the conclusion's reliability. (4) Despite correct strategic interpretation and contextual relevance, the quantitative inaccuracies—especially the wrong year assignments for key values—severely impact correctness. The answer is partially complete and well-reasoned but fails on core factual accuracy, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 458,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "From 2022 to 2024 Netflix expanded its membership strategy by first adding games to its streaming library and launching a lower‑priced ad‑supported subscription tier in 2022, then continuing to roll out games and the ad‑supported plan in 2023, and in 2024 adding live programming and a new ad‑supported tier while adjusting pricing to reflect the broader content mix. In each year the risk disclosures warned that if new features, pricing changes or content offerings are not perceived as valuable, members could churn or new members may not join, and that competition and enforcement of multi‑household usage could further erode acquisition and retention.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in timing and sequence. It incorrectly states that Netflix launched the ad-supported tier in 2022, when the ground truth confirms it was introduced in 2023. This misalignment affects the multi-year evolution narrative. Additionally, the claim of introducing 'a new ad-supported tier' in 2024 is unsupported by the original answer, which only mentions the continuation of risk disclosures and the addition of live programming. The games were correctly attributed to 2022, and live programming to 2024, which is accurate. (2) There are no explicit numbers (e.g., pricing amounts, subscriber counts) in either answer, so quantitative accuracy is not heavily applicable; however, the misattribution of events to incorrect years constitutes a factual error in temporal data, which is critical in this context. The format and consistency of year references are otherwise correct. (3) The multi-hop reasoning is partially sound—Netflix did expand offerings and disclose risks around value perception, churn, and competition across years. However, the incorrect sequencing of the ad-supported tier launch undermines the logical progression. The synthesis of risks related to pricing, features, and member perception is semantically aligned with the original, and the mention of multi-household usage enforcement adds context not in the ground truth but plausibly related. (4) Despite the chronological errors, the answer remains contextually relevant, addressing all key themes: service expansions (games, ads, live), pricing adjustments, and associated risks. The core risk narrative—that changes may not be valued and could impact acquisition/retention—is correctly conveyed. However, due to the significant error in timing of a major strategic move (ad-tier launch), the qualitative and overall correctness scores are reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 511,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑style exposure grew from $3.7 B in equity securities in 2022 to $4.9 B in 2023 and remained at that level in 2024 (page 52).  Equity‑method investments in healthcare operating businesses fell slightly from $1.5 B in 2022 to $1.4 B in 2023 but then surged to $3.8 B in 2024, more than doubling the 2022 figure (page 52).  This pattern shows the company is keeping a steady overall venture portfolio while aggressively expanding its stake in operating healthcare firms, underscoring a strategic focus on deepening its footprint and influence in the sector.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy in the equity-method investment value for 2022. The ground truth states $1.3 billion, but the LLM reports $1.5 billion, which is incorrect. All other numbers are accurate: equity securities correctly reported as $3.7B (2022), $4.9B (2023 and 2024), and equity-method investments correctly noted as $1.4B in 2023 and $3.8B in 2024. (2) The calculation describing the 2024 equity-method investment as 'more than doubling' the 2022 figure is logically sound *only if* the 2022 value were $1.5B — but since the true 2022 value is $1.3B, $3.8B is actually nearly triple (≈2.92x), so the 'more than doubling' statement is still factually valid, though based on an incorrect baseline. The core growth trend is correctly interpreted. (3) The multi-hop reasoning is strong: the model synthesizes data across three years for two distinct investment types and draws a valid strategic conclusion about UnitedHealth’s increasing engagement in operating healthcare businesses. The narrative of steady equity securities but surging equity-method investments aligns with the ground truth and supports the strategic interpretation. (4) The contextual relevance is excellent — all parts of the question are addressed, including evolution over time and strategic implications. The qualitative reasoning is sound despite the numerical error, hence high scores in qualitative accuracy and contextual relevance. The quantitative accuracy is penalized due to the incorrect $1.5B figure, but not severely, as most numbers and the overall trend are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 444,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s relationship with Sojitz America remained unchanged: Sojitz America continued to be the sole owner of the company’s authorized redeemable preferred stock (par $1, redeemable at $0.3 million) and the cumulative dividend of $0.10 per share is payable annually on May 31, with no common‑stock dividends allowed until the preferred dividend is fully paid. The preferred‑stock terms and dividend obligations did not vary across the three fiscal years. Sojitz America’s role in Nike’s international operations stayed the same as a provider of import‑export financing services that support Nike’s global supply chain and financing, with no shift in responsibilities or influence.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key quantitative elements: Sojitz America remained the sole holder of Nike's redeemable preferred stock, the annual cumulative dividend was $0.10 per share, and this dividend was payable annually. However, there are factual inaccuracies in the quantitative details: the par value is stated as $1 and redeemable at $0.3 million, while the ground truth specifies the par value as $0.3 million (not $1), indicating a misstatement of financial terms. The answer correctly notes no changes in dividend obligations or stock ownership across FY2022–FY2024, aligning with the ground truth on financial continuity. However, it fails a critical qualitative and contextual point: the evolution in Sojitz America’s strategic role. The ground truth states that in FY2024, Nike explicitly highlighted Sojitz America’s strategic importance in mitigating global trade risks, marking a shift from purely financial to operationally strategic engagement. The LLM incorrectly asserts there was 'no shift in responsibilities or influence,' contradicting the documented evolution in Nike’s disclosures. This omission represents a failure in multi-hop reasoning—synthesizing financial consistency with emerging strategic emphasis. While the answer is factually sound on static financial terms, it misses the dynamic strategic narrative that is central to the question. Thus, despite strong contextual relevance and partial quantitative accuracy, the answer is significantly flawed in qualitative accuracy and overall correctness due to the missed strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 431,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 carried **$1,637 million** at the end of FY 2022, remained essentially unchanged at **$1,637 million** at the end of FY 2023, and declined to **$1,604 million** at the end of FY 2024 (NVDA 10‑K 2022, p. 78; NVDA 10‑K 2023, p. 67; NVDA 10‑K 2024, p. 67). This slight downward trend signals a modest reduction in long‑term debt, reflecting a stable and manageable long‑term debt profile for the company.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the values were $2,147M (FY2022), $1,604M (FY2023), and $2,000M (FY2024). The LLM incorrectly reports $1,637M for both FY2022 and FY2023 and $1,604M for FY2024, which contradicts the actual trend. The correct trend is a decrease from 2022 to 2023, then a substantial increase in 2024. The LLM instead reports a flat trend followed by a minor decline, which is factually wrong. (2) The numbers are quantitatively inaccurate: the FY2022 value is off by $510 million, and the direction of change in FY2024 is completely reversed. Even allowing for format variations, the values do not match any plausible interpretation of the ground truth. (3) The multi-hop reasoning is flawed—the LLM fails to correctly synthesize data across the three fiscal years. It misidentifies the trajectory of the debt, leading to an incorrect conclusion about a 'slight downward trend' and 'modest reduction', whereas the ground truth indicates a temporary reduction followed by a strategic increase. This misrepresents NVIDIA's long-term debt positioning. (4) Contextual relevance is moderate because the answer addresses the right metric (carrying value of 3.50% Notes Due 2050) and attempts to interpret the trend, but the incorrect data renders the analysis invalid. The citations to 10-K pages are plausible but do not excuse the factual errors. Overall, the answer is mostly incorrect due to major quantitative and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 426,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term debt fell from $175 million in 2022 to $119 million in 2023 but surged to $465 million in 2024, a shift that reflects a growing use of commercial paper backed by its unsecured revolving credit facility.  Across all three years the company reiterated that its global funding mix—short‑term and long‑term debt, collateral financing, junior subordinated securities, PABs, credit and committed facilities, and a shelf registration—provides flexibility, limits dependence on any single market, and generally lowers the cost of funds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any specific dollar amounts for MetLife's short-term debt in 2022, 2023, or 2024, nor does it indicate a decline from $175M to $119M or a surge to $465M in 2024. These figures are entirely fabricated and not supported by the original answer or the underlying knowledge graph. There is no mention of numerical trends in the original answer—only qualitative descriptions of strategy. (2) The quantitative accuracy is very low because the model invents precise numbers that do not appear in the ground truth. Even if the direction of change were acceptable (e.g., increasing reliance), the specific values and implied volatility are unsupported. The original answer emphasizes consistency and stability in funding structure, contradicting the LLM's narrative of a 'surge' in 2024. (3) Qualitatively, the LLM correctly identifies key elements of MetLife’s funding strategy—use of commercial paper, unsecured revolving credit facilities, diversification across funding sources (e.g., PABs, shelf registration), and the goal of reducing dependence on single markets and lowering cost of capital. It also correctly frames the multi-year narrative around funding flexibility. However, it fails to reflect the stable, consistent nature of the strategy emphasized in the original answer, instead implying a shifting reliance. (4) Contextual relevance is moderate: the answer addresses the right concepts and structure, showing understanding of the question's intent, but undermines credibility with hallucinated data. The synthesis across years is partially sound but distorted by incorrect numerical trends. Overall, the answer misrepresents the core factual basis despite capturing some strategic themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 499,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantees remained non‑material throughout 2022‑24 (Note 4, page 81).  The company’s short‑term notes payable to subsidiaries rose from $8.7 B in 2022 to $9.9 B in 2023 and then fell sharply to $2.0 B in 2024, while long‑term notes payable to subsidiaries jumped from $0 B in 2023 to $14.4 B in 2024 (page 78).  This shift reflects a rebalancing of liquidity commitments toward longer‑term financing, reducing short‑term liquidity exposure but increasing contractual obligations over a longer horizon.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the ground truth states that notes payable to subsidiaries were $8.1B in 2022, the LLM reports $8.7B, which is incorrect. The 2023 value ($9.9B) and 2024 value ($2.0B) for short-term notes are correct. However, the LLM introduces a claim about long-term notes payable to subsidiaries increasing to $14.4B in 2024, which is not present in the original answer and cannot be verified from the provided ground truth. This addition introduces major factual errors and misrepresents the data. (2) The original answer makes no distinction between short-term and long-term notes; it only provides a single aggregate figure per year. Therefore, the LLM's breakdown into short-term and long-term components appears to be an unsupported inference or error. The sharp drop to $2.0B in 2024 is correctly noted, but the explanation involving long-term debt is not supported by the ground truth. (3) On qualitative reasoning, the LLM attempts sound multi-hop synthesis by linking liquidity commitments to financing trends and interpreting the shift as a rebalancing toward longer-term financing. However, this conclusion is based on fabricated data (the $14.4B long-term notes), undermining the validity of the reasoning. The point about service level guarantees being non-material is correctly cited and consistent with the original answer. (4) Contextual relevance is high—the response addresses both service level guarantees and notes payable, links them to liquidity and contractual risk, and attempts to interpret trends over time. Despite incorrect numbers and unsupported breakdowns, the overall structure and intent align well with the question. The correctness score is reduced primarily due to the incorrect 2022 figure and the introduction of unverified long-term debt data, which distort the financial picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 511,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 through 2024, American Express remained the fourth‑largest general‑purpose card network worldwide, but it faced mounting regulatory scrutiny over interchange‑fee caps, network‑licensing rules and its new Category III status, prompting the company to exit EU and Australian licensing businesses and to tighten compliance, risk‑management and governance frameworks (see pages 12, 13, 34, 35).  Competitive pressure from Visa, Mastercard, China UnionPay and alternative payment platforms intensified, leading AmEx to invest in digital services, loyalty programs and innovation to preserve its premium positioning (page 12).  In response, the company adjusted pricing and product offerings, strengthened its compliance infrastructure, and focused on regulatory compliance to mitigate impacts on its network operations (pages 34, 35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original (ground truth) answer. (1) All key facts are correct: American Express remained the fourth-largest general-purpose card network from 2022–2024, faced increasing regulatory scrutiny, exited EU and Australian licensing businesses, was designated a Category III firm in 2024, and faced competitive pressure from Visa, Mastercard, China UnionPay, and alternative platforms like PayPal and Alipay. The strategic responses—investment in digital services, loyalty programs, compliance infrastructure, and product adjustments—are all correctly identified. (2) Quantitative accuracy is perfect: no numerical errors; dates (2022–2024), rankings (fourth-largest), and regulatory classifications (Category III) are all factually correct. Format variations (e.g., 'Category III' vs 'Category III') are acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics, regulatory changes, and strategic responses across time, correctly linking Amex’s evolving positioning to external pressures and internal adaptations. The only minor omission is the lack of explicit mention of regional systems like NPCI (India), which appears in the original answer and adds nuance to competitive pressures. Additionally, the original emphasizes a shift in tone and strategic posture—from market-driven competition to regulatory navigation—more explicitly, which the LLM implies but does not fully articulate. (4) Despite these small gaps in depth, the LLM answer captures the core evolution accurately, uses appropriate terminology, and maintains semantic equivalence. Contextual relevance is excellent, directly addressing all aspects of the question. Thus, the correctness score is 9 (not 10) due to slight incompleteness in competitive landscape detail and strategic narrative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1631,
        "completion_tokens": 499,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "ConocoPhillips has kept the same dividend‑equivalent structure for its cash‑settled PSUs for performance periods that began in 2018 or later: recipients receive an accrued reinvested dividend equivalent that is charged to compensation expense and paid only at settlement (page 136, 2022 10‑K; page 124, 2023 10‑K; page 126, 2024 10‑K).  The unchanged approach from 2022 through 2024 shows the company’s commitment to long‑term incentive alignment, tying employee rewards to performance and shareholder value while providing a deferred cash benefit that reinforces long‑term ownership.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of ConocoPhillips' dividend equivalent structure for cash-settled PSUs starting in 2018 or later, correctly stating that recipients receive accrued reinvested dividends paid at settlement, with this structure remaining unchanged from 2022 to 2024. The cited pages from the 10-K filings (2022 p.136, 2023 p.124, 2024 p.126) support this claim, confirming quantitative and entity accuracy. The answer correctly identifies the company, time period, and incentive structure. However, it omits a key comparative element present in the original answer: the contrast between pre-2018 and post-2018 structures (i.e., no payments during performance period before 2018 vs. accrued reinvestment starting in 2018). This missing comparison weakens the multi-hop synthesis required to fully explain the evolution of the strategy. While the LLM infers that the consistent approach reflects long-term alignment—consistent with the ground truth—this conclusion is drawn without referencing the shift in policy, thus missing a critical reasoning step. The answer is semantically aligned in parts and contextually relevant, but incomplete in delivering the full evolution narrative. Hence, correctness and qualitative accuracy are slightly reduced, though quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 369,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "Special‑use funds rose from about **$7.34 billion in 2022** (page 88) to **$8.83 billion in 2023** (page 87) and **$9.80 billion in 2024** (page 64).  During the same period the potential derivative collateral that would be required if credit ratings were downgraded fell from roughly **$5.2 billion in 2022** to **$2.4 billion in 2023** (page 86), and the actual collateral posted declined from **$4.62 billion** to **$2.29 billion**.  The widening liquidity cushion from the expanding special‑use funds, relative to the shrinking derivative collateral exposure, signals a stronger liquidity position that better supports the company’s derivative‑related collateral obligations over 2022‑2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers. According to the ground truth, Special Use Funds were $8,698 million in 2023, not $8.83 billion as stated, and there is no mention of $7.34 billion in 2022 in the original answer—this figure is unverified. The ground truth does not provide a 2022 Special Use Funds value, so the LLM's inclusion of one is speculative. More critically, the LLM incorrectly states that actual collateral posted declined from $4.62 billion to $2.29 billion, while the ground truth reports a rise from $84 million in 2022 to $691 million in 2023—this is a major quantitative error. (2) The potential collateral drop from $5.2 billion in 2022 to $2.4 billion in 2023 is correctly reported and aligns with the ground truth. The 2024 Special Use Funds value of $9.80 billion is accurate. However, the 2022 and 2023 Special Use Funds figures are inconsistent with the ground truth, which only confirms 2023 and 2024 values. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that growing Special Use Funds and declining potential collateral exposure indicate improved liquidity positioning. This logical synthesis is valid and relevant. However, the flawed data on actual collateral posted undermines the reasoning, as the trend is misrepresented (it increased, not decreased). (4) The contextual relevance is high—the answer addresses liquidity positioning in relation to derivative collateral obligations across the period and attempts proper synthesis. Due to significant numerical errors, especially in actual collateral posted and unsupported 2022 Special Use Funds, the correctness and quantitative accuracy scores are low. The qualitative reasoning is reasonable but based on incorrect inputs, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 491,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600% Notes stayed at a $700 million balance at each year‑end, with amortization of $3.7 million in 2022, $2.6 million in 2023 and $1.5 million in 2024 (see the “Adjustments to Principal Amount” columns in the 2023 table on page 110 and the 2024 table on page 113). This gradual, low‑rate principal reduction indicates a conservative debt‑management approach that prioritizes liquidity and a stable debt profile while slowly trimming the 1.600% Notes balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the amortization amounts. According to the ground truth, the adjustments to principal were (3.7) million in 2022, (2.6) million in 2024, with no value provided for 2023 in the original answer. However, the LLM claims amortization was $3.7M in 2022, $2.6M in 2023, and $1.5M in 2024 — inserting a 2023 figure not in the source and incorrectly extending the downward trend to $1.5M in 2024, which contradicts the ground truth that only confirms a decline to (2.6) million in 2024. This represents a clear quantitative error. (2) The principal amount of $700 million is correctly stated across all years, which is accurate. However, the amortization trajectory is misrepresented — the LLM fabricates intermediate values and projects an unjustified continuation of the trend. (3) The multi-hop reasoning is partially sound in that it attempts to infer a debt management strategy from the pattern of amortization, but it does so on incorrect numerical foundations. The conclusion about a 'conservative debt-management approach' and 'slowly trimming the balance' implies active principal reduction, which contradicts the ground truth that the outstanding principal remained constant at $700 million. Thus, the reasoning misinterprets 'adjustments to principal' (likely accrued interest or non-cash adjustments) as actual amortization of principal, leading to flawed synthesis. (4) Contextual relevance is high because the answer addresses both parts of the question — the trajectory and the strategic implication — and focuses on the correct instrument and company. However, due to major quantitative errors and flawed reasoning based on fabricated data points, the overall correctness score is low. The answer creates a misleading narrative unsupported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 499,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes stayed a persistent regulatory risk from 2022 through 2024, as CMS continued to reduce or freeze benchmarks and periodically alter the risk‑adjustment calculation methodology【page_25】【page_20】【page_20】. In each filing the company explained that it had responded by selectively adjusting member benefits and premiums, withdrawing plans in certain counties, and tightening medical and operating cost controls to offset the funding pressures【page_25】【page_20】【page_20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024, as well as the company's strategic responses. (1) All factual elements are correct: CMS consistently altered risk adjustment methodologies and benchmarks across the three years, and UNH responded with selective benefit and premium adjustments, county exits, and intensified cost controls. The answer correctly identifies these actions as recurring across the period. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent regulatory pressure and corresponding strategic responses across multiple years and filings (as indicated by the citations), showing understanding of the evolving dynamic. The only minor shortcoming is that the original answer provides slightly more granular year-by-year progression (e.g., 'in 2022...', 'by 2024...'), while the LLM generalizes the response across the period. This slight loss of temporal specificity prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question—evolution of exposure and strategic adjustments—with precise and appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 389,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023 and 2024 all describe employee merchandise discounts simply as “merchandise and other discounts” that are part of the overall benefits package (see 2022 p. 7, 2023 p. 7, 2024 p. 7).  None of the filings disclose a change in the discount rate, eligibility criteria or program structure, indicating that Target has kept the benefit broad and unchanged over this period.  This consistency suggests a strategy that values a steady, cost‑saving benefit to support team members’ financial well‑being without pursuing incremental expansion or redesign.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key qualitative developments in Target's employee benefits strategy from 2022 to 2024. While it correctly notes that merchandise discounts were consistently mentioned across the 10-K filings and that no specific changes to discount rates or structures were disclosed, it fails to capture the evolving context in which these benefits were presented. The ground truth highlights a strategic shift—such as the expansion of starting wages, addition of sick pay, tuition-free education, and integration with broader financial wellness and belonging initiatives—none of which are acknowledged in the LLM response. (2) There are no numerical inaccuracies; the LLM does not introduce false figures and correctly refrains from asserting changes in discount percentages or dollar amounts, which aligns with the source data. Thus, quantitative accuracy is high. (3) The multi-hop reasoning is weak: the question asks not only whether the discount program changed structurally but also what the progression indicates about Target’s strategy in supporting employee financial well-being. The LLM stops at surface-level consistency and misses the synthesis across years showing an expanding benefits ecosystem. It does not connect wage increases, new benefits, or well-being programs to the broader strategic narrative present in the original answer. (4) Contextual relevance is strong because the LLM addresses the core topic—employee merchandise discounts—and correctly identifies their stable presence. However, by overlooking the strategic evolution in framing and bundling of benefits, the answer provides an incomplete picture, resulting in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 469,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "Across 2022‑2024, American Express kept its foreign‑government‑bond portfolio almost entirely short‑term—most of the $630 million were due within one year, with only a handful maturing in the 1–5‑year window and virtually none beyond 10 years—and the weighted‑average yield stayed near 2 % (1.74 % for 1‑year, 2.42 % for 1–5 years, 5.46 % for 5–10 years, 3.10 % for >10 years, overall 2.08 %【page_121】). The 2024 10‑K shows no significant shift in this maturity mix or yield, underscoring a cautious, liquidity‑focused risk appetite and a deliberate asset‑allocation strategy that prioritizes low‑duration, low‑yield foreign‑bond holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims that American Express maintained a stable yield and maturity distribution from 2022 to 2024, but the ground truth shows significant changes in yields year-over-year, especially the sharp rise in 2023 and drop in 2024. The LLM incorrectly states that yields remained near 2% throughout, when in fact the 1-year yield rose to 6.45% in 2023 and was 5.86% in 2024. It also fabricates data for 5–10 year and >10 year maturities (5.46% and 3.10%) not present in the original answer and irrelevant since the original only discusses up to 5 years. (2) The dollar amount ($630 million) is correct, and the 2022 yields (1.74% and 2.42%) are accurately cited, but all subsequent years are wrong. The LLM fails to report the 2023 and 2024 yield changes entirely, instead asserting no significant shift, which contradicts the ground truth. (3) The multi-hop reasoning is flawed: the question asks for evolution across three years and what it suggests about risk appetite. The LLM incorrectly concludes a 'cautious, liquidity-focused' strategy, while the ground truth indicates a dynamic shift—increased risk-taking in 2023 and partial retreat in 2024. The LLM misses this entire narrative. (4) The contextual relevance is moderate because it addresses the right company, asset class, and general time frame, and attempts to infer strategy, but the factual inaccuracies and missed trends severely undermine the response. The citation of 'page_121' does not compensate for the incorrect synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 436,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell from **$1.494 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024**—all figures reported as part of “Other assets, including intangibles – net.” The steady decline indicates that the company is reducing the collateral it must post for netting, suggesting more efficient hedging, a lower derivative exposure, or improved counterparty‑risk management.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,494 million (expressed as $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024—format variations are acceptable and semantically equivalent. (2) The answer is complete, addressing both the change in collateral over time and the implication regarding derivative exposure management. (3) Entity accuracy is correct: ExxonMobil (XOM), the financial metric 'collateral under master netting arrangements' within 'Other assets, including intangibles - net', and the years 2022–2024 are all properly identified. (4) The reasoning is sound and reflects valid multi-hop synthesis: the downward trend is correctly interpreted as indicating reduced derivative exposure or improved risk management, with plausible explanations such as more efficient hedging or better counterparty-risk management. The LLM provides a slightly broader but still accurate interpretation, enhancing rather than distorting the conclusion. All criteria for correctness, precision, reasoning, and relevance are fully met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 319,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "The 2.700% senior unsecured notes were issued on March 29 2021 at a fixed 2.700% rate with a 2031 maturity and have remained unchanged through 2024 (no new issuances or amendments)【page_113】.  In 2024 AMT raised new, higher‑rate debt (5.200% and 5.450% notes) and used the proceeds to repay its 2021 Multicurrency Credit Facility, but left the 2.700% notes intact, indicating a strategy of locking in low rates early and maintaining a stable, long‑term debt base while refinancing other obligations as market rates rose【page_112】【page_114】.  This pattern shows AMT capitalized on a low‑rate environment in 2021 and then shifted to higher‑rate debt as rates climbed, using the 2.700% notes as a low‑cost anchor in its capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the terms of the 2.700% Notes, particularly around maturity date and interest rate spread changes. According to the ground truth, the maturity date evolved from April 15, 2031 in 2022 to January 15, 2031 by 2023 and remained so in 2024 — a key change that the LLM omits, instead stating a generic '2031 maturity' without acknowledging the shift. Additionally, the ground truth notes a decrease in interest rate spread from (5.0) to (4.4) by 2024, which the LLM fails to mention entirely. Instead, the LLM incorrectly claims that AMT issued new higher-rate notes (5.200% and 5.450%) in 2024 to refinance a credit facility, which is not reflected in the original answer and introduces unrelated debt instruments. (2) Quantitative accuracy is low: while the $700 million principal and 2.700% interest rate are correctly implied, the maturity date is oversimplified and technically incorrect due to the unacknowledged change from April to January 2031. The interest rate spread adjustment — a key quantitative detail in the ground truth — is missing. The mention of 5.200% and 5.450% notes has no support in the original answer and appears fabricated. (3) The reasoning is partially sound in interpreting AMT’s strategy of locking in low rates, which aligns with the ground truth’s conclusion about stable long-term financing. However, the multi-hop synthesis is flawed because it draws conclusions about financing strategy based on debt instruments not mentioned in the original data, undermining the logical foundation. The model infers refinancing activity that isn’t part of the verified narrative. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of the 2.700% Notes and attempting to interpret strategic implications. The core idea — that AMT maintained low-cost debt as an anchor — is consistent with the ground truth’s interpretation, earning moderate qualitative and high relevance scores. However, the absence of key changes in maturity and spread, plus the introduction of unsupported debt issuances, reduces overall correctness to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 583,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00% Notes Due 2031 carried a constant $1,250 million at the end of fiscal 2022, 2023, and 2024 (see the 2023 10‑K table on page 68 and the 2024 10‑K table on page 72). The balance, with a 6.4‑year remaining term and 2.09% effective rate, stayed unchanged, indicating the company’s intent to keep a stable, low‑interest, long‑term debt position rather than expanding or retiring this particular note—an approach that underscores a disciplined, diversified long‑term debt strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, the fair value of the 2.00% Notes Due 2031 was $1.2 billion in 2022, increased slightly to $1.044 billion at the beginning of 2023, remained stable at $1.057 billion by the end of 2023, and reached a carrying value of $1.25 billion in 2024. However, the LLM claims the amount was a constant $1,250 million (i.e., $1.25 billion) across all three years (2022, 2023, and 2024), which directly contradicts the ground truth progression. This misrepresentation of the financial obligation’s evolution is a critical error. (2) The numbers are not accurate: the 2022 value is overstated (claims $1.25B vs. actual $1.2B), the 2023 values (both beginning and end) are misrepresented (claims $1.25B vs. $1.044B and $1.057B), and while the 2024 value matches ($1.25B), it is presented as part of a stable trend when in fact it reflects an increase. The LLM also introduces a '6.4-year remaining term' and '2.09% effective rate' not mentioned in the ground truth, adding unverified details. (3) The multi-hop reasoning is flawed: the model fails to capture the actual progression of the debt value over time and incorrectly infers stability from 2022 to 2024 when there is a clear fluctuation and eventual increase. The conclusion about a 'disciplined, diversified long-term debt strategy' may be plausible, but it is based on incorrect data. (4) Despite the incorrect numbers, the answer is contextually relevant—it addresses the right financial instrument, the correct company, and attempts to interpret the strategic implication. However, due to major quantitative errors and flawed reasoning, the correctness score is low. The qualitative score reflects partial understanding of the concept but failure in execution. Contextual relevance is moderate because the structure and intent align with the question, even if facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 527,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances expanded markedly from 2022 to 2023, then eased slightly in 2024.  At the end of 2022 the company had about $1.8 billion in deposit assets and $1.4 billion in deposit liabilities (Note 6, page 216).  Those balances grew to $5.1 billion in assets and $1.3 billion in liabilities in 2023, and then settled at $4.6 billion in assets and $1.2 billion in liabilities in 2024 (Note 6, page 206).  The trend—large gains in deposit assets coupled with a modest decline in liabilities—indicates MetLife is increasingly using deposit‑method agreements to transfer risk and preserve liquidity while maintaining a net positive deposit position that mitigates counter‑party exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly reports deposit assets of $1.8 billion in 2022 and $5.1 billion in 2023, it incorrectly states that deposit assets were $4.6 billion in 2024, whereas the ground truth indicates they were $5.1 billion in 2024 (no decline). This is a critical error affecting the core trend interpretation. Deposit liabilities are correctly reported as $1.4B (2022), $1.3B (2023), and $1.2B (2024), aligning with the original answer. (2) The calculation of trends is flawed due to the incorrect 2024 asset figure. The LLM suggests assets 'eased slightly' to $4.6B, implying a decrease from 2023, but in reality, assets remained at $5.1B or increased slightly depending on interpretation—no drop occurred. This undermines the accuracy of the trend analysis. (3) The reasoning and multi-hop synthesis are otherwise sound: the LLM correctly infers that rising deposit assets reflect increased use of deposit-method reinsurance for risk transfer and liquidity management, and it appropriately references the Global Atlantic transaction contextually (though not explicitly named). The conclusion about maintaining a net positive deposit position is reasonable and aligns with the strategic interpretation in the ground truth. (4) Contextual relevance is high—the response addresses all parts of the question, uses proper financial terminology, cites relevant notes and pages, and attempts a strategic interpretation. However, the major factual error in the 2024 asset value reduces the correctness score significantly, as it distorts the central trend. Quantitative accuracy is penalized heavily for this error, though other numbers are correct. Qualitative reasoning remains strong despite the data flaw.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 483,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities fell from a fair value of **$679 million** and carrying value of **$696 million** in 2022 to **$596 million** and **$603 million** in 2023, and further to **$508 million** and **$512 million** in 2024 (2023 10‑K, page 53; 2024 10‑K, page 56). The steady decline in both fair value and carrying value indicates a shrinking portfolio—likely due to maturities or sales—while the fair value remaining below carrying value each year shows that the company is not recognizing unrealized losses on securities held to maturity. This pattern reflects a conservative investment strategy that prioritizes credit quality and maturity certainty, with market‑valuation adjustments driven mainly by interest‑rate movements rather than credit deterioration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values for fair value and carrying value across 2022, 2023, and 2024 are correct and match the ground truth exactly: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024). There are no calculation or formatting errors. (2) The LLM answer fully addresses the question’s requirements—tracking the evolution of both fair and carrying values over the three-year period and interpreting the trend. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across multiple years and filings (2023 and 2024 10-Ks), identifies the consistent downward trend, and draws a logical inference about portfolio contraction. It adds value by noting that fair value remains below carrying value, indicating no recognition of unrealized losses—consistent with held-to-maturity accounting rules. (4) While the original answer attributes the decline to 'strategic reduction or repositioning,' the LLM offers a more detailed interpretation involving maturities, sales, interest rate movements, and conservative strategy. This goes beyond the ground truth but remains factually plausible and contextually appropriate, not contradicting any facts. The slight deduction in qualitative accuracy (9 instead of 10) is due to the introduction of additional causal claims (e.g., 'driven mainly by interest-rate movements') that, while reasonable, are not explicitly confirmed in the ground truth. However, these do not constitute errors, just interpretation. Overall, the answer is factually correct, complete, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 428,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The Target Circle Card penetration fell from **19.8 % in 2022 to 18.6 % in 2023 and further to 17.8 % in 2024**【page_29】. This modest decline suggests that, while the card remains widely used, its ability to generate incremental sales is weakening or plateauing, indicating diminishing returns from the credit‑card strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported penetration rates. According to the ground truth, the rate was 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024. The LLM incorrectly states 19.8% in 2022 (should be 20.5%), 18.6% in 2023 (should be 19.8%), and 17.8% in 2024 (should be 18.6%). These errors affect all three data points, with the 2024 figure being off by 0.8 percentage points. (2) The quantitative inaccuracies undermine the reliability of the trend analysis. While the direction of decline is correct, the magnitude is exaggerated, especially in 2024. (3) The reasoning partially aligns with the original answer—correctly interpreting the decline as a sign of weakening effectiveness—but misses the nuance that Target still sees strategic value in incremental sales driven by the card. The LLM concludes 'diminishing returns' without acknowledging the ongoing value noted in the ground truth, thus failing a key multi-hop synthesis between declining penetration and persistent incremental sales impact. (4) Contextually, the answer addresses both parts of the question—trend and strategic implication—but due to incorrect numbers and incomplete qualitative reasoning, the overall correctness is significantly compromised. The citation [page_29] suggests a source, but the data still conflicts with ground truth, indicating either misinterpretation or data error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 392,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike continued to own and operate its Laakdal, Belgium distribution center throughout fiscal 2022‑2024, with no change in ownership or operational footprint noted in the 10‑K filings for those years【page 29 (2022)】【page 29 (2023)】【page 29 (2024)}. This steady ownership of a key European hub underscores Nike’s strategic focus on maintaining owned logistics infrastructure in Europe to secure control, improve supply‑chain resilience, and support its global distribution network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Nike maintained ownership and operation of the Laakdal facility from fiscal years 2022 to 2024, with no changes in footprint—consistent with the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years (2022, 2023, 2024) are correctly referenced and matched to the source pages, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes consistent descriptions across three years from the 10-K filings to infer stability in ownership and operational role, and correctly infers the strategic implication—maintaining control over key European logistics infrastructure. (4) The answer is semantically equivalent to the ground truth, with slightly expanded interpretation (e.g., 'supply-chain resilience') that is reasonable and contextually appropriate, though not explicitly stated in the original. The only minor gap is that the original emphasizes the facility being 'one of the most significant international distribution centers'—a detail present in the source but not fully echoed in the LLM response. However, calling it a 'key European hub' captures the essence. Thus, the answer is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 402,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum has been listed as a competitor in NVIDIA’s 10‑K filings for all three years—2022 (pages 9, 15), 2023 (page 11) and 2024 (page 11)—always grouped with other networking and optical‑module suppliers.  Over this period NVIDIA’s supply‑chain strategy shifted toward greater redundancy and diversification in the Asia‑Pacific region (pages 9, 10), reducing its dependence on any single optical‑module vendor and thereby limiting Lumentum’s leverage.  At the same time, NVIDIA’s IP protection has deepened (expanded patent portfolio, licensing agreements and export‑control compliance measures; pages 9, 10), strengthening its competitive moat and further curbing Lumentum’s relative influence in the market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Lumentum Holdings was listed as a competitor in NVIDIA’s 10-K filings for fiscal years 2022, 2023, and 2024, and accurately references the domain of networking and optical modules. It also correctly notes NVIDIA’s supply chain diversification and enhanced IP protection strategies. However, the LLM introduces specific page numbers (e.g., pages 9, 15, 11) not present in the ground truth, which cannot be verified and may be hallucinated. While the general strategic trends align with the original answer, the LLM overemphasizes the reduction of Lumentum’s leverage due to supply chain diversification—a plausible inference but not explicitly supported in the ground truth. The original answer emphasizes Lumentum’s persistent competitive relevance despite NVIDIA’s advancements, whereas the LLM frames it as a diminishing influence, which shifts the interpretation. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is fully preserved (score 10). (3) The multi-hop reasoning is partially sound: the LLM connects Lumentum’s competitor status across years and links it to NVIDIA’s supply chain and IP strategies. However, it draws a stronger causal conclusion about reduced leverage and influence than the ground truth supports, weakening qualitative accuracy. (4) The answer is highly contextually relevant, addressing all parts of the question and synthesizing information across years and strategic domains, though with a slight interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 428,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 10‑K filings from 2022‑24 consistently state that the company’s ability to deliver content hinges on licensing from third‑party rights holders and that a refusal to license could materially harm the business (2022 page 13; 2023 page 5; 2024 page 5). While this reliance has not diminished, the filings increasingly highlight a growing investment in original content projects (2023 page 4; 2024 page 4), signaling a strategic shift to reduce licensing dependence amid intensifying competition. The 2024 filing’s “Regulation” section (page 5) also notes rising content‑quota, levy, and ownership‑restriction pressures, underscoring the need for a more self‑sufficient content mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Netflix's continued reliance on third-party rights holders is consistently noted across 2022–2024 filings, with increasing emphasis on original content investment (2023 and 2024) and regulatory pressures (2024). The specific risk of rights holders refusing to license, which could materially harm the business, is correctly cited with page numbers, and the strategic shift toward original content is accurately portrayed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable in that sense—but all years (2022, 2023, 2024) and page references are correctly stated, and no calculations are required. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, identifies the evolving narrative from competition to include regulation, and infers a strategic shift toward self-sufficiency. The only minor shortcoming is that the LLM does not explicitly mention 'rising competition' as a framing context in 2022 (though it is implied), and the phrase 'content quotas, levy, and ownership-restriction pressures' is slightly more specific than the original’s 'content quotas and investment obligations,' but this adds precision rather than inaccuracy. (4) The answer is contextually excellent—directly addresses the evolution of licensing reliance and what it reveals about strategy. Overall, the LLM captures the core progression and strategic implications with high fidelity, warranting a 9/10 due to slight under-articulation of the 2022 competitive context, though not enough to drop further.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 477,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "Southern Company has consistently treated scheduled lease payments under outdoor‑lighting contracts as immaterial, classifying them as lease income from operating leases and not including them in wholesale revenues.  The payments are shown in the maturity analysis as part of the operating‑lease obligations, and this presentation has remained unchanged from the 2022 to the 2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incorrect in its core claim that Southern Company 'consistently treated' outdoor lighting lease payments as immaterial and unchanged from 2022 to 2024, which directly contradicts the ground truth. In 2022, the company deemed these payments immaterial, but by 2023 and 2024, it began including them in maturity analyses, indicating a materiality reassessment and evolving disclosure practice. The LLM incorrectly states that the presentation 'remained unchanged,' when the ground truth shows a clear progression toward greater transparency and formal inclusion. While the general classification of these payments as operating leases is consistent with the original answer, the LLM fails to capture the key evolution in treatment over time—particularly the shift in materiality assessment and expanded disclosure in maturity analyses. There are no numerical values to verify, so quantitative accuracy is not heavily penalized, but the qualitative reasoning is flawed due to incorrect synthesis across years. The answer is contextually relevant to the topic but fundamentally wrong on the central point of evolution in disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 328,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO’s 5.000% senior notes due April 2030 had an outstanding principal balance of **$606 million** at the end of FY 2023 (October 29, 2023) and remained unchanged at **$606 million** at the end of FY 2024 (November 3, 2024)【page_81】.  The 2022 10‑K shows the same balance of **$606 million** at the end of FY 2022, indicating that the company has not reduced the principal on this instrument during the three‑year period.  This steady balance suggests a debt‑management strategy that prioritizes maintaining a stable long‑term financing base—preserving liquidity and flexibility for future growth or refinancing—rather than aggressively paying down the notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. It states that the outstanding principal balance was $606 million in FY 2022, but the ground truth shows it was $1,086 million in FY 2022, decreasing to $606 million in FY 2023. This error completely inverts the trend. The LLM incorrectly asserts no reduction occurred, while the truth is a $480 million reduction occurred in 2023. The FY 2023 and FY 2024 balances are correctly stated as $606 million. (2) The calculation of change over time is therefore wrong: the model fails to recognize a significant debt reduction in 2023. The citation to the 2022 10-K is incorrect if it claims $606 million, as per ground truth. (3) The multi-hop reasoning is flawed: the model should have compared balances across three fiscal years and identified a reduction in 2023 followed by stability in 2024. Instead, it concludes no change occurred, missing the key strategic shift in 2023. (4) The qualitative reasoning about maintaining stable financing is plausible but based on false premises, so it cannot be credited. Contextual relevance is moderate because the answer addresses the right instrument and time frame, but with critical factual errors. Quantitative accuracy is very low due to the incorrect FY 2022 figure. Correctness score is low because the core factual progression is wrong, leading to an incorrect interpretation of debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 394,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "GM’s weighted‑average long‑term rate of return on U.S. pension‑plan assets was 6.3 % at December 31 2022 and stayed unchanged at 6.3 % at December 31 2023, but rose to 6.5 % at December 31 2024 after a new investment‑policy study (Note 16, pages 87 and 88). The increase signals a deliberate shift toward higher‑return, higher‑risk asset classes—evidenced by the 2024 target mix of 11 % equity, 60 % debt and 29 % alternative investments versus 8 % equity, 69 % debt and 23 % alternatives in 2022—to improve funded status and dampen volatility in a changing market environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported rate of return for 2022. The ground truth states that GM's long-term rate of return was 5.4% in 2022, but the LLM claims it was 6.3% in 2022 — this is incorrect. The values for 2023 (6.3%) and 2024 (6.5%) are correct. This error affects the entire trajectory interpretation. (2) The calculation of the trend — a 1.1 percentage point increase from 5.4% to 6.5% — is misrepresented because the LLM implies only a 0.2 percentage point increase from 6.3% to 6.5%, missing the actual 3-year evolution. (3) The LLM introduces specific asset mix percentages (e.g., 11% equity in 2024 vs 8% in 2022) that are not present in the original answer and may be fabricated or misattributed; the ground truth does not provide these exact figures, so including them as facts undermines accuracy. While the qualitative reasoning about a shift toward higher-risk, higher-return strategies aligns with the original answer’s interpretation, the faulty baseline numbers and unsupported asset allocation data weaken the multi-hop synthesis. (4) Despite these issues, the answer is contextually relevant, addressing both the evolution of return assumptions and strategic implications, and correctly identifies the 2024 increase and its rationale (investment policy study). However, due to major quantitative inaccuracies and unsupported specifics, the correctness score is significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 402,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "Across the 2022‑2024 filings, the 2.700% Senior Notes due 2031 are consistently listed in Supplemental Indenture No. 8 (dated March 29, 2021) and appear in the company’s debt schedules.  This treatment shows that American Tower is treating the notes as part of a structured long‑term debt program that locks in a moderate coupon for a 10‑year maturity, reflecting a strategy of maintaining a diversified, predictable debt profile to support growth and capital expenditures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2.700% Senior Notes due 2031 are consistently referenced under Supplemental Indenture No. 8 dated March 29, 2021, across the 2022–2024 filings, which matches the original answer. The date and indenture number are correctly cited. (2) Quantitative accuracy is perfect: the interest rate (2.700%), maturity year (2031), and effective date of the indenture (March 29, 2021) are all precisely stated. (3) The multi-hop reasoning is sound—by observing consistent treatment across three consecutive 10-K filings, the model correctly infers a stable, long-term financing strategy. The conclusion about a 'structured long-term debt program' and 'predictable debt profile' is a valid interpretation of the consistent documentation. (4) The only minor shortcoming is that the LLM does not explicitly mention the absence of modifications over the three years or the strategic confidence implied by this stability, which is emphasized in the original answer. However, the core message about strategic consistency and use of fixed-rate long-term debt is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the question about long-term financing strategy based on multi-year filing trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 377,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal’s exposure to abusive behaviors remained a persistent risk from 2022 through 2024, with the risk‑factor language increasingly emphasizing new fraud schemes tied to expanded credit products and cross‑border transactions (page_26, page_26, page_24). To mitigate these risks, the company diversified its payment‑processor network, migrated to alternative processors, invested in fraud‑detection and credit‑risk models, and in 2023 sold a large portion of its U.K./European BNPL loan receivables to reduce credit exposure (page_25). Across the period, PayPal continued to monitor cross‑border regulatory, currency, and tariff risks while tightening underwriting for its consumer and merchant credit offerings (page_24).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and timeline. (1) It accurately identifies the persistent risk of abusive behaviors from 2022 to 2024, particularly in credit products and cross-border transactions, and correctly notes PayPal's strategic actions across the period. The mention of selling U.K./European BNPL loan receivables in 2023 matches the original answer, and while the exact €40 billion figure is omitted, the qualitative description of it as a 'large portion' is reasonable and does not misrepresent the action. No incorrect numbers or dates are present, so quantitative accuracy is perfect. (2) The LLM references page numbers (e.g., page_24, page_25, page_26), which are likely from source documents, but since the ground truth does not include page references, this does not affect scoring. (3) The multi-hop reasoning is sound: the answer synthesizes risk identification (2022), risk transfer via receivables sale (2023), and ongoing mitigation through fraud detection and underwriting (2024). However, it omits the explicit framing of PayPal’s evolving strategy—specifically the shift from identifying risk (2022), offloading exposure (2023), to managing third-party dependencies and detection (2024)—which is a key analytical thread in the original answer. It also does not mention the specific risk from third-party lenders and processors undermining consumer confidence, a notable point in 2024. (4) Despite these omissions, the answer remains contextually relevant and factually accurate overall, capturing the core evolution and mitigation strategies. The correctness score is 8 due to missing nuanced but important elements in the strategic narrative, particularly around third-party risk in 2024 and the structured three-year progression emphasized in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 500,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan assets in “Collective trust and other funds” fell from **$622 million in 2022** (page 70) to **$370 million in 2023** (page 57), then rose modestly to **$382 million in 2024** (page 58). This pattern— a sharp decline followed by a small rebound—indicates the company’s shift away from these less‑liquid, higher‑risk funds toward a more diversified, lower‑risk mix (e.g., debt securities), consistent with its broader de‑risking strategy for long‑term employee benefits.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, UNP's allocation was $756 million in 2022 and decreased to $382 million in 2023, whereas the LLM reports $622 million in 2022 and $370 million in 2023, then incorrectly states a rise to $382 million in 2024. The correct trend is a drop from $756M to $382M (2022–2023), with no updated dollar figure for 2024—only a methodological note about NAV-based valuation. The LLM falsely implies a rebound in 2024, which is not supported by the ground truth. (2) The quantitative inaccuracies are material: the 2022 figure is off by $134 million, and the characterization of 2024 as an increase is factually wrong. Even allowing for format variation, the numbers do not match any valid interpretation of the ground truth. (3) The reasoning is partially sound—de-risking is correctly inferred—but it is based on incorrect data and misses the key point that in 2024, no updated dollar value was provided; instead, the emphasis was on valuation methodology (NAV), which the LLM omits as a strategic signal. This reflects a failure in multi-hop synthesis: the model conflates asset value changes with strategic reporting enhancements. (4) Contextual relevance is high because the answer addresses the question’s structure and attempts to interpret strategic intent. However, due to major numerical errors and a misleading trend description, the overall correctness score is low. The qualitative score is moderate because the de-risking interpretation aligns with the ground truth, but it is derived from flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 449,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "From 2022 through 2024 Pfizer had **no Breakthrough Performance Awards (BPAs) granted or outstanding** (the 2023 and 2024 10‑Ks both state “No BPAs were granted…and no BPAs were outstanding as of December 31”).  The company continued to **value BPAs at intrinsic value based on the closing price of its common stock and amortize the fair‑value expense on a straight‑line basis over the probable vesting term into operating expenses (cost of sales, selling, informational and administrative, and R&D)**, with periodic adjustments for changes in stock price or vesting probability.  Thus, the valuation methodology and accounting treatment remained unchanged across the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect. It claims that 'no BPAs were granted or outstanding' from 2022 through 2024, directly contradicting the ground truth, which states that in 2022, Pfizer issued 1,165 thousand BPAs with 859 thousand outstanding at year-end. The LLM incorrectly generalizes the 2023 and 2024 disclosures (no grants, none outstanding) to 2022, which is factually wrong. (2) Quantitative accuracy is very low: the LLM omits the specific grant volume (1,165 thousand), year-end outstanding (859 thousand), and two key intrinsic values ($38.73 and $59.05 per share) from 2022. These numbers are critical and entirely missing. (3) Multi-hop reasoning fails: the question asks about the evolution across 2022–2024. The correct answer requires recognizing that BPAs were active in 2022, discontinued or fully resolved in 2023, and then a new methodology was formalized in 2024. The LLM incorrectly asserts no activity in all three years and claims the methodology remained unchanged, while the ground truth shows a clear evolution: from active grants in 2022, to none in 2023, to a new structured valuation approach in 2024. (4) Contextual relevance is moderate because the answer discusses the right topic (BPAs, valuation, accounting treatment) and correctly describes the intrinsic value method and amortization, but applies it incorrectly across time. However, the core factual timeline and quantitative data are wrong, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 411,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements fell from **$1.49 billion** at December 31 2022 to **$800 million** at December 31 2023 and further to **$491 million** at December 31 2024 (page 102, page 99). This downward trend indicates that the company’s derivative exposure or the amount of collateral needed for initial‑margin purposes has been shrinking, likely reflecting reduced trading volumes or more efficient netting/clearing arrangements that lower margin requirements over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: $1.49 billion (equivalent to $1,494 million) in 2022, $800 million in 2023, and $491 million in 2024 — minor formatting differences ($1.49 billion vs $1,494 million) are semantically equivalent. (2) The answer addresses all parts of the multi-part question: it reports the change in collateral over time (2022–2024) and interprets the trend regarding derivative exposure and margin requirements. (3) Entity accuracy is correct: ExxonMobil (XOM), the metric 'collateral under master netting arrangements', and the years 2022, 2023, and 2024 are all properly identified. (4) The reasoning is sound: the downward trend is correctly interpreted as indicating reduced derivative exposure or lower margin requirements, with plausible contributing factors such as reduced trading volumes or improved netting/clearing efficiency. The answer demonstrates proper multi-hop synthesis across years and correctly infers implications from the trend. All criteria for correctness, completeness, and relevance are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 321,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 10‑K (p. 8) lists industrial fiber optics as a key product in its industrial portfolio. In 2023 and 2024 the company kept that product but expanded the application scope to cover industrial automation, power‑generation and distribution, medical systems, defense and aerospace, and automotive subsystems such as EV powertrain, infotainment and ADAS (p. 3‑7). This consistency and broadened scope signals a strategic focus on using fiber‑optic connectivity to drive growth in high‑margin industrial segments—especially automotive electrification and advanced driver‑assist technologies—while maintaining a diversified industrial portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual and reasoning errors. The ORIGINAL ANSWER states that in 2022, Broadcom already covered industrial automation, power systems, medical, defense, aerospace, and automotive—including EVs—so the claim that these were 'expanded' in 2023 and 2024 is incorrect. The LLM incorrectly frames the evolution as a broadening of application scope, when the ground truth shows consistency in applications with only a shift in presentation format (e.g., structured tables in 2023, integration emphasis in 2024). Additionally, the LLM introduces specific automotive subsystems like 'infotainment and ADAS' not mentioned in the ground truth, which over-specifies without evidence. The strategic focus on high-margin segments like automotive electrification is a plausible inference but not directly supported by the provided truth, which emphasizes structured communication and integration rather than strategic growth drivers. The LLM answer is contextually relevant and addresses the question's intent but fails on key factual evolution details, missing the actual trajectory of Broadcom's positioning (consistency with improved clarity, not expansion). Thus, correctness is partially accurate but contains significant misrepresentations of the timeline and changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 402,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s 2022‑24 10‑K notes consistently state that the company “has full discretion in determining the fee charged to customers” and “bear[s] full margin risk when completing a payment transaction,” even when it uses third‑party processors (2022 page 78‑79; 2023 pages 75‑77; 2024 page 77).  Thus, its exposure to margin risk remained high and unchanged over the period, with PayPal retaining control over transaction pricing and the associated margin risk throughout.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures the key factual points: PayPal bore full margin risk and maintained full discretion over transaction pricing from 2022 to 2024, despite using third-party processors. The statement is consistent across all three years, indicating no material change in risk exposure. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the cited page numbers (2022: 78-79; 2023: 75-77; 2024: 77) align with the source documents and support the claim, demonstrating accurate referencing. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual reports (2022, 2023, 2024), showing continuity in PayPal's risk profile and pricing control. (4) The LLM answer is concise but complete, addressing all parts of the question: evolution of margin risk, control over pricing, and use of third-party processors. Wording differs slightly from the original but preserves the exact meaning. All entities (PayPal, third-party processors, margin risk, transaction pricing) are correctly identified and contextualized. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 346,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer sold its Meridian subsidiary in 2021 for about $51 million in cash, recording a $167 million net loss (2022 10‑K, page 117).  After the sale, Pfizer entered into interim TSAs and a three‑year MSA (with a two‑year extension) with the purchaser, but the related revenues and costs were immaterial in 2023 (2023 10‑K, pages 73‑74).  By 2024 no further financial or contractual activity with Meridian is disclosed, underscoring Pfizer’s divestiture of its generic/consumer‑healthcare assets and a long‑term focus on its core biopharma and specialty businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $51 million sale price and $167 million net loss are accurately reported, consistent with the 2022 10-K. The timing of the 2021 sale is correctly noted. (2) The contractual arrangements are accurately described: the three-year MSA with a two-year extension option is correctly identified, and the mention of interim Transition Services Agreements (TSAs) adds detail not in the original but is plausible post-sale arrangements. The statement that related revenues and costs were immaterial in 2023 (citing 2023 10-K, pp. 73–74) supports the absence of ongoing financial impact. (3) The evolution from ownership to a contract-based relationship is correctly inferred, and the strategic shift toward core biopharma and specialty businesses (including mRNA/platform technologies, though not explicitly mentioned in the LLM answer) is reasonably interpreted. (4) The only minor gap is that the 2024 mention of Meridian in Pfizer’s glossary as 'Meridian Medical Technologies, Inc.'—indicating formal recognition—is not included in the LLM answer. However, the conclusion that no further activity is disclosed by 2024 is consistent with available information. The reasoning across years and documents (2022, 2023, and implied 2024 disclosures) demonstrates sound multi-hop synthesis. Wording differs but semantic meaning matches the original. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 455,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 to 2024 PMI’s 10‑K filings consistently flag product‑regulation risks that could commoditize its portfolio and curtail adult‑consumer communication about RRPs/SFPs. In 2022 the company warned that regulation could diminish product differentiation and restrict truthful information about SFPs (page 13, page 15, page 16). The 2023 filing reiterated that limits on branding, communication and product differentiation could hamper adult‑smoker conversion to RRPs (page 18, page 20), and the 2024 filing maintained the same emphasis, noting that restrictions on branding and communication continue to threaten the commercialization of its SFPs (page 17, page 20). Thus, the impact has remained a persistent, material risk with no substantive shift in PMI’s competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All factual elements are correct: the persistent regulatory pressure on product differentiation and adult consumer communication for RRPs/SFPs from 2022 to 2024 is accurately described. The evolution across years is correctly represented—2022 highlights restrictions on differentiation and truthful information, 2023 emphasizes impact on commercialization and smoker conversion, and 2024 maintains similar concerns under the SFP terminology. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly identifies the continuity in risk disclosure, showing understanding of the evolving terminology (RRPs to SFPs) and consistent regulatory challenges. (4) The only minor shortcoming is that the LLM states there is 'no substantive shift' in competitive positioning, while the ground truth suggests a possible intensification ('deepening regulatory challenge'). This downplays the evolving severity implied in the original answer. However, the core facts, entity accuracy (PMI, RRPs/SFPs, years), and contextual relevance are excellent, and the answer fully addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 395,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements fell from $1.494 billion in 2022 to $491 million in 2024, a net reduction of about $1.003 billion (page_99; page_102). This decline indicates the company has tightened collateral requirements, reflecting more efficient derivative hedging and stronger risk‑management controls.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall downward trend in collateral from 2022 to 2024 and reports the correct 2022 ($1.494 billion) and 2024 ($491 million) values, which match the ground truth. However, it omits the 2023 value of $800 million, which is a key intermediate data point in the multi-year trend. This omission reduces completeness and weakens the multi-hop synthesis. (2) The net reduction calculation of $1.003 billion is mathematically correct (1,494 - 491 = 1,003 million), but the answer skips the 2023 figure, implying a direct drop from 2022 to 2024, which misrepresents the gradual decline. (3) The reasoning about risk management is plausible and aligns with the trend, but the phrase 'tightened collateral requirements' is semantically imprecise — the decrease in posted collateral more likely reflects reduced derivative exposure or lower margin demands, not tighter requirements. The original answer correctly frames it as a potential reduction in exposure or shift in risk practices. (4) Despite missing the 2023 data point, the LLM captures the core trend and provides a reasonable interpretation, supporting a correctness score of 7. Quantitative accuracy is penalized due to incomplete time-series data, though the numbers present are accurate. Qualitative and contextual scores remain high due to sound logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 382,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy’s TSR‑based performance‑award model lowered its market‑risk assumption over the period: the model used an expected volatility of 28.6 % in 2023 (page 206) and 18.7 % in 2024 (page 215).  The 2022 10‑K does not disclose an expected‑volatility figure, but the subsequent decline from 28.6 % to 18.7 % signals that the company is now viewing its relative market risk as lower and more stable compared with its peer group.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 expected volatility value. The ground truth states that Duke Energy's expected volatility was 26.9% in 2022, but the LLM claims the 2022 10-K does not disclose this figure. This omission and misstatement undermine the accuracy of the trend analysis. The values for 2023 (28.6%) and 2024 (18.7%) are correctly reported, matching the ground truth. (2) Quantitatively, two out of three years are correct; however, the missing 2022 value and incorrect claim about non-disclosure constitute a major error, especially since the trend from 2022 to 2024 is central to the question. The calculation of the decline from 28.6% to 18.7% is accurate, but the full evolution across all three years is misrepresented. (3) The reasoning is partially sound: the conclusion that the company views its market risk as lower and more stable is consistent with the drop in 2024. However, the multi-hop synthesis fails because it misses the initial 2022 baseline and incorrectly asserts non-disclosure, leading to an incomplete and slightly misleading trend narrative (it omits the increase from 26.9% to 28.6% in 2023 before the drop). (4) Contextual relevance is high—the answer addresses the right metric, company, and time frame, and draws a reasonable qualitative inference from the data it does report. However, due to the missing 2022 data point and incorrect assertion about disclosure, the overall correctness score is reduced to 5, reflecting partial accuracy with significant factual gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 427,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125% senior notes due January 2025 have remained unchanged at a principal of $495 million and a current‑portion balance of $495 million in FY 2022, FY 2023 and FY 2024 (see the senior‑notes table on page 81 of the 2024 10‑K, which lists the same amount for 2023 and 2024 and the 2022 filing shows the identical $495 million balance). This stability indicates that Broadcom has kept a predictable short‑term debt base while using proceeds from new senior‑note issuances (e.g., the $10 billion of notes issued in 2024) to refinance larger, longer‑term maturities and repay term‑loan balances, underscoring a strategy of maintaining a steady short‑term debt profile while selectively refinancing long‑term obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of $495 million for the 3.125% notes due January 2025 and associates it with the correct fiscal years. However, it incorrectly states that the current portion was $495 million in all three years (2022, 2023, and 2024), which contradicts the ground truth: in 2022 and 2023, the obligation was part of long-term debt and only became a current portion in 2024. This misrepresents the evolution of the debt classification. (2) Quantitatively, the $495 million principal is accurate across years, and the reference to new $10 billion note issuance in 2024 aligns with broader refinancing activity, though not directly tied to this specific note. The error lies in the misclassification of the current portion in 2022 and 2023, which should not have been reported as current. (3) The multi-hop reasoning is partially sound—linking stable principal amounts to predictable short-term debt management is reasonable, and referencing new issuances for refinancing shows understanding of capital structure strategy. However, the conclusion that the current portion remained $495M throughout all three years reflects a failure to correctly synthesize the transition from long-term to current debt in the final year, a key point in the ground truth. (4) Contextually, the answer addresses the question about debt evolution and refinancing strategy, and includes relevant context about refinancing with new notes. But due to the significant mischaracterization of the debt's classification in 2022 and 2023, the qualitative and correctness scores are reduced. The answer would imply no change in short-term obligations until maturity, which understates the significance of the 2024 reclassification. Thus, while some facts are correct, the core evolution of the obligation is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 500,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "AMD’s 10‑K filings from 2022 through 2024 consistently show that AMD protects AIB manufacturers’ inventory against price reductions and that system integrators use discrete graphics to differentiate their board‑level products.  Across all three years the wording and emphasis on these inventory‑protection policies and the role of discrete graphics remained unchanged, with no substantive policy shifts or new differentiation tactics noted.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the consistent inventory protection policy AMD maintained from 2022 to 2024 for AIB manufacturers, which is explicitly mentioned in the original answer. The role of discrete graphics in differentiation by system integrators and AIBs is also correctly stated. (2) There are no numeric values, dates, or financial figures in either the question or answers that require verification—thus, quantitative accuracy is not applicable but assumed correct due to absence of errors. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers no substantive policy shifts, consistent with the original answer’s conclusion of 'sustained strategic focus.' However, the LLM omits some key contextual details present in the ground truth, such as AMD providing component-level graphics and chipset products to AIBs, the short design cycles, and rapid response to technology as part of the strategic emphasis. These omissions reduce completeness slightly. (4) Despite these minor gaps, the LLM conveys the core factual content and correctly interprets the stability of AMD's strategy. Wording is concise and semantically equivalent on key points, earning high marks for contextual relevance and qualitative accuracy. The answer would benefit from slightly more depth on AMD's ongoing support mechanisms for AIBs, but no factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 408,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "From 2022 to 2024 Disney shifted its DTC strategy from a broad re‑organization and heavy content‑marketing spend aimed at driving subscriber growth and launching an ad‑supported Disney+ (2022 risk factor, page 29) to a more focused, cost‑realignment‑driven approach that includes content curation, removal of under‑performing titles, and the launch of ESPN’s flagship DTC service (2023 risk factor, page 55). By 2024 the company emphasized further cost realignment, expanded its Star India joint venture, and continued to invest in ad‑supported Disney+ and new pricing models to compete in a crowded streaming market, while projecting that these investments would drive subscription‑fee and advertising‑revenue growth to offset declines in linear network revenue (2024 risk factors, pages 22‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) It correctly captures the evolution of Disney's DTC strategy from 2022 to 2024: starting with a risk-aware, investment-heavy phase in 2022, shifting to a more confident growth-oriented strategy in 2023, and maturing into a competitive, cost-optimized, and operationally critical focus by 2024. Key elements such as the launch of ad-supported Disney+, content curation, removal of underperforming titles, ESPN’s DTC service, Star India joint venture, and pricing models are all consistent with the strategic shifts described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct and properly attributed. (3) The multi-hop reasoning is sound: the LLM synthesizes strategic shifts across three years, correctly identifying changes in investment focus, competitive positioning, and revenue expectations. It links cost realignment and competitive pressures to revenue offset projections, mirroring the original’s logic. (4) Minor deduction in qualitative accuracy due to slightly more emphasis on operational tactics (e.g., content removal, Star India JV) not explicitly detailed in the ground truth, though these are plausible elaborations consistent with the broader strategic narrative. Overall, the answer is semantically equivalent, contextually complete, and factually correct, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 420,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s Fixed‑rate 2.850% notes, issued in September 2019, remained a $1.5 billion senior unsecured obligation with a 10/1/2029 maturity throughout 2022‑2024. The principal and effective interest rate (2.96%) stayed constant, and the note continued to be part of the company’s $10.6 billion term‑debt portfolio with no changes to its maturity schedule or redemption terms during that period【104】【107】【105】【108】【103】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that PayPal's 2.850% fixed-rate notes remained outstanding at $1.5 billion from 2022 to 2024 with a maturity date of 2029, which aligns with the ground truth. It also accurately notes the constant principal and effective interest rate (2.96%), and confirms no changes in maturity or redemption terms. However, the LLM omits key details about the evolution of the broader debt structure — specifically, the increase from $9.0 billion in 2022 to $10.638 billion in 2023 and a slight decline to $10.574 billion in 2024. Instead, it generalizes the term debt as a static $10.6 billion across all years, which oversimplifies and inaccurately represents the year-over-year changes. Additionally, the LLM fails to mention the issuance of new higher-interest debt in 2024 (5.150% and 5.500% notes), which is a critical part of the evolving financing strategy highlighted in the original answer. (2) Quantitatively, the $1.5 billion principal, 2.850% coupon rate, 2.96% effective rate, and 2029 maturity are all correct. The $10.6 billion figure is approximately accurate for 2023 and 2024 but does not reflect the $9.0 billion in 2022, introducing a minor inaccuracy in trend representation. (3) The reasoning is sound in recognizing the stability of the 2.850% notes but falls short in multi-hop synthesis by not connecting the unchanged status of these notes with the broader shifts in debt composition and financing strategy over the three years. (4) The answer is contextually relevant and focused on the question, but the lack of comparative debt figures across years and omission of new debt instruments reduces completeness and qualitative accuracy, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 472,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension‑plan corporate‑stock holdings fell sharply from **$1,111 million (≈37 % of plan assets) in 2022** to **$181 million (≈5 % of plan assets) in 2023**, then rose modestly to **$226 million (≈7 % of plan assets) in 2024**【page_58】【page_56】.  \nThis swing shows a deliberate de‑risking move away from direct equity exposure—aligning with the plan’s target equity range of 20‑30 %—and a subsequent, modest re‑balancing back toward equities while still keeping the allocation well below the 2022 level.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The 2022 allocation is reported as $1,111 million, but the ground truth states $1,990 million—a major discrepancy. The 2023 value ($181 million) is correct, and the 2024 value is stated as $226 million in the LLM answer, but the ground truth indicates that by 2024, UNP no longer held significant common stock and instead reclassified remaining equity holdings into Level 1 and Level 2 investments, with no mention of an increase to $226 million. Thus, the reported increase in 2024 is factually incorrect. Additionally, the percentages (37%, 5%, 7%) are not supported by the ground truth, which does not provide percentage allocations. (2) Calculations and comparisons are therefore flawed: the claimed 'modest re-balancing' in 2024 contradicts the ground truth’s indication of a strategic reduction and reclassification, not an increase in equity holdings. (3) The multi-hop reasoning is unsound—the LLM fails to recognize the shift in investment classification (Level 1 vs Level 2) and misrepresents the nature of the strategy. The ground truth emphasizes a move toward transparent valuation methods and reduced direct equity exposure, while the LLM incorrectly frames it as a temporary de-risking followed by re-balancing. (4) Contextual relevance is moderate because the answer addresses pension plan equity allocation and attempts to interpret strategy, but the incorrect data and flawed reasoning undermine the conclusion. The strategic implication in the ground truth—shift to observable valuations and structured equity via preferred shares—is entirely missed. Hence, despite some correct elements (2023 value), the answer is largely incorrect in numbers, reasoning, and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 479,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost declined from **$800 million at December 31 2022** to **$719 million at December 31 2024** (a drop of $81 million)【page_87】【page_83】. This modest contraction indicates the company has reduced its allocation to illiquid alternative assets, suggesting a strategic shift toward a more balanced or less concentrated private‑equity exposure over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's investment increased from $623M in 2022 to $755M in 2023 before declining to $719M in 2024. However, the LLM claims the investment was $800M in 2022 and only reports the 2024 figure correctly at $719M. This misrepresents both the starting value and the trend. The claimed 'decline' from $800M to $719M ignores the intermediate increase in 2023, which is a critical part of the multi-hop reasoning. (2) Calculations are partially correct—the difference between $800M and $719M is indeed $81M—but this is based on incorrect input values. The actual change from 2022 to 2024 is an increase of $96M ($719M - $623M), though with a peak in 2023. (3) The reasoning is flawed because it fails to capture the two-step trend: growth in 2023 followed by a partial pullback in 2024. Instead, the LLM presents a simple linear decline, missing the strategic nuance of short-term expansion and subsequent cautious retrenchment. This indicates a failure in multi-hop synthesis across the three years. (4) While the conclusion about a 'cautious approach' has some alignment with the ground truth, the overall interpretation is based on incorrect data, reducing qualitative accuracy. Contextual relevance is high because the answer addresses the right metric, company, and time frame, and attempts to interpret strategic intent, even if incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 406,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 to 2024, Mastercard’s multi‑layered security strategy deepened collaboration with issuers, acquirers, merchants, governments and industry associations to set technical standards and share best practices, while expanding its real‑time payment infrastructure from 12 of the top 50 markets in 2022 to 13 markets in 2023 and further global real‑time clearing and settlement capabilities in 2024 (page_11, 2022‑2024). Throughout this period, the company strengthened cyber resilience by deploying Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, conducting regular vulnerability testing, and integrating enterprise resilience programs and insurance coverage, all while monitoring and responding to threats—including those from third‑party providers—through public‑private partnerships (page_11, 2022‑2024). These enhancements have enabled Mastercard to maintain a robust, multi‑layered security posture that protects the global payments ecosystem and supports the rapid expansion of its real‑time payment services.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements include: the evolution of Mastercard's multi-layered security approach from 2022–2024, emphasis on third-party collaboration, real-time payment infrastructure expansion, and cyber threat resilience. The mention of Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center in 2022 is correct. The expansion to 13 markets for real-time payments by 2023 matches the original answer. The progression into broader global expansion in 2024 is also consistent. (2) Quantitative accuracy: The LLM states real-time payments expanded from '12 of the top 50 markets in 2022 to 13 markets in 2023' — while the ground truth only confirms 13 markets as of 2023 year-end, it does not specify the 2022 count. This is a minor extrapolation but not contradicted by the source. No calculation errors are present. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and domains (security infrastructure, third-party involvement, real-time payments) correctly. It appropriately links collaboration with issuers, acquirers, governments, etc., to threat monitoring and standards development, reflecting the public-private partnership model. (4) The only minor shortcoming is the lack of explicit mention of EMV standards in the context of technical standards (mentioned in ground truth), though 'best practices' and collaboration on standards are referenced generally. Otherwise, the answer captures all key dimensions of the question with strong factual and conceptual fidelity. Wording differs but semantic meaning is equivalent. Thus, a score of 9 is justified — excellent accuracy with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 472,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1,494 million in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (page 102; page 99). The steady decline—about 45 % from 2022‑23 and 38 % from 2023‑24—suggests the company has reduced its derivative exposure or improved netting and hedging practices, thereby lowering the initial‑margin collateral required and indicating more efficient derivative‑risk management over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and timeline. According to the ground truth, the collateral was $641 million at the end of 2021 (reported in 2022 filing), $800 million at the end of 2022 (reported in 2023 filing), and $491 million at the end of 2023 (reported in 2024 filing). The LLM incorrectly states that the value was $1,494 million in 2022, which is not supported by the ground truth and represents a major deviation. The correct trend is an increase from 2021 to 2022, then a decline in 2023, whereas the LLM describes a continuous decline from $1,494M in 2022 to $800M in 2023 to $491M in 2024, which misrepresents both the starting point and the direction of change in the early period. (2) The percentage declines cited (45% from 2022–23 and 38% from 2023–24) are based on incorrect base values. While the 38% decrease from 2022 to 2024 in the ground truth is accurate (from $800M to $491M), the LLM misattributes this drop to the 2023–2024 period alone. The actual 38% decline is over two years (2022–2023 filings), not one. (3) The multi-hop reasoning is partially sound in interpreting the trend as reflecting improved derivative risk management or reduced margin requirements, which aligns with the ground truth’s interpretation. However, because the underlying data is wrong, the reasoning is applied to an incorrect trajectory. (4) The contextual relevance is high—the answer addresses the question format, cites relevant financial behavior, and attempts to interpret the trend. However, due to major quantitative errors in key financial figures and misalignment with the correct time periods, the overall correctness score is low. The qualitative reasoning is plausible but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 483,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "From 2022 to 2024, Duke Energy’s relative TSR model’s expected volatility rose from 26.9 % in 2022 to 28.6 % in 2023, then fell sharply to 18.7 % in 2024【page_214】【page_206】【page_216】. This multi‑year swing indicates that market participants viewed the company’s equity as riskier in 2023, but perceived a significant reduction in risk by 2024, likely reflecting improved stability or lower expected market volatility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—are accurately reported with no discrepancies. The trend description (increase then sharp decrease) aligns with the data. (2) The answer is complete, addressing both the change in expected volatility over the three years and the implied shift in market risk perception. (3) Entities—Duke Energy, the relative TSR model, and the correct time frame (2022–2024)—are correctly identified. (4) The reasoning is sound: the increase in volatility suggests higher perceived risk in 2023, and the drop to 18.7% in 2024 is correctly interpreted as a reduction in perceived risk, indicating improved stability. The conclusion is logically derived and semantically equivalent to the original answer. Minor wording differences (e.g., 'sharp fall' vs 'significant decline') do not affect factual accuracy. All citations (page references) support the data points. Multi-hop synthesis across years and interpretation of market implications is accurate and appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 315,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022 through 2024, GM’s indemnification obligations to Stellantis under the Opel/Vauxhall sale remained uncertain and subject to thresholds, caps, and time limits, with no material accruals recorded. The company continued to indemnify Stellantis for an immaterial amount for certain recalls—including those related to Takata inflators in legacy Opel vehicles—and it believed any further indemnification would be remote. Consequently, GM could not estimate a material loss from emissions claims or Takata recalls, so the accruals for these obligations stayed immaterial throughout the period (see pages 92–93 of the 2024, 2023, and 2022 10‑K filings).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall vehicles, including Takata recalls and emissions claims, were consistently described as immaterial across 2022–2024. The LLM correctly states that no material accruals were recorded and that further indemnification was considered remote, matching the original answer’s timeline and substance. (2) There are no numeric inaccuracies—while no specific dollar amounts are given, the term 'immaterial' is used consistently with the filings and the ground truth, which also state the amounts are immaterial. The absence of quantifiable accruals is correctly reported. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and two types of liabilities (Takata recalls and emissions investigations), correctly linking GM’s indemnification obligations under the Opel sale agreement to Stellantis’ subsequent claims. It also appropriately references the European Commission and UK CMA investigations indirectly via the mention of emissions claims, though slightly less explicitly than the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 accrual related to the European Commission and UK CMA investigations, instead generalizing it under 'could not estimate a material loss.' This omits a small but relevant detail about an immaterial accrual being recorded for regulatory investigations, which slightly affects completeness. However, since the immateriality is preserved and the overall trend is accurately conveyed, this does not significantly detract from correctness. Wording differences are within acceptable semantic equivalence. Contextual relevance is perfect—the response directly addresses the evolution of indemnifications and accruals over time in relation to the specified claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 526,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks, AMD consistently cites the 2011 Executive Incentive Plan as Exhibit 10.2 to the 2011 10‑Q, with identical wording in the Exhibits section (see 2022 p. 91, 2023 p. 99, 2024 p. 98).  The unchanged reference shows that the plan remains in effect and is a core element of the company’s executive‑compensation framework.  This consistency signals a long‑term, stable strategy that relies on a single, enduring incentive plan rather than frequent redesigns.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core claims but contains a minor factual discrepancy in the exhibit number and filing type. The ground truth states the 2011 Executive Incentive Plan was listed as Exhibit 10.1 and filed on April 2, 2011, while the LLM claims it is Exhibit 10.2 to the 2011 10-Q. This is a specific error in exhibit number and form type (10-Q vs. original filing context), which affects quantitative accuracy. However, the key point—that AMD consistently referenced the same plan across 2022–2024 without changes—is correct and well-supported. The reasoning about long-term stability in executive compensation strategy is logically sound and semantically equivalent to the original answer. The answer addresses all parts of the question: evolution (no change), consistency, and strategic implication. Page numbers cited (2022 p.91, etc.) are plausible and contextually appropriate, though not verifiable without access to filings. Despite the exhibit/form inaccuracy, the overall qualitative reasoning and contextual relevance are strong, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 312,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "PayPal’s 2022 10‑K identified bad‑transaction risk, credit‑product default risk, cross‑border trade disruption, and third‑party payment‑processor dependence as material risks. The 2024 filing reiterated these concerns but added more detail on evolving fraud schemes, trade‑barrier impacts, and the potential for partner‑bank lending interruptions, underscoring the continued exposure. In 2023, PayPal mitigated these risks by selling a €40 bn portfolio of UK and European BNPL loan receivables (with a forward‑flow arrangement) and accelerating diversification of its payment‑processor network to reduce reliance on a single partner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified bad transaction risk in 2022 related to credit defaults, cross-border trade, and third-party dependencies; in 2023, it sold up to €40 billion of U.K. and European BNPL loan receivables to mitigate credit risk; and in 2024, it continued to highlight fraud, third-party reliance, and regulatory uncertainty. The strategic action in 2023—selling BNPL receivables—is correctly identified with the exact amount (€40 billion) and regions (UK and Europe). (2) Quantitative accuracy is perfect: the €40 billion figure matches the original, and no incorrect numbers are introduced. Format (€40 bn) is acceptable. (3) Multi-hop reasoning is sound: the answer synthesizes risk evolution across 2022–2024 and correctly links the 2023 strategic action to credit risk mitigation. It also adds value by mentioning a 'forward-flow arrangement' and 'accelerating diversification of payment processors,' which are plausible elaborations consistent with the theme of reducing third-party dependency, though not explicitly in the ground truth. (4) The only minor shortcoming is that the original emphasizes the Synchrony Bank U.S. credit product in 2022 and regulatory concerns about loan sales post-transfer in 2024, which the LLM omits. However, the core entities (PayPal, BNPL, third-party processors), years, and strategic actions are correct. The answer remains semantically equivalent in overall meaning and intent, with excellent contextual relevance to all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 434,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "Union Pacific’s owned multiple‑purpose locomotives fell from 6,204 in 2022 to 5,971 in 2023 and 5,973 in 2024, while the average age rose from 22.5 to 24.3 to 25.2 years (2022: page 24 of the 2022 10‑K; 2023: page 19 of the 2023 10‑K; 2024: page 19 of the 2024 10‑K). This gradual reduction in fleet size coupled with a steadily aging core signals a deliberate strategy of retiring older units and slowly replacing them with newer, more efficient locomotives to modernize the fleet while maintaining a leaner, more cost‑effective operation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer is partially correct on quantitative details but contains a minor error in the 2024 owned locomotive count (reports 5,973 correctly but incorrectly states 5,971 in 2023; ground truth shows no 2023 value provided, only 2022 and 2024). More significantly, the leased locomotive data is entirely omitted, which is a key component of the original answer and relevant to fleet management strategy. The average age progression (22.5 to 25.2 years) is correctly reported, though the intermediate 24.3 figure for 2023 is not in the ground truth and appears to be an interpolation not supported by the source data.\n\n2) Quantitative accuracy is mostly correct: 2022 owned (6,204) and 2024 owned (5,973) match; average age increase from 22.5 to 25.2 years is accurate. However, the inclusion of a 2023 owned count (5,971) and average age (24.3) introduces data not present in the ground truth, reducing precision. Leased units (1,038 in 2022 → 920 in 2024) are completely missing, a significant omission.\n\n3) The reasoning is flawed in interpretation: while the LLM suggests a strategy of 'retiring older units and slowly replacing them with newer, more efficient locomotives to modernize,' the ground truth concludes the opposite—that the company is not substantially purchasing new units, indicating cost control over modernization. The aging fleet combined with reductions in both owned and leased units (especially leased) does not support active modernization, contradicting the LLM's inference. This misrepresents the strategic implication, failing the multi-hop synthesis between fleet size, leasing trends, and age data.\n\n4) Contextual relevance is high—the answer addresses ownership trends and aging, cites correct document sources, and attempts to interpret strategy. However, due to missing leased data and incorrect strategic conclusion, the qualitative accuracy is reduced. The correctness score is 6 due to mostly accurate numbers but significant omissions and flawed reasoning in drawing the opposite strategic conclusion from the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 553,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral exposure under master‑netting arrangements tied to equity‑company receivables fell sharply: it was $1.494 billion at year‑end 2022, dropped to $800 million in 2023, and further declined to $491 million in 2024 (see XOM 10‑K 2023, p. 102 and XOM 10‑K 2024, p. 99). This consistent downward trend suggests the company is tightening its derivative risk management—likely trimming derivative positions or improving netting efficiency to reduce collateral costs and counter‑party exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. However, the LLM states it was $1.494 billion in 2022, which is more than double the correct value. This major error undermines the factual foundation of the response. The 2023 and 2024 figures ($800 million and $491 million) are correct and match the ground truth. (2) Calculations and comparisons are flawed due to the incorrect 2022 figure. The LLM describes a 'consistent downward trend' from 2022 to 2024, but the actual trend shows an increase from 2022 to 2023 followed by a decrease in 2024—a peak in the middle, not a steady decline. This misrepresents the pattern. (3) The reasoning is partially sound: the LLM correctly infers that reduced exposure may reflect tighter risk management or improved netting, which aligns with the ground truth's suggestion of a strategic shift. It also correctly identifies the relevance of derivative risk management. However, it fails to mention the use of level 3 fair value inputs, a key qualitative point in the original answer that speaks to valuation methodology and internal modeling. (4) Despite the incorrect 2022 number, the answer addresses both parts of the question—trend over time and implications for risk management—and cites specific 10-K pages, suggesting plausible sourcing. The conclusion is reasonable given the numbers it uses, but the factual error in the starting value severely limits correctness. Semantic equivalence fails on the 2022 data point, which is materially off. Contextual relevance is high as the response stays focused and interprets the trend appropriately, albeit based on incorrect data for the first year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 498,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ “Other” category continued to be defined the same way in each filing – packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware, and other items (see Note 17, page 86).  Revenue in the category rose from $6.89 B (21 % of total) in 2022 to $7.71 B (22 %) in 2023, then fell slightly to $7.54 B (21 %) in 2024, keeping its share of total revenue roughly 21‑22 % (page 86).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer addresses the evolution of Starbucks' 'Other' category revenue composition from 2022 to 2024 but introduces significant quantitative inaccuracies not present in the ground truth. The original answer states that the composition remained stable with no mention of revenue figures or percentages, focusing solely on the qualitative consistency of included items (e.g., single-serve coffees, royalty income, etc.). However, the LLM answer fabricates specific revenue amounts—$6.89B in 2022, $7.71B in 2023, and $7.54B in 2024—and corresponding percentages of total revenue (21%, 22%, 21%), which are not supported by the ground truth. These numbers and calculations cannot be verified against the provided knowledge and appear to be hallucinated. This severely undermines quantitative accuracy. On qualitative grounds, the LLM correctly identifies the consistent components of the 'Other' category across years—packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware—aligning with the original answer’s description. It also correctly concludes that the category’s composition remained largely unchanged, which matches the ground truth’s emphasis on stability. The reference to 'Note 17, page 86' suggests document grounding, but since the evaluation is based solely on alignment with the provided ground truth (not external documents), this cannot validate the numbers. Contextually, the answer is relevant and structured appropriately, addressing both composition and trends. However, the inclusion of unsourced financial figures constitutes a major factual deviation. While the reasoning about compositional stability is sound and matches the multi-hop intent of comparing disclosures across years, the unsupported numerical claims reduce overall correctness. Thus, the answer is partially correct in content but significantly flawed in factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 519,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 onward Alphabet continued to monetize inventory on Google Network properties (AdMob, AdSense, and Google Ad Manager) using impression‑based metrics—cost‑per‑impression is defined as the ratio of impression‑based and click‑based revenue to total impressions (2022 page 31; 2023 page 57; 2024 page 56).  In 2023 the company clarified that it reports revenue for these ads on a **gross basis**—the full amount billed to customers is recorded as revenue, while partner payments are treated as cost of revenues (2023 page 57; 2024 page 56).  This gross‑revenue reporting approach remained unchanged in 2024, underscoring a consistent recognition policy for Google Ad Manager inventory across the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Google monetized advertising inventory through Google Ad Manager using impression-based and click-based models from 2022–2024; cost-per-impression was used as a metric in 2022; gross revenue reporting (full amount billed as revenue) was confirmed in 2023 and continued in 2024; partner payments were treated as cost of revenue. These points match the ground truth. (2) There are no numeric inaccuracies—though no specific dollar amounts are mentioned, the qualitative metrics (e.g., cost-per-impression definition, gross reporting) are correctly described and tied to the appropriate years and pages. Format variations (e.g., 'gross basis') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years (2022–2024), correctly identifying the evolution from metric usage to accounting policy clarification. It accurately links the gross revenue model to Google’s role as principal (implied by treatment of partner payments), though this specific phrase is not used. (4) The only minor omission is that the original answer notes increasing 'transparency and accounting clarity over time' as part of the evolution, which the LLM answer implies but does not explicitly state. However, this does not detract from factual correctness. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 416,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "Across 2022, 2023 and 2024 MDLZ’s exposure to sales‑ and media‑marketing restrictions has remained essentially unchanged – the company continues to be subject to front‑of‑pack labeling rules for nutrient and environmental claims and to marketing limits on promotions of products with specified nutrient profiles.  The extended‑producer‑responsibility (EPR) landscape, however, has broadened: the company notes EPR mandates in more than 25 EU member states and the ongoing implementation or contemplation of similar policies in India, Vietnam and U.S. states, indicating a widening jurisdictional scope while the nature of the exposure stays consistent.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some key facts correctly but misses critical evolution in MDLZ's exposure across the years, particularly regarding front-of-pack labeling and jurisdictional shifts in EPR policy. (1) Quantitatively, the statement that 'more than 25 EU member states' have EPR policies matches the 2022 and 2023 ground truth, and the expansion to India, Vietnam, and U.S. states aligns with the 2024 update—these entity and number references are accurate. (2) However, the LLM incorrectly claims that sales and media marketing restrictions 'have remained essentially unchanged,' which contradicts the ground truth: in 2023, MDLZ emphasized *increased attention* to front-of-pack labeling based on nutrient profiles and environmental claims, and in 2024, there was a noted shift from policy contemplation to enforcement, especially with the EU’s adoption of the Packaging and Packaging Waste Directive. This evolution is entirely omitted. (3) The multi-hop reasoning is partially sound—information about EPR expansion is synthesized across jurisdictions and years—but fails to integrate the progressive tightening of marketing restrictions and labeling requirements over time. (4) While the answer is contextually relevant and uses appropriate terminology, it underrepresents the growing regulatory burden and specificity in marketing restrictions, leading to a misleading conclusion of 'consistent' exposure. Thus, the correctness and qualitative accuracy scores are moderate due to significant omissions in trend analysis despite factual accuracy in isolated data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 430,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Mastercard’s A‑class common shares continued to carry **one vote per share and dividend rights** in each of the three reporting years.  The 2022, 2023 and 2024 10‑K “Classes of Capital Stock” tables all list A shares as “One vote per share Dividend rights”【page_98】【page_101】【page_96】.  This unchanged status demonstrates a deliberate capital‑structure strategy that preserves stable voting power and predictable dividend policy for common shareholders, underscoring Mastercard’s commitment to a consistent, shareholder‑friendly governance framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that A Class shares maintained one vote per share and dividend rights across 2022, 2023, and 2024, matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly cited, and the qualitative attributes (voting rights, dividend rights) are factually accurate. (3) The multi-hop reasoning is sound—by referencing the 'Classes of Capital Stock' tables across three consecutive 10-K filings, the model correctly synthesizes information over time to infer stability in capital structure. (4) The LLM adds contextual interpretation—'deliberate capital-structure strategy', 'predictable dividend policy', 'shareholder-friendly governance'—that is reasonable and consistent with the evidence of stability, enhancing the answer without introducing inaccuracies. All entities (Mastercard, A-class shares, 10-K filings) are correctly identified. The answer fully addresses both parts of the question: the evolution (or lack thereof) and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 324,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: $1.49 billion in 2022, $800 million in 2023 and $491 million in 2024.  The decline—primarily tied to initial‑margin requirements on “Investments, advances and long‑term receivables”—suggests the company has reduced its net derivative exposure or shifted to more cleared, lower‑margin contracts, easing its margin obligations over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 value: it reports $1.49 billion, whereas the ground truth is $641 million. The 2023 ($800 million) and 2024 ($491 million) values are correct. This major discrepancy in the starting value undermines the accuracy of the trend description. The answer incorrectly frames the trend as a 'sharp fall' from 2022 to 2024, while the actual trend is an increase from 2022 to 2023, then a decrease in 2024—indicating volatility, not a consistent decline. (2) Quantitative accuracy is compromised due to the incorrect 2022 figure; all other numbers are correctly stated. Calculations are not required in this question, but the directional trend is misrepresented due to the wrong initial value. (3) The reasoning partially aligns with the ground truth: the reduction in 2024 is correctly interpreted as potentially reflecting reduced margin obligations, and the link to derivative exposure is reasonable. However, the LLM misses the nuance of increased requirements in 2023, which is a key part of the multi-hop synthesis. The suggestion of a shift to 'cleared, lower-margin contracts' is speculative but not unsupported. (4) Contextual relevance is high—the answer addresses collateral changes, ties them to derivative exposure and margin requirements, and references the correct financial category. However, due to the significant error in the 2022 figure and the resulting flawed trend analysis, the overall correctness is only partial.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 412,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ 2022 10‑K (page 12) stated that its fixed‑price and price‑to‑be‑fixed purchase commitments, together with forward contracts, futures and collars, would secure an adequate supply of green coffee through fiscal 2023. The 2023 and 2024 10‑Ks (page 12) extend that coverage to fiscal 2025, showing a deliberate shift to longer‑term hedging and supply agreements. This evolution indicates the company is proactively locking in supply and hedging price risk over a broader horizon to strengthen its resilience against coffee price volatility and supply disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks secured green coffee supply through fiscal 2023 in 2022, extended to 2025 in 2023, and maintained that through 2025 in 2024. The use of forward contracts, futures, and collars is correctly noted. (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2024, 2025) are correctly cited and sequenced; no numerical errors. (3) Multi-hop reasoning is sound—information is synthesized across three fiscal years and filings, showing evolution over time. The conclusion about longer-term hedging and resilience is logically supported. (4) The only minor omission is that the LLM does not explicitly state that the same risk management instruments (forward/futures/collars) were used consistently across all three years, though it is implied. This slightly reduces qualitative completeness but does not detract from the core correctness. Wording differs but semantic equivalence is strong. Contextual relevance is excellent—directly addresses supply chain evolution and strategic implications for price volatility and supply risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 323,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "From fiscal 2023 to fiscal 2025 ACN moved its U.S. defined‑benefit plans to a 100 % debt‑only mix, dropping the 5 % cash allocation it held in 2023, while its non‑U.S. plans increased equity exposure from 19 % to 28 % and reduced debt from 43 % to 36 % (cash rose from 6 % to 7 %). This shift shows a deliberate move to match U.S. plan assets more closely to liability duration with a conservative debt focus, while taking on higher equity risk abroad to lift expected returns. Overall, the multi‑year adjustment signals a long‑term strategy aimed at achieving risk‑adjusted returns that exceed inflation over time, consistent with the plans’ stated investment objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The claim that ACN moved its U.S. defined-benefit plans to a 100% debt-only mix and dropped a 5% cash allocation in 2023 is not supported by the ground truth. Similarly, the specific percentage shifts in non-U.S. plans (equity from 19% to 28%, debt from 43% to 36%, cash from 6% to 7%) are fabricated and do not appear in the original answer. The ground truth does not provide any specific numerical allocations for any year, only qualitative descriptions of strategy. (2) There are no verifiable numbers in the original answer to support the LLM's precise percentages, so all quantitative claims are inaccurate. The LLM invents data that is not present in the source material, failing the quantitative accuracy test completely. (3) The multi-hop reasoning is flawed because the LLM fabricates granular asset allocation data rather than acknowledging the absence of specific numbers. While it attempts to interpret strategic intent (e.g., liability matching in the U.S., higher equity risk abroad), this interpretation is not grounded in the provided information. The original answer emphasizes continuity, flexibility, and risk-adjusted returns without citing plan-specific shifts. (4) Despite the factual inaccuracies, the LLM does address the general theme of long-term strategy and risk-adjusted returns, which keeps it contextually relevant. However, the invented details severely undermine correctness. The qualitative reasoning is plausible but not supported by evidence from the ground truth, leading to low scores in accuracy. The answer suggests a false precision that misrepresents the actual disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 462,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen has consistently positioned Olpasiran as an siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease, with the molecule listed under cardiovascular disease in the product‑candidate tables of the 2022, 2023, and 2024 10‑K filings (page_24). The composition‑of‑matter patents for Olpasiran, issued in the U.S. and EU, are projected to expire in 2036, a timeline that has remained unchanged across the three reports (page_26). Thus, Olpasiran’s therapeutic focus and IP protection strategy have been stable from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA drug for atherosclerotic cardiovascular disease and accurately reports the 2036 patent expiration for U.S. and European composition-of-matter patents, which aligns with the ground truth. These factual elements—therapeutic focus and IP timeline—are quantitatively and factually correct. However, the LLM incorrectly implies stability in Olpasiran’s development status across 2022–2024 by stating it was listed in product-candidate tables in all three years, whereas the ground truth indicates a progression: in 2022 it was in phase 2 trials, and by 2024 it was indicated for 'Cardiovascular disease' with implications of advancing development. The LLM misses this evolution, which is central to the question about 'evolution' and 'strategic positioning' over time. (2) All numbers and dates (e.g., 2036 patent expiry) are accurate and consistent with the original answer; no calculation errors. (3) The multi-hop reasoning is flawed: while the LLM synthesizes information across years, it fails to detect the strategic shift from early-phase investigation to advanced development, misrepresenting the narrative as static rather than evolving. The ground truth emphasizes progression; the LLM emphasizes stability, contradicting the intended insight. (4) Despite correct entities and dates, the qualitative inaccuracy in capturing the developmental trajectory reduces the correctness score. The answer is contextually relevant and factually grounded but misses the core dynamic the question seeks: change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 435,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "From 2022 through 2024, American Express’s reliance on aggregators shifted from a growing but secondary role to a core component of its merchant‑acceptance ecosystem, with the 2024 10‑K (pp. 33‑37) explicitly listing aggregators among the third‑party service providers that support card acquisition and transaction processing. In 2022 and 2023 (pp. 27‑31), the company warned that aggregators might not promote card usage or could pursue business interests that conflict with its own, creating a risk of merchant steering away from the network and loss of partner relationships. By 2024, the disclosures broadened the risk narrative to include the operational complexity and governance challenges of a larger third‑party base, the potential for service disruptions or data‑security incidents, and the regulatory and reputational consequences of failing to meet service‑level or compliance obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—American Express, aggregators, years 2022–2024—are correctly identified. There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised. (2) The LLM correctly traces the evolution of American Express’s reliance on aggregators: from initial concerns in 2022 about conflicting interests and merchant steering, to increased dependency in 2023, and broader operational, regulatory, and reputational risks in 2024. The mention of specific page ranges (pp. 27–31 for 2022–2023, pp. 33–37 for 2024) adds precision and suggests accurate sourcing. (3) The multi-hop reasoning is sound—information is synthesized across years and disclosures, showing a clear progression in risk emphasis. The LLM captures the shift from merchant behavior (steering, surcharging) to systemic issues (operational complexity, data security, compliance), which matches the ground truth’s narrative of expanding risk awareness. (4) Minor difference: the original answer explicitly mentions 'litigation exposure' and 'surcharging' in 2024, which the LLM implies via 'regulatory and reputational consequences' and 'service-level or compliance obligations' but does not state directly. However, the semantic meaning is sufficiently close, and the core risks are accurately conveyed. Wording differs slightly but maintains factual and conceptual equivalence. No irrelevant or extraneous information is included—response is focused and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 440,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks’ 2022 10‑K noted that green‑coffee price volatility was influenced by commodity index funds and that the company hedged exposure with forward contracts, futures and collars, with forward supply commitments covering up to fiscal 2023 (page_12, 2022). The 2023 filing reiterated the same exposure and hedging approach, extending forward commitments through fiscal 2024 (page_12, 2023). By fiscal 2024, the company further extended forward supply commitments to cover through fiscal 2025, indicating a longer‑term hedging horizon while the exposure to index funds remained a stated risk (page_12, 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Starbucks cited commodity index funds as a factor in green coffee price volatility and used hedging instruments like forward contracts, futures, and collars across all three fiscal years. However, there is a key discrepancy in the forward supply commitment timeline. The original answer states that in 2022, commitments covered through fiscal 2023; in 2023, the outlook was extended to fiscal 2025 (a two-year extension), and this remained unchanged in 2024. The LLM answer incorrectly states that in 2023, commitments were extended only through fiscal 2024, and then further to 2025 in 2024. This misrepresents the timing of the strategic shift, making it appear incremental year-by-year rather than a significant extension in 2023. (2) The fiscal year references (2022, 2023, 2024) are correctly used, but the forward coverage years (2023, 2024, 2025) are inaccurately sequenced. The original answer emphasizes that the extension to 2025 occurred in 2023 and was maintained in 2024, which the LLM answer fails to reflect. (3) The multi-hop reasoning is partially sound—information is synthesized across years and filings, and the role of index funds and hedging strategies is correctly noted. However, the synthesis of the forward commitment timeline is flawed, missing the significance of the 2023 extension and its stability into 2024. (4) The contextual relevance is high as all parts of the question are addressed, and the terminology (hedging, forward commitments, index fund exposure) is accurate. The qualitative accuracy is strong but reduced by the incorrect sequencing of supply commitment extensions. Quantitative accuracy is impacted by the misstatement of the forward coverage years, though no numerical values (e.g., dollar amounts) are incorrect. Correctness score is 7 due to core factual accuracy on exposure and hedging, but significant error in the evolution timeline of supply commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 530,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture’s share‑repurchase activity grew from $4.11 B in fiscal 2022 (12.18 M shares) to $4.5 B in fiscal 2024 (2.07 M shares in Q4 alone, part of a $4.5 B total)【page_94】【page_40】【page_39】. Its aggregate available authorization for the open‑market program fell from $3.129 B in 2022 to $2.694 B in 2024, while the total outstanding authority for all share purchases rose to $6.694 B after a $4.0 B boost【page_93】【page_94】【page_39】. This trajectory signals Accenture’s intent to scale its capital‑return program, balancing dividends with an expanding share‑buyback capacity as cash flow permits.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. It claims Accenture repurchased $4.11B in fiscal 2022 and $4.5B in fiscal 2024, but the ground truth states only $605 million in repurchases in fiscal 2023 and no total repurchase amount for 2024—only an increase in authorization. The share counts (12.18M in 2022, 2.07M in Q4 2024) are not supported by the ground truth, which only reports 2,000,308 shares (~2M) purchased in fiscal 2023. The available authorization is misrepresented: the LLM says it fell from $3.129B in 2022 to $2.694B in 2024, but the ground truth shows $2.694B was the amount as of August 31, 2024, after activity, not the full-year 2024 level, and this was followed by a $4B increase to $6.694B. (2) Calculations are flawed: the LLM implies a continuous decline in authorization, but the truth shows a replenishment—Accenture used part of its authorization ($3.129B → $2.694B) and then added $4B, bringing total to $6.694B. The LLM incorrectly treats $2.694B as the end-of-2024 available amount without acknowledging the subsequent $4B boost. (3) Multi-hop reasoning is partially sound—the model attempts to synthesize repurchase activity and authorization trends across years and draws a reasonable conclusion about capital return strategy. However, it conflates total repurchase activity with authorization and misattributes timing and magnitudes. (4) Despite incorrect numbers, the answer captures the strategic direction—Accenture is expanding buyback capacity and returning capital—so the qualitative and contextual elements are partially valid. However, due to major quantitative errors, the correctness score is limited to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 464,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google’s long‑term marketable equity securities that are subject to lock‑up restrictions fell from **$803 million at December 31, 2022** to **$266 million at December 31, 2024** (a decline of $537 million)【page_65】【page_67】. This sharp reduction indicates a deliberate shift away from illiquid equity holdings, suggesting the company is rebalancing its portfolio toward more liquid or higher‑return assets to improve liquidity and reduce illiquidity risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM states it was $803 million in 2022 and dropped to $266 million in 2024, which is incorrect on both starting value and trend. The LLM also omits the 2023 figure entirely and misrepresents the 2024 value. (2) The quantitative inaccuracies are severe: the correct values are $1,400M (2022), $803M (2023), $1,400M (2024); the LLM reports $803M (2022) and $266M (2024), missing the rebound and misstating the base year. The claimed decline of $537 million is therefore incorrect. (3) The reasoning is flawed due to incorrect data: instead of identifying a cyclical pattern or strategic rebalancing suggested by the rise and fall and return, the LLM infers a 'sharp reduction' and shift away from illiquid assets, which contradicts the actual stabilization back to the original level. The multi-hop synthesis failed—correct interpretation requires comparing all three years, but the LLM only references two and with wrong numbers. (4) Despite incorrect facts, the answer attempts to address the question's intent regarding investment strategy, so contextual relevance is moderate. However, correctness and quantitative accuracy are severely compromised, warranting low scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 388,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "In Q4 2022 GE classified its captive insurer, Electric Insurance Company (EIC), as a held‑for‑sale asset, valuing it at $541 million in assets and $378 million in liabilities with a $124 million valuation allowance (net book value ≈$39 million). In Q3 2023 it signed a binding sale agreement and recorded a $109 million loss in other income (loss) reflecting the valuation allowance and expected disposal. The sale was completed in Q2 2024 for $120 million in cash, generating a net gain of roughly $81 million and offsetting the prior loss, leaving a net positive cash impact of about $11 million over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in timing and financial figures. According to the ground truth, EIC was not classified as held for sale in Q4 2022; rather, in 2022, GE only disclosed EIC as a captive insurer with $0.2 billion in net claim reserves. The classification as held for sale occurred in 2023, not 2022. The LLM incorrectly states that the $124 million valuation allowance was recorded in 2022, which is not supported by the original answer. The $109 million loss was recorded in 2023 upon classification as held for sale, not in Q3 2023 as part of a binding agreement. Additionally, the LLM invents a 'net gain of $81 million' in 2024 from the $120 million sale, implying a reversal of the prior loss, but the original answer does not mention any gain at completion—only that the sale was completed for $120 million in cash. There is no indication of offsetting gains or net positive cash impact of $11 million in the ground truth; this calculation is speculative and unsupported. (2) Key numbers like assets ($541M) and liabilities ($378M) in 2023 are correctly stated, and the $109M loss and $120M sale price in 2024 are accurate. However, the $124M valuation allowance and the implied net book value of $39M are not in the original answer and appear to be fabricated. The net gain calculation ($120M - ($541M - $378M - $124M)? = $81M) is based on incorrect assumptions and is not corroborated. (3) The multi-hop reasoning is partially sound in tracking EIC across years and recognizing strategic disposition, but the sequencing and causality are flawed. The model incorrectly infers a gain on sale and misattributes the timing of key events (classification, agreement, sale). It also fails to reflect the strategic narrative of exiting a non-core business with a loss, instead suggesting a net positive outcome. (4) Contextual relevance is strong—the answer addresses strategic positioning, valuation, disposition, and financial impact over the three years. However, due to major quantitative and factual errors, especially in timing and financial results, the correctness score is low. The answer conveys a misleading financial narrative despite using some correct data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 600,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 portfolio expanded from 13 programs in February 2022 (AMGN 10‑K 2022, page 26) to 18 by January 2023 (AMGN 10‑K 2023, page 26) and to 24 by January 2024 (AMGN 10‑K 2024, page 26) – a 25th program was added in early 2025. This growth, driven by Horizon acquisitions, new study initiations and regulatory approvals, reflects a deliberate strategy to broaden the late‑stage pipeline, deepen assets in oncology, immunology and cardiovascular areas, and leverage Amgen’s focus on human‑genetics‑based modalities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Amgen's Phase 3 programs from 13 in 2022 to 18 in 2023 and 24 in 2024, aligning with the ground truth. However, it states that the 25th program was added in early 2025, whereas the original answer indicates the total reached 25 by 2024. This is a minor temporal inaccuracy, as the ground truth does not specify a 2025 addition but rather includes the 25th program within the 2024 count. All other numbers and years (13 in 2022, 18 in 2023, 24 in 2024) are accurate. (2) The quantitative progression is mostly correct: 13 → 18 → 24 is accurate; the difference lies in the timing of the 25th program. The LLM attributes the growth to Horizon acquisitions, new studies, and regulatory approvals, which matches the original answer’s emphasis on Horizon’s five acquired programs and new initiations. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years of 10-K filings, correctly tracks the pipeline expansion, and infers strategic focus areas (oncology, immunology, cardiovascular) and human-genetics-based modalities, which, while slightly more detailed than the original, are consistent with Amgen’s known R&D focus and do not contradict the ground truth. (4) The answer is highly contextually relevant, addressing both the evolution of the portfolio and the strategic implications. The minor error in the timing of the 25th program prevents a perfect score, but overall factual accuracy, completeness, and reasoning are strong. Hence, correctness is 9/10, with high marks across all subcategories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 436,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "From 2022, American Express operated a global card network that was the fourth‑largest general‑purpose network worldwide, competing directly with Visa, Mastercard, UnionPay, JCB, Discover and Diners Club (see 2022 page 12). By 2024, heightened regulatory scrutiny—especially over interchange‑fee caps, network routing and merchant‑acceptance rules—has forced the company to exit its network‑licensing businesses in the EU and Australia and to tighten its cobrand and network arrangements, reflecting a shift toward tighter compliance and a more cautious competitive stance (see 2024 page 34). These changes illustrate how regulatory pressures and evolving competition have reshaped American Express’s engagement with global card networks over the two‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies American Express's competitive position in 2022 as a direct competitor to major card networks, citing Visa, Mastercard, UnionPay, and others, which matches the original answer’s emphasis on competition. (2) The shift in 2024 due to regulatory pressures—specifically the exit from network licensing in the EU and Australia—is factually correct and matches the ground truth. The mention of interchange-fee caps, network routing, and merchant-acceptance rules reflects accurate regulatory context. (3) The reasoning across years is sound: it captures the evolution from competition to regulatory constraint, particularly internationally, which is the core of the multi-hop synthesis required. (4) Minor omission: the LLM answer does not mention the growing competitive threat from alternative payment platforms like Alipay and PayPal in 2023, nor the specific uncertainty around cobrand arrangements in the EU due to differing regulatory interpretations, which are present in the original. However, it does reference tightening cobrand arrangements, which partially captures this. All entities (AXP, EU, Australia, Visa, etc.) and years (2022, 2024) are correct. Number formats and dates are accurate. The answer is semantically equivalent in most key aspects, with only slight reduction in completeness regarding 2023 dynamics. Thus, high scores across all categories with a 9 on correctness due to minor contextual omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 417,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in the first quarter of 2022, selling the remaining 91 million shares and immediately applying the proceeds to share repurchases.  The company repurchased 87.7 million shares in 2022, 48.6 million shares in 2023, and 49.1 million shares in 2024, for a cumulative cost of **$34.3 billion** through December 2024【page_112 (COP_10k_2024)】.  Thus, the monetization ended in 2022 and the proceeds were used each year to buy back shares, with the repurchase volume falling from 87.7 million to about 49 million shares per year while the total outlay reached $34.3 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. While it correctly states that ConocoPhillips sold its remaining 91 million CVE shares in 2022, it incorrectly reports the share repurchase volumes: it claims 87.7 million shares in 2022, 48.6 million in 2023, and 49.1 million in 2024, totaling approximately 185.4 million shares repurchased over three years. However, the ground truth states that 383 million shares were repurchased in 2022 alone, with a cumulative total of 433 million shares by 2024. This represents a major discrepancy—over 200 million shares missing from the 2022 figure alone. The LLM’s cumulative cost of $34.3 billion by end-2024 matches the ground truth, but this appears to be coincidental given the incorrect underlying share volumes. (2) The dollar amounts are partially correct: $34.3 billion cumulative cost by 2024 is accurate, but the LLM fails to mention the $29 billion spent in 2022 alone or the increase in authorization to $65 billion in October 2024. The absence of these figures undermines completeness and accuracy. (3) The reasoning is partially sound in linking the monetization of CVE shares to share repurchases, and the timeline (monetization ending in 2022, repurchases continuing through 2024) aligns with the original answer. However, the failure to correctly represent the scale and timing of repurchases—especially the massive 2022 buyback—indicates flawed multi-hop synthesis. The model incorrectly implies a gradual, declining repurchase pace starting from 87.7 million shares, whereas the truth shows a dominant 2022 buyback wave. (4) Despite these errors, the answer is contextually relevant and attempts to address the evolution of the strategy and use of proceeds. The mention of $34.3 billion cumulative cost provides some alignment with ground truth. However, due to severe quantitative inaccuracies in core metrics (share volumes), the correctness score is low. Minor flexibility is allowed for phrasing (e.g., 'first quarter of 2022' vs. unspecified 2022 sale), but numbers must be accurate—especially in financial reporting. The model likely misread or misattributed data from the cited document (COP_10k_2024, page 112), leading to incorrect disaggregation of repurchase volumes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 612,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "In 2022 the Omnibus Plan had about **117 million shares** available for future grants (page 65). By 2024 that pool had fallen to roughly **77 million shares** (page 66), a drop of about 40 million shares. The decline shows that Home Depot has been actively issuing stock‑based awards, consuming a large portion of its authorized shares and tightening the pool for future grants, which indicates a high utilization of its stock‑based compensation capacity over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that the available shares declined from 117 million in 2022 to 77 million in 2024, but the ground truth shows a decline to 77 million by 2023 and further to 70 million by 2024. The LLM incorrectly skips the 2023 figure and misattributes the 77 million number to 2024, which is factually wrong. Additionally, the drop of 'about 40 million shares' is inaccurate—the actual drop from 2022 to 2024 is 47 million (117M to 70M), and the decline to 77M already occurred in 2023, not 2024. (2) The entity accuracy is mostly correct—Home Depot and the Omnibus Plan are correctly identified, and the years 2022 and 2024 are addressed, though 2023 is omitted. The financial metric (shares available) is correct in concept but wrong in execution. (3) The reasoning is partially sound—the conclusion that the company is actively using stock-based compensation is supported by the trend, and the interpretation of tightening future capacity is reasonable. However, the multi-hop synthesis fails because it does not incorporate the 2023 data point, leading to an incorrect trajectory. The answer also omits mention of the replenishment mechanism tied to expirations and forfeitures, which is a key part of the original answer and relevant to understanding capacity. (4) The contextual relevance is high—the answer addresses the evolution of share availability and interprets the trend in terms of utilization and capacity. However, due to the incorrect numbers and missing intermediate year, the overall correctness is significantly compromised. The answer conveys a similar direction (decline and high utilization) but with incorrect magnitude and timing, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 478,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "Accenture’s authorized pool for the Amended 2010 SIP grew from **127 million Class A shares in 2022** (ACN_10k_2022, p. 91) to **141 million shares in 2024** (ACN_10k_2024, p. 98) – an increase of 14 million shares (≈ 11 %). This steady expansion signals a deliberate strategy to broaden the share‑based incentive program, giving the company greater flexibility to reward employees and align their interests with shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the authorized share numbers for 2022 (127 million) and 2024 (141 million), matching the ground truth. It notes the increase of 14 million shares (≈11%), which is accurate: (141M - 127M) / 127M ≈ 11.02%. However, the ground truth specifies that the 141 million share authorization was already in place by 2023 and remained in 2024, but the LLM answer skips 2023 and jumps from 2022 to 2024, missing the continuity across all three years as implied in the question's 'evolve from 2022 through 2024'. This is a minor omission in completeness but does not distort the overall trend. (2) All numeric values and calculations are correct. The 14 million increase and ≈11% growth are accurately computed. (3) The reasoning is sound: the LLM correctly infers that the increase indicates a strategic expansion of share-based incentives to align employee and shareholder interests, which is consistent with the ground truth's interpretation. The multi-hop synthesis across 2022 and 2024 filings is valid, though the lack of explicit mention of 2023 data slightly weakens the full temporal evolution. (4) The answer is contextually relevant, directly addressing both the quantitative evolution and strategic implication. The minor omission of 2023 data prevents a perfect score, but the core facts, calculations, and strategic interpretation are correct and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 392,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "American Express’s weighted‑average yield on foreign government bonds and obligations climbed from **2.08 % in 2022** (total weighted average yield for all investment securities, which includes the foreign‑bond portfolio【page 121】) to **6.1 % in 2024** (the non‑U.S. portion of taxable investment securities, which includes foreign government bonds【page 176】). This sharp rise indicates that the company’s foreign‑bond holdings are now earning higher yields, reflecting higher international rates and a greater sensitivity of its earnings to global interest‑rate movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield on foreign government bonds and obligations due within one year was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM incorrectly states the 2022 yield as 2.08% and the 2024 yield as 6.1%, both of which are factually wrong. Additionally, the LLM conflates 'total weighted average yield for all investment securities' (2.08%) with the specific yield on foreign government bonds, which is a distinct and more relevant metric. It also references the 'non-U.S. portion of taxable investment securities' in 2024, which is not equivalent to the foreign government bonds and obligations specified in the question. (2) The numbers cited are incorrect: 2.08% and 6.1% do not match the ground truth values of 5.86%, 6.45%, and 5.86% across the years. The trend described — a steady increase — contradicts the actual volatile pattern with a peak in 2023 and a return to baseline in 2024. (3) The multi-hop reasoning is flawed: the model fails to isolate the correct financial instrument (foreign government bonds due within one year) and instead uses broader or unrelated yield figures. It does not track the correct three-year trend or acknowledge the 2023 peak and 2024 reversal. (4) While the general idea of linking yield changes to international interest rate exposure is contextually relevant, the incorrect data and misidentified metrics severely undermine the answer’s validity. The conclusion about increasing sensitivity is not supported by the actual trend, which shows stabilization by 2024. Hence, the correctness and quantitative accuracy scores are low; qualitative accuracy is slightly higher due to correct intent in reasoning about interest rate exposure, and contextual relevance is moderate because the topic and direction of analysis are appropriate, albeit based on wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 526,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s foreign‑government‑bond holdings were heavily short‑term in 2022 (630 $ m fair value, 628 $ m due within one year)【page_121】, and the weighted‑average yield on that portfolio fell from 6.45 % in 2023 to 5.85 % in 2024. The decline in yields signals a shift toward lower‑yielding, higher‑quality sovereign debt as global risk premiums eased and monetary conditions tightened, reflecting a more conservative investment stance and a response to falling market yields.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $630 million total fair value in 2022 with $628 million maturing within one year, weighted average yield of 6.45% in 2023, and 5.85% in 2024. These match the ground truth exactly, with acceptable formatting (e.g., '630 $ m' for $630 million). (2) Quantitative accuracy is perfect—no calculation errors or misstatements of numbers, percentages, or timeframes. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across 2022 (portfolio duration), 2023 (peak yield), and 2024 (decline), and infers strategic and market implications. The interpretation aligns closely with the ground truth, noting a yield decline and suggesting a strategic shift. The only minor gap is that the LLM emphasizes a move toward 'higher-quality sovereign debt' and 'tightened monetary conditions,' while the ground truth highlights a possible reduction in short-duration instruments and ties the change more explicitly to falling interest rates or risk management. These are semantically similar but not identical interpretations. (4) The answer is fully contextually relevant, addressing both the evolution of the yield profile and the implications for strategy and market conditions. The slight difference in emphasis prevents a perfect 10, but the core facts, synthesis, and reasoning are highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 384,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In 2022 ConocoPhillips listed its 7% debentures due 2029 in the securities‑registration table together with common stock, without a separate CUSIP or trading symbol. By 2023 the company moved the debentures to a distinct row and identified it by its CUSIP (718507BK1), giving clearer identification. The 2024 filing returns to a combined listing but still shows the CUSIP, indicating a consistent, investor‑friendly approach that balances concise presentation with regulatory transparency.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 7% Debentures due 2029, the CUSIP number (718507BK1), and the progression from 2022 to 2023. However, it makes a critical factual error in stating that the 2024 filing 'returns to a combined listing'—the ground truth confirms that COP maintained the separate row for the debentures in 2024, not a recombination. This misrepresents the trend toward increasing transparency. (2) Quantitatively, all numbers (7%, 2029 maturity, CUSIP) are accurate, and no calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—correctly identifying changes between 2022 and 2023—but fails in the 2024 analysis, breaking the logical progression. The conclusion about a 'consistent, investor-friendly approach' is plausible but based on incorrect premises. (4) Contextual relevance is strong as the answer addresses disclosure evolution and implications, but the incorrect 2024 characterization undermines the overall correctness. The answer captures the intent but misses a key factual development, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 317,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 were $1,044 million in FY 2023 (the same level reported for FY 2022) and climbed to $1,250 million in FY 2024, a 20 % increase【page 67】【page 72】.  The modest, incremental build‑up shows a disciplined long‑term debt strategy that adds low‑rate, long‑maturity debt in a controlled way to finance growth while keeping the overall debt profile stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM states it was $1,044 million in both 2022 and 2023, which contradicts the ground truth—especially the 2022 figure, which is off by over $150 million. The 2024 value of $1,250 million ($1.25 billion) is correct. (2) The calculation of a '20% increase' is based on the incorrect baseline: from $1,044M to $1,250M is actually a ~19.7% increase, which rounds to 20%, so the percentage is approximately correct—but only because it uses its own incorrect starting point. The actual increase from $1.057B to $1.25B is about 18.2%, and from $1.2B to $1.25B is only ~4.2%, so the 20% figure is misleading. (3) The qualitative reasoning about a 'disciplined long-term debt strategy' and 'controlled' addition of low-rate debt is reasonable and aligns with the ground truth's interpretation of a stable financing approach. The entity (NVIDIA, 2.00% Notes Due 2031) and years (FY2022–2024) are correctly identified, and the answer addresses both parts of the question—evolution of exposure and strategic implication. (4) Despite incorrect numbers, the overall direction (slight increase over time) and strategic interpretation are consistent with the ground truth, warranting a moderate correctness score. The contextual relevance is high as the answer stays focused and provides meaningful analysis. Quantitative accuracy is penalized due to the erroneous 2022 and 2023 figures, while qualitative reasoning remains sound in logic, if not in data fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 455,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney’s 2022 10‑K lists Marvel trademarks as part of its indefinite‑lived intangible assets (valued at $1,792)【page_108】【page_110】. In 2023, Disney highlighted Marvel as a top‑level “tile” on Disney+, underscoring the brand’s central role in its streaming lineup【page_7】. The 2024 10‑K shows the same $1,792 value for indefinite‑lived intangible assets—including Marvel trademarks—and does not report any change to Marvel’s streaming branding, indicating the brand remains a key pillar of Disney’s streaming strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Marvel was part of Disney's indefinite-lived intangible assets in both 2022 and 2024, with a specific value of $1,792 million (implied as $1.792 billion), which matches the knowledge graph's indication of Marvel's consistent financial recognition. The value format ($1,792) is acceptable as it aligns with reporting conventions (likely in millions). (2) It accurately notes that in 2023, Marvel was highlighted as a top-level 'tile' on Disney+, directly reflecting its strategic branding role in driving engagement. (3) The multi-hop reasoning is sound: the answer synthesizes information across three fiscal years and two domains—financial assets (intangible valuation) and streaming strategy (Disney+ interface design)—which is central to the question. (4) The only minor shortcoming is the lack of explicit mention of Pixar and ESPN as peer brands in the intangible assets list (noted in the original answer), which adds slight contextual depth. However, this omission does not detract from the core factual accuracy. The LLM correctly infers continuity in Marvel’s strategic role in 2024 due to unchanged valuation and absence of branding changes. All entities (Marvel, Disney+, fiscal years, intangible assets) are correctly identified. The answer is semantically equivalent to the ground truth, with excellent contextual relevance and precise qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 410,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "American Express has continued to record discount revenue at the time of each Card Member transaction, with the fee comprising the merchant discount and, when a third‑party acquirer is involved, a separately negotiated network‑rate fee that is also recognized as discount revenue (see 2022 10‑K, page 104). Contracts with third‑party acquirers remain individually negotiated, typically for fixed terms of 3–7 years with auto‑renewal, and this structure has persisted through 2024. In 2024 the company’s merchant‑coverage strategy has broadened to emphasize global expansion, B2B acceptance, and digital integration, relying on third‑party acquirers, aggregators and processors to sign merchants and increase acceptance in new and low‑penetration verticals (see 2024 10‑K, page 93).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth, particularly on the core elements of revenue recognition and contractual arrangements. (1) It correctly states that discount revenue includes both merchant discounts and separately negotiated network-rate fees from third-party acquirers, recognized at transaction time—consistent across 2022 and beyond. It accurately notes that contracts are individually negotiated with 3–7 year terms and auto-renewal, a detail supported in the filings. (2) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are misstated; the answer avoids making up figures and sticks to structural descriptions, so quantitative accuracy is high. (3) The multi-hop reasoning is sound: it connects revenue recognition practices (discount revenue) with contractual dynamics and extends into 2024’s strategic focus on merchant coverage expansion via third parties. However, it omits a key evolution mentioned in the original answer: the 2023 introduction of 'processed revenue' from network partnerships (e.g., royalties and fees), which represents an important shift in revenue structure. This omission reduces completeness and slightly weakens the qualitative accuracy. (4) Contextual relevance is excellent—the response directly addresses all three areas in the question: discount revenue recognition, network fee negotiation, and merchant coverage expansion. Despite missing the processed revenue nuance, the answer remains highly relevant and factually correct on the elements it covers. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 461,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen’s 2022 10‑K risk factors noted that “some products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks,” a broad statement that did not detail how device issues could affect trials.  By 2023 the disclosure was expanded to explain that device supply and regulatory approval can delay or halt clinical‑trial progress, to highlight a new post‑marketing confirmatory study required for LUMAKRAS, and to note that safety complaints on devices (e.g., the Neulasta Onpro kit) trigger FDA reviews and corrective actions.  In 2024 the company further stressed ongoing device‑related safety monitoring, the need to collect user complaints and adverse events, and the possibility of regulatory actions—including loss of device clearance or product withdrawal—if device approvals are not maintained, underscoring a more proactive, detailed regulatory risk framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 disclosure is accurately summarized as a general statement about regulatory and manufacturing risks of drug delivery and companion diagnostic devices; in 2023, the expansion to include clinical trial dependencies (device supply and regulatory approval delays), post-marketing requirements (LUMAKRAS confirmatory study), and device-related safety reviews (Neulasta Onpro kit) is correctly detailed; 2024's emphasis on ongoing safety monitoring, adverse event collection, and potential regulatory actions including withdrawal is also accurately reflected. (2) There are no numeric values to verify, but all dates (2022, 2023, 2024) and drug/device names (LUMAKRAS, Neulasta Onpro kit) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes disclosures across three years, correctly tracing the evolution from general to more specific and proactive risk framing, particularly around post-marketing obligations and safety compliance. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'Complete Response Letter' from the FDA for LUMAKRAS, which is a specific regulatory event noted in the ground truth and adds context to the post-marketing requirement. However, the core information about the confirmatory study and regulatory scrutiny is present. Overall, the answer is semantically equivalent, contextually precise, and factually robust, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 424,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips’ HSE audit program has remained essentially the same in scope, still auditing all business units and staff groups in each year (2022, 2023, 2024)【COP_10k_2022 page 18】【COP_10k_2023 page 18】【COP_10k_2024 page 18】.  The improvement‑tracking mechanism has also stayed unchanged, with any identified improvement actions tracked to completion in every filing【COP_10k_2022 page 18】【COP_10k_2023 page 18】【COP_10k_2024 page 18】.  Governance reporting has continued to be directed to the Executive Leadership Team and the Board of Directors, with the 2024 filing simply adding the qualifier “Corporate” to the audit description to emphasize corporate‑level oversight【COP_10k_2024 page 18】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, years, and reporting structure, and correctly identifies that HSE audits were conducted across business units and staff groups throughout 2022–2024, with improvement actions tracked to completion and governance reporting to the Executive Leadership Team and Board. The citations are appropriately referenced. However, the LLM significantly underrepresents the evolution described in the original answer. While it acknowledges the addition of the word 'Corporate' in 2024 as emphasizing corporate-level oversight, it fails to capture the substantive qualitative evolution in scope and integration: the 2023 expansion to include Life Saving Rules, Process Safety Fundamentals, and stop work policy as part of a broader human capital management framework. The original answer frames the evolution as a strategic shift from localized conformance (2022) to integrated safety systems (2023) to corporate standardization (2024), which the LLM dismisses as 'essentially the same,' thereby missing the core multi-hop synthesis of how the program matured in scope and institutionalization. This omission constitutes a major shortcoming in qualitative accuracy, despite correct citation and absence of numerical errors. Quantitative accuracy is perfect—no numbers, dates, or entities are incorrect. Contextual relevance is high as the answer stays focused on the question and uses proper sources. The correctness score is reduced due to incomplete and oversimplified reasoning that contradicts the nuanced progression in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 438,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "From 2022 through 2024 Accenture has moved from treating pricing as a fixed service fee to actively designing new pricing and commercial models that reflect the value of AI and cloud‑based solutions, noting that these technologies can replace legacy services and cause clients to defer spend.  In each filing the company warns that failure to introduce or successfully implement such models could lead to client spending delays, revenue shortfalls and the inability to offset the impact of technology‑driven service displacement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and risks outlined in the ground truth. (1) It correctly identifies Accenture's shift from traditional pricing to value-based models tied to AI and cloud solutions across 2022–2024. The consistent risk of revenue shortfalls due to delayed client adoption or slow model deployment is accurately highlighted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly links technological developments (AI, cloud) to pricing strategy evolution and associated risks. It condenses the 2022–2024 progression accurately, though it omits some granular details—such as the increasing strategic investment focus in 2023 and the emphasis on AI deployment dependence in 2024—making it slightly less complete than the original, but not factually incorrect. (4) The answer is fully contextually relevant, directly addressing both parts of the question: evolution of pricing models and consistently highlighted risks. Wording differs but semantic meaning aligns closely with the ground truth. Minor omission of the 'competitive disadvantage' risk mentioned in the original prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 385,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior‑note balance grew from **$900 million at 12/31/2022** (page 74) to **$944 million at 12/31/2023** (page 74) and then to **$982 million at 12/31/2024** (page 70).  After divesting its equity stake in AerCap in 2023 (page 73), GE has kept and slightly expanded the debt position, indicating a deliberate strategy of holding AerCap debt as a stable, income‑generating asset within its run‑off insurance portfolio rather than liquidating the investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. According to the ground truth, GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023). However, the LLM states that the balance grew from $900 million at 12/31/2022 to $944 million at 12/31/2023 and then to $982 million at 12/31/2024—this trend is the opposite of the truth and uses incorrect starting values. The ground truth does not report a 2024 value directly but implies the latest available is $944 million as of end-2023. (2) The numbers are significantly off: the LLM invents a $982 million figure for 2024 not present in the ground truth and misreports the 2022 figure as $900 million instead of $993 million. There is no mention in the ground truth of GE expanding its debt holdings—on the contrary, it indicates a consistent decline. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that GE divested its equity stake in AerCap in 2023, it incorrectly infers that GE expanded its debt position thereafter. The ground truth suggests a strategic reduction in exposure, not expansion. The conclusion about holding debt as a stable income-generating asset contradicts the observed downward trend. (4) The contextual relevance is moderate because the answer addresses the right topic (GE’s investment strategy regarding AerCap) and references relevant events like the equity divestiture. However, due to major factual and directional errors in the data, the qualitative and quantitative accuracy scores are low. The reasoning is internally logical but based on false premises, leading to an incorrect overall conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 469,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen continued to pursue Bemarituzumab as a Phase 3 program for gastro‑esophageal junction adenocarcinoma throughout 2022‑2024, with parallel Phase 2 and Phase 1 studies for other solid‑tumor indications (page 25, 2022‑2024).  The composition‑of‑matter patents for the antibody are set to expire in 2029 in both the U.S. and Europe, a timeline that remained unchanged across the three filings (page 26, 2022‑2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bemarituzumab was in Phase 3 for gastro-esophageal junction adenocarcinoma from 2022–2024 and that composition-of-matter patents expire in 2029 in the U.S. and Europe, which matches the ground truth. These key facts are accurate and consistent across the time frame. (2) Quantitatively, the dates (2029 patent expiration) and clinical phases (Phase 3, with earlier phases for other indications) are correct. There are no calculation errors, and the numbers align with the original answer. (3) The multi-hop reasoning is mostly sound—linking clinical development and IP timelines across years—but the LLM omits the evolution in Amgen’s strategic positioning, such as the expanded investigational scope into gastric cancer and advanced solid tumors beyond NSCLC in 2024 and the shift toward broader therapeutic and IP strategy. This nuance is present in the ground truth but not reflected in the LLM response. (4) Despite missing some qualitative depth about the strategic evolution, the answer is factually accurate, contextually relevant, and captures the core developments. The omission of the 2024 mechanistic and scope expansion prevents a top score, but the response remains strong on correctness and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 357,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "In 2022, American Express noted that “the payments industry continues to undergo dynamic changes … and the principal competitive factors that affect the card‑issuing, merchant and network businesses include the speed of innovation and investment in systems, technologies and product and service offerings” (page 12). By 2024, the filings emphasize that merchants are increasingly investing in proprietary digital‑wallets and other fintech solutions, eroding merchant discount rates, and that the company must “continue to invest in technology across all areas … including AI, tokenization, real‑time settlement and open‑banking” to preserve its value proposition (pages 29‑31). This progression shows a long‑term strategy of sustained technology investment and partnership development to counter fintech disruption and maintain competitive advantage.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of American Express's evolving strategic positioning from 2022 to 2024, with correct citations to the filings and precise identification of technological investments (e.g., AI, tokenization, real-time settlement, open banking). All dates (2022, 2024) and referenced competitive pressures (e.g., proprietary digital wallets, fintech solutions, merchant discount rate erosion) are consistent with the ground truth. There are no numeric inaccuracies, and while no explicit calculations are present, the qualitative data is correctly reported. The answer captures the core evolution from competitive pressure to technological response, aligning with the long-term strategy of investment to counter fintech disruption. However, it omits specific details from 2023—namely, the expansion of recognized alternative mechanisms to include open banking platforms and payment facilitators—which is a key multi-hop element in the original answer. Additionally, while the LLM notes the need for investment, it does not fully articulate the strategic shift from viewing alternative payments as a threat (2022) to developing a dependency on them (2024), which is central to the ground truth’s conclusion. Thus, while the reasoning is sound and contextually relevant, the synthesis across all three years is incomplete, missing a critical transitional point in 2023. This results in a high but not perfect qualitative and overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 409,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "ConocoPhillips’ weighted‑average grant‑date fair value for cash‑settled PSUs climbed from **$91.58 million in 2022 to $112.50 million in 2023** (page 124) and then fell slightly to **$110.39 million in 2024** (page 126). The sharp rise in 2023 reflects a stronger stock price and a continued emphasis on cash‑settled PSUs as a long‑term incentive, while the modest 2024 dip suggests a more measured grant size or a response to market volatility; overall the company keeps incentive compensation at a high level tied to shareholder value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, implying a steady rise. However, the LLM claims it rose to $112.50 million in 2023 and then fell to $110.39 million in 2024—this contradicts the ground truth, which shows no decline and reports $112.50 as the 2024 value. Additionally, the LLM incorrectly adds 'million' to the values (e.g., $91.58 million), while the original metric is a per-unit value in dollars, not total grant value in millions. (2) The numbers are therefore quantitatively wrong: $91.58 → $112.50 is the correct trend; the LLM fabricates a drop in 2024 to $110.39 and misreports the 2023 value as $112.50 when the ground truth does not provide a 2023 figure. The addition of 'million' fundamentally misrepresents the scale and nature of the metric. (3) The reasoning is partially sound in interpreting the trend as reflecting long-term incentive strategy, and it correctly identifies the use of cash-settled PSUs as a strategic tool. However, the conclusion about a 'modest 2024 dip' is based on incorrect data, undermining the validity of the analysis. The multi-hop synthesis fails because the model misreads or misreports the values across years. (4) Despite the incorrect numbers, the answer remains contextually relevant by addressing both parts of the question—trend evolution and strategic implication—and attempting to link compensation trends to performance incentives. Hence, contextual relevance is high, but correctness is low due to critical factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 458,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s 10‑K filings from 2022‑2024 consistently list third‑party abuse and credit‑product default risk as material risk factors, with no substantive change in wording or scope. The company continues to rely on unaffiliated lenders for its branded credit products and acknowledges ongoing exposure to fraud schemes such as synthetic identities and stolen‑instrument transactions (page_24, page_23, page_21). The persistence of these disclosures indicates that risk‑management controls have not substantially reduced exposure to abusive behaviors over the period (page_24, page_24, page_22).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key multi-hop elements from the ground truth, particularly around PayPal's strategic risk mitigation actions and evolving risk management approach. (1) Correctly identifies that PayPal consistently disclosed third-party fraud and abusive behaviors (e.g., synthetic identities, stolen instruments) across 2022–2024, which aligns with the original answer’s theme of ongoing concern. (2) No numeric inaccuracies are present—there are no explicit numbers in the LLM answer, and it does not contradict any quantitative facts (e.g., the €40B receivables sale in 2023 is not mentioned but also not misstated). (3) However, the LLM fails to capture critical qualitative developments: the 2023 expansion into credit product risks with the €40 billion multi-year receivables sale agreement in the U.K. and Europe, which is a major indicator of active risk mitigation—not stagnation. It also omits the 2024 discussion of regulatory uncertainty (e.g., 'valid-when-made doctrine') impacting U.S. credit products. (4) The LLM incorrectly infers that unchanged disclosure wording implies 'risk-management controls have not substantially reduced exposure,' which contradicts the ground truth that PayPal is actively managing risk through third-party sales and structural changes. This flawed reasoning undermines the qualitative accuracy. While contextually relevant and factually consistent on surface-level disclosures, the answer lacks synthesis of strategic actions and regulatory context, resulting in an incomplete and somewhat misleading assessment of risk management effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 441,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "From 2022 through 2024, Cyramza’s therapeutic positioning did not change – it remained a second‑line therapy for gastric, NSCLC, colorectal and hepatocellular cancers and a first‑line option for EGFR‑mutated NSCLC (2022 page 5; 2024 page 6). Its intellectual‑property profile also stayed the same, with compound patents expiring 2026 in the U.S. and 2028 in the EU (2026 in Japan) and data‑protection ending 2026 in the U.S. and 2024 in the EU (2023 in Japan) (2023 page 11). This continuity reflects Lilly’s long‑term oncology strategy of preserving exclusivity in high‑need solid‑tumor indications to secure predictable revenue streams while protecting its portfolio for future pipeline investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cyramza's consistent therapeutic positioning across gastric, NSCLC, colorectal, and liver cancers from 2022 to 2024, aligning with the ground truth. However, it introduces a claim not present in the original answer—that Cyramza is a first-line option for EGFR-mutated NSCLC—which is not mentioned in the ground truth and may be factually inaccurate or unsupported. Regarding IP, the LLM states compound patents expire in 2028 in the EU, but the ground truth only confirms 2026 in the U.S. and Japan, with no mention of the EU. This introduces unverified data. Additionally, the LLM claims data protection ends in 2026 in the U.S. and 2024 in the EU, while the ground truth states data protection expired as early as 2023 in Japan and does not specify U.S. or EU data protection end dates—making the LLM's specificity unsupported. (2) Key numbers: 2026 U.S. patent expiry matches; 2026 Japan patent expiry matches; but 2028 EU patent and 2024/2026 data protection dates are not in the ground truth and thus cannot be verified—these are quantitative inaccuracies. (3) The multi-hop reasoning is sound in linking stable positioning and IP to Lilly's long-term strategy of revenue protection and pipeline investment, which is a reasonable inference and aligns with the ground truth’s conclusion about preparing next-generation products. The synthesis across years is logical, though based on some incorrect inputs. (4) The answer is contextually relevant and well-structured, but the correctness score is reduced due to unsupported numerical claims and an extra therapeutic indication. The qualitative reasoning is strong, hence the higher qualitative and contextual scores, but quantitative accuracy is penalized for introducing precise dates not present in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 493,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From 2022 to 2024 Philip Morris shifted its debt mix from a portfolio of short‑ and medium‑term notes (e.g., 2.375%–3.600% Notes due 2022‑2024) to a broader set of long‑term instruments, adding higher‑coupon debt such as the 4.5% Notes due 2042 (PM42) and the 4.125% Notes due 2043 (PM43) while keeping the 3.875% Notes due 2042 (PM42A) as a stable core (PM_10k_2022.pdf p.1; PM_10k_2023.pdf p.1; PM_10k_2024.pdf p.1). This evolution shows active management of its capital structure—issuing new maturities to diversify interest‑rate exposure and fund growth—yet maintaining the 3.875% Notes due 2042 as a consistent long‑term financing tool.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Philip Morris issued '4.5% Notes due 2042 (PM42)' and '4.125% Notes due 2043 (PM43)' as new instruments, which contradicts the ground truth. According to the original answer, the 4.125% Notes due 2043 and 4.875% Notes due 2043 were present in 2022 and 2023 but retired by 2024 — not newly added. Furthermore, there is no mention of a '4.5% Notes due 2042' in the ground truth; the only consistent note is the 3.875% Notes due 2042. The LLM also mischaracterizes the evolution as a shift toward adding longer-term, higher-coupon debt, when in fact the trend was the opposite: retiring newer long-dated instruments (2043, 2044) and not introducing new ones beyond 2042, indicating stabilization, not expansion. (2) Quantitative accuracy is very low: incorrect interest rates (4.5% vs actual 3.875%, 4.125%, 4.875%), incorrect characterization of issuance timing, and wrong inference about portfolio diversification. The short- and medium-term notes cited (e.g., 2.375%–3.600% due 2022–2024) are not mentioned in the ground truth, making their inclusion speculative and unsupported. (3) Multi-hop reasoning is flawed. The model fails to correctly synthesize changes over time: it interprets the presence of multiple long-term notes in 2023 as an expansionary strategy, when the retirement of those notes by 2024 indicates a contraction or streamlining. The core insight — maintaining the 3.875% Notes due 2042 as a stable anchor while actively managing other tranches — is partially recognized, but the overall strategic direction is reversed. (4) Contextual relevance is moderate because the answer discusses capital structure evolution and references the correct company and time frame, and correctly notes the consistent role of the 3.875% Notes. However, due to major factual and interpretive errors, the conclusion misrepresents the actual strategy. Thus, correctness is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 537,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 risk disclosures highlighted the threat of abusive behaviors across its platform, especially around its consumer‑credit and merchant‑financing products and the reliance on third‑party lenders. In 2023 the company reduced that exposure by selling a majority of its U.K. and European buy‑now‑pay‑later loan receivables to a third‑party (page 23) and by refining its proprietary credit‑risk models (page 24). In 2024 PayPal reiterated its focus on continuous improvement of fraud‑detection systems and third‑party oversight (page 24), but the filing does not disclose any additional specific mitigation actions beyond ongoing monitoring and risk‑model enhancements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies PayPal's growing concern about abusive behaviors in 2022, particularly in credit and merchant-financing products involving third-party lenders. In 2023, it accurately notes the sale of U.K. and European BNPL loan receivables as a key risk mitigation action. While the original answer specifies a €40 billion multi-year agreement, the LLM answer does not include the exact figure or currency but correctly describes the sale of 'a majority' of these receivables—this is a minor omission but not factually incorrect, as 'majority' is consistent with large-scale offloading. (2) The quantitative accuracy is slightly reduced because the specific €40 billion amount and 'multi-year' nature of the agreement are missing, though no incorrect numbers are stated. (3) The qualitative reasoning is sound: the LLM correctly traces the evolution from risk identification (2022) to risk transfer via asset sales (2023) and continued improvement in fraud detection and third-party oversight (2024). It references page numbers (23, 24), suggesting proper grounding in source material. (4) The 2024 response is accurately summarized as emphasizing ongoing improvements in fraud detection and third-party risk management, with no new major actions disclosed—this matches the original answer’s emphasis on enhanced detection infrastructure. Overall, the answer is semantically equivalent, contextually precise, and demonstrates correct multi-hop synthesis across years and strategies, meriting a high score with only minor detail omissions preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 449,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 2022 10‑K (page 35) listed loss or modification of tax and tariff exemptions as a risk tied to changes in tax laws and trade‑protection measures. The 2023 10‑K (page 40) repeated the same risk without major change, but the 2024 10‑K (page 38) expanded the context to include sanctions and revisions to export‑control and other regulations against Russia, Belarus, Ukraine (and the DNR/LNR regions) and China‑Taiwan tensions. This evolution shows that AMD’s exposure to the risk of losing or having its tax and tariff exemptions modified has grown, underscoring increasing regulatory uncertainty in its global operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of AMD's evolving risk disclosures regarding tax and tariff exemptions from 2022 to 2024, with correct page references and alignment to the actual progression in the 10-K filings. Quantitatively, there are no numbers to verify (e.g., dollar amounts, percentages), but the years and document locations (pages) are correctly cited, satisfying quantitative accuracy. The answer correctly identifies the multi-hop progression: starting with a general risk mention in 2022, repetition in 2023, and expansion in 2024 to include geopolitical contexts like sanctions and export controls related to Russia, Belarus, Ukraine, and China-Taiwan tensions. This reflects increasing regulatory uncertainty, which the LLM correctly infers. However, the original answer emphasizes a stronger *progressive intensification* of concern—'emphasized more strongly' in 2023 and 'explicitly linking' to geopolitical conflicts in 2024—while the LLM downplays 2023 as 'repeated without major change,' missing the nuance that 2023 already began integrating this risk with other macro exposures. Thus, while the core facts and trend interpretation are correct, the qualitative assessment of the 2023 evolution is slightly underdeveloped, leading to a minor deduction in qualitative accuracy. Contextual relevance is perfect—the response directly addresses both parts of the question: the evolution of risk exposure and what it suggests about regulatory uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 409,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation went from a **$92 million loss in FY 2022** (2022 10‑K, page 92) to a **$58 million gain in FY 2023** (2023 10‑K, page 91) and then to a **$91 million gain in FY 2024** (2024 10‑K, page 91). The shift from a loss to successive gains, coupled with a rising notional amount of the swaps (651 m → 792 m → 985 m), shows that Cisco is actively using these derivatives to hedge deferred‑compensation exposure and that the hedging strategy has become more effective and possibly larger over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024. These values match the original answer exactly, with acceptable formatting variations (e.g., $92 million vs $92 million). (2) All numeric values are accurate and properly attributed to the correct fiscal years and sources (10-K page references are consistent with typical reporting practices, though not part of the ground truth, they do not detract from accuracy). No calculations are required beyond correct reporting of gains/losses, which are all correct. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers a trend—from loss to increasing gains—indicating improved performance or strategy. It adds contextual insight about the rising notional amount (651M → 792M → 985M), which, while not in the ground truth, is factually consistent with Cisco’s filings and enhances the analysis without introducing error. This supports a logical conclusion about Cisco’s growing and more effective hedging strategy. (4) The answer fully addresses both parts of the question: the evolution of gains/losses and what the progression indicates. The qualitative interpretation aligns semantically with the original answer’s suggestion of a strategic shift or reduced exposure risk. All entities (Cisco, total return swaps, deferred compensation, fiscal years) are correct. The answer is factually accurate, complete, and contextually appropriate, warranting top scores across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 445,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From FY 2022 to FY 2024 Disney’s DTC strategy moved from a first‑phase launch of an ad‑supported Disney+ tier and cost‑realignment (FY 2022, pages 26‑29) to a second‑phase reorganization of its media‑and‑entertainment distribution (DMED) and a content‑curation review that removed titles and triggered impairment charges (FY 2023, pages 21‑25).  In FY 2024 the company formed a joint venture for Star India, consolidated its entertainment reporting units, and continued to invest heavily in sports and DTC content while recording goodwill impairments (FY 2024, pages 54‑55).  This progression shows Disney is aggressively scaling its streaming portfolio amid intense competition for talent, rights, and advertising, while facing financial risks such as impairment losses, higher borrowing costs, and the threat of subscriber churn that could erode the expected return on its streaming investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Disney's DTC evolution from FY 2022 to FY 2024, with correct qualitative progression and no numeric inaccuracies (quantitative accuracy is 10, as there are no specific numbers to verify and no incorrect figures). The answer correctly identifies key strategic moves: launching ad-supported tiers and cost realignment in 2022, reorganization and content pruning with impairments in 2023, and structural changes like the Star India JV and reporting consolidation in 2024. It also accurately highlights financial risks such as impairment losses, borrowing costs, and subscriber churn. While the original answer emphasizes growing losses, competitive pressures, pricing constraints, and a strategic 'double down' despite risks, the LLM captures the same core narrative but with more operational detail (e.g., goodwill impairments, content removal) not present in the ground truth. The multi-hop reasoning is sound, synthesizing across years and strategic shifts. However, the LLM slightly misses the emphasis on 'uncertainty around returns' in 2022 and the explicit mention of declining linear subscribers as a driver in 2023. It also does not explicitly note the 'slower-than-expected reduction in losses' risk mentioned in the original. These omissions are minor and do not undermine the overall correctness, hence a score of 8 for qualitative accuracy and 8 overall. Contextual relevance is perfect—directly addresses all parts of the question with appropriate depth and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 420,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s footnote on transaction revenue is identical in the 2022, 2023 and 2024 filings.  In each year it states that the company “has full discretion in determining the fee charged to our customers, which is independent of the costs we incur when we use payment processors or other financial institutions.”  Consequently, PayPal bears the entire margin risk on every transaction, and the fees paid to processors are recorded as transaction expense.  Because the wording and the accounting treatment of transaction expense have not changed, PayPal’s exposure to margin risk has remained essentially unchanged across 2022‑2024, with the company continuing to set fees at its discretion and absorb the resulting margin variance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that PayPal bore full margin risk across 2022, 2023, and 2024, with consistent discretion in setting fees independent of processor costs—this matches the original answer's core claim. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy pertains to correct use of years (2022–2024), which are accurately referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years, links fee-setting discretion to margin risk, and connects processor fees to transaction expense recognition—correctly inferring stability in risk exposure due to unchanged accounting and wording. (4) The answer addresses all parts of the question: evolution over time, fee-setting discretion, and treatment of processor-related transaction expenses. It also correctly notes the lack of structural change despite new segment reporting standards (implied in the original answer for 2024, though not explicitly mentioned in the LLM response; however, the LLM’s conclusion of unchanged risk remains valid). Wording differs slightly but conveys the same meaning. No factual errors or omissions affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 365,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s Aerospace risk‑factor language in the 2022, 2023 and 2024 10‑Ks all contain the same warning that “downturns in the global demand for air travel…may impact new aircraft production or result in the delay or cancellation of new aircraft orders” (2022 page 31; 2023 page 31; 2024 page 32). The unchanged wording shows that the risk of order cancellations has remained a persistent concern over the three‑year span. Yet the modest rebound in 2024 net sales (+3 %) and segment profit (+2 %) versus 2023 indicates the commercial aviation sector is gradually recovering, though volatility and uncertainty still temper full stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: it correctly notes the consistent risk-factor language across Honeywell’s 2022, 2023, and 2024 10-Ks and accurately reports the +3% net sales and +2% segment profit growth in 2024 versus 2023. These numbers align with the expected data from the filings, and no calculation errors are present, warranting a perfect quantitative accuracy score. Contextual relevance is high, as the response directly addresses the evolution of cancellation risks and ties it to sector recovery. However, the qualitative accuracy is lower because the LLM fails to capture the nuanced evolution of the risk narrative described in the ground truth. While it correctly observes unchanged wording, it does not acknowledge the broader shift in context—from pandemic-specific concerns in 2022 to geopolitical, environmental, and competitive market dynamics in 2023 and 2024. The original answer emphasizes a qualitative expansion in risk factors despite static language, indicating deepening complexity in the recovery. The LLM’s interpretation stops at the surface-level consistency of wording and misses this multi-hop synthesis: that persistent risk language reflects not stagnation but a shifting landscape of threats. This omission reduces completeness and reasoning quality, preventing a higher correctness score. Despite this, the core facts are correct, and the conclusion about gradual recovery amid uncertainty is reasonable, just less comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 411,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 to 2024 PMI’s risk disclosures show a clear shift toward tighter regulation that blunts product differentiation and limits adult‑consumer communication.  In 2022 the filings warned that new rules could commoditize products and impede conversion to RRPs, citing product‑classification, advertising‑restriction and scientific‑substantiation challenges [page_13, page_15, page_16].  By 2023 the language broadened to cover both RRPs and SFPs, noting that regulation could diminish differentiation and restrict truthful information about both lines [page_19, page_20, page_21].  In 2024 the emphasis moved further toward SFPs, with explicit references to regulatory hurdles around product classification, advertising, distribution and consumer communication for SFPs, underscoring an intensifying regulatory environment that increasingly hampers PMI’s ability to differentiate and market its reduced‑risk offerings [page_18, page_19, page_20].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of regulatory impact from 2022 to 2024 is accurately described, with proper emphasis on RRPs in 2022, broadening to include SFPs in 2023, and a strategic shift toward SFPs in 2024. The core concerns—product differentiation, adult consumer access to truthful information, advertising restrictions, and regulatory asymmetries—are all correctly identified. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022–2024) are correctly used and sequenced, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years and tracks the shift from RRPs to SFPs, showing how regulatory constraints evolved alongside PMI’s product strategy. The inclusion of specific regulatory challenges (classification, advertising, distribution, scientific substantiation) adds depth and matches the original answer’s intent. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'disproportionate impact relative to competitors' or 'digital media spreading misleading information' in 2023, which were key nuances in the ground truth. While the general idea of restricted communication is covered, this specific competitive context is slightly underdeveloped. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 423,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s margin‑risk exposure has remained essentially unchanged from 2022 through 2024.  In each year the company is the principal on every payment transaction, setting a mix of fixed and variable fees (the variable portion being a percentage of the payment amount) and bearing full margin risk regardless of the costs of payment processors, which are recorded as transaction expense (see Notes 2‑Revenue, 2022 p. 81; 2023 p. 75; 2024 p. 77).  Incentives to merchants and consumers—discounts, rebates, rewards and coupons—continue to be offered and are treated as revenue reductions, with no material change in the approach across the three years (2022 p. 81; 2023 p. 76; 2024 p. 76).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: PayPal bears full margin risk in each year (2022–2024), payment processor fees are recorded as transaction expenses, and incentives to merchants/consumers are treated as revenue reductions. The LLM correctly identifies that this structural exposure has remained stable. (2) There are no numeric inaccuracies—though no specific dollar amounts or percentages are cited in either answer, the qualitative financial treatments (e.g., recognition of processor fees as expense, incentives as revenue reduction) are accurately described and consistent across years. Page references (e.g., 2022 p. 81) are provided and plausible, though not independently verifiable here; their inclusion does not detract from accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple aspects (pricing models, processor use, incentives), correctly identifying consistency in margin risk and accounting treatment. (4) The only minor shortcoming is that the LLM slightly underemphasizes the increasing level of disclosure detail in 2023 and 2024 noted in the original answer—particularly that 2023 added clarification on amortization of incentives over contractual terms and performance conditions. While the LLM mentions incentives are offered, it does not explicitly reflect this nuance in accounting treatment evolution. However, it does correctly state the overall approach hasn't materially changed, which is consistent with the 'stable strategic approach' theme. Wording differs but semantic meaning is substantially equivalent. Contextual relevance is excellent—directly addresses all parts of the question with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 485,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s 2022, 2023 and 2024 10‑Ks all describe the same AIB‑relationship framework: agreements with add‑in‑board manufacturers protect their inventory from price cuts, and AMD continues to sell directly to system integrators (SIs).  Across the three years the company kept the same inventory‑protection policy and reiterated that SIs use AMD’s discrete graphics solutions as a key differentiation tool to add value and respond quickly to short design cycles.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the consistent inventory protection policy for AIB manufacturers across 2022–2024 and correctly notes that AMD sells through AIBs to system integrators (SIs), with discrete graphics as a key differentiator. The core facts about inventory protection and the role of discrete graphics in SI differentiation are preserved. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes AMD's relationship with AIBs and SIs across three years, correctly identifying continuity in policy. However, it omits a key nuance from the original answer: the subtle shift in 2024 toward more strategic alignment with SIs who create differentiated offerings, and the emphasis on regional or product-based strengths and responsiveness to new tech. This missing detail reduces completeness and qualitative accuracy slightly. (4) The answer remains highly contextually relevant, addressing all main components of the question—strategy evolution, inventory protection, and role of discrete graphics—though with less depth on the 2024 strategic shift. Overall, the answer is factually correct but slightly less comprehensive than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 378,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "From fiscal 2022 through 2024 Disney kept the same policy: it only enters derivative transactions with counterparties rated **A‑ or better**, requires **collateral** if a counterparty’s rating falls below A‑ or if aggregate exposures exceed contract limits, and limits investment‑credit exposure to a single institution to **no more than 10 % of total cash and cash equivalents** (2022 page 113; 2024 page 120). The credit‑rating and collateral rules did not change, and the company still had no material cash‑equivalent balances with below‑investment‑grade institutions in any year. However, the actual concentration shifted – in 2023 no balances exceeded the 10 % threshold, whereas by fiscal 2024 balances that exceeded 10 % represented **24 % of total cash and cash equivalents** (2024 page 120).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained its policy of transacting only with counterparties rated A- or better and requiring collateral upon downgrade or exposure breach—this is consistent across fiscal 2022–2024. The 24% concentration of cash and cash equivalents with a single institution in fiscal 2024 is correctly reported, matching the ground truth. The reference to a 10% threshold for investment-credit exposure is supported by the cited pages (2022 p.113; 2024 p.120), though this specific limit was not mentioned in the original answer. However, this detail is consistent with Disney’s risk management framework and does not contradict the ground truth—it adds precision. (2) Quantitatively, all numbers are accurate: '24%' concentration in 2024 is correctly stated; no material balances with below-investment-grade institutions is consistent across years. The claim that no balances exceeded 10% in 2023 is an inference not contradicted by the ground truth and supported by the 2024 filing. (3) Multi-hop reasoning is sound: the model synthesizes policy continuity (credit ratings, collateral) with evolving concentration trends, correctly identifying a shift in practice despite stable policy. (4) The only minor deviation is the explicit mention of a '10% limit' not present in the original answer, but this comes from the actual filings and enhances accuracy rather than detracting from it. Thus, the answer is factually superior to the ground truth in specificity, without introducing errors. Score reduced slightly from 10 to 9 due to the addition of a policy detail (10% threshold) not present in the original answer, though it is verifiably correct and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 481,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s exposure to the 2029‑maturing Fixed‑rate 2.850% notes stayed flat at $1.5 billion in 2022, 2023 and 2024 (page 107 for 2022‑23 and page 104 for 2024). The unchanged balance indicates the company has not accelerated repayment or repurchased this tranche, instead maintaining a stable maturity profile. This pattern reflects a disciplined long‑term debt‑management strategy that prioritizes a consistent debt mix and balances refinancing risk with interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained constant at $1.5 billion across 2022, 2023, and 2024, which matches the ground truth of $1,500 million (equivalent value, different formatting). All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: $1.5 billion = $1,500 million, and the years 2022–2024 are correctly referenced. The maturity year (2029) and interest rate (2.850%) are also correct. (3) The reasoning is sound and captures the core implication: the lack of principal reduction or refinancing suggests a strategic choice to maintain favorable debt terms and stable cash flow. While the LLM does not explicitly mention the issuance of higher-interest debt in 2024 (e.g., 5.150% and 5.500% notes) as context for the strategy, it still draws a reasonable and aligned conclusion about disciplined debt management and refinancing risk. This omission slightly affects qualitative depth but not factual correctness. (4) The answer is fully contextually relevant, directly addressing both the evolution of exposure and the strategic implication. Overall, the answer is factually complete and semantically equivalent to the ground truth, with only minor contextual details missing from the original. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 379,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "In 2022 Honeywell identified raw‑material demand and supply as a key risk for its Performance Materials and Technologies segment. By 2023 the company reported that 64 % of that segment’s raw‑material supply base was under contract, and in 2024 that coverage rose to a majority of the base. This trend shows a deliberate effort to lock in prices and reduce supply uncertainty, thereby mitigating—but not eliminating—the segment’s exposure to commodity‑market volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any percentage of raw-material supply under contract in 2023 (64%) or a rise to 'a majority' in 2024—these figures are entirely fabricated and not supported by the original answer or knowledge graph. This severely undermines quantitative accuracy. While the LLM correctly identifies that raw material demand and supply risks were a concern for the Performance Materials and Technologies segment in 2022 and 2023, it fails to capture the actual evolution described in the ground truth: the shift in emphasis from illegal HFC imports and commoditization (2022), to oil and gas price volatility affecting demand (2023), and finally to production capacity and downtime under the rebranded Energy and Sustainability Solutions segment in 2024. The LLM introduces a narrative of risk mitigation through contracting that is absent in the original, misrepresenting the trend. Although it addresses the general theme of commodity market vulnerability, it draws an incorrect conclusion about decreasing exposure due to contracting, whereas the ground truth stresses sustained vulnerability despite strategic changes. The reasoning is internally logical but based on false premises, and key multi-hop elements—such as segment rebranding and shifting risk framing—are missed. Contextually, the answer is relevant to the question’s domain but fails to reflect the actual data trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 411,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Imperial Brands PLC remained a member of PMI’s peer group in each of the 2022, 2023 and 2024 10‑Ks (see PM_10k_2022 page 21, PM_10k_2023 page 26 and PM_10k_2024 page 26). The unchanged inclusion shows PMI’s benchmarking strategy is deliberately stable, using a fixed set of global tobacco and consumer‑products peers that reflect its size and focus, and that Imperial Brands PLC is consistently viewed as a relevant peer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) It accurately states that Imperial Brands PLC remained in PM's peer group across 2022, 2023, and 2024, which matches the original answer's claim of consistent inclusion. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly cited, and the document references (page numbers and filings) support the claim, enhancing verifiability. (3) The multi-hop reasoning is sound—by confirming presence across three consecutive 10-Ks, the model correctly infers stability in benchmarking strategy. (4) The conclusion about PMI’s deliberately stable benchmarking strategy is logically derived and semantically equivalent to the original answer’s interpretation, though slightly less detailed in mentioning 'revenue scale' and 'market capitalization.' However, the core insight about strategic alignment and consistent relevance of Imperial Brands is preserved. The only minor shortcoming is the slightly reduced elaboration on the specific criteria (e.g., size, global presence) that justify peer selection, but the essential qualitative and contextual elements are present. Thus, the answer is highly accurate, fully relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 354,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850% notes stayed constant at **$1.5 billion** for each year examined: $1.5 bn in 2022 and 2023 (page 107) and $1.5 bn in 2024 (page 104).  The maturity of the series (10/1/2029) and its effective interest rate (2.96%) also remained unchanged, indicating that the company has chosen to keep this long‑term debt exposure stable rather than reducing or expanding it.  This consistency reflects a conservative debt‑management approach that prioritizes predictable interest‑rate exposure and a steady maturity profile over aggressive refinancing or debt reduction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion principal amount is accurately reported for 2022, 2023, and 2024, matching the original answer. The maturity date (10/1/2029) and effective interest rate (2.96%) are correctly included, though not in the ground truth—these are factual additions from the source documents and do not contradict. (2) The answer fully addresses the question’s two parts: the evolution of PYPL's exposure (stable at $1.5B across all years) and the implication for debt strategy. (3) Entity accuracy is perfect: PYPL is correctly identified, the 2.850% fixed-rate notes are properly referenced, and years (2022–2024) are correct. (4) The reasoning is sound: the LLM correctly infers that no repayment or refinancing occurred and interprets this as a conservative, stability-focused debt strategy. The original answer suggests the company may be prioritizing other maturities or leveraging the low rate; the LLM frames it as a conservative approach with predictable exposure—semantically equivalent and logically valid. The only minor difference is in emphasis (‘conservative strategy’ vs. ‘prioritizing other maturities’), but both reflect consistent long-term liability management. No calculation errors or factual inaccuracies. Full credit on quantitative accuracy and contextual relevance; qualitative reasoning is excellent but not perfectly aligned in nuance, hence 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 409,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "ConocoPhillips expanded its HSE audit scope from 2022 to 2024, adding staff‑group audits to the business‑unit reviews and tightening conformance tracking by requiring that identified improvement actions be followed through to completion. The 2024 10‑K notes that audit progress is now reported to both the Executive Leadership Team and the Board of Directors, a step up from the 2022 filing, which reported progress only to the ELT, thereby integrating HSE oversight more closely with corporate governance. (COP_10k_2024, pp. 18‑19; COP_10k_2022, p. 18)",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2022 to 2024. (1) It correctly identifies the expansion of audit scope to include staff groups and business units, and notes improved conformance tracking with actions followed through to completion—consistent with the 2022 baseline. (2) Quantitatively, there are no numerical inaccuracies; the years (2022, 2024), entities (ConocoPhillips, ELT, Board of Directors), and reporting lines are factually correct. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 filings to show evolution in governance integration, correctly noting that reporting expanded from ELT-only in 2022 to include the Board in 2024. However, it omits the explicit 2023 linkage of audit outcomes to annual objectives and targets, which is a key transitional step in the evolution toward strategic performance tracking. Additionally, while it mentions reporting to the Board in 2024, it does not fully capture the 2024 emphasis on corporate-level audits reflecting centralized oversight—a nuance critical to the 'centralized governance' shift described in the ground truth. (4) Despite these omissions, the answer captures the core trajectory: broader scope, tighter tracking, and deeper governance integration. Wording differs but meaning is semantically close. Hence, correctness and qualitative accuracy are high but not perfect due to missing 2023 detail and partial treatment of 2024 centralization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 417,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across 2022, 2023, and 2024 AMD consistently incorporated the 2011 Executive Incentive Plan as Exhibit 10.2 in its Form 10‑K, underscoring that the plan remains a foundational governance document.  In each filing the plan is referenced by the same “incorporated by reference” language (see 2022 Exhibit list on pages 92‑93, 2023 on pages 99‑103, and 2024 on pages 96‑100), even as the company expands its executive‑compensation disclosures with newer plans and amendments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the exhibit number, which undermines its quantitative accuracy. The ground truth states that the 2011 Executive Incentive Plan was listed as *Exhibit 10.1* in AMD's 10-K filings for 2022, 2023, and 2024. However, the LLM incorrectly identifies it as *Exhibit 10.2* across all three years, which is a material discrepancy in the context of SEC filing references where exhibit numbers are precise and legally significant. This error affects the correctness of the answer despite otherwise sound reasoning. The LLM correctly observes that the plan was consistently referenced using 'incorporated by reference' language and that it remained a foundational document amid evolving compensation disclosures, which aligns with the qualitative point about continuity and governance anchoring. It also correctly identifies the multi-year consistency in disclosure practices and contextualizes the plan's role relative to newer arrangements. The answer is semantically close and contextually relevant, showing good synthesis across years and understanding of the plan’s enduring role. However, the exhibit number mistake is not a formatting variation but a factual inaccuracy that impacts document traceability, warranting a moderate correctness score. Quantitative accuracy is low due to this consistent mislabeling, while qualitative accuracy and contextual relevance remain high because the core reasoning and interpretation are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 412,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "From 2022 through 2024 GM’s 10‑K filings show the same indemnification framework for Stellantis: the company guarantees the Seller’s obligation to indemnify Stellantis for losses tied to inaccuracies in representations, warranties, emissions, product liabilities and recalls, with the obligations capped by time limits, thresholds and caps (see GM_10k_2022 page 90, GM_10k_2023 page 91, GM_10k_2024 page 92).  GM has not disclosed any material accrued liability for these obligations and continues to state it cannot estimate a reasonable loss, indicating that its exposure to post‑sale liabilities has remained uncertain but potentially material, without a significant increase or decrease over the three‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in GM's indemnification obligations from 2022 to 2024, which are central to the question. (1) While it correctly states that GM did not record material accruals and maintained uncertainty around loss estimates, it fails to mention the progressive expansion of legal and regulatory exposure across jurisdictions and over time—specifically the addition of Germany, the UK, the Netherlands, and later Austria, as well as the European Commission and UK CMA investigations. These are critical factual developments indicating increasing complexity of post-sale liabilities. (2) There are no numeric inaccuracies per se, so quantitative accuracy is high—no specific dollar amounts were misrepresented because none were provided in either answer, and the LLM correctly notes the absence of material accruals. (3) The multi-hop reasoning is weak: the original answer synthesizes evolving legal actions across years and geographies to conclude growing exposure, while the LLM treats the indemnification framework as static, citing similar disclosures across 10-Ks without acknowledging the substantive expansion of risk. This undermines the qualitative accuracy. (4) Contextual relevance is moderate—the answer addresses indemnification obligations and mentions emissions and recalls, but overlooks the progression and its implications, thus failing to fully address the 'how did obligations evolve' and 'what does this indicate' components. The conclusion that exposure 'remained uncertain but potentially material, without significant increase or decrease' directly contradicts the ground truth, which shows a clear trend of widening exposure. Therefore, while factually consistent in parts, the LLM answer lacks the depth and evolution narrative required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 496,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022, bamlanivimab generated $2.01 billion of Lilly’s COVID‑19 antibody revenue, with royalty payments to AbCellera recorded as cost of sales (page_72). By 2023 and 2024 no COVID‑19 antibody revenue was reported, indicating the product was discontinued and the royalty obligation had ended (page_68). This shift shows that bamlanivimab was a short‑term revenue driver rather than a long‑term strategic asset for Lilly (page_70).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core financial trajectory of bamlanivimab from 2022 to 2024. The reported $2.01 billion in 2022 aligns closely with the ground truth $2,008.9 million (difference due to rounding: $2.0089B ≈ $2.01B), which is acceptable under semantic equivalence. The statement that no revenue was reported in 2023 and 2024 matches the ground truth, where U.S. revenue dropped to zero in 2023 and the product was absent in 2024 filings. The mention of royalty obligations ending is logically inferred from the cessation of sales, consistent with the ground truth that royalties were tied to global sales. (2) Quantitatively, the only minor deviation is the rounding of $2,008.9 million to $2.01 billion instead of $2.009 billion, but this is within acceptable financial reporting variation and does not constitute a factual error. All other numerical assertions (zero revenue in 2023/2024) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and entities (Eli Lilly, AbCellera), infers the end of royalty obligations from discontinued sales, and draws a valid strategic conclusion about the product’s short-term nature. It references cost of sales as the royalty recording mechanism, which adds detail not in the ground truth but is plausible and consistent with accounting practices. (4) The answer is contextually excellent—concise, directly responsive, and focused on revenue evolution, royalty implications, and strategic importance. It omits the specific tiered royalty range (mid-teens to mid-twenties), which is a minor completeness gap, but this does not undermine the overall correctness. Hence, a 9 is justified—very high accuracy with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 480,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Philip Morris International continued to list Jackpot as a local Philippine brand in its 2022, 2023 and 2024 10‑Ks, with no change in its strategic emphasis on the brand【page_5】【page_6】【page_5】.  During the same period the company narrowed its international cigarette lineup from seven brands in 2022 to five brands in 2023 and 2024, while keeping Jackpot (alongside Fortune) in its local portfolio【page_5】【page_6】【page_5】.  This three‑year trajectory shows that PMI is maintaining a steady focus on local brands in key markets even as it streamlines its global brand mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that Jackpot was consistently listed as a local brand in the Philippines across 2022–2024, which matches the original answer’s timeline and entity accuracy. (2) The quantitative claim about PMI narrowing its international cigarette lineup from seven brands in 2022 to five in 2023 and 2024 is precise and supported by the source data; no calculation errors are present, and the retention of Jackpot and Fortune in the local portfolio is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes information across years and brand categories (local vs. international), correctly inferring that maintaining Jackpot while reducing global brands reflects a strategic focus on local market relevance. (4) The only minor shortcoming is that the LLM does not explicitly mention PMI’s broader strategic pivot toward smoke-free products and wellness in 2024, which the original answer includes to contextualize the dual strategy. However, this omission does not undermine the core factual accuracy or the central insight about local brand focus. Wording differs but semantic meaning is equivalent. All entities (Jackpot, Fortune, Philippines, PMI) and years are correct. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 392,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In 2022 PayPal’s credit and BNPL products carried direct exposure to bad transactions, with credit‑risk models and default rates affecting its receivables. The 2023 sale of up to €40 billion of U.K. and European BNPL loan receivables reduced future exposure, but the forward‑flow arrangement is contingent on conditions that could delay benefits. In 2024, persistent fraud and third‑party processing disruptions continue to pose significant risks, potentially increasing bad‑transaction exposure even after the BNPL sale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of PayPal's exposure to bad transactions from 2022 through 2024. (1) Quantitatively, all key facts are correct: the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables is accurately stated with correct currency, amount, geography, and year. No calculations were required, and the temporal sequence (2022 → 2023 → 2024) is preserved. (2) The answer addresses all parts of the multi-hop question: it covers PayPal’s initial exposure in 2022, the risk-reducing effect of the 2023 sale, and the ongoing risks in 2024 from fraud and third-party processing. It correctly notes that the sale reduces future exposure but is subject to conditions, aligning with the ground truth’s mention of 'execution risks' and 'conditions'. (3) Entity accuracy is strong: 'PayPal', 'BNPL', 'U.K. and European', '2022–2024', and 'third-party processing' are all correctly identified. (4) Reasoning is sound: the LLM synthesizes the impact of the asset sale while acknowledging that residual risks (fraud, disruptions) could still increase bad-transaction exposure, which matches the ground truth’s emphasis on persistent underlying risks despite reduced direct credit exposure. The only minor shortcoming is that the LLM does not explicitly mention 'synthetic identities' or 'account takeover attempts'—specific fraud vectors noted in the original—but it does correctly highlight 'fraud' and 'third-party processing disruptions' as ongoing issues. This omission slightly affects qualitative completeness but does not undermine the overall correctness. The answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 456,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "Honeywell’s 2022 risk‑factor disclosure warned that “fluctuations in retail markets” could hurt its Safety and Productivity Solutions segment, and the company’s 2022 segment results showed a decline in sales and margin for that business.  In 2024, the newly‑realigned Industrial Automation segment faced the same retail‑market risk, yet the company’s overall profit rose to $1.52 billion (page 28), indicating that other drivers (e.g., advanced‑materials demand) offset the retail impact.  In 2023, the risk‑factor statement again highlighted retail‑market volatility for both Safety and Productivity Solutions and Industrial Automation, underscoring Honeywell’s continued sensitivity to retail demand swings across its industrial portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative claims not present in the original answer or ground truth. It states that Honeywell's 2022 segment results showed a 'decline in sales and margin' for Safety and Productivity Solutions, which is not mentioned in the ground truth and cannot be verified from the provided information. Additionally, it cites a specific profit figure of '$1.52 billion (page 28)' for 2024, which is both unverified and irrelevant to the question—no such number appears in the original answer, and the ground truth does not provide any financial performance outcomes, only risk disclosures. These invented figures significantly undermine factual correctness. (2) The use of '$1.52 billion' and attribution to 'page 28' suggests fabrication or hallucination of data, failing the quantitative accuracy criterion. There are no calculations in the ground truth to validate or compare, but the introduction of unsupported numbers is a serious error. (3) On qualitative reasoning, the LLM correctly identifies the multi-hop pattern of risk evolution: retail market fluctuations affecting Safety and Productivity Solutions in 2022, persisting in 2023, and reappearing in the restructured Industrial Automation segment in 2024. It also correctly infers that this indicates ongoing sensitivity to retail demand across the industrial portfolio, aligning with the ground truth’s conclusion. This shows sound synthesis across years and segments. (4) Contextually, the answer is highly relevant and structured well around the question, addressing each time period and segment. However, the inclusion of false quantitative data reduces the correctness score significantly. While the narrative flow and conceptual understanding are strong, the addition of unverified financials breaks factual integrity. Thus, the answer is partially correct but compromised by hallucinated metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 524,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 to 2024 the Incyte collaboration kept its financial structure as a worldwide license and collaboration: tiered double‑digit royalties up to 20 % on worldwide net sales (plus an additional low‑teens royalty for COVID‑19 sales above a threshold) (page 72). Milestone payments were capitalized as intangible assets and amortized to cost of sales; the amounts were $260 million in 2021 and $210 million in 2020, and no material net milestones were recorded in 2023 or 2024, though Incyte remained eligible for up to $100 million in additional sales‑based milestones (page 73). Olumiant’s revenue grew from $830.5 million in 2022 to $957.4 million in 2024, underscoring its increasing importance to LLY’s revenue base (page 74).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the $260 million milestone was paid in 2021 (not 2022 as per ground truth), and references $210 million in 2020, which is irrelevant to the 2022–2024 timeframe. The ground truth specifies that Incyte was eligible for up to $200 million in additional contingent payments (split between regulatory and sales milestones), but the LLM incorrectly reduces this to $100 million in sales-based milestones only, misrepresenting both the total amount and the structure. While the royalty structure (up to 20%, plus low teens for COVID-19 sales) is correctly described, the LLM fails to mention the split between regulatory and sales milestones, weakening the financial accuracy. (2) The revenue figures for Olumiant ($830.5M in 2022, $957.4M in 2024) are plausible and support the claim of growing importance to LLY’s revenue base, but these specific numbers are not present in the ground truth, making it unclear if they are accurate or fabricated. The ground truth emphasizes the strategic evolution and expanded use (e.g., EUA, follow-on compounds), which the LLM only partially captures by noting revenue growth without discussing strategic framing shifts. (3) The multi-hop reasoning is partially sound—linking milestone payments, royalties, and revenue impact—but fails to synthesize the evolution across years correctly. For example, the claim that no material milestones were recorded in 2023 or 2024 contradicts the ground truth’s emphasis on ongoing royalty payments being recognized as cost of sales, indicating continued financial activity. The LLM also omits the strategic deepening highlighted in 2024, such as therapeutic expansion and long-term commitment. (4) Despite these issues, the answer remains contextually relevant, addressing all key components: financial structure, milestones, royalties, and Olumiant’s revenue role. The qualitative reasoning is coherent but based on incorrect or outdated numbers, leading to a moderate score. The answer captures the tiered royalty and general trend of increasing importance but misses the nuanced evolution in strategic focus and financial obligations from 2022 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 604,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria’s relationship with UST remained essentially unchanged from 2022 to 2024: UST continued to be a wholly‑owned subsidiary and its indefinite‑lived intangible assets—$8.8 billion of MST and snus trademarks and $2.6 billion of cigar trademarks acquired in 2009—were still reported as part of Altria’s intangible assets with no impairment disclosed (page_66). The 2024 10‑K continues to list UST as a wholly owned subsidiary and reports no change in ownership or intangible‑asset valuation (page_4). UST’s moist‑smokeless tobacco products remain a core component of Altria’s “smoke‑free” transition strategy, which is further reinforced by the 2024 joint venture with JTIUH for heated‑tobacco stick and the acquisition of NJOY (page_4).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that UST remained a wholly owned subsidiary of Altria throughout 2022–2024 and that the $8.8 billion in indefinite-lived intangible assets related to MST and snus trademarks from the 2009 acquisition was still reported with no impairment. However, it introduces a new figure—$2.6 billion in cigar trademarks—not mentioned in the ground truth, which lacks verification and distracts from the core focus. This unsupported number reduces quantitative accuracy. (2) The ground truth does not mention cigar trademarks or their valuation, so including this figure, even if accurate elsewhere, is extraneous and not aligned with the provided knowledge graph. The core $8.8 billion figure is correct and consistently referenced, but the addition of unverified data undermines precision. (3) The reasoning around ownership structure and lack of changes in valuation is sound and correctly synthesizes continuity across years. The mention of the JTIUH joint venture and NJOY acquisition in 2024 aligns with Altria’s broader smoke-free strategy, which complements the ground truth’s emphasis on strategic diversification. However, the LLM implies UST’s MST products are part of the 'smoke-free' transition without clarifying that this legacy business is being supplemented—not replaced—by newer alternatives like Helix and NJOY, slightly oversimplifying the strategic evolution. (4) The answer is contextually relevant and captures the essence of structural continuity and strategic shift, but the inclusion of unverified financial data and lack of nuance in describing UST’s role relative to newer platforms justifies a score of 7 for overall correctness. Qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 476,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50% senior note stayed at a $500 million principal balance through FY 2022‑FY 2024, but its effective interest rate climbed sharply—from 3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024【page 89】. This steep rise in the effective rate signals that borrowing costs for Cisco’s debt rose markedly, reflecting a tightening of capital‑market conditions and higher yields on comparable corporate debt during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key factual information: the effective interest rates for Cisco's 3.50% Senior Note were 3.20% in FY 2022, 6.38% in FY 2023, and 6.66% in FY 2024—matching the ground truth exactly. The principal balance of $500 million is an additional accurate detail not in the original answer but does not contradict it. (2) All numeric values are correct and consistent with the ground truth; no calculation errors. The upward trend from 3.20% to 6.66% is accurately described as a 'sharp rise' or 'steep rise,' which aligns with the magnitude of change. (3) The multi-hop reasoning is sound: the model correctly infers that rising effective interest rates on an existing note reflect higher borrowing costs and links this to tightening capital market conditions and higher yields on corporate debt—consistent with the original answer’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly state the total increase (3.46 percentage points) or label it a 'significant upward trend' verbatim, but the meaning is semantically equivalent. The inclusion of the $500M principal, while not required, adds context without error. Overall, the answer is factually complete, logically sound, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 356,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16.0 billion** at December 31, 2022 to **$15.0 billion** at December 31, 2023 and further to **$13.0 billion** at December 31, 2024 (Table 6, 2023 and 2024 filings). This steady decline shows Amazon is actively paying down older, higher‑rate debt, reducing interest expense and improving its leverage profile—evidence of a disciplined, proactive debt‑management strategy over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. All numeric values and time periods are accurate, with acceptable formatting (e.g., $16.0 billion vs $16.0 billion). (2) Quantitative accuracy is perfect—no calculation errors, and the trajectory of reduction ($16B → $15B → $13B) is correctly presented. (3) The reasoning is sound and adds value: the LLM infers that Amazon is paying down older, higher-rate debt to reduce interest expense and improve leverage, which is a reasonable interpretation of the trend. While the ground truth mentions Amazon’s broader long-term debt reduction (from $67.2B to $52.6B), the LLM does not include this specific context, resulting in a minor omission. However, the core multi-hop synthesis—linking declining 2017 Notes balance to a strategic debt management approach—is correctly executed and logically supported. (4) The answer is fully contextually relevant, directly addressing both the evolution of the debt balance and its implications. The slight deduction in qualitative accuracy is due to the missing reference to the broader long-term debt trend, but the conclusion drawn is still valid and insightful. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 401,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "In fiscal 2022 the 5.000% notes due April 2030 were not listed in the debt table (page 80), implying a $0 outstanding balance.  In fiscal 2023 and 2024 the notes remained at an outstanding principal of $606 million with an effective interest rate of 5.18% (page 81).  This steady balance and unchanged rate show that AVGO has kept the instrument as a stable, long‑term financing source without refinancing or altering its terms, reflecting a disciplined debt‑management strategy focused on predictable interest costs and maturity structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the 5.000% notes due April 2030 were not listed in the fiscal 2022 debt table, implying a $0 balance. This contradicts the ground truth, which confirms an outstanding principal of $606 million in fiscal 2022. The $606 million balance and 5.18% effective interest rate are correctly reported for 2023 and 2024, so those years are accurate. (2) Quantitatively, two out of three years are correct; however, the incorrect assertion about 2022 undermines the multi-year progression analysis. The numbers for 2023 and 2024 match the ground truth exactly ($606 million, 5.18%), so those are precise. (3) The reasoning is partially sound—maintaining a steady balance suggests a stable debt strategy, which aligns with the ground truth’s interpretation. However, the conclusion is based on flawed premises because it ignores the presence of the debt in 2022. The multi-hop synthesis fails due to the omission of correct data in one key year, leading to an inaccurate evolution narrative. (4) The contextual relevance is high because the answer addresses the question's structure—tracking changes over time and inferring strategy—but the incorrect starting point reduces its validity. Due to the significant error in the 2022 balance, the overall correctness is reduced to a mid-range score despite accurate data in later years and reasonable interpretation of strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 398,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "Netflix formally amended and restated its Performance Bonus Plan in December 2022 (Exhibit 10.5†, 2023 10‑K). The 2023 10‑K incorporated the amended plan into the company’s executive‑compensation framework, with the plan referenced in the Executive Compensation section and as Exhibit 10.5†. In 2024 the plan was again amended and restated (Exhibit 10.5† filed 9 Dec 2023) and further integrated into the updated executive‑compensation agreements for 2024, reflecting a continued formalization and alignment of the bonus structure with executive pay【page 69 (2023)】【page 69 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and references are correct: the Amended and Restated Performance Bonus Plan was indeed filed on December 9, 2022 (as reflected in the 2023 10-K), and the 2024 amendment was filed on December 9, 2023—correctly cited with exhibit numbers and filing years. The timeline across 2022–2024 is accurately represented. (2) The answer correctly identifies the formalization in 2023 (via the 2022 8-K filing) and the further integration in 2024, including linkage to executive compensation agreements. (3) Multi-hop reasoning is sound: the model synthesizes information across filings (2023 and 2024 10-Ks), connects the plan’s evolution to broader compensation architecture, and correctly infers increasing formalization and integration. (4) Minor deduction in qualitative accuracy because the LLM mentions a '2024 amendment and restatement' not explicitly confirmed in the ground truth, which only states the plan was 'further embedded'—not necessarily amended again. However, referencing the December 9, 2023 filing (for the 2024 plan) as an amendment is plausible and consistent with SEC practices. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 355,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "AIG’s approach to international terrorism exposure did not materially change between 2022 and 2024.  In each filing the company states that it models losses with a third‑party vendor, monitors concentration, and purchases targeted reinsurance for selected lines while relying on government‑sponsored terrorism pools in non‑U.S. jurisdictions (2022: page 169; 2023: page 121; 2024: page 88).  No new modeled loss estimates for international terrorism were disclosed, and the reinsurance and mitigation strategy remained essentially unchanged across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims AIG's approach did not materially change from 2022 to 2024, but the original answer shows clear evolution: in 2023, AIG emphasized targeted reinsurance and monitoring, and in 2024, it implemented specific attachment points ($200M for Japan, $125M for rest of world) and purchased global property per risk covers outside North America—details entirely missing in the LLM response. (2) Quantitatively, the LLM fails to report the $1.3 billion modeled loss estimate for a five-ton bomb in NYC (2022) and omits the $20.1 billion in collateral held for reinsurance recoverables in 2024—both key figures in the ground truth. These are not disclosed, per the LLM, but they are present in the original answer. (3) The multi-hop reasoning is flawed: the LLM incorrectly synthesizes consistency across years when the data shows strategic deepening in reinsurance and risk alignment. It references page numbers but draws the wrong conclusion about stability. (4) While the mention of third-party modeling, concentration monitoring, and use of government pools provides some contextual relevance, the overall answer misses the core evolution in strategy and specific financial figures, leading to a low correctness score. The answer is semantically divergent from the ground truth despite some surface-level alignment in general practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 388,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio expanded markedly between 2022 and 2024.  Equity‑security holdings grew from **$3.7 billion in 2022 to $4.9 billion in 2023** and remained at that level in 2024 (page 50).  Equity‑method investments in healthcare operating businesses dipped slightly from **$1.5 billion in 2022 to $1.4 billion in 2023** but then **more than doubled to $3.8 billion in 2024**, reflecting a shift toward larger, strategic healthcare investments (page 52).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in structure and interpretation but contains minor inaccuracies in the 2022 figures. The ground truth states that in 2022, UnitedHealth Group held $3.5 billion in equity securities, while the LLM reports $3.7 billion—a material discrepancy. Similarly, the LLM claims equity-method investments were $1.5 billion in 2022, but the correct figure is $1.3 billion. These errors affect the quantitative accuracy. However, the 2023 and 2024 numbers are fully accurate: equity securities correctly reported as $4.9 billion in both years, and equity-method investments correctly noted as $1.4 billion in 2023 and $3.8 billion in 2024. (2) Calculations and comparisons are otherwise sound: the more than doubling from $1.4B to $3.8B in equity-method investments is correctly interpreted. The growth trend and plateau in equity securities are accurately described. (3) The multi-hop reasoning is strong—the model synthesizes data across years and investment types, correctly inferring a strategic shift toward deeper operational involvement in healthcare businesses, which aligns with the original answer’s conclusion. (4) Contextual relevance is perfect: the response directly addresses the evolution of UnitedHealth’s venture investment strategy across the specified time frame, focusing on both equity securities and equity-method investments. Despite the incorrect 2022 figures, the overall narrative and directional analysis remain valid, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 418,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 1.700% Notes due 2025 were first issued in 2022 and remained on the books in the 2023 and 2024 10‑K filings, with no change to the coupon or maturity (see the “Securities registered” list on page 1 of each filing).  The notes continued to form a core part of the company’s long‑term debt mix, reflecting a deliberate strategy of keeping a stable, low‑interest debt base to support capital‑allocation decisions such as share repurchases and the transition to a smoke‑free portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Altria's 1.700% 2025 Notes were present in the capital structure in 2022, 2023, and 2024, which aligns with the ground truth. The coupon rate (1.700%) and maturity year (2025) are accurate, and there is no indication of changes to these terms across years, matching the original answer. (2) Quantitatively, all numbers—interest rate (1.700%), years (2022, 2023, 2024), and maturity (2025)—are correct. No calculations are required, but the consistency of the note across filings is accurately reported. (3) The multi-hop reasoning is mostly sound: the model correctly infers from the continued presence of the notes in successive 10-Ks that they remain a stable part of the capital structure. However, the LLM omits key context from the ground truth about the maturity of the 1.000% 2023 Notes in 2023, which is a critical element in demonstrating Altria’s active debt management strategy. This omission weakens the completeness of the synthesis. Additionally, while the LLM labels the 2025 Notes as 'long-term debt,' they become short-term as 2025 approaches, so 'mid-term' or 'intermediate-term' would be more precise. (4) Despite missing the comparative evolution with other debt instruments (e.g., the retirement of 2023 Notes), the core conclusion about maintaining stable, low-cost debt is consistent with the original answer. The strategic interpretation—supporting share repurchases and smoke-free transition—is plausible and contextually relevant, though not explicitly confirmed in the ground truth. Thus, the answer is factually correct on key points but lacks full completeness in multi-hop synthesis, warranting a score of 8 for correctness and qualitative accuracy, 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 485,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock rose from **$51.354 B** at the end of 2022 to **$60.429 B** in 2023 and to **$71.431 B** in 2024, reflecting a growing share‑repurchase program. This trend shows the company is prioritizing the return of excess cash to shareholders—using buybacks to support earnings per share and signal a shareholder‑friendly capital‑allocation strategy rather than allocating capital to new growth projects.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the upward trend in Mastercard's Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 ($60,429 million) and 2024 ($71,431 million) values, matching the ground truth. However, the 2022 value is reported as $51.354B, which does not match the ground truth of $(36,658) million. This is a significant discrepancy: $51.354 billion = $51,354 million, whereas the correct value is $36,658 million. The sign (negative) is also omitted, though this may reflect presentation differences in financial statements (treasury stock is typically a contra-equity account). 2) The 2023 and 2024 figures are accurate in both amount and year. The calculation of increasing trend is correct, but the starting point is wrong, affecting the quantitative accuracy. 3) The reasoning is sound: the LLM correctly infers that increasing treasury stock (i.e., more repurchases) suggests a capital allocation strategy focused on shareholder returns via buybacks, signaling confidence and support for EPS. This aligns with the ground truth interpretation. 4) The answer is contextually excellent—directly addresses both parts of the question (evolution of investment and strategic implication), uses appropriate financial terminology, and synthesizes multi-year data to draw a logical conclusion. The error in the 2022 figure prevents a higher score, but the rest of the response is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 390,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return‑swap exposure for deferred compensation swung from a loss to a gain and then grew larger in 2024.  The operating‑expense entry for the swaps was a **$92 million loss in FY 2022**, turned into a **$58 million gain in FY 2023**, and rose to a **$91 million gain in FY 2024**【page_91】.  The notional amount of the swaps expanded in parallel—$651 million in 2022, $792 million in 2023, and $985 million in 2024【page_92】—reflecting a larger hedging position that ultimately produced net gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024—matching the ground truth exactly. Number formats are consistent and acceptable (e.g., $92 million = $92M). (2) Quantitative accuracy is perfect: all dollar amounts and fiscal years are correct, and no calculations were required beyond accurate reporting. (3) The LLM adds contextual detail not in the original answer—the notional amounts ($651M, $792M, $985M)—which supports the reasoning about increasing exposure and aligns with the evolution described. While this information is accurate and enhances the response, the original answer did not require it, so the core multi-hop synthesis (tracking performance shift over time) is fully correct and slightly enriched. (4) The reasoning is sound: it identifies the reversal from loss to gain and the increasing magnitude, concluding a growing net benefit, which matches the semantic meaning of the ground truth. The only minor difference is that the LLM emphasizes the expanding notional amount as a driver, which is valid but not part of the original answer—this adds insight without contradicting facts. Thus, the answer is factually complete, quantitatively precise, and contextually relevant, warranting a high score with only slight deduction in qualitative accuracy for introducing unrequested (though correct) detail that slightly shifts focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 398,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "From 2022 to 2024, Netflix’s risk disclosures show a deepening reliance on third‑party rights holders: the 2022 filing (pages 9‑13) warned that refusal or withdrawal of licenses could harm the business; the 2023 filing (pages 2‑6) added that rights holders are increasingly launching their own streaming platforms, intensifying competition for exclusive content and driving up licensing costs; and the 2024 filing (pages 2‑6) further highlighted regulatory pressures—content quotas, levies, investment obligations, and formal content reviews—that can force removal or modification of licensed titles, amplifying the risk of content unavailability and the need for favorable licensing terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Netflix's increasing dependency on rights holders from 2022 to 2024, rising competition as rights holders launch their own platforms, increased licensing costs, risks of content unavailability, and growing regulatory pressures. The answer correctly identifies the evolution across the three years, matching the original answer’s progression. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings, correctly attributing evolving risks to each year and linking them to licensing, competition, and regulation. It adds specific page references (e.g., pages 9–13, 2–6), which are plausible and enhance credibility, though not present in the ground truth—this does not detract from accuracy. (4) The semantic meaning fully matches the original: while the LLM uses slightly more structured phrasing and includes page numbers, it captures all core risks and their escalation over time. One minor point preventing a perfect 10 is that the original emphasizes 'strategic challenge' in maintaining content libraries, a high-level synthesis slightly underdeveloped in the LLM version—though the supporting facts are all present. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 417,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s parent company reported that the amounts accrued, paid or charged to income for service‑level guarantees were **non‑material** as of December 31 2024, 2023 and 2022【page_81】.  In other words, the dollar values of those guarantees did not change materially over the three‑year period.  This steady, non‑material level of obligation suggests that the company’s service‑delivery commitments to its subsidiaries have remained stable and consistent across the years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the amounts accrued, paid, or charged to income for service level guarantees were immaterial (referred to as 'non-material') in 2022, 2023, and 2024, which aligns with the ground truth. This reflects accurate reporting of the key financial fact regarding service level guarantees. However, the LLM omits a critical part of the original answer: the significant fluctuations in the parent company's notes payable to subsidiaries—rising from $8.1B in 2022 to $9.9B in 2023, then dropping sharply to $2.0B in 2024. This internal financing data is central to the multi-hop aspect of the question, which asks about the evolution of financial obligations and what the trend suggests about stability in service delivery commitments across subsidiaries. (2) Quantitatively, the LLM does not misstate any numbers because it avoids citing specific dollar amounts related to notes payable, but it also fails to include them. Where it does speak (on immateriality), the information is factually correct. (3) The reasoning is partially sound but incomplete. The conclusion that service delivery commitments have remained stable due to non-material charges is reasonable, but the LLM ignores the contradictory signal from the volatile internal financing structure, which the ground truth highlights as potentially indicative of shifting liquidity strategies or operational adjustments. A full multi-hop synthesis would have connected both the external guarantee stability and internal financial shifts to provide a nuanced view of subsidiary commitment stability. (4) The correctness score is 6 due to partial accuracy: core facts about service guarantees are right, but a major dimension of financial obligations (intercompany notes) is omitted, weakening completeness and qualitative accuracy. Quantitative accuracy is 10 because no numbers are wrong—only missing. Qualitative accuracy is 5 due to incomplete reasoning and failure to synthesize across financial dimensions. Contextual relevance is 8 because the answer addresses the main theme but misses a key layer of analysis requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 573,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria cut its exposure to below‑investment‑grade debt in its long‑duration fixed‑income holdings: for pension assets the allocation fell from roughly 18 % of fixed‑income holdings in 2022 (1,032 of 5,769 dollars) to about 11 % in 2023 and to 8 % in 2024; for postretirement assets it fell from about 16 % in 2022 (756 of 4,715 dollars) to 9 % in 2023 and to 8 % in 2024 (page 92, 86, 89).  The steady decline signals a more risk‑averse appetite, with the company tightening credit quality to better hedge its long‑term pension and postretirement liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, Altria's pension plan had 16% (not 18%) of fixed income holdings in below investment grade securities, and the postretirement plan had 8% (not 16%). The 2023 figures are partially correct: 11% for pensions (matches ground truth), but postretirement is reported as 9% in both sources, so that aligns. However, the LLM claims 8% for both pension and postretirement in 2024, which is incorrect because the original answer states that specific percentages for 2024 were not disclosed. The dollar amounts cited (e.g., 1,032 of 5,769) are not present in the ground truth and appear fabricated or misattributed. (2) Calculations: The LLM attempts to justify percentages with ratios (e.g., 1,032/5,769 ≈ 17.9%, rounded to 18%), but these numbers do not appear in the original answer and are therefore unsupported. Similarly, 756/4,715 ≈ 16%, again not found in the ground truth. These figures contradict the known data and suggest incorrect sourcing. (3) Multi-hop reasoning: The LLM correctly identifies the need to track changes over time across two plans (pension and postretirement), but fails to accurately represent the trend. The ground truth shows a decrease in pension risk and a slight increase in postretirement exposure, indicating a mixed but cautious strategy. The LLM instead portrays a uniform decline across both plans, missing the nuance. Furthermore, it incorrectly extends data to 2024 when no such breakdown was provided. (4) Despite these errors, the answer is contextually relevant—addressing the right question about risk appetite and linking allocation trends to risk management. However, due to major quantitative inaccuracies and flawed reasoning based on non-existent data, the correctness score is low. The qualitative reasoning would be higher if based on accurate inputs, and contextual relevance is fair because the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 544,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard has continued to estimate gross settlement exposure by multiplying the average daily payment volume over the three months preceding year‑end by the estimated number of days of exposure—a method unchanged from 2022 through 2024 (see pages 108, 112, 105).  Although the exposure rose from $64.9 million in 2022 to $78.4 million in 2024, the consistent calculation framework and periodic reviews (page 112) demonstrate a disciplined, stable risk‑management approach that remains robust despite mounting regulatory scrutiny and litigation pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Mastercard's consistent methodology for estimating settlement exposure from 2022 to 2024: using average daily payment volume over the three months prior to year-end multiplied by estimated days of exposure. This matches the original answer exactly in substance. (2) The quantitative figures—$64.9 million in 2022 and $78.4 million in 2024—are factually correct and reflect increasing exposure, though the original answer does not include these specific numbers. Their inclusion is acceptable as long as they are accurate and do not contradict the ground truth; no discrepancy is found. (3) The reasoning is sound: the LLM correctly infers that a stable methodology amid rising regulatory and litigation risks indicates a disciplined and robust risk management approach, which is consistent with the original answer’s conclusion. (4) The LLM omits specific mention of certain litigation (e.g., U.S. Liability Shift Litigation, TCPA) and regulatory bodies (FTC, DOJ, European Commission), and does not explicitly note the unchanged requirement for cash collateral or credit enhancements based on risk assessments—minor omissions that prevent a perfect score. However, the core multi-hop synthesis—linking consistent methodology to stable risk management under pressure—is correctly executed. Wording differs but semantic meaning is equivalent. Contextual relevance is full, as all parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 420,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90% senior note stayed at a $2.0 billion principal each year, with an effective interest rate of 6.11% in FY 2022, FY 2023 and FY 2024 (see the long‑term debt tables on page 89 of each 10‑K). The unchanged utilization and rate show that Cisco is not adding or retiring this high‑coupon note and that its effective cost remains stable, reflecting a disciplined long‑term debt strategy that prioritizes predictable interest expense and maturity management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2.0 billion principal (equivalent to $2,000 million) on its 5.90% Note across fiscal years 2022–2024, and that the effective interest rate remained stable at 6.11%—all matching the ground truth exactly. Number formats are acceptably varied ($2.0 billion vs $2,000 million) and semantically equivalent. (2) All quantitative values—dollar amount, interest rate, and fiscal years—are accurate with no calculation errors. The reference to page 89 of each 10-K adds contextual support, though not required for correctness. (3) The reasoning correctly infers that the unchanged balance and rate indicate a strategy of maintaining predictable interest obligations, aligning with the ground truth’s conclusion about strategic retention of high-yield debt. The LLM slightly softens the implication by not explicitly mentioning 'despite potential opportunities to optimize financing costs in a changing rate environment,' which is a minor omission in qualitative depth. (4) The answer is fully contextually relevant, directly addressing both the evolution of utilization/rate and the strategic implication. The only reason for not scoring a 10 is the slightly less precise articulation of strategic trade-offs, but core facts, synthesis, and interpretation remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 372,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 were not outstanding at the end of FY 2022 (the 2022 10‑K, pages 101‑105, does not list the instrument, implying a $0 balance).  The notes were issued in FY 2023, with an outstanding principal balance of $495 million (page 81), and the balance remained unchanged at $495 million in FY 2024 (page 81).  This steady balance shows that the company has chosen to hold the notes as a long‑term financing tool without additional issuance or repayment, reflecting a conservative, stable debt‑management approach for this specific instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the 3.125% notes due January 2025 were not outstanding in FY 2022 and were issued in FY 2023, implying a $0 balance in 2022. However, the ground truth states that the outstanding principal balance was $495 million in each of the fiscal years 2022, 2023, and 2024. This misstatement of the existence and timing of the debt instrument is a major factual error. The only correct quantitative element is the $495 million balance in FY 2023 and 2024. (2) Quantitative accuracy is partially correct for FY 2023 and 2024 but fails for FY 2022, where it incorrectly reports $0 instead of $495 million. The note's presence in the 2023 and 2024 10-Ks at the same amount is correctly noted, but the absence in the 2022 10-K is misinterpreted—absence from detailed listings does not imply zero balance, especially for long-term debt carried forward. (3) The multi-hop reasoning is flawed: the model incorrectly infers issuance timing based on disclosure presence/absence across filings, failing to recognize that long-term debt instruments can appear in later disclosures without being newly issued. The conclusion about a 'conservative, stable debt-management approach' is reasonable given a steady balance, but it's based on an incorrect premise regarding the FY 2022 balance. (4) Contextual relevance is fair—the response addresses the evolution of the debt and attempts to interpret strategy—but the core factual error undermines the analysis. Due to the critical error in the FY 2022 balance and misattribution of issuance timing, the overall correctness score is low despite partial accuracy in later years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 461,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "CM CSA has kept wireless bundled with broadband since 2022, offering customers shared‑data or per‑gigabyte options as part of those bundles【page_5】.  In 2024 the company broadened that flexibility by adding prepaid unlimited data plans under the NOW brand, while still offering shared‑data and per‑gigabyte plans and keeping the bundled‑service model【page_6】.  Thus, the evolution moved from a purely shared‑data/​per‑GB offering to a more flexible mix that now includes prepaid unlimited plans, all within the same bundled‑service framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of CMCSA's shared data plan offerings from 2022 to 2024. (1) It correctly states that shared data and per-gigabyte options were offered as part of broadband bundles starting in 2022, and that in 2024, prepaid unlimited plans were added under the NOW brand—this aligns with the ground truth. (2) All dates (2022, 2024) and service offerings (shared data, per-GB, prepaid unlimited) are factually correct; no numerical inaccuracies present. (3) The multi-hop reasoning is sound: it synthesizes information across time periods and service lines, correctly identifying the continuity of bundling and the expansion of flexibility. (4) The only minor omission is that the 2023 developments—where the shared data plan was maintained with continued emphasis on bundling—are not explicitly mentioned. While not critical, including this would have made the progression clearer. However, the answer still conveys the essential strategic shift toward greater flexibility within the bundled framework, maintaining semantic equivalence with the original answer. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 333,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained persistent from 2022 through 2024, as CMS repeatedly reduced or froze Medicare Advantage benchmarks and altered the way risk‑adjustment payments are calculated. In each filing the company noted that it had responded by selectively adjusting members’ benefits and premiums, discontinuing plans in certain counties, and intensifying both medical and operating cost‑management efforts to offset the funding pressures. These same strategic adjustments were reiterated in the 2023 and 2024 reports, indicating a consistent approach to mitigating the recurring Medicare Advantage payment challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: UnitedHealth Group faced persistent exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024 due to CMS benchmark reductions and methodology changes. The company responded with selective benefit and premium adjustments, plan discontinuations in certain counties, and intensified cost management—strategies consistently reiterated in 2023 and 2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers that the recurring nature of CMS changes led to ongoing strategic responses. The mention of 'discontinuing plans in certain counties' is a minor addition not explicitly in the original answer, but it is a plausible and contextually consistent strategic move that does not contradict the ground truth. (4) The LLM captures the core theme—that UnitedHealth remained in a reactive, adaptive posture across the three years—demonstrating strong qualitative accuracy and contextual relevance. The only reason for not scoring a 10 is that the original answer emphasizes the lack of a 'full resolution' and a 'reactive posture' more explicitly, which the LLM implies but does not state as clearly. Overall, the answer is factually correct, complete, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 423,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard’s multi‑layered security approach has remained consistent but broadened its scope: each filing (2022‑24, p. 11) stresses collaboration with issuers, acquirers, merchants, governments, industry associations and public‑private partners to set technical standards and conduct third‑party assessments.  The company has deepened real‑time service integration by embedding fraud‑scoring, tokenisation and other value‑added services into its globally integrated, peer‑to‑peer network architecture and operating real‑time clearing and settlement infrastructure (p. 11).  Geographically, its real‑time payments infrastructure expanded from 12 markets (as of 2021) to 13 markets by 2023—a figure that remains unchanged in the 2024 filing, signalling continued expansion into new jurisdictions (p. 11).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding the geographic expansion timeline. The original answer states that Mastercard operated in 12 top GDP markets in 2022, expanded to 13 in 2023, and continued expansion in 2024 with specific mention of China via a joint venture. The LLM incorrectly attributes the 12-market figure to 2021 (not mentioned in the ground truth for this context) and states the count remains at 13 in 2024, missing the 2024-specific development in China, which is a notable omission. (2) Quantitatively, the numbers (12 to 13 markets) are accurate, but the baseline year (2021 vs 2022) is misaligned, affecting temporal precision. The LLM correctly notes the expansion to 13 markets by 2023, matching the ground truth. However, it fails to reflect the 2024 advancement in China, which represents both geographic and infrastructural evolution. (3) The reasoning is sound in synthesizing third-party collaboration and real-time service integration across years, correctly identifying fraud scoring, tokenization, and public-private partnerships as consistent themes. It accurately reflects the deepening of real-time services within transaction routing. However, it does not fully capture the 2024 evolution in domestic processing in China, a key multi-hop element linking geographic expansion with security integration. (4) Despite missing the China joint venture detail in 2024, the answer remains contextually relevant and conveys the overall trajectory of Mastercard's security evolution. The core elements—collaboration, real-time integration, and gradual geographic growth—are well represented, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 464,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon has kept the 1.500 % note due 2030 unchanged through 2022‑24, with the note listed in the 2020 officers’ certificate and referenced in each subsequent 10‑K (2022 p. 75, 2023 p. 75, 2024 p. 72). No amendments, repayments, or new issuances of that note appear in the filings, indicating that Amazon has treated it as a stable, low‑cost long‑term debt instrument and has not accelerated its refinancing. This reflects a long‑term debt‑management approach that prioritizes predictable, fixed‑rate obligations and postpones refinancing until maturity rather than pursuing aggressive restructuring.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of Amazon's evolving financing strategy, particularly the introduction of new credit facilities that are central to the multi-hop reasoning required. (1) Quantitatively, the LLM correctly identifies the 1.500% Note due 2030 and its consistent presence across 2022–2024 filings, with accurate references to its origin in 2020 and inclusion in annual 10-Ks. No numeric errors are present. (2) However, the answer incorrectly implies that Amazon’s financing strategy remained static, stating 'no amendments, repayments, or new issuances' and that the note was 'unchanged'—this overlooks the critical evolution in strategy revealed by the introduction of new credit agreements: the Term Loan Agreement on January 3, 2023 (Exhibit 10.8) and the 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), both of which signal a shift toward layered liquidity management. (3) The reasoning is flawed in that it fails to synthesize information across exhibits and years to recognize that while the 2030 note remained stable, Amazon actively expanded its short-term financing tools—this multi-hop insight is missing. The conclusion that Amazon 'postpones refinancing until maturity rather than pursuing aggressive restructuring' is plausible but incomplete; the truth emphasizes a strategic balance between fixed-rate long-term debt and flexible short-term facilities, not just passivity. (4) Thus, while the core fact about the 2030 note is accurate (supporting high quantitative accuracy), the qualitative analysis lacks depth and misses the strategic evolution, reducing the correctness score. Contextual relevance remains high as the response addresses the question’s focus on long-term debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 477,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "In 2022 CMCSA’s 10‑K simply listed “wireless telecommunications companies” as broadband competitors, without reference to specific technologies. By 2024 the filing expands that threat to include carriers offering 5G‑fixed‑wireless and 4G/5G broadband services, and notes that federal and state broadband‑deployment subsidies could bring additional subsidized networks into its footprint. The 2024 report links this heightened wireless competition to net broadband customer losses and to the company’s push to roll out new broadband platforms (X1, Sky Q, Flex) and bundled offerings, indicating the pressure is already reshaping CMCSA’s market positioning and customer‑retention strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of the competitive threat from wireless telecommunications companies to CMCSA's broadband business from 2022 to 2024. In 2022, the 10-K only generically listed wireless telecoms as competitors, which matches the ground truth noting 4G/5G competition without emphasis. By 2024, the LLM correctly highlights the shift to 5G fixed wireless and the inclusion of unlimited data and bundling strategies, consistent with the original answer’s emphasis on technological advancement and service bundling. (2) There are no numeric values requiring calculation, but the years (2022, 2024) and technological references (4G, 5G, fixed wireless) are factually correct and match the ground truth. Format and terminology are consistent. (3) The multi-hop reasoning is sound: the LLM connects the intensifying wireless threat to CMCSA’s customer losses and strategic responses (e.g., new platforms like X1, Sky Q, Flex, and bundled offerings), which is supported in the ground truth’s mention of retention innovations. The addition of federal/state subsidies as a competitive pressure is not in the original answer but is contextually plausible and does not contradict it. (4) The LLM omits the 2023 intermediate step (deployment of 5G fixed wireless routers, etc.) mentioned in the ground truth, which slightly reduces completeness. However, the core trajectory and impact on CMCSA’s strategy are accurately captured. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 449,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell sharply from $67.5 billion at December 31 2023 to $38.0 billion at December 31 2024 (AIG 2023 Form 10‑K, pp. 122–123; AIG 2024 Form 10‑K, pp. 86–87), indicating a lower exposure to potential insurance‑loss claims and a shift in its reinsurance strategy. The 2022 figure is not disclosed in the pages supplied.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the quantitative evolution of AIG's reinsurance recoverable assets: $67.5 billion in 2023 and $38.0 billion in 2024, with a sharp decline between those years. It accurately notes that the 2022 figure is not disclosed, which aligns with the ground truth. All numeric values and dates are correct, and the cited sources (10-K pages) are plausibly referenced.\n\n2) Quantitative accuracy is perfect: the dollar amounts for 2023 and 2024 match the ground truth exactly. The drop from $67.5B to $38.0B is correctly characterized as a sharp decline. No calculation errors.\n\n3) The reasoning is mostly sound but less complete than the original answer. While the LLM correctly infers reduced exposure to insurance loss risk and a strategic shift, it omits key details about the composition of the recoverables—specifically, the breakdown into ceded loss reserves and life reinsurance recoverables. The ground truth highlights that life reinsurance recoverables plummeted from $28.2B to $0.8B, indicating a major de-risking in the life segment. This critical insight is missing in the LLM answer, weakening the qualitative depth and multi-hop synthesis.\n\n4) Contextual relevance is high—the answer directly addresses the evolution of reinsurance recoverables and interprets the trend in terms of risk exposure and strategy. However, the lack of detail on the components of the recoverables limits completeness. The answer is concise and factually correct but does not fully capture the nuance of the trend’s implications, particularly regarding the life insurance segment.\n\nOverall, the answer is factually accurate and relevant but lacks the full qualitative depth of the ground truth, particularly in explaining *why* the drop occurred and what it indicates about life insurance risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 493,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure methodology has stayed the same from 2022 through 2024: it estimates gross exposure by multiplying the three‑month average daily payment volume by the number of days of exposure and then applies risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) to arrive at net exposure.  The amounts of both gross exposure (from $64.9 B in 2022 to $78.4 B in 2024) and risk‑mitigation coverage (from $9.2 B to $13.5 B) grew each year, raising net exposure from $55.7 B to $64.9 B, and the company periodically reviewed and revised its methodology—correcting the 2022 net estimate in 2023—though it disclosed no material changes in response to ongoing FTC, DOJ, EU and other regulatory scrutiny, instead maintaining or expanding its risk‑mitigation and compliance programs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details not present in the ground truth. The original answer states that Mastercard's settlement exposure methodology remained unchanged from 2022 to 2024 and does not mention specific dollar amounts for gross exposure, risk-mitigation coverage, or net exposure. However, the LLM introduces precise figures—$64.9B gross exposure in 2022, $78.4B in 2024, mitigation from $9.2B to $13.5B, and net exposure rising from $55.7B to $64.9B—which are not supported by the ground truth. These numbers appear fabricated or hallucinated, as the original answer contains no such data. Additionally, the claim that Mastercard 'corrected the 2022 net estimate in 2023' is not mentioned or implied in the ground truth and introduces a false event. (2) The calculation of net exposure (e.g., $64.9B - $9.2B = $55.7B) may be mathematically consistent, but since the inputs are unsupported by the source, the entire quantitative framework is invalid. The ground truth emphasizes consistency in methodology, not evolving numerical estimates or corrections. (3) On qualitative reasoning, the LLM correctly identifies that regulatory scrutiny occurred (FTC, DOJ, EU) and that Mastercard maintained its risk mitigation tools (cash collateral, letters of credit, guarantees), which aligns with the original answer. It also correctly notes no material changes were disclosed in response to scrutiny, which matches the ground truth’s conclusion of 'no explicit evidence of a change.' However, the claim that the company 'periodically reviewed and revised its methodology' contradicts the ground truth assertion that the methodology 'remained unchanged' across all three years. This is a critical error in multi-hop synthesis. (4) Despite these serious factual and quantitative flaws, the LLM captures the broader context—ongoing regulatory pressure and sustained use of credit risk mitigation—giving it moderate qualitative and contextual scores. The answer is relevant and structured well, but fails on core factual accuracy, especially regarding numerical data and methodological stability, warranting a mid-low correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 588,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "AIG’s 2022 10‑K (pp. 165‑167) described loss‑reserve risk as being managed through internal controls and oversight of the reserve‑setting process, with periodic reviews by external experts. By 2023 (pp. 118‑119) the company added formal review‑and‑challenge procedures, actuarial profitability and reserve reviews, and began using stochastic, sensitivity and scenario‑based modeling to quantify reserve uncertainty. In 2024 (pp. 86‑87) the approach was further tightened by explicitly incorporating external expert reviews, integrating third‑party catastrophe models, and applying advanced stochastic, scenario and experience‑study techniques to both catastrophe and general‑line reserves, thereby strengthening internal controls and broadening the modeling toolkit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years (2022–2024), and aspects of loss reserve risk management (internal controls, external expert involvement, modeling techniques)—are correctly identified and addressed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates and page references are consistent with document-based reporting and do not affect factual correctness. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AIG’s evolving approach across three years. In 2022, internal controls and external reviews are noted—matching the original. In 2023, the addition of stochastic, sensitivity, and scenario analyses is accurately reported, along with actuarial reviews, which aligns with the expansion of risk measurement tools. In 2024, the LLM correctly identifies further strengthening, including model enhancements (third-party catastrophe models, experience studies), and stronger validation—consistent with the original’s emphasis on model risk management and updated assumptions. (4) Minor difference: the original emphasizes 'model risk management frameworks' and 'validation processes' in 2024 more explicitly, while the LLM focuses on 'external expert reviews' and 'third-party models'—which are related but not perfect semantic matches. However, the LLM’s phrasing ('applying advanced stochastic, scenario and experience-study techniques') captures the maturing analytics approach. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight variation in emphasis. Hence, a 9/10 for correctness and qualitative accuracy, 10s elsewhere.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 494,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "UnitedHealth’s sensitivity of medical‑cost‑PMPM estimates to benefit‑mix changes has risen steadily from 2022 through 2024.  In 2023 a 3 % shift in PMPM trend factors increased medical‑cost payable by $1,128 million (page 41), and in 2024 the same shift raised it to $1,264 million (page 38), up from a lower impact in 2022 (page 39).  This upward trend shows the company’s medical‑cost estimates are becoming more responsive to benefit‑design changes, indicating a growing exposure to benefit‑mix variability over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and interpretation. The ground truth states that UnitedHealth Group discussed the mix of benefits as a sensitivity factor in 2022, noted a negative impact in 2023, and then reported a more neutral stance in 2024—indicating stabilization. In contrast, the LLM claims a steady *increase* in sensitivity and exposure over time, which contradicts the trajectory described in the original answer. (2) The LLM introduces specific quantitative figures—$1,128 million in 2023 and $1,264 million in 2024 from a 3% shift in PMPM trend factors—that are not present in the ground truth and cannot be verified. The original answer contains no such numbers, calculations, or page references. These figures appear fabricated or misattributed, failing the quantitative accuracy test entirely. (3) The multi-hop reasoning is flawed: instead of synthesizing the evolving qualitative assessment of benefit mix sensitivity (from neutral to risky to stabilized), the model invents a trend based on non-existent dollar impacts, showing poor reasoning and misinterpretation of the underlying concept. It also incorrectly infers growing exposure, while the ground truth suggests risk peaked in 2023 and stabilized in 2024. (4) While the LLM addresses the general topic—sensitivity of PMPM estimates to benefit mix—and covers the 2022–2024 timeframe, making it contextually relevant, its factual inaccuracies and invented data severely undermine correctness. The qualitative analysis is oversimplified and directionally wrong, warranting low scores in correctness and quantitative accuracy despite appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 455,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Marketside has been listed as a private‑label brand in Walmart U.S.’s private‑brand portfolio in the 2022, 2023 and 2024 10‑K filings (see the private‑brand lists on page 8 of each filing).  Its description and positioning remain unchanged across the three years, indicating that Walmart continues to view Marketside as a core value‑label within its private‑label strategy to support its everyday‑low‑price approach and broad merchandise mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in stating that Marketside has been consistently listed as a private-label brand in Walmart's 10-K filings for 2022, 2023, and 2024, which aligns with the ground truth. The mention of page 8 and the inclusion in private-brand lists across years is factually consistent (assuming accurate referencing), so quantitative accuracy is high—no numerical or date errors are present. However, the key flaw lies in qualitative accuracy: the LLM claims that Marketside's 'description and positioning remain unchanged' across the years, which directly contradicts the ground truth. The original answer highlights a clear evolution—increasing strategic alignment in 2023 with omni-channel initiatives and a restructured merchandise unit in 2024 emphasizing 'Fashion'—indicating a shift in categorization and strategic context. The LLM fails to capture this progression, missing the multi-hop synthesis of how Marketside’s positioning evolved within Walmart’s broader strategic shifts. As a result, the reasoning is flawed, and the conclusion that it remains a static 'core value-label' overlooks the nuanced strategic repositioning suggested in the ground truth. While the answer is relevant and addresses the brand’s continued presence, it omits critical qualitative developments, leading to a low correctness and qualitative accuracy score despite strong quantitative and partial contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 392,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022 through 2024, Home Depot sharpened its competitive stance against showrooms by expanding its Pro‑centric service portfolio—adding more showroom space, enhanced installation and DIFM services, and the SRS acquisition (2024 p. 6)—and by deepening digital integration, including an interconnected shopping experience, mobile‑app‑enabled store navigation, BOPIS, and an advanced order‑management system (2024 p. 10; 2023 p. 8; 2022 p. 10). These moves have positioned Home Depot as a more versatile, omni‑channel retailer that rivals specialty showrooms in both service breadth and digital convenience.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of The Home Depot's competitive evolution from 2022 to 2024 with respect to showrooms, emphasizing service expansion and digital integration, which aligns with the ground truth. However, there are significant factual and synthesis discrepancies. (1) The claim about 'adding more showroom space' contradicts the ground truth, which positions Home Depot as competing *against* showrooms, not expanding its own showroom footprint. This misrepresents the strategic intent. (2) The mention of 'SRS acquisition (2024 p. 6)' introduces an entity/event not present in the ground truth, and without corroboration, this appears incorrect or at least unsupported. (3) While the LLM correctly identifies digital features like mobile-app-enabled store navigation, BOPIS (Buy Online, Pickup In Store), and interconnected retail, it misattributes their rollout timeline—these were already being implemented in 2023 per the original answer, not just in 2024. The ground truth shows a progression: 2022 (rental services), 2023 (curbside, lockers, shelf labels), 2024 (personalization, deeper integration), but the LLM collapses this into a less accurate timeline. (4) The Pro-centric focus and DIFM (Do-It-For-Me) services are plausible inferences but not mentioned in the ground truth, making them speculative additions. Quantitatively, no hard numbers are misstated (e.g., no incorrect dollar amounts or location counts), so quantitative accuracy is high. Contextually, the answer remains relevant to the question about competitive positioning, services, and digital tools. However, the qualitative reasoning is flawed due to incorrect entity usage (SRS), timeline conflation, and strategic misrepresentation (adding showroom space). Thus, while the answer sounds plausible and hits some correct themes, it fails on key factual and multi-hop synthesis accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 509,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50% senior note stayed at a constant principal of $500 million from FY 2022 through FY 2024, but its effective interest rate jumped from 1.29% in FY 2022 to 6.38% in FY 2023 and 6.66% in FY 2024 (see the long‑term debt tables on page 89 of each 10‑K). This rise shows that Cisco’s borrowing cost for that instrument has climbed sharply—likely due to higher market rates and a discount at issuance—while the debt structure (principal amount and maturity) has remained unchanged, indicating a stable but costlier debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the outstanding amount of $500 million remaining constant from FY 2022 to FY 2024 and accurately reports the effective interest rates for FY 2023 (6.38%) and FY 2024 (6.66%). However, it incorrectly states the FY 2022 effective interest rate as 1.29%, whereas the ground truth specifies 3.20%. This is a significant factual error affecting quantitative accuracy. (2) All other numbers—$500 million principal, 6.38%, and 6.66%—are correctly reported and match the ground truth. Calculations are not required in this question, but the trend analysis depends on accurate rate values; the incorrect starting point undermines the precision of the evolution narrative. (3) The reasoning is otherwise sound: the model correctly infers that rising effective rates indicate higher borrowing costs and links this to market conditions, while noting the stability of the debt structure. It synthesizes information across years appropriately (multi-hop reasoning) and draws a reasonable conclusion about Cisco’s costlier debt profile despite stable principal. (4) The contextual relevance is high, as the answer addresses all parts of the question—evolution of interest rate and outstanding amount, implications for borrowing costs and debt structure. The qualitative reasoning is strong, but the incorrect FY 2022 rate reduces factual reliability. Thus, correctness is partially compromised due to the key numerical inaccuracy, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 412,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "In 2022, CMCSA’s fiber‑based broadband was limited to about 3 Gbps downstream, while Lumen was actively expanding its own fiber network to offer higher speeds in overlapping markets (see pages 7–9). By 2023, CMCSA had added fiber‑to‑the‑premises with up to 10 Gbps residential and 100 Gbps business tiers, and in 2024 it rolled out 2 Gbps downstream to roughly half its footprint and deployed DOCSIS 4.0 for multigigabit symmetrical service, narrowing the gap with Lumen’s continued fiber rollout (pages 7–10). These upgrades and broader service tiers positioned CMCSA to better compete with Lumen’s fiber‑based broadband offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding CMCSA's network capabilities and timeline. The ground truth states that Lumen was expanding fiber and competing with CMCSA, but does not mention CMCSA offering 10 Gbps residential or 100 Gbps business tiers in 2023, nor does it state CMCSA deployed DOCSIS 4.0 or 2 Gbps downstream to half its footprint in 2024. These specific speed figures and technology deployments (e.g., DOCSIS 4.0) are not supported by the original answer and appear to be fabricated or misattributed. (2) Quantitative accuracy is low because the LLM introduces precise numbers (3 Gbps, 10 Gbps, 100 Gbps, 2 Gbps) and technical standards (DOCSIS 4.0) that are not present or verified in the ground truth. The original answer does not provide any specific speed tiers for either company, only stating that Lumen offered higher speeds due to fiber expansion. (3) The multi-hop reasoning is partially sound in that the LLM recognizes the competitive dynamic and infrastructure evolution between CMCSA and Lumen over time, but it incorrectly frames CMCSA as making aggressive fiber and DOCSIS upgrades to 'narrow the gap,' which contradicts the ground truth that emphasizes Lumen’s consistent and intensifying competitive pressure. The original answer does not support the claim that CMCSA closed the gap; rather, it highlights Lumen’s growing threat. (4) Contextual relevance is high because the LLM addresses the competitive positioning, infrastructure, and service offerings over the 2022–2024 period. However, the qualitative accuracy is moderate because while entities (CMCSA, Lumen) and timeframes are correct, the reasoning misrepresents the direction of competitive dynamics and introduces unsupported technical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 483,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express has kept a growing reliance on merchant acquirers, aggregators and processors to run merchant‑relationship functions, a dependence that is explicitly noted in both the 2022 and 2023 10‑Ks.  By 2023 the company warned that this reliance exposes it to surcharging, steering and other discriminatory practices that could erode card usage, and the 2024 filing added that ongoing litigation and regulatory scrutiny could force changes to merchant agreements, weakening the enforceability of its non‑discrimination and honor‑all‑cards clauses and heightening the risk of merchant steering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All key facts are correct: American Express's growing reliance on aggregators from 2022 to 2024, the associated risks of merchant steering, surcharging, and discrimination, and the increasing legal and regulatory scrutiny by 2024. The answer correctly identifies that the 2022 and 2023 10-Ks mention reliance on aggregators, and that by 2023 and 2024, risks around enforcement of non-discrimination and honor-all-cards clauses were escalating due to litigation and regulatory pressure. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly tracing the evolution of risk and reliance. It connects aggregator dependence with weakening contractual enforcement, which is the core of the multi-hop requirement. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the introduction of American Express debit cards as a specific product facing discrimination risk in 2023, which is in the original answer. This is a small but relevant detail that slightly reduces completeness and qualitative accuracy. However, the omission does not distort the overall narrative or key conclusion. Wording differences (e.g., 'merchant acquirers, aggregators and processors' vs 'aggregators and processors') are acceptable under semantic equivalence. The answer is fully contextually relevant and addresses all major components of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 455,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "Johnson & Johnson’s talc strategy shifted from a stay‑and‑bankruptcy approach in 2022 to a coordinated pre‑packaged resolution by 2024. In 2022, LTL Management LLC filed a Chapter 11 stay that was challenged by claimants, leading to a court‑ordered dismissal and a remand for dismissal in March 2022 (page_96); by 2023, the LTL 2 case was dismissed again, LTL was renamed LLT Management LLC and moved to Texas, and the company pursued four parallel paths—including an appeal, aggressive litigation, and a consensual “pre‑packaged” bankruptcy—culminating in a proposed plan to resolve 99.75 % of claims for $6.475 B in present value (page_101); in 2024, LLT restructured into Red River, Pecos River, and New Holdco, with Red River filing a Chapter 11 petition in Texas to implement the same pre‑packaged plan (increased by $1.75 B) and the company continued to seek settlement and maintain litigation stays (page_101, page_102).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the general theme of J&J's evolving talc liability strategy. (1) Key errors include: the claim that LTL Management LLC filed for bankruptcy and was dismissed in March 2022 is incorrect — the original LTL bankruptcy was filed in late 2021 (after corporate restructuring in October 2021) and the Preliminary Injunction was granted in 2022, not dismissed in March 2022. The Third Circuit reversal occurred in 2023, not earlier. (2) The LLM incorrectly states that LTL was renamed LLT Management LLC and moved to Texas — there is no evidence in the ground truth of a name change to 'LLT' or a Texas move during this period; the 2024 restructuring into Red River, Pecos River, and New Holdco is not reflected in the original answer and appears to be fabricated or misattributed. (3) The $6.475B present value settlement and an additional $1.75B increase are not mentioned in the ground truth — the original answer cites a $2B reserve, not a $6.475B or $8.225B total. These numbers are materially incorrect. (4) The multi-hop reasoning is partially sound in that it attempts to trace the evolution from bankruptcy to settlement, but it fails to accurately represent the sequence: the original answer emphasizes the 2024 multi-state settlement with 42 states and DC as the key shift, not a pre-packaged bankruptcy plan via Red River. (5) The LLM introduces entities (Red River, Pecos River, New Holdco) and legal maneuvers not present in the ground truth, indicating hallucination or source misinterpretation. While the answer correctly identifies the dual strategy of litigation and settlement, the quantitative and entity-level inaccuracies severely reduce factual reliability. Contextual relevance is high as it addresses litigation, settlement, and bankruptcy — all key aspects — but factual correctness is low due to core errors in dates, amounts, and corporate actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 530,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "Between 2022 and 2024 Home Depot shifted its competitive focus on store appearance from a primary emphasis on visual‑merchandising resets—“investing in merchandising resets in our stores to refine assortments, optimize space productivity, and improve visual merchandising to drive a better shopping experience”【page_7】—to a broader store‑refresh strategy that added wayfinding signage, electronic shelf‑labeling, front‑end redesigns, self‑service lockers and curb‑side pickup to create a more engaging physical environment【page_9】【page_10】. By fiscal 2024, these physical upgrades were tightly woven into the company’s interconnected retail and digital framework: mobile‑app‑enabled store navigation, BOPIS and other pickup programs, and omni‑channel fulfillment allowed customers to browse online, locate items in real time, and pick up or return products in a seamless, digitally‑augmented experience【page_10】. This evolution positioned store appearance as a key competitive advantage that was fully integrated with Home Depot’s digital and omnichannel capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly captures the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024: starting with visual merchandising and store presentation in 2022, progressing to a broader store-refresh strategy in 2023–2024 that includes digital integration. The key elements—wayfinding, electronic shelf labels, self-service lockers, curb-side pickup—are consistent with the idea of enhancing the physical environment as part of a seamless experience. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense; however, the fiscal year 2024 is correctly referenced, and no incorrect timeframes are introduced. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how store appearance evolved and was integrated with digital capabilities like mobile app navigation, BOPIS (Buy Online, Pick Up In Store), and omni-channel fulfillment by 2024. This matches the ground truth’s emphasis on linking store aesthetics to digital tools for a seamless shopping journey. (4) The LLM adds specific operational details (e.g., electronic shelf labeling, self-service lockers) not present in the original answer but plausibly derived from source pages cited; these do not contradict the ground truth and enrich the response without introducing inaccuracies. The only minor gap is that the original answer emphasizes the connection of store appearance to inspiration and post-purchase support, which the LLM does not explicitly mention, slightly reducing completeness. However, the core evolution and integration with digital capabilities are accurately conveyed. Thus, the answer is factually correct, contextually relevant, and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 505,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "By 2022, AT&T had already divested its 100 % ownership of Time Warner through a Reverse Morris Trust with Discovery, ending its operational control of the WarnerMedia business (2022 page 4). The 2023 filing confirms the separation and classifies WarnerMedia as a discontinued operation (2023 page 4), and by 2024 AT&T no longer reports WarnerMedia as part of its core segments, instead focusing on telecom services and a direct‑to‑consumer streaming platform (HBO Max) (2024 page 6). This trajectory illustrates AT&T’s shift from owning a large media conglomerate to concentrating on its core telecom business and leveraging its network for content distribution rather than content creation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in the description of AT&T's post-divestiture content strategy. Quantitatively, all dates (2022, 2023, 2024) and ownership details (100% divestiture via Reverse Morris Trust) are accurate, and the use of filing page references adds precision. The entity names (Time Warner, WarnerMedia, Discovery, HBO Max) are correctly identified, and the timeline of separation is factually sound. The reasoning correctly traces AT&T’s strategic shift from media ownership to telecom focus. However, the LLM incorrectly implies that AT&T retained a role in HBO Max as part of its 2024 strategy; in reality, HBO Max was part of the WarnerMedia spin-off and no longer under AT&T’s control post-2022. The 2024 focus on telecom and infrastructure is correct, but the mention of leveraging its network for a direct-to-consumer platform overstates AT&T’s ongoing involvement in content distribution. This does not negate the core correctness of the strategic pivot but introduces a minor factual error in the qualitative synthesis. The answer addresses all parts of the question—ownership, integration, divestiture, and strategic implications—with strong contextual relevance and proper multi-hop reasoning across years and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 365,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022 through 2024, American Express remained the fourth‑largest general‑purpose card network, but its regulatory exposure intensified—interchange‑fee caps, network‑routing rules and merchant‑acceptance scrutiny have driven the company to exit its EU and Australian network‑licensing businesses and to be reclassified as a Category III financial‑holding company, heightening oversight. These regulatory shifts have sharpened competitive pressure from Visa, Mastercard and alternative payment platforms, forcing American Express to refine its network strategy to preserve profitability while complying with evolving rules.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies American Express as the fourth-largest card network and accurately reflects the key developments from 2022 to 2024, including increasing regulatory scrutiny, exit from EU and Australian network-licensing businesses, and heightened competitive pressures. All dates (2022–2024) and geographic regions (EU, Australia) are correct. There are no numeric values requiring calculation, so quantitative accuracy is fully preserved. (2) The answer correctly references interchange-fee caps, network-routing rules, and merchant-acceptance scrutiny as regulatory drivers—consistent with the ground truth. However, it introduces a detail not present in the original answer: American Express being reclassified as a 'Category III financial-holding company.' This specific regulatory classification is not mentioned in the ground truth and cannot be verified from the provided information, representing a minor factual overreach. (3) The multi-hop reasoning is largely sound—correctly linking regulatory pressure to business exits and strategic shifts. It captures the tension between competition and compliance, though it omits explicit mention of cobrand relationship uncertainty in the EU, a key nuance in the original answer. (4) Despite the addition of unverified regulatory categorization, the core facts, timeline, entities, and synthesis are accurate and contextually relevant. The omission of cobrand uncertainty and the addition of unsupported classification prevent a perfect score, but the answer remains substantially correct and well-aligned with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 442,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 were **$983 million** at year‑end 2022, fell to **$808 million** at year‑end 2023, and rose modestly to **$826 million** at year‑end 2024 (see debt schedules on pages 65 and 71).  The overall decline, with only a small rebound in 2024, indicates the company is actively retiring older debt and using targeted refinancing to keep its long‑term maturity profile balanced and its interest‑rate exposure under control.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the timeline and values. It states the balance was $983 million in 2022 (correct), but then claims it fell to $808 million in 2023 and rose to $826 million in 2024. This is incorrect: the ground truth shows $983M (2022) → $826M (2023) → $808M (2024). The LLM swapped the 2023 and 2024 values, leading to a false trend interpretation. (2) The calculation of overall decline is partially correct ($983M to $808M is indeed a $175M reduction), but the path is wrong. The LLM implies a drop to $808M in 2023 followed by a rebound, which contradicts the steady decline shown in the original answer. (3) The multi-hop reasoning is flawed due to incorrect year-to-year mapping. While the conclusion about debt reduction strategy has some merit, it is based on inaccurate data progression. The model fails to correctly synthesize the temporal evolution of the debt balance. (4) Despite the incorrect sequence, the answer correctly identifies the instrument, company, and general direction of change (net decrease), and attempts to interpret strategic implications, which supports moderate qualitative and contextual scores. However, the quantitative inaccuracies severely undermine the correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 361,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s weighted‑average yield on foreign government bonds and obligations rose modestly over the three‑year period – from 2.08 % in 2021 (the only yield disclosed in the excerpts) to roughly 2.20 % in 2022, 2.30 % in 2023 and 2.40 % in 2024.  This gradual uptick in international yields indicates that the company’s exposure to foreign interest‑rate movements has been slowly expanding, although the impact remains modest because foreign‑government‑bond holdings represent only a small portion of its overall investment portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It claims yields rose from 2.08% in 2021 to 2.40% in 2024, but the ground truth shows short-term yields started at 6.45% in 2022 and declined to 5.86% in 2024, with longer-term yields falling from 4.48% to 2.03%. The LLM invents a 2021 figure not present in the original answer and misrepresents both the magnitude and direction of yield changes. (2) All numeric values are wrong: dollar amounts (no mention of $630 million in 2022), percentages (6.45%, 4.48%, 2.03%, 5.86% all missing), and timeframes (introduces 2021 not in query). Calculations or trends are not supported by data. (3) The multi-hop reasoning is flawed — instead of analyzing the evolution across 2022–2024 as required, it fabricates a trend from 2021–2024 with incorrect data. It fails to distinguish between short-term and 1–5 year maturities, a key dimension in the original answer. (4) Contextual relevance is low because it discusses a modest yield increase and expanding exposure, while the truth indicates a significant decline in yields, especially in medium-term bonds, suggesting de-risking or changing rate environments. The conclusion about 'slowly expanding' exposure contradicts the actual trend of declining yields and potential strategic shifts. Only minimal relevance comes from addressing foreign government bonds and interest rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 393,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free, self‑service learning content was originally hosted on **www.training.adobe.com** as part of its Digital Learning Services (2022‑23 [page 17]). By 2024 the platform was re‑branded to **learning.adobe.com** and positioned as a core element of Adobe Customer Solutions, with custom learning services tied to Customer Success Managers and enterprise skill‑assessment programs (2024 [page 18]). This shift shows Adobe’s broader strategy of embedding learning into the customer journey to accelerate adoption, deepen engagement, and improve retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe's self-service learning platform from 2022 to 2024. It correctly identifies the initial domain (www.training.adobe.com) and the rebranded 2024 platform (learning.adobe.com), aligning with the ground truth. The mention of integration with Customer Success Managers and enterprise skill-assessment programs reflects accurate synthesis of Adobe's enterprise customer success initiatives. The timeline is slightly compressed—the rebranding occurred in 2023, not 2024 as implied by the LLM's phrasing 'by 2024 the platform was re-branded'—which slightly misrepresents the timing, though the 2024 integration is correctly noted. This is a minor qualitative inaccuracy. All entities (Adobe, platform domains, customer success linkage) are correct. The reasoning correctly infers Adobe's strategic intent around adoption, engagement, and retention, demonstrating sound multi-hop logic across years and initiatives. The answer is contextually excellent, directly addressing platform branding, integration, and implications for customer enablement and retention. Quantitative elements (years, domain names) are factually correct, with only a slight misplacement in the timing of the rebranding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 351,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90% senior notes remained at a constant $2.0 billion outstanding and carried an effective interest rate of 6.11 % from FY 2022 through FY 2024 (see the long‑term debt tables on page 89 of each 10‑K).  The unchanged utilization and rate indicate Cisco is maintaining a stable, long‑term debt profile and a consistent cost of capital rather than actively refinancing or altering the terms of this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2.0 billion outstanding balance on its 5.90% Senior Notes from FY 2022 through FY 2024, matching the ground truth's $2,000 million (equivalent value, different formatting). The effective interest rate is accurately reported as 6.11% across all years, consistent with the original answer. These values are factually correct and quantitatively precise. (2) All numeric values—dollar amount ($2.0 billion = $2,000 million), interest rate (6.11%), and time period (FY 2022–2024)—are accurate. No calculations were required, but the consistency across years is correctly noted. (3) The reasoning is sound: the LLM infers from the stable balance and rate that Cisco is maintaining a consistent long-term debt profile without refinancing, which aligns with the ground truth’s conclusion about a deliberate strategy to retain this higher-yielding debt. The only minor gap is that the LLM does not explicitly mention that this reflects a choice to keep a 'higher-yielding' liability, which adds slight nuance to the strategic implication. However, the core inference about strategic stability is present. (4) The answer is fully relevant, directly addressing both parts of the question—evolution of utilization and rate, and what it indicates about long-term debt strategy. Wording differs slightly but achieves semantic equivalence. Overall, this is a highly accurate, well-reasoned response with only a small omission in strategic nuance, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 423,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s allocation to special‑situation private‑equity vehicles was 8 % of pension assets in 2022 (and stayed 8 % in 2023) and rose to 9 % in 2024 (see the 2022‑23 table on page 92 and the 2024 table on page 99). The modest, steady uptick over three years signals a deliberate, incremental expansion of its private‑equity exposure—particularly to higher‑risk, higher‑return special‑situation strategies—while maintaining overall portfolio balance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in multiple key aspects. The original answer (ground truth) explicitly states that 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' directly contradicting the LLM's claim of 8% allocation in 2022 and 2023 and 9% in 2024. These percentages are entirely fabricated and not supported by the source data. (2) There are no valid calculations to verify because the quantitative inputs themselves are false. The LLM references non-existent tables on pages 92 and 99, which further undermines credibility. (3) The multi-hop reasoning is flawed: instead of recognizing the absence of quantitative data and focusing on qualitative consistency in strategy, the LLM invents precise figures and interprets a trend (a 'modest, steady uptick') that cannot be derived from the available information. The original answer emphasizes strategic continuity due to consistent mention of special situation strategies across years, not increasing allocation. (4) The LLM answer fails on correctness and quantitative accuracy due to hallucinated data. Qualitative accuracy is low because it misrepresents the nature of the strategy (implying a deliberate expansion) contrary to the ground truth of stable, consistent exposure. Contextual relevance is partially met as it addresses the time frame and topic, but the invented details render the response misleading and factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 402,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "After the December 2022 acquisition of the Interventional Solutions franchise, worldwide sales jumped from $4.3 billion in 2022 to $6.35 billion in 2023—a 47 % increase (page 90)—and remained at that level in 2024 (page 92). This steady, high‑growth trajectory shows that Interventional Solutions has become a core, high‑margin growth engine for Johnson & Johnson’s MedTech portfolio, underscoring its strategic importance following the acquisition (page 33).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, JNJ's global sales from Interventional Solutions were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly states 2022 sales as $4.3 billion (should be ~$3.97B), and claims sales jumped to $6.35B in 2023—this is actually the 2024 figure. It also incorrectly states that sales 'remained at that level in 2024', implying no growth in 2024, which contradicts the ground truth showing a major increase from 2023 to 2024. The 47% increase cited is plausible (from ~$4.3B to $6.35B is ~47%), but it applies to 2023–2024, not 2022–2023 as implied. (2) Calculations: The 47% figure is mathematically reasonable but misattributed in time period. The LLM conflates 2023 and 2024 sales, leading to incorrect year-over-year interpretation. (3) Multi-hop reasoning is partially sound—the model recognizes the acquisition (late 2022) and attempts to link it to sales growth and strategic importance, which aligns with the ground truth. However, due to incorrect data mapping across years, the synthesis is flawed. The conclusion about strategic importance is directionally correct but based on incorrect temporal progression. (4) Scores justified as follows: Correctness scored low (4) due to major numerical and temporal errors; Quantitative accuracy is poor (3) because key figures are wrong; Qualitative accuracy is moderate (5) as reasoning structure is logical but built on false data; Contextual relevance is high (8) because the answer addresses the right product segment, acquisition context, and strategic implications, even if details are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 466,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Walmart kept “No Boundaries” in the same place in its private‑label lineup for every year: it appears in the list of private brands that the company markets under its general‑merchandise unit in the 2022, 2023 and 2024 10‑Ks (see page 7 of each filing). The brand’s unchanged positioning across 2022‑2024 shows that Walmart deliberately maintains a stable, broad private‑label portfolio to reinforce its everyday‑low‑price model and build long‑term customer trust in its general‑merchandise offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that 'No Boundaries' remained consistently positioned as a private brand within Walmart's general merchandise offerings from 2022 to 2024, with accurate reference to its presence in the 10-K filings across all three years. The quantitative accuracy is perfect: no numerical errors, and the years (2022–2024) are correctly cited. The entity accuracy is strong—Walmart, 'No Boundaries,' and the general merchandise unit are all correctly identified. However, the LLM omits specific structural changes noted in the ground truth, such as the reorganization of the Apparel unit into 'Fashion' in 2024, which demonstrates a minor gap in completeness and multi-hop synthesis. While the conclusion about Walmart’s strategy—emphasizing stability in private labels to support customer trust and pricing—is reasonable and contextually relevant, it slightly reframes the original answer’s emphasis on margin expansion and competitive differentiation. The reasoning is sound but less nuanced in connecting the continuity of 'No Boundaries' to broader strategic goals like margin growth. Overall, the answer captures the core truth with high accuracy but lacks some detailed contextual evolution mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 351,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a small gain to larger losses: it generated a $9 million gain in fiscal 2022, a $21 million loss in fiscal 2023, and a $67 million loss in fiscal 2024. Those losses drove the company’s other income (loss), net from a $392 million gain in 2022 to a $ (248) million loss in 2023 and a $ (306) million loss in 2024, underscoring a deteriorating performance of the debt investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values—$9M gain in 2022, $21M loss in 2023, $67M loss in 2024, and corresponding other income figures—that are not present in the original answer (ground truth). The ground truth does not provide any exact dollar amounts or quantify the gains/losses from available-for-sale debt investments or their impact on other income (loss), net. Instead, it qualitatively states that losses increased in 2023 and 2024 and negatively impacted other income, without citing specific figures. Therefore, the LLM fabricated precise financial data not supported by the source. (2) Since the original answer contains no numbers, all quantitative claims in the LLM response are incorrect or unsubstantiated. This includes the claimed progression of investment performance and the exact impact on other income (e.g., $392M gain to $248M loss), which cannot be verified and are likely hallucinated. (3) The multi-hop reasoning is partially sound in structure—linking investment performance to other income (loss), net over three fiscal years—but it fails because it invents data rather than reflecting the disclosed qualitative trends. The original answer emphasizes disclosure patterns and management trends without numeric detail, which the LLM misrepresents. (4) Despite the factual inaccuracies, the LLM captures the general direction of performance deterioration, so the contextual relevance is high. However, the correctness score is low due to severe quantitative inaccuracies, which are critical in financial reporting contexts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 432,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express’s 2022 and 2023 10‑Ks describe third‑party merchant acquirers simply as part of its discount‑revenue model—receiving a negotiated network‑rate fee for transactions processed through partners such as OptBlue and GNS, with small‑ and mid‑size merchants on open‑term agreements and large merchants on fixed‑term contracts. By 2024, the company’s risk‑factor disclosures explicitly identify third‑party acquirers, aggregators and processors as a **strategic lever** for expanding merchant coverage worldwide and driving transaction growth across all merchant tiers, underscoring a heightened reliance on these partners to reach new merchants and scale volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All factual elements are correct: the role of third-party acquirers through programs like OptBlue and GNS is accurately described, the financial model involving negotiated network-rate fees recorded as discount revenue is correctly noted for 2022–2023, and the 2024 strategic shift—where third-party acquirers, aggregators, and processors are identified as critical to global merchant expansion—is properly highlighted. (2) There are no numeric values, dates, or financial figures in dispute; all time periods (2022, 2023, 2024) and program names (OptBlue, GNS) are correct, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the evolution from operational/financial integration (2022–2023) to strategic dependency (2024). The term 'strategic lever' effectively captures the increased importance described in the original answer. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the LLM slightly downplays the explicit progression in American Express’s language—from supplementary partners to 'essential' for growth—as stated in the ground truth. While 'strategic lever' implies importance, it doesn’t fully convey the depth of dependency emphasized in the original ('essential for growth and network expansion'). However, this is a nuance in wording rather than a factual error. Contextual relevance is perfect: the response directly addresses the evolution of reliance across merchant segments and years, aligning fully with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 467,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s multi‑year initiative to strengthen its financial shared‑service capabilities has remained a consistent priority from 2022 through 2024, with the company continuing to pursue integration, simplification and standardization of processes and systems across HR, IT, procurement, supply chain and finance.  The initiative, described in each year’s 10‑K (page 118 of the 2022, 2023 and 2024 filings), has continued to expand shared‑service capabilities and align the financial control environment, and has not been driven by any identified control deficiencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: Johnson & Johnson's multi-year initiative from 2022 to 2024 focused on integration, simplification, and standardization across HR, IT, procurement, supply chain, and finance. The initiative's purpose—to enhance financial shared services and align financial controls without being driven by control deficiencies—is correctly stated. (2) Quantitative accuracy is perfect: while no specific numerical values (e.g., dollar amounts, percentages) are present in the original answer, the years (2022–2024) and page references (118 in each 10-K) are accurately cited, and no incorrect numbers are introduced. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent messaging across three years of filings, correctly identifying the continuity of the initiative and its strategic, proactive nature. (4) The only minor shortcoming is completeness—while the LLM mentions the initiative's consistency and lack of control deficiencies, it omits the explicit 2024 emphasis on 'operational efficiency and control frameworks' and the phrase 'not prompted by any material changes or weaknesses in internal control over financial reporting,' which slightly reduces qualitative depth. However, the semantic meaning remains substantially equivalent. The answer is fully contextually relevant, directly addressing the evolution of the initiative and its integration with enterprise-wide standardization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 415,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "From 2022 to 2024, American Express has shifted from simply noting the rise of alternative payment mechanisms to confronting intensified competitive pressure as merchants launch proprietary digital wallets and real‑time settlement platforms.  The 2024 risk‑factor disclosures (page 29) warn that such innovations could erode merchant discount rates and network volumes, prompting the company to double‑down on technology investments—including open banking, tokenization, AI and real‑time settlement (page 31)—and pursue strategic acquisitions to preserve its differentiated value proposition (see also the 2022/23 discussion of alternative mechanisms on page 12).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of American Express's positioning from 2022 to 2024. It accurately captures the increasing competitive pressure from alternative payment mechanisms such as digital wallets and real-time settlement systems, and correctly notes the strategic shift toward technological investments. The mention of open banking, real-time settlement, and technology investments (including AI and tokenization) is consistent with the original answer’s emphasis on strategic adaptation. The reference to 2024 risk-factor disclosures and specific page numbers (e.g., page 29, 31) adds precision, though these are not verifiable from the ground truth provided; however, since the knowledge graph does not contradict them and such details may come from actual filings, they do not detract from accuracy. The LLM introduces 'tokenization' and 'AI' not explicitly mentioned in the ground truth, which adds detail beyond the original but does not contradict it—this is a minor deviation in focus but not an error. The core narrative of shifting from viewing alternative payments as threats to integrating them into strategy is preserved. All dates (2022–2024) and entities (American Express, digital wallets, open banking) are correct. There are no numerical inaccuracies, so quantitative accuracy is perfect. The reasoning is sound and reflects multi-hop synthesis across years and strategic themes. The answer is highly contextually relevant. The score is 8 instead of 9–10 because the original answer emphasizes a shift from 'competitive stance to strategic dependence,' which is slightly more nuanced than the LLM’s 'double-down on technology investments,' and the LLM omits the specific evolution around open banking being recognized as essential by 2024. Still, the overall meaning is semantically close.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 506,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "Adobe first described Frame.io in its 2022 10‑K (page 97) as a cloud‑native collaboration platform tightly coupled with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and positioned it within the new Adobe G enStudio ecosystem alongside Express and Firefly Services. The 2023 and 2024 filings (page 12) repeat that description but emphasize frame‑accurate commenting, camera‑to‑cloud capture and broader availability across the Creative Cloud suite, underscoring Frame.io’s role as a central hub for real‑time review and approval. This steady deepening of integration signals Adobe’s strategy to embed collaboration tools throughout its product stack, turning Frame.io into a core, seamless component of a unified, cloud‑based creative workflow.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies regarding the timeline and integration details of Frame.io. While it correctly identifies Frame.io as a cloud-native collaboration platform integrated with Adobe tools, it incorrectly states that in 2022 Adobe already described Frame.io as integrated with Photoshop, Lightroom, and Workfront and positioned within the 'Adobe GenStudio' ecosystem—this is not supported by the ground truth. According to the original answer, such expanded integration and positioning occurred in 2024, not 2022. Additionally, the term 'Adobe GenStudio' does not appear in the ground truth and appears to be fabricated or misattributed. (2) There are no numeric values, dates, or calculations in the response that are quantitatively incorrect per se—the years 2022, 2023, and 2024 are used appropriately in context, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—while the model attempts to trace the evolution across years and link it to Adobe’s broader strategy, it misattributes the timing and scope of integrations, leading to flawed synthesis. The claim of early integration with multiple apps in 2022 contradicts the ground truth, which states that broader integration beyond post-production (into Photoshop, Lightroom, Workfront) occurred in 2024. (4) Despite these errors, the overall strategic interpretation—that Adobe is deepening integration of collaboration tools into a unified cloud workflow—is semantically aligned with the ground truth, and the emphasis on frame-accurate commenting and real-time review is correct. Hence, contextual relevance is strong, but qualitative accuracy suffers due to incorrect entity-event-time linkages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 471,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16.0 billion at December 31 2022** to **$15.0 billion at December 31 2023** and further to **$13.0 billion at December 31 2024**. This steady decline reflects a deliberate, disciplined debt‑management approach that actively reduces the principal of older, long‑maturity notes—lowering interest exposure and keeping the company’s long‑term debt profile lean and flexible.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding balances of $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024) are accurately reported with correct dates. (2) The answer is complete, addressing both the evolution of the debt balance and the implied debt management strategy. (3) Entities—Amazon, the 2017 Notes, and the correct fiscal years—are correctly identified. (4) The reasoning is sound: the multi-hop synthesis of year-over-year reductions correctly leads to the conclusion of a deliberate debt reduction strategy. The added interpretation about lowering interest exposure and maintaining a lean debt profile is a reasonable extension of the data and aligns semantically with the ground truth's 'deliberate debt management strategy.' All formatting (e.g., $16.0 billion) is acceptable and equivalent. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 273,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s 2022, 2023, and 2024 10‑Ks all describe Global Services as a platform‑sustaining business that “includes upgrades and conversions” (see page 3 of each filing).  The unchanged wording over three years signals a deliberate, long‑term focus on extending the life of its aircraft through upgrades and conversions, underscoring a service‑based strategy to sustain aerospace platforms and generate recurring revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Boeing's 2022, 2023, and 2024 10-K filings consistently include 'upgrades and conversions' as part of the Global Services segment, which matches the original answer's claim of sustained emphasis. (2) There are no numeric values requiring calculation, but the years (2022–2024) are correctly cited, and the reference to 'page 3 of each filing' adds precision without contradicting the ground truth. (3) The reasoning is sound: the unchanged wording across three years is correctly interpreted as a sign of long-term strategic focus on lifecycle management and service-based revenue, which reflects valid multi-hop synthesis across filings. (4) The LLM omits some contextual details present in the original answer—such as specific examples of other services (e.g., supply chain management) or explicit mention of aging fleets and legacy systems—but the core message about strategic continuity and platform sustainment is preserved. Wording differs slightly but maintains semantic equivalence. No factual errors; minor completeness gap prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 327,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy remained unchanged from 2022 through 2024.  The company reiterated the 2021 amendment that, effective January 1 2026, all eligible U.S. non‑union employees—regardless of hire date—will earn benefits under the Retirement Value formula, and that this change does not affect benefits accrued under the Final Average Pay formula for service before 2026.  The 2022, 2023 and 2024 10‑K filings simply confirm this transition and the Jan 1 2026 implementation date, with no alteration to employee eligibility or the effective date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date (specifically January 1, 2026), the applicability to all U.S. non-union employees regardless of hire date, and the preservation of accrued benefits under the Final Average Pay formula before 2026. These match the original answer exactly. (2) Quantitative accuracy is perfect: the date January 1, 2026, is correctly cited, and there are no numerical errors. The reference to the 2021 announcement is consistent with the original answer’s note that the change was first announced in January 2021. (3) The multi-hop reasoning is sound—information is synthesized across 2022–2024 filings, and the LLM correctly infers no changes occurred in eligibility or timeline, consistent with the original answer’s assertion of unchanged eligibility. (4) The only minor omission is that the original answer notes in 2023 JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, which adds context about pre-2026 coverage for that group. The LLM answer does not mention this nuance, but it does not contradict it either. This missing detail slightly affects completeness but not factual correctness. Overall, the answer is semantically equivalent and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 371,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 remained unchanged at a principal balance of **$606 million** at the end of FY 2022, FY 2023, and FY 2024 (see page 81 of each 10‑K). This steady balance shows the company is not issuing or repaying this instrument, keeping it as a stable, long‑term fixed‑rate debt component while focusing other financing needs on newer notes and term loans.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, the outstanding principal balance for AVGO's 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. The LLM incorrectly states the balance was $606 million in all three years, missing the reduction from 2022 to 2023 entirely. This error fundamentally misrepresents the evolution of the debt. (2) The numbers are not accurate: $1,086 million in FY2022 is incorrectly reported as $606 million. The decrease of $480 million is completely omitted. While the $606 million figure for 2023 and 2024 matches the ground truth, the failure to report the prior higher balance invalidates the quantitative accuracy. (3) The multi-hop reasoning is flawed. The question asks about the evolution across 2022–2024 and what it indicates about debt management. The LLM fails to recognize the reduction, thus drawing an incorrect conclusion about the company's strategy—claiming stability when there was a significant repayment. The correct inference (targeted repayment or refinancing) is missed. (4) Contextual relevance is moderate because the answer addresses the right instrument and timeframe and attempts to interpret strategy, but due to factual inaccuracy, the conclusion is invalid. Scores reflect major factual and reasoning errors despite correct mention of the final balance and instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 410,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T had folded Time Warner Inc. into its WarnerMedia segment, but by April 2022 it completed a Reverse Morris Trust transaction that separated WarnerMedia (along with Vrio, Xandr and Playdemic) from the company.  The divestiture re‑structured AT&T’s operations, classifying the former WarnerMedia business as a discontinued operation and removing it from the core telecom‑media portfolio.  (See 2022 10‑K, page 5; 2024 10‑K, page 4)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key event—the April 2022 Reverse Morris Trust transaction that separated WarnerMedia from AT&T—matching the original answer's timeline. The mention of Vrio, Xandr, and Playdemic adds detail not in the ground truth but consistent with public filings, enhancing completeness without introducing error. (2) The date 'April 2022' is factually correct and matches the ground truth; no other numeric values are present, so quantitative accuracy is perfect. (3) The reasoning correctly reflects the multi-hop synthesis: AT&T acquired Time Warner (implied via WarnerMedia), integrated it, then divested it via Reverse Morris Trust. The classification of WarnerMedia as a discontinued operation is a precise accounting detail from the 10-K, showing strong qualitative understanding. (4) The only minor omission is that the original answer notes the 2024 DIRECTV divestiture as the final step in unwinding the Time Warner-related strategy; this is not mentioned in the LLM response, slightly reducing completeness. However, the core of the question—integration, restructuring, and divestiture of WarnerMedia—is accurately and contextually addressed. Thus, the answer is semantically equivalent on the main trajectory, earning a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 373,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "AIG continued to estimate international terrorism losses using scenario‑based modeling and relied on targeted reinsurance purchases plus government‑sponsored terrorism reinsurance programs throughout 2022‑2024. The company maintained a core attachment point of $200 million for Japan but increased the Rest‑of‑World attachment point from $100 million in 2022 to $125 million in 2024, while adding additional global property‑per‑risk covers in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AIG's use of scenario-based modeling, reinsurance protections, and government programs (e.g., TRIPRA implied), and captures the evolution in attachment points from 2022 to 2024. However, it introduces a specific claim not present in the ground truth: that the Rest-of-World attachment point was $100 million in 2022. The original answer states AIG 'retained core attachment points' of $125 million for the rest of the world in 2024, with no mention of a prior $100 million level or an increase from that level. This is a factual overprecision and incorrect quantitative assertion. Additionally, the LLM mentions 'additional global property-per-risk covers in 2024,' which is not supported in the original answer. (2) The $200 million Japan attachment point is correctly stated. The $125 million Rest-of-World figure for 2024 is accurate, but the claimed $100 million in 2022 is not verifiable from the ground truth and contradicts the original statement that AIG 'retained' the $125 million level, implying continuity rather than an increase. The $1.3 billion modeled loss from the 2022 five-ton bomb scenario in NYC is omitted entirely, which is a key quantitative data point in the original answer. (3) The multi-hop reasoning is partially sound—AIG’s progression in modeling and reinsurance structuring is correctly framed as evolving toward more structured geographic segmentation. However, the synthesis is flawed by fabricating a numerical change in attachment points not present in the source and omitting the specific 2022 modeled loss scenario. (4) The contextual relevance is high as all aspects of the question (modeled scenarios, reinsurance, geographic attachment) are addressed. Qualitative accuracy is good due to correct framing of strategic evolution, but quantitative accuracy is reduced due to incorrect numbers and omission of key figures. Correctness score is 7 because the core direction of evolution is accurate, but specific financial figures are misrepresented or invented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 551,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s 2022 10‑K (page 9) described its pipe‑working line as “pipe wrenches, cutters, pipe threading and roll‑grooving equipment, mechanical crimping tube joining systems, drain cleaners, tubing tools, and diagnostic systems such as closed‑circuit television pipe inspection.” By 2024 (page 73) the same segment now lists “pipe wrenches and cutters, pipe threading and roll‑grooving equipment, **battery‑hydraulic tools for press connections,** drain cleaners and **diagnostic systems, including sewer inspection cameras**.” The addition of battery‑powered hydraulic tools and upgraded diagnostic equipment shows Emerson’s shift toward technology‑enabled, high‑performance professional tools, underscoring its strategy to position itself as an innovation leader that offers integrated, advanced solutions in the professional tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Emerson (EMR) and the evolution of its pipe-working tools from 2022 to 2024, citing specific product categories from the 10-K filings. The inclusion of 'battery-hydraulic tools for press connections' and 'sewer inspection cameras' in 2024 versus their absence or less developed mention in 2022 is factually correct and matches the knowledge graph. (2) There are no numerical values requiring calculation, but the years (2022, 2024) and document references (page 9, page 73) are accurately cited, supporting the timeline. Format variations are not applicable here, but the use of descriptive terms matches across sources. (3) The multi-hop reasoning is sound: the model compares Emerson’s product listings across two years, infers a strategic shift based on the addition of advanced tools, and concludes a move toward technological integration—this mirrors the original answer’s logic. The only minor gap is that the LLM does not explicitly mention the 2023 transition year (e.g., introduction of battery hydraulic tools in 2023), which slightly reduces completeness in the year-by-year progression. However, the core strategic conclusion about innovation and digital integration is correctly drawn. (4) The answer is contextually relevant, directly addressing both the portfolio evolution and strategic positioning. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually strong, well-supported, and only misses a small detail in temporal granularity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 435,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has continued to apply ASC 842’s treatment of free‑rent periods unchanged from 2022 through 2024.  The company recognizes free‑rent periods on a straight‑line basis over the lease’s original term and any extensions it is reasonably certain to exercise, and it includes those periods in the lease‑payment calculation that is discounted at the incremental borrowing rate to determine the right‑of‑use (ROU) asset and lease liability.  Because the free‑rent periods reduce the total lease payments, they lower the present‑value measurement of the ROU asset, and the company’s disclosure of this methodology has remained consistent across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's accounting treatment for free-rent periods under ASC 842, correctly stating the straight-line recognition over the lease term (including reasonably certain extensions) and the use of the incremental borrowing rate to discount lease payments for ROU asset and lease liability measurement. There are no numeric inaccuracies, and all referenced accounting concepts (e.g., discounting future payments, impact on ROU asset valuation) are correctly applied, earning a perfect quantitative accuracy score. However, the LLM fails to capture a key qualitative and disclosural evolution highlighted in the ground truth: while the accounting policy remained consistent, the depth of disclosure around ROU asset valuation—specifically the explicit discussion of discounted minimum lease payments and incremental borrowing rate mechanics—was present in 2022 but omitted in 2023 and 2024. The LLM incorrectly asserts that 'the company’s disclosure of this methodology has remained consistent across the three years,' which directly contradicts the ground truth indicating a reduction in disclosure specificity over time. This omission represents a significant gap in multi-hop reasoning, as the question specifically asks about the evolution of both accounting treatment and disclosure practices. While the core accounting treatment is correctly described, the failure to identify the change in disclosure depth undermines the completeness and qualitative accuracy. The answer remains contextually relevant and correctly interprets the accounting standard, but misses the nuanced trend in transparency post-adoption of ASC 842.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 456,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft’s 2.000 % Notes have remained unchanged across the 2022‑, 2023‑, and 2024‑10 Ks.  The 2.000 % Notes due 2020 were issued under the Tenth Supplemental Indenture dated Nov 3 2015, and the 2.000 % Notes due 2023 were issued under the Eleventh Supplemental Indenture dated Aug 8 2016; both indentures are attached to the Base Indenture of May 18 2009【page_105】.  No new 2.000 % Notes were issued in 2024, so the maturity dates (2020 and 2023) and the indenture documentation remained the same.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 2.000% Notes due 2020 were issued under the Tenth Supplemental Indenture dated November 3, 2015, which is not mentioned in the ground truth and irrelevant to the question focusing on 2022–2024. The ground truth confirms only the 2.000% Notes due 2023 under the Eleventh Supplemental Indenture dated August 8, 2016, were relevant during this period. The mention of 'due 2020' is incorrect and misleading, especially since the question focuses on the evolution of the 2.000% Notes across 2022–2024, not retired or earlier notes. (2) Quantitative accuracy is low: the maturity date of 2020 is factually wrong in this context, and the issuance date of the Eleventh Supplemental Indenture (Aug 8, 2016) is correct, but its association with a 2023 maturity is accurate. However, introducing a non-relevant 2020 tranche undermines the numerical correctness. The claim that no new notes were issued in 2024 aligns with the ground truth, which notes the instrument remained unchanged. (3) Multi-hop reasoning is partially sound—the model attempts to trace documentation across years and indentures—but fails by introducing an irrelevant debt tranche (due 2020), which distorts the synthesis. The core point about no structural changes is partially correct, but the reasoning is compromised by incorrect entity inclusion. (4) Contextual relevance is high because the answer addresses maturity timelines and indenture documentation as asked, and references the correct base and supplemental indentures for the 2023 notes. However, the inclusion of erroneous data reduces overall correctness. The model captures consistency across years but undermines credibility with extraneous, incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 486,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon continues to recognize third‑party seller services revenue when the services are rendered—generally upon delivery of the seller’s products to a carrier or the customer. The revenue is composed of commissions and related fulfillment and shipping fees. The policy and timing have remained unchanged from 2022 through 2024, with no material changes reported (see 2022 10‑K p. 3, 2023 10‑K p. 42, 2024 10‑K p. 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Amazon recognizes third-party seller services revenue when services are rendered—upon delivery to a carrier or customer—and that the composition includes commissions and fulfillment/shipping fees. It correctly asserts no material changes occurred from 2022 through 2024, which aligns with the ground truth noting consistency in timing and lack of specific changes in 2024. The citations to the 10-Ks (2022 p. 3, 2023 p. 42, 2024 p. 3) support the claim and are plausible, though not verified here. However, the LLM omits the 2022 detail from the original answer about revenue sources including fixed fees, percentage of sales, per-unit fees, and interest—this nuance about composition evolution is missing. While the core timing and policy stability are correctly conveyed, the answer underrepresents the increasing disclosure clarity highlighted in the ground truth, particularly Amazon’s more specific articulation in 2023. There are no quantitative inaccuracies (dates, years, and references are correct), and the reasoning is sound in concluding consistency across years. The answer is highly relevant and synthesizes information across all three years, but lacks full completeness regarding the compositional details disclosed in 2022. Hence, a score of 8 is appropriate: core facts and timing are correct, but minor omissions in compositional evolution prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 394,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s continued guarantee of Southwestern Bell Telephone Co.’s obligations in 2022, 2023 and 2024 shows that the company is deliberately keeping long‑term liability exposure for legacy telecom entities on its books rather than divesting or releasing those obligations. By maintaining the guarantee, AT&T hedges against potential default risk and ensures it remains fully accountable for the settlement of those legacy obligations until they are satisfied, reflecting a conservative, risk‑averse liability‑management strategy (see 2023 10‑K, Item 4, page 103).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core claim: AT&T maintained its guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024, indicating a stable, ongoing liability management strategy. All dates and years are correct, and there are no numerical inaccuracies (quantitative accuracy is perfect). The entity identification (AT&T, Southwestern Bell Telephone Co.) is accurate, and the time frame is correctly referenced. The reasoning correctly infers that this reflects a conservative, risk-averse strategy of retaining liability rather than divesting it. However, the LLM adds interpretive language—such as 'hedges against potential default risk' and 'ensures it remains fully accountable'—that, while plausible, are not explicitly supported by the ground truth, which emphasizes the *unchanging nature* of the commitment as evidenced by the repeated Exhibit 4-b filings. The ground truth focuses on the *lack of restructuring* and *persistence of language*, whereas the LLM shifts toward a risk-management rationale not directly stated. This introduces a subtle but notable interpretive leap, slightly reducing qualitative accuracy. Contextual relevance is high, as the answer directly addresses the question about long-term liability strategy. Overall, the answer is substantially correct but includes minor unsupported inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 386,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s balance of the 2.250 % Notes due 2050 fell from **$983 million in 2022** (page 67) to **$826 million in 2023** and further to **$808 million in 2024** (page 72). This steady decline shows the company is actively paying down or refinancing that long‑dated debt, reflecting a conservative long‑term debt strategy that prioritizes reducing exposure to older, higher‑maturity notes while maintaining a stable, low‑cost debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $983 million in 2022, $826 million in 2023, and $808 million in 2024, matching the ground truth exactly. These figures are accurately cited with page references, confirming quantitative precision. 2) All financial amounts and years are correct, with no calculation errors. The minor reduction trend is accurately described. 3) The reasoning is largely sound: the LLM correctly infers a conservative debt strategy from the declining balance. However, it states the company is 'paying down or refinancing' without direct evidence of refinancing, and omits mention of the fixed effective rate of 2.29%, a key detail in the original answer that supports the stability of the cost of capital. This omission slightly weakens the qualitative completeness. 4) Despite this, the LLM captures the core implication—Johnson & Johnson is managing long-dated liabilities cautiously—making the answer contextually relevant and semantically aligned with the ground truth. The conclusion is logically supported, though slightly less nuanced than the original. Overall, the answer is factually correct and well-reasoned, meriting a high score with minor deduction for missing the fixed-rate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 346,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375% Senior Notes due June 2027 stayed at a carrying value of $1.25 billion in 2022, 2023 and 2024—no principal was repaid or newly issued.  While the company reduced its overall long‑term debt by paying off the 2.750% Senior Notes due May 2024, it left the 1.375% notes unchanged, indicating a strategy of keeping a stable, low‑interest debt base while eliminating higher‑rate debt and preserving liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the 1.375% Senior Notes due June 2027 remained unchanged at $1.25 billion (equivalent to $1,250 million) across 2022, 2023, and 2024, matching the ground truth. It also accurately reflects the broader trend of declining total long-term debt, though it does not explicitly cite the total debt figures ($6,590M, $6,484M, $5,919M) from the original answer. However, the key quantitative elements—note amount, interest rate, maturity date, and stability over time—are all correct. (2) The LLM correctly identifies the repayment of the 2.750% Senior Notes due May 2024 as a driver of the overall debt reduction, which aligns with the multi-hop reasoning required: connecting the stable 1.375% notes with the retirement of higher-cost debt. While the exact total debt numbers are omitted, the qualitative trend (reduction in overall debt) is accurately conveyed. (3) The reasoning is sound: the model infers a capital management strategy focused on maintaining low-cost debt while retiring higher-rate obligations, which is consistent with and supported by the ground truth. This shows effective synthesis across multiple debt instruments and years. (4) The answer is contextually complete and relevant, addressing both the evolution of the specific notes and the implied capital strategy. The only minor shortcoming is the omission of precise total long-term debt figures, which slightly reduces completeness but does not impair the core factual or inferential accuracy. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 428,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s real‑time payments infrastructure grew from 11 markets in 2022 to 13 markets by the end of 2023, while its multi‑layered security approach evolved from a basic cyber‑security program to a comprehensive framework that now includes an enterprise resilience program, insurance coverage, rigorous testing, and industry‑wide technical standards such as EMV. This parallel evolution shows that Mastercard is deliberately aligning its risk‑management architecture with its global expansion, embedding robust, layered controls into every new payment channel it launches to ensure that scaling the network does not compromise security or processing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. According to the ground truth, Mastercard was operating or implementing real-time payments in 12 markets as of December 31, 2021 (reported in 2022), expanded to 13 markets by 2023, and described broader global deployment qualitatively in 2024. The LLM incorrectly states 11 markets in 2022, which contradicts the source. Additionally, the claim that the security approach evolved from a 'basic cyber-security program' to a 'comprehensive framework' including enterprise resilience, insurance, and EMV standards is not supported by the original answer, which states Mastercard maintained the same multi-layered security approach across all years, emphasizing third-party assessments and partnerships by 2023. (2) The numbers are partially correct for 2023 (13 markets), but the 2022 figure is wrong (11 vs. actual 12), and no data is provided for 2024 beyond a vague 'several countries.' There are no calculations in the response, but the comparative growth narrative is based on incorrect baseline data. (3) The multi-hop reasoning is flawed: while the LLM correctly infers strategic alignment between security and infrastructure expansion, it fabricates evolution in the security framework that isn't present in the filings. The original answer explicitly states the security approach remained consistent, with only incremental emphasis on third-party risk, not a transformation into a broader resilience program. Thus, the synthesis misrepresents the source data. (4) Despite these issues, the answer is contextually relevant—addressing both the evolution of infrastructure and security and drawing a reasonable strategic conclusion about risk management. However, the correctness score is low due to major factual and descriptive inaccuracies, especially in quantitative and qualitative details that undermine the validity of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 527,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft’s FY 2022, 2023, and 2024 10‑K filings all list the same third supplemental indenture (Exhibit 4.6) that contains 4.000% Notes due 2021, but the company issued no new 4.000% Notes or altered that maturity in any of those years. The 4.000% Notes, which matured in 2021, remain referenced only as part of the historic indenture, showing that Microsoft has not pursued additional short‑term debt and instead relies on a long‑term, low‑rate debt structure—an indicator of a disciplined, long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Microsoft, 4.000% Notes due 2021, Exhibit 4.6, Third Supplemental Indenture, and fiscal years 2022–2024—are correctly identified. The statement that no new notes were issued and no changes occurred is consistent with the original answer. (2) Quantitative accuracy is perfect: the interest rate (4.000%), maturity year (2021), exhibit number (4.6), and fiscal years (2022–2024) are all correct. No calculations are required, but the temporal logic (notes matured in 2021, yet still disclosed through 2024) is handled accurately. (3) The reasoning is sound: the LLM correctly infers that continued disclosure of a post-maturity note reflects reliance on long-term, low-rate debt and disciplined debt management. It captures the core implication of the pattern, though it does not explicitly mention possible rollover or delayed settlement as the original answer does, which slightly reduces completeness in qualitative terms. (4) The answer is highly contextually relevant, directly addressing the evolution across years and the strategic implication. The only minor gap is the absence of speculation about why the note remains disclosed post-maturity (e.g., rollover, disclosure requirements), but the overall semantic meaning and factual core match the ground truth. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 411,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated inclusion of the 1.500% Note due 2030 in its 2020, 2022, 2023 and 2024 10‑Ks (the 2020 Officers’ Certificate is incorporated in each filing) signals that the company treats this mid‑term, moderate‑rate debt as a core, stable part of its long‑term capital structure [page_75, page_72, page_76].  Compared with the very short‑term, low‑coupon notes (0.4‑0.8% due 2023‑2025) and the longer‑term, higher‑coupon notes (2.5‑4.9% due 2050‑2060), the 1.5% Note offers a balanced cost‑duration profile, helping Amazon smooth interest expense and lock in predictable financing for the near future [page_75].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several inaccuracies but captures some correct elements. The core idea—that Amazon's repeated reference to the 1.500% Note due 2030 reflects a strategic use of long-term debt—is supported in both answers. However, the LLM incorrectly states that the note was included in the 2020 10-K and that an 'Officers’ Certificate' from 2020 is incorporated into later filings; this detail is not present in the ground truth and cannot be verified from the question context. More critically, the LLM mischaracterizes the 1.500% Note as 'mid-term' and suggests it helps finance 'the near future,' which contradicts the ground truth that positions it as part of a long-dated, fixed-rate strategy. (2) Quantitative inaccuracies include the incorrect claim of inclusion in the 2020 filing (ground truth specifies 2022–2024), undermining timeline accuracy. While the coupon (1.500%), maturity (2030), and comparison instruments (e.g., 4.700% Note due 2032) are mentioned in the correct context in the ground truth, the LLM introduces unverified short-term notes (0.4–0.8% due 2023–2025) and long-term rates (2.5–4.9% due 2050–2060) without grounding in the provided truth. These ranges may exist in filings but are not referenced in the original answer, making their inclusion speculative. (3) The multi-hop reasoning is partially sound—comparing the 1.5% Note to other instruments to infer capital structure strategy—but fails to reflect the evolution across years as required. The ground truth emphasizes how the 2022, 2023, and 2024 references show a layered maturity profile and refinancing risk mitigation, while the LLM flattens this into a static observation. It misses the dynamic strategy of balancing low-cost legacy debt with new, higher-cost issuances. (4) Despite these flaws, the answer remains contextually relevant and conveys a plausible interpretation of debt strategy. The correctness score is 6 due to correct identification of the instrument and its strategic role, but penalized for factual errors in timeline, unsupported details, and weaker synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 561,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "From 2022 through 2024, AT&T maintained a 41.3 % equity stake in SKY Mexico, accounting for it under the equity method until the June 2024 sale that eliminated the investment and the equity‑method recognition (page 94; page 66). The 2024 10‑K confirms the disposition and the end of equity‑method accounting for SKY Mexico, while the 2022 10‑K notes the stake and equity‑method treatment (page 94; page 66). This three‑year trajectory, coupled with the earlier Vrio sale in 2021, underscores AT&T’s systematic divestiture of international pay‑TV assets as it refocuses on its core wireless and broadband businesses (page 94).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: AT&T's 41.3% ownership stake in SKY Mexico is accurately stated, the equity method accounting treatment in 2022 and 2023 is confirmed, and the exit is correctly dated to June 2024. The reference to page numbers (e.g., page 94, 66) suggests proper sourcing from 10-K filings, though these are not part of the ground truth verification. (2) The answer correctly captures the multi-hop trajectory: continued ownership in 2022, equity-method accounting in 2023, and full exit in 2024. (3) The reasoning is sound, linking the SKY Mexico exit to the broader divestiture strategy, including the prior Vrio sale, and correctly inferring AT&T’s strategic refocus on core U.S. wireless and broadband operations. (4) Minor omission: the ground truth mentions Gigapower as another equity-method investment alongside DIRECTV and SKY Mexico, which the LLM omits—this is a small completeness gap but does not affect the core accuracy. Also, the LLM references the 2021 Vrio sale, which is contextually relevant but slightly outside the 2022–2024 scope; however, it strengthens the strategic narrative. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only slight room for added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 376,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy—outlined in each filing—lowers the share of return‑seeking (equity) assets as the plan’s funded ratio improves, shifting toward liability‑hedging fixed‑maturity securities.  The target allocation changed from 15 % equity/75 % fixed/10 % other in 2022 (page 310) to 8 % equity/77 % fixed/15 % other in 2023 (page 252), and then to 9 % equity/80 % fixed/11 % other in 2024 (page 182).  This progression reflects a gradual de‑risking of the U.S. pension portfolio in response to a stronger funded status, with the modest equity rebound in 2024 likely reflecting a small shift in funding or interest‑rate assumptions (glide‑path description on page 184).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It provides specific target allocations (e.g., 15% equity/75% fixed/10% other in 2022) that are not present in the original answer (ground truth), which does not include any numerical breakdowns of asset allocations. These percentages appear to be fabricated or extracted from a source not reflected in the ground truth. There is no mention in the original answer of an '8% equity/77% fixed' allocation in 2023 or '9% equity/80% fixed' in 2024, nor any reference to 'other' categories. Additionally, the LLM cites specific page numbers (310, 252, 182, 184), which are absent from the ground truth and cannot be verified. (2) The calculations or numbers provided by the LLM cannot be validated against the ground truth and directly contradict its qualitative-only description. The original answer discusses the *direction* of change (increasing liability-hedging, reducing growth assets) but provides no percentages. By introducing precise figures not in the source, the LLM fails on quantitative accuracy. (3) The multi-hop reasoning and qualitative interpretation are sound: the LLM correctly identifies AIG’s de-risking strategy, links it to funded status improvements, and interprets the glide path as shifting from return-seeking to liability-hedging assets over time. It also correctly frames the strategy within liability-driven investing principles, aligning with the original answer’s conclusion. The mention of a 'modest equity rebound in 2024' shows an attempt to interpret non-linear trends, though this is speculative without supporting data. (4) Despite strong contextual relevance and reasonable qualitative logic, the inclusion of fabricated numerical data severely undermines factual correctness. The answer gives the impression of precision where none exists in the ground truth, leading to a correctness score of 6—partially correct but with major factual flaws. Quantitative accuracy is low (4), qualitative reasoning is decent (7), and relevance is high (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 552,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard has scaled its credit‑risk buffers for settlement exposure from $9.2 billion in 2022 to $13.5 billion in 2024, while its qualified cash settlement fund and accrued MDL liabilities rose in tandem with growing litigation and regulatory scrutiny. The company continues to require cash collateral, letters of credit and guarantees for customers that fall outside its risk standards, and it has kept risk‑mitigation arrangements for Mastercard‑branded travelers cheques stable at roughly $272 million. These adjustments demonstrate Mastercard’s agile risk‑management framework, expanding its credit‑risk safeguards and monitoring practices to meet escalating legal and regulatory pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not mention any specific dollar amounts such as a $9.2 billion or $13.5 billion credit-risk buffer, nor does it reference a 'qualified cash settlement fund' or 'accrued MDL liabilities' rising in tandem with litigation. These figures and terms are entirely absent from the original answer and cannot be verified from the provided knowledge. The $272 million figure for Mastercard-branded travelers cheques is also not present in the ground truth. (2) Quantitative accuracy is very low because all cited numbers are fabricated or hallucinated. There are no calculations in the original answer to verify, but the LLM invents precise figures without basis, which severely undermines factual reliability. (3) The multi-hop reasoning is partially sound in structure—linking regulatory scrutiny and litigation to risk management adaptations—but fails in execution because it substitutes real qualitative insights with false quantitative claims. The original answer emphasizes consistency in risk mitigation tools (collateral, letters of credit, guarantees) and evolving context due to FTC/DOJ investigations and litigation, which the LLM captures only superficially. However, it misses the key point that Mastercard reported consistently low losses from settlement failures, a critical indicator of effectiveness. (4) The contextual relevance is moderate because the LLM addresses the general theme of evolving risk strategies under pressure, but the use of invented metrics and lack of reference to actual regulatory actions (e.g., FTC consent agreement, DOJ antitrust probe, European Commission investigation) reduces accuracy. The conclusion about 'agile risk-management' is speculative and not directly supported by the ground truth, which notes consistency rather than scaling of buffers. Overall, the answer misrepresents the data and fails the core requirement of factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 533,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "Home Depot’s equity‑award pool shrank markedly: the 2022 10‑K reported about **117 million shares** available for future grants under the 2005 Plan (page 68); the 2023 10‑K shows the amended Omnibus Plan authorizes **80 million shares** (plus up to 10 million from outstanding awards) (page 65); by January 2024 the available pool had fallen to roughly **77 million shares** (page 67). This downward trend signals a more conservative, performance‑driven equity‑compensation strategy aimed at limiting dilution and aligning awards with shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies the 117 million shares available in 2022 under the 2005 Plan, matching the ground truth. However, it incorrectly states that the amended Omnibus Plan authorizes '80 million shares (plus up to 10 million from outstanding awards)'—this figure does not align with the ground truth, which reports 77 million shares available as of January 28, 2024 (2023 filing), and 70 million as of February 2, 2025 (2024 filing). The LLM mentions 77 million shares by January 2024, which is accurate, but fails to report the 2024 availability of 70 million shares, omitting the final data point required by the question. (2) The quantitative accuracy is compromised: while 117M → 77M is correct, the intermediate claim of an 80M authorized pool (plus 10M) introduces a number not found in the ground truth and misrepresents the plan amendment. The final 70M figure for 2024 is entirely missing. (3) The multi-hop reasoning is partially sound—LLM recognizes the downward trend and attempts to interpret it—but draws a different conclusion than the ground truth. While the ground truth suggests increased reliance on equity compensation due to declining availability, the LLM interprets the trend as 'more conservative' and 'performance-driven,' which contradicts the implication of active issuance. This misinterpretation affects qualitative accuracy. (4) Contextual relevance is high—the answer addresses share availability and infers strategy—but correctness is limited by missing data, incorrect figures, and flawed reasoning on the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 452,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom had no 3.625% notes due October 2024 outstanding in FY 2022.  In FY 2023 the note was outstanding at $622 million (effective interest rate 3.98 %【page_81】).  By FY 2024 the note had matured/been repaid, leaving zero principal outstanding【page_81】.  This pattern shows a disciplined short‑term debt strategy—issuing the note and then repaying it before maturity to keep long‑term debt exposure low and manage interest costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline: it claims there were no 3.625% notes outstanding in FY 2022, which contradicts the ground truth stating a $622 million obligation existed in FY 2022. The LLM correctly reports $622 million in FY 2023 and $0 in FY 2024, aligning with the ground truth for those years. However, the misstatement about FY 2022 undermines the accuracy of the evolution narrative. (2) Quantitatively, the dollar amounts for FY 2023 and FY 2024 are correct ($622 million and $0), and the mention of maturity/repayment by FY 2024 is accurate. The interest rate (3.98%) is an additional detail not in the ground truth but is not incorrect—however, the core error is the absence of the liability in FY 2022, which should have been $622 million. This breaks the quantitative chain of the obligation’s evolution. (3) The multi-hop reasoning is partially sound—recognizing that the debt went from present to zero indicates repayment before or at maturity. However, the failure to acknowledge the obligation in FY 2022 disrupts the correct synthesis across all three years. The conclusion about a disciplined short-term debt strategy is plausible but based on an incorrect premise (i.e., that the note was issued in or after FY 2023). (4) Contextually, the answer addresses the question’s focus on evolution and strategy, and the final repayment is correctly noted. However, due to the significant error in the starting point of the obligation, the overall correctness score is reduced to 5—partially correct but with a major factual flaw in the temporal progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 443,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "AT&T’s relationship with Time Warner began with the 2018 acquisition, which was integrated into its WarnerMedia segment [page_4]. In 2022, AT&T planned and executed a divestiture via a Reverse Morris Trust with Discovery, effectively exiting the business and classifying it as a discontinued operation [page_4][page_6]. By 2024 the company no longer holds any WarnerMedia assets and its 10‑K focuses on 5G, fiber and network infrastructure, underscoring a strategic pivot from entertainment to core telecommunications services [page_5].",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key timeline and strategic moves: the 2018 acquisition of Time Warner (though not part of the 2022–2024 scope, it provides context), the 2022 divestiture planning and execution via Reverse Morris Trust with Discovery, and the post-exit focus on telecommunications in 2024. However, it omits the specific 2024 DIRECTV sale to TPG, which is a key part of T's final exit from media assets and mentioned in the ground truth. This is a notable omission affecting completeness. (2) Quantitatively, all dates (2018, 2022, 2024) are accurate and correctly contextualized. There are no numerical errors, and the timeline aligns with the ground truth. Format and references to pages support factual grounding. (3) The multi-hop reasoning is largely sound—linking the divestiture to strategic repositioning—but misses the DIRECTV component, which weakens the synthesis of T’s full exit strategy. The answer correctly infers the shift to 5G, fiber, and infrastructure as evidence of strategic refocus, which is well-supported. (4) The answer is contextually excellent, directly addressing the evolution of the relationship and strategic implications. The omission of DIRECTV sale reduces completeness but does not distort the overall narrative. Hence, correctness is high but not perfect, warranting a score of 8. Quantitative accuracy is flawless (10), qualitative accuracy is strong but missing one key link (8), and relevance is full (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 410,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In 2022 Emerson positioned its Pipe Cutters as part of the Safety & Productivity segment’s pipe‑working tools, noting their use with battery‑hydraulic press‑connection tools and diagnostic systems such as sewer‑inspection cameras (page 9). By 2023‑24 the positioning remained unchanged, but the description broadened to highlight battery‑hydraulic tools for cutting and crimping electrical cable and a wider range of diagnostic equipment, underscoring a continued emphasis on portable, battery‑powered, tech‑enabled tools across the segment (page 73).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the evolution of Emerson's Pipe Cutters strategic positioning. According to the ground truth, in 2022, Pipe Cutters were standalone tools with no mention of integration with battery-hydraulic press tools or diagnostic systems. However, the LLM claims that in 2022 they were already used with battery-hydraulic press tools and diagnostic systems (e.g., sewer inspection cameras), which contradicts the original timeline. The correct evolution is that integration began in 2023, not 2022. Additionally, the LLM states that the positioning 'remained unchanged' from 2022 to 2024, which directly conflicts with the ground truth showing a clear strategic shift over time. (2) There are no numeric values, percentages, or dollar amounts in the question or answers, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is flawed: the LLM failed to correctly synthesize the chronological progression across years. It incorrectly attributes 2023–2024 developments (integration with battery-powered and diagnostic systems) to 2022, collapsing the evolution into a static description rather than showing change over time. This undermines the core of the multi-hop analysis required. (4) While the LLM answer is relevant to the topic and mentions correct product categories (battery-hydraulic tools, diagnostic systems), its factual misrepresentation of when integration occurred and the lack of recognition of strategic evolution significantly reduce correctness. The contextual relevance is moderate because it discusses the right segment and technologies but misplaces them temporally. Thus, the correctness score is low due to major qualitative inaccuracies despite proper context and no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 493,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson has maintained a **multi‑year, enterprise‑wide initiative** that “integrates, simplifies and standardizes processes and systems for the human resources, information technology, procurement, supply chain and finance functions” to grow its financial shared‑service capabilities and standardize financial systems (2022 page 117; 2023 page 118; 2024 page 119). The unchanged wording across the 2022‑24 filings shows a sustained, proactive commitment to standardizing financial processes, underscoring the company’s strategic priority of improving efficiency, consistency and control in its global financial operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies Johnson & Johnson's multi-year initiative from 2022 to 2024 focused on integrating, simplifying, and standardizing processes across finance and other functions. The consistent emphasis on growing financial shared-service capabilities and standardizing systems is accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—however, the years (2022–2024) and page numbers cited (117, 118, 119) are correctly referenced and align with the consistent narrative across filings, supporting factual precision. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that unchanged wording indicates a sustained strategic focus. It accurately concludes that the initiative reflects a strategic priority on efficiency, consistency, and control. (4) The only minor shortcoming is that the LLM mentions 'human resources, information technology, procurement, supply chain' as part of the initiative, which, while likely accurate, slightly shifts focus from the question’s emphasis on *financial* process standardization. The original answer more tightly emphasizes the financial control environment and standardization in finance, making it slightly more precise in context. However, the inclusion of other functions does not contradict the ground truth and may reflect broader scope mentioned in the filings. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a small deduction for slight over-broadening of functional scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 478,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "In FY 2022, FY 2023, and FY 2024 Costco’s 10‑K lists the Executive Health Plan as Exhibit 10.1* and files it with the 10‑K itself (no separate filing) – the exhibit’s “Form” column is “10‑K” and the original filing date remains 10/19/2012 (COST_10k_2022 p. 66; COST_10k_2023 p. 66; COST_10k_2024 p. 66). The unchanged filing status shows Costco’s continued commitment to a stable, long‑term executive benefits program and consistent disclosure of its terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Executive Health Plan is consistently listed as Exhibit 10.1* in the 10-K filings for FY 2022, 2023, and 2024; the original filing date is correctly stated as October 19, 2012; and the plan has not been separately refiled or amended. The reference to page 66 in each filing adds precision and supports verifiability. (2) Quantitative accuracy is perfect: dates (10/19/2012) match exactly, fiscal years are correct, and no erroneous numbers are introduced. Format (e.g., '10/19/2012' vs 'October 19, 2012') is acceptable variation. (3) Reasoning is sound: the LLM correctly infers that the unchanged filing status over three years indicates stability in executive benefits strategy, which is a valid conclusion from the lack of amendments. The only minor shortcoming is that the LLM does not explicitly mention the 'Period Ended' date of September 2, 2012, which is part of the ground truth and reinforces the lack of updates. This omission slightly weakens completeness but does not affect the overall correctness. (4) The answer is contextually relevant, directly addressing both the evolution (or lack thereof) in disclosure and the strategic implication. Semantic equivalence is strong—wording differs but meaning matches. Thus, a 9 is warranted due to near-perfect accuracy with a minor detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 390,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "From 2022 to 2024, Mastercard’s Class A shares retained the same voting structure—one vote per share and dividend rights—while the quarterly cash dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (2022 page 98; 2023 page 99; 2024 page 94). This consistency shows a shareholder‑friendly governance strategy that preserves equal voting influence for Class A holders while steadily enhancing dividend payouts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend payout amounts per share ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024), which are not present in the ground truth and contradict the original answer stating only that dividend rights were 'standard'—with no specific amounts or increases mentioned. These figures may be factual in context but are not supported by the provided ground truth, making their inclusion a significant factual overreach. (2) The ground truth emphasizes that both dividend rights and voting rights remained consistent in nature (one vote per share, standard dividend rights) across all three years, without any mention of increasing dividends. The LLM conflates dividend *amounts* (a financial payout decision) with dividend *rights* (a governance feature), which are distinct concepts. Dividend rights refer to the entitlement to receive dividends, not the amount or growth. (3) The multi-hop reasoning is partially sound in that it correctly identifies the stability of voting rights (one vote per share) across years, which aligns with the ground truth. However, it fails to correctly synthesize the qualitative nature of dividend *rights* versus actual dividend *payouts*, leading to an incorrect inference about a 'shareholder-friendly' strategy focused on 'steadily enhancing dividend payouts'—a point not supported by the original answer or the question about governance rights. (4) The contextual relevance is high because the answer addresses the evolution of rights and attempts to infer governance strategy. However, the correctness score is low due to the introduction of unsupported quantitative data and the conflation of dividend rights with dividend amounts, undermining the factual accuracy. The qualitative accuracy is moderate because core governance elements (voting rights) are correct, but the reasoning is flawed in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 510,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform continued to provide the same core capabilities across FY 2022, 2023 and 2024: it rapidly interprets mainframe security posture, identifies risks and generates remediation steps that can be fed into customers’ in‑house SIEM tools. The 10‑K descriptions for all three years are identical, indicating no significant evolution in its integration with in‑house security tools or its risk‑identification functionality (page_11, 2022; page_11, 2023; page_11, 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Broadcom's Security Insights Platform maintained consistent functionality across fiscal years 2022, 2023, and 2024, with stable integration with in-house security tools (specifically SIEM) and consistent risk identification capabilities. The core description being 'identical' across the 10-K filings matches the ground truth's assertion of 'stable functionality' and 'consistent integration'. (2) There are no numeric values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly referenced, and the claim of identical descriptions is supported by citation to the same page number (page_11) across all years, which is consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the model synthesized information across three annual reports and correctly inferred that no textual changes imply no significant evolution, which is a valid conclusion given the context. (4) The only minor gap is that the original answer notes a subtle enhancement in FY2023 where the platform was 'more explicitly tied to ongoing and ad hoc remediation planning'—a nuance not captured in the LLM response, which claims the descriptions were 'identical'. While the wording may have been very similar, the ground truth suggests a slight evolution in emphasis. This justifies a 9 instead of 10 on correctness and qualitative accuracy. Otherwise, the answer is factually correct, complete, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 419,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 to 2024 AIG continued to use internal controls, oversight and third‑party catastrophe models to estimate loss reserves, but the 2023 and 2024 filings added explicit review‑and‑challenge procedures, escalation paths, actuarial profitability and reserve reviews, and experience‑monitoring updates to assess adequacy (2023 10‑K, pp. 119‑120; 2024 10‑K, pp. 86‑88). Across all three years, external experts consistently reviewed and validated reserve estimates, providing independent oversight of the reserve‑setting process (2022 10‑K, pp. 165‑169; 2023 10‑K, pp. 119‑120; 2024 10‑K, pp. 86‑88). Thus, the methodology evolved from a general internal‑control framework in 2022 to a more structured, transparent, and review‑centric approach by 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG's evolution from a general internal-control framework in 2022 to a more structured, review-intensive approach by 2023 and 2024 is accurately described. The use of internal controls, external expert validation, actuarial reviews, and enhanced oversight mechanisms is consistent across both answers. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifying progression in methodology and the consistent role of external experts. It references specific pages (e.g., 2023 10-K pp. 119–120), which supports traceability. (4) The only minor gap is that the LLM answer does not explicitly mention 'stochastic and deterministic modeling' or 'ERM second-line reviews'—specific terms from the original answer that reflect depth in 2023–2024 enhancements. However, the concepts of 'review-and-challenge procedures', 'actuarial profitability and reserve reviews', and 'experience-monitoring updates' convey similar meaning, indicating a structured and maturing framework. Thus, while slightly less detailed in technical terminology, the LLM captures the essence and trajectory of AIG’s evolving reserve risk management. Semantic equivalence is maintained, and the answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 425,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson’s Industrial Solutions product offering has consistently included electrical distribution equipment across 2022‑2024 (see page 76 for 2022 and page 73 for 2023‑2024). In each filing the same product is also highlighted as a core element of the Discrete Automation segment—listed alongside solenoid valves, pneumatic actuators and linear‑motion solutions (page 73). The segment’s sales remained stable (2022 $2,612 M, 2023 $2,635 M, 2024 $2,506 M) (page 75), underscoring Emerson’s deliberate emphasis on discrete‑automation markets where electrical distribution equipment is a key enabler.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that Electrical Distribution Equipment is part of Emerson's offerings and associated with Discrete Automation in 2023–2024, and it accurately references stable sales figures across years ($2,612M, $2,635M, $2,506M), which aligns with the ground truth in spirit though not explicitly required by the original answer. However, it incorrectly states that the equipment was part of both Industrial Solutions and Discrete Automation simultaneously in all three years, contradicting the ground truth that shows a reorganization: in 2022 it was under Industrial Solutions, and only from 2023 onward was it moved into Discrete Automation. This misrepresents a key strategic evolution. (2) Quantitatively, the sales figures provided are plausible and internally consistent, but the original answer does not include these numbers, so their accuracy cannot be fully verified against the ground truth. Still, no obvious calculation errors are present, and the formatting is acceptable. (3) The multi-hop reasoning is flawed: the model fails to recognize the structural change over time—specifically the 2023 reorganization—which is central to the question. Instead, it assumes consistent positioning across years, missing the strategic shift entirely. This undermines the qualitative accuracy. (4) Contextually, the answer is relevant and attempts to address Emerson’s strategic emphasis in discrete automation, correctly identifying related product lines like solenoid valves and linear-motion solutions. However, due to the incorrect timeline and organizational placement, the conclusion about 'consistent' inclusion weakens the reasoning. The answer captures part of the strategic narrative but misses the evolution, which is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 501,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson’s pension structure has not changed through 2024 – the company continues to operate a dual‑formula system (Final Average Pay for hires before 2015 and Retirement Value for hires after 2014) and the 2021 amendment that will bring all eligible U.S. non‑union employees under the Retirement Value formula is still scheduled to take effect on Jan 1 2026【page_73】【page_77】.  The 2022‑2024 filings simply confirm that the transition remains pending and that benefit obligations and plan assets are being adjusted in anticipation of the change.  This multi‑year rollout reflects a long‑term strategy to standardize and simplify pension benefits, align them with total compensation, and manage pension liabilities more predictably for the workforce.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding the dual-formula system's timeline. The ground truth states that the Retirement Value formula will apply to *all* eligible U.S. non-union employees effective January 1, 2026, regardless of hire date, while preserving pre-2026 Final Average Pay accruals. The LLM incorrectly implies that the current split (Final Average Pay for pre-2015 hires, Retirement Value for post-2014 hires) remains structurally unchanged up to 2024, when in fact the company is transitioning *all* employees to the Retirement Value formula starting in 2026. This misrepresents the scope of the change. However, the key date (January 1, 2026) and the strategic direction are correctly identified. (2) Quantitatively, all dates (2022–2024 filings, 2026 effective date) and references (page 73, page 77) are accurate. No numerical calculations were required. Format and date usage are correct. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across years and infers long-term strategy from repeated messaging. It correctly identifies the standardization, alignment with total compensation, and liability management as strategic goals—consistent with the ground truth. However, it misses the full extent of the structural shift (applying Retirement Value to *all*, not just new hires), which weakens the qualitative accuracy slightly. (4) Contextual relevance is perfect—the response directly addresses both the evolution of the pension structure and the implications for workforce strategy. Despite the minor error in describing the current dual system’s applicability, the overall factual content, strategic interpretation, and synthesis across years are strong, warranting a high score but not full marks due to the structural mischaracterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 500,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from **$25.7 billion** at December 31 2022 (Table 8.1, page 178) to **$31.2 billion** at December 31 2023 (Table 8.2, page 179), then fell modestly to **$30.7 billion** at December 31 2024 (Table 9.1, page 188). The pattern—an increase followed by a slight decline—suggests the company has been using notes to fund growth and refinance, while the 2024 dip indicates a gradual debt‑reduction or refinancing effort to manage leverage and interest‑rate exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, the carrying value was $27,219 million in 2022, $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM reports $25.7 billion (2022), $31.2 billion (2023), and $30.7 billion (2024), which are incorrect for 2022 and 2024. The 2022 figure is off by over $1.5 billion, and the 2024 value incorrectly shows a decline when the ground truth shows no change from 2023 to 2024. (2) Calculations and comparisons are therefore flawed: the LLM suggests a 'modest fall' to $30.7B in 2024, but the actual data shows the value remained flat at $31,248M. This undermines the conclusion about a debt-reduction effort. (3) The multi-hop reasoning is partially sound—identifying a trend over three years and interpreting strategic implications—but it is based on incorrect data, leading to an invalid conclusion. The LLM correctly identifies the relevance of senior and subordinated notes to financing strategy but misinterprets the trend. (4) Contextual relevance is high as the answer addresses the evolution of notes and attempts to infer strategy. However, due to major quantitative errors, the correctness and qualitative accuracy scores are low. Minor formatting differences like $31.2B vs $31,248M are acceptable, but the discrepancies here exceed acceptable tolerance and affect the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 399,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "From 2022 through 2024 AT&T maintained a 41.3 % equity‑method investment in SKY Mexico (page 93), recognizing its share of net income and distributions under the equity method (page 66). In June 2024 the company sold that stake, terminating the equity‑method accounting and removing the investment from its balance sheet (page 64). This three‑year pattern—holding a significant minority stake, accounting for it via the equity method, then divesting the asset—illustrates AT&T’s broader strategy to systematically exit Latin American pay‑TV holdings and refocus on core or streaming businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T (referred to as 'T' in the question) maintained a 41.3% ownership stake in SKY Mexico from 2022 through June 2024, applied equity method accounting throughout the holding period, and exited the investment in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% stake and June 2024 exit date are correctly stated; no calculations were required, but the numeric and temporal data are precise and consistent with the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years—stable ownership in 2022, continued equity method treatment in 2023, and divestiture in 2024—and infers the broader strategic intent behind the move. The conclusion about AT&T’s strategy to exit Latin American pay-TV and refocus on core or streaming businesses is a valid interpretation supported by the trajectory. (4) The only minor shortcoming is that the LLM does not explicitly name DIRECTV and Gigapower as other equity method investments (mentioned in the original answer), which slightly reduces completeness in contextual detail, but this does not affect the core accuracy. Wording differs (e.g., 'systematically exit' vs 'deliberate strategic shift'), but semantic equivalence is maintained. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 403,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor disclosures about limits on capital returns to shareholders stayed essentially the same.  Each filing repeatedly stated that the Board’s discretion and U.S. banking laws—specifically capital‑planning rules, Delaware law, and the requirement to pay full and timely dividends on preferred stock—can restrict capital distributions, and that failing to meet “well‑capitalized” and “well‑managed” regulatory standards or other capital‑adequacy and liquidity rules could further limit activities.  No new regulatory or dividend‑policy language was added in the 2024 filing beyond what was already disclosed in 2022 and 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core regulatory constraints mentioned—U.S. banking laws, capital adequacy, Delaware law, preferred dividends, and Board discretion—and correctly identifies that these were consistently present from 2022 to 2024. There are no numeric inaccuracies, and the dates (2022–2024) are correct, earning full marks for quantitative accuracy. However, the LLM incorrectly asserts that 'no new regulatory or dividend-policy language was added in the 2024 filing,' which directly contradicts the ground truth stating that by 2024, BNY Mellon added emphasis on the Parent company’s reliance on subsidiary dividends and the impact of strategic transformation initiatives on liquidity and capital planning. Additionally, the 2023 expansion to include ESG-related regulatory pressures and strategic initiatives is omitted. This represents a significant failure in multi-hop reasoning and synthesis across years, undermining the qualitative accuracy. While the answer addresses regulatory requirements and capital adequacy, it misses evolving contextual elements related to ESG and strategic initiatives, resulting in partial completeness. The answer is relevant and well-structured but misses key qualitative developments, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 368,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "3M kept structural adhesives within its Safety and Industrial segment throughout 2022‑2024, but the 2024 filing shows the former Industrial Adhesive & Tapes division was merged into a newly created Industrial Specialties division that also houses closure systems and personal‑safety products【page_110】.  The shift from a standalone adhesive‑tape grouping to a broader “industrial specialties” bundle signals that 3M views adhesives as a core, cross‑cutting technology that underpins integrated industrial solutions—providing structural integrity and bonding across metalworking, automotive, construction and safety markets【page_131】【page_107】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Structural Adhesives remained in the Safety and Industrial segment from 2022–2024 and notes the organizational shift in 2024 involving the merger of the Industrial Adhesive & Tapes division into a new Industrial Specialties division—consistent with the strategic bundling evolution described in the original answer. The surrounding context of integration with construction, metalworking, and safety markets matches the ground truth’s emphasis on specialized industrial applications. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model infers from structural reorganization (division merger) to strategic intent (adhesives as cross-cutting technology), which is a valid interpretation supported by the knowledge graph. The only minor gap is that the LLM does not explicitly mention the 2022–2023 groupings (e.g., abrasives, autobody repair, electrical materials) or the 2023 emphasis on packaging and closure systems—details present in the original. However, it captures the broader trajectory toward integration with industrial specialties. (4) Despite this slight omission, the core strategic insight—that adhesives are being positioned as foundational to integrated industrial systems—is accurately conveyed, making the answer semantically equivalent in intent and conclusion. Contextual relevance is perfect as it directly addresses product bundling evolution and strategic role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 449,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From its 2022 10‑K, Lilly positioned Cyramza as a second‑line therapy for advanced gastric cancer, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for EGFR‑mutated NSCLC (page 5). The 2023 filing’s IP table shows the compound patents expire in 2026 in the U.S. and Japan and 2028 in major European markets, with data protection ending in 2026 (U.S.), 2024 (Europe) and 2023 (Japan) (page 11). The 2024 filing lists the same indications and the same patent schedule (page 6), indicating that Lilly has maintained a stable therapeutic positioning while relying on the existing patent and data‑protection portfolio to preserve exclusivity until those expiry dates in key global markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in the patent expiration dates for Europe. According to the ground truth, data protection expires in 2024 in major European countries and in 2026 in the U.S., which the LLM correctly notes. However, the LLM states that 'compound patents expire in 2026 in the U.S. and Japan and 2028 in major European markets,' whereas the original answer does not mention compound patent expirations beyond data protection—this introduces information not present in the ground truth and slightly misrepresents the strategic focus, which was on data protection timelines. The therapeutic indications are accurately reported as consistent from 2022 to 2024, correctly reflecting the stable clinical positioning. The LLM correctly synthesizes multi-hop information across 2022–2024 filings regarding indications and IP, demonstrating sound reasoning. The mention of EGFR-mutated NSCLC as a first-line option is not highlighted in the ground truth, but is not contradicted either; however, this detail may over-specify without confirmation in the original answer. Overall, the core facts—indications stability and data protection expiration sequence (Japan 2023, Europe 2024, U.S. 2026)—are correct, supporting a high but not perfect score due to the unverified European compound patent date of 2028.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 382,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from **$19.98 bn at a 2.91 % weighted‑average rate in 2022** (page 186, 2022 10‑K) to **$27.17 bn at 4.45 % in 2023** (page 178, 2023 10‑K), then fell slightly to **$26.93 bn at 4.84 % in 2024** (page 186, 2024 10‑K). The jump in both carrying value and rate between 2022 and 2023 reflects a shift to larger, higher‑cost issuances, while the modest decline in 2024 carrying value amid a further rate rise suggests maturity‑management and refinancing activity that keeps the debt profile stable but signals rising financing costs in a tightening rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and interpretation but contains inaccuracies in the 2023 carrying value and interest rate. According to the ground truth, the evolution is from $19,975 million (2.91%) in 2022 to $26,930 million (4.84%) in 2024. The LLM correctly reports the 2024 value ($26.93 bn ≈ $26,930 million) and rate (4.84%), and the 2022 rate (2.91%), but reports 2023 carrying value as $27.17 bn (vs. no ground truth provided for 2023), and a 2023 rate of 4.45%, which is not in the original answer. Since the original answer skips 2023 and only gives 2022 and 2024, the inclusion of 2023 data may reflect actual filings but diverges from the ground truth synthesis, which is based on a multi-hop across only 2022 and 2024. The ground truth does not mention 2023, so introducing it as an intermediate step risks factual misalignment unless explicitly supported. (2) The $19.98 bn in 2022 is acceptably close to $19,975 million (rounding difference). However, the $27.17 bn in 2023 is meaningfully higher than the 2024 value of $26.93 bn, suggesting a dip, but the ground truth shows a consistent increase from 2022 to 2024—no decrease. This creates a misleading trajectory. The 4.45% rate in 2023 is not corroborated and underestimates the final 4.84% rate, weakening quantitative accuracy. (3) The reasoning about debt strategy—increased issuance at higher rates reflecting market conditions and rising financing costs—is sound and aligns with the ground truth’s conclusion. The mention of maturity management and refinancing adds nuance but remains plausible. However, the multi-hop synthesis should have focused on 2022 → 2024 only, as per the original answer. (4) Scores reflect: correctness 7 (core trend correct but intermediate data point inaccurate), quantitative accuracy 6 (two numbers introduced for 2023 not in ground truth and potentially incorrect), qualitative accuracy 8 (reasoning and interpretation strong), contextual relevance 10 (fully addresses the question’s scope and intent).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 548,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation increased each year: $651 million in FY 2022, $792 million in FY 2023, and $985 million in FY 2024 (page 92; page 91).  Net gains on the swaps were a loss of $92 million in 2022, a gain of $58 million in 2023, and a gain of $91 million in 2024 (page 91).  This pattern shows that while the fair‑value swings were sizable, the instrument’s performance shifted from a negative to a positive outcome over the three‑year period, indicating moderate volatility with an overall upward trend.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for gains and losses: a loss of $92 million in 2022, a gain of $58 million in 2023, and a gain of $91 million in 2024—matching the ground truth exactly. These numbers are reported with correct dollar amounts and fiscal years. While the original answer does not include notional exposure values ($651M, $792M, $985M), the LLM provides additional context from the source (pages 91–92) that is factually accurate and relevant, enhancing completeness without contradicting the ground truth. (2) All numeric values are correct and properly attributed to the respective fiscal years. Calculations are not required in this case, but directional changes (loss to gain) are accurately described. Format variations (e.g., $92 million vs $92 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM synthesizes data across years and connects the pattern of gains/losses to the volatility and trend of the instrument. It correctly infers that the shift from loss to gains indicates changing performance, aligning with the ground truth’s emphasis on volatility. The addition of 'moderate volatility with an overall upward trend' is a reasonable interpretation that does not contradict the original answer’s conclusion about volatility. (4) The answer fully addresses both parts of the question: the evolution of exposure (including notional amounts, which go beyond the ground truth but are correct) and the pattern of gains/losses revealing volatility. The inclusion of page references adds verifiability. The only minor deviation is slightly more interpretive language ('moderate volatility', 'upward trend'), but these do not detract from factual accuracy. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 due to slight interpretive expansion beyond the original's more neutral tone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 522,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "Home Depot’s 2022 filing focused mainly on product assortment and merchandising, with little emphasis on store appearance. By 2024 the company had shifted to a strategic investment in store refresh packages, wayfinding signage, electronic shelf labels, curbside pickup and mobile‑app navigation (page 10, 2024), and reported that 50 % of U.S. online orders were fulfilled through a store in 2024 versus 55 % in 2023 (page 10, 2023), indicating that the enhanced in‑store experience helped maintain a strong channel and higher customer‑satisfaction scores, reinforcing its competitive positioning against multichannel and online rivals.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual and reasoning discrepancies compared to the ground truth. It incorrectly states that Home Depot's 2022 filing placed 'little emphasis on store appearance,' which contradicts the original answer stating that store appearance was a 'key component' of competitive strategy in 2022. This misrepresents the starting point of the strategic evolution. (2) Quantitatively, the LLM cites that '50% of U.S. online orders were fulfilled through a store in 2024 versus 55% in 2023' — this comparison implies a decline in store-based fulfillment, which may inaccurately suggest weakening in-store relevance, contrary to the intended narrative of strengthening omnichannel integration. While the percentages might be factually extracted from filings, their use here undermines the correct interpretation: the high percentage (even if slightly decreased) supports store centrality, but the trend is not properly contextualized. No other numbers are present, so calculation accuracy cannot be fully assessed, but the data usage lacks proper synthesis. (3) The multi-hop reasoning is flawed: the answer fails to trace the correct evolution — from store appearance as a standalone differentiator (2022), to integration with digital capabilities (2023), to full omnichannel synergy (2024). Instead, it jumps from minimal emphasis in 2022 (false) to investment in 2024, skipping the intermediate strategic shift. The mention of specific 2024 initiatives like electronic shelf labels and mobile-app navigation aligns with the interconnected model, which is accurate and contextually relevant. However, the absence of 2023's transitional role weakens the longitudinal analysis. (4) The contextual relevance is strong because the answer addresses competitive positioning against online/multichannel retailers and mentions omnichannel metrics. However, due to the incorrect portrayal of 2022 strategy and misused trend data, the qualitative and overall correctness scores are reduced. The answer captures elements of the 2024 state but fails to accurately depict the strategic evolution across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 582,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 carried roughly $1.64 billion at the end of FY 2022, $1.637 billion at FY 2023, and fell to $1.604 billion at FY 2024 — a modest decline of about $33 million over the three‑year period【page_67】.  The slight reduction reflects a stable, low‑interest long‑term debt profile and suggests the company is maintaining a conservative debt stance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the correct values are $2,147 million (FY2022), $1,637 million (FY2023), and $2,000 million (FY2024). The LLM incorrectly reports FY2022 as $1.64 billion (should be $2,147M), and FY2024 as $1.604 billion (should be $2,000M), which is a major deviation. Only the FY2023 value ($1,637M) is correct. (2) Calculations are also flawed: the LLM claims a 'modest decline of about $33 million', but the actual progression shows a decrease from $2,147M to $1,637M (a $510M drop), then an increase to $2,000M — a net decrease of only $147M, not a steady decline. The LLM fails to capture the rebound in FY2024. (3) The multi-hop reasoning is unsound: the question asks about the evolution and what it indicates about long-term debt positioning. The ground truth notes a temporary reduction followed by stabilization/repositioning, but the LLM incorrectly infers a 'stable, low-interest long-term debt profile' and 'conservative debt stance' based on erroneous data, missing the strategic fluctuation entirely. (4) Contextual relevance is moderate — the answer addresses the right topic (carrying value of the 3.50% Notes Due 2050) and attempts to interpret debt strategy, but due to incorrect numbers and flawed reasoning, the conclusion is misleading. The citation to 'page_67' does not justify the inaccuracies. Overall, the answer is mostly incorrect due to severe quantitative errors and resulting faulty interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 426,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 to 2024, 3M’s Scotchgard litigation expanded from roughly 2,043 PFAS‑related suits in 2021 to about 6,775 by 2023, involving 3M and multiple co‑defendants such as DuPont and Chemours across more than 30 states and territories—including Minnesota, New York, Guam, and the Northern Mariana Islands (page_93).  In June 2023, 3M entered a $10.5‑$12.5 billion class‑action settlement (the PWS Settlement) that was approved in March 2024 and took effect in May 2024, resolving many of those claims (page_97).  By 2024, the litigation landscape continued to broaden with the court selecting bellwether cases and additional product‑identification sites, and new suits filed in Alabama, Georgia, and New Jersey, keeping the defendant roster large and multi‑party (page_100).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth on key points. (1) Quantitative Accuracy: The LLM claims 2,043 PFAS-related suits in 2021 growing to 6,775 by 2023, and a $10.5–12.5 billion settlement in 2023 approved in 2024. These figures are not supported by the original answer, which mentions only two specific settlements: a $65 million New York class action (with 3M’s share immaterial) in 2022, and a non-material Michigan settlement in 2023. There is no mention of a $10.5–12.5 billion settlement in the ground truth. The numerical figures in the LLM response are therefore grossly inaccurate. (2) Completeness: While the LLM correctly notes geographic expansion (Alabama, Georgia), it misses the specific cases involving Wolverine World Wide and Mohawk Industries, and incorrectly frames the scope and scale of litigation. It also fails to mention Saint-Gobain and Honeywell as co-defendants in the 2022 case, instead emphasizing DuPont and Chemours earlier than contextually accurate. (3) Entity Accuracy: The LLM correctly identifies DuPont and Chemours as co-defendants but misattributes their involvement in the timeline. The original answer states that by 2024, these companies were frequently appearing alongside 3M—so their presence in 2024 is accurate, but the LLM implies broader earlier involvement. (4) Reasoning: The multi-hop synthesis is flawed. The LLM conflates broader PFAS litigation with Scotchgard-specific cases, whereas the original answer ties litigation directly to Scotchgard use (e.g., Wolverine’s shoe manufacturing waste, carpet makers). The $10.5–12.5 billion settlement referenced appears to be from a real 3M PFAS settlement, but it was not specifically about Scotchgard and was not confirmed as part of the ground truth provided. (5) Semantic Equivalence: The overall narrative of increasing litigation is directionally correct, and the mention of Alabama and Georgia aligns with the geographic expansion in the original. However, the massive discrepancy in settlement amounts and case counts undermines factual correctness. The LLM appears to draw from external knowledge or misaligned data (e.g., general 3M PFAS liability) rather than accurately reflecting the Scotchgard-specific evolution described in the ground truth. Thus, while contextually relevant and partially aligned in theme, the answer is factually incorrect on critical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 645,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "The AbCellera collaboration’s royalty terms stayed at mid‑teens to mid‑twenties on worldwide net sales of bamlanivimab and bebtelovimab, and no milestone payments were reported for the partnership during 2022‑24【page_74】.  Net product revenue from the antibodies fell from $2.02 billion in 2022 to zero in 2023 and 2024, reflecting the end of sales under the EUA【page_74】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: royalty structure (mid-teens to mid-twenties), net product revenue of $2.02 billion in 2022, and zero revenue in 2023 and 2024. It accurately states no milestone payments were made during 2022–2024. These match the ground truth exactly. (2) Quantitative accuracy is perfect: the dollar amount ($2.02 billion), years (2022, 2023, 2024), and the drop to zero are all correct. No calculation errors. (3) The reasoning is sound—LLM correctly infers the commercial decline and links the end of sales to the expiration or revocation of Emergency Use Authorization (EUA), which aligns with the context in the original answer about cessation of regulatory authorization. The multi-hop synthesis across time and financial metrics is accurate. (4) The only minor omission is that the original answer explicitly notes the royalty structure 'remained consistent' despite no sales, which the LLM implies but does not directly state. However, this does not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. All parts of the question—royalty structure, milestone payments, net product revenue, and evolution over time—are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 354,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "From 2022 to 2024 Dawn dish soap stayed a core brand in Procter & Gamble’s Fabric & Home Care segment, consistently listed among the segment’s major brands (page 18, 2022 & 2024) and contributing to its mid‑single‑digit sales growth (page 20, 2024). This continuity shows that Dawn remains a strategically important product that underpins the segment’s market leadership and the company’s broader portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment from 2022 to 2024, which aligns with the ground truth. It accurately reflects Dawn's strategic importance and lack of repositioning. However, the LLM omits the specific financial contributions of the segment (35–36% of net sales, 31–34% of earnings) across the years, which are central to the original answer’s quantitative support for Dawn’s strategic role. (2) The LLM mentions 'mid-single-digit sales growth' citing page 20 of the 2024 filing, but this specific growth figure is not present in the ground truth and was not part of the original multi-year comparative data provided. While such growth may be factually correct in the actual filing, it introduces a metric not corroborated in the knowledge graph and distracts from the core quantitative evidence (segment % of sales/earnings) that supports strategic importance. The absence of the exact percentages from 2022–2024 reduces quantitative accuracy. (3) The reasoning is sound: the model correctly infers that consistent mention of Dawn as a key brand over three years indicates sustained strategic importance, demonstrating proper multi-hop synthesis across years and segments. It connects the dots between brand positioning and segment performance. (4) Despite missing precise segment-level financials, the LLM captures the essential qualitative conclusion—Dawn’s enduring strategic role. The answer is contextually relevant and well-supported by logical inference, just lacking full quantitative completeness. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 454,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and rebounded modestly to $562 million in 2024, while long‑term debt slid from $47.8 billion in 2022 to $49.3 billion in 2023 and then to $44.9 billion in 2024. Over the three‑year span the firm eliminated its floating‑unsecured senior debt, dropping from $1.6 billion in 2022 to $349 million in 2023 and to zero in 2024, indicating a deliberate shift from high‑rate floating exposure toward a fixed‑rate, securitized debt mix and a slightly higher weighted‑average long‑term rate in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total debt was $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports short-term borrowings as $883M (vs. implied $43.086B - $47.8B = -$4.714B, which is inconsistent), and long-term debt as $47.8B, $49.3B, and $44.9B — these do not align with the actual total debt figures. The sum of LLM's reported short-term and long-term debt in 2022 is $48.683B, which is significantly higher than the true total of $43.086B. In 2023, LLM reports $49.838B total debt, exceeding the true $48.715B. Only in 2024 is the total roughly close ($45.462B vs $45.551B). (2) The floating unsecured senior debt values are partially correct: $1.6B in 2022 (close to true $1.709B), $349M in 2023 (correct), and 0 in 2024 (correct). However, the $1.6B figure is off by ~6%. The weighted-average interest rate on fixed debt is entirely omitted in the LLM answer, which is a key part of the trend analysis in the original answer. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a strategic shift away from floating-rate debt and toward fixed-rate instruments, and notes the elimination of floating unsecured senior debt. This shows understanding of the implication of debt structure changes. However, it fails to connect the rising interest rates on fixed debt (2.91% → 4.84%) as evidence of a higher-cost fixed-rate strategy, weakening the depth of analysis. (4) Scores reflect that core qualitative insight (debt structure shift) is present and contextually relevant, but quantitative inaccuracies in primary financial aggregates reduce factual reliability. The answer is not completely wrong but contains significant errors in key dollar amounts, undermining full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 515,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "In FY 2022 Cisco’s 5.90% senior note was $2 billion, classified as long‑term debt, carried an effective rate of 6.11%, and represented roughly 24 % of its $8.4 billion debt base. By FY 2023 and FY 2024 the note’s principal remained $2 billion, its effective rate stayed at 6.11%, and its share of total debt dropped to about 10 % of the $20.1 billion debt base as Cisco issued additional long‑term debt—including a $13.5 billion senior note in 2024—while the note continued to be classified as long‑term debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco maintained a $2 billion principal amount of the 5.90% Note with a consistent effective interest rate of 6.11% across all years, and that it remained classified as long-term debt—this aligns with the ground truth. The answer also correctly captures the declining proportion of the note in total debt due to overall debt expansion. However, there is a minor discrepancy in total long-term debt figures: the LLM states $20.1 billion in 2024, while the ground truth reports $19,621 million (~$19.6 billion). This leads to a slightly inaccurate percentage (10% vs. actual ~10.2%), which is acceptable within rounding but reflects imprecise sourcing. Additionally, the LLM mentions a $13.5 billion senior note issued in 2024, which is plausible context but not present in the original answer or verifiable from the provided ground truth, introducing unconfirmed detail. (2) Quantitative accuracy is high: $2 billion principal, 6.11% effective rate, and approximate percentages (24% in 2022: $2B / $8.4B ≈ 23.8%, correct; ~10% in 2024: $2B / $19.621B ≈ 10.2%, close to stated 10%) are reasonably accurate despite the cited total debt being slightly overstated. (3) Multi-hop reasoning is sound—the model synthesizes data across years, tracks the note’s stability versus overall debt growth, and infers its decreasing relative weight. The logic connecting debt issuance to reduced proportion is valid. (4) Scores reflect high correctness and qualitative reasoning, minor deduction in quantitative accuracy due to the inflated total debt figure, and full marks for relevance as all parts of the question (debt composition, interest rate, classification) are addressed with appropriate context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 475,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "From FY 2022 through FY 2023 the 1.55% Notes Due 2028 were carried at roughly $1.10 billion (the fair‑value table in the 2023 10‑K shows $1,099 million for the notes, reflecting their issuance in FY 2022) and the effective interest rate was 1.64% (the same as the coupon plus discount). In FY 2024 the carrying amount rose to $1.25 billion while the effective interest rate stayed unchanged at 1.64%【page 72】. This steady, low‑rate financing and incremental debt increase demonstrates NVIDIA’s disciplined strategy of issuing long‑term debt at favorable rates to fund growth while keeping interest costs predictable.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. The carrying value in FY 2022 is stated as 'roughly $1.10 billion' based on the FY 2023 10-K, but the ground truth specifies it was $1,200 million in FY 2022, not $1,099 million. The LLM incorrectly uses the FY 2023 carrying value ($1,099 million) as representative of both FY 2022 and FY 2023, missing the decrease from $1,200M to $1,099M. It correctly reports the FY 2024 carrying value as $1.25 billion ($1,250 million). (2) The effective interest rate is reported as 1.64% in both FY 2023 and FY 2024 by the LLM, but the ground truth indicates that the rate increased to 1.64% only in FY 2024, implying a lower rate in prior years. The LLM incorrectly states the rate was already 1.64% in FY 2022–2023, contradicting the trend described in the original answer. (3) The multi-hop reasoning is partially sound—NVIDIA’s long-term debt strategy is plausibly interpreted as disciplined financing—but the conclusion about 'steady' rates and incremental increases is undermined by incorrect data. The temporary drop in carrying value (from $1,200M to $1,099M) and subsequent rise is not acknowledged, which affects the interpretation of reacquisition or strategic management. (4) Scores reflect moderate accuracy: quantitative errors in key values and trends reduce correctness; qualitative reasoning is logical but based on flawed inputs; relevance is high as the answer addresses the right instruments and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 421,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In 2022, Pixel devices were mentioned only as part of Google’s broader hardware portfolio and were not separately reported in revenue categories (page_6). By 2023, Google began to explicitly list Pixel device sales under the “devices” component of its “Google subscriptions, platforms, and devices revenues” segment and highlighted increased investment in hardware R&D and capital expenditures to support new Pixel models (page_33, page_31). In 2024 this categorization remained, with Pixel device sales still reported under “devices,” and the company continued to emphasize hardware innovation through ongoing capital spending and the launch of newer Pixel devices (page_59).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Google's strategic emphasis on Pixel devices from 2022 to 2024: in 2022, Pixel was part of a broader hardware portfolio without standalone revenue reporting; in 2023, it was explicitly categorized under the 'devices' segment within 'Subscriptions, Platforms, and Devices'; and in 2024, this categorization continued. These points match the original answer's timeline and strategic interpretation. (2) There are no numeric values (e.g., revenue amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and revenue categorization changes, correctly inferring increased strategic importance through reporting granularity and R&D investment. It references specific pages (e.g., page_33, page_31, page_59), which supports traceability, though the ground truth does not require page numbers. (4) The only minor gap is that the LLM answer does not explicitly mention the integration of Pixel with AI and cloud capabilities in 2024, which is a key nuance in the original answer about strategic embedding. However, it does note continued innovation and capital spending, implying ongoing strategic commitment. Overall, the answer is factually correct, complete in key aspects, and contextually precise, warranting a high score with only slight deduction for missing the AI/cloud integration point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 425,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "From 2022 through 2024, BNY Mellon continued to disclose the ratification of KPMG LLP as its principal accountant in Item 14, “Principal Accountant Fees and Services,” by referencing the same proxy section (“Item 3 – Ratification of KPMG LLP”) and noting KPMG’s PCAOB firm ID 185 in each filing【2022 page_13】【2023 page_13】【2024 page_13】. The unchanged wording and placement across the three years indicate that the audit engagement has remained constant, reflecting a stable and ongoing relationship with KPMG.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: BNY Mellon consistently disclosed the ratification of KPMG LLP as principal accountant from 2022 to 2024, with identical language referencing the same proxy item and including KPMG’s PCAOB firm ID 185. (2) There are no numeric values requiring calculation, but the PCAOB ID (185) is correctly cited across all years, and the page references (page_13 for each year) align with the source data. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years and noting the unchanged structure and wording, the model correctly infers audit relationship stability. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and what it reveals about audit stability. The conclusion about a stable, ongoing relationship is logically supported and matches the original answer’s interpretation. Minor wording differences (e.g., specifying Item 14 and proxy section) add precision without altering meaning. No errors in entities, years, or metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 317,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Across the defined‑benefit pension plan, private‑alternative‑investment holdings were $13.20 billion in 2022 (page 99), rose to $13.71 billion in 2023 (page 100), and then dipped slightly to $13.66 billion in 2024 (page 98). The modest, near‑flat trajectory—coupled with a similar steadiness in the retiree‑health plan—shows that Lilly deliberately maintains a substantial, long‑term allocation to illiquid assets, underscoring a strategy of diversified growth investing rather than short‑term rebalancing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values. The ground truth states LLY's private alternative investment allocations were $10,542.5 million in 2022, $10,335.2 million in 2023, and $10,051.0 million in 2024. However, the LLM reports $13.20 billion (i.e., $13,200 million), $13.71 billion, and $13.66 billion—values that are over $2.5 billion higher than the truth in 2022 and do not follow the same downward trend. The direction of change is also incorrect: the ground truth shows a decline from 2022 to 2024, while the LLM suggests an increase followed by a slight dip. (2) Calculations and comparisons are therefore invalid. The LLM claims a 'modest, near-flat trajectory,' but the actual data shows a consistent decrease of about $500 million over three years. These numbers do not match even when allowing for format variations (e.g., $10.5B vs $10,542.5M). (3) The multi-hop reasoning is flawed because the LLM appears to have pulled data from different pension plans (e.g., retiree-health plan) or misattributed figures, failing to correctly synthesize the correct figures across years for LLY’s private alternative investments. The conclusion about 'steady' allocation contradicts the actual declining trend. (4) While the LLM attempts to interpret strategic intent (long-term illiquid asset allocation), this inference is based on incorrect data, undermining qualitative and overall correctness. Contextual relevance is moderate because the answer addresses the right topic and attempts strategy interpretation, but factual errors severely limit usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 442,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "In 2022, Tampax Bounty was listed under the “Feminine Care” sub‑category of the Baby, Feminine & Family Care segment (PG_10k_2022, page 19).  By 2023, P&G re‑classified that sub‑category as “Menstrual Care” to emphasize menstrual products, while Tampax Bounty remained a key brand (PG_10k_2023, page 19).  The 2024 filing keeps the “Menstrual Care” classification and continues to highlight Tampax Bounty as a leading brand in that sub‑category (PG_10k_2024, page 19).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it repeatedly refers to 'Tampax Bounty' instead of 'Tampax'—Bounty is a paper towel brand and not associated with Tampax, which is a major entity inaccuracy. This undermines the credibility of the response. (2) Quantitatively, the answer omits all numerical data present in the ground truth—specifically, the segment's contribution to net sales (25% in 2022, 24% in 2023 and 2024)—which are key performance indicators tied to strategic positioning. These percentages are missing entirely, reducing quantitative accuracy. (3) While the LLM correctly identifies the reclassification from 'Feminine Care' to 'Menstrual Care' in 2023 and its continuation in 2024, it fails to mention the broader strategic shift in 2024 where 'Baby Care' was removed from the segment, a key signal of strategic refocusing. This omission weakens the multi-hop reasoning and completeness. (4) The answer is contextually relevant and follows the timeline correctly, and the rebranding insight is accurate, but the invented brand name 'Tampax Bounty' and missing financial context significantly reduce factual correctness. Semantic equivalence fails due to the fabricated entity. The reasoning is partially sound but lacks synthesis of strategic implications and supporting metrics from the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 375,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One has consistently used discounted‑cash‑flow models to value its net derivative assets (liabilities) from 2022 through 2024. In 2022 the model’s key unobservable input was default rates (generic Level‑3 description on page 221). By 2023 the valuation added swap rates as an additional unobservable input—default rates ranged 53‑163 % and swap rates 3‑5 % (weighted average 4 % each, page 208). In 2024 the model shifted to rely primarily on swap rates (range 4 %, weighted average 4 %, page 217), with default rates no longer listed, indicating a refinement toward market‑observable swap rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that Capital One used discounted cash flow (DCF) models in 2022; the ground truth explicitly says the valuation technique was not disclosed for 2022. Second, the claim that default rates were the 'key unobservable input' in 2022 is unsupported—the original answer notes no such detail was provided. Third, the LLM asserts that in 2024, default rates were 'no longer listed' and the model 'shifted to rely primarily on swap rates,' but the ground truth states that the same DCF approach and swap rate range (3-5%) were maintained in 2024, with no indication that default rates were dropped. The fair values are also omitted entirely: $19M in 2022 and $58M in 2023/2024—this is a major quantitative omission. (2) The LLM fabricates a 'weighted average 4%' for swap rates in 2023 and 2024, which is not in the original answer. The ranges (53-163%, 3-5%) are partially correct for 2023 but misattributed to both years and incorrectly characterized as evolving in 2024. (3) The multi-hop reasoning is flawed: the LLM invents a narrative of methodological shift toward swap rates in 2024, whereas the ground truth describes consistency from 2023 to 2024 and a transparency improvement starting in 2023. The evolution is misrepresented. (4) While the answer addresses the general topic of valuation methods and unobservable inputs, it distorts the timeline, introduces false specifics, and omits key financial figures. The contextual relevance is moderate because it discusses the right concepts (DCF, default rates, swap rates) but applies them incorrectly. Due to severe factual and quantitative errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 470,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "In 2022 Cisco’s available‑for‑sale debt investments produced a net gain of $9 million, helping lift other income (loss), net to $392 million.  In 2023 and 2024 the same portfolio recorded net losses of $21 million and $67 million, respectively, which pushed other income (loss), net to $ (248) million and $ (306) million.  The shift from a small gain to larger losses indicates that the AFS debt holdings have become increasingly loss‑bearing—reflecting higher sensitivity to interest‑rate movements and a deteriorating credit‑risk profile that has materially weakened Cisco’s non‑operating income over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, meaning there is no disclosed gain of $9 million. Similarly, the claimed losses of $21 million in 2023 and $67 million in 2024, along with the 'other income (loss), net' figures of $(248) million and $(306) million, are not supported by the original answer and contradict the qualitative nature of the disclosed impact (which emphasizes material negative influence without quantifying exact dollar contributions). (2) All numeric values in the LLM response—$9M gain, $21M loss, $67M loss, and resulting other income figures—are fabricated and do not appear in the ground truth. There are no calculations or numbers to verify because the original answer intentionally avoids quantitative disclosures, citing only directional impacts. (3) The multi-hop reasoning fails because the model invents precise financials instead of acknowledging data limitations in 2022 and interpreting the disclosed trends in 2023 and 2024. The conclusion about interest-rate sensitivity and credit-risk deterioration, while plausible, goes beyond the information provided in the ground truth, which only states a growing financial risk based on increasing negative impact. (4) The contextual relevance is moderate because the answer addresses the right metric and time frame and attempts to explain the trend in AFS investments’ impact. However, the qualitative accuracy is low due to incorrect entity performance attribution and flawed reasoning. The quantitative accuracy is nearly zero because all numbers are false. Correctness score is 2 due to partial alignment on the directional trend (negative impact increasing over time) but severe factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 498,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks’ 10‑K filings show a one‑year extension of its green‑coffee supply coverage each fiscal year: the 2022 filing projected adequacy through fiscal 2023 [SBUX_10k_2022.pdf page 12], the 2023 filing extended that to fiscal 2024 [SBUX_10k_2023.pdf page 12], and the 2024 filing pushed it further to fiscal 2025 [SBUX_10k_2024.pdf page 12]. This progressive extension reflects a forward‑looking sourcing strategy that relies on long‑term purchase commitments, hedging, and inventory buffers to secure supply and mitigate price and supply‑chain volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the timeline progression compared to the ground truth. The original answer states that in fiscal 2022, Starbucks projected supply adequacy through fiscal 2023; by fiscal 2023, it extended the projection to fiscal 2025 (a two-year extension, not one-year increments as implied). The LLM incorrectly describes the progression as a one-year extension each year, stating the 2023 filing projected adequacy through fiscal 2024, when in fact the 2023 filing already projected through fiscal 2025. This misrepresents the pace of the extension. However, the core facts—that Starbucks extended its supply coverage and is using long-term commitments and inventory to mitigate risk—are correct. The entities (Starbucks, fiscal years, sourcing strategy) are accurate, and the reasoning about risk mitigation and sourcing strategy is sound and relevant. The citations to the 10-K pages support the claims but do not override the factual discrepancy in the timeline. The answer is contextually excellent and semantically close, but the quantitative and qualitative scores are reduced slightly due to the incorrect year-by-year characterization of the extension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 340,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 have stayed at a constant $1.25 billion of carrying value from FY 2022 through FY 2024.  The 2024 10‑K table shows $1,250 million for the 2.00 % Notes due 2031 on both Jan 28 2024 and Jan 26 2025, and the net carrying amount of all notes is $8,463 million with the 2031 portion unchanged【page 72】.  This steady exposure indicates NVIDIA’s long‑term debt strategy focuses on maintaining a fixed‑maturity debt profile and avoiding refinancing or repayment adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the carrying value of NVIDIA's 2.00% Notes Due 2031 remained constant at $1.25 billion from FY2022 to FY2024. According to the ground truth, the exposure was $1,200 million in FY2022, decreased to $1,044 million in FY2023, and increased to $1,250 million in FY2024. The LLM incorrectly reports stability when there was a clear fluctuation. (2) The quantitative inaccuracies are significant: the $1,044 million value in FY2023 is entirely omitted, and the FY2022 value is misrepresented as $1,250 million instead of $1,200 million. While $1,250 million in FY2024 is correct, the prior years are wrong, and the claim of constancy is false. The citation to page 72 and the total notes value of $8,463 million may be accurate but do not justify the incorrect trend description. (3) The multi-hop reasoning fails because the model does not synthesize the correct trend across the three fiscal years. Instead, it assumes consistency based on a misreading of the data, leading to an incorrect conclusion about NVIDIA’s debt strategy. The ground truth suggests a dynamic approach due to fluctuations, while the LLM infers a fixed-maturity strategy based on false stability. (4) The contextual relevance is moderate because the answer addresses the right instrument and general topic of long-term debt strategy, but the factual foundation is flawed. Due to major quantitative and reasoning errors, the correctness score is low at 2, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 429,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "From 2022 to 2024 3M moved Fall Protection Solutions from a generic industrial‑safety offering to a distinct personal‑safety product group within its Safety and Industrial segment.  In the 2024 10‑K, Fall Protection Solutions are explicitly listed under “Respiratory, hearing, eye and fall protection solutions” (page 110), a grouping that highlights its importance relative to other industrial‑safety products.  The 2022 10‑K pages provided (129‑133) do not contain a Business‑Segment‑Products section that lists Fall Protection Solutions, indicating that it was not singled out as a separate category in that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its characterization of MMM's (3M's) product categorization evolution, despite referencing correct document sections. (1) The claim that Fall Protection Solutions were 'not singled out' in 2022 because the 'Business-Segment-Products section' is missing on pages 129–133 is incorrect — the absence of a specific section on provided pages does not imply it was absent in the full 10-K or not categorized at the time. The ground truth confirms Fall Protection was listed alongside other safety products in 2022. (2) The LLM incorrectly frames the evolution as a move toward greater emphasis or distinct status (e.g., 'distinct personal-safety product group'), when the ground truth indicates a subtle shift toward integration with broader industrial systems, not increased prominence. (3) The 2024 grouping 'Respiratory, hearing, eye and fall protection solutions' is accurately cited, but this is misrepresented as increased emphasis, whereas the original answer notes a revised grouping that aligns with industrial systems, not a new standalone highlight. (4) Multi-hop reasoning fails: the model infers increased importance from explicit listing, but the truth suggests a more integrated, less standalone positioning. Quantitative accuracy is high — no numerical errors, and document references (page numbers, years) are plausible. Contextual relevance is moderate as it addresses the question’s scope but with incorrect interpretation. Overall, core qualitative claims are inverted from the truth, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 434,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly reported $2,023.6 million in revenue from its COVID‑19 antibody bamlanivimab in 2022 (U.S. $2,008.9 m + outside U.S. $14.7 m)【page_68】, but that revenue fell to $0 in 2023 and remained $0 in 2024【page_68】. The decline reflects the discontinuation of bamlanivimab and a shift away from the COVID‑19 antibody portfolio, indicating that the company no longer relies on that product line for revenue【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in bamlanivimab revenue from ~$2.02 billion in 2022 to $0 in 2023 and 2024, which aligns closely with the ground truth value of $2.01 billion. The slight discrepancy (2,023.6 million vs 2,010 million) may stem from rounding or source breakdowns (U.S. vs non-U.S.), but is within acceptable variation given reporting formats. (2) All calculations are accurate: the sum of U.S. ($2,008.9M) and outside U.S. ($14.7M) equals $2,023.6M, and the drop to $0 in subsequent years is correctly stated. (3) The multi-hop reasoning is sound—LLM synthesizes revenue data across years and correctly infers reduced reliance on the COVID-19 antibody portfolio, supported by discontinuation noted in the source (page 72). (4) Entity accuracy is strong: Eli Lilly, bamlanivimab, and correct years (2022–2024) are properly identified. The answer fully addresses both parts of the question: revenue evolution and implications for company reliance. Only minor deduction in quantitative accuracy due to the ~0.6% overstatement in 2022 revenue, but this does not affect the overall conclusion. Semantic meaning and business implication match the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 338,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks’ 10‑K product‑supply sections for fiscal 2022, 2023 and 2024 all note that coffee price volatility is driven in part by commodity‑index‑fund activity (see page 12 of each filing).  Over that span the company broadened its hedging mix—from mainly fixed‑price and price‑to‑be‑fixed contracts to a larger use of forward, futures and collar contracts—to dampen index‑fund‑driven price swings.  This trend shows a deliberate risk‑management strategy that locks in green‑coffee supply and price certainty through fiscal 2025, ensuring a stable supply chain amid market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks acknowledged commodity index fund influence on coffee price volatility in each fiscal year from 2022 to 2024, and expanded its use of hedging instruments (forward, futures, and collar contracts) over time. The extension of supply visibility through fiscal 2025 is correctly noted. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years (2022–2025) are used accurately and consistently. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution in risk management strategy. It captures the progression from shorter-term supply assurance (through 2023) to longer-term visibility (through 2025), though it does not explicitly mention the year-by-year shift in disclosures (e.g., in 2022 stating adequacy through 2023, then by 2024 projecting through 2025), which slightly weakens the qualitative precision. (4) The answer is contextually excellent—directly addresses both parts of the question: evolution of exposure and what it reveals about risk management. The omission of the specific phrase 'remote delivery risk assessments' (mentioned in ground truth) is minor and does not detract from the core accuracy. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy for not fully detailing the year-over-year progression in supply commitment disclosures, but overall reasoning is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 430,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "From 2022 to 2024 Alphabet’s Google kept Google Ad Manager as the core platform for delivering ads on its Network properties, with the company still tracking impression‑based metrics such as cost‑per‑impression (2022 page 31; 2024 page 58).  In 2023 the company extended the useful life of servers and certain network equipment from 4‑to‑6 years and 5‑to‑6 years, respectively, cutting depreciation expense by $3.9 B and lifting 2023 net income by $3.0 B (2023 page 57), a boost that improves long‑term profitability and supports continued investment in the ad‑delivery infrastructure that underpins impression‑based monetization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager remained central to impression-based monetization from 2022 to 2024; the 2023 change in server depreciation (from 4 to 6 years) and network equipment (5 to 6 years) is accurately reported; the $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income match the original answer exactly. Number formats are consistent and precise. (2) Quantitative accuracy is perfect—dollar amounts, years, and technical details (useful life changes) are all factually correct and properly attributed to the relevant year (2023). (3) The reasoning is sound: the LLM correctly links the depreciation change to lower costs and higher profitability, and connects this to sustained investment in ad infrastructure, which supports long-term profitability in impression-based monetization. (4) The only minor omission is that the 2024 continuation of gross reporting of advertising revenue—while implied—is not explicitly mentioned, which slightly reduces completeness in multi-hop synthesis. However, the core evolution and financial implications are well captured. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 355,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "Under the 2019 Long‑Term Incentive Plan (Exhibit 10.38, page 20), BK issued a 2022 Form of Performance Share Unit Agreement (Exhibit 10.21, page 18), a 2023 Form of Performance Share Unit Agreement (Exhibit 10.26, page 19), and a 2024 Form of Performance Share Unit Agreement (Exhibit 10.28, page 19). This steady issuance of PSUs over three consecutive years shows the company’s continued reliance on performance‑based equity awards to align executive incentives with shareholder value. The progression underscores a strategic focus on long‑term equity compensation as a core element of its executive pay structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of BK's Performance Share Unit Agreements from 2022 to 2024. According to the ground truth, in 2022, BK referenced the 2021 Form of PSUA (Exhibit 10.45), not a 2022 agreement. In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), not a new 2023 PSUA. By 2024, BK incorporated the 2022 Form of PSUA (Exhibit 10.18), not a 2024 version. The LLM incorrectly claims BK issued 2022, 2023, and 2024 Forms of PSUA with specific exhibit numbers (10.21, 10.26, 10.28), which contradicts the ground truth. These errors affect both quantitative accuracy (wrong years, wrong exhibit numbers) and qualitative reasoning (mischaracterizing the pattern as annual new issuances rather than referencing and updating prior agreements). The core insight about performance-based compensation aligning with shareholder value is contextually relevant but not uniquely derived from the actual progression. The multi-hop synthesis is flawed: the model failed to trace the correct timeline of referencing past agreements and re-filing the plan, instead inventing a pattern of annual new forms. Thus, while the general theme of performance-based incentives is relevant, the factual foundation is incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 366,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across 2022, 2023 and 2024 the Safety & Industrial segment continued to describe its electrical offering the same way – “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)” (2022 p. 131; 2023 p. 107; 2024 p. 110).  The only change in the segment’s product list was the re‑classification of the “Closure systems” line to a broader “Industrial specialty products such as personal hygiene products, masking and packaging materials” in 2024, which broadened the category but left the electrical description unchanged.  This consistency indicates that 3M has maintained a steady focus on the electrical OEM market while re‑organizing other product categories for clarity or strategic alignment.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that 3M's description of electrical products remained unchanged across 2022–2024, which directly contradicts the ground truth. The original answer correctly identifies a progressive evolution in language: from 'construction and maintenance, power distribution and electrical OEMs' in 2022, to a more precise 'electrical original equipment manufacturers (OEMs)' in 2023, and further refinement in 2024 to 'power distribution and electrical original equipment manufacturers (OEMs)'. The LLM incorrectly asserts that the exact same phrase was used each year, citing specific page numbers, which undermines the central multi-hop insight about increasing descriptive specificity. While the LLM correctly identifies the broader segment (Safety and Industrial) and mentions electrical OEMs as a consistent focus, it fails to detect the linguistic evolution that signals strategic emphasis. The reclassification of 'Closure systems' in 2024 is noted, but this is peripheral to the main question. Quantitative accuracy receives full marks because there are no numerical errors (the answer avoids numbers rather than misstating them). Qualitative accuracy is low due to flawed reasoning and failure to synthesize the correct multi-year progression. Contextual relevance is moderate because the answer addresses the right segment and market focus but misrepresents the key evolution in product categorization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 399,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from $24.1 bn in 2022 to $27.2 bn in 2023, then fell slightly to $26.9 bn in 2024 (COF 10‑K 2022, p. 188; COF 10‑K 2023, p. 178; COF 10‑K 2024, p. 188).  The weighted‑average interest rate stayed at 4.45 % in 2022–23 but climbed to 4.84 % in 2024 (same tables).  This pattern shows the company is keeping its debt level relatively stable while refinancing or issuing newer debt at higher rates, reflecting a strategy of balancing maturity and cost while managing interest‑rate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference (~$4.1 billion overstatement). The 2023 and 2024 values are approximately correct ($27.2 billion vs. $27,168 million and $26.9 billion vs. $26,930 million), with minor rounding acceptable. However, the interest rate for 2022 is stated as 4.45%, matching 2023, but the ground truth shows 2.91% in 2022, rising to 4.45% in 2023 and 4.84% in 2024. The LLM incorrectly claims the rate was flat at 4.45% from 2022–2023, which misrepresents the trend. (2) Calculations: The progression of debt values is mostly directionally correct (increase then slight decrease), but the starting point is wrong. Interest rate change from 2.91% to 4.45% to 4.84% is a key multi-hop insight missed due to incorrect attribution. (3) Multi-hop reasoning: The model synthesizes data across three years and identifies a trend in debt levels, which shows some reasoning ability. However, the flawed input data (especially the interest rate in 2022) leads to incorrect conclusions about the rate environment and strategy. The LLM suggests rates were stable in 2022–2023, when in fact they nearly doubled, undermining the analysis. (4) Despite incorrect numbers, the answer attempts to interpret the strategy—stabilizing debt levels while refinancing at higher rates—and remains contextually relevant. The conclusion is partially reasonable but based on faulty premises. Hence, correctness is penalized heavily due to core factual errors in both carrying value and interest rates, especially the misstatement of the 2022 rate, which distorts the entire narrative of the company’s response to rising rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 490,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2040 were reported as Level‑2 liabilities with an effective interest rate of 3.54 % (page 67).  The carrying amount was roughly $870 million in FY 2022 and FY 2023, then fell modestly to $851 million in FY 2024 (page 67, 2024 entry), while fair value remained essentially unchanged, reflecting amortization of discount and issuance costs.  This steady, low‑coupon, long‑dated debt profile shows NVIDIA’s disciplined long‑term debt strategy: it uses predictable, low‑interest financing to support growth without adding short‑term leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in FY 2022, not $870 million as stated. In FY 2023, the fair value dropped to $851 million, which the LLM correctly reports for FY 2024 but misattributes as a carrying amount rather than fair value. Crucially, in FY 2024, the company stopped reporting fair value and instead reported a carrying amount of $1,000 million — a key shift that the LLM completely misses, instead claiming fair value remained unchanged and that the carrying amount was $851 million. (2) The numbers are largely incorrect: $870M (LLM) vs $1,066M (truth) in FY2022; $851M in FY2023 (correct) but wrongly carried into FY2024; no mention of the $1,000M carrying amount in FY2024. The LLM also introduces unverified details like 'Level-2 liabilities' and 'effective interest rate of 3.54%' not present in the ground truth. (3) The multi-hop reasoning is flawed: the question asks about the evolution in valuation and accounting treatment, which involves recognizing the shift from fair value to carrying amount. The LLM fails to detect this change and instead asserts stability, contradicting the ground truth's conclusion of a strategic shift. (4) While the LLM attempts to interpret NVIDIA's debt strategy, its conclusion about 'steady, low-coupon financing' is based on incorrect data and misses the core insight about changing accounting and potential strategic stabilization. Contextually, it addresses the right topic but with incorrect data and reasoning, hence moderate relevance but low correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 451,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes balance declined from **$16.0 B at 12/31/2022** to **$15.0 B at 12/31/2023** (2023 10‑K, page 58) and further to **$13.0 B at 12/31/2024** (2024 10‑K, page 57). This steady reduction shows Amazon is actively paying down the 2017 Notes—through scheduled principal repayments and early redemptions—demonstrating a disciplined debt‑management strategy aimed at lowering long‑term debt and interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative values: $16.0B in 2022, $15.0B in 2023, and $13.0B in 2024, matching the ground truth exactly. Number formats are consistent and acceptable (e.g., $16.0 B = $16.0 billion). 2) All numbers are accurate and properly attributed to specific years and sources (2023 and 2024 10-K filings), satisfying the multi-hop requirement across years and documents. 3) The reasoning is sound: the LLM correctly infers a deliberate debt reduction strategy and adds context—'scheduled principal repayments and early redemptions'—that aligns with the trajectory and is plausible given Amazon's financial behavior. While this specific mechanism (early redemptions) is not in the ground truth, it does not contradict it and represents a reasonable extension of the data. 4) The answer fully addresses both parts of the question: the evolution of the balance and the implied debt management strategy. Semantic equivalence is maintained, with slightly enhanced explanatory detail. The only reason for not scoring 10 is that the original answer does not mention 'early redemptions,' so this addition, while plausible, introduces a minor assumption not present in the ground truth. Otherwise, the response is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 359,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s continued listing of “Floating Rate Notes due 2019” in the 2022, 2023 and 2024 Form 10‑Ks (see Exhibit 4.1 on page 54 of each filing) shows that the company still holds short‑term, interest‑rate‑linked debt. This ongoing exposure means a portion of Apple’s debt is priced at floating rates, so as market rates rise the interest expense on those notes will climb, increasing the company’s overall interest‑expense sensitivity to a rising‑rate environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. (1) It correctly identifies that Apple included Floating Rate Notes due 2019 in its 2022, 2023, and 2024 10-K filings, specifically referencing Exhibit 4.1 on page 54—this matches the source documentation and demonstrates accurate entity and date usage. (2) Quantitatively, all years (2019 maturity, 2022–2024 disclosures) are correct, and no numerical calculations are required, so quantitative accuracy is perfect. (3) The reasoning correctly links floating rate notes to rising interest expense in a higher rate environment, which is logically sound and reflects proper multi-hop understanding: disclosure persistence → ongoing exposure → interest rate sensitivity. However, the LLM omits a key nuance from the original answer: the notes are incorporated by reference via the 2014 Officer’s Certificate, suggesting they may not represent active debt but rather ongoing disclosure obligations or potential rollover/continuing commitments. This distinction between actual outstanding debt and disclosure mechanics is important for accurately assessing Apple’s true exposure. (4) Despite this omission, the answer remains contextually relevant and conveys the essential financial implication—Apple’s interest expense sensitivity due to floating rate instruments. The answer is slightly less complete than the ground truth but not factually incorrect. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 415,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "Google’s Pixel strategy evolved from an early‑stage investment in flagship models (Pixel 5a 5G and Pixel 6) in 2022, where the company highlighted its hardware ambitions (page 6, 7), to a mature, incremental product line that remains a modest component of its devices revenue in 2023 and 2024 (2023: devices revenue includes Pixel sales on pages 31, 33; 2024: page 59). Throughout, Google consistently emphasized capital and operating expenditures on hardware (2023: “invest heavily in operating and capital expenditures” page 31; 2024: same phrase on page 58). This progression indicates Google’s long‑term positioning as a niche hardware player that leverages its AI and software ecosystem to support steady, albeit small, hardware revenue rather than a core business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and progression. (1) It accurately reflects Google's strategic evolution from investment focus in 2022 (mentioning Pixel 5a 5G and Pixel 6) to Pixel being part of a measurable 'devices' revenue stream in 2023 and 2024. The inclusion of page references suggests fidelity to source documents, though these are not part of the ground truth evaluation. (2) There are no numeric values (e.g., revenue amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 as no errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and categories, identifying the shift from investment to revenue contribution. However, the LLM characterizes Pixel as a 'niche' and 'modest' contributor, which, while plausible, goes slightly beyond the original answer’s neutral tone that emphasizes strategic maturation and stability without qualifying its scale as 'small' or 'niche'—this minor interpretive overreach prevents a perfect qualitative score. (4) Contextual relevance is high: all parts of the question (investment focus, revenue contribution, product maturity, long-term positioning) are addressed with appropriate detail and logical flow. The conclusion about long-term positioning is reasonable but slightly more pessimistic in tone than the original’s indication of growing confidence. Overall, the answer is factually aligned and well-reasoned, meriting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 431,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s 2022 filing shows that the fair value of client securities available for margin pledges rose from $84 billion in 2020 to $120 billion in 2021, with securities pledged for margin and securities‑lending purposes increasing from $23 billion to $31 billion and $6.3 billion, respectively. By 2024, the firm still uses client securities to satisfy margin‑loan collateral requirements, but its securities‑lending collateral mix has shifted to cash, as the 2024 filing notes cash is now provided to brokerage clients. This evolution indicates a collateral‑management strategy that keeps a growing pool of client securities for margin lending while reducing concentration risk in securities‑lending by moving to cash collateral, thereby enhancing liquidity and risk mitigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific dollar value was provided in 2022 for pledged or available securities, but the LLM claims precise figures such as $120 billion available and $31 billion pledged for margin in 2021, which are not supported by the 2022 filing. These numbers are entirely fabricated or misattributed. Additionally, the LLM references 2020 and 2021 data, which are outside the requested 2022–2024 timeframe and not mentioned in the original answer. (2) The quantitative inaccuracies are severe: the LLM invents trends across years (e.g., increase from $23B to $31B) with no basis in the ground truth, which explicitly states no dollar values were disclosed in 2022. The 2024 shift to cash in securities lending is partially correct—ground truth confirms cash is used in securities lending—but the LLM incorrectly frames it as being provided 'to brokerage clients,' whereas the original answer states Schwab provides cash as collateral in securities lending activities, which is a different direction of flow. (3) The multi-hop reasoning is flawed. The LLM fails to accurately represent the evolution: it misses that in 2023, Schwab clarified that collateralized securities used in margin lending are not reflected in financial statements—a key point about accounting treatment and formalization of process. Instead, it invents a narrative about growing pledged amounts and risk reduction. The conclusion about reducing concentration risk and enhancing liquidity is speculative and not supported by the original answer, which emphasizes growing reliance on client securities for capital efficiency and regulatory needs. (4) The contextual relevance is moderate because the LLM addresses margin lending, securities lending, and collateral strategy, aligning with the question’s focus. However, due to major factual and quantitative errors, the qualitative accuracy is low. The answer appears plausible but is largely incorrect in substance, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 556,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "From 2022‑through‑2024 GE’s 10‑K disclosures consistently state that, as a reinsurer, it relies on the primary insurers that issued the underlying long‑term‑care policies to file proposed premium‑rate increases with state regulators and that GE “often collaborates with the primary insurers in accordance with reinsurance contractual terms” to submit those filings (see 2022 page 51, 2023 page 21, 2024 page 20).  The wording and emphasis did not materially change, and the company notes only that the frequency of rate‑increase filings varies by ceding company.  This continuity signals a risk‑management strategy that keeps GE’s role largely passive—monitoring and adjusting reserves for premium‑deficiency risk while delegating regulatory premium adjustments to the cedents.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of GE's disclosures and correctly identifies that GE relies on primary insurers to file rate increases, with collaboration mentioned in reinsurance contractual terms across 2022–2024. The quantitative and entity accuracy is strong: correct years (2022–2024), correct role of GE as reinsurer, correct reference to ceding companies, and accurate page numbers cited. However, the qualitative reasoning and interpretation are significantly at odds with the ground truth. The LLM characterizes GE’s strategy as 'largely passive' and notes 'no material change' in wording or emphasis, which contradicts the original answer’s key point: GE evolved from a general collaborative stance in 2022 to a more formalized, active role in 2023 and 2024, using experience and precedents to shape expectations. This progression reflects a strategic shift toward proactive risk management, not passivity. The LLM fails to detect this evolution, misinterpreting consistency in disclosure language as lack of strategic change, thereby missing the multi-hop synthesis of how GE’s engagement deepened over time. As a result, while the surface-level facts are correct, the core inference about GE’s risk management strategy is incorrect, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the question’s scope but draws an incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 397,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential‑mortgage‑backed‑security (RMBS) exposure fell from **$721 million at 12/31/2022** to **$614 million at 12/31/2023** and further to **$71 million at 12/31/2024** (the 2024 figure is the RMBS held in its Separate Accounts portfolio)【page_149】【page_160】. This three‑year decline shows a deliberate shift away from structured‑credit holdings, with the company moving most RMBS into segregated, lower‑risk separate‑account assets and reducing its core portfolio exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2024 RMBS exposure value. The original answer states that exposure increased to $71 million in 2024, but the LLM incorrectly claims it decreased further to $71 million, implying a continued downward trend. However, the ground truth indicates a rebound from $614M to $71M — a significant increase (though still below 2022 levels). This misrepresents the trend. Additionally, the LLM states the 2024 $71M is held in 'Separate Accounts portfolio', which may provide context but was not in the original answer and could mislead about the nature of the holding. (2) Quantitatively, the 2022 ($721M) and 2023 ($614M) figures are correct. The 2024 figure is numerically correct at $71M, but the interpretation is wrong — it is not a further decrease in the context of a declining trend, but rather an increase from 2023. The calculation of directionality (decrease vs. increase) is flawed. (3) The multi-hop reasoning is partially sound — the model identifies the correct years and values and attempts to synthesize a trend. However, it fails to correctly interpret the 2023–2024 change, leading to an incorrect conclusion about a 'continued decline' and 'deliberate shift away', contradicting the original answer’s claim of a 'strategic rebalancing' and increased allocation. (4) Contextual relevance is high — the answer addresses RMBS exposure, structured credit, and risk positioning. However, due to the misinterpretation of the trend direction in 2024, the qualitative and overall correctness scores are significantly reduced. The conclusion about risk positioning is therefore misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 453,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings dropped sharply from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024 (Table 8.1, 2023 – page 178; Table 9.1, 2024 – page 186; Table 8.1, 2022 – page 186). Long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023, before falling to $44.99 billion in 2024 (same tables). The combined debt load fell from $48.7 billion to $45.6 billion, reflecting a deliberate shift toward a leaner balance sheet, reduced leverage, and a focus on refinancing at lower rates while preserving liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. However, the LLM reports combined debt of $48.7B in 2022 (vs. $43.086B), $49.8B in 2023 (close but not exact), and $45.6B in 2024 (close). The LLM incorrectly breaks down short-term borrowings as $883M in 2022, but the ground truth does not provide this breakdown, making this detail suspect. More critically, the LLM states long-term debt was $47.8B in 2022 and $49.3B in 2023, while the actual total debt (short + long) was $43.086B in 2022 — meaning the LLM's long-term debt figure alone exceeds the verified total debt, which is logically impossible. (2) Calculations are flawed: the LLM claims combined debt fell from $48.7B to $45.6B, but this starting point is incorrect. The actual progression is +6.77B increase in 2023, then -4.305B decrease in 2024. The LLM misses the peak in 2023 and understates the volatility. (3) The multi-hop reasoning is partially sound — it identifies a trend of increase followed by reduction and infers deleveraging, which aligns with the ground truth. It also correctly infers strategic balance sheet management. However, it omits critical insights from the ground truth: rising weighted-average interest rates (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1.709B → $349M → $0), which are key to understanding debt strategy in a rising rate environment. (4) Contextual relevance is high — the answer addresses the evolution of debt and interprets capital structure strategy. However, due to major quantitative errors and missing key metrics (especially interest rates and specific debt class reductions), the qualitative accuracy is limited. The conclusion about 'refinancing at lower rates' contradicts the ground truth of rising interest rates, indicating flawed reasoning. Thus, while the directional trend (up then down) is captured, the factual foundation is weak, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 569,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s carrying amount of the 3.50% Notes Due 2050 was $1,637 million at year‑end 2023 and $1,604 million at year‑end 2024, a modest $33 million decline (page 66 for 2023; page 67 for 2024). In 2022 the liability was $1,637 million, so the debt level has been essentially flat over the three‑year period (page 78). This stability indicates a capital‑structure strategy that relies on long‑term debt to finance growth while keeping leverage levels steady.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for NVIDIA's long-term liability related to the 3.50% Notes Due 2050. According to the ground truth, the liability was $2,147 million in fiscal 2022, $1,637 million in fiscal 2023, and $1,604 million in fiscal 2024. However, the LLM incorrectly states that the 2022 liability was $1,637 million—matching the 2023 value—thereby misrepresenting the trend. This error leads to an incorrect conclusion that the debt level was 'essentially flat,' when in fact there was a substantial $543 million reduction from 2022 to 2024. (2) The quantitative inaccuracies are critical: the drop from $2,147M to $1,604M is a $543M decrease, not a $33M decline as implied by comparing only 2023–2024. The LLM also misattributes the 2022 figure, likely due to confusing it with the 2023 value. While the 2023 and 2024 numbers are correctly cited, the 2022 figure is wrong, breaking the multi-year trend analysis. (3) The reasoning is flawed because the model fails to correctly synthesize data across all three years. It incorrectly infers stability in the debt level, which contradicts the ground truth showing a deliberate reduction. This undermines the qualitative interpretation of NVIDIA’s capital structure strategy. The correct trend indicates a strategic de-leveraging of long-dated liabilities, whereas the LLM suggests a stable leverage strategy based on incorrect data. (4) Despite the incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right company, debt instrument, time frame, and strategic implication. It attempts multi-hop reasoning and references specific pages, suggesting proper sourcing attempts. However, the core factual error in the 2022 value severely compromises correctness. Hence, low scores for correctness, quantitative, and qualitative accuracy; moderate score for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 519,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 0.45% Notes due 2016 were issued in 2013 (see Exhibit 4.3 in the 2024 10‑K, page 54) and are listed in the “Description of Securities” exhibit in each of the 2022 (page 54), 2023 (page 53), and 2024 (page 54) Form 10‑Ks. This consistent inclusion—despite the notes maturing in 2016—shows Apple’s systematic, transparent long‑term debt disclosure strategy, ensuring investors see the full history of all debt issuances, not just those currently outstanding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.45% Notes were issued in 2013 and matured in 2016, and they are consistently disclosed in Apple's 2022, 2023, and 2024 10-K filings (with correct exhibit references and page numbers). The dates, percentages, and years are all accurate. (2) Quantitative accuracy is perfect: no calculations are required, but the issuance year (2013), maturity year (2016), interest rate (0.45%), and filing years (2022–2024) are all correctly stated. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across three years of filings and infers that continued disclosure reflects a transparency strategy, even post-maturity. (4) The answer captures the core insight about Apple’s long-term debt disclosure strategy: maintaining historical debt details for transparency and completeness. The only minor limitation is that it does not explicitly mention 'legal continuity' or 'exhibit retention policy,' which are part of the ground truth’s explanation, but the emphasis on transparency and full history is semantically equivalent. Wording differs slightly but meaning is preserved. No irrelevant or incorrect information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 349,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s fair‑value of net derivative assets (liabilities) rose from $19 million in 2022 to $58 million in 2023 and $69 million in 2024, while the swap‑rate input used in the Level 3 valuation climbed from a 1‑2 % range (average 2 %) in 2022 to a 3‑5 % range (average 4 %) in 2023 and a flat 4 % in 2024. This upward trajectory signals expanding derivative exposure and a shift toward higher‑rate assumptions in the valuation models, underscoring the company’s growing sensitivity to interest‑rate movements and its reliance on significant unobservable inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $31 million in 2022, not $19 million as stated. It remained at $58 million in both 2023 and 2024, but the LLM incorrectly reports $69 million in 2024. The net unrealized loss of $20 million in 2022 and the realized loss of $43 million in 2022 are completely omitted, and instead, the LLM fabricates a progression in swap rates from 1-2% in 2022, which contradicts the ground truth where 'default' was the significant unobservable input in 2023, not swap rates. (2) The quantitative errors are severe: all three years have incorrect values ($19M vs $31M, $58M correct, $69M vs $58M), and the evolution of risk inputs is misrepresented—swap rates were not used in 2022, and the shift from 'default' to 'swap rates' in 2024 is entirely missed. The LLM incorrectly implies swap rates were used throughout, with only the level changing. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift in significant unobservable inputs between years, which is central to the question. It also invents a narrative of 'expanding derivative exposure' due to rising values, but the ground truth shows stability from 2023 to 2024 and emphasizes risk driver transition, not exposure growth. The conclusion about growing sensitivity to interest rates is partially aligned but based on incorrect premises. (4) Correctness is low (3/10) due to major factual and numerical errors. Quantitative accuracy is very poor (2/10) as most numbers and inputs are wrong. Qualitative accuracy is low (3/10) due to incorrect entity relationships and reasoning. Contextual relevance is moderate (6/10) as the answer addresses derivative valuation and risk inputs but with incorrect data and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 501,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s net carrying amount for the 1.55% Notes due 2028 remained at $1.25 billion from FY 2022 through FY 2024 (see the debt schedule in page 72), while the fair value of the notes rose modestly from $1.099 billion in FY 2023 to $1.115 billion in FY 2024 (page 67). This steady exposure shows that NVIDIA’s long‑term debt strategy focuses on maintaining a predictable, low‑interest borrowing base to fund growth without increasing leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for NVIDIA's exposure to the 1.55% Notes Due 2028. According to the ground truth, the exposure was $1.2 billion in 2022, $1.1 billion in 2023, and $1.25 billion in 2024. However, the LLM claims the net carrying amount was $1.25 billion for all three years, which contradicts the documented decrease in 2023. This misrepresentation of the core financial data severely undermines the answer's correctness. (2) The quantitative inaccuracies are critical: the LLM fails to reflect the $100 million reduction from 2022 to 2023 and the subsequent $150 million increase in 2024. While it correctly notes a rise in fair value from $1.099 billion to $1.115 billion between 2023 and 2024, the question focuses on financial exposure (i.e., carrying amount/book value), not fair value. Thus, inclusion of fair value data, while accurate, is secondary and does not compensate for the primary metric error. (3) The reasoning is partially sound in interpreting a stable debt strategy, but it is based on incorrect data. The ground truth shows a slight dip and recovery, suggesting strategic maintenance with minor adjustments, whereas the LLM implies complete stability, missing the nuance. The multi-hop synthesis across years is attempted but flawed due to incorrect inputs. (4) Despite the factual errors, the answer remains contextually relevant by addressing the evolution of debt exposure and linking it to long-term strategy. However, the quantitative accuracy score is low due to major discrepancies in key figures, dragging down the overall correctness. The qualitative reasoning is somewhat logical but built on false premises, warranting a moderate score. Contextual relevance is fair as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 495,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 10‑K filings from 2022 through 2024 consistently reference trailing legal liabilities that stem from the 2015 Alstom acquisition and shareholder suits over past financial reporting.  Each year’s disclosure—2022 (page 73), 2023 (page 36), and 2024 (page 33)—uses identical language to describe ongoing legacy proceedings, expected cash outflows, and reserves, showing no substantive change in exposure.  This continuity indicates that these contingent liabilities remain persistent and continue to pose a material financial risk that could materially affect GE’s cash flows and financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key elements: GE's trailing legal liabilities from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting, spanning 2022–2024. The specific mention of consistent disclosures across years (with page numbers) supports the claim of persistent exposure. (2) There are no numeric values (e.g., dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) and the 2015 acquisition are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings and correctly infers that unchanged language indicates no material reduction in liability, which logically supports the conclusion of persistent financial risk. This matches the ground truth’s emphasis on ongoing cash outflows, reputational harm, and potential adverse impacts. (4) The only minor shortcoming is that the LLM omits explicit mention of 'reputation' as a recurring risk (mentioned in the original for 2022 and 2024) and does not note the 2023 warning that liabilities could exceed estimates. However, the core factual progression and financial impact are accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 389,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan grew its hedge‑fund limited‑partnership exposure from **$225 million in 2022 to $280 million in 2024** (page 174 and page 166), a $55 million increase.  The plan’s target allocation for hedge funds rose from 3 % in 2022 to 4 % in 2024 (page 169), underscoring a deliberate shift toward greater alternative‑investment exposure to enhance returns and diversify risk while keeping these holdings measured at NAV rather than through the fair‑value hierarchy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's exposure was $214 million in 2022, $225 million in 2023, and $252 million in 2024. However, the LLM claims $225 million in 2022 and $280 million in 2024, which misrepresents both the starting value and the final value. The increase is stated as $55 million, but the correct increase from 2022 to 2024 is $38 million ($252M - $214M). Additionally, the LLM skips the 2023 data point entirely, failing to reflect the year-by-year progression. (2) The cited target allocation increase from 3% to 4% is not present in the original answer and cannot be verified against the ground truth, introducing unverified information. While alternative investments and NAV reporting are contextually plausible, they are not part of the original conclusion and may reflect overinterpretation. (3) The multi-hop reasoning is partially sound in that it attempts to synthesize trends over time and infer strategic intent, but because the underlying numbers are incorrect, the conclusion is based on flawed premises. The original answer emphasizes a 'consistent upward trend' with accurate year-over-year data, while the LLM invents a steeper increase and omits intermediate data. (4) The contextual relevance is moderate because the answer addresses pension fund strategy and alternative investments appropriately, but the qualitative accuracy is low due to incorrect figures and unsupported claims. The correctness score is low primarily due to severe quantitative errors that undermine the validity of the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 449,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 Africa/Eurasia generated an operating profit of **$228 million** (page 116). In 2023 the Global Productivity Initiative allocated roughly **5 % of the $32 million restructuring charges** to the region—about **$1.6 million** (pages 86‑87). In 2024 depreciation and amortization for Africa/Eurasia was **$8 million**, a slight decline from $9 million in 2023, indicating a modest but steady investment in maintaining the region’s assets (page 117).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The operating profit for Africa/Eurasia in 2022 is reported as $228 million, whereas the ground truth is $203 million. The restructuring charge allocation is stated as 5% of $32 million (~$1.6 million), but the correct figure is 10% of expected charges, estimated at $20–24 million. Only the 2024 depreciation and amortization of $8 million is correct, consistent with the ground truth. (2) Quantitative accuracy is low: two out of three core numbers are incorrect, and the calculation of restructuring charges is based on wrong percentages and total amounts. The $1.6 million charge is a severe understatement of the actual regional allocation. (3) The reasoning is partially sound—LLM correctly identifies the Global Productivity Initiative and links restructuring to the region, and correctly notes the decline in depreciation from $9M to $8M. However, the conclusion that this reflects 'modest but steady investment' contradicts the ground truth interpretation of reduced capital investment or aging assets, misrepresenting the operational focus. (4) Contextual relevance is high as the answer addresses all three time points and relevant metrics. Qualitative accuracy is moderate due to correct use of initiative names and regional focus, but flawed data undermines reasoning. Correctness score is low due to major errors in financial figures and misinterpretation of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 410,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "In 2022, AIG reported a modeled loss estimate of **$1.3 billion** for a five‑ton bomb attack net of TRIPRA and reinsurance recoveries, with international attachment points of **$200 million for Japan and $100 million for the rest of the world**. By 2024, the company had **reduced the Japan attachment point to $150 million and increased the rest‑of‑world point to $125 million**, while its reinsurance recoverable assets fell from **$67.5 billion in 2023 to $38.0 billion at year‑end 2024**, indicating a tightening of recoverable exposure; no new modeled loss estimate for international terrorism was disclosed in 2023 or 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key inaccuracies. While it correctly reports AIG's 2022 modeled loss estimate of $1.3 billion net of TRIPRA and reinsurance, and the 2024 reinsurance recoverable assets of $38.0 billion, it incorrectly states that the rest-of-world attachment point was $100 million in 2022 and later increased to $125 million in 2024. The ground truth specifies that the core attachment points were consistently $200 million in Japan and $125 million elsewhere over the entire period, with no indication of a prior $100 million threshold. Additionally, the LLM claims the Japan attachment point was reduced to $150 million in 2024, which contradicts the original answer stating AIG 'retained core attachment points' without change. (2) The claim that reinsurance recoverable assets fell from $67.5 billion in 2023 to $38.0 billion in 2024 is factually unsupported; the original answer states only that the 2024 figure was $38.0 billion (with $29.1 billion in ceded loss reserves) and does not provide a 2023 value, let alone $67.5 billion. This is a major quantitative error. (3) The multi-hop reasoning is flawed: the LLM infers changes in attachment points and a decline in recoverables without evidence in the source, and fails to mention AIG's continued use of third-party models and scenario-based international exposure estimation in 2023, a key part of the evolution. (4) Despite these issues, the answer is contextually relevant, addressing modeled losses, attachment points, and reinsurance recoverables as asked. However, due to significant factual and numerical errors—especially the invented $67.5 billion figure and incorrect attachment point trends—the correctness score is low. Quantitative accuracy is partially preserved for the $1.3 billion and $38.0 billion figures, but not for others. Qualitative accuracy suffers due to incorrect synthesis and missing key details about consistent modeling practices and reinsurance expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 533,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The 2.00 % Notes Due 2031 fell from about $1.20 billion in FY 2022 to $1.044 billion in FY 2023, then rose to roughly $1.25 billion in FY 2024 (see Note 9, page 67 and Note 12, page 72). This modest fluctuation shows NVIDIA is keeping the long‑term debt level relatively stable—re‑financing or issuing new notes to replace maturing debt while still using the low‑rate 2031 notes to fund growth, indicating a conservative, balance‑sheet‑friendly debt‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024, matching the ground truth exactly (with acceptable formatting variations like 'about' and 'roughly'). These figures are accurate and consistent with the original answer. (2) All calculations and comparisons are sound—no mathematical errors, and the description of a 'modest fluctuation' aligns with the slight dip and rebound in liability. The mention of 'Note 9, page 67' and 'Note 12, page 72' adds document-level support, though not required for correctness. (3) The multi-hop reasoning is strong: the model synthesizes trends across three fiscal years and infers a stable long-term debt strategy, correctly interpreting the temporary decline and rebound as indicative of active but conservative management rather than a shift in strategy. It appropriately links the use of low-rate debt to funding growth, which is semantically equivalent to the ground truth's emphasis on supporting R&D and operations without refinancing risk. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'strategic intent to preserve stable long-term liabilities' or 'no material alteration in exposure,' which are key nuances in the original. However, the core conclusion—that NVIDIA maintains a stable, conservative debt approach—is accurately conveyed. Thus, while highly accurate and contextually relevant, it loses one point for slight incompleteness in qualitative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 422,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple issued the 1.05% Notes due 2017 in 2014 (Officer’s Certificate dated May 6 2014) and they matured in 2017, as shown in the description of securities in the 2022 and 2024 10‑K filings (page 56). By the 2022–2024 filings the instrument is no longer outstanding, illustrating Apple’s disciplined, long‑term debt‑management strategy and clear maturity schedule that ensures continuity and transparency in its debt structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. (1) Quantitatively, the dates and interest rate are accurate: the 1.05% Notes due 2017 were indeed issued in 2014 (per the Officer’s Certificate on May 6, 2014), and matured in 2017. These details align with the original answer. However, the LLM incorrectly asserts that the instrument is 'no longer outstanding' in the 2022–2024 filings, which contradicts the ground truth stating that the notes are consistently referenced across all three years as part of Apple’s documented debt structure. This misrepresents the core fact of the instrument’s continued disclosure. (2) The original answer emphasizes that despite maturity in 2017, the notes remain included in filings through 2024, suggesting rollover, refinancing, or retention under the same indenture—indicating continuity in disclosure and debt management transparency. The LLM fails to capture this persistence and instead implies clean retirement of the debt, missing the nuance of ongoing documentation. (3) The reasoning is flawed in the multi-hop synthesis: while the LLM correctly identifies issuance and maturity, it draws an incorrect conclusion about the current status of the instrument based on likely misinterpretation of 'description of securities' sections. The ground truth infers continued relevance due to consistent inclusion, whereas the LLM assumes absence of outstanding status negates structural continuity. (4) Contextually, the answer addresses Apple’s debt strategy and transparency, which is relevant, but supports it with incorrect premises. Thus, while some facts are right, the central claim about the evolution and visibility of the instrument is inaccurate, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 487,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "In 2022, under the 2019 IDA agreement, Schwab could migrate up to **$10 billion of IDA balances each year**—but only floating‑rate balances—and had to keep a **minimum $50 billion IDA balance** while ensuring **80 % of balances were fixed‑rate through 2026**【page_102】. The 2023 IDA agreement replaced those terms, **eliminating the $10 billion cap and the fixed‑rate requirement** and instead imposing new balance limits: a **$30 billion maximum above fixed‑rate balances until September 10 2025**, then a **$60 billion minimum and $90 billion maximum thereafter**; Schwab did not migrate any balances in 2023 or 2024【page_102】【page_100】. Thus, Schwab’s migration ability shifted from a capped, fixed‑rate‑restricted regime to a more flexible but still constrained framework governed by evolving minimum/maximum balance thresholds and capital considerations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key quantitative details compared to the ground truth. While it correctly states that in 2022 Schwab could migrate up to $10 billion annually under the 2019 IDA agreement, it adds specific conditions—'only floating-rate balances', 'minimum $50 billion IDA balance', and '80% fixed-rate through 2026'—that are not present in the original answer and contradict the ground truth, which makes no mention of rate-type restrictions or minimum balance requirements in 2022. These additions introduce significant factual errors. The claim that the 2023 agreement eliminated the $10 billion cap is misleading; the ground truth states Schwab 'no longer exercised this migration option' rather than that the cap was removed, implying a strategic choice under new constraints, not increased flexibility. The LLM introduces new thresholds—$30B max above fixed-rate until Sept 10, 2025, then $60B min/$90B max—that do not appear in the original answer, which only notes 'new minimum and maximum balance thresholds' without specifics. These fabricated numbers severely impact quantitative accuracy. (2) Calculations are not applicable, but the use of exact dollar figures and dates (e.g., September 10, 2025) suggests precision not supported by the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly identifies a shift from migration in 2022 to no migration in 2023–2024 and attributes this to a change in agreements. However, it overinterprets and invents specific terms of the 2023 agreement rather than acknowledging the lack of migration as a strategic shift under 'stricter constraints', as per the original. (4) Despite these issues, the answer captures the high-level evolution—migration in 2022, cessation in 2023–2024, and a shift in agreement terms—making it contextually relevant and qualitatively reasonable in structure, though factually flawed in critical details. Hence, correctness is reduced to 6 due to major quantitative inaccuracies, while qualitative reasoning and relevance remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 563,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "GE’s exposure to Bank BPH’s borrower litigation grew from an estimated loss of $1.36 billion in 2022 to $2.67 billion in 2023, then eased to $2.46 billion in 2024 (page 52, 50). To shore up capital, GE injected $530 million in cash in 2022 and later forgave $1.80 billion of inter‑company debt in 2023, with no further cash contribution in 2024 (page 52, 48). The Polish mortgage portfolio’s carrying value was fully offset by valuation allowances, leaving a net zero balance as of December 31 2023 and 2024 (page 48, 50).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's financial exposure and strategic actions regarding Bank BPH's borrower litigation from 2022 to 2024. Estimated losses are accurately reported as $1.36 billion in 2022 (vs. $1,359 million ground truth — acceptable rounding), $2.67 billion in 2023 (vs. $2,669 million — minor rounding), and $2.46 billion in 2024 (vs. $2,461 million — again, acceptable rounding). Capital contributions are correctly stated: $530 million cash in 2022 and $1.80 billion non-cash (via intercompany loan forgiveness) in 2023 (vs. $1,797 million — minor rounding). The LLM correctly notes no further contributions in 2024. The carrying value of the mortgage portfolio is correctly stated as zero by end of 2023 and 2024 due to full valuation allowance, aligning with the ground truth of a full write-down by end of 2024. (2) All numbers are within acceptable rounding thresholds; no calculation errors. The $1,014 million charge in Q2 2023 is not explicitly mentioned, which is a minor omission, but the overall capital contribution and loss figures reflect its impact. (3) Multi-hop reasoning is sound: the LLM synthesizes data across years and financial actions (loss estimates, capital injections, valuation allowances), correctly linking GE’s strategic handling to the litigation exposure. (4) The answer is contextually complete and highly relevant, with only negligible rounding differences and one minor omitted detail (Q2 charge), not affecting overall correctness. Thus, a score of 9 is justified — excellent accuracy with only trivial deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 440,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "From 2022 to 2023, CVS’s commercial mortgage‑backed securities (CMBS) fair value climbed from **$992 million to $1,066 million** while unrealized losses fell from **$155 million to $100 million** (page 149). In 2024 the company’s CMBS exposure in separate accounts dropped to **$3 million** (down from $6 million in 2023) with no unrealized losses reported (page 160). This pattern—higher fair value coupled with lower losses and a subsequent trimming of CMBS holdings—suggests CVS is actively managing interest‑rate and credit‑quality risk by limiting exposure and maintaining a conservative, loss‑controlled investment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's CMBS fair value was $574M in 2022 and $675M in 2023, but the LLM reports $992M and $1,066M respectively—overstating values by nearly 70-100%. Similarly, unrealized losses in 2022 were $12M (ground truth), not $155M as claimed. While the 2024 fair value of $3M matches the ground truth, the LLM incorrectly states it dropped from $6M in 2023, which contradicts both the ground truth ($675M in 2023) and its own prior claim of $1,066M. (2) Calculations and comparisons are therefore invalid. The trend described—rising fair value with falling losses—is factually incorrect; in reality, fair value increased slightly while unrealized losses surged from $12M to $100M, indicating deteriorating portfolio performance, not improvement. (3) The multi-hop reasoning is partially sound in that the model identifies a reduction in exposure by 2024 and infers risk management implications, which aligns with the ground truth’s conclusion. However, because the underlying data is wrong, the reasoning is based on false premises. The mention of 'separate accounts' and page references suggests sourcing from real documents, but the numbers do not match the verified truth. (4) Contextual relevance is fair—the answer addresses the evolution over time and attempts to interpret risk strategy. However, due to severe quantitative errors, the qualitative assessment is undermined. Correctness score is low because financial accuracy is paramount in such questions, and the model fails on core data points despite capturing the final-year outcome and general direction of de-risking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 464,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑brand lineup—including Marketside—was unchanged from FY 2022 through FY 2024, with the same 23 private labels listed in each filing (Allswell, Athletic Works, Bonobos Fielder, Eloquii Elements, Equate, Free Assembly, Freshness Guaranteed, George, Great Value, Holiday Time, Hyper Tough, Mainstays, Marketside, No Boundaries, onn., Ozark Trail, Parent’s Choice, Sam’s Choice, Scoop, Spring Valley, Time and Tru, Way to Celebrate, Wonder Nation) (page_8 FY2022, page_8 FY2023, page_8 FY2024). This steady lineup over three years signals that Walmart’s grocery private‑label strategy prioritizes a stable, broad assortment of low‑price brands to support its EDLP model and customer loyalty, rather than frequent brand churn (page_8 FY2022, page_8 FY2023, page_8 FY2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies Marketside as part of Walmart's private brand portfolio in each year from 2022 to 2024, it falsely claims that the lineup was 'unchanged' and lists 23 specific brands as being identical across all three years, including non-grocery brands like Bonobos, George, and Mainstays. The original answer (ground truth) does not support this level of detail or claim of no change. More critically, the ground truth states that Walmart introduced a new private brand, 'bettergoods,' in 2024, which directly contradicts the LLM's assertion of a completely stable lineup. This omission and misrepresentation of strategic evolution severely weakens the reasoning. The LLM also introduces specific brand counts and names not present in the ground truth, which cannot be verified and appear fabricated. While the general idea of stability is partially aligned, the answer fails to capture the key nuance of strategic expansion and modernization alongside legacy brand retention. The quantitative accuracy is moderate because no actual financial figures or incorrect dates are cited—fiscal years are correct—but the invented list of 23 brands and claim of no change constitute serious factual errors. The qualitative reasoning is flawed due to incorrect synthesis: it misses the multi-hop insight that Walmart maintained Marketside while introducing new brands, reflecting a dual strategy. Contextual relevance is fair because the answer addresses the private brand portfolio and Marketside’s inclusion, but the erroneous framing of 'no change' distorts the strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 457,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022‑2024, Lowe’s broadened supplier oversight by updating its human‑rights policy to address modern slavery, adding a conflict‑minerals policy, and tightening its Vendor Code of Conduct with enhanced environmental standards. In 2023 it overhauled its wood‑sourcing policy—introducing country‑specific risk levels, improved monitoring, and a forestry grievance process—and in 2024 it further refined that policy with a risk‑based approach and new monitoring tools. The company also invested $300‑$400 million in energy‑efficiency and renewable‑energy projects, encouraged suppliers to report scope‑3 emissions to CDP, and set a net‑zero target for scope 1‑3 emissions by 2050 to strengthen supply‑chain sustainability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Lowe's supplier monitoring and policy enhancements from 2022 to 2024, including updates to the wood sourcing policy in 2023 with country-specific risk levels, improved monitoring, and a forestry grievance process, which aligns with the ground truth. The 2024 refinement with a risk-based approach is also correctly noted. However, the LLM incorrectly states that Lowe's 'added a conflict-minerals policy' and 'updated its human-rights policy to address modern slavery' during this period, while the ground truth indicates these policies were already in place by 2022. This misrepresents the timeline and nature of policy changes. (2) Quantitatively, the LLM claims investments of '$300-$400 million in energy-efficiency and renewable-energy projects', but the ground truth reports 'over $550 million by 2022' and 'over $400 million through 2023' in broader operational sustainability initiatives. The LLM underestimates the total investment, mischaracterizes the timing (failing to note the $550M already spent by 2022), and narrows the scope to only energy projects, which is not supported in the original. (3) The multi-hop reasoning is partially sound—LLM correctly synthesizes policy evolution across years and identifies key initiatives like grievance mechanisms and risk-based sourcing. However, it fails to accurately reflect the continuity of existing policies (human rights, conflict minerals) from 2022 and misattributes their introduction to the 2022–2024 window. The addition of CDP reporting encouragement and a net-zero 2050 target, while plausible, are not mentioned in the ground truth and represent unverified content. (4) The contextual relevance is high as the answer addresses supplier monitoring, policy updates, and investments. However, due to significant quantitative inaccuracies and incorrect attribution of policy introductions, the overall correctness is reduced to a 6. The qualitative accuracy is moderate due to correct structural understanding but flawed entity/timeline mapping. Quantitative accuracy is low due to incorrect investment figures and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 576,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple disclosed the 2.40% Notes due 2023 in its 2022 10‑K as part of the “Description of Securities” exhibit (page_58). The 2023 10‑K, as shown in the provided pages, contains no reference to those notes, implying they had matured or been repaid by year‑end 2023 (pages 53‑57). The 2024 10‑K again lists the 2.40% Notes due 2023 in the same exhibit (page_58), indicating Apple re‑issued or retained similar debt and reflecting a disciplined approach to short‑term debt issuance and retirement to support liquidity and a flexible capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2.40% Notes due 2023 were not mentioned in the 2023 10-K, claiming they had 'matured or been repaid by year-end 2023.' However, the ground truth confirms that Apple *did* include the notes in its 2023 filing, showing continuity as the maturity approached. This misrepresents a key data point. (2) The claim that the notes reappeared in the 2024 10-K because Apple 're-issued or retained similar debt' is incorrect: the ground truth clarifies that Apple continued to disclose the *same* 2.40% Notes due 2023 in 2024 for transparency, even though they were set to mature that year—not because they were re-issued. The LLM misinterprets continued disclosure as re-issuance, which reflects a flawed understanding of debt reporting practices. (3) The LLM references specific page numbers (e.g., page_58) not present in the original context, introducing fabricated details. (4) While the question asks about the evolution of disclosure and what it indicates about Apple’s debt management strategy, the LLM draws an incorrect conclusion about a 'disciplined approach to short-term debt issuance and retirement,' which is unsupported—the actual pattern reflects *transparency in disclosure*, not active re-issuance. The reasoning fails the multi-hop synthesis: it should have connected consistent inclusion across years to a stable disclosure policy, not inferred repayment and re-issuance. Quantitative elements (interest rate: 2.40%, maturity year: 2023) are correct, hence a partial score on quantitative accuracy. Contextually, the answer addresses the right topic and timeframe but with incorrect interpretation, limiting relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 474,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap note holdings grew from $900 million at the end of 2022 to $944 million at the end of 2023 and stayed at that level through 2024. The modest, incremental rise followed by stability indicates a cautious, risk‑managed approach that prioritizes investment‑grade debt while monetizing equity interests elsewhere, reflecting a deliberate strategy of maintaining a steady, long‑term debt exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, GE's holdings of the AerCap note were $976 million in 2022, decreased to $944 million in 2023, and then increased to $982 million in 2024. The LLM incorrectly states the 2022 value as $900 million (off by $76 million), claims growth from 2022 to 2023, and asserts that the holding remained stable at $944 million through 2024—when in fact it increased to $982 million. These errors affect both directionality and magnitude of changes. (2) Quantitative accuracy is severely compromised: all three data points are either wrong or incomplete. The only correct number is $944 million in 2023, but it is mischaracterized as part of an upward trend rather than a decrease followed by a rebound. No correct calculation or trend analysis can be derived from these numbers. (3) The multi-hop reasoning is flawed—the LLM fails to capture the fluctuating nature of the holdings (down then up), instead portraying a simple increase and stabilization. The conclusion about a 'cautious, risk-managed approach' and 'steady long-term debt exposure' does not align with the actual volatility observed in the data, nor does it reflect the broader portfolio shifts mentioned in the ground truth (e.g., changes in corporate debt and MBS). (4) Contextual relevance is moderate because the answer addresses the general theme of investment strategy in financial instruments, but the incorrect data leads to an unsupported interpretation. The mention of monetizing equity interests is speculative and not grounded in the provided truth. Overall, major factual errors in numbers and trends severely undermine correctness and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 470,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy – which ties the “return‑seeking” portion of the U.S. pension portfolio to the plan’s funded ratio and prevailing interest rates – remained unchanged from 2022 through 2024, but the target mix was shifted to a more conservative stance as the plan became better funded.  In 2022 the glide path called for 15 % equity, 75 % fixed‑maturity and 10 % other; by 2024 the target had moved to 9 % equity, 80 % fixed‑maturity and 11 % other, reflecting a deliberate reduction in growth assets and an increase in liability‑hedging assets.  This progression demonstrates AIG’s de‑risking strategy: as the funded ratio improves, the plan systematically lowers equity exposure and boosts fixed‑income holdings to reduce risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct qualitative direction of AIG's glide path evolution and de-risking strategy, noting a shift from growth to liability-hedging assets as funded status improved. However, it introduces specific numeric allocations (e.g., 15% equity in 2022, 9% in 2024) that are not present in the original answer (ground truth), which does not provide exact percentages or asset class breakdowns. This is a critical quantitative inaccuracy because the ground truth only describes the *direction* and *principle* of the glide path (increasing liability-hedging, decreasing growth assets) without citing specific portfolio weights. The LLM fabricates precise numbers, which undermines factual reliability. While the reasoning about de-risking and liability-driven investing aligns with the original, the inclusion of unsupported quantitative details constitutes a significant error. The answer is contextually relevant and correctly identifies the multi-year evolution and strategic intent, but the made-up percentages reduce correctness. Multi-hop synthesis is partially sound—linking funded status to allocation changes—but the lack of citation for specific asset weights suggests hallucination rather than accurate retrieval.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 346,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept embedded‑processing at the heart of its strategy from 2022 through 2024, with each MD&A (2022 page 19; 2023 page 18; 2024 page 19) stating that its strategic focus is on analog and embedded‑processing products.  The company repeatedly ties that focus to long‑term free‑cash‑flow‑per‑share growth (2022 page 21; 2023 page 20; 2024 page 20), underscoring that embedded‑processing remains a core driver of the cash‑generating model that fuels shareholder value over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing alongside analog products from 2022 to 2024, and this focus is explicitly tied to long-term free cash flow per share growth across all three years. The answer correctly identifies the strategic centrality of embedded processing and its role in TI's cash-generating model. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the citation of specific MD&A page numbers (e.g., 2022 p.19, 2023 p.18, 2024 p.19 for strategy; p.20 for free cash flow) is consistent with typical 10-K structures and supports the claims—no quantitative inaccuracies present. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers continuity in strategic emphasis, linking it to long-term financial outcomes. (4) The only minor shortcoming is that the LLM answer does not elaborate on *how* embedded processing contributes to competitive advantages (e.g., supply chain control, customer reach, diversified returns) as detailed in the original answer, nor does it mention the 'more opportunity per customer' rationale from 2023. While the core message is preserved, this slight reduction in qualitative depth prevents a perfect 10. However, the answer remains semantically equivalent in intent and factual content, fully addressing both parts of the question with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 421,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "Lowe’s IP strategy has consistently protected its private‑brand names—including Kobalt—through trademarks, domain names and patents, as noted in the 2022, 2023 and 2024 10‑K intellectual‑property sections (page 7).  Over the same period the company has shifted its product‑selection narrative to highlight high‑value private brands (2023 and 2024 product‑selection sections, page 6) and has woven those brands into its expanding omnichannel and digital ecosystem—online shopping, mobile apps and digital inspiration tools—supporting its broader digital‑transformation agenda (2023 and 2024 omnichannel sections, page 5–6).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but omits a critical multi-hop observation present in the original answer: the evolution of brand portfolio emphasis through the addition and subsequent removal of 'RONA' and 'Reno Depot' from intellectual property disclosures between fiscal 2022 and 2023. While the LLM correctly identifies the consistent protection of private brands like Kobalt via trademarks and the integration of private brands into digital transformation (e.g., omnichannel, mobile apps), it fails to note the narrowing of brand focus in the IP section, which is central to the question about 'brand portfolio emphasis.' The answer correctly references the continuity of IP protection across 2022–2024 and links private brands to digital initiatives in 2023 and 2024, aligning with the ground truth’s conclusion about digital integration. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are cited), and the entities (Kobalt, fiscal years, digital transformation elements) are accurate. However, the absence of the strategic shift in disclosed brand names weakens the qualitative accuracy, as it misses a key signal of strategic refocusing. Contextual relevance is high because the answer addresses both brand strategy and digital integration, though incompletely. Thus, the correctness score is 7—core facts are right, but a significant detail about portfolio evolution is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 405,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM’s 10‑K filings from 2022 through 2024 consistently list “client relationships and trust” as a core competitive differentiator, showing a sustained focus on building long‑term client partnerships. In 2024 the company expands this emphasis by explicitly pairing trust with security in its hybrid‑cloud platform narrative, underscoring a deeper commitment to secure, trusted AI solutions. This steady, then deepening emphasis signals IBM’s strategic positioning as a trusted partner in the hybrid‑cloud and AI market, leveraging incumbency and expertise to differentiate from competitors and drive growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024, and correctly identifies the increasing linkage between trust and security, especially in the context of hybrid cloud and AI. The answer accurately reflects that IBM maintained a consistent focus on trust as a differentiator and deepened it by 2024 with an emphasis on security. However, it omits key multi-hop details present in the original answer that are critical for full completeness: specifically, the expansion of strategic partnerships with AWS, Microsoft, SAP in 2023 and the addition of cybersecurity partners like Palo Alto Networks in 2024. These ecosystem developments are central to the evolution of IBM’s trust narrative and its strategic positioning. While the LLM captures the general trend and correctly frames trust as increasingly tied to security and technical capabilities, it fails to synthesize the specific partner ecosystem growth that underpins the multi-year progression. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning is sound but incomplete. The answer remains contextually relevant and conveys a semantically plausible summary, but lacks the full depth of entity-specific evolution required for a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 379,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "Gilead’s El Segundo, California site moved from a purely clinical cell‑therapy manufacturing role in 2022 to a dual clinical‑and‑commercial manufacturing hub by 2023, a role it continued to play in 2024.  In 2023 the company described the facility as “utilized for clinical and commercial manufacturing and processing of our cell therapy products”【page_12 (2023)】, and the same description appears in the 2024 filing【page_12 (2024)】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the El Segundo facility transitioned from a 'purely clinical' role in 2022 to a dual clinical-and-commercial role in 2023. However, the ground truth indicates that the facility already had both clinical and commercial responsibilities in 2022, with no significant change over time. This misrepresents the evolution of the facility's role and introduces a false progression. (2) There are no numeric values or calculations in the response, so quantitative accuracy is not heavily applicable; however, the cited years (2022, 2023, 2024) are correct and relevant, supporting a high score in this category. (3) The multi-hop reasoning is flawed: while the model correctly identifies the dual role in 2023 and 2024, it fails to accurately characterize the 2022 role, breaking the logical synthesis across years. The model appears to infer a shift based on repeated phrasing in 2023 and 2024 filings without verifying the 2022 status, leading to incorrect before-after comparison. (4) Contextual relevance is high because the answer addresses the facility, location, time frame, and manufacturing roles as asked. However, the core factual error about the evolution of responsibilities significantly undermines the correctness, warranting a moderate score of 4 out of 10 for overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 373,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "From 2022 through 2024 Lowe’s continued to hold its 4.550% Notes that were issued in 2019 with a maturity of April 5, 2049【page_75】, and no new 4.550% Notes were issued during that period.  Instead, the company issued shorter‑term notes to create a staggered maturity ladder—4.400% Notes due 2025 in 2022【page_77】 and 4.800% Notes due 2026 in 2023【page_78】—while keeping the long‑dated 4.550% Notes unchanged.  This multi‑year pattern shows a long‑term debt strategy that relies on a stable, long‑dated fixed‑rate instrument while using shorter‑term debt to manage liquidity and refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 4.550% Notes due April 5, 2049, issued under the 2019 indenture, and notes their consistent presence from 2022–2024, which aligns with the ground truth. The maturity date (April 5, 2049) and interest rate (4.550%) are accurate. However, the ground truth does not mention the issuance of 4.400% Notes due 2025 in 2022 or 4.800% Notes due 2026 in 2023—these specific new issuances are not part of the verified knowledge graph data and introduce unverified details. While Lowe’s may have issued other notes, the ORIGINAL ANSWER focuses solely on the continuity of the 4.550% Notes and does not support the claim about a deliberate 'staggered maturity ladder' based on these specific instruments. (2) Quantitatively, all cited dates and percentages are plausible and internally consistent, but the addition of new notes (4.400% and 4.800%) lacks corroboration from the ground truth, reducing quantitative accuracy slightly. (3) The reasoning about a long-term debt strategy using long-dated fixed-rate debt is sound and aligns with the ground truth; however, the multi-hop synthesis overreaches by inferring a 'staggered maturity ladder' strategy from unsupported specific issuances. The core insight—using long-term debt to avoid refinancing risk—is valid, but the supporting evidence in the LLM answer includes extraneous, unverified details. (4) The answer is contextually relevant and addresses both the evolution (or lack thereof) in the 4.550% Notes and the strategic implication. It earns a correctness score of 7 because the central facts about the 4.550% Notes are correct, but the added detail about other note issuances introduces inaccuracies that affect completeness and reasoning fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 475,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 through 2024, 3M’s exposure to lawsuits over Scotchgard remained largely unchanged— the company continued to face a pending Wolverine‑related class action but reported only immaterial liabilities (2022 10‑K, p. 122; 2023 10‑K, p. 94).  The final settlement payment was made in June 2023, and the 2024 10‑K still lists only immaterial amounts (p. 96).  This trend shows that while PFAS litigation continues to expose 3M to legal risk, the specific costs tied to Scotchgard have been small and have not materially impacted the company’s financial position.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth on multiple key points. (1) Quantitatively, it falsely claims that liabilities were 'immaterial' and that the final settlement payment was made in June 2023, with no material changes in 2024. However, the ground truth states that a $65 million settlement was finalized in New York in 2024, which is a significant financial outlay, and that litigation is ongoing with trial dates set for 2026—indicating material and escalating exposure. The $65 million settlement in both 2022 and 2024 is a major financial event that cannot be classified as immaterial. (2) The answer omits critical developments: the expansion of litigation into Alabama and Georgia in 2024, the growing number of AFFF and PFAS suits (68 outside MDL by 2023), and new cases in Illinois and Canada. It also fails to mention that 3M contributed to a $65 million settlement in 2022 alongside other companies, and that similar liabilities continued. (3) The reasoning is flawed: the LLM concludes that Scotchgard-related costs 'have been small and have not materially impacted' 3M, while the ground truth shows a clear trend of increasing geographic spread, case volume, and financial settlements—indicating escalating financial impact. (4) The answer references 10-K pages but misinterprets or selectively reports data, failing to reflect the growing trend of liability. While it addresses the general topic of PFAS litigation and mentions Scotchgard and Wolverine, it misrepresents the evolution and financial significance. The contextual relevance is moderate because it discusses the right company and product, but the factual inaccuracies and omission of escalating trends severely undermine its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 472,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In 2022, Foster City was described as the corporate headquarters that “houses our administrative, manufacturing and R&D activities” (page 31). By 2023 the facility’s role had become more specialized: it “conducts process chemistry research, analytical method development and formulation and device development activities, and manufactures API and drug product for our clinical trials” (page 11). The same focus is reported for 2024 (page 10). Thus, over this period the site evolved from a broad HQ‑level hub to a dedicated R&D‑manufacturing center that supports early‑stage clinical production, aligning its activities with Gilead’s global pipeline and manufacturing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Foster City's transition from a broad administrative, manufacturing, and R&D hub in 2022 to a more specialized center focused on process chemistry, analytical development, formulation, device development, and clinical trial manufacturing in 2023–2024 is accurately described. The use of direct quotes from the filings (with page numbers) supports fidelity to source material. (2) There are no numerical values requiring calculation in this question; dates (2022, 2023, 2024) are correctly used and consistent with the original answer. (3) The multi-hop reasoning is sound—information is synthesized across three years and correctly interpreted as an evolution in strategic focus. The conclusion that Foster City became more specialized in early-stage development and clinical manufacturing while commercial-scale operations shifted elsewhere is logically inferred and consistent with the ground truth, even if the LLM does not explicitly name La Verne or Oceanside. (4) Semantic equivalence is strong: the LLM captures the narrowing of scope and strategic alignment with global operations, though it could have slightly improved completeness by mentioning the decentralization to other sites as part of the global strategy. This minor omission prevents a perfect 10 on qualitative accuracy, but overall the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 408,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "In 2022 AIG’s loss‑reserve oversight was largely business‑unit‑level, with chief risk officers, risk committees and pricing committees reviewing pricing and reserving models, actuarial reserve reviews, and external‑expert assessments of reserve adequacy. By 2023 the company added a formal ERM second‑line review and challenge function that evaluated pricing, reserving, and modeling assumptions, while retaining a model‑risk‑management framework that validated both stochastic and deterministic reserve models. In 2024 the oversight structure expanded further to include ERM second‑line review, internal‑audit audits and continuous monitoring of remediation, and a structured external‑expert review process—all integrated within a comprehensive model‑risk‑management and validation framework that governs the entire loss‑reserve setting process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, risk oversight mechanisms, modeling approaches, and external reviews—are correctly identified and appropriately contextualized. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM traces the evolution of AIG’s loss reserve risk management across three years, correctly identifying the progression from decentralized, business-unit-level oversight in 2022 to a more integrated, second-line ERM review in 2023 and further institutionalization in 2024 with internal audit and continuous monitoring. It accurately reflects the increasing sophistication in modeling (stochastic and deterministic model validation) and governance integration. (4) While the LLM emphasizes structural oversight (e.g., committees, second-line review) more than the original’s emphasis on analytical methods (e.g., sensitivity analyses, experience studies), it does not contradict them and can be seen as complementary. The omission of explicit mention of 'sensitivity and scenario analyses' and 'experience studies' from the 2023 developments slightly reduces qualitative completeness, but the core evolution in governance and model validation is accurately captured. Overall, the answer conveys semantic equivalence with the ground truth and demonstrates strong contextual relevance and logical synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 446,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "From 2022 through 2024 Texas Instruments kept a single Melaka, Malaysia site that is listed only for analog manufacturing (the property table shows an “X” in the Analog column and a blank in Embedded Processing for Melaka in each year’s 10‑K). The tables in TXN_10k_2022.pdf page 16, TXN_10k_2023.pdf page 16, and TXN_10k_2024.pdf page 16 all confirm this unchanged designation. This three‑year consistency indicates TI has maintained a focused analog‑only footprint in Melaka, with no expansion into embedded‑processing production in that region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that Texas Instruments maintained a single site in Melaka, Malaysia from 2022 to 2024 dedicated exclusively to Analog manufacturing, with no Embedded Processing activities—this matches the original answer's claim of 'exclusively on Analog manufacturing' and 'no expansion into Embedded Processing.' (2) The LLM correctly references the specific pages (page 16) and documents (10-K filings for 2022, 2023, and 2024), confirming consistency across years. While no numerical values (e.g., dollar amounts, headcount, area) are present in the question or ground truth, the qualitative data (presence/absence of manufacturing type) is treated accurately as binary indicators ('X' vs blank), and the LLM interprets them correctly. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings, confirms no change over time, and draws the correct conclusion about the strategic focus. (4) The answer demonstrates semantic equivalence: it conveys the same core facts—unchanged Analog-only status, no Embedded Processing expansion, and the implication of a specialized, stable role in TI’s global footprint. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 374,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "In FY 2022 Lowe’s had a forward‑interest‑rate‑swap notional amount of $2.56 billion (page_61). By FY 2023 the fair value of those swaps had fallen to $251 million (page_54), and by FY 2024 the company had no forward‑interest‑rate‑swap exposure (page_54). This evolution shows that Lowe’s hedging strategy is tightly linked to its forecasted debt issuances, scaling the hedges up when new issuances are expected and trimming or eliminating them as issuances mature or are no longer anticipated (page_46).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the elimination of forward interest rate swaps by FY2024 and references a $251 million fair value in FY2023, which matches the ground truth. However, it introduces a $2.56 billion notional amount for FY2022 that is not present in the original answer or supported by the ground truth, which only mentions the use of swaps in relation to prior hedging activities (2019–2021) without specifying a notional value. This is a significant quantitative inaccuracy. (2) The $251 million figure for FY2023 is correctly cited and aligns with the ground truth (fair value, not notional), but the introduction of a $2.56 billion notional in FY2022 is unsupported and contradicts the original answer’s lack of specific notional amounts. (3) The reasoning about the strategic shift is partially sound—correctly identifying the cessation of forward swaps by FY2024 and linking it to forecasted debt issuances—but misses the key qualitative shift emphasized in the ground truth: the move from cash flow hedges (forward swaps for anticipated debt) to fair value hedges (fixed-to-floating swaps on existing debt). The LLM answer does not mention this important strategic pivot in hedging instruments or objectives. (4) The contextual relevance is high because the answer addresses the evolution over the three years and attempts to interpret the strategy. Qualitative accuracy is reduced due to the missing discussion of the shift to fixed-to-floating swaps. Quantitative accuracy is penalized for the unsupported $2.56 billion figure. Correctness score is 7 because core facts (discontinuation by 2024, $251M in 2023) are correct, but major details (notional amount, nature of hedging shift) are inaccurate or omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 476,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 10‑K filings for 2022 (page 31), 2023 (page 21) and 2024 (page 19) all reference the 6.50% Debentures due 2028 as “Exhibit 2 to Form 8‑K, filed on January 8, 1998,” with no change in wording or additional detail. The identical, unchanged filing date shows that the debt was issued in 1998 and has remained in force without amendment, underscoring a long‑term, stable debt structure that IBM continues to rely on the original indenture for.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: IBM's 2022, 2023, and 2024 10-K filings consistently reference the 6.50% Debentures due 2028 with the same Exhibit 2 to Form 8-K filed on January 8, 1998. The dates, percentages, and exhibit details are correct. (2) Quantitative accuracy is perfect: the filing date (January 8, 1998), the interest rate (6.50%), and maturity year (2028) match the ground truth exactly. No calculations are required, but the temporal consistency across filings is correctly interpreted. (3) The multi-hop reasoning—synthesizing disclosures across three years of filings—is sound: the LLM correctly infers that the unchanged reference indicates no amendments or refinancing, reflecting a stable, long-term debt structure. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the disclosure across years and the implication of the consistent filing date. Wording differs slightly from the original answer but conveys the same meaning with equal or greater detail (e.g., including specific page numbers). Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 327,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective Signage is listed as a product in the Transportation and Electronics segment in all three years – 2022 (page 131), 2023 (page 107) and 2024 (page 108). In 2024 the segment was reorganized to create the Commercial Branding and Transportation division, which incorporates the former Commercial Solutions and Transportation Safety units, effectively grouping Reflective Signage with other safety‑and‑branding offerings (page 110). The unchanged product listing and its placement in a newly formed safety‑focused division indicate that Reflective Signage remains a core, strategically important component of 3M’s transportation portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric inaccuracies (e.g., correct years and page references), so quantitative accuracy is high. However, it fails to accurately describe the evolving *positioning* of Reflective Signage within the product list across the years, which is the core of the question. The ground truth emphasizes a shift from 5th to 4th position in 2023 and maintenance in 4th in 2024, with specific preceding and succeeding product categories indicating strategic emphasis. The LLM instead introduces a reorganization in 2024 into a 'Commercial Branding and Transportation division' that is not reflected in the ground truth and misrepresents the nature of the changes. The original answer does not mention a structural reorganization grouping Reflective Signage with safety-and-branding offerings; rather, it focuses on list-order changes within the same segment. This reflects a failure in multi-hop reasoning: the model conflates structural reorganization with product listing order, missing the nuanced signal of strategic importance through rank positioning. While it correctly notes the product's consistent presence, it draws an incorrect conclusion about strategic importance based on a fabricated organizational change. Thus, despite correct dates and references, the qualitative accuracy is low due to incorrect entity relationships and reasoning. Contextual relevance is moderate because it addresses strategic importance but with flawed evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 402,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site is identified in both the 2023 and 2024 10‑K filings as a commercial manufacturing and processing facility for its cell‑therapy products, underscoring its role as a core hub for commercial production (see 2023 p. 11 and 2024 p. 10).  The 2022 filing does not explicitly describe the Hoofddorp site, indicating that its commercial manufacturing function has become more prominent and strategically important in the years that followed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that in 2023 and 2024, the Hoofddorp facility was explicitly described as being used for commercial manufacturing and processing of cell therapy products, citing the correct pages from the 10-K filings. It also accurately notes that the 2022 filing did not explicitly describe Hoofddorp’s role, implying a growing strategic emphasis—consistent with the ground truth stating that in 2022 it was identified as a principal facility but without explicit mention of cell therapy commercial manufacturing. The only minor shortcoming is that the original answer clarifies that in 2022, Hoofddorp was already recognized as one of Gilead’s principal manufacturing facilities, which the LLM omits. This does not contradict the truth but slightly underrepresents the facility's earlier operational status. All entities (Gilead, Hoofddorp, Netherlands, cell therapy, commercial manufacturing), years (2022–2024), and strategic progression are correctly interpreted. The reasoning is sound: the model infers increasing strategic importance based on more explicit disclosures in later years, which is logically supported. No numerical inaccuracies; dates and references are correct. Semantic equivalence is high, with only slight incompleteness regarding the 2022 characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 379,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The equity‑compensation tables for 2022, 2023 and 2024 list only the 2009 LTIP, the 2014 ESPP and the 2018 Director Plan as plans with shares available for future issuance (see 2022 table note (c) on page 63, 2023 table note (c) on page 61, and 2024 table note (c) on page 59). The 2003 Director Compensation Plan is not mentioned in any of these “available for future issuance” columns, implying that no shares remain available under that plan in any of those years. This trend shows that Texas Instruments has phased out the 2003 plan and no longer uses it for director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) It claims that the 2003 Director Compensation Plan is not listed as having shares available for future issuance in 2022, 2023, or 2024, implying zero shares remain. However, the ground truth states that there were 1,843,134 shares available in 2022, 1,786,785 in 2023, and 1,745,284 in 2024—clearly indicating the plan still had available shares each year. These numbers are completely contradicted by the LLM’s assertion. (2) The quantitative accuracy is extremely low because all stated numbers (implied zeros) are wrong, and the trend of gradual decline is entirely missed. (3) The reasoning is flawed: the LLM likely misread the equity-compensation tables, possibly confusing the 2003 plan with newer plans like the 2018 Director Plan, and failed to recognize that the 2003 plan was still active and being used. Instead of concluding active usage from declining balances, it concluded phase-out due to absence—contrary to data. (4) Contextual relevance is low but not zero because the answer addresses director compensation plans and attempts to interpret trends, albeit incorrectly. The core facts, numbers, and conclusion are all wrong, resulting in a correctness score of 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 343,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "From 2022 to 2024 IBM shifted from a minimal disclosure of its 0.950% Notes due 2025—only referenced in the exhibits with no trading symbol—to an explicit listing of the notes as a NYSE‑registered security (IBM25B) in the 2024 10‑K.  In 2023 the notes were still only cited in the exhibits (page 20), whereas by 2024 they were highlighted in the table of registered securities (page 1).  This progression signals a deliberate move to boost capital‑market transparency, enhance liquidity and investor confidence, and demonstrate a more proactive engagement with bond investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were initially referenced via the May 22, 2017 Form 8-K (Exhibit 4.1) in 2022 and 2023, and in 2024 were assigned the trading symbol IBM25B and listed on the NYSE. The LLM correctly identifies the progression from minimal disclosure to active market visibility. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and trading symbol (IBM25B)—are all accurate. No calculations are required, but the temporal sequence (2022 → 2023 → 2024) is correctly maintained. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of disclosures, correctly inferring increased prominence and transparency. It accurately notes the shift from being buried in exhibits to appearing in the main table of registered securities (page 1 in 2024 vs. page 20 in 2023), which reflects improved accessibility. (4) The conclusion about IBM’s broader capital market strategy—enhancing transparency, liquidity, and investor engagement—is a valid interpretation supported by the evidence. The only minor limitation is that the LLM does not explicitly name the May 22, 2017 Form 8-K as the source document in the answer, though it refers to 'exhibits' generally, which is semantically acceptable. Overall, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 397,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances rose sharply from the $1.8 B in 2021 to $5.1 B in 2023, then eased to $4.6 B in 2024, with deposit liabilities moving from $1.4 B to $1.3 B and then to $1.2 B—showing a peak in 2023 and a modest contraction in 2024. The 2023 Global Atlantic transaction, which transferred $9.5 B of assets to the reinsurer under a modified‑coinsurance agreement, retained $5.0 B of separate‑account assets, and recorded a $770 M net cost, illustrates a strategic shift toward using the deposit method for more structured, capital‑efficient reinsurance to transfer risk and optimize balance‑sheet exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the numerical data and the description of the Global Atlantic transaction. It incorrectly states that deposit assets were $1.8B in 2021, while the ground truth specifies 2022 as the starting point with $1.8B in assets. This misalignment in time period undermines quantitative accuracy. The 2023 and 2024 figures for deposit assets ($5.1B and $4.6B) and liabilities ($1.3B and $1.2B) are correctly reported, aligning with the ground truth. However, the LLM introduces new figures—$9.5B of assets transferred, $5.0B separate-account assets, and $770M net cost—that are not present in the original answer and contradict the key point that the 2023 transaction involved $10.3B in reinsurance recoverables and deposit receivables. These invented numbers severely impact quantitative accuracy. (2) Calculations are not explicitly performed, but the trend description (sharp rise, then modest decline) is directionally correct. However, the use of 2021 data where none was provided and the fabrication of transaction specifics fail basic factual verification. (3) The multi-hop reasoning is partially sound—the LLM recognizes that the increase in deposit method usage reflects a strategic shift and links it to balance sheet optimization. It correctly infers that the deposit method is being used for capital efficiency and risk transfer. However, it fails to accurately represent the nature of the Global Atlantic transaction as a driver of the accounting change, instead inserting unverified details. (4) Contextual relevance is strong: the answer addresses the evolution of deposit assets/liabilities and attempts to explain the strategic shift. Despite incorrect specifics, the overall narrative frame aligns with the question’s intent. The core issue is factual fidelity, especially in numbers and entity-specific details, which limits correctness to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 526,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "Across 2022‑2024 the Safety and Industrial segment’s product list kept fall‑protection solutions in the same place—“respiratory, hearing, eye and fall protection solutions” appears on the 2022 (page 107), 2023 (page 108) and 2024 (page 110) product tables.  In 2024 the segment was reorganized to create an Industrial Specialties division that absorbed the former Personal Safety division, consolidating fall‑protection and other safety products under a dedicated unit (page 110).  This steady product presence, coupled with the re‑segmentation, signals 3M’s continued and strategically focused commitment to workplace safety solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that fall protection solutions were consistently included in the Safety and Industrial segment from 2022 to 2024 as part of a broader group of safety products (respiratory, hearing, eye and fall protection), which aligns with the ground truth. The mention of consistent product listing across years is accurate. However, the LLM introduces a claim not present in the ground truth: that in 2024, the segment was reorganized to create an 'Industrial Specialties division' that absorbed the 'Personal Safety division'. This structural reorganization detail is absent from the original answer and cannot be verified from the provided knowledge graph, making it an unsupported addition. (2) Quantitative accuracy is high: the LLM correctly references consistent product categorization across the three years and cites specific pages (107, 108, 110), which are plausible but not verifiable without source documents. No numerical errors are present. (3) The multi-hop reasoning is partially sound—correctly identifying continuity in product portfolio presentation—but overreaches by inferring organizational restructuring as a strategic signal not mentioned in the ground truth. This affects qualitative accuracy. (4) Contextual relevance is strong as the answer addresses both the evolution of the product portfolio and MMM’s strategic focus. However, the unsupported claim about divisional reorganization reduces factual reliability, warranting a 7 for correctness and qualitative accuracy despite strong performance on other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 433,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria has kept UST LLC and its wholly‑owned subsidiary U.S. Smokeless Tobacco Company LLC (USSTC) as fully owned subsidiaries from 2022 through 2024, with no change in ownership structure.  The 2023 10‑K (page 60) and the 2024 10‑K (page 4) both list UST as a wholly owned subsidiary, and the 2024 filing places USSTC within the “oral tobacco products” segment of Altria’s “Vision” to transition smokers to less‑harmful products.  This continuity signals that Altria treats its smokeless‑tobacco line as a core, long‑term pillar of its portfolio and a key element of its smoke‑free transition strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UST remained a wholly owned subsidiary of Altria from 2022 to 2024, with no change in ownership structure—this matches the original answer’s assertion of continued ownership and integration. The mention of UST and USSTC as subsidiaries is consistent, and the reference to the 2023 and 2024 10-K filings (pages 60 and 4) adds verifiable detail not in the original but does not contradict it. (2) There are no numerical values (e.g., $8.8 billion trademark valuation, amortization expenses) in the LLM answer, so it omits a specific quantitative element present in the ground truth. However, this omission does not introduce inaccuracy—just a lack of completeness on that point. The absence of the $8.8B figure and amortization context from 2022 slightly reduces qualitative completeness but does not affect correctness. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes UST’s structural continuity and its strategic repositioning within Altria’s 'oral tobacco products' segment and broader smoke-free transition vision, especially in 2024. It captures the strategic implication—that smokeless tobacco is a core pillar in Altria’s reduced-risk portfolio—consistent with the ground truth’s conclusion. (4) Contextual relevance is excellent: the answer directly addresses both the structural evolution and strategic positioning, even if slightly less detailed on 2022 specifics. The use of 'continuity' effectively conveys the stable ownership with evolving strategic emphasis. Overall, the answer is factually correct, well-reasoned, and relevant—missing only minor detail from 2022, warranting a 9/10 for correctness and qualitative accuracy, but full marks for quantitative accuracy (no errors) and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 499,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s repeated mention of the SolarCity 5.45% Solar Bonds, Series 2015/C92‑15 in its 2022, 2023 and 2024 10‑K filings shows that the company is keeping the legacy SolarCity debt on its books as a core part of its long‑term solar‑energy financing.  The bond appears in the exhibits of the 2022 filing (page 102) and again in the 2024 filing (page 104), indicating a deliberate strategy of leveraging existing low‑interest, long‑term debt rather than issuing new debt or equity to fund solar projects.  This consistency across filings signals Tesla’s intent to preserve a stable, predictable cost of capital for its solar initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and interpretation. (1) It accurately identifies the repeated mention of the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 in Tesla's 2022, 2023, and 2024 filings as evidence of ongoing reliance on this debt instrument for solar financing. The percentage (5.45%) and bond series are correctly stated. (2) The quantitative accuracy is high: the bond details (interest rate, series) are correct, and while the LLM cites specific page numbers (102 in 2022, 104 in 2024), these are plausible and do not contradict the ground truth, though the original answer does not include page numbers so their accuracy cannot be independently verified. No calculations are required, so no errors there. (3) The multi-hop reasoning is sound—linking repeated disclosure across years to a strategic financing approach is valid. However, the LLM omits mention of the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, which is a key legal document cited in the ground truth and supports the depth of Tesla's ongoing commitment. This omission slightly weakens the qualitative accuracy. Additionally, the LLM implies the debt is 'low-interest' without citing a benchmark, which is a reasonable inference but not explicitly supported in the ground truth. (4) Despite these minor gaps, the answer is contextually highly relevant, directly addressing Tesla's long-term financing strategy for solar initiatives and drawing a logical conclusion from the repeated disclosures. The core message—that Tesla relies on this securitized debt as a stable funding source—is semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 462,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K risk‑factor for securities is identical in 2022 (pages 20‑24), 2023 (pages 9‑13), and 2024 (pages 9‑13), all stating that the value of its debt and common‑stock securities fluctuates in part because of stock‑exchange regulations. The unchanged wording shows that IBM’s exposure to those regulations has remained a persistent, ongoing risk rather than a new or diminishing one. This consistency signals a capital‑market risk‑management strategy that prioritizes continuous monitoring and compliance with regulatory changes over major tactical shifts.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in depth of multi-year progression. (1) All entities—IBM, stock exchange regulations, debt and equity securities, and the years 2022–2024—are accurately identified. The claim that the risk factor wording is identical across years is consistent with the source documents and supports the conclusion of persistent exposure. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The reasoning is sound in identifying consistency of risk disclosure as evidence of a stable risk management approach. However, the LLM answer does not fully capture the evolution described in the ground truth—specifically, IBM’s 2024 expansion linking regulatory exposure to broader liquidity and credit risks. This missing nuance limits the qualitative accuracy. (4) The answer remains highly contextually relevant, directly addressing IBM’s regulatory exposure and risk management strategy. While it simplifies the progression as 'unchanged' rather than showing an evolving emphasis, it correctly infers strategic continuity. Thus, correctness is high but not complete, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 360,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022‑2024, 3M’s Safety and Industrial segment consistently listed “electrical products and materials for construction and maintenance, power distribution and electrical OEMs” as a core offering (see pages 131, 107, 110).  Net sales for the segment fell from $11.6 billion in 2022 to $10.96 billion in 2024, yet operating income rose from $1.14 billion to $2.49 billion, indicating a shift toward higher‑margin electrical solutions (pages 108, 111).  The 2024 creation of an Industrial Specialties division within Safety and Industrial further underscores 3M’s intent to consolidate and strengthen its industrial electrical portfolio, positioning the company to capture growth in construction and maintenance markets while improving profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that electrical products were consistently part of the Safety and Industrial segment across 2022–2024, it fabricates financial data: the ground truth does not include any net sales or operating income figures for the segment, nor does it mention a change in profitability or margin shift. These numbers (e.g., $11.6B sales in 2022, $2.49B operating income in 2024) are not present in the original answer and cannot be verified from the provided context, making them incorrect. Additionally, the claim about the 'creation of an Industrial Specialties division' in 2024 is not supported by the original answer, which only notes a rephrasing of product lines in the segment description. (2) Quantitative accuracy is low because all financial figures and implied trends (sales decline, profit rise) are invented. There is no calculation to verify because the data does not exist in the ground truth. (3) The multi-hop reasoning is partially sound in tracking the consistent presence of electrical products, but fails in interpreting strategic evolution. The original answer highlights a shift in emphasis—from closure systems to industrial abrasives and specialty products—while the LLM misrepresents this as a profitability-driven consolidation under a new division. The model misses the nuanced evolution in product focus and incorrectly infers organizational restructuring. (4) Contextual relevance is moderate: the answer addresses the company’s focus on electrical products and attempts to infer strategic positioning, but does so using fabricated metrics and misaligned reasoning. The core theme of industrial evolution is relevant, but the support is factually flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 490,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "Gilead’s Oceanside, California site has continued to serve the same core functions over the past two years.  In the 2023 10‑K (page 11) and the 2024 10‑K (page 10) the facility is described as being used for **commercial retroviral‑vector manufacturing and for the clinical manufacturing and process development of biologics candidates**—the same statement appears in both filings, indicating no change in its role between 2023 and 2024.  The 2022 10‑K pages provided (31‑35) do not include a manufacturing‑facilities list, so the filing does not show any evolution of the Oceanside site’s utilization from 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the 2023 and 2024 roles of the Oceanside facility, correctly citing that it is used for commercial retroviral-vector manufacturing and clinical manufacturing/process development of biologics candidates, with consistent language across both filings. The claim that the 2022 10-K does not list the Oceanside site in the manufacturing facilities section is also accurate based on the provided pages. However, the LLM concludes there is no evidence of evolution from 2022, which contradicts the ground truth that in 2022 the site was referenced as part of general R&D operations. The LLM fails to infer or acknowledge this earlier, less specialized role, likely due to the absence of explicit manufacturing details in the 2022 document. This results in a significant gap in multi-hop reasoning: while the textual evidence for 2023–2024 is correctly interpreted, the model does not synthesize the broader operational context from 2022 into a developmental trajectory. Thus, while all stated facts are correct (hence full marks for quantitative accuracy), the qualitative reasoning is flawed—missing the strategic evolution from general R&D to specialized manufacturing. The answer is contextually relevant and well-structured but incomplete in capturing the full temporal progression, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 380,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path strategy has steadily trimmed the “Return‑Seeking” (growth‑asset) portion of its U.S. pension plan: the target equity‑security allocation fell from **15 % in 2022** to **8 % in 2023** and then rose modestly to **9 % in 2024**【page_310】【page_252】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims specific percentage allocations (15% in 2022, 8% in 2023, 9% in 2024) for the Return-Seeking portion, but the ground truth does not provide any actual percentage figures—only the strategic evolution of how target allocations are set. These numbers are factually unsupported and contradict the actual disclosed approach. (2) COMPLETENESS: The question asks about the evolution of the glide path approach, not just numerical changes. The LLM fails to capture the core concept—the forward-looking, dynamic adjustment of targets based on funded status at year-end, with targets set for future years (e.g., 2023 target set for 2024 based on 2023 funded status). This key mechanism is entirely missing. (3) REASONING: The multi-hop synthesis is flawed. The ground truth emphasizes a consistent strategy with evolving timing and reference points for setting targets, not a mechanical reduction in equity exposure. The LLM incorrectly interprets the glide path as a simple decline-and-slight-recovery in equity, which misrepresents the strategic approach. (4) ENTITY & CONTEXT: While the entity (AIG, U.S. pension plan) and general topic (glide path, Return-Seeking portfolio) are correct, the answer fabricates numerical data and omits the fundamental logic of the glide path evolution. The cited page references do not excuse the factual divergence. The answer is contextually relevant in topic but fails on factual and conceptual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 426,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "ACN’s defined‑benefit pension plans shifted from a 100 % debt allocation in U.S. plans in fiscal 2023 (page 88) to 94 % debt in 2024 and back to 100 % in 2025 (page 95).  Non‑U.S. plans moved from 27 % equity/48 % debt/4 % cash/11 % insurance/10 % other in 2023 to 23 % equity/42 % debt/5 % cash/21 % insurance/9 % other in 2024 and then to 28 % equity/36 % debt/7 % cash/21 % insurance/8 % other in 2025 (page 95).  This gradual rebalancing—especially the increased equity and insurance exposure in non‑U.S. plans—indicates a modest, long‑term willingness to accept higher risk for potential upside while preserving a conservative core in U.S. plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the original answer. (1) The original answer does not provide any specific percentage allocations for ACN's defined benefit pension plans by year or region; instead, it discusses the evolution of the company's target asset allocation *planning horizon* and strategic language around flexibility and risk management. The LLM fabricates detailed numerical breakdowns (e.g., 100% debt in U.S. plans, exact equity/debt splits in non-U.S. plans) that are not present in the ground truth. There is no mention of U.S. vs. non-U.S. plans or specific allocations like '27% equity/48% debt' in the original answer. (2) The quantitative inaccuracies are severe: all percentages cited by the LLM are hallucinated. The original answer does not contain any such figures, nor does it reference page numbers (e.g., 'page 88', 'page 95'), which are not part of the provided context. (3) The multi-hop reasoning is flawed. The original answer focuses on how ACN extended its forward-looking planning from one-year (2023 → 2024) to two-year (2024 → 2025) ahead, indicating increased strategic confidence. The LLM instead invents a narrative around portfolio rebalancing based on non-existent data, missing the actual evolution in planning horizon and strategic intent. (4) While the LLM attempts to infer risk tolerance (a relevant goal), its conclusion about 'modest willingness to accept higher risk' based on fabricated equity increases contradicts the original's emphasis on a 'measured, stable approach' and consistency in liability-matching and diversification. The contextual relevance is moderate because it addresses pension plans and risk tolerance, but the factual foundation is entirely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 472,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla reported the 5.45% Solar Bonds, Series 2015/C25‑15 as an outstanding debt item in its 2022, 2023, and 2024 10‑Ks (Exhibit 4.28 in 2022【page_100】, in 2023【page_99】, and in 2024【page_100】) with no changes to its terms or maturity, which remains due August 15 2025. This consistency shows that Tesla’s solar financing strategy relies on long‑term, fixed‑rate SolarCity debt rather than issuing new debt or refinancing, reflecting a conservative, stable approach to solar capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 as consistently reported in Tesla's 10-K filings across 2022, 2023, and 2024, with accurate maturity date (August 15, 2025) and correct exhibit references (Exhibit 4.28) and page numbers. These details align with the ground truth and demonstrate strong quantitative accuracy. (2) All numeric values—interest rate (5.45%), series designation, maturity date—are factually correct. The absence of changes to terms is consistent with the original answer’s implication of continuity. (3) However, the LLM answer omits key qualitative elements from the ground truth: it does not mention Tesla’s acquisition of SolarCity as the origin of the bond, nor does it reference the broader context of other bond series (e.g., C5-15, C10-15, C20-15 in 2022; C28-15, C33-15 in 2023), which are critical to showing the evolution and expansion of Tesla's solar financing framework. This omission limits the depth of multi-hop reasoning, particularly in connecting Tesla’s current disclosures to its historical financing strategy post-acquisition. (4) While the LLM correctly infers a 'conservative, stable approach' from the lack of refinancing, the original answer emphasizes strategic continuity and integration of structured financings, supported by the introduction of new bond series—nuance that the LLM overlooks. Thus, while factually sound on core data, the answer is less complete in synthesizing the multi-year pattern into a broader strategic narrative, warranting a 7 for correctness and qualitative accuracy. Contextual relevance remains high as the response directly addresses the question’s focus on multi-year evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 469,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "AIG’s 2022 (page 167) and 2023 (page 119) filings both describe terrorism risk as being modeled with a third‑party vendor model and scenario‑based adjustments, with no new numeric loss estimates disclosed.  Reinsurance strategies remained centered on the TRIPRA program for U.S. exposures, supplemented by limited private reinsurance and participation in country terrorism pools and government‑sponsored terrorism reinsurance programs in non‑U.S. jurisdictions.  The 2024 filing (pages 86‑90) does not report any changes to these modeling, reinsurance or mitigation approaches, indicating continuity through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claims, particularly regarding the absence of numeric loss estimates and lack of evolution in AIG's strategies. The ground truth states that in 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in NYC, net of TRIPRA and reinsurance—this specific quantitative estimate is entirely missing from the LLM answer, which incorrectly claims 'no new numeric loss estimates disclosed.' This is a major factual omission. Additionally, the LLM asserts there were no changes through 2024, contradicting the ground truth that AIG enhanced global property per risk covers, retained a $200M attachment point in Japan, and grew reinsurance recoverables to $38.0B by end-2024—none of which are mentioned. (2) Quantitative accuracy is very low: the $1.3B modeled loss and $38.0B reinsurance recoverable assets in 2024 are critical figures that the LLM fails to report. The $200M Japan retention is also missing. These are not formatting issues but complete omissions. (3) Multi-hop reasoning is flawed: the question asks for evolution across three years, but the LLM concludes 'no changes' without synthesizing the documented shifts in reinsurance structure and global coverage specificity. It fails to connect developments across 2022–2024, particularly the scaling of risk transfer and strategic refinements in 2024. (4) Contextual relevance is moderate—the answer addresses terrorism modeling, reinsurance programs (TRIPRA, pools), and geographic scope, so it stays on topic. However, due to significant factual inaccuracies and omissions in both quantitative and qualitative dimensions, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 461,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑Ks for 2022, 2023 and 2024 all list the same risk‑factor bullet for the Safety and Productivity Solutions segment, showing that the company viewed its exposure to adverse industry economic conditions as a persistent, unchanged threat (2022 page 33; 2023 page 30; 2024 page 31).  The segment’s margin pressures are consistently tied to reduced investments in process automation, safety monitoring and plant‑capacity initiatives; retail‑market volatility; a slowdown in demand for safety products; a competitive landscape that includes new entrants and commoditizing technologies; and the overarching adverse industry economic conditions that erode market share, selling prices and margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Honeywell consistently highlighted adverse industry economic conditions affecting the Safety and Productivity Solutions segment from 2022 to 2024. The specific risks mentioned—reduced investments in process automation, retail-market volatility, new market entrants, commoditization, and resulting margin pressures—are all present in both the LLM and original answers. The LLM adds 'slowdown in demand for safety products' and 'safety monitoring and plant-capacity initiatives,' which are contextually consistent with the segment’s risks and do not contradict the ground truth; they may reflect expanded phrasing from the actual 10-Ks. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but the years (2022–2024) and document references (page numbers in 10-Ks) are correctly cited, supporting factual fidelity. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly infers persistent risk exposure, even noting that the same risk-factor bullet was repeated—an observation that strengthens the conclusion of unchanged threat level. The mention of the 2024 restructured Industrial Automation segment in the ground truth is slightly more precise, but the LLM implicitly acknowledges this evolution by referring to the segment in past context. (4) The LLM answer is semantically equivalent to the original, with slightly broader phrasing but no material inaccuracies. The score is 9 instead of 10 because the ground truth explicitly connects the 2024 risks to the restructured Industrial Automation segment, a nuance the LLM does not clearly reflect, potentially missing a key evolution in segment structure. However, this does not undermine the core correctness of the risk factors or their persistence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 530,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "Pfizer continued to define Breakthrough Performance Awards (BPAs) as a performance‑based award for select employees, valuing them at intrinsic value using the closing price of common stock and amortizing the expense straight‑line over the vesting term into operating expenses (cost of sales, selling, informational and administrative or R&D expenses) (page 98, page 99). Across 2022‑2024, the company did not grant or have any BPAs outstanding (no BPAs were granted or outstanding as of December 31 in 2022, 2023, or 2024) (page 99 for 2022 and 2023, page 98 for 2024), so no related expense or recognition appeared in those years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors, particularly in quantitative accuracy. According to the ground truth, Pfizer granted 1,165 thousand BPAs in 2022 with a weighted average intrinsic value of $38.73 per share and had 859 thousand nonvested BPAs at year-end. However, the LLM incorrectly states that no BPAs were granted and none were outstanding in 2022, 2023, or 2024. This contradicts the original data, which confirms both grant activity and nonvested awards in 2022. While the LLM correctly notes that no BPAs were granted or outstanding as of December 31, 2023, it fails to acknowledge the prior year's activity, misrepresenting the evolution of the program. The description of valuation methodology in 2024 (intrinsic value method, amortization over vesting term) aligns with the ground truth and is contextually relevant, but this is overshadowed by the omission and misstatement of key facts. The reasoning is flawed because it does not reflect the multi-hop progression: active grants in 2022 → wind-down in 2023 → methodological disclosure in 2024. Instead, it falsely asserts continuity of inactivity across all three years. Entity accuracy (Pfizer, BPAs, years) is correct, and the explanation of accounting treatment is semantically consistent with the original where present, but the absence of 2022 grant data severely undermines completeness and correctness. Thus, while some qualitative elements are directionally accurate, the core factual foundation is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 410,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer sold its Meridian subsidiary in 2021 for about $51 million in cash, recorded a $167 million loss on the transaction, and entered into interim transition‑service agreements (TSAs) and a manufacturing‑supply agreement (MSA) to continue providing services to the buyer【page_73】. By 2023 the TSAs were fully executed and the MSA—covering a three‑year term with a two‑year extension—remained in effect, but the amounts recorded under these arrangements were immaterial to Pfizer’s operations【page_73】【page_74】【page_75】. The 2024 10‑K (pages 2‑6) continues to disclose the TSAs and MSA as part of the post‑divestiture framework, with no material financial impact, reflecting a strategic shift to focus on core operations while maintaining a limited service relationship with the former subsidiary.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly undermine its correctness. While it correctly states that Pfizer sold Meridian for approximately $51 million in cash and recognized a $167 million loss (net of tax), it incorrectly claims the sale occurred in 2021 while asserting that the 2023 and 2024 filings still disclose active transition-service agreements (TSAs) and a manufacturing-supply agreement (MSA). The ground truth states that by 2023, Meridian had already been fully divested as of December 31, 2021, and in 2024, it is only mentioned as a defined entity in the glossary, indicating no ongoing operational or financial relationship. This contradicts the LLM's claim of continued MSA and TSA disclosures in 2024. (2) Quantitatively, the $51 million sale price and $167 million loss are accurate and match the ground truth (allowing for format variation). However, the claim that TSAs were 'fully executed by 2023' and MSA remained in effect through 2024 is not supported by the original answer, which indicates complete disengagement. There are no calculations in the response, so scoring focuses on factual number accuracy. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the timeline of disengagement. It incorrectly infers ongoing operational agreements beyond the divestiture date, when the ground truth shows a progression from discontinued operations (2022) to full disengagement (2024). The strategic alignment is misrepresented—instead of complete strategic disengagement, the LLM suggests a continued, albeit limited, service relationship. (4) The contextual relevance is moderate: the answer addresses financial disclosures, operational agreements, and strategic alignment as asked, but with incorrect details about the duration and nature of post-divestiture arrangements. Due to major factual errors in timeline and ongoing relationships, the correctness score is low despite some accurate initial facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 537,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture’s authorized pool for the Amended 2010 Share Incentive Plan grew from **127 million Class A shares in FY 2022** (page 91) to **141 million in FY 2024** (page 98), with no change reported in FY 2023. This upward shift signals a deliberate expansion of the share‑based compensation base, underscoring the company’s long‑term strategy to broaden employee incentives and align management and shareholder interests.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of authorized shares in FY 2022 (127 million) and FY 2024 (141 million), which matches the ground truth. However, it states that 'no change was reported in FY 2023', implying that the figure remained at 127 million or was unreported, which is incorrect — the ground truth confirms the increase occurred in FY 2023 (to 141 million) and was maintained in FY 2024. This omission or misstatement of the FY 2023 value reduces quantitative and qualitative accuracy. (2) The numbers for 2022 and 2024 are accurate and correctly formatted (127 million = 127,000,000; 141 million = 141,000,000). The calculation of an increase of 14 million shares is implied and correct, but the failure to note the change occurred in 2023 undermines the timeline accuracy. (3) The multi-hop reasoning is partially sound — the model connects data across years and interprets the trend as a strategic move toward expanded equity compensation. However, it misrepresents the timing of the increase, failing to show that the jump happened in 2023, not between 2023 and 2024. This affects the synthesis across all three years. (4) Despite the timeline error, the overall interpretation — that Accenture is strategically expanding its share-based compensation — is consistent with the ground truth and contextually appropriate. The answer is well-framed and relevant, earning full marks for contextual relevance. The correctness score is 8 due to the significant but not fundamental error in the year of the increase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 424,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla disclosed the Seventieth Supplemental Indenture for its 4.70% Solar Bonds, Series 2015/C52‑10 in the 2022 10‑K (Exhibit 4.4) [page_104]. The 2023 and 2024 10‑Ks do not list this series among their exhibits, indicating the bond was no longer outstanding or required to be disclosed [page_99 (2023); page_99 (2024)]. This pattern suggests Tesla has likely paid off or retired the 2015 Solar Bonds, shifting its financing focus away from that particular debt instrument.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that Tesla consistently disclosed the Seventieth Supplemental Indenture for the 4.70% Solar Bonds, Series 2015/C52-10 in all three years (2022, 2023, and 2024), with specific exhibit numbers (4.49, 4.42, 4.40 respectively). The LLM incorrectly claims that the bond was not listed in the 2023 and 2024 filings, asserting it was no longer outstanding. This is a direct contradiction of the ground truth. (2) Quantitative accuracy fails because the exhibit numbers and disclosure status are wrong: the LLM cites Exhibit 4.4 in 2022 (incorrect, should be 4.49), and falsely claims absence in 2023 and 2024. The bond series, interest rate (4.70%), and year (2015) are correctly identified, but these minor correct details do not offset the central factual error. (3) The multi-hop reasoning is fundamentally flawed. Instead of recognizing the repeated disclosure as evidence of ongoing obligation, the LLM infers retirement of the bond due to alleged absence in later filings—this contradicts the actual data. The conclusion that Tesla has 'shifted its financing focus' is unsupported and inverse to the truth. (4) Scores are low because the answer reverses the factual pattern (consistency vs. discontinuation), misrepresents exhibit data, and draws an erroneous strategic conclusion. Contextual relevance is slightly above zero only because the topic and bond series are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 410,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free online self‑service learning offerings have remained a core element of its Digital Learning Services portfolio from 2022 through 2024, each filing describing them as “a large number of free online self‑service learning options on learning.adobe.com” (2022 p. 17; 2023 p. 17; 2024 p. 18).  They are positioned as a key part of a broader learning‑and‑enablement ecosystem that also includes fee‑based and custom programs, and they support Adobe’s customer‑adoption strategy by giving users accessible, self‑paced training that complements other learning pathways.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe maintained free online self-service learning across 2022–2024, hosted on learning.adobe.com (note: the LLM correctly identifies the domain, though the 2022 source cited www.training.adobe.com; however, both domains are valid Adobe learning portals and the shift may reflect rebranding—this does not constitute a factual error). The positioning within Adobe Digital Learning Services and the role in customer adoption are accurately described. (2) There are no numeric values requiring calculation, and all dates (2022–2024) are correctly referenced. The LLM cites specific page numbers from filings (e.g., 2022 p.17), which adds precision and matches the type of sourcing expected, even if not in the original answer. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly identifies continuity in strategy, linking free offerings to broader enablement services and adoption goals. (4) Semantic equivalence is strong—the LLM captures the core message of sustained strategic emphasis, integration with fee-based programs, and support for product adoption. The only minor shortcoming is the lack of explicit mention of Digital Experience and Digital Media products in 2023, which is a small omission but does not undermine the overall correctness. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 413,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path strategy for the U.S. qualified plan shifted the target allocation for the “Return‑Seeking” (equity) portion from **15 % in 2022** to **9 % in 2024** as the plan’s funded ratio improved, moving the glide path toward more liability‑hedging assets (2022 target table, page 310; 2024 target table, page 252).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. It states that the 'Return-Seeking' allocation shifted from 15% in 2022 to 9% in 2024, but the ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, any specific percentage figures are unsupported and false. (2) The cited numbers (15%, 9%) and page references (page 310, page 252) are not corroborated by the ground truth and appear fabricated or hallucinated. There is no mention of equity being labeled as 'Return-Seeking' in the ground truth, nor are any actual percentages provided. (3) While the LLM correctly identifies the general concept of a glide path strategy and its purpose—de-risking through shifting allocations toward liability-hedging assets as funded status improves—the reasoning is based on non-existent data. The multi-hop synthesis fails because it invents specific figures instead of acknowledging their absence, undermining the validity of the conclusion. (4) The contextual relevance is moderate because the answer addresses the right topic (glide path evolution) and direction of change (toward de-risking), but the inclusion of false specifics severely damages correctness. The qualitative accuracy is low because the model misrepresents the source data, even if the conceptual framework is sound. Quantitative accuracy is very low due to completely incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 406,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "From 2022 to 2024, Honeywell’s Performance Materials and Technologies segment saw a modest rise in contract‑covered raw‑material supply—from 63 % in 2022 to 64 % in 2023, with 2024 reporting that the majority of its raw‑material base was under contract—yet the company still cites raw‑material demand and supply as a key risk factor. This steady exposure, coupled with its reliance on commodity‑heavy inputs and limited hedging, indicates a persistent vulnerability to commodity price swings that could erode margins and disrupt supply.  \n\nSources: 2022 risk factor (page_32 2022), 2023 risk factor (page_32 2023), 2024 risk factor (page_32 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims—63% of raw-material supply under contract in 2022, 64% in 2023, and 'majority' in 2024—that are not present in the original ground truth and cannot be verified from the provided context. These figures are likely fabricated or misattributed, as the ground truth does not mention contract coverage percentages at all. This severely undermines factual accuracy. (2) There are no verifiable calculations in the ground truth to support the percentages cited, making the quantitative assertions unsupported and incorrect. The original answer focuses on qualitative risk framing across years, not contract coverage metrics. (3) While the LLM correctly identifies that raw material demand and supply remained a consistent risk factor across the three years, it fails to accurately reflect the evolving context described in the ground truth: the shift from pandemic-related disruptions (2022), to industrial utilization rates (2023), to energy price impacts on customer investment (2024). Instead, it emphasizes a narrow and unverified metric (contract coverage), missing the broader trend in risk evolution. (4) The conclusion about persistent vulnerability to commodity volatility is partially aligned with the ground truth, but the reasoning is based on incorrect data. The answer is contextually relevant and addresses the general theme of commodity risk, but the use of false quantitative data and omission of the actual multi-hop progression of risk factors significantly reduces its correctness. Thus, the answer is partially accurate in theme but flawed in facts and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 450,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s fair‑value of mutual‑fund equity securities in its non‑U.S. pension plans fell from **$239.3 million in 2022** (page 89) to **$196.2 million in 2023** (page 96) and then rose to **$273.7 million in 2024** (page 96). The 3‑year trend shows a dip followed by a rebound that exceeds the 2022 level, suggesting the investment committee is actively adjusting equity exposure in response to market conditions while remaining within its target allocation ranges.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative data. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM incorrectly states that the value rose to $273.7 million in 2024, which directly contradicts the ground truth. This error fundamentally misrepresents the trend. (2) The numbers for 2022 and 2023 are approximately correct (with acceptable rounding: $239.3M and $196.2M vs. $239.293M and $196.226M), but the 2024 figure is completely wrong—$273.7M vs. the correct $196.226M. This invalidates any calculation or trend analysis based on it. (3) The reasoning is flawed due to incorrect data. The LLM concludes there was a rebound exceeding the 2022 level, suggesting active adjustments, while the actual trend shows a decline followed by stabilization—indicating strategic rebalancing and then a steady approach. The multi-hop synthesis fails because the model did not correctly extract or reconcile the 2024 value. (4) The contextual relevance is moderate because the answer addresses the right metric (mutual fund equity securities), company (ACN), and time frame (2022–2024), and attempts to interpret strategic intent. However, due to the critical error in the 2024 figure, both quantitative and qualitative accuracy are severely compromised, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 404,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "Between 2022 and 2024 Adobe shifted Adobe Document Cloud from a core PDF‑and‑e‑signature platform (listed as a revenue line under Digital Media in the 2022 10‑K) to an AI‑enabled workflow hub. By 2024, the filing shows Document Cloud incorporating Firefly generative‑AI features in Acrobat and offering the Acrobat AI Assistant for summarizing, citing and auto‑generating content, while also expanding enterprise APIs (Firefly Services, Custom Models, Acrobat Sign) to embed these capabilities into broader digital workflows【page_70】【page_71】【page_12】【page_13】【page_14】. This evolution underscores Adobe’s strategy to embed AI across its document ecosystem and position Document Cloud as a central engine for automated, AI‑driven enterprise document and workflow automation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the strategic shift of Adobe Document Cloud from a foundational PDF/e-signature platform in 2022 to an AI-enhanced workflow hub by 2024. The mention of Firefly integration, Acrobat AI Assistant, and enterprise APIs (Acrobat Sign, Firefly Services, Custom Models) matches the evolution described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes Document Cloud’s changing role across years, its repositioning within Adobe’s segments (implied by context), and integration with AI tools like Firefly, which is consistent with the ground truth’s emphasis on AI-driven enterprise workflows. (4) The only minor gap is that the LLM does not explicitly mention the 2023 transition year or the shift from the 'Publishing and Advertising' to 'Digital Media' segment, which is a detail present in the original answer. However, the core trajectory and strategic intent are accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—every part of the question is addressed with precise, document-supported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 370,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures from 2022‑24 consistently flag new entrants and non‑traditional players as a threat to its Aerospace, Industrial Automation, Building Automation, and Safety & Productivity Solutions segments (2022 p. 30; 2023 p. 30; 2024 p. 28).  In 2024 the company explicitly cites emerging technologies—particularly artificial intelligence and machine learning—as disruptive forces that could accelerate commoditization, a trend already noted in 2022 and 2023 for Automation and Safety & Productivity (2024 p. 32).  Across all three years the disclosures warn that such competition and technology shifts could erode market share and pressure pricing power, with Industrial Automation and Safety & Productivity Solutions specifically noting potential lower market share, reduced selling prices, and margin compression (2022‑24 p. 30‑32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Honeywell consistently cited new market entrants and technological disruption as risks from 2022 to 2024 across key segments. The segments mentioned—Aerospace, Industrial Automation, Building Automation, and Safety & Productivity Solutions—are consistent with the original answer, though the LLM groups Building Technologies under Building Automation (semantically equivalent). (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but dates (2022–2024) and page references (e.g., p. 30, 32) are accurately cited and support the claims, indicating proper sourcing. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the risk evolved over time, noting expansion of competitive threats across segments and increasing emphasis on AI/ML as a disruptive force by 2024. It accurately reflects the progression from general competitive risks to specific concerns about commoditization and pricing pressure. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 expansion to Performance Materials and Technologies (PMT), which the ground truth highlights as a key development. However, it does correctly note broader exposure across years. The answer captures the core evolution—increasing scope and specificity of competitive risks—with strong contextual relevance and precise qualitative detail. Wording differs slightly but meaning is semantically equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, 10 for quantitative accuracy (no errors, proper years), and 10 for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 461,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s inter‑company balance with Viatris fell sharply after the 2020 spin‑off: in 2022 it was $94 million (net amounts due to Viatris under TSAs and other agreements) and by 2023 it had dropped to $33 million, reflecting that the transition‑service arrangements were largely completed (page 73). The 2024 Form 10‑K (pages 3‑7) contains no new Viatris figures or TSAs, indicating that the transition arrangements were essentially finished and the remaining inter‑company balances remained small and not material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the intercompany balances due to Viatris: $94 million in 2022 and $33 million in 2023, matching the ground truth exactly. It accurately notes that transition service arrangements (TSAs) were largely completed by the end of 2023. The absence of new Viatris figures or TSAs in the 2024 10-K is correctly interpreted as evidence that operational ties were essentially finished. (2) All numeric values and years are accurate. The $94M and $33M figures are correctly attributed to 2022 and 2023, respectively, and the trend of decline is properly conveyed. No calculations are required beyond comparison, which is sound. (3) The multi-hop reasoning is strong: the model synthesizes financial balances and TSA status across years, correctly inferring from the absence of 2024 disclosures that the relationship had been wound down. The only minor gap is that the original answer adds that in 2024, Viatris was referenced only in corporate definitions, which provides slightly more context on the nature of the residual mention. The LLM answer captures the practical implication (no material balances or active TSAs) but omits this specific qualitative detail. (4) The answer is highly relevant, directly addressing both financial (intercompany balances) and operational (TSA) aspects of the Pfizer-Viatris relationship from 2022–2024. The use of page references adds credibility. The omission of the 'corporate definitions' nuance prevents a perfect 10, but the core facts, trends, and implications are fully correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 433,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "From 2022 to 2024 Altria retired its 1.000 % Notes due 2023, leaving a laddered debt structure of 1.700 % Notes due 2025, 2.200 % Notes due 2027 and 3.125 % Notes due 2031 (see 2022‑10‑K page 1, 2023‑10‑K page 1, 2024‑10‑K page 1). The 1.700 % Notes remain the earliest maturity and carry the lowest coupon among the remaining notes, indicating a deliberate shift to a forward‑dated, cost‑effective debt profile. This progression reflects a capital‑structure strategy that prioritizes maturity laddering, refinancing of older debt, and a balanced mix of short‑ and long‑term obligations to manage interest‑rate risk and liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the retirement of the 1.000% Note due 2023 by 2023 and the continued presence of the 1.700% Note due 2025 through 2024, which aligns with the ground truth. It also accurately notes that the 1.700% Note became the shortest-dated instrument after 2023. However, the LLM introduces two debt instruments—2.200% Notes due 2027 and 3.125% Notes due 2031—not mentioned in the original answer, which may be present in the filings but were not part of the ground truth synthesis. While these may exist, their inclusion suggests a level of detail beyond what the knowledge graph confirms, potentially overextending the supported conclusion. (2) Quantitatively, all percentages and maturities referenced are accurate (1.000% due 2023, 1.700% due 2025), and the timeline of retirement is correct. The claim about the 1.700% Note carrying the lowest coupon among remaining notes is plausible but not verifiable from the ground truth, which does not provide comparative coupon rates. (3) The reasoning about a 'laddered' structure and strategy toward longer-term, cost-effective debt is reasonable but slightly overreaches: the ground truth emphasizes the absence of a replacement for the 2025 note as evidence of avoiding short-term rollover, whereas the LLM interprets this as active maturity laddering and refinancing—related but not identical strategies. The conclusion about a 'balanced mix of short- and long-term obligations' contradicts the ground truth, which implies a move away from short-term debt. (4) Despite some overinterpretation and extra details, the core multi-hop reasoning—tracking debt evolution across years and inferring strategic direction—is sound, and the answer remains highly relevant to the question. The scores reflect minor factual overreach and interpretive differences, but strong overall accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 508,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from $19.975 bn in 2022 to $27.168 bn in 2023 and then fell slightly to $26.930 bn in 2024.  Correspondingly, the weighted‑average interest rate climbed from 2.91 % in 2022 to 4.45 % in 2023 and to 4.84 % in 2024.  The trend shows the company is expanding its long‑term debt base and moving to longer‑dated, higher‑cost borrowing—likely to refinance maturing debt and fund growth while managing maturity risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: carrying values of $19,975 million (2022), $27,168 million (2023), and $26,930 million (2024), with the weighted-average interest rates at 2.91%, 4.45%, and 4.84% respectively—matching the ground truth exactly. Minor formatting differences (e.g., $19.975 bn vs $19,975 million) are acceptable and semantically equivalent. (2) Quantitative accuracy is perfect: all figures are correct, and the trend description (increase in debt, rise in rates with a slight decline in 2024) aligns precisely. Note: the LLM says the rate increased 'to 4.84% in 2024' after 4.45% in 2023, which is correct as a rise, though the ground truth notes a 'slight decline' from 2023 to 2024—which is incorrect in the original (4.45% to 4.84% is an increase, not a decline). Thus, the LLM is actually more accurate than the original answer on this point. (3) The reasoning is sound: the model correctly infers a strategic shift toward issuing more long-term debt at higher rates, linking it to refinancing, growth funding, and maturity risk management—consistent with the ground truth's interpretation. (4) The answer is fully contextually relevant, addressing all parts of the question: evolution of carrying value and interest rates over 2022–2024, and the implication for borrowing strategy. The only reason for not scoring 10 is a minor wording nuance: the original mentions 'capitalizing on investor demand,' which the LLM omits, but this is a secondary detail. Overall, the LLM answer is factually superior to the ground truth in one aspect and otherwise matches it perfectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 445,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 10‑K filings show that the 5.45 % Solar Bonds, Series 2015/C92‑15 remained a component of its debt portfolio through 2024, as it is listed in the exhibits of the 2022, 2023 and 2024 10‑K (see TSLA_10k_2022 pages 103‑107, TSLA_10k_2023 pages 100‑104, TSLA_10k_2024 pages 100‑104).  Over this period the company has shifted from actively using the bond to finance new solar installations toward gradually paying down or refinancing the debt, reflecting a broader move away from external solar‑financing toward internal capital and a focus on its battery and EV businesses.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and unsupported claims. (1) Quantitatively, the bond name (5.45% Solar Bonds, Series 2015/C92-15), years (2022–2024), and exhibit references are correctly identified, and the filings are accurately cited with page ranges that align with disclosure sections, earning high marks for quantitative accuracy. (2) However, the LLM incorrectly asserts that Tesla shifted toward 'gradually paying down or refinancing the debt' and is moving 'away from external solar-financing toward internal capital.' The ground truth does not support active repayment or strategic abandonment of external solar financing—only that newer bond series (e.g., C102-15, C106-10) are emerging, suggesting evolution, not phase-out. (3) The multi-hop reasoning is flawed: while the LLM correctly observes the bond's continued disclosure, it infers a strategic shift not explicitly stated in the filings. The original answer notes sustained reporting and growing prominence of newer instruments, but does not claim reduced reliance or repayment. (4) Contextually, the answer addresses Tesla’s solar financing strategy and covers the time span, but introduces unsupported conclusions about debt retirement and business prioritization (battery/EV over solar), which are not in the ground truth. Thus, while factually grounded in document references, the interpretation overreaches, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 405,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "From 2022 through 2024 AIG kept the same core oversight framework for loss reserves—internal controls, a formal reserve‑setting process, and periodic reviews by external experts.  The 2023 and 2024 filings added detail on the modeling side, noting that reserve and concentration analyses use both stochastic (probability‑distribution) and deterministic (single‑point) approaches and that a formal model‑risk management and validation framework underpins those calculations.  The integration of external reviews stayed constant in scope and frequency, with the 2024 filing simply reinforcing that the model‑risk framework supports those external assessments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of entities, years, and general practices (e.g., internal controls, external reviews, use of stochastic/deterministic models), and there are no numerical inaccuracies—thus earning a high quantitative accuracy and contextual relevance score. However, it fails to capture the key evolution emphasized in the ground truth: the progressive maturation of AIG's risk management from 2022 to 2024. Specifically, the original answer highlights that in 2023, AIG expanded its toolkit to include sensitivity and scenario analyses, stochastic methods, and experience studies, and in 2024 integrated these into a more holistic ERM system with enhanced reporting, audits, and second-line reviews. The LLM answer incorrectly suggests that the oversight framework remained largely unchanged, stating that external reviews 'stayed constant in scope and frequency,' which contradicts the ground truth's emphasis on growing governance and structured integration. While the LLM mentions a 'formal model-risk management and validation framework,' it does not place this within the broader context of ERM evolution or enhanced committee reporting and internal audits. Thus, the qualitative accuracy is reduced due to incomplete and somewhat static characterization of a dynamic, multi-year progression. The answer is semantically close but misses the core narrative of maturation and integration, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 400,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan allocated roughly **$1.15 billion** to U.S. Treasury and foreign‑government securities in 2022 and 2023, but this fell to **$562 million** in 2024 – a 51 % decline (2023: $1,114 m U.S. Treasuries + $33 m foreign gov’t = $1,147 m; 2024: $508 m U.S. Treasuries + $54 m foreign gov’t = $562 m)【page_86】【page_87】. The sharp reduction reflects a deliberate shift away from government securities toward a broader fixed‑income mix—primarily corporate bonds—consistent with Altria’s liability‑driven investment framework that prioritizes rate‑sensitive debt to hedge pension liabilities and maintain funded status.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that Altria's allocation to U.S. Treasury and foreign government securities was 19% in 2022, 16% in 2023, and 8% in 2024—percentages of total pension assets—not absolute dollar amounts. The LLM incorrectly reports these as dollar values ($1.15 billion in 2022/2023 and $562 million in 2024), which are not supported by the original answer and represent a fundamental misrepresentation of the data. There is no mention in the ground truth of dollar amounts, so this is a critical error. (2) The calculation of a '51% decline' is based on these incorrect dollar figures and is therefore invalid. Additionally, the breakdown of $1,114M + $33M = $1,147M in 2023 and $508M + $54M = $562M in 2024 appears fabricated and is not present in the original answer. These specific numbers and calculations are not corroborated by the ground truth, which only provides percentages. (3) While the LLM correctly infers a strategic shift away from government securities and toward other fixed-income instruments like corporate bonds, this reasoning is applied to incorrect data. The original answer links the trend to a broader reduction in below-investment-grade securities and a decline in expected return on pension assets (from 6.6% to 6.1%), which the LLM omits entirely. Thus, the multi-hop synthesis is partial—correct in direction but incomplete in scope. (4) Despite the quantitative errors, the LLM captures the general trend (declining allocation) and offers a plausible interpretation (shift within fixed income, liability-driven strategy), which maintains some contextual relevance. However, the failure to report percentage allocations and the invention of precise dollar figures result in a low correctness and quantitative accuracy score. The qualitative reasoning is partially sound but lacks key supporting evidence from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 529,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024 (page 186, 2024; page 178, 2023). Long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023, before declining to $44.9 billion in 2024 (page 178, 2023; page 186, 2024). Over the three years the firm shifted away from floating‑rate debt (from $1.7 billion in 2022 to $0 in 2024), expanded fixed unsecured senior debt (peaking at $27.2 billion in 2023) and cut securitized debt obligations (from $16.97 billion in 2022 to $14.26 billion in 2024), reflecting a move toward a more fixed‑rate, lower‑floating‑rate structure and a modest tightening of securitized exposure (page 178, 2023; page 186, 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports short-term borrowings as $883M, $538M, $562M — which are off by nearly an order of magnitude — and long-term debt as $47.8B, $49.3B, $44.9B, which partially aligns but still diverges from the correct totals. These discrepancies suggest confusion between components (e.g., reporting only a subset like floating unsecured debt as 'short-term borrowings') rather than total liabilities. (2) The securitized debt obligations are reported as $16.97B in 2022 by the LLM, but ground truth is $14.994B; while 2024's $14.26B is accurate. Fixed unsecured senior debt is cited as peaking at $27.2B in 2023, whereas ground truth shows $26.930B in 2024 — close but misaligned in timing and value. Interest rates on floating/fixed/securitized debt are entirely omitted in the LLM answer, a major omission given their centrality to the question about interest rate exposure. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate debt and away from floating-rate exposure, noting the drop from $1.7B to $0 in floating unsecured senior debt, which matches the ground truth trend. It also notes reduced securitized debt, consistent with the slight decline by 2024. However, it fails to incorporate interest rate trends (e.g., securitized debt rate rising from 1.51% to 3.48%), which are critical for assessing rate exposure. (4) Despite numerical inaccuracies, the qualitative direction of the narrative — shifting to fixed-rate, reducing floating and securitized debt — aligns with the ground truth. Contextual relevance is high as it addresses all aspects of the question’s intent, but quantitative accuracy is significantly compromised, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 549,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the 5.45% Solar Bonds, Series 2015/C25‑15 as an exhibit (see Exhibits on pages 102, 100 and 97), indicating that the company still relies on this bond series to finance its solar projects. The repeated inclusion of the same bond across three consecutive filings shows that the debt remains outstanding and continues to be a key component of Tesla’s capital structure, underscoring its ongoing role in funding solar initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the 5.45% Solar Bonds, Series 2015/C25-15, and correctly notes their repeated inclusion in Tesla's 2022, 2023, and 2024 10-K filings. The quantitative details—such as the bond series name, interest rate, and the fact that it appears across three consecutive years—are all accurate. The LLM correctly infers that the bond remains outstanding and is a key part of Tesla's capital structure for solar financing, which matches the original answer's conclusion. The only minor shortcoming is that the LLM does not mention the specific document (Thirty-Sixth Supplemental Indenture) or the exact issuance date (April 14, 2015), which are included in the ground truth and add precision to the context of the bond's ongoing legal and financial status. However, this omission does not undermine the core factual accuracy or reasoning. The multi-hop synthesis—linking the bond's repeated disclosure over years to its ongoing strategic role—is sound and logically presented. The answer is semantically equivalent to the original in intent and meaning, with appropriate wording flexibility. All entities (Tesla, bond series, years) are correct, and the reasoning supports the conclusion of continued reliance on this financing instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 368,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s share‑buyback program accelerated from 2022 to 2024, with purchases of Class A treasury stock rising from $8.8 billion in 2022 to $9.1 billion in 2023 and then to $11.0 billion in 2024, while the book value of treasury stock climbed from $51.4 billion to $60.4 billion to $71.4 billion【page_70】. This trend signals a capital‑allocation strategy focused on returning excess cash to shareholders and boosting earnings per share through share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024 and accurately interprets the implication for capital allocation. The book values of treasury stock—$51.4 billion in 2022, $60.4 billion in 2023, and $71.4 billion in 2024—align with the ground truth values of $(51,354) million, $(60,429) million, and $(71,431) million when adjusted for rounding ($51.4B ≈ $51,354M, etc.). However, the LLM incorrectly states that purchases were $8.8B in 2022 and $9.1B in 2023, which are not supported by the ground truth; the original answer reflects cumulative book value, not annual purchase amounts. This is a minor misinterpretation of the metric (annual buybacks vs. cumulative treasury stock balance), but the overall trend and strategic conclusion remain valid. (2) The numbers cited for book value are accurate within acceptable rounding (e.g., $51,354 million = $51.354 billion → reported as $51.4 billion). The annual purchase figures ($8.8B, $9.1B, $11.0B) are not verifiable from the ground truth, which only provides cumulative treasury stock balances, not yearly flows—this introduces a small factual inaccuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the increasing treasury stock balances over time and links them to a capital allocation strategy emphasizing buybacks. It synthesizes the trend and infers the correct strategic intent. (4) Despite the confusion between annual repurchases and cumulative treasury stock value, the core facts—increasing treasury stock and strategic focus on buybacks—are correct. The answer is semantically equivalent in intent and conclusion, warranting a high score. Minor deduction in quantitative accuracy due to unsupported annual purchase figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 490,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions risk factor was worded the same in 2022, 2023 and 2024, each time noting that the segment could be hurt by “reduced investments in process automation, safety monitoring, and plant capacity‑utilization initiatives” (2022 page 32; 2023 page 31; 2024 page 32). The unchanged wording signals that the company viewed these headwinds as persistent, reflecting ongoing macro‑economic pressures—constrained capital budgets, inflation, supply‑chain constraints and a slowdown in industrial demand—that dampened investment in automation and capacity expansion. This continuity indicates a sustained downturn in industrial activity and a cautious outlook for automation and plant utilization over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Honeywell's Safety and Productivity Solutions segment faced persistent risks from reduced investments in process automation and plant capacity utilization from 2022 to 2024, citing consistent risk factor language across all three years. The inclusion of specific page numbers (2022 p.32, 2023 p.31, 2024 p.32) adds verifiable detail and supports the claim of unchanged wording. (2) There are no numerical values requiring calculation, so quantitative accuracy is not compromised—dates and page references are correct. (3) The reasoning is sound: the LLM infers from the unchanged disclosure language that the macroeconomic pressures (e.g., constrained capital budgets, inflation, supply-chain issues, industrial slowdown) were ongoing, which is a valid interpretation supported by the filings. This reflects correct multi-hop synthesis across years. (4) While the original answer emphasizes an evolution toward 'sharper focus on broader macroeconomic volatility' in 2024, including geopolitical and trade policy concerns, the LLM answer does not explicitly mention this escalation. However, it captures the core continuity and implications of sustained industrial weakness. The omission of the slight intensification in tone in 2024 prevents a perfect 10, but the answer remains factually correct, contextually relevant, and semantically equivalent in substance. Minor deduction in qualitative accuracy for not reflecting the deepening concern noted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 431,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 through 2024, Cyramza’s therapeutic portfolio stayed the same—second‑line treatment of advanced gastric cancer or gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, hepatocellular carcinoma, and first‑line treatment of metastatic NSCLC with EGFR mutations (see pages 5–6). The 2023 10‑K’s IP table shows that the U.S. compound patent and biologics data protection expire in 2026, the EU compound patent in 2028, while data protection ends in the EU in 2024 and Japan in 2023, indicating a gradual erosion of exclusivity (page 11). Thus, Cyramza’s lifecycle is moving from a period of robust exclusivity toward an approaching expiration window, with no new indications added by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cyramza maintained the same therapeutic indications from 2022 to 2024, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. The LLM adds specificity by mentioning first-line treatment for metastatic NSCLC with EGFR mutations, which is consistent with the data and adds detail not contradicted by the original answer. (2) Quantitative accuracy is perfect: the IP expiration dates—Japan (2023), EU data protection (2024), U.S. compound patent (2026), and EU compound patent (2028)—are all correctly reported. These match the ground truth exactly, with no calculation or date errors. (3) Multi-hop reasoning is sound: the model synthesizes therapeutic indications and IP timelines across years and geographies, correctly inferring that exclusivity is narrowing despite ongoing therapeutic relevance. (4) The only minor deviation is that the LLM answer includes a slightly more detailed indication (first-line NSCLC with EGFR mutations) not explicitly mentioned in the ground truth, but this does not contradict it and may reflect additional context from the source. The conclusion about lifecycle progression toward reduced exclusivity is logically sound and well-supported. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to the added detail not confirmed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 421,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities fair value grew markedly from 2022 to 2024 – $5 million at December 31 2022, $58 million at December 31 2023 and $69 million at December 31 2024.  The instruments remained Level 3 and were valued by discounted‑cash‑flow models; the only significant unobservable input in the models was the swap‑rate assumption, which widened from a 1‑2 % range (weighted average 2 %) in 2022 to a 3‑5 % range (weighted average 4 %) in 2023 and to a 4 % weighted average in 2024, reflecting higher swap‑rate assumptions in the valuation models.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, not $5 million as stated by the LLM. The 2023 value is correctly reported as $58 million, but the LLM incorrectly states $69 million for 2024, whereas the ground truth confirms it remained at $58 million. These numerical discrepancies directly impact the correctness of the trend analysis. (2) The unobservable inputs are partially accurate: the LLM correctly notes the shift in swap rates from 1–2% (weighted at 2%) in 2022 to 3–5% (weighted at 4%) in 2023 and 2024. However, the ground truth also mentions default rates (53–163%) as a key unobservable input in 2023 and 2024, which the LLM omits, incorrectly stating that swap rates were the 'only significant unobservable input'. This is a material omission affecting the completeness and accuracy of the valuation methodology description. (3) The multi-hop reasoning is structurally sound—the LLM attempts to track changes over time and link valuation methods across years—but fails due to incorrect base numbers and incomplete input factors. It correctly identifies the use of discounted cash flow models and the evolution of swap rate assumptions, showing an understanding of valuation model consistency. (4) The contextual relevance is high, as the response addresses fair value trends and unobservable inputs as asked. However, due to major quantitative errors and incomplete qualitative details, the overall correctness score is reduced to 4. The quantitative accuracy is particularly low (3) due to incorrect dollar amounts for two out of three years. Qualitative accuracy is moderate (5) because while the direction of change and some inputs are correct, key details like default rates and exact values are wrong or missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 513,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "In fiscal 2022, thousands of Qualcomm employees participated in the charitable‑match program, which supported more than 1,500 organizations; by fiscal 2024 the same scale of employee engagement persisted, but the number of organizations benefited had fallen to just over 1,300.  This steady employee participation, coupled with a modest decline in the breadth of supported charities, reflects Qualcomm’s ongoing emphasis on human‑capital initiatives—progress on such programs is explicitly tied to executive bonus modifiers (a 0.9–1.1× multiplier) in both 2022 and 2024, aligning philanthropic engagement with executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that thousands of employees participated in Qualcomm's charitable match program in both 2022 and 2024, with over 1,500 organizations supported in 2022 and just over 1,300 in 2024—this matches the ground truth exactly in substance. The slight decrease in the number of organizations is accurately reflected. (2) All numeric values (thousands of employees, >1,500 in 2022, >1,300 in 2024) are factually correct and consistent with the original answer. The fiscal years are properly referenced, and the executive bonus modifier range (0.9–1.1) is accurately cited. (3) The multi-hop reasoning is sound: the model correctly links employee participation and organizational reach to the broader human capital goals and ties these to executive compensation via the non-financial modifier. It synthesizes information across time (2022 to 2024) and across domains (philanthropy, HR strategy, executive pay). (4) The only minor shortcoming is that the LLM answer omits explicit mention of Qualcomm’s 2025 DEI goals, which are referenced in the original as part of the broader human capital strategy. While the alignment with human capital goals is noted, the forward-looking 2025 context adds depth that is missing. However, this does not undermine the core factual accuracy. Overall, the answer is semantically equivalent, highly accurate, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 391,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "Acrobat has been positioned as the core PDF engine of Adobe Document Cloud, integrated with Adobe Sign, APIs and AI‑driven features such as Liquid Mode and Sensei, and available on web, mobile and desktop (pages 5‑8). The 2023 filing reiterated this role, stressing further improvements to Acrobat web, expanded task‑based actions, and deeper Sign integration, but did not disclose new product enhancements beyond those already described (pages 4‑5). The 2024 filing’s provided pages contain no additional Acrobat enhancements, indicating the positioning remains unchanged (pages 94‑98).",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect and incomplete in key aspects. While it correctly identifies Acrobat as part of Document Cloud and mentions integration with Adobe Sign and AI features, it falsely claims that the 2024 filing 'contains no additional Acrobat enhancements' and that positioning 'remains unchanged'—which directly contradicts the ground truth that 2024 marked a strategic shift with the introduction of the 'Acrobat AI Assistant' as a registered trademark. This is a major omission and misrepresentation of the evolution. The 2023 filing did disclose new AI-driven enhancements and forward-looking statements about innovation, contrary to the LLM's claim that 'no new product enhancements' were disclosed. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations are present, hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the evolution across years, incorrectly asserting stagnation in 2023–2024 when the ground truth shows a clear progression from market leadership (2022) to AI integration (2023) to formal AI productization (2024). The model does not capture the strategic trajectory. (4) Contextual relevance is moderate—it addresses Acrobat’s role and integrations but misses the core theme of AI-driven transformation. The references to 'pages' suggest reliance on document excerpts but misinterpret or omit critical disclosures. The answer lacks the forward-looking and strategic insights emphasized in the original, resulting in a low correctness score despite accurate mention of some features like Liquid Mode and Sensei.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 463,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "From 2022 through 2024 the AbCellera collaboration produced a single year of revenue.  In 2022 the company recognized **$2.02 billion** in net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab) under the AbCellera license, but in 2023 and 2024 there were **no sales** and thus no net product revenue.  Royalty payments to AbCellera were recorded as cost of sales and are described as “mid‑teens to mid‑twenties percent” of worldwide net sales, but the filing does not disclose the dollar amounts of those royalties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: $2.02 billion in net product revenue in 2022, no sales or revenue in 2023 and 2024, and royalty payments in the 'mid-teens to mid-twenties percent' range of worldwide net sales. The statement that there were no royalty payments due in 2023 and 2024 (implied by no sales) is logically sound, even though the LLM notes the exact dollar amounts of royalties are not disclosed—this is consistent with the original answer’s implication. (2) Quantitative accuracy is perfect: the $2.02 billion figure is correctly cited, years are accurate, and the absence of sales in 2023–2024 matches the ground truth. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes that no sales leads to no royalties, and identifies the temporal evolution across three years. The only minor gap is that the original answer explicitly mentions the wind-down reflects 'reduced demand or regulatory changes affecting EUA-based sales,' which adds context the LLM omits—hence a 9 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of revenue and royalty payments over the specified period with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 352,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife has consistently reinsured **59 % of its closed block** through a modified coinsurance agreement in each of the three reporting years: 59 % in 2022 (page 214), 59 % in 2023 (page 227), and 59 % in 2024 (page 204). This unchanged percentage shows that the company deliberately maintains a fixed portion of the closed block under the same modified‑coinsurance arrangement, underscoring a stable, long‑term risk‑transfer strategy that relies on a predictable, deposit‑method reinsurance structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent percentage of MetLife's closed block reinsured through the modified coinsurance agreement across 2022–2024. However, it states 59% for all three years, while the ground truth specifies 59.25% in 2022. This minor discrepancy in precision—rounding 59.25% to 59%—affects quantitative accuracy slightly but does not undermine the overall correctness, especially since the subsequent years (2023 and 2024) are accurately reported as 59%. (2) The numbers are otherwise correct in context, with appropriate years and consistent values. The rounding is a common practice in reporting, but strict factual accuracy requires acknowledging the 59.25% figure for 2022. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers strategic continuity in risk transfer, aligning with the ground truth’s interpretation of long-term stability. The conclusion about a deliberate, stable risk-transfer strategy is logically supported by the consistent percentages. (4) The answer is contextually excellent, addressing both parts of the question—evolution over time and strategic implication—and uses semantically equivalent phrasing (e.g., 'predictable, deposit-method reinsurance structure' aligns with 'strategic continuity in managing closed block liabilities'). Scores reflect high accuracy with a minor deduction in quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 398,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "From 2022 to 2024 Mastercard expanded its real‑time account‑based payment infrastructure from 12 to 13 markets (2022 10‑K p. 11; 2024 10‑K p. 11) while deepening its multi‑layered security model by formalising collaboration with issuers, acquirers, merchants, governments and industry associations to set technical standards and monitor third‑party risks (2022 10‑K p. 12; 2024 10‑K p. 12). This evolution signals a cybersecurity strategy that prioritises ecosystem‑wide resilience, proactive threat monitoring, and continuous expansion of secure real‑time payment channels.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy in the evolution of real-time payment infrastructure. The ground truth states that Mastercard operated in 12 markets in 2022 and expanded to 13 in 2023, with a more general description in 2024 ('several countries globally'). The LLM correctly notes the 12-to-13 market expansion but attributes the 13-market figure to 2024 (via citation to the 2024 10-K), which may misrepresent the timeline—this is a subtle but important misalignment, as the expansion occurred in 2023. (2) Quantitatively, the numbers (12 to 13 markets) are accurate and consistent with the ground truth, and no calculations are incorrect. The citation to the 2022 and 2024 10-Ks supports the data, though the temporal attribution is slightly off. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years and identifies the strategic emphasis on third-party collaboration (with issuers, acquirers, governments, etc.) and real-time infrastructure expansion. It captures the essence of Mastercard’s evolving cybersecurity strategy as ecosystem-wide and proactive. However, it omits the 2024 detail about 'ongoing third-party assessments and resilience programs,' which adds depth to the third-party risk management narrative. (4) The answer is contextually excellent—directly addresses the question’s focus on evolution, third-party collaboration, and real-time infrastructure. The conclusion about a strategy prioritizing ecosystem resilience is semantically equivalent to the ground truth’s 'proactive and adaptive security posture.' The minor omission and slight misplacement of the 13-market milestone prevent a top score, but core facts and reasoning remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 477,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From 2022 to 2024 the fair‑value of equity‑like funds in Lilly’s defined‑benefit pension plans moved from $4,014.1 million in 2022 to $4,093.7 million in 2023 and then to $3,931.5 million in 2024, while the retiree‑health‑plan portion rose from $332.8 million to $335.1 million and then to $346.1 million. The allocation has remained broadly stable, with only modest year‑to‑year swings, indicating that Lilly maintains a consistent, long‑term commitment to illiquid private‑alternative investments as part of its growth‑investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, LLY's allocation to equity-like funds was $2,844.7 million in 2022, increased to $4,014.1 million in 2023, and then to $4,093.7 million in 2024. However, the LLM incorrectly states the 2022 value as $4,014.1 million (which is actually the 2023 figure), reports $4,093.7 million for 2023 (which is the correct 2024 value), and then drops to $3,931.5 million in 2024 — a figure not present in the ground truth. This misalignment completely distorts the trend. (2) The quantitative inaccuracies are severe: the starting point is wrong, the trajectory is misrepresented (LLM suggests a decline in 2024 when the truth shows continued growth), and the final value is fabricated. Even allowing for format variations, the numbers do not match any valid interpretation of the data. (3) The multi-hop reasoning is flawed — the model fails to correctly identify the time-series evolution of the investment allocation, leading to an incorrect conclusion about 'broadly stable' allocation with 'modest swings.' In reality, the ground truth shows a significant increase from ~$2.84B to ~$4.09B over two years, indicating a strategic ramp-up, not stability. The LLM also introduces retiree health plan figures not asked for in the question, which distracts from the core focus. (4) While the general idea of long-term commitment to illiquid assets is contextually relevant, the conclusion is based on incorrect data, undermining qualitative and overall correctness. The contextual relevance is moderate because the answer addresses the right topic and attempts to infer strategy, but the faulty data renders the insight invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 476,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Cascade remained a core brand in the Home Care sub‑category of Procter & Gamble’s Fabric & Home Care segment, with its product categorization (Air Care, Dish Care, P&G Professional, Surface Care) unchanged from 2022 through 2024【page_19】.  The segment’s share of the company’s net sales grew from 35 % in 2022 to 36 % in 2024, indicating a modest rise in Cascade’s relative contribution to overall net sales【page_18】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cascade remained a core brand in the Fabric & Home Care segment with consistent product categorization from 2022 to 2024, and accurately reports the segment's net sales share increasing from 35% in 2022 to 36% in 2024. However, the original answer specifies that the 36% share was already reached in 2023 and maintained in 2024, while the LLM answer implies the increase occurred directly from 2022 to 2024, missing the intermediate year's data point. This is a minor omission in temporal precision. (2) Quantitatively, all percentages (35%, 36%) and years (2022, 2024) are correct, and no calculations are required beyond accurate reporting. The LLM correctly reflects the growth in segment contribution, though it skips the 2023 detail present in the ground truth. (3) The multi-hop reasoning is mostly sound: the model correctly links Cascade’s positioning to the segment’s performance over time and infers stable strategic importance. However, it fails to fully synthesize the year-by-year evolution by omitting the 2023 data point that confirms when the increase occurred. (4) Despite this, the answer remains contextually relevant and conveys the essential trend—stable positioning and slightly increased relative contribution—making it largely accurate with only a minor gap in completeness. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 387,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "In 2022, Lowe’s policy required all wood to come from well‑managed, non‑endangered forests and its Vendor Code of Conduct included enhanced environmental standards (page 10, 2022). In 2023 the wood‑sourcing policy was updated with country‑specific risk levels, stronger monitoring and a new forestry grievance process, tightening supplier sustainability oversight (page 9, 2023). By 2024 Lowe’s expanded monitoring by encouraging suppliers to report emissions to CDP and bolstered its investment strategy with over $300 M in energy‑efficiency and renewable‑energy projects, rooftop solar at 100+ sites, and a $350 M community‑investment commitment (page 10, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Lowe's supplier sustainability and wood sourcing practices across 2022–2024 and correctly identifies key policy updates in each year, such as the 2022 emphasis on well-managed forests and the Vendor Code of Conduct, the 2023 introduction of country-specific risk levels, enhanced monitoring, and a forestry grievance process. However, it introduces significant factual inaccuracies in financial figures. The ground truth states that Lowe's invested over $550 million in environmental facility upgrades in 2022 and committed $50 million via the Gable Grants program in 2023. The LLM incorrectly states that by 2024, Lowe’s made over $300M in energy-efficiency and renewable-energy projects, rooftop solar at 100+ sites, and a $350M community-investment commitment—none of which appear in the original answer and directly contradict the verified data. (2) Quantitative accuracy is low: the $300M and $350M figures are unsupported and replace the actual $550M (2022) and $50M (2023) investments. There is no mention of the $50M Gable Grants program in the LLM answer, and the $550M investment is omitted entirely. (3) The multi-hop reasoning is partially sound—the model correctly traces policy enhancements year-by-year and links them to supplier monitoring and wood sourcing. However, it fails to synthesize the correct investment strategy details across years, inserting fabricated figures instead. (4) Contextual relevance is high as the response stays focused on the question and follows a logical year-by-year structure. Qualitative accuracy is moderate because the policy descriptions are largely accurate, but the incorrect financial data undermines the reliability of the investment strategy component, which is a core part of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 491,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures for 2022‑24 (all on page 30 of each filing) consistently flag competitive‑landscape changes—new entrants and emerging technologies—as threats to market share, pricing, and margins in Safety and Productivity Solutions, Building Technologies, and Industrial Automation.  The language for Safety and Productivity Solutions and Industrial Automation explicitly cites product commoditization each year, while Building Technologies references new entrants and tech but not commoditization.  This unchanged, persistent emphasis signals that market pressures and commoditization risks remain high and are likely intensifying across these core businesses.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in its qualitative analysis, despite correct use of timeframes and entities. (1) It incorrectly states that the risk of product commoditization was cited 'each year' for Safety and Productivity Solutions and Industrial Automation, while the ground truth shows commoditization was first mentioned for Safety and Productivity Solutions in 2022, then for Building Technologies in 2023 (without mention of commoditization), and finally for Industrial Automation in 2024. The LLM falsely attributes explicit commoditization language to all three segments annually. (2) The LLM claims the language is 'unchanged, persistent,' which contradicts the ground truth showing a progressive expansion of the risk across business units over time—indicating evolution, not stasis. This misrepresents the core trend the question asks about. (3) The ground truth emphasizes a 3-year *progression* where risks spread from one division to others, signaling increasing systemic pressure; the LLM instead describes a static, uniformly applied risk, missing the temporal evolution. (4) While the LLM correctly identifies the relevant businesses and years and notes new entrants and technology as factors, it fails to accurately reflect the incremental spread of the risk disclosure across divisions, which is central to the multi-hop reasoning required. (5) The claim about all disclosures being on 'page 30 of each filing' is extraneous and not verifiable from the ground truth, though not directly contradictory. Overall, the answer gets key entities and general themes right but misrepresents the progression and evolution of risk disclosures, leading to an incorrect conclusion about the nature of market pressures over time. Quantitative elements (years, business units) are accurate, hence a high quantitative score, but qualitative reasoning is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 508,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K (page 8) described a nascent digital‑cockpit focus, with automotive revenue at $1.5 billion—just 4 % of its QCT segment. By 2024, that figure had nearly doubled to $2.9 billion (8.8 % of QCT revenue) and the company recognized $558 million of previously satisfied performance obligations, indicating earlier delivery of digital‑cockpit and ADAS/AD components (2024 10‑K, page 83). Segment reporting shows the QCT automotive sub‑segment’s earnings rebounding to $9.5 billion in 2024 from $7.9 billion in 2023, underscoring Qualcomm’s strategic pivot toward high‑performance, low‑power computing for connected vehicles (2023 10‑K, page 73).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Qualcomm evolved from discussing digital cockpit market potential in 2022, to recognizing digital cockpit products in revenue streams in 2023, and integrating them into structured segment reporting by 2024. However, the LLM answer fabricates specific financial figures not present in the ground truth: it claims automotive revenue was $1.5B in 2022 and $2.9B in 2024, with digital cockpit specifically tied to $558M of satisfied performance obligations in 2024. These numbers are not in the original answer and cannot be verified from the provided truth. Additionally, the claim about QCT automotive sub-segment earnings rebounding to $9.5B in 2024 from $7.9B in 2023 is entirely absent from the ground truth. (2) Quantitative accuracy is low because the LLM introduces precise numbers (e.g., $1.5B, $2.9B, $558M, $9.5B) that are not supported by the original answer. There is no mention of performance obligations or segment earnings in the ground truth. The percentages (4%, 8.8%) are also invented. (3) The multi-hop reasoning is partially sound in that the LLM attempts to trace Qualcomm's strategic evolution using financial disclosures across years, but it fails to accurately reflect the actual progression described in the ground truth—shifting from vision to monetization to integration—instead substituting this with unsupported revenue growth claims. (4) Contextual relevance is moderate because the answer addresses Qualcomm’s strategic positioning in the digital cockpit market across 2022–2024 and references segment reporting and revenue recognition, which are relevant themes. However, due to the invented data and lack of alignment with the actual disclosures in the ground truth, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 507,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "By 2024, Frame.io had broadened its media support to still images, design files, PDFs and video, added camera‑to‑cloud uploads, and expanded cross‑product integration from Premiere Pro and After Effects to also include Photoshop, Lightroom and Workfront, while becoming available in Adobe G enStudio for enterprise‑scale production [page_12]. These enhancements reflect a clear evolution from the 2022 offering, which was limited to video, still images, design files and PDFs and integrated only with Premiere Pro and After Effects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Frame.io's integration with Premiere Pro and After Effects by 2023, expansion to Photoshop, Lightroom, and Workfront by 2024, inclusion in Adobe GenStudio, and support for video, still images, design files, and PDFs. The mention of 'camera-to-cloud uploads' is a minor addition not explicitly in the ground truth but plausible as part of cloud-native expansion and does not contradict. (2) Quantitative accuracy is perfect—no numerical errors; years (2022, 2023, 2024) are correctly used and reflect the evolution timeline. (3) Multi-hop reasoning is sound: the model correctly synthesizes the progression across years and products, showing integration depth over time. (4) The only minor shortcoming is that the original answer highlights new use cases beyond post-production (casting, location scouting, marketing), which the LLM omits. This contextual expansion is important for 'functional evolution' but not entirely absent from the LLM’s mention of 'enterprise-scale production'. Thus, the answer is slightly less complete but still semantically aligned. Wording differences are acceptable, and core information is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 345,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022‑2024, Mastercard’s Class A common stock retained the same voting structure—one vote per share (see Note 16, page 98)—with no change in voting rights.  The declared dividend per share, however, rose each year: $2.04 in 2022 (page 97), $2.37 in 2023 (page 99), and $2.74 in 2024 (page 98).  This steady voting right combined with a progressively higher dividend payout indicates a stable, shareholder‑friendly governance framework over the three‑year span.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors despite addressing the question's structure. (1) The original answer (ground truth) states that there were no changes to dividend rights or voting rights for MA's A Class shares from 2022 to 2024—specifically, both 'One vote per share' and 'Dividend rights' remained unchanged. The LLM incorrectly interprets increasing dividend payouts as changes in 'dividend rights', which are legal entitlements, not payment amounts. Dividend rights refer to the class's eligibility to receive dividends, not the amount paid. (2) The LLM introduces specific dividend per share figures ($2.04, $2.37, $2.74) that are not part of the ground truth and were not mentioned in the original answer, making them factually unsupported in this context. These numbers may reflect actual payouts, but the question is about the evolution of rights, not payment amounts. (3) The multi-hop reasoning is flawed: the model conflates dividend payments with dividend rights, leading to an incorrect conclusion about governance stability based on payout increases, whereas the ground truth emphasizes structural stability due to no changes in rights. (4) While the voting rights description ('one vote per share') is consistent and correctly reported, the erroneous interpretation of dividend rights undermines the core factual accuracy. The answer is contextually relevant and well-structured but fundamentally incorrect on key facts, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 408,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment was repeatedly flagged as vulnerable to “fluctuations in retail markets,” which can lower demand for safety products and squeeze margins (2022‑23 risk factors, page 30; 2024 risk factors, page 32).  In 2023 the segment’s net sales and profit fell versus 2022, and the 2024 results still show the segment under pressure, underscoring its ongoing sensitivity to consumer‑demand volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in completeness and precision regarding segment name changes and specific risk mechanisms. (1) Correct elements: The LLM correctly identifies that Honeywell's Safety and Productivity Solutions segment was exposed to retail market fluctuations in 2022–2024, that this affects demand for safety products and margins, and that the risk persists into 2024 under the restructured Industrial Automation segment. It appropriately cites risk factor pages (30 in 2022–23, 32 in 2024), which supports its claims. (2) Quantitative accuracy: No explicit numerical data (e.g., sales figures) are misstated—the mention of declining net sales and profit in 2023 vs. 2022 is consistent with filings and does not contradict the ground truth. However, the original answer does not include specific financials, so the LLM’s general statement about performance decline is acceptable and likely accurate. (3) Multi-hop reasoning: The LLM synthesizes across years and recognizes the continuity of risk despite segment renaming (Safety and Productivity Solutions → Industrial Automation), which reflects sound reasoning. However, it does not explicitly clarify the rebranding in 2024 as clearly as the ground truth, potentially obscuring the structural change. (4) Semantic equivalence: The core message—that the segment remains vulnerable to consumer demand volatility over time—is preserved. Missing minor details include the mention of commoditization risk in 2023 and the impact on investments in process automation and safety monitoring in 2022. These omissions reduce completeness slightly but do not invalidate the overall correctness. Contextual relevance is strong as all content directly addresses the question’s focus on exposure and vulnerability over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 497,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Olumiant collaboration kept a tiered double‑digit royalty (capped at 20 %) for inflammatory/autoimmune sales and an additional low‑teens royalty on COVID‑19 sales above a threshold that was added in the 2020 amendment and has remained unchanged (see page 72, 2023‑24).  Milestone obligations were material in 2020 ($210 M) and 2021 ($260 M) but have not been material since 2022, indicating a reduction in milestone payments (page 72, 2023).  Net product revenue rose from $830.5 M in 2022 to $957.4 M in 2024, reflecting expanded sales—including the COVID‑19 indication (page 73, 2023‑24).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core royalty structure correctly—tiered double-digit royalties up to 20% for inflammatory/autoimmune indications and an additional low-teens royalty on COVID-19 sales above a threshold, consistent from 2022 to 2024. However, it omits the specific $100 million regulatory and $100 million sales-based milestone caps mentioned in the ground truth for 2022, which are key financial obligations. Instead, it references past milestone payments in 2020 ($210M) and 2021 ($260M), which are not part of the 2022–2024 evolution asked in the question. These figures, while possibly accurate, shift focus away from the requested timeframe and do not confirm whether any milestones were actually paid in 2022 or beyond. (2) The net product revenue numbers ($830.5M in 2022, $957.4M in 2024) are precise and support the claim of sales growth, including from the COVID-19 indication. However, the ground truth does not mention these revenue figures, so their relevance depends on external data; more critically, the LLM fails to mention the 2023 accounting change—capitalizing milestone payments as intangible assets and amortizing them into cost of sales—which is a key evolution in financial obligations. This is a significant omission in both quantitative and qualitative terms. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that milestone payments were no longer material after 2022, aligning with the ground truth’s implication that the model shifted to royalty-based payments. It also correctly notes the stability of the royalty structure. However, it does not synthesize the accounting treatment change in 2023, which requires connecting financial reporting practices to the collaboration terms—a critical multi-hop element in the original answer. (4) The contextual relevance is high, as the response addresses royalty rates, new indications (COVID-19), and milestone trends. The qualitative reasoning is logical and well-structured, but the absence of the 2023 accounting evolution and the misplacement of milestone focus into 2020–2021 reduce factual completeness. Quantitative accuracy is moderate: while cited numbers are precise, they include extraneous data and omit key figures from the ground truth, particularly the $100M/$100M milestone framework and the 2023 accounting shift. Overall, the answer is directionally correct but lacks full fidelity to the ground truth’s financial and temporal scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 657,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "Procter & Gamble re‑structured its Baby, Feminine & Family Care segment between 2022 and 2024, dropping the baby‑care sub‑category and the Pampers/Luvs brands so that only feminine‑care and family‑care products remained【page_19】.  The 2023–24 tables list Always, Always Discreet, Tampax Bounty, Charmin and Puffs as the segment’s major brands, whereas 2022 included Luvs and Pampers【page_18】.  This shift positioned Always as the flagship brand in the remaining feminine‑care sub‑category, where it holds over 20 % global market share and competes with Tampax for the top 25 % share, thereby increasing its prominence relative to other segment brands【page_18】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims that Procter & Gamble dropped the baby-care sub-category and removed Pampers/Luvs from the Baby, Feminine & Family Care segment by 2023–2024, which contradicts the ground truth: the original answer makes no mention of such a structural change, and in fact, the segment name remains consistent, implying continuity. The removal of Pampers/Luvs is not supported by the ground truth. (2) The claim that Always became the 'flagship brand' with over 20% global market share and that it competes with Tampax for the top 25% share is entirely absent from the original answer and introduces unverified quantitative claims—there are no market share figures in the ground truth. This results in a major failure in quantitative accuracy. (3) While the LLM correctly identifies Always, Always Discreet, Tampax, Bounty, Charmin, and Puffs as major brands in the segment in 2023–2024, it misattributes their significance to a reorganization that isn't documented in the ground truth. (4) The ground truth focuses on a refinement in product categorization—from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023 and 2024—and highlights Always’s increasing association with menstrual care. This nuanced evolution in positioning is missed by the LLM, which instead fabricates a broader segment restructuring. (5) Despite these issues, the LLM does capture the continued prominence of Always within the segment and correctly notes the consistent presence of Always, Always Discreet, and Tampax, showing partial qualitative understanding. The contextual relevance is moderate because it addresses brand prominence and categorization trends, albeit with incorrect reasoning. Overall, the answer is partially correct in brand listing but fundamentally flawed in structure, reasoning, and invented metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 529,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN’s 2023 target allocation (from the 2022 filing) was 100 % debt for U.S. plans and, for non‑U.S. plans, 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other. In the 2023 filing (August 31 2023) the 2024 target shifted to 94 % debt for U.S. plans and, for non‑U.S. plans, 23 % equity, 42 % debt, 6 % cash, 21 % insurance and 9 % other. The 2025 target (shown in both 2023 and 2024 filings) returned U.S. plans to 100 % debt and, for non‑U.S. plans, increased equity to 28 %, lowered debt to 36 %, raised cash to 7 %, kept insurance at 21 % and reduced other to 8 %. This progression shows ACN keeping a debt‑heavy, duration‑matching core for U.S. plans while gradually tilting non‑U.S. plans toward higher equity and insurance exposure to boost risk‑adjusted returns while still maintaining a conservative, duration‑aligned asset mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative breakdown of asset allocations. The ground truth does not provide specific percentage allocations by asset class or by U.S./non-U.S. plans for any fiscal year. Instead, it describes a high-level, consistent strategy focused on duration matching and diversification without citing exact figures like '100% debt' or '27% equity'. These precise numbers appear to be fabricated or hallucinated, as no such granular data exists in the original answer. (2) There are no verifiable calculations in the original answer to assess, but the LLM invents a detailed progression of percentages across years and geographies that are not supported by the ground truth. For example, stating that U.S. plans went from 100% debt in 2023 to 94% in 2024 and back to 100% in 2025 is not corroborated and contradicts the original answer’s emphasis on strategic continuity and broad framework stability. (3) The multi-hop reasoning is flawed because the LLM assumes a level of detail not present in the source material. While it correctly identifies the three-year progression and filings from 2022, 2023, and 2024, it misrepresents the content of those filings. The original answer emphasizes consistency and high-level strategy, whereas the LLM infers tactical shifts and specific reallocations that aren’t stated. (4) Despite the factual errors, the LLM captures some contextual elements—such as the focus on duration matching, conservative posture, and balancing risk-adjusted returns—which aligns with the general theme of the original answer. However, the hallucinated specifics severely undermine correctness. The contextual relevance is moderate because the structure and intent of the response match the question, but the substance is largely incorrect. Thus, the correctness score is low due to major quantitative inaccuracies, even though the qualitative direction is partially aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 530,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "In 2022 Lowe’s held $2.56 billion of forward interest‑rate swaps as cash‑flow hedges (page_46).  By 2023 that exposure fell to $251 million, still measured at fair value (Level 2) and treated as a cash‑flow hedge (page_54, page_46).  In 2024 the company had no forward swaps, instead using fixed‑to‑floating swaps as fair‑value hedges on existing debt (page_54, page_46).  This evolution shows a shift from hedging forecasted debt issuances with forward swaps to hedging current debt with fair‑value swaps, reflecting a change in its interest‑rate risk management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 forward interest rate swap value. The original answer (ground truth) states that no current fair value was listed for 2022, with disclosures only referencing past impacts of swaps on earnings and OCI. However, the LLM claims Lowe's held $2.56 billion in forward swaps in 2022, which is not supported by the ground truth and contradicts it directly. This number appears to be fabricated or misattributed. The 2023 value of $251 million is correct and matches the ground truth, as is the classification as Level 2 and placement in 'Other current assets' (though the LLM omits the asset classification). The 2024 statement that Lowe's held no forward swaps and instead used fixed-to-floating swaps as fair value hedges is accurate and aligns with the ground truth. (2) Quantitative accuracy is severely compromised due to the incorrect $2.56 billion figure for 2022. There is no indication in the ground truth that such a value existed, so this is a major error. The drop from $2.56B to $251M is therefore misleading and based on false premises. The 2023 and 2024 numbers are correct. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift from cash flow hedges (forecasted debt) to fair value hedges (existing debt), which is consistent with the ground truth. However, the reasoning is built on an incorrect quantitative foundation for 2022, undermining confidence in the synthesis. The use of document page references (e.g., page_46) suggests source grounding but does not validate the accuracy. (4) Contextual relevance is high—the answer addresses both parts of the question: the evolution of exposure and the implications for risk management strategy. The qualitative interpretation of the strategic shift is accurate and insightful. However, the major quantitative inaccuracy in the 2022 exposure severely limits overall correctness. Thus, while the direction of the narrative is correct, the factual basis for the initial state is wrong, leading to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 559,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s debt schedule shows a $606 million principal balance for the 5.000% notes due April 2030 in FY2023 and FY2024 (page 81 of each filing), and the same balance was reported in FY2022. The unchanged exposure indicates a disciplined debt‑management approach that prioritizes maintaining a stable maturity profile and interest‑rate exposure rather than expanding or reducing that particular instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the principal balance was unchanged at $606 million in FY2022, FY2023, and FY2024. The ground truth shows that AVGO's exposure was $1,086 million in 2022 and decreased to $606 million in both 2023 and 2024. This error fundamentally misrepresents the trend. (2) Quantitative accuracy is severely compromised: the $1,086 million figure for 2022 is entirely omitted and replaced with an incorrect claim of $606 million, which distorts the progression. No calculation is needed here, but the comparison across years is wrong. (3) The multi-hop reasoning fails because the model does not recognize the decrease from 2022 to 2023, leading to an incorrect conclusion about a 'stable' maturity profile rather than an active reduction strategy. The synthesis across fiscal years is flawed. (4) While the answer addresses debt management strategy and refers to the correct instrument (5.000% notes due April 2030), the incorrect data leads to an invalid interpretation. Contextual relevance is moderate because it discusses the right topic and cites plausible document locations, but factual inaccuracies undermine the response. The conclusion about 'disciplined' strategy is speculative and contradicted by the actual repayment pattern shown in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 369,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS disclosed the 7.620% debentures in 2022 (page 120) with an explicit interest‑rate history—8.375% until April 1 2020, then 7.620% thereafter—and detailed redemption terms. In the 2023 (page 105) and 2024 (page 108) filings the interest rate is omitted, but the notes continue to describe the same redemption structure—redeemable at any time at the greater of par plus accrued interest or the present value of remaining payments discounted at a treasury yield plus 5 bps—and the maturity remains April 1 2030. Thus, the evolution is a simplification of the interest‑rate disclosure while keeping the redemption and maturity terms unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative details are correct: the interest rate change from 8.375% to 7.620% in April 2020, the maturity date of April 1, 2030, and the redemption terms (callable at any time, redemption price based on either par plus accrued interest or present value discounted at treasury yield plus 5 bps) are all factually correct. The principal amount ($276 million) is missing in the LLM answer, which is a minor omission but does not affect core accuracy. (2) The evolution in disclosure—more detailed interest rate history in 2022 and simplified reporting in 2023 and 2024—is correctly identified. The LLM accurately notes that the interest rate is omitted in later filings, which reflects a simplification in disclosure, consistent with the ground truth's observation of increasing clarity and emphasis on other terms. (3) The multi-hop reasoning across 2022–2024 filings is sound: the model correctly synthesizes changes (or lack thereof) in disclosure practices over time and correctly attributes consistent redemption and maturity terms. (4) The answer is semantically equivalent to the original in substance, though it does not explicitly mention the 2024 emphasis on semi-annual payments or the absence of sinking fund requirements—minor contextual details that slightly reduce completeness. However, these omissions do not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 424,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen’s 2022 10‑K described Olpasiran as a phase‑2 siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease. The 2023 filing kept the program in phase 2 with the same cardiovascular focus, and the 2024 filing announced that the program had advanced to a phase‑3 trial for ASCVD, underscoring a strategic push for a first‑in‑class Lp(a)‑lowering therapy. Composition‑of‑matter patents for Olpasiran in the U.S. and Europe are projected to expire in 2036, giving the company a multi‑year exclusivity window.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as a phase-2 siRNA targeting lipoprotein(a) for atherosclerotic cardiovascular disease (ASCVD) in 2022 and 2023, and accurately reports the U.S. and European composition-of-matter patents expiring in 2036. However, it incorrectly states that in 2024, Olpasiran advanced to phase-3 trials for ASCVD. The ground truth indicates that in 2024, the therapeutic indication was broadened to 'cardiovascular disease'—not a phase advancement. This is a significant factual error affecting the clinical phase progression narrative. (2) Quantitatively, the patent expiration year (2036) is correct, and no other numbers (e.g., financials) are present. The phase numbers (phase 2, phase 3) are misapplied in 2024, but the phase 2 status in 2022–2023 aligns with the original answer. (3) The multi-hop reasoning is partially sound—Amgen’s strategic progression across years is addressed, and IP protection is correctly synthesized. However, the clinical development timeline is misrepresented: the original answer shows consistent phase 2 status with a broadening of indication, while the LLM incorrectly infers phase 3 advancement, likely due to overinterpretation of strategic intent. (4) The contextual relevance is high—Amgen, Olpasiran, therapeutic focus, clinical phase, and IP are all addressed. But due to the incorrect phase progression claim, which is central to the question, the correctness and qualitative accuracy scores are reduced. The answer conveys some but not all correct developments, particularly failing on the 2024 clinical phase detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 441,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Tampax has remained a major brand in P&G’s Baby, Feminine & Family Care segment throughout the period, appearing in the “major brands” list in 2022, 2023, and 2024 (PG_10k_2022, p. 19; PG_10k_2023, p. 19; PG_10k_2024, p. 19).  The segment’s sub‑category description, however, shifted from “Feminine Care (Adult Incontinence, Feminine Care)” in 2022 to “Feminine Care (Adult Incontinence, Menstrual Care)” by 2024, reflecting a clearer focus on menstrual products (PG_10k_2024, p. 19).  Despite this re‑categorization, Tampax’s prominence as a key brand in the segment remained unchanged across all three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies Tampax's consistent prominence as a major brand in P&G’s Baby, Feminine & Family Care segment across 2022–2024, citing the correct pages from each 10-K filing. The evolution in sub-category labeling—from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' by 2024—is accurately reported, reflecting the shift in terminology emphasizing menstrual care. The LLM correctly notes that despite the re-categorization, Tampax remained a highlighted brand throughout, which matches the ground truth’s conclusion of consistent strategic emphasis. The only minor omission is that the 2024 segment name reverted to 'Baby, Feminine & Family Care'—a detail implied but not explicitly stated in the LLM response. However, this does not detract significantly from the overall accuracy. All entities (Tampax, P&G, segment names), years (2022–2024), and contextual changes are correctly identified and synthesized across filings. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly traces multi-hop evolution across three years of reclassification. The answer is semantically equivalent to the original, with clear, concise, and relevant information directly addressing the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 381,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 2022 10‑K (page 101) notes that “when we acquire non‑agency RMBS and CMBS that have not been previously evaluated by the NAIC, an internally developed designation is used until a NAIC designation becomes available.” By 2023 and 2024, the tables for those years (pages 95 and 86) show all RMBS and CMBS amounts assigned to NAIC designations—no internal designations appear—indicating that NAIC coverage of non‑agency RMBS/CMBS had expanded to cover the entire portfolio. This multi‑year trend shows that the NAIC’s availability of designations increased, and MetLife’s acquisition strategy has shifted toward securities that already carry NAIC designations, thereby reducing its reliance on internally developed ratings.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims and reasoning, despite referencing correct document locations. (1) The key error is the assertion that by 2023 and 2024, all RMBS and CMBS were assigned NAIC designations and no internal designations appeared—this directly contradicts the ground truth, which states that MetLife consistently used internally developed designations from 2022 to 2024. The persistence of internal designations indicates ongoing acquisition of securities without immediate NAIC evaluations. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable, but the LLM misrepresents the presence/absence of internal designations as a qualitative fact, treating it as a measurable condition (e.g., 'no internal designations appear') that is unsupported. (3) The multi-hop reasoning fails: instead of synthesizing the continuity of internal designation use as evidence of strategy and NAIC lag, the LLM incorrectly infers a shift in strategy and improved NAIC coverage. This misreads or misrepresents the data from the cited pages. (4) Contextual relevance is moderate because the answer addresses the right topic (NAIC vs internal designations) and cites correct document sections, but draws the opposite conclusion of the ground truth. The LLM likely misinterpreted the presentation format in later years’ filings (e.g., consolidated tables) as indicating full NAIC coverage, when in reality the internal designation policy remained active. Thus, the answer is factually inverted and reflects a significant misunderstanding of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 454,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "Accenture repurchased 9.6 million shares ($3.15 million) under its open‑market program in fiscal 2022, with an available authorization of $3.129 million that was increased to $6.129 million after a $3 million add‑on. In fiscal 2023 the company bought roughly 2.0 million shares ($605 million) under the same program and raised its available authorization to $6.694 million with a $4 million add‑on. By fiscal 2024 the open‑market purchases remained around 2.0 million shares ($605 million) and the authorization stayed at $6.694 million. The steady rise in authorized capacity and consistent, dollar‑heavy repurchases signal a deliberate, expanding commitment to returning capital to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that Accenture repurchased 9.6 million shares for $3.15 million in fiscal 2022 — this is off by orders of magnitude (correct: $3.13 billion available authorization, not $3.129 million). The LLM also claims a $3 million add-on in 2022, but the ground truth does not mention this; instead, the $4 billion increase occurred in September 2024. In fiscal 2023, the LLM says 2 million shares were bought for $605 million — while the dollar amount matches a transaction in fiscal 2024 (Q4), not 2023, and no such repurchase is reported for 2023 in the ground truth. The LLM incorrectly states that repurchases occurred in both 2023 and 2024 at $605 million, but the ground truth only confirms the $605 million purchase in Q4 of fiscal 2024. The available authorizations are also wrong: LLM reports $6.694 billion after a $4 million add-on, confusing millions with billions. The correct sequence is: $3.13B (2022), then increase to $6.69B after $4B add-on in September 2024, not prior. (2) Calculation and number verification: $3.15 million vs $3.13 billion is a 1,000x error. $4 million add-on vs $4 billion is similarly catastrophic. The $605 million repurchase is correctly stated in amount but misattributed to 2023 and 2024 as recurring, when it only occurred once in Q4 2024. (3) Multi-hop reasoning: The LLM attempts to show a trend in repurchases and authorizations, but due to incorrect data, the synthesis is flawed. It fabricates repurchase volumes and misplaces events across years. The conclusion about increasing capital return is directionally correct but based on false premises. (4) Correctness score is low due to severe quantitative inaccuracies. Qualitative accuracy is slightly higher because the general idea of increasing authorization and repurchases aligns with the trend, but reasoning is undermined by false data. Contextual relevance is acceptable as the answer addresses the right program and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 546,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom continued to list **industrial fiber optics** as a key product offering under its “Industrial” end‑market segment in each of the 2022, 2023 and 2024 10‑Ks (see the product‑portfolio tables on page 5 of each filing).  The same fiber‑optic component line is also described in the “Fiber Optic Components” section of the “Physical Layer Devices” narrative (page 6 of each filing).  This unchanged positioning signals a sustained strategic emphasis on industrial connectivity—particularly for factory automation, renewable‑energy, and automotive electronics—while keeping fiber optics central to its industrial portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in Broadcom's product positioning across the three years, which is central to the question. (1) It correctly identifies that industrial fiber optics remained a listed product in the Industrial segment in all three years (2022–2024) and references consistent documentation in the 10-Ks (pages 5 and 6), which aligns with the ground truth. There are no numeric inaccuracies—dates and years are correct, and no incorrect financial figures are presented, hence quantitative accuracy is high. (2) However, the LLM fails to capture the qualitative evolution described in the ground truth: in 2022, the product was part of a broader, less-structured portfolio; in 2023, it was formally categorized in a structured table; and in 2024, it was explicitly linked to specific applications (factory automation, renewable energy, automotive electronics) and listed alongside more advanced components like Ethernet PHYs and camera microcontrollers. The LLM incorrectly characterizes the positioning as 'unchanged,' which contradicts the ground truth showing increasing specificity and strategic alignment over time. (3) This reflects a failure in multi-hop reasoning: the model did not synthesize subtle but important shifts in categorization and application focus across filings. Instead, it defaulted to surface-level consistency (same product listed) without recognizing the maturation in product strategy. (4) While contextually relevant and factually sound on surface details, the answer lacks depth in capturing strategic evolution, warranting a moderate correctness score. The conclusion about 'sustained strategic emphasis' is plausible but oversimplifies a more nuanced trajectory of increasing application focus and portfolio refinement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 488,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "In 2022 and 2023, UPS SurePost was a residential ground service for non‑urgent, lightweight shipments that used UPS’s ground network and relied on the U.S. Postal Service for final delivery (UPS_10k_2022, page 6; UPS_10k_2023, page 6).  In 2024 the model remained the same, but UPS announced a strategic shift to insource the service beginning January 1 2025, thereby reducing its reliance on USPS and gaining greater control over the final leg of delivery (UPS_10k_2024, page 6).  This change reflects UPS’s broader effort to tighten control over its residential delivery network.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost served as a residential ground service for non-urgent, lightweight shipments in 2022–2024; final delivery relied on USPS through 2024; and UPS announced a strategic shift to insource final delivery starting January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors exist. Format variations (e.g., 'January 1 2025' vs 'January 1, 2025') are minor and do not affect meaning. (3) Multi-hop reasoning is sound—information is correctly synthesized across UPS’s 2022, 2023, and 2024 10-K filings, showing continuity from 2022–2023 and the announced change in 2024. (4) Entity accuracy is strong: 'UPS SurePost', 'U.S. Postal Service', and correct years (2022–2024) are properly identified. The answer fully addresses the question’s focus on role, delivery model evolution, reliance on USPS, and strategic changes. Wording differs slightly but conveys the same meaning, including the intent to reduce reliance on USPS and enhance control over service quality. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 335,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 pipeline grew from 13 programs in 2022 (as of Feb 8, 2022) to 18 in 2023 (as of Jan 31, 2023) and to 24 in 2024 (as of Jan 31, 2024)【2022 page 26】【2023 page 26】【2024 page 26】. In 2024 the company added five programs via acquisition from Horizon, launched three new Phase 3 studies, secured an FDA approval and concluded one program, while in 2023 it had three FDA approvals and one Japan approval【2024 page 26】. This steady rise—combining organic growth with strategic acquisitions—underscores Amgen’s deliberate expansion of its R&D pipeline, diversification of therapeutic areas, and acceleration of development timelines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of Phase 3 programs for each year: 13 as of Feb 8, 2022, 18 as of Jan 31, 2023, and 24 as of Jan 31, 2024, matching the ground truth exactly. It also correctly notes the addition of five programs via the Horizon Therapeutics acquisition. The mention of three new Phase 3 studies, one FDA approval, and conclusion of one program in 2024 aligns with the progression logic. However, the ground truth specifies that by February 4, 2025 (reported in the 2024 filing), the count reached 25 programs, which the LLM omits. This is a minor omission in timeline completeness but does not invalidate the core quantitative trend. (2) All numbers, dates, and calculations are accurate. The progression from 13 → 18 → 24 is correctly stated, and the attribution of five programs to Horizon is factually sound. (3) The multi-hop reasoning is strong: the LLM synthesizes data across three annual reports (2022–2024), correctly identifies internal and external growth drivers, and infers strategic intent. It links acquisitions to pipeline expansion and recognizes the combination of organic and inorganic growth. The only gap is not explicitly projecting the 25-program milestone mentioned in the 2024 filing, which slightly weakens completeness. (4) The answer is contextually fully relevant, addressing both the quantitative evolution and strategic implications of Amgen’s R&D expansion. The conclusion about diversification and accelerated development timelines is semantically equivalent to the ground truth’s interpretation. The omission of the 25-program update prevents a perfect 10, but all other aspects are factually and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 461,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture raised the authorized share pool for the Amended 2010 SIP from 127 million shares in 2022 (page 91) to 141 million shares in 2024 (page 98), with no change reported in 2023. This expansion signals a strategic focus on equity‑based rewards to attract, retain and incentivize employees, aligning their interests with shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key numbers: 127 million shares in 2022 and 141 million in 2024, matching the ground truth. It accurately notes no change was reported in 2023, which aligns with the ground truth stating the number increased by 2023 and remained at 141 million into 2024. While the ground truth explicitly states the increase occurred by 2023, the LLM's phrasing 'to 141 million in 2024' is slightly less precise but not factually incorrect, as the amount did apply in 2024. 2) Quantitatively, all figures are accurate: 127,000,000 and 141,000,000 are correctly reported as 127 million and 141 million. No calculations are required beyond recognition of the increase, which is correctly implied. 3) The reasoning is sound: the increase in authorized shares is correctly interpreted as a strategic move to enhance equity-based compensation for talent retention and alignment with shareholders, which matches the ground truth's interpretation. The multi-hop synthesis across fiscal years is accurate. 4) The answer is contextually relevant, addressing both the numerical evolution and the strategic implication. The only minor shortcoming is the lack of explicit confirmation that the increase occurred by 2023 (not just by 2024), but since the 2023 data point is correctly noted as unchanged from 2024, this does not constitute a factual error. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 396,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks projected green‑coffee supply coverage through fiscal 2023 in its 2022 10‑K, extended that coverage to fiscal 2025 in its 2023 10‑K, and maintained coverage through fiscal 2025 in its 2024 10‑K (SBUX_10k_2022 page_12; SBUX_10k_2023 page_12; SBUX_10k_2024 page_12). This shift from a one‑year to a two‑year coverage horizon reflects a proactive inventory and hedging strategy aimed at securing a longer‑term supply and reducing exposure to price volatility and supply disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Starbucks' green coffee supply coverage: from coverage through fiscal 2023 in the 2022 10-K, extended to fiscal 2025 in the 2023 10-K, and maintained through fiscal 2025 in the 2024 10-K. This matches the ground truth exactly in terms of timeline and projection changes. (2) All dates and fiscal years are accurate, and no numerical calculations are required beyond correct interpretation of time spans. The shift from one-year to two-year coverage horizon is correctly characterized. (3) The multi-hop reasoning across three fiscal years’ filings is sound and properly synthesized. The conclusion about a proactive inventory and hedging strategy aligns with the ground truth’s emphasis on long-term supply assurance and risk reduction. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'purchase commitments' as a mechanism, focusing instead on 'hedging'—which is part of the strategy but slightly narrower than the original answer’s broader reference to commitments and hedging. However, this does not materially distort the meaning. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for partial omission of strategic mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 374,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 through 2024 UPS made no substantive changes to the UPS/IBT Full‑Time Employee Pension Plan except for the 2023 Teamsters master agreement, which added wage and benefit‑rate increases that were reflected in year‑end measurements【page 82】. No remeasurement events were reported for the plan in 2023 or 2024, but the discount rate for U.S. pension benefits fell from 5.79 % in 2023 to 5.42 % in 2024 and the expected return on plan assets rose from 7.07 % to 7.17 %, thereby increasing the projected benefit obligation【page 84】【page 88】. The plan continues to be governed by collective‑bargaining agreements, with no further amendments or remeasurements disclosed during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses a critical fact from the ground truth: in 2022, the UPS/IBT Full-Time Employee Pension Plan was remeasured due to the American Rescue Plan Act, resulting in a $3.3 billion pre-tax gain. This remeasurement is a central element of the financial and strategic evolution and is entirely omitted in the LLM answer, which incorrectly states 'No remeasurement events were reported for the plan in 2023 or 2024' without acknowledging the 2022 event. This is a major factual omission that undermines the correctness of the response. (2) Quantitatively, the LLM correctly reports the discount rate (5.79% in 2023 to 5.42% in 2024) and expected return on assets (7.07% to 7.17%) changes, which are consistent with typical pension disclosures and support the increase in projected benefit obligation. However, it fails to include the $3.3 billion/$2.5 billion gain figures from 2022, which are key quantitative facts. (3) In terms of reasoning, the LLM correctly identifies the 2023 Teamsters agreement impact on wage and benefit rates and their reflection in year-end measurements, showing understanding of collective bargaining impacts. However, it fails to connect the 2022 regulatory change (American Rescue Plan Act) to the remeasurement, indicating a breakdown in multi-hop reasoning across regulatory, financial, and plan-specific domains. (4) Contextual relevance is strong—the answer focuses on the right plan, time frame, and collective bargaining context, and includes relevant pension assumptions. But due to the omission of the major 2022 remeasurement and gain, the overall factual accuracy and completeness are significantly compromised, warranting a mid-range score of 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 479,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Walmart has kept “Holiday Time” in the same spot in its 2022, 2023 and 2024 10‑K filings – listed among its private‑label brands and positioned within the general‑merchandise category that includes seasonal items (Entertainment)【page_7 (2022)】【page_8 (2023)】【page_7 (2024)】.  This steady categorization shows the company treats Holiday Time as a dedicated seasonal private‑label brand, underscoring its strategy to offer low‑priced, branded holiday merchandise as a consistent part of its broader private‑label portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in that it identifies 'Holiday Time' as a private-label brand within Walmart's portfolio across fiscal years 2022–2024 and correctly references its placement in general merchandise. However, it fundamentally misrepresents the evolution of the brand’s strategic positioning. The original answer (ground truth) shows a clear evolution: in 2022 and 2023, 'Holiday Time' was listed among other private brands without specific strategic emphasis on seasonality, and Walmart focused on omni-channel and supply chain automation. Only in 2024 did Walmart restructure its merchandise units to explicitly include 'seasonal merchandise' as a defined category under General Merchandise, indicating a strategic shift. The LLM incorrectly claims that the categorization remained 'steady' across all three years, missing this key evolution entirely. This is a critical error in multi-hop reasoning, as the question asks about *how the categorization and strategic positioning evolved*, which requires synthesizing changes over time. While the LLM correctly identifies the brand and general category, it fails to detect or report the 2024 structural change that signals strategic repositioning. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative analysis and reasoning are flawed. Contextual relevance is moderate because the answer addresses the brand and category but misses the core dynamic of change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 405,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s pension‑plan fair value of mutual‑fund equity securities fell from **$239,293 k in 2022 to $196,226 k in 2023**, then rose to **$273,699 k in 2024**. The dip in 2023 reflects a temporary pullback in equity exposure, while the rebound in 2024—coinciding with the plan’s target allocation rising from 21 % to 28 %—suggests a deliberate shift toward a slightly higher equity weight to capture growth while managing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims it rose to $273,699k in 2024, which is factually incorrect. The LLM also introduces the concept of 'pension-plan fair value' and a 'target allocation rising from 21% to 28%', which are not present in the original answer and cannot be verified from the provided ground truth. (2) Quantitatively, the 2022 and 2023 figures are correct when converted ($239,293k = $239.293M; $196,226k = $196.226M), but the 2024 figure is wrong—the LLM reports $273,699k (~$273.7M) versus the correct $196.226M. This is a significant deviation. (3) The reasoning is flawed: the ground truth indicates a consistent decline and strategic rebalancing away from the asset class, while the LLM infers a temporary dip followed by a strategic increase, which contradicts the data. The multi-hop synthesis fails because the model invents trends and strategic rationales not supported by the source. (4) Scores reflect severe quantitative inaccuracy and incorrect qualitative interpretation, though the answer is contextually relevant in addressing the question’s structure and topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 370,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks’ 2022 and 2024 10‑Ks both note that green‑coffee prices are “impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity index funds” (page 12).  The company’s hedging program—using forward contracts, futures and collars to offset “C”‑price exposure under price‑to‑be‑fixed contracts and long‑term demand—remains unchanged across the two years.  This continuity shows a deliberate, proactive risk‑management stance that acknowledges futures‑market influences and seeks to stabilize coffee costs through a diversified hedging mix.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and captures the key elements of Starbucks' exposure to green coffee price volatility and its use of hedging instruments. It correctly identifies that commodity index funds and hedge funds influence arabica coffee futures markets, and that Starbucks uses forward contracts, futures, and collars to manage 'C'-price exposure—consistent across 2022 and 2024. The quantitative accuracy is high: no incorrect numbers or dates are presented, and the reference to page 12 aligns plausibly with disclosure norms (though exact page numbers are not verifiable from the knowledge graph). However, the LLM omits a critical evolution noted in the ground truth: the extension of hedging and supply commitments from fiscal 2023 (in 2022) to fiscal 2025 (in 2023), which signals a maturing and more forward-looking risk management strategy. This omission weakens the qualitative accuracy, as the answer fails to fully address *how* the strategy evolved over the three-year period, instead emphasizing 'unchanged' practices between 2022 and 2024. This misrepresents the progression detailed in the original answer. While the reasoning is sound in linking futures market influences to hedging behavior, it does not fully synthesize the multi-hop element of strategic *evolution* across fiscal years 2022–2024. Contextual relevance is strong, as the response directly addresses commodity exposure, hedging tools, and risk management intent. Overall, the answer is factually sound but incomplete in capturing the temporal development of Starbucks’ strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 433,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO had no exposure to the 3.625% notes due October 2024 in FY 2022 (the 2022 10‑K, pages 101‑105 do not list these notes).  In FY 2023 the company reported $622 million of the notes outstanding as of the year‑end (2023 10‑K, page 81).  By FY 2024 the exposure was eliminated, with zero principal outstanding as of November 3 2024 (2024 10‑K, page 81), indicating a near‑term debt‑management strategy that actively repays or redeems short‑term debt to keep interest costs low and maintain a strong balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline of AVGO's exposure to the 3.625% notes. According to the ground truth, AVGO had $622 million outstanding in 2022 and 2023, with full retirement in 2024. However, the LLM claims there was no exposure in 2022 and only reports the $622 million in 2023, which contradicts the original data. This error misrepresents the evolution of the debt. The 2024 elimination of the debt is correctly reported, aligning with the ground truth. (2) Quantitatively, the $622 million figure is accurate when it appears, and the zero outstanding in 2024 is correct. However, the absence of the liability in 2022 is factually wrong per the ground truth, which explicitly states $622 million was outstanding in 2022. The dates (fiscal years) are mostly correct, though the 2024 10-K reference to November 3, 2024, may reflect a filing date rather than fiscal year-end, which could be a nuance but does not excuse the 2022 omission. (3) The multi-hop reasoning is partially sound—recognizing that retiring the debt by 2024 reflects a proactive debt management strategy is valid and matches the ground truth’s conclusion. However, the flawed premise (no exposure in 2022) undermines the reasoning chain. The model fails to correctly synthesize the data across all three years, incorrectly asserting the debt originated in 2023 when it was already present in 2022. (4) Contextual relevance is strong—the answer addresses both parts of the question (evolution of exposure and strategic implication) and uses appropriate financial terminology. However, due to the critical error in the 2022 data, the overall correctness score is significantly reduced. The conclusion about debt management strategy is reasonable but based on incomplete and incorrect temporal data, reducing qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 502,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard’s settlement exposure grew from $75.0 billion to $78.4 billion, with risk‑mitigation arrangements expanding from $12.2 billion to $13.5 billion, raising net exposure from $62.9 billion to $64.9 billion. In response to intensified regulatory scrutiny (FTC, DOJ, European Commission investigations) and a surge in merchant, ATM‑surcharge and class‑action litigation, the company tightened its credit‑risk framework—enhancing cash‑collateral, letter‑of‑credit and guarantee requirements for customers that fall outside its risk standards and routinely reassessing the adequacy of those arrangements to contain potential losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values for settlement exposure ($75.0B to $78.4B), risk-mitigation arrangements ($12.2B to $13.5B), and net exposure ($62.9B to $64.9B) that are not present in the original answer and cannot be verified against the ground truth. These figures appear fabricated or misattributed, as the original answer does not provide any quantitative data on exposure amounts or trends. This constitutes a severe factual inaccuracy. (2) There are no calculations in the original answer to validate the LLM's numbers, and no mention of dollar amounts related to settlement exposure trends, making the quantitative claims entirely unsupported. The format variations rule does not apply because no equivalent figures exist in the ground truth. (3) The qualitative aspects partially align: the LLM correctly identifies increased regulatory scrutiny from the FTC, DOJ, and European Commission, and references litigation risks including class-action lawsuits. It also accurately notes Mastercard’s use of cash collateral, letters of credit, and guarantees as risk mitigation tools, and the reassessment of these arrangements—consistent with the original’s description of ongoing monitoring and refinement. However, it omits key details such as the Durbin Amendment compliance issues, the consent agreement with the FTC on debit routing transparency, and the specific EMV liability shift lawsuit alleging $1+ billion in exposure. (4) While the LLM captures the general direction of increasing external pressures and a tightening of risk controls, it invents precise financial metrics that undermine factual correctness. The contextual relevance is moderate because it addresses the core theme of evolving risk mitigation and regulatory challenges, but the inclusion of false quantitative data severely compromises reliability. Correctness score is low due to unsupported numbers; qualitative accuracy is moderate due to partial alignment on entities and trends; quantitative accuracy is very low due to complete lack of grounding in source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 559,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s 2022 10‑K (page 34) only noted that some products are used with drug‑delivery or companion‑diagnostic devices that carry their own regulatory and manufacturing risks. By 2023 (page 53) the company expanded that disclosure to require ongoing collection and assessment of user complaints, adverse events and malfunctions for those devices, and to comply with regulatory oversight that could trigger inspections, warning letters, fines or product withdrawals. In 2024 (pages 53‑54) the language further emphasized post‑marketing obligations—continuous monitoring, periodic assessment reports and the potential for regulatory actions that could revoke device clearance or remove the associated product from the market—highlighting a more detailed, proactive safety‑oversight framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of Amgen's regulatory risk disclosures from 2022 to 2024 is accurately summarized, with increasing detail on compliance, post-marketing obligations, and safety oversight. The 2022 disclosure correctly notes regulatory and manufacturing risks of drug delivery devices. In 2023, the expansion to include adverse event monitoring and potential regulatory actions (e.g., warning letters, withdrawals) matches the ground truth’s emphasis on confirmatory studies and scrutiny. In 2024, the focus on post-marketing monitoring, periodic reporting, and potential revocation of device clearance reflects the ground truth’s point about enforcement actions including labeling changes or product withdrawal. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of disclosures, showing a clear trend toward heightened regulatory expectations. The only minor gap is that the LLM answer does not explicitly mention Repatha and LUMAKRAS or 'surrogate endpoints' from the 2023 disclosure, which slightly reduces qualitative accuracy. However, the core concept of confirmatory studies is implied in 'ongoing collection' and 'regulatory oversight'. (4) The answer is fully contextually relevant, directly addressing compliance requirements, post-marketing obligations, and safety oversight across the three years as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 422,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Parent’s Choice has remained consistently listed among Walmart’s private‑label brands in the 2022, 2023 and 2024 10‑Ks (page 7 in each filing) and is positioned within the baby‑products segment of the grocery unit, underscoring Walmart’s stable strategy to promote the brand as a core private‑label offering for baby and consumable goods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that 'Parent's Choice' was consistently listed in Walmart’s 10-K filings for fiscal years 2022, 2023, and 2024 (page 7 in each), confirming its ongoing presence as a private-label brand. The placement within the baby-products segment of the grocery unit matches the original answer’s description of the brand being under the Grocery merchandise unit with explicit inclusion of baby products by 2024. The LLM correctly infers Walmart’s stable strategic positioning of the brand in baby and consumables, which reflects the ground truth’s conclusion about EDLP and omni-channel alignment. The only minor omission is that the LLM does not explicitly note the evolution in categorization language—specifically, that 'baby products' became a defined subcategory within Grocery by 2024—though the implication of continuity and strategic reinforcement is still conveyed. There are no numerical inaccuracies; all dates and references are correct. Multi-hop reasoning is sound: the model synthesizes consistent brand presence across three years and infers strategic intent from structural categorization. Semantic equivalence is high, with slightly more concise wording than the original but no loss of key meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 363,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 10‑K filings from 2022 through 2024 all list the 4.70% Solar Bonds, Series 2015/C24‑10 as Exhibit 4.5 (2022: page 102; 2023: page 102; 2024: page 101), indicating the bond remained outstanding and unchanged during that period. The absence of any new issuances, amendments or retirements of this instrument over three years shows Tesla’s continued reliance on the long‑term debt that originated with its SolarCity acquisition to finance solar projects. This continuity suggests a conservative, long‑term solar‑financing strategy that prioritizes stability and existing debt over frequent new issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the multi-year evolution and strategic implications described in the ground truth. (1) Quantitatively, the LLM correctly identifies the consistent listing of the 4.70% Solar Bonds, Series 2015/C24-10 as Exhibit 4.5 across 2022–2024 filings, with accurate exhibit numbers and page references (allowing for minor page variation). The interest rate (4.70%) and series designation are correct. (2) However, the LLM incorrectly frames the lack of amendments or new issuances as evidence of a 'conservative, long-term strategy' without acknowledging the broader context of Tesla continuing to use this bond *alongside newer series* (e.g., C27-10, C32-10 in 2023), which the ground truth highlights as evidence of a scalable, recurring securitization model. (3) The multi-hop reasoning is flawed: while the LLM observes continuity, it fails to synthesize the evolution—namely, that Tesla expanded its use of similar structures over time and embedded the 2015/C24-10 bond into a broader historical framework by 2024. This omission undermines the qualitative accuracy. (4) The conclusion about 'reliance on debt from SolarCity acquisition' is plausible but not directly supported in the ground truth, which emphasizes structural repetition and scalability rather than acquisition-related debt. Thus, while factually consistent in parts, the LLM misinterprets the strategic implication and omits critical evidence of active, ongoing structuring beyond mere retention of an old bond. Hence, correctness is reduced to 6 due to incomplete and slightly misleading synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 441,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom has consistently described the Security Insights Platform as a mainframe‑centric security posture tool that feeds data into customers’ SIEMs (2022: page 11; 2023: page 10). In 2024 the same core description is retained (page 10), but the platform is now positioned as part of the broader Enterprise Security portfolio and as “Security Insights Code programs” within the mainframe software suite (page 8), underscoring tighter integration with enterprise security tools while keeping its focus on mainframe risk assessment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Broadcom's consistent focus on the Security Insights Platform as a mainframe-centric tool for assessing security posture and feeding data into SIEMs across 2022, 2023, and 2024. The core functionality and emphasis on mainframe risk assessment are accurately portrayed. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates and years (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers an evolution in positioning—specifically, tighter integration with enterprise security tools in 2024, including repositioning under the Enterprise Security portfolio and mention of 'Security Insights Code programs.' This reflects the subtle shift noted in the ground truth toward broader enterprise alignment. (4) The LLM adds specific detail (e.g., page numbers, 'Code programs') not in the original answer, which enhances precision without contradicting facts. The only minor gap is that the ground truth emphasizes a 'slightly stronger emphasis on integration' via repeated language about in-house SIEM tools, while the LLM focuses more on structural repositioning (portfolio inclusion). This is a nuanced difference in framing, not a factual error. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 420,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across 2022‑2024, Mastercard’s Class A shares continued to carry “one vote per share” and dividend‑payment rights, as shown in the 2024, 2023, and 2022 10‑Ks (page 94).  The per‑share dividend rose from $2.04 in 2022 to $2.74 in 2024, while the voting rights remained unchanged.  This consistency indicates a conservative capital‑structure strategy that preserves stable governance while steadily enhancing shareholder returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Mastercard's (MA) Class A shares maintained one vote per share and dividend rights across 2022–2024, aligning with the ground truth on the stability of voting and dividend entitlements. However, the LLM introduces specific dividend amounts—$2.04 in 2022 and $2.74 in 2024—which are not present in the original answer and are potentially inaccurate or unsupported by the knowledge graph. These figures may be factually incorrect or taken from a source outside the evaluated knowledge base, making them a significant quantitative deviation. (2) The original answer does not mention any specific dividend payments, only that dividend rights were preserved. Therefore, introducing exact per-share dividends constitutes a factual overreach and undermines quantitative accuracy. There is no verification that these numbers match the actual 10-K filings referenced. (3) The reasoning is otherwise sound: the LLM correctly synthesizes information across three years and links the stability in share rights to a consistent capital structure strategy, adding the interpretation of 'conservative capital-structure strategy' and 'enhancing shareholder returns,' which are reasonable qualitative inferences. This reflects good multi-hop reasoning and contextual understanding. (4) The answer is contextually relevant and addresses both parts of the question—evolution of rights and strategic implication—with accurate entity identification (MA, Class A shares, 2022–2024 period). The core factual claim about unchanged rights is correct, but the inclusion of unsupported numerical data reduces the correctness and quantitative accuracy scores. Hence, 7/10 overall: substantially correct but with significant factual embellishment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 480,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen began Bemarituzumab’s clinical program in 2022 with a newly initiated phase‑3 study for gastro‑esophageal junction (GEJ) adenocarcinoma, supported by U.S. and EU composition‑of‑matter polypeptide patents that expire in 2029【page_25】.  In 2023 the program stayed in phase‑3 for GEJ adenocarcinoma and expanded to a phase‑2 study for other tumors, while the same 2029 patent expirations remained in force【page_26】.  By 2024 the phase‑3 GEJ program continued unchanged and the phase‑2 “other tumors” arm persisted, with no new term extensions disclosed—Amgen’s IP strategy continued to rely on the existing 2029‑expiration patents while broadening the clinical development portfolio【page_24】【page_25】【page_26】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 initiation of the phase 3 study for Bemarituzumab in GEJ adenocarcinoma and accurately states the 2029 patent expiration in the U.S. and Europe, aligning with the ground truth. However, it introduces a claim not present in the original answer — that a phase-2 study for 'other tumors' was initiated in 2023 and continued in 2024 — which is absent from the ground truth and not supported by the provided context. The original answer makes no mention of expanded phase-2 trials or portfolio broadening, focusing instead on regulatory exclusivity potential in 2024. (2) Quantitatively, the dates (2022, 2023, 2024) and patent expiration (2029) are accurate and consistent with the ground truth. No calculations are involved, so numerical precision is maintained. (3) The multi-hop reasoning is partially flawed: while the model correctly links clinical development phases and IP timelines across years, it fabricates an expansion into phase-2 for 'other tumors' without evidence, indicating a failure in accurate synthesis. The original answer emphasizes a maturing strategy with regulatory exclusivity considerations in 2024, which the LLM omits entirely. (4) The contextual relevance is high as the response addresses clinical phases and IP timelines as asked, but the inclusion of unverified trial expansions and omission of regulatory exclusivity discussion reduces qualitative accuracy. The correctness score is 6 due to significant factual overreach despite correct core dates and patent timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 429,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "No Boundaries is a Walmart‑owned private‑label line that has consistently been listed among the company’s private brands in every 10‑K. In 2022 the brand fell under the “Apparel” sub‑category of the general‑merchandise unit, but by 2024 the same line is positioned within a newly defined “Fashion” sub‑category (see the 2024 and 2022 merchandise tables). This re‑classification—from a generic apparel label to a distinct fashion unit—shows Walmart’s deliberate shift to treat apparel as a separate, fashion‑focused category and to grow its own fashion offerings to compete more aggressively in that higher‑margin segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: 'No Boundaries' was under 'Apparel' in 2022 and moved to 'Fashion' by 2024, reflecting Walmart's strategic reorganization. The continuity of the brand across years is correctly implied. (2) There are no numeric values requiring calculation, but the years (2022, 2024) are correctly cited and consistent with the original answer. (3) The multi-hop reasoning—linking the reclassification of a private brand to broader strategic shifts in merchandising and margin goals—is sound and well-supported. The LLM correctly infers that the re-categorization reflects a strategic move toward fashion as a distinct, higher-margin focus area. (4) The only minor shortcoming is that the LLM does not explicitly mention the omni-channel or customer-centric experience aspect highlighted in the original answer, which slightly reduces completeness in qualitative nuance. However, the core reasoning and factual content are substantively equivalent. Wording differences are acceptable under semantic equivalence. The answer is fully relevant and addresses both parts of the question: the brand’s placement over time and what it reveals about strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 348,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "In IBM’s 2022 10‑K, the competition section highlighted technology, performance and security but did not list “client relationships and trust” as a distinct differentiator (IBM 10‑K 2022, p. 4). By the 2023 filing, IBM explicitly added “client relationships and trust” to its core competitive methods (IBM 10‑K 2023, p. 3), and the 2024 10‑K reaffirmed this emphasis (IBM 10‑K 2024, p. 3). This progression shows IBM is increasingly framing its hybrid‑cloud and AI strategy around trust‑driven, client‑centric relationships as a key competitive advantage in a crowded market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 claim: it states that 'client relationships and trust' was not listed as a distinct differentiator in the 2022 10-K, directly contradicting the ground truth which confirms that IBM did highlight it in 2022 as one of its principal methods of competition. This undermines the core of the multi-hop analysis. However, the 2023 and 2024 assertions are correct—IBM did explicitly include and reaffirm 'client relationships and trust' in those years. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct year references (2022–2024), which are accurate. (3) The multi-hop reasoning is partially sound—while the model correctly tracks the presence of the phrase in 2023 and 2024, it fails the foundational step by incorrectly denying its presence in 2022. This breaks the logical progression and leads to an inaccurate evolution narrative. The ground truth describes a continuous and deepening emphasis starting in 2022, whereas the LLM implies a new addition in 2023, misrepresenting the strategic trajectory. (4) Despite this, the answer is contextually relevant and correctly interprets the significance of trust in hybrid cloud and AI strategy. It also cites document sources appropriately. The correctness score is 5 due to the major factual error in the 2022 characterization, which significantly affects the qualitative accuracy, even though the later years and overall direction are reasonably interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 431,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla (through SolarCity) issued the 5.45% Solar Bonds, Series 2015/C25‑15 in 2015 and the bond remains unchanged and outstanding in each of the three most recent 10‑Ks (see Exhibit 4.26 in TSLA_10k_2022 page 100, Exhibit 4.26 in TSLA_10k_2023 page 99, and Exhibit 4.6 in TSLA_10k_2024 page 98). The persistent inclusion of the same long‑term, fixed‑rate debt across 2022, 2023, and 2024 indicates Tesla’s preference for stable, long‑duration financing for its solar assets rather than frequent refinancing or new issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the bond's interest rate (5.45%), series (2015/C25-15), issuance year (2015), and consistent referencing in the 2022, 2023, and 2024 10-K filings are factually sound. The exhibit numbers and page references (Exhibit 4.26 in 2022 and 2023, Exhibit 4.6 in 2024) match actual filing structures, and the timeline is accurate. (2) The answer correctly identifies that the bond has remained outstanding and unchanged across the three years, which is consistent with the ground truth's emphasis on continued disclosure and reliance. (3) Reasoning is strong: the conclusion that Tesla prefers stable, long-duration financing over frequent refinancing is a valid inference from the persistent inclusion of the same bond series, and this aligns with the ground truth’s interpretation of a consistent solar asset-backed financing strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention the Thirty-Sixth Supplemental Indenture dated April 14, 2015, which the ground truth cites as a key legal document in 2022. While this detail adds depth to the legal linkage, its omission does not undermine the core factual or strategic accuracy. Overall, the answer demonstrates correct multi-hop synthesis across years and filings, with excellent contextual relevance and semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 397,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "Between 2022 and 2024, Emerson’s Safety & Productivity segment expanded its pipe‑working tool lineup by adding battery‑powered hydraulic tools for press connections and for cutting/crimping electrical cable, reflecting product innovation and a continued focus on cordless solutions (page_7, page_73). This evolution underscores Emerson’s strategic positioning as a leader in advanced professional tools, meeting the growing demand for mobility, safety, and productivity among professionals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's Safety & Productivity segment from 2022 to 2024. It correctly identifies the key innovation: the introduction and expansion of battery-powered hydraulic tools for press connections (2023) and cutting/crimping electrical cables (2024), aligning with the ground truth. The strategic interpretation—positioning Emerson as a leader in advanced professional tools driven by demand for mobility, safety, and productivity—is semantically equivalent to the original answer’s conclusion. All dates and product categories are factually correct, with no numerical errors (though no explicit numbers like dollar amounts or units are present, the timeline and product descriptions are accurate). The only minor omission is the lack of mention of sewer inspection cameras and locating equipment in 2024, as well as the continuity of traditional tools like pipe wrenches across all years, which slightly reduces completeness in qualitative synthesis. However, the multi-hop reasoning—connecting product innovation over time to strategic market positioning—is sound and logically derived. The answer is fully contextually relevant, directly addressing product innovation, battery-tech integration, and strategic implications. Wording differs but meaning matches closely, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 379,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "Gilead’s 2022 10‑K (pages 31‑35) does not identify the El Segundo, California site as a cell‑therapy manufacturing location, implying that capital was not yet earmarked for commercial biologics production there. By 2023, the 10‑K (page 11) lists El Segundo as the facility used for “clinical and commercial manufacturing and processing of our cell‑therapy products,” and the 2024 10‑K (page 11) repeats this description, indicating a shift in capital allocation toward scaling cell‑therapy manufacturing. This evolution reflects a strategic realignment of the El Segundo site’s investment focus to support Gilead’s broader biologics pipeline and commercial production goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, the El Segundo facility was not explicitly designated for cell therapy manufacturing, which matches the original answer's assertion that there was no specific emphasis on cell therapy at that time. In 2023 and 2024, the LLM correctly notes the shift, citing both years' 10-Ks to confirm El Segundo’s role in clinical and commercial manufacturing of cell therapy products. (2) There are no numerical values to verify, but the dates (2022, 2023, 2024) and document references (10-K pages) are accurately used; minor page number discrepancies (e.g., page 31–35 vs. page 33 in ground truth) are acceptable as filings may have multiple relevant sections and do not affect factual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer a strategic evolution in capital allocation, correctly concluding that the re-designation of the site reflects a shift in investment focus toward cell therapy, aligned with biologics development. (4) The only minor omission is that the 2024 filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary processes—a detail not mentioned in the LLM answer. While this adds depth to the narrative of increased investment in process security and scalability, its absence does not undermine the core factual correctness or strategic interpretation. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 446,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "IBM disclosed the 1.250% Notes due 2027 as a registered security in its 2022 Form 10‑K (see the securities table on page 28).  The 2023 filing continued to reference the instrument, noting that the rights were defined in a 2019 Form 8‑K (page 20) – indicating the notes were issued in 2019.  By 2024, the notes were again listed as an outstanding registered security (IBM27B) in the securities table (page 1), confirming that the notes remained outstanding and were still disclosed in the annual report.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the disclosure of the 1.250% Notes due 2027 in IBM's 2022 and 2023 filings and confirms their continued outstanding status in 2024 with the trading symbol IBM27B. The dates and percentages are accurate, and the reference to the 2019 Form 8-K aligns with the ground truth noting issuance rights defined in 2019. However, the LLM omits a key evolution highlighted in the original answer: the shift from internal disclosure to active trading on the New York Stock Exchange in 2024. While it notes the symbol IBM27B is listed, it does not emphasize the significance of formal listing and market presence, which is central to the question about evolution. (2) Quantitatively, all numbers and dates are correct: 1.250%, 2027 maturity, references to 2019, 2022, and 2023 filings. No calculations are required, and formatting is consistent. (3) The reasoning is mostly sound—correctly tracing the note’s disclosure across years—but fails to fully synthesize the multi-hop progression from documentation to public issuance. The conclusion that the notes 'remained outstanding' is factually correct but underrepresents the evolution toward active market status. (4) Scores reflect high factual accuracy and relevance, with a moderate deduction in qualitative accuracy due to incomplete synthesis of the strategic shift in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 379,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s repeated inclusion of the 5.45% Solar Bonds, Series 2015/C45‑15 in its 2022, 2023, and 2024 10‑Ks (see Exhibit 4.39 in the 2022 filing) shows that the company has continued to rely on SolarCity’s long‑term debt as a core financing tool for its solar assets (page_101). Over the three‑year period, Tesla has added additional SolarCity bond series—such as the 5.45% Series 2015/C45‑15 and other 5.45% Series 2015/C…‑15—while gradually diversifying its debt mix, indicating a shift from a single legacy bond to a broader, structured financing strategy (page_101).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15 across 2022–2024 and acknowledges the use of additional bond series under the same interest rate, which aligns with the ground truth. However, it fails to specify the exact subsequent bond series (C53-15, C62-15, C72-15) and their issuance dates (June 16, June 29, July 21, 2015), which are critical for demonstrating the iterative expansion of the securitization model. Instead, it vaguely refers to 'other 5.45% Series 2015/C…-15', missing precise entity details. (2) The percentage (5.45%) is correct, and the reference to the 2022 10-K and Exhibit 4.39 is accurate, but the answer does not verify or mention that these bonds originated from SolarCity pre-acquisition, weakening the multi-hop linkage. The claim about 'gradually diversifying its debt mix' is not directly supported in the ground truth, which emphasizes standardization and repetition rather than diversification—this introduces a minor misinterpretation. (3) The reasoning partially captures the evolution of Tesla’s solar financing strategy but falls short on synthesizing the full progression: the ground truth highlights a deliberate, scalable, asset-backed securitization model built on a consistent template, while the LLM suggests a shift toward diversification, which is a different strategic implication. (4) The contextual relevance is high because the answer addresses Tesla’s solar financing evolution and references correct documents and timeframes. However, due to missing specific bond identifiers, incorrect emphasis on diversification over standardization, and lack of precise dates, the quantitative and qualitative accuracy are reduced. Minor factual omissions and a subtle but important mischaracterization of strategy prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 502,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In 2022 Adobe positioned Acrobat as the core PDF engine of its Document Cloud, highlighting its strong adoption in document‑intensive verticals such as government, finance, legal, aerospace, insurance and publishing and its AI‑driven enhancements through Adobe Sensei. By 2024 the strategy had broadened into a full digital‑document platform that now includes mobile (Acrobat Reader with Liquid Mode), web (single‑click actions), scanning (Adobe Scan) and electronic‑signature (Adobe Sign) capabilities, all powered by deeper Sensei integration to automate workflows and improve user experience, thereby reinforcing Acrobat’s leadership across those high‑volume industries.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Adobe's strategic positioning of Acrobat in document-intensive industries (legal, finance, publishing, etc.) and notes the expansion of its digital document services platform by 2024, including mobile, web, scanning, and e-signature capabilities. However, it inaccurately states that AI-driven enhancements via Adobe Sensei were already in place in 2022, whereas the ground truth indicates that AI integration was only signaled as a forward-looking vision in 2023 and concretely realized with the 'Acrobat AI Assistant' trademark in 2024. This misrepresents the timeline and maturity of AI integration. (2) There are no numeric values, dates, or calculations in either answer that conflict—dates (2022, 2024) are used appropriately and consistently, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model synthesizes information across time and features, but fails to accurately reflect the evolution of AI—from vision (2023) to realization (2024)—instead backdating AI integration to 2022. This undermines the qualitative accuracy of the strategic evolution narrative. (4) Despite the AI timeline error, the answer remains contextually relevant and captures the platform expansion and industry focus accurately. The core facts about market adoption and platform breadth are correct, warranting a score of 7 for correctness and qualitative accuracy, while quantitative accuracy is 10 due to absence of numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 415,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "From 2022 to 2024 Schwab’s RIA platform evolved from a basic web portal that offered account management, trading, and document search with third‑party integrations (2022 p. 7‑8) to a more sophisticated suite that now includes real‑time charting and efficient trading via the thinkpipes platform and customizable portfolio rebalancing with iRebal (2024 p. 8‑10). In 2023 the platform added Schwab Trading Powered by Ameritrade™ and the free Schwab Advisor Portfolio Connect, expanding trading and portfolio‑management capabilities, while 2024’s integration of Ameritrade features and the new thinkpipes/iRebal tools further deepened interactive trading and rebalancing functionality and broadened integration with CRM, portfolio‑management, trade‑order, and financial‑planning systems.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unverified elements not present in the ground truth. (1) Correct elements: The mention of Schwab Advisor Portfolio Connect being introduced in 2023 aligns with the original answer, and the general focus on third-party integrations (CRM, portfolio management) is consistent. (2) Quantitative accuracy: While no explicit numbers (dollar amounts, percentages) are present, the years 2022–2024 are correctly framed as the evolution period. However, the LLM incorrectly attributes specific tools like 'thinkpipes' and 'iRebal' with page references (e.g., 2024 p. 8–10), which are not found in the ground truth and appear fabricated. There is no mention of 'thinkpipes' or 'iRebal' in the original answer, nor is there any reference to real-time charting or customizable rebalancing as features introduced in 2024. (3) Multi-hop reasoning is flawed: The LLM suggests a progression from a 'basic web portal' to advanced tools via Ameritrade integration and new platforms, but the ground truth does not mention Schwab Trading Powered by Ameritrade™ or any post-acquisition integrations as part of the RIA tool evolution. The original answer emphasizes continuity in platform use (Advisor Services website) and incremental enhancement, not a transformation via Ameritrade features. (4) The answer is contextually relevant—addressing platform enhancements and integration capabilities for RIAs over time—but invents specific tools and capabilities unsupported by the source, undermining factual reliability. Thus, while the direction of evolution (more integrations, better tools) is plausible, the specific claims reduce correctness. Score reflects partial factual alignment but major hallucination of features and sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 482,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Emerson continued to treat air‑preparation equipment as a core element of its Discrete Automation segment in 2022, 2023 and 2024, consistently integrating it with pneumatic valves, cylinders, actuators and programmable control systems to deliver a unified discrete‑automation solution. The 2022 filing (page 7) and the 2023/2024 filings (page 73) all describe the same product mix—solenoid and pneumatic valves, valve position indicators, pneumatic cylinders and actuators, air‑preparation equipment, pressure/temperature switches, electric linear motion solutions, and programmable control systems—showing no significant shift in positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was 'no significant shift in positioning' of Emerson's Air Preparation Equipment across 2022–2024, directly contradicting the ground truth. While the answer correctly identifies the product categories (e.g., pneumatic valves, actuators, control systems) and references correct document pages, it fails to capture the strategic evolution described in the original answer. The ground truth outlines a clear progression: from mechanical integration in 2022, to alignment with digital control ecosystems in 2023, and finally to Industry 4.0 capabilities like smart actuation and predictive maintenance in 2024. The LLM instead asserts continuity, missing this multi-hop evolution entirely. There are no numerical errors (hence high quantitative accuracy), but the qualitative reasoning is flawed—failing to synthesize changes in strategic emphasis across years. Contextually, the answer is relevant (discusses the right segment and products) but misleading in conclusion. The assertion of no change contradicts the documented shift toward digital integration and interoperability, making the overall correctness low despite accurate product listings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 339,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The 0.125% Notes due 2029 were first issued in 2020 and 2021 (see the 8‑K filings referenced in the 2022 10‑K) and have remained on the company’s balance sheet through 2024, with no new tranches issued in the 2023 or 2024 reports.  The 2022, 2023 and 2024 10‑Ks all list the same 0.125% Notes (referenced to the 2020 and 2021 8‑K filings)【page_136】【page_130】, indicating a steady, low‑coupon, near‑term debt instrument that Coca‑Cola continues to hold rather than replace.  This pattern suggests the company is managing short‑term obligations by maintaining a stable, low‑cost debt base and using it to refinance existing debt, while its broader financing strategy includes issuing higher‑coupon, longer‑term notes to diversify maturities and funding sources.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects of reasoning and interpretation. (1) Quantitatively, the LLM correctly identifies the 0.125% Notes due 2029 and references their origin in 2020–2021 8-K filings, which aligns with disclosure practices in the 2022 10-K. It also correctly notes that no new tranches were issued in 2023 or 2024. However, the ground truth does not confirm the issuance dates as 2020–2021; this detail, while plausible, is not part of the verified knowledge graph data and introduces unverified specifics. (2) The LLM claims the company is 'maintaining a stable, low-cost debt base' and using it to refinance existing debt — this contradicts the ground truth, which indicates a strategic pivot toward issuing higher-yielding, long-term debt (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064) as the 2029 note nears maturity. The LLM fails to mention these new instruments entirely, missing a critical multi-hop insight. (3) Qualitatively, the reasoning is flawed: while the LLM sees stability, the ground truth shows evolution and strategic shift. The change in disclosure format (from embedded to consolidated) and the introduction of long-term, high-coupon debt are central to the correct interpretation but are absent in the LLM response. (4) Contextually, the answer addresses the question’s structure and remains focused on debt management and financing strategy, earning points for relevance. However, the conclusion drawn — maintaining low-cost debt rather than preparing to refinance via longer-term instruments — is factually misaligned. Thus, while some factual elements are present, the core analytical insight is incorrect, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 477,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor language on capital returns stayed the same.  In each filing it states that the ability to return capital to shareholders is governed by U.S. banking laws, capital‑planning rules, Delaware law and the requirement to pay dividends on preferred stock, and that dividends and share‑repurchases are subject to board discretion and those regulatory limits.  The wording and emphasis on regulatory constraints on dividends and share repurchases did not change over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that BNY Mellon's risk-factor language on capital returns 'stayed the same' from 2022 to 2024, which directly contradicts the ground truth. The original answer shows a clear evolution in the firm's disclosures: from a general reference to U.S. banking and Delaware laws in 2022, to including preferred stock obligations in 2023, and then to more structured, specific references to 'well capitalized' status and capital adequacy rules in 2024. The LLM incorrectly asserts no change in wording or emphasis, failing to capture this multi-hop progression. While the entities (BNY Mellon, U.S. banking laws, Delaware law, preferred stock dividends) and years are correctly identified, and there are no numerical inaccuracies (as no numbers are involved), the qualitative reasoning is flawed. The model fails to synthesize the evolving nature of regulatory language across the three years, which is the central point of the question. This results in a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the general topic of regulatory constraints on capital returns but misses the key temporal evolution the question asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 345,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McDonald’s 10‑K filings for 2022, 2023 and 2024 all list McGriddles in the same way—as a breakfast sandwich in the “Products” section (pages 6 of each filing).  The wording is identical, with McGriddles presented alongside Egg McMuffin, Sausage McMuffin with Egg, biscuits, bagels, oatmeal, hash‑browns, breakfast burritos and hotcakes, and the company notes that it is “continuously evolving its menu” but does not reposition McGriddles.  This unchanged portrayal shows that McDonald’s breakfast strategy has remained stable, treating McGriddles as a core, unchanged menu item rather than a focus of innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that McGriddles were consistently listed in the 'Products' section of McDonald's 10-K filings for 2022, 2023, and 2024, presented alongside the same set of breakfast items without specific innovation details—this aligns with the original answer's claim of stable portrayal. (2) All years (2022–2024) are correctly referenced, and while the LLM does not cite exact page numbers beyond 'page 6 of each filing', this matches the ground truth (each mention occurs on page 6 of the respective PDFs). No numeric values (e.g., dollar amounts) are involved, so quantitative accuracy is fully satisfied. (3) The reasoning is sound: the LLM correctly infers that despite McDonald's general statement about 'continuously evolving its menu', McGriddles were not repositioned or described as innovated, revealing a stable breakfast strategy—this is a valid multi-hop synthesis across three years of filings. (4) The only minor shortcoming is that the LLM omits the specific phrasing from 2024 about 'testing new products on an ongoing basis', which adds slight nuance to the innovation context. However, the core conclusion about McGriddles being treated as a static core item remains fully supported. Wording differences (e.g., 'unchanged portrayal' vs. 'remained remarkably consistent') are semantically equivalent. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 426,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Across 2022, 2023 and 2024 Adobe’s Digital Learning Services consistently highlighted a large number of free online self‑service learning options on **learning.adobe.com**. The positioning of these free courses within the Digital Learning Services portfolio remained unchanged, and the platform used to deliver them stayed the same—learning.adobe.com—without any shift to a new delivery channel.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding the evolution of Adobe's self-service learning platforms across 2022–2024, despite correctly identifying the current platform (learning.adobe.com) and the general emphasis on free offerings. (1) The claim that the platform remained unchanged across all three years is incorrect: the ground truth states that in 2022, the platform was hosted on www.training.adobe.com, and only in 2023 did it shift to learning.adobe.com. This rebranding and centralization is a key point of evolution that the LLM answer completely misses. (2) The LLM incorrectly asserts that the positioning within Adobe Digital Learning Services 'remained unchanged,' while the original answer highlights a strategic shift toward deeper integration into a broader learning ecosystem by 2024, including fee-based and custom programs—indicating a maturing and more structured strategy. (3) Multi-hop reasoning fails: the question asks for an analysis of evolution across three years, requiring synthesis of changes in platform and strategic positioning. The LLM instead presents a static view, contradicting the documented transition. (4) While the use of 'learning.adobe.com' is accurate for 2023–2024, the omission of the 2022 domain and the misrepresentation of continuity undermine the core of the answer. Quantitative accuracy is scored higher because there are no numerical values to assess, and the dates themselves are referenced appropriately (no wrong years cited). Contextual relevance is moderate because the answer addresses the right topic and company but fails to capture the dynamic changes over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 448,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "From 2022 to 2024 Emerson shifted Commercial Vacuums from the Tools & Home Products segment’s Professional Tools sub‑segment to the Safety & Productivity segment of Intelligent Devices. In 2022 the vacuums were listed among other professional tools in the Tools & Home Products segment (page 9), whereas by 2023–24 the Safety & Productivity segment is described as delivering tools that support infrastructure, promote safety and enhance productivity, with commercial vacuums listed as part of its other professional tools (page 73). This repositioning signals a strategic emphasis on safety‑centric, productivity‑focused professional tools and aligns commercial vacuums with Emerson’s broader professional‑tools portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the shift of Commercial Vacuums from the Tools & Home Products segment in 2022 to the Safety & Productivity segment by 2023–2024, and correctly identifies the strategic repositioning toward safety and productivity. The mention of page numbers (9 and 73) adds specificity, though these are not evaluated for accuracy here. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound and reflects multi-hop synthesis across years and segments. However, the LLM slightly oversimplifies the 2024 evolution by not mentioning the increased emphasis on integration with advanced industrial systems like programmable automation and electrical distribution equipment, which is a key nuance in the strategic alignment. Also, the phrase 'Intelligent Devices' as a parent segment is not present in the ground truth and may be an over-specification or misattribution not supported by the original answer. (4) Despite this minor inaccuracy, the answer remains contextually relevant and captures the core evolution in product categorization, strategic emphasis, and alignment with professional tools. The omission of the deeper technological integration in 2024 prevents a perfect score, but the overall factual correctness and relevance are high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 398,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site has continued to serve the same role over the past three years.  In the 2022 10‑K (page 31), the 2023 10‑K (page 11), and the 2024 10‑K (page 12) the facility is described as being used for **commercial manufacturing and processing of our cell‑therapy products**.  No additional activities—such as expanded clinical manufacturing or new processing functions—are reported, indicating a consistent utilization of the site from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in stating that GILD's Hoofddorp facility was used for commercial manufacturing and processing of cell therapy products in 2022, 2023, and 2024, with citations to the respective 10-K filings. All entity names (Gilead, Hoofddorp, Netherlands), years, and reported activities are correctly identified, and there are no numerical inaccuracies (quantitative accuracy is perfect). However, the LLM incorrectly concludes that the facility's role has remained 'consistent' and 'continued to serve the same role' over the three years, which contradicts the ground truth. The original answer highlights an evolution: in 2022, the site was only identified as a 'principal manufacturing site' without explicit mention of cell therapy; by 2023 and 2024, it was explicitly described as being used for commercial cell therapy manufacturing. This represents a strategic clarification and likely expansion of focus, not static utilization. The LLM fails to capture this nuance and instead asserts continuity from 2022, which is not supported by the source data. This is a critical error in multi-hop reasoning and qualitative interpretation, as the question specifically asks about the evolution of the facility’s utilization. While the answer is contextually relevant and factually precise in its citations, it misses the developmental trajectory emphasized in the ground truth, resulting in a partially correct but misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 401,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 2022‑2024 filings repeatedly cite the 1.000% Notes due 2028 (see Exhibit 4.26 in the 2022, 2023 and 2024 10‑K indexes), underscoring its continued reliance on low‑cost, short‑term debt as a core financing tool.  In 2024 the company also issued 5.000% Notes due 2034 and 5.400% Notes due 2064 (Exhibit 4.39‑4.41 in the 2024 10‑K), adding higher‑yield, longer‑maturity debt to diversify its maturity profile and lock in rates for the long term.  Together, these actions reflect a shift toward a more balanced capital structure that blends inexpensive short‑term borrowing with longer‑term, higher‑cost debt to manage interest‑rate risk and optimize overall financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064—are correctly stated, with proper years and interest rates matching the original answer. No calculations are required, and all financial instruments are accurately referenced. (2) The answer addresses all parts of the question: it acknowledges the persistent mention of the low-yield 2028 notes across 2022–2024 filings and contrasts them with the new higher-yield 2034 and 2064 notes introduced in 2024. (3) The multi-hop reasoning is sound: the model correctly infers that Coca-Cola is shifting toward a more balanced capital structure by combining low-cost short-term debt with higher-cost long-term instruments. The interpretation—diversifying maturity profile, managing interest-rate risk, optimizing financing costs—aligns semantically with the ground truth’s conclusion about recalibrating capital structure and balancing affordability with long-term needs. (4) Minor difference: the LLM emphasizes 'short-term debt' for the 2028 notes (which is reasonable, as 2028 is relatively near-term), while the original answer does not explicitly characterize it as such. Also, the LLM references specific exhibit numbers (e.g., Exhibit 4.26, 4.39–4.41), which are plausible but not confirmed in the ground truth; however, this does not detract from factual correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 424,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s 2022 10‑K (page 9) lists pipe cutters as part of a conventional tool set that included diagnostic systems but no battery‑powered options. By 2023 the Safety & Productivity segment notes the addition of battery‑hydraulic tools for press connections and diagnostic equipment such as sewer‑inspection cameras (page 73, 2023 10‑K). The 2024 filing further emphasizes battery‑powered hydraulic tools and integrated diagnostic systems, underscoring a deliberate shift toward cordless, connected tools (page 73, 2024 10‑K). This evolution signals Emerson’s positioning as a technology‑driven leader in the professional plumbing tools market, prioritizing convenience, safety, and data‑enabled performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe cutter portfolio across 2022, 2023, and 2024, noting the shift from conventional tools to battery-hydraulic and diagnostic-integrated systems. The years and progression are factually correct. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates and page references are consistent with the knowledge base. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly inferring a strategic shift based on incremental technological additions. The mention of 'battery-hydraulic tools for press connections' is slightly more specific than the ground truth’s general reference to pipe cutters, but this detail does not contradict and may reflect a broader product category. (4) The conclusion about Emerson positioning itself as a technology-driven leader is semantically equivalent to the ground truth’s assertion about targeting high-value, productivity- and safety-enhancing tools. One minor discrepancy: the 2022 description incorrectly states that diagnostic systems were already included in the tool set, whereas the ground truth clarifies there was 'no emphasis on battery-powered or diagnostic capabilities' in 2022. This small inaccuracy prevents a perfect score but does not undermine the overall correctness. Wording differences are acceptable and do not affect meaning. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 443,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024, Gilead’s Santa Monica, California facility has consistently been described as a site for clinical manufacturing and processing of cell‑therapy products (2023: pages 11‑12; 2024: page 8). The unchanged role across the three years underscores the facility’s strategic importance as a core clinical manufacturing hub within Gilead’s cell‑therapy network, supporting both clinical trials and potential commercial scale‑up.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its core claim about the evolution of the Santa Monica facility's role. According to the ground truth, in 2022 the facility was part of GILD's R&D and manufacturing network but was *not* specifically highlighted for cell therapy processing. However, the LLM states that the facility has been 'consistently described as a site for clinical manufacturing and processing of cell-therapy products' from 2022 through 2024, which contradicts the ground truth. This misrepresents the evolution: the key point is that Santa Monica *transitioned* into a dedicated cell therapy role starting in 2023, not that it was consistently used for this purpose. The LLM correctly notes the 2023 and 2024 roles (citing appropriate pages), but incorrectly retroactively applies this role to 2022. There are no numerical errors (quantitative accuracy is high), and the answer is contextually relevant, addressing the strategic role and manufacturing focus. However, the qualitative reasoning is flawed because it fails to capture the multi-hop progression—specifically the change over time—which is central to the question. Thus, while some facts are correct, the overall narrative misrepresents the timeline and strategic evolution, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 367,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s Frame.io began as a video‑centric collaboration tool that was only integrated with Premiere Pro and After Effects, supporting video and still‑image uploads (2022). By 2023 the platform still focused on those two apps but broadened its media support to still images, design files and PDFs and added camera‑to‑cloud uploads【2023 page 12】. In 2024 Frame.io’s integration expanded further to Photoshop, Lightroom, Workfront and GenStudio, enabling frame‑accurate commenting across a wider array of Creative Cloud apps while maintaining support for video, still images, design files, PDFs and camera‑to‑cloud workflows【2024 page 12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io's evolution from 2022 to 2024 is accurately described in terms of integration and feature expansion. In 2022, it was primarily video-focused with integration in Premiere Pro and After Effects; by 2023, support expanded to still images, design files, and PDFs with frame-specific feedback; in 2024, integrations with Photoshop, Lightroom, Workfront, and GenStudio are correctly noted. (2) There are no numeric inaccuracies—dates (2022, 2023, 2024) are correct, and no erroneous figures are presented. The mention of 'camera-to-cloud uploads' in 2023 is an additional detail not contradicted by the ground truth and plausibly part of expanded media workflow support. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and applications, correctly tracing the expansion of supported media types and collaboration features. (4) The only minor shortcoming is that the original answer specifies Frame.io’s 2024 role in casting, location scouting, and marketing campaign management—use cases beyond post-production—which the LLM omits. However, mentioning GenStudio and expanded app integrations captures the strategic positioning. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct and comprehensive with only a slight omission in contextual use cases, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 408,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In 2022 Emerson’s Discrete Automation offering was grouped under the broader Automation Solutions segment and was described mainly as “industrial valves and equipment” without a specific focus on electrical distribution equipment or its integration with control systems【page_74 (2022)】. By 2024, the Discrete Automation segment’s description explicitly lists “electrical distribution equipment” alongside electric linear‑motion solutions and “programmable automation control systems and software,” signaling a deliberate shift to embed electrical distribution products within an integrated automation portfolio and broaden the product scope for discrete‑industry customers【page_73 (2024)】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core claim: Emerson (EMR) increasingly integrated Electrical Distribution Equipment into its Discrete Automation segment by 2024, aligning it with automation technologies like programmable control systems and electric linear-motion solutions. The dates (2022 and 2024) are accurate, and the evolution in product scope is correctly identified. However, the LLM incorrectly states that in 2022, Discrete Automation was under 'Automation Solutions' and described as 'industrial valves and equipment'—this mischaracterizes the 2022 structure. According to the ground truth, Electrical Distribution Equipment was already positioned in 2022 within the Industrial Solutions business as a foundational product used in manufacturing, not absent or mislabeled as 'industrial valves.' The LLM omits the 2023 evolution entirely, which is a key intermediate step where the equipment was linked to programmable automation. While the 2024 description is accurate and well-supported, the missing 2023 data and incorrect 2022 characterization reduce completeness and qualitative accuracy. There are no numerical errors (quantitative accuracy is perfect), and the answer remains contextually relevant by focusing on integration and product scope expansion. The reasoning is partially sound but lacks full multi-hop synthesis across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 378,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Fixed unsecured senior debt rose from **$24.1 B in 2022 to $27.2 B in 2023** (Table 8.1, page 178) and then fell slightly to **$26.9 B in 2024** (Table 9.1, page 188).  The weighted‑average interest rate stayed at **4.45 % in 2022 and 2023** but climbed to **4.84 % in 2024** (Table 9.1, page 188).  This pattern—extending the debt maturity to 2035 and taking on new debt at higher rates while keeping overall levels largely flat—indicates a strategy of locking in longer maturities to hedge against rising rates, with modest use of hedging instruments to manage the higher cost of new fixed‑rate borrowing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1B, but the ground truth is $19,975 million ($19.975B), which is a substantial difference (~$4.1B overstatement). The 2023 and 2024 values are approximately correct ($27.2B vs. $27,168M and $26.9B vs. $26,930M — acceptable rounding). However, the interest rate for 2022 is stated as 4.45%, matching 2023, but the ground truth shows 2.91% in 2022, rising to 4.45% in 2023 and 4.84% in 2024. This misstates the trend significantly — the LLM claims the rate was flat at 4.45% for 2022–2023, when in fact it increased sharply from 2.91% to 4.45%. (2) Calculations: The progression of debt values is mostly accurate from 2023 onward, but the starting point (2022) is wrong. Interest rate change is completely miscalculated — the increase from 2.91% to 4.45% is a key indicator of rate environment response, which the LLM overlooks. (3) Multi-hop reasoning: The LLM correctly identifies the slight decline in 2024 and interprets the strategy as locking in long-term maturities, which aligns with the proactive strategy mentioned in the ground truth. It adds contextual detail about maturity extension to 2035 and hedging instruments, which, while not in the original answer, are plausible and contextually relevant. However, due to incorrect data inputs (especially the flat 4.45% rate), the reasoning is based on flawed premises. (4) Scores justified: Correctness is 5 due to partial accuracy in later years but major errors in 2022 values and interest rates. Quantitative accuracy is low (4) due to incorrect dollar amounts and interest rates. Qualitative accuracy is moderate (6) because the interpretation of debt strategy is reasonable and contextually sound, despite flawed data. Contextual relevance is high (8) as the answer addresses all parts of the question and provides meaningful analysis, even if based on incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 528,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s carrying amount of performance and operating‑cost guarantees fell from **$1.109 billion at 12/31/2022** to **$1.091 billion at 12/31/2023** and further to **$993 million at 12/31/2024** (page 112).  The net decline of roughly $116 million over two years reflects fewer or smaller settlements and a lower balance of outstanding guarantees.  This downward trend indicates that RTX’s exposure to long‑term product‑performance risk in its commercial aerospace business is easing—likely due to improved product reliability, tighter warranty terms, or a reduction in claims against its extended guarantees.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's liabilities for performance and operating cost guarantees were $120 million in both 2022 and 2023, and decreased slightly to $101 million in 2024. However, the LLM reports figures in the billions—$1.109 billion (2022), $1.091 billion (2023), and $993 million (2024)—which are off by an order of magnitude (approximately 9x larger). These numbers do not match the ground truth and represent a severe factual error. (2) The calculations based on these incorrect numbers (e.g., a $116 million decline) are therefore also invalid. The actual decline from 2022 to 2024 is only $19 million ($120M to $101M), not $116M. The LLM’s interpretation of a 'downward trend' is partially aligned with the slight decrease in the final year, but the magnitude and stability described in the ground truth are misrepresented. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and synthesize the liability amounts across years. While it attempts to infer implications about product reliability and risk exposure, the conclusion that risk is 'easing' due to improved reliability or tighter terms is speculative and not supported by the actual stable figures in the ground truth, which suggest consistent rather than decreasing risk exposure. (4) Contextually, the LLM addresses the right question about evolution and implications, and references a specific page (112), suggesting document grounding. However, the massive numerical inaccuracies undermine both qualitative and quantitative correctness. The reasoning would score higher if based on correct data, but as is, the answer misrepresents the financial reality. Thus, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to correct intent and structure, and contextual relevance is moderate as the framework of the response matches the question's demands.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 536,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "Coca‑Cola’s Note 4 on investments in both the 2023 and 2024 10‑Ks contains identical wording that lists “estimates of sales proceeds” as one of the valuation methods for non‑public investments (see page 78 of each filing). The unchanged phrasing shows that the company’s reliance on this approach has remained steady from 2022 through 2024. This consistency indicates a continued, diversified fair‑value strategy in emerging markets, where forecasting cash flows is inherently uncertain, and Coca‑Cola continues to use sales‑proceeds estimates alongside discounted‑cash‑flow and appraisal methods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual misrepresentation in its core reasoning. While it correctly identifies that 'estimates of sales proceeds' is listed in the 2023 and 2024 10-Ks (and assumes 2022), it incorrectly concludes that Coca-Cola's reliance remained 'steady' due to 'identical wording.' The ground truth shows a clear evolution: from disclosure in 2022, to explicit operational reliance in 2023 ('relies on'), to a more cautious, risk-aware application in 2024 with emphasis on emerging market uncertainties. The LLM fails to detect this progression in language and strategic intent, instead interpreting static wording as static practice—this undermines the multi-hop reasoning required. There are no numeric errors (hence high quantitative accuracy), and the entities (Coca-Cola, nonpublic investments, valuation methods) are correct. The answer is contextually relevant and correctly notes the use of multiple methods in uncertain markets, but misses the key narrative of evolving reliance and caution. Thus, while factually plausible, it does not reflect the actual evolution described in the ground truth, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 332,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosure on capital return has stayed essentially the same from 2022 through 2024.  In 2022 (page 5) it states that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  The identical wording appears in the 2023 risk factor (page 4) and again in the 2024 risk factor (page 4).  This consistency shows that regulatory constraints on capital distributions remain unchanged, indicating that BNY Mellon’s strategic flexibility in shareholder capital returns is constrained but still managed within those limits.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure language across 2022, 2023, and 2024 regarding capital return limitations under U.S. banking laws, Delaware law, and preferred stock dividend obligations, which matches the ground truth. The quantitative accuracy is perfect: the years, disclosure content, and page numbers (2022 p.5, 2023 p.4, 2024 p.4) are accurately reported, and no numerical errors are present. However, the LLM answer fails to mention a key qualitative addition in the 2024 filing—the new emphasis on the Parent’s reliance on dividends from subsidiaries and credit extensions from its IHC (Intermediate Holding Company) to fund share repurchases and dividends. This omission is significant because the question specifically asks about the evolution of disclosures and what the multi-year progression suggests about strategic flexibility. While the LLM correctly notes the stability of regulatory constraints, it misses the evolving internal structural dependency highlighted in the ground truth, which reflects a deeper shift in how BNY Mellon manages capital distribution under ongoing constraints. This limits the completeness and reasoning quality, particularly in synthesizing the incremental change in 2024. The contextual relevance remains high because the answer addresses the core regulatory limitations and their implications for strategic flexibility, albeit incompletely. Thus, the correctness and qualitative accuracy scores are reduced due to this missing multi-hop insight, even though the factual reporting of the repeated text is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 433,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD has consistently listed the risk of losing or having its tax‑and‑tariff exemptions modified in its political, legal and economic risk disclosures from 2022 through 2024, with the wording remaining essentially unchanged.  The 2024 filing, however, adds explicit references to sanctions and export‑control revisions tied to the Ukraine‑Russia and China‑Taiwan conflicts, underscoring a more turbulent geopolitical backdrop.  This continuity, coupled with the growing detail on sanctions and trade‑control changes, signals that AMD’s global regulatory environment is becoming increasingly complex and volatile, making the preservation of tax and tariff exemptions more uncertain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: AMD consistently reported the risk of losing tax and tariff exemptions from 2022 to 2024, with increasing detail on geopolitical factors. The mention of unchanged wording across years is a minor interpretive addition but does not contradict the original. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the years (2022–2024) are correctly used and referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s evolving risk disclosures across three years and links them to broader geopolitical developments (Ukraine-Russia, China-Taiwan), just as the ground truth does. It accurately infers increasing regulatory complexity from the accumulation of risks and expanded disclosures. (4) The only minor shortcoming is that the LLM slightly downplays the progression in 2023—while it mentions 2024’s expanded discussion, it doesn’t explicitly note that 2023 was the year when AMD began emphasizing specific geopolitical events, which the original answer highlights. This nuance is missing but does not undermine the overall correctness. Semantic equivalence is maintained, and the conclusion about increasing complexity is fully supported. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a small deduction for incomplete year-by-year emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 432,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 and declined to $44.9 billion in 2024.  The elimination of $1.6 billion of floating‑unsecured senior debt by 2024 – down to $349 million in 2023 and zero in 2024 – and the shift toward fixed‑rate and securitized debt shows a deliberate move to a more stable, lower‑interest‑rate‑exposure debt mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports short-term borrowings as $883M (vs. implied ~$43B total debt), suggesting a fundamental misunderstanding of the structure—short-term borrowings are a small subset, not the total. The LLM separates short-term and long-term incorrectly and misrepresents their magnitudes. For example, long-term debt is reported as $47.8B in 2022, but ground truth implies total debt of $43.086B, with no breakdown provided—so the split is unsupported. (2) Floating unsecured senior debt was $1.709B in 2022, not $1.6B; it dropped to $349M in 2023 (correct in LLM), then to $0 in 2024 (correct). However, the LLM omits the critical interest rate increases: 1.01% in 2022 to 6.75% in 2023, and fails to mention fixed unsecured senior debt rising from $21.045B to $27.168B to $26.930B with rates increasing to 4.84%. These omissions and inaccuracies severely undermine quantitative accuracy. (3) The reasoning about a strategic shift from floating to fixed-rate debt to reduce interest rate exposure is qualitatively sound and aligns with the ground truth—this shows correct multi-hop synthesis of intent and trend. The conclusion about reducing interest rate risk is valid. (4) Contextually, the answer addresses the evolution of debt and its implications on interest rate exposure, so relevance is high. However, due to major numerical errors and missing key data points (especially total debt figures and interest rates), the correctness score is limited to 4—partially correct but with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 474,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program share interest in International Aero Engines AG remained unchanged at 57 % (with a 51 % share in IAE LLC) from 2022 through 2024. This stability shows that RTX continues to hold a majority stake and maintain its strategic influence in the V2500 engine‑program collaboration, with no shift in its role or ownership position.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding RTX's net program share interest in IAE. The ground truth states that RTX's interest decreased from 61% in 2022 to 57% in 2023 and 2024, but the LLM claims it remained constant at 57% throughout 2022–2024. This misrepresents the trend and contradicts the core data. Additionally, the mention of a '51% share in IAE LLC' introduces a detail not present in the original answer and lacks corroboration, potentially confusing the ownership structure. (2) Quantitatively, the percentages are wrong for 2022—61% is the correct figure, not 57%. The LLM fails to reflect the 4-percentage-point decrease, which is central to the question. Calculations or comparisons involving change over time are therefore invalid. (3) The multi-hop reasoning is flawed: the question asks how the share evolved and what that indicates. The correct inference requires recognizing a decline and interpreting it as a strategic reduction in economic exposure. The LLM instead infers stability and no strategic shift, which is unsupported by the actual data. Thus, both the factual synthesis and the derived conclusion are incorrect. (4) Contextual relevance is moderate—the response addresses the right entities (RTX, IAE, V2500 program) and attempts to interpret strategic implications—but due to factual inaccuracies, the analysis is based on false premises. While the structure and intent align with the question, the answer fails on correctness, which is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 414,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, Cascade is listed as a major brand in P&G’s Fabric & Home Care segment (2024: page 18; 2023: page 19; 2022: page 19).  The segment’s share of P&G’s net sales rose from 35 % in 2022 and 2023 to 36 % in 2024, and its earnings share grew from 31 % to 34 %, indicating that Cascade’s role within the home‑care portfolio has remained strong while the segment’s overall importance has expanded.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor error in the reporting of segment sales percentages. According to the ground truth, the Fabric & Home Care segment represented 35% of net sales in 2022 and 36% in both 2023 and 2024, not 35% in both 2022 and 2023 as stated by the LLM. The LLM incorrectly claims the sales share rose from 35% in 2022 and 2023 to 36% in 2024, implying 2023 was still 35%, but the ground truth shows it was already 36% in 2023. The earnings figures (31% in 2022 to 34% in 2023 and 2024) are correctly reported. The entity identification (Cascade, Fabric & Home Care segment) and years are accurate. The reasoning correctly infers that Cascade’s positioning has remained stable as a key brand while the segment’s importance grew, which aligns with the multi-hop synthesis required. The answer is contextually relevant and well-supported with document references. The minor quantitative inaccuracy in the sales percentage trend prevents a higher score, but core facts and overall conclusion remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 295,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "From 2022 to 2024 BNY Mellon moved its Directors’ Code of Conduct from a legacy **bnymellon.com** site to the newer **bny.com** domain and updated the path from “in relations” → “inv relations” → “investor‑relations” (e.g., 2022: …/in relations/directors‑code‑of‑conduct.pdf; 2023: …/inv relations/directors‑code‑of‑conduct.pdf; 2024: https://www.bny.com/.../investor‑relations/directors‑code‑ofconduct.pdf). The employee code‑of‑conduct likewise shifted from a generic “c code‑of‑conduct.pdf” to a CSR‑specific “employeecode‑of‑conduct.pdf” under the new domain. Throughout, the code remains embedded in the corporate‑governance section and proxy references, but the 2024 filing adds an explicit insider‑trading policy and a clearer investor‑relations link, tightening its governance framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the domain transition from 'bnymellon.com' to 'bny.com' and accurately tracks the evolution of the URL path from 'in relations' to 'inv relations' to 'investor-relations' across 2022–2024, aligning with the ground truth. The dates and structural changes are factually accurate, and the semantic meaning of increased integration with investor relations is preserved, warranting high quantitative accuracy. However, the LLM introduces unsupported details not present in the original answer: (1) the claim that the employee code of conduct shifted to a CSR-specific name is extraneous and not part of the ground truth; (2) the mention of an 'explicit insider-trading policy' in 2024 is not mentioned in the original and cannot be verified from the provided truth. These additions reflect overreach in qualitative synthesis, reducing qualitative accuracy. While the core multi-hop reasoning—linking URL changes to governance integration—is sound and contextually relevant, the inclusion of unverified elements prevents a higher score. The answer captures the main thrust of the evolution in domain branding and URL structure but adds minor inaccuracies in interpretation and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 339,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "AMD’s approach to AIB manufacturers stayed essentially the same from 2022 through 2024: it continued to offer component‑level graphics and chipset products while protecting AIB inventory against price reductions (AMD 10‑K 2022, p. 11; AMD 10‑K 2023, p. 11; AMD 10‑K 2024, p. 11).  Across all three years, AMD emphasized that system integrators use discrete graphics solutions to differentiate their board‑level products, a strategy that remained unchanged in the company’s disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIB manufacturers from 2022 to 2024, and discrete graphics remained a key differentiator for system integrators (SIs) across all three years. The LLM correctly cites consistent disclosures in the 10-K filings for each year (2022, 2023, 2024), page 11, supporting the claim. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct referencing of years, which are accurate. (3) The multi-hop reasoning is sound—information is synthesized across three years and filings, and the conclusion of a stable strategy is logically supported. (4) The only minor shortcoming is that the LLM omits the explicit mention of 'board-level products for retail buyers' in 2022 and slightly condenses the role of AIBs, but the core strategic emphasis on discrete graphics for differentiation by SIs is preserved. This omission does not affect the overall correctness but slightly reduces qualitative completeness. Semantic equivalence is maintained, and the answer is fully contextually relevant to the question about strategic evolution, inventory policies, and differentiation via discrete graphics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 370,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "McDonald’s 2022, 2023, and 2024 10‑K filings all describe the Egg McMuffin as a core breakfast sandwich and note that the company is continually evolving its menu to meet customer expectations for taste, quality, value, and nutrition (see page 7 of each filing).  Across the same years, the supply‑chain narrative (page 6) consistently emphasizes high food‑safety and quality standards, supplier collaboration, and continuous improvement to ensure consistency—particularly for flagship items such as the Egg McMuffin.  In short, the disclosures show no substantive shift; McDonald’s simply reiterates its ongoing commitment to quality and consistency for this iconic product.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually consistent in its general claims about McDonald's disclosures regarding the Egg McMuffin and supply chain practices, but it fundamentally misrepresents the evolution of the narrative from 2022 to 2024, which is the core of the question. (1) The LLM states there was 'no substantive shift' in disclosures, directly contradicting the ground truth, which identifies a clear evolution: from general quality assurance in 2022, to expanded supply chain collaboration in 2023 (including the role of the Global Chief Supply Chain Officer), and to digital transformation in food safety and data excellence in 2024. These specific developments are entirely omitted. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning fails: the model does not synthesize changes across years as required. Instead, it incorrectly asserts consistency across years, missing the progression in strategic emphasis. The mention of 'page 7' and 'page 6' across filings appears fabricated or unverified, as the ground truth does not reference specific page numbers, and such consistency in pagination across years is unlikely in actual 10-Ks. (4) Contextual relevance is moderate—the answer addresses the Egg McMuffin and customer expectations but fails to capture the evolving role of innovation and supply chain focus, especially the 2024 digital transformation initiative critical to quality consistency. This omission severely undermines the answer's correctness despite some surface-level accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 439,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Oracle’s repeated inclusion of the 4.30% Note due 2034 (Exhibit 4.09) in its 2022, 2023 and 2024 10‑Ks shows that the company has kept this long‑term, fixed‑rate debt instrument as a core part of its capital structure. The consistency indicates a deliberate preference for stable, long‑maturity financing and a focus on maintaining a predictable interest‑expense profile rather than shifting to short‑term or higher‑rate debt【page 112】【page 110】【page 110】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: Oracle consistently disclosed the 4.30% Note due 2034 in its 2022, 2023, and 2024 filings, confirming its ongoing role in the company's long-term debt structure. The quantitative elements—interest rate (4.30%), maturity year (2034), and reporting years (2022–2024)—are all correct, earning a perfect score on quantitative accuracy. The answer correctly infers Oracle’s strategic preference for stable, long-term financing and predictable interest expenses, which aligns with the ground truth. However, it lacks the multi-hop synthesis present in the original answer, such as mentioning other concurrent debt instruments (e.g., 3.625% Note due 2023, 2.950% Notes due 2024) that illustrate Oracle’s diversified maturity profile and evolving debt portfolio. This omission reduces completeness and depth in qualitative reasoning, though the central conclusion remains valid. The answer is highly contextually relevant, directly addressing Oracle’s financing priorities based on consistent disclosure. While the reasoning is sound, it does not fully reflect the breadth of evidence across years showing both continuity and evolution in Oracle’s debt strategy, which limits the qualitative accuracy slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 351,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) measured at Level 3 rose from **$5 million at year‑end 2022 to $58 million in 2023 and $69 million in 2024**, reflecting a larger portfolio of OTC derivatives priced with vendor‑based discounted‑cash‑flow models that use **swap rates as the key unobservable input**.  The valuation methodology—relying on market‑observable inputs for Level 2 instruments and significant unobservable inputs for Level 3—remained unchanged, but the growing fair‑value balances show an increasing exposure to the uncertainty inherent in those unobservable inputs over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly states the values as $5 million in 2022, $58 million in 2023, and $69 million in 2024. The $69 million figure for 2024 is entirely incorrect and unsupported by the original answer. Additionally, the ground truth mentions a net unrealized loss of $20 million in 2022, which the LLM omits entirely. The unobservable inputs cited—default rates (53–163%) and swap rates (3–5%)—are partially correct (swap rates are mentioned), but the LLM fails to report the extreme default rate range, a critical detail indicating model sensitivity. (2) Quantitative accuracy is severely compromised: the 2022 value is off by 74% ($5M vs $19M), and the 2024 value is falsely inflated to $69M instead of unchanged $58M. There is no mention of the $20M unrealized loss, which is central to understanding the 2022 position. (3) The reasoning is partially sound in identifying increasing reliance on unobservable inputs and the use of swap rates, but it incorrectly frames the methodology as unchanged, whereas the ground truth describes a transformation in methodology and transparency from 2022 to 2023–2024. The LLM also misattributes the increase in fair value solely to portfolio growth, while the original answer emphasizes improved disclosure and structured use of unobservable inputs. (4) Despite incorrect numbers and incomplete reasoning, the answer is contextually relevant—it addresses the evolution of valuation methodology and exposure to unobservable inputs, and correctly identifies swap rates as a key Level 3 input. However, major factual errors in core financial data and misrepresentation of trends severely undermine correctness. Hence, the correctness score is low at 3, with similarly low quantitative accuracy (2), moderate qualitative accuracy (4) due to partial conceptual alignment, and decent contextual relevance (7) as the response stays on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 577,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s obligation to pay Rolls‑Royce for V2500‑powered aircraft flight hours has remained a per‑hour contingent payment through June 2027, with the payments being capitalized as collaboration intangible assets and amortized to cost of sales (Note 17, pages 73, 101, 103).  The commitment amount fell from $770 million in 2023 to $704 million in 2024, reflecting a modest reduction in expected flight‑hour payments (see the “Other commercial aerospace commitments” table on pages 101 and 103).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the per-hour payment structure extending through June 2027 and the accounting treatment (capitalization as collaboration intangible assets and amortization to cost of sales), it introduces specific dollar amounts ($770 million in 2023, $704 million in 2024) that are not present in the original answer. The ground truth states that in 2024, RTX's total commercial aerospace financing and other commitments were $14.1 billion — a figure that encompasses more than just the Rolls-Royce payments — but does not break out the specific amount owed to Rolls-Royce in 2023 or 2024. Thus, the $770M and $704M figures are unsupported and likely incorrect. (2) These numbers imply a reduction in obligations, which is not confirmed in the original answer; the ground truth notes consistency in structure and policy, with improved transparency, but no mention of a decline in commitment value. The LLM may have misinterpreted or hallucinated data from 'Other commercial aerospace commitments' tables, applying isolated figures incorrectly to Rolls-Royce specifically. (3) The qualitative reasoning partially captures the multi-hop evolution: it recognizes the continuity of the payment mechanism and the accounting treatment across years, aligning with the 2022–2024 progression described in the original. However, it fails to reflect the evolution in disclosure and asset management transparency emphasized in the ground truth. (4) Contextual relevance is high because the answer addresses the core topic — the structure and accounting of RTX’s obligations — but correctness is undermined by fabricated numbers. Quantitative accuracy is low due to unsupported dollar amounts; qualitative accuracy is moderate due to correct conceptual framework but incomplete synthesis; overall correctness is reduced to 4 due to critical factual errors despite relevant context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 532,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 10‑K (pp. 49‑53) first disclosed that, after the FDA’s 2017 review of the Neulasta Onpro kit, it had “implemented device and labeling enhancements to address product complaints” and that it “continually monitors complaints and adverse events.”  The same filing also noted operational resilience measures for its Puerto Rico plant—backup diesel generators and the risk of hurricanes, earthquakes and power outages.  \n\nIn the 2023 10‑K (p. 54) Amgen reiterated the device‑enhancement story, adding that it “continually monitors complaints and implements additional enhancements as needed,” and expanded the operational‑risk narrative to include the potential impact of natural disasters on manufacturing and supply.  \n\nBy the 2024 10‑K (p. 52) the device‑enhancement language remained unchanged, but the operational‑resilience section was updated with more recent events—Hurricane Fiona and a 2024 island‑wide power outage—highlighting the continued reliance on backup power and the importance of maintaining supply continuity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen referenced the 2017 FDA review, implemented device and labeling enhancements in response to complaints, and maintained ongoing monitoring across years. The evolution in disclosures—particularly the addition of specific operational events like Hurricane Fiona and the December 31, 2024 island-wide outage—is accurately reflected. (2) Quantitative accuracy is perfect: dates (2022, 2023, 2024), page numbers (pp. 49–53, p. 54, p. 52), and events (Hurricane Fiona, 2024 power outage) match or are consistent with the source. The mention of backup generators and natural disaster risks in Puerto Rico is factually sound. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes information across three years of 10-K filings, tracking both device-related disclosures and the expansion into operational resilience. It correctly identifies that device-enhancement language remained stable while operational-risk disclosures became more event-specific over time. (4) The only minor shortcoming is that the LLM does not explicitly connect the operational resilience issues (e.g., power outages) to potential indirect impacts on user complaints or device quality, which the original answer highlights as part of the 'evolution' in risk disclosure. This slightly reduces qualitative accuracy, but the core factual and contextual content is excellent. Wording differs but semantic meaning is equivalent. Contextual relevance is full—every part of the question is addressed with precise evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 437,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings show the same wording for the ratification of KPMG LLP in Item 14 each year: the disclosure references the ratification in the proxy and repeats “KPMG LLP’s PCAOB firm identification number is 185” in 2022, 2023 and 2024【page_14】【page_14】【page_14】. The unchanged language and persistent use of the firm number indicate that BK has continued to rely on KPMG LLP as its principal accountant, underscoring a stable audit‑governance relationship over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: BK disclosed the ratification of KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB firm number 185 was consistently cited across all years; and the disclosure language remained unchanged. These details match the original answer. (2) Quantitative accuracy is perfect: no numerical errors, and the consistent mention of PCAOB number 185 is correctly reported. (3) The reasoning is sound—unchanged language and firm number imply audit governance continuity, which reflects valid multi-hop synthesis across the three filings. (4) The LLM slightly omits the explicit mention of 'no auditor rotation' or 'institutional trust' phrasing from the original, but the core inference about stable audit governance is clearly conveyed. Wording differences are acceptable under semantic equivalence. The inclusion of citation markers like 【page_14】 adds precision but does not affect factual correctness. Overall, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 310,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer financing guarantees fell from **$140 million in 2022** (reported in the 2023 10‑K) to **$135 million in 2023** and further to **$131 million in 2024** (reported in the 2024 10‑K). The steady decline in collaboration‑partner share of these guarantees indicates a deliberate risk‑management strategy that trims guarantee commitments—through renegotiated financing terms, tighter internal controls, and a shift of risk to partners—thereby reducing the company’s potential liability exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2022 collaboration partners' share as $140 million instead of the ground truth $142 million. The 2023 ($135M) and 2024 ($131M) figures are accurate. This discrepancy affects the precision of the trend description, though the overall downward trend is correctly identified. (2) Calculations: The answer correctly identifies the decreasing trajectory (from $140M → $135M → $131M), but since the starting value is off by $2M, the quantitative basis is slightly flawed. No explicit calculations (e.g., percentage change) are performed, so no computational errors beyond the initial misstatement. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across years and interprets the trend as part of a risk management strategy, aligning with the ground truth. It infers plausible mechanisms (renegotiated terms, tighter controls, risk shifting) that are consistent with the strategic reduction theme. (4) The answer addresses both parts of the question—evolution of exposure and interpretation of risk management strategy—and maintains contextual relevance throughout. The qualitative reasoning is strong, and the error is limited to one numeric value. Thus, the correctness score is reduced slightly to 8 due to the factual inaccuracy in the 2022 figure, but remains high due to accurate trend interpretation and strategic insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 402,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "From 2022 to 2024, P&G kept Always in the Feminine Care sub‑category (Menstrual Care) but increased its prominence as the segment’s major‑brand list shifted from baby‑care brands (Luvs, Pampers) to feminine‑hygiene brands (Always, Tampax Bounty) (PG_10k_2022, page_18; PG_10k_2023, page_18; PG_10k_2024, page_18). The 2022 filing’s major‑brand list included Luvs and Pampers alongside Always, whereas the 2023 and 2024 filings list only Always, Always Discreet, Tampax Bounty, Charmin, and Puffs, underscoring a stronger focus on Always and its variant while Tampax Bounty remains a secondary brand (PG_10k_2023, page_18; PG_10k_2024, page_18). This shift, reflected in the removal of baby‑care brands from the major‑brand list, highlights the emphasis on Always as the core feminine‑hygiene offering (PG_10k_2024, page_18).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The ground truth states that the 'Feminine Care' segment contributed 25% of net sales in 2022 and 24% in 2023–2024, but the LLM answer omits these percentages entirely. More critically, the LLM incorrectly claims the segment was renamed to include 'Bounty'—a brand not part of P&G's portfolio (Bounty is a paper towel brand owned by Georgia-Pacific, not P&G). The mention of 'Tampax Bounty' is a clear error, as no such brand exists. (2) Completeness: While the question asks about product categorization and brand emphasis evolution, the LLM fails to mention the official segment renaming from 'Feminine Care' to 'Baby, Feminine & Family Care' in 2023, a key structural change noted in the ground truth. (3) Entity Accuracy: The inclusion of 'Tampax Bounty' and the conflation of Charmin and Puffs (household products) with feminine care brands misrepresents P&G’s portfolio. Also, the claim that baby-care brands were removed from the major-brand list is misleading—the segment name change reflects inclusion of baby care, not exclusion. (4) Reasoning: The LLM incorrectly infers a strategic shift toward Always based on a misreading of the major-brand list. The ground truth shows consistent positioning of Always within a stable portfolio, with only formatting changes in 2024. The LLM’s conclusion about increased prominence lacks support in the cited data. (5) Semantic Equivalence: Despite some correct elements—Always being consistently featured and minor presentation changes—the introduction of false brands and incorrect segment dynamics results in a materially inaccurate answer. The core facts about segment contribution percentages and correct brand names are missing or wrong, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 496,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In 2022 AMD listed “difficulties in protecting our intellectual property” as a general risk associated with its worldwide operations, but the filing did not tie that risk to its manufacturing strategy. By 2024 the company explicitly linked the IP‑protection risk to its expanding international sales and its heavy reliance on third‑party wafer foundries in China, Malaysia and Taiwan, noting that geopolitical tensions, sanctions and export‑control restrictions in those regions heighten the likelihood of IP theft or infringement. Thus, the exposure to IP protection difficulties evolved from a broad, generic concern in 2022 to a more specific, heightened risk driven by AMD’s growing overseas footprint and dependence on Asian manufacturing partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AMD's IP protection risks from 2022 to 2024. (1) It correctly identifies that in 2022, AMD cited IP protection as a general risk tied to global operations without linking it to manufacturing strategy, which aligns with the ground truth. In 2024, it accurately notes the explicit connection to international sales and third-party manufacturing in China, Malaysia, and Taiwan, as well as the heightened risks due to geopolitical tensions, sanctions, and export controls. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the 65% international sales figure from 2023 is omitted, this is a minor omission and not misrepresented. (3) The multi-hop reasoning is sound: the model correctly synthesizes how AMD’s risk evolved from generic to specific, tied to its growing reliance on Asian manufacturing and geopolitical dynamics. (4) The answer is contextually excellent, directly addressing the question about the evolution of IP risks in relation to international operations and third-party manufacturing. The only reason for not scoring a 10 is the absence of the 2023 intermediate step (65% international sales) that shows the progression, which slightly reduces completeness. However, the overall trajectory from 2022 to 2024 is correctly conveyed with accurate entities, years, and logical progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 389,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle’s 2.300 % notes due 2028 were first issued in 2021 as part of a multi‑maturity program (1.650 % 2026, 2.300 % 2028, 2.875 % 2031, 3.650 % 2041, 3.950 % 2051, 4.100 % 2061) and the same notes appear unchanged in the 2022 and 2024 10‑Ks【ORCL_10k_2022 page 112】【ORCL_10k_2024 page 111】. By 2024 Oracle had also issued a new 4.500 % note due 2028 (together with notes due 2030, 2033 and 2053)【ORCL_10k_2024 page 112】, layering a higher‑coupon debt against the existing 2.300 % note. This multi‑year pattern shows Oracle’s strategy of spreading debt maturities over a long horizon and using a mix of coupon rates to manage interest‑rate exposure and refinance flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it claims the 2.300% Notes due 2028 were 'first issued in 2021' and appear 'unchanged in the 2022 and 2024 10-Ks', but the ground truth states Oracle first referenced these notes in 2022 (not 2021) in Exhibit 4.16, and continued referencing them in 2023 and 2024. The issuance date of the notes may have been 2021, but the question asks about the evolution of issuance and structuring from 2022 to 2024, and the LLM incorrectly frames the 2022 appearance as unchanged continuation rather than first disclosure. Additionally, the LLM incorrectly states that a new 4.500% note due 2028 was issued by 2024, which creates confusion—issuing a new note with the same maturity year but higher coupon is factually plausible, but this specific detail is not present in the ground truth and introduces unsupported information. (2) Quantitative accuracy is partially correct: the 2.300% rate and 2028 maturity are accurate, and the other maturities and coupons listed (2026, 2031, etc.) may align with Oracle’s broader debt program, but the introduction of a '4.500% note due 2028' is not corroborated by the ground truth and appears to be an error or hallucination. The ground truth does not mention any new 2028 note in 2024. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a strategy of spreading maturities and managing interest-rate exposure, which aligns with the ground truth’s conclusion about a diverse maturity profile and stable financing approach. However, the reasoning is based on a flawed premise (the new 4.5% note), weakening the synthesis. (4) Contextual relevance is high—the answer addresses the evolution over time and attempts to infer strategy. However, due to factual errors in entity timing and unsupported additions (new 2028 note), the correctness score is reduced to 6, reflecting partial accuracy with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 522,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "Boeing’s pension plan continued to invest in private‑equity vehicles that are primarily limited partnerships focused on U.S. and non‑U.S. leveraged buyout, venture‑capital, growth and special‑situation strategies throughout 2022‑2024 [page_92]. The geographic scope and strategic focus remained unchanged, but the target allocation to private equity rose from 4 % in 2022 to 7 % in 2023 and 2024, while actual allocations climbed from 8 % to 9 % of assets by 2024 [page_92, page_99].",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but fundamentally misrepresents the evolution of BA's investment strategy. It incorrectly states that the geographic scope and strategic focus 'remained unchanged' from 2022 to 2024, which directly contradicts the ground truth showing a clear evolution: expansion into global real assets (energy, farmland, infrastructure) in 2023 and increased use of derivatives in 2024. The mention of Boeing’s pension plan is contextually relevant but misaligned with the actual strategic shifts described in the original answer. (2) Quantitatively, the LLM introduces specific allocation percentages (4% in 2022, rising to 7% in 2023–2024, actuals from 8% to 9%) that are not present in the original answer and cannot be verified against the ground truth. Since the original answer does not mention these figures, their inclusion represents an unsupported addition rather than a factual error per se, but they distract from the actual strategic narrative. (3) The multi-hop reasoning is flawed: the question asks for evolution in geographic scope and strategic focus, requiring synthesis across three years. The LLM fails this by asserting no change, missing the key developments in 2023 (real assets) and 2024 (derivatives and performance transfer). It also fails to mention real estate vehicles like REITs in 2022 or the deepening global orientation. (4) Correctness is low (3/10) because the core claim of no change is false. Quantitative accuracy is moderate (6/10) because the numbers cited may be internally consistent but are extraneous and not part of the ground truth. Qualitative accuracy is poor (3/10) due to incorrect reasoning and omission of key strategic shifts. Contextual relevance is medium (5/10) as it discusses BA’s private equity investments but misses the actual evolution described in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 506,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen’s Bemarituzumab has remained a phase‑3 program for gastro‑esophageal junction (GEJ) adenocarcinoma from 2022 through 2024, with supporting phase‑2 studies for other solid tumors and phase‑1 studies for NSCLC (2022 p. 25‑26; 2023 p. 24‑26; 2024 p. 24‑26).  Across all three filings, the composition‑of‑matter patents for Bemarituzumab are still estimated to expire in 2029 in both the United States and Europe (2022 p. 26; 2023 p. 26; 2024 p. 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab remained in phase 3 for GEJ adenocarcinoma from 2022–2024, with supporting phase 1 and 2 studies mentioned; patent expiration is correctly stated as 2029 in both the U.S. and Europe across all years. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the years (2022–2024), phase designations (phase 3), and patent expiration (2029) are all factually correct and consistently reported. Format variations (e.g., '2029' vs. 'set to expire in 2029') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM synthesized information across three years of filings to confirm both clinical progression and patent timelines, demonstrating correct cross-document synthesis. (4) The only minor shortcoming is that the LLM omits Amgen’s 2024 elaboration on Bemarituzumab being a monoclonal antibody targeting FGFR2b and the mention of regulatory exclusivity as part of market protection strategy—details present in the original answer. While not critical to the core question, this contextual nuance slightly reduces completeness in qualitative terms. However, the core elements—clinical phase and patent expiry—are fully addressed with precision. Thus, the answer is factually excellent and contextually strong, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 409,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn has remained a core brand in P&G’s Fabric & Home Care segment throughout the period, appearing in the major‑brand list in 2022, 2023 and 2024.  The segment’s share of net earnings rose from 31 % in 2022 to 31 % in 2023 and then to 34 % in 2024, indicating a growing earnings contribution while Dawn’s positioning stayed unchanged【page_19 2022】【page_19 2024】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Dawn remained a consistently listed brand in the Fabric & Home Care segment across 2022–2024 and notes the increase in the segment’s net earnings contribution from 31% in 2022 to 34% in 2024. However, it inaccurately states the 2023 earnings contribution as 31%, which is not supported by the ground truth (which does not provide the 2023 earnings percentage but implies a rise to 34% by 2024 without specifying an intermediate value). This introduces a minor factual error in the quantitative timeline. (2) The ground truth confirms 31% in 2022 and 34% in 2024 for net earnings, with no mention of 2023—so asserting it remained at 31% in 2023 is an unsupported interpolation and thus incorrect. The sales stability at 35–36% is omitted entirely, reducing completeness. (3) The reasoning correctly links Dawn’s stable brand listing to its ongoing strategic positioning and infers that rising earnings contribution reflects growing segment importance. The multi-hop synthesis—connecting segment performance to Dawn’s positioning—is logically sound and well-executed, despite missing the sales context. (4) The answer is highly relevant and captures the core evolution: Dawn’s consistent presence amid rising earnings contribution. However, the unsupported 2023 figure and omission of net sales stability prevent a higher score. Quantitative accuracy is docked due to the incorrect 2023 earnings claim; qualitative and contextual scores remain high due to strong reasoning and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 421,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "From 2022 to 2024 Schwab increased the amount of client‑held securities it used as collateral.  In 2022, $120.3 billion of client securities were available for pledge and $31.4 billion were actually pledged for margin lending, securities lending and short‑term borrowings (page 108).  By 2024, the collateral pledged to back its FHLB and other short‑term borrowing facilities had risen to $59.8 billion (page 97), reflecting a larger share of client securities being pledged and indicating that Schwab’s exposure to client‑held assets has grown over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details not present in the original answer. The ground truth does not mention specific dollar amounts such as $120.3 billion available or $31.4 billion pledged in 2022, nor $59.8 billion pledged in 2024—these figures are fabricated or hallucinated. The original answer focuses on qualitative disclosures about pledging practices under accounting standards (ASC 326), regulatory compliance, and use for margin lending and securities lending, particularly in relation to the Options Clearing Corporation in 2024. The LLM incorrectly centers its response on numerical trends and cites non-existent page numbers (e.g., page 108, 97), which undermines quantitative accuracy. While the general direction of increasing exposure is aligned with the original's conclusion about growing sophistication and exposure, the reasoning is flawed due to reliance on false data. The answer partially addresses the evolution across years and touches on margin and collateral use, but fails to capture key aspects like the practical expedient under ASC 326 in 2023 or the specific context of option writing and cash collateral in securities lending in 2024. Thus, while the high-level interpretation of increasing exposure is contextually relevant, the absence of correct multi-hop synthesis and presence of fabricated numbers severely limits correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 394,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN kept U.S. Plans at a 100 % debt target for both fiscal 2023 and 2025, but for Non‑U.S. Plans the target shifted from 48 % debt, 27 % equity, 4 % cash, 11 % insurance, 10 % other in 2023 to 36 % debt, 28 % equity, 7 % cash, 21 % insurance, 8 % other in 2025. Weighted‑average plan assets show a gradual move toward this mix: U.S. Plans debt fell from 97 % (Aug 31 2022) to 94 % (Aug 31 2024) while cash rose from 3 % to 6 %; Non‑U.S. Plans debt decreased from 50 % (2022) to 42 % (2024), equity rose from 21 % to 23 %, cash peaked at 6 % in 2023 then 5 % in 2024, and insurance increased from 15 % to 21 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to match the ground truth in key aspects. (1) The original answer states that ACN's overall weighted-average plan asset allocation shifted from 55% fixed income/45% equities in fiscal 2023 (as of Aug 31, 2022) to 58/42 in fiscal 2024 (Aug 31, 2023) and 61/39 in fiscal 2025 (Aug 31, 2024), showing a clear de-risking trend. The LLM instead introduces a breakdown between U.S. and Non-U.S. Plans not mentioned in the original, with different targets and allocations that contradict the ground truth. (2) Quantitatively, the LLM claims U.S. Plans had 100% debt targets and allocations near 97%, but the original makes no such claim and reports a 55-61% fixed income range overall. The LLM’s figures for Non-U.S. Plans (e.g., 48% debt in 2023, 36% in 2025) are inconsistent with the original’s 55% total fixed income in 2023 rising to 61% in 2025. The LLM also reports increasing insurance and cash, while the original focuses on fixed income vs. equities. (3) The multi-hop reasoning is flawed: the question asks for evolution based on weighted-average allocations as of Aug 31 in 2022, 2023, and 2024, but the LLM misrepresents the data and introduces unverified sub-plan breakdowns. (4) The answer is contextually relevant in discussing pension asset allocation over time, but the factual inaccuracies and incorrect segmentation severely undermine correctness. The core trend of increasing fixed income exposure is missed due to erroneous data. Thus, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 428,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024 (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K).  Long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023, but declined to $44.9 billion in 2024, so total debt peaked at $49.9 billion in 2023 and fell to $45.6 billion in 2024.  Over the three‑year span the weighted‑average long‑term rate has hovered in the mid‑4 % range, and the 2024 mix—no floating unsecured senior debt and a higher fixed‑rate proportion—suggests a deliberate shift toward a more stable, fixed‑rate debt structure to reduce interest‑rate sensitivity.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total debt (short-term + long-term) was $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports long-term debt alone as $47.8B in 2022 and $49.3B in 2023, which already exceeds the total debt in the ground truth. This suggests a fundamental misrepresentation of the data. Additionally, the LLM claims short-term borrowings were $883M in 2022 and $538M in 2023, but the ground truth does not provide a breakdown, only total debt figures, so these specific short-term values cannot be verified and appear inconsistent with the total. (2) The LLM's calculation of total debt is partially correct in direction: it notes a peak in 2023 and decline in 2024, which aligns with the trend. However, the actual totals are off: LLM reports $49.9B in 2023 vs. $48.715B (GT), and $45.6B in 2024 vs. $45.551B (GT) — close in 2024 but overestimated in 2023. The interest rate trend is inaccurately described: LLM says 'hovered in the mid-4%' range, but ground truth shows a rise from 1.51% to 3.01% to 3.48% on securitized debt — a clear upward trend, not mid-4%. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate debt due to the elimination of floating unsecured senior debt in 2024, which matches the ground truth. This shows good synthesis. (4) Despite incorrect base numbers, the LLM captures the directional trend (increase then slight decrease) and the strategic move away from floating-rate debt. Hence, qualitative reasoning and contextual relevance are decent, but quantitative accuracy is significantly compromised, leading to a correctness score of 5 — partially correct but with major data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 506,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Fleet‑support services costs have stayed essentially flat, representing about 1 % of Boeing’s total consolidated costs each year from 2022 through 2024 (page 36). In contrast, abnormal production costs for the 787 program climbed to $2.7 billion through 2023, and reach‑forward losses for the 777X program totaled roughly $3.5 billion in 2024 (page 39), underscoring that the bulk of the company’s cost pressure comes from production and certification issues rather than fleet‑support expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) Quantitatively, all numbers are correct: the 1% fleet support cost ratio across 2022–2024, $2.7 billion in 787 abnormal production costs through 2023, and $3.5 billion in 777X reach-forward losses in 2024 (sum of $2,608M + $891M = $3,499M ≈ $3.5B) are accurately reported. Format variations (e.g., $2.7 billion vs $2.7B) are acceptable. (2) The answer addresses both parts of the multi-hop question: the trend in fleet support costs and their contrast with abnormal/forward-loss costs in the 787/777X programs. (3) Entities—Boeing (BA), 787 and 777X programs, fleet support services, abnormal production costs, reach-forward losses—are correctly identified and contextualized. (4) The reasoning is sound: it correctly contrasts stable service costs with rising production-related losses, concluding that cost pressure stems from production issues, not services. The only minor omission is the absence of specific quarterly breakdowns for the 777X losses (Q3 and Q4 2024), which are in the ground truth but not essential to the overall trend. This does not detract from the correctness but slightly limits completeness. Semantic equivalence is maintained, and the citation of page numbers (36, 39) suggests proper sourcing. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 400,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s money‑market‑fund and time‑deposit balances fell from **$21 million at year‑end 2022** to **$10 million at year‑end 2023** and remained at **$10 million in 2024**【page_79】【page_84】. The sharp drop in 2023, followed by a flat level in 2024, suggests the company is trimming its idle cash buffer and reallocating liquidity into other short‑term instruments or operational uses while still maintaining a modest, stable short‑term liquidity cushion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, AbbVie's allocation was $12M in 2022, increased to $21M in 2023, and decreased to $10M in 2024. However, the LLM states it was $21M in 2022, dropped to $10M in 2023, and remained at $10M in 2024—reversing the actual trend between 2022 and 2023. This misrepresents the entire trajectory of the company's liquidity strategy. (2) The quantitative inaccuracies are severe: the $21M figure is assigned to 2022 instead of 2023, and the $12M 2022 value is omitted entirely. The 2024 value is correct at $10M, but the 2023 value is wrong. These are not formatting issues but fundamental errors in data retrieval. (3) The reasoning is based on an incorrect trend (decline followed by stability) rather than the actual fluctuation (increase then decrease), leading to an invalid conclusion about 'trimming idle cash' starting in 2023. The ground truth suggests a temporary conservative move in 2023, not a reduction. The LLM fails to correctly synthesize the multi-hop trend across three years. (4) While the answer addresses the question's structure and attempts interpretation, the factual foundation is flawed, severely undermining correctness. Contextual relevance is moderate because the response discusses the right concepts (liquidity strategy, reallocation), but the analysis is based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 396,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture’s share‑buyback activity surged from a modest $4.1 million in fiscal 2022 to $4.5 billion in fiscal 2024, while its authorized repurchase capacity rose from $6.129 million to $6.694 million (with $50.1 billion authorized for all share purchases and redemptions). This growth in both actual buybacks and available authority shows a deliberate, flexible capital‑return strategy that prioritizes returning value to shareholders while keeping a large buffer for future repurchases.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Accenture's actual share repurchases increased from $4.1 million in fiscal 2022 to $4.5 billion in fiscal 2024, but the ground truth does not provide data on actual repurchase amounts for those years—only on authorized capacity. Thus, the $4.1M and $4.5B figures are fabricated or misattributed. Additionally, the LLM states that authorized capacity rose from $6.129 million to $6.694 million, but the ground truth shows $3,129,296 thousand ($3.129 billion) in fiscal 2022, not $6.129 million. This is a 500-fold error. The $50.1 billion cumulative authorization since 2001 is correctly mentioned, but it is incorrectly presented as concurrent with the $6.129 million figure, creating confusion. (2) The correct numbers are: FY2022 remaining authorization: ~$3.13 billion; FY2023: $2.694 billion remaining; FY2024: $6.694 billion after a $4 billion increase. The LLM incorrectly implies a steady rise in actual buybacks, which is unsupported by the provided data. (3) The multi-hop reasoning is flawed—the model conflates actual repurchase activity with authorized capacity and misrepresents the timeline and scale of authorizations. It fails to accurately track the evolution of remaining authorization across years. (4) Despite these issues, the answer correctly identifies the general trend of increasing authorization and ties it to a capital return strategy, which aligns with the question’s intent, hence moderate contextual relevance and qualitative reasoning scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 428,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s amended and restated certificate of incorporation and bylaws have consistently maintained a provision that stockholders may only remove directors for cause, as disclosed in the 2022 10‑K (page 46), the 2023 10‑K (page 27), and the 2024 10‑K (page 27). The unchanged clause shows a deliberate board‑entrenchment strategy that shields the board from shareholder pressure and gives AbbVie’s directors more time to evaluate and negotiate takeover offers. By keeping this restriction in place, AbbVie signals its long‑term commitment to defending against hostile bids and preserving strategic control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AbbVie maintained the 'removal for cause only' provision across 2022, 2023, and 2024, citing specific page numbers from each 10-K (2022: p.46, 2023: p.27, 2024: p.27), which matches the original answer’s claim of consistent disclosure. These page references are precise and factually correct, demonstrating strong quantitative and entity accuracy. (2) All years and document types (10-K filings) are correctly identified, and there are no numerical or date inaccuracies. (3) The reasoning is sound: the LLM correctly infers that the unchanged provision reflects a deliberate board-entrenchment strategy and links it to takeover defense, consistent with the multi-hop synthesis required. It accurately connects the governance provision to broader strategic implications—discouraging hostile takeovers and preserving board control—though it omits mention of related defenses like staggered boards and supermajority requirements, which slightly reduces completeness. (4) Despite this minor omission, the core factual content, logical inference, and strategic interpretation are semantically equivalent to the ground truth. The answer is fully relevant, directly addressing both the evolution (no change) and strategic implication (takeover defense). Thus, the correctness score is 9 due to high accuracy with a slight deduction for missing contextual details about other anti-takeover provisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 412,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo listed the 4.000 % Senior Note due 2047 in the exhibits section of each 10‑K, referencing the same 2017 8‑K (Exhibit 4.5) in 2022 (page 127, 4.16), 2023 (page 127, 4.16), and 2024 (page 126, 4.16). The unchanged description and exhibit number show that the note remains an outstanding, material component of the company’s long‑term debt portfolio, underscoring PepsiCo’s strategy of maintaining a diversified, long‑maturity capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo consistently referenced the 4.000% Senior Note due 2047 in its 2022, 2023, and 2024 10-K filings, citing Exhibit 4.5 from the May 2, 2017 8-K filing each year. This matches the ground truth exactly in terms of the exhibit number and originating filing date. The LLM also accurately notes the consistency across years, which supports the conclusion about the note's stability. (2) All quantitative elements are correct: the interest rate (4.000%), the maturity year (2047), and the reference to the May 2, 2017 8-K are all factually accurate. The inclusion of page numbers (e.g., page 127, 126) adds precision and aligns with typical 10-K formatting, though these were not in the ground truth; however, they do not contradict it and are plausible. (3) The multi-hop reasoning is sound: the model synthesizes disclosure patterns across three years and correctly infers that the unchanged reference indicates no modifications to the note’s terms, reflecting stability in PepsiCo’s capital structure. The conclusion about a diversified, long-maturity capital structure is a reasonable interpretation of the consistent disclosure, though slightly broader than the ground truth’s more conservative statement about stability since 2017. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in disclosure and the strategic implication. The only minor shortcoming is that the LLM does not explicitly state that the note has remained unchanged 'with no modifications needed to its form or terms'—a nuance present in the ground truth—but this is implied by the unchanged exhibit reference. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 486,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in 2014 as part of a series of fixed‑rate notes (Exhibit 4.09). In its 2023 and 2024 10‑Ks the note is again disclosed in the debt schedule and in Exhibit 4.09, confirming it remains outstanding and part of Oracle’s long‑term debt mix【page_110】【page_110】. The consistent disclosure over these years reflects Oracle’s strategy of maintaining a diversified portfolio of long‑dated, fixed‑rate notes to lock in borrowing costs and provide predictable debt service.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that Oracle issued the 4.30% Note due 2034 in 2014, which directly contradicts the ground truth that Oracle first disclosed the note in 2022. This misstatement undermines the core timeline of the multi-year evolution. While the note's interest rate (4.30%) and maturity year (2034) are correct, the issuance date is factually wrong. (2) Quantitatively, the percentage (4.30%) and maturity (2034) are accurate, but the issuance year (2014 vs. 2022) is incorrect, which is a major error in temporal context. The LLM references 'Exhibit 4.09' and consistent disclosure in 2023 and 2024, which aligns with the ground truth's emphasis on reaffirmation, but the foundational event (first disclosure) is misplaced by a decade. (3) The reasoning partially captures the multi-hop pattern—Oracle maintaining the note in 2023 and 2024 disclosures—but fails on the initial step (2022 first disclosure), leading to flawed synthesis. The conclusion about a diversified, long-term fixed-rate strategy is semantically similar to the ground truth’s 'stable long-term debt strategy' and 'diversified maturity profiles,' so the qualitative inference is reasonable but built on incorrect premises. (4) Contextual relevance is high because the answer addresses disclosure patterns and strategic implications as asked, but the incorrect origin point severely limits factual correctness. The model appears to confuse this note with earlier debt issuances, possibly due to hallucinated exhibit references or misattribution from training data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 437,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "Accenture’s Amended 2010 Share Incentive Plan authorized 127 million Class A shares in fiscal 2022 (page 91) and expanded to 141 million shares by fiscal 2024 (page 98).  The 2023 10‑K pages provided do not disclose a change, suggesting the pool likely remained at 127 million until the 2024 increase.  This upward trend reflects a deliberate expansion of the equity‑award pool, underscoring Accenture’s long‑term strategy to reward employees with broader share‑based compensation and align their interests with shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 127 million shares authorized in fiscal 2022 and the 141 million in fiscal 2024, which matches the ground truth. However, it incorrectly states that the increase occurred by fiscal 2024 without acknowledging the documented increase in fiscal 2023. The ground truth specifies that the number increased to 141 million in fiscal 2023 and remained unchanged through 2024, but the LLM implies the change happened between 2023 and 2024, which is inaccurate. (2) The numbers themselves (127M and 141M) are factually correct and properly formatted, but the timeline of the change is wrong, leading to a flawed understanding of the progression. There are no calculation errors, but the temporal sequencing is a significant quantitative inaccuracy. (3) The reasoning is partially sound: the conclusion about a long-term strategy to expand share-based compensation is consistent with the ground truth. However, the multi-hop synthesis fails to correctly identify that the increase occurred in 2023, not 2024, and incorrectly assumes no change in 2023 due to lack of disclosure, which contradicts the provided data. (4) The answer is contextually relevant and addresses both parts of the question—evolution of shares and strategic implication—but the misstatement of when the increase occurred undermines full accuracy. The strategic interpretation remains reasonable given the upward trend, but the factual timeline error reduces correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 410,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "The 2.750% Senior Note due 2051 was first incorporated in PepsiCo’s 2022 10‑K (page 128) as Exhibit 4.51, referencing an 8‑K filed Oct 21 2021, and the 2023 10‑K (page 129) kept the same reference, but the 2024 10‑K (page 131) omitted the note, indicating it was not issued or was retired. This multi‑year filing pattern shows PepsiCo’s disciplined long‑term debt strategy: it issues long‑dated, low‑rate senior notes and periodically revises its debt mix to manage maturity and interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 2.750% Senior Note due 2051 was first referenced in 2022 in Exhibit 4.60 as part of a Board resolution, not Exhibit 4.51 in 2022 as claimed. In 2023, it appeared as Exhibit 4.51 (not the same exhibit in 2022), and in 2024 it was listed as Exhibit 4.48 — not omitted, as the LLM incorrectly states. The claim that the note was 'omitted' in 2024 is false; the ground truth confirms it was still referenced, indicating ongoing validity. (2) Quantitative accuracy is poor: the LLM misrepresents exhibit numbers and filing years, and incorrectly infers retirement or non-issuance due to a change in exhibit numbering, which contradicts the actual pattern of evolving but consistent documentation. Dates like 'Oct 21 2021' are mentioned but not relevant to the 2022–2024 evolution asked in the question. (3) Multi-hop reasoning is flawed: instead of recognizing the progression from authorization (2022) to formalization (2023) to stability (2024), the LLM incorrectly interprets the change in exhibit number as evidence of discontinuation, showing a failure to synthesize the phased documentation strategy. The conclusion about 'disciplined strategy' is plausible but based on incorrect premises. (4) Contextual relevance is moderate — the answer addresses long-term debt strategy, but the reasoning is built on incorrect data. Due to major factual and interpretive errors, especially the false claim of omission in 2024 and incorrect exhibit history, the correctness score is low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 436,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In 2022, American Express was the fourth‑largest general‑purpose card network worldwide, behind China UnionPay, Visa and Mastercard (page 12). By 2024 the firm has faced heightened regulatory scrutiny—becoming a Category III bank‑holding entity and exiting network‑licensing operations in the EU and Australia (pages 32‑34)—while the rapid expansion of alternative payment mechanisms (digital wallets, buy‑now‑pay‑later, real‑time settlement, fintech and blockchain platforms) has intensified competition, prompting American Express to strengthen its compliance framework and innovate its network offerings to preserve its competitive position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: American Express's position as the fourth-largest general-purpose card network in 2022 is confirmed, and the timeline (2022 to 2024) is properly framed. The mention of regulatory actions by 2024, including exit from EU and Australia, aligns with intensified scrutiny in the original answer, even if Australia wasn't explicitly in the ground truth—this is a minor addition, not a contradiction. (2) The reference to becoming a Category III bank-holding company is factually consistent with increased regulatory oversight and matches public regulatory developments. (3) The qualitative reasoning is sound: the LLM correctly identifies regulatory pressure and alternative payment mechanisms (digital wallets, BNPL, fintech platforms) as competitive challenges, and notes Amex's strategic response—compliance strengthening and innovation—which is logically consistent with the original answer’s emphasis on altered strategic dynamics. (4) The original answer highlights cobrand relationships and closed-loop systems as differentiators, which the LLM omits, representing a minor gap in completeness. However, the core multi-hop synthesis—linking regulatory evolution and competitive landscape shifts to strategic positioning—is well executed. Wording differs but semantic meaning is equivalent. No calculation errors. Contextual relevance is strong as all parts of the question are addressed with appropriate focus on regulatory and competitive evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 429,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s 2024 10‑K lists upgrades and conversions as a distinct element of its Global Services portfolio – “…engineering, maintenance and modifications, **upgrades and conversions**, …” – and notes that BGS aims to grow market share through customer satisfaction and productivity. In 2022 the company grouped upgrades with modifications – “…maintenance and engineering, **modifications and upgrades**, …” – without highlighting them separately. This shift indicates a stronger strategic focus on aftermarket upgrades and conversions to drive recurring revenue and deepen customer relationships within its services business.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Boeing's changing presentation of 'upgrades and conversions' in its 10-K filings from 2022 to 2024, noting the shift from grouping 'modifications and upgrades' together in 2022 to highlighting 'upgrades and conversions' more distinctly in 2024. This aligns with the ground truth's observation of increasing strategic emphasis. However, the LLM answer omits a key element from the original answer: the introduction and integration of 'data analytics and digital services' in 2024 as complementary to upgrades, which is a critical part of Boeing's strategic shift toward technology-enabled service differentiation. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is partially sound: the model correctly infers a growing strategic focus based on textual changes in segment descriptions across years. However, it fails to synthesize the full evolution, particularly the 2024 addition of digital services as a strategic enabler, which limits the depth of the strategic interpretation. (4) The correctness score is 7 because core facts about the structural presentation of upgrades/conversions are accurate and the inference about strategic focus is reasonable, but the omission of the digital services component reduces completeness and qualitative accuracy. Contextual relevance is high as the response directly addresses the question’s focus on strategic evolution in services.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 426,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo first issued the 5.50% Senior Note due 2035 in 2018, and each of its 2022, 2023, and 2024 10‑K filings continues to list the note as a 5.50% Senior Note due 2035, Series A, incorporated by reference to the same 8‑K filing (PEP_10k_2022 p. 126; PEP_10k_2023 p. 126; PEP_10k_2024 p. 125). The unchanged terms and consistent documentation across three reporting periods demonstrate PepsiCo’s disciplined long‑term debt strategy—maintaining fixed‑rate, long‑maturity notes and ensuring transparent, stable disclosure of its debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 5.50% Senior Note due 2035 was issued in 2018 and consistently documented in the 2022, 2023, and 2024 10-K filings as 'Series A' under the same 8-K filing reference. The exhibit numbers (not explicitly mentioned in the LLM answer) are omitted, but the core documentation pattern is accurately conveyed. (2) Quantitative accuracy is perfect: the interest rate (5.50%), maturity year (2035), and issuance year (2018) are all correct. The LLM correctly notes the consistent referencing across years without suggesting any changes to the note’s terms. (3) Reasoning is sound: the conclusion about PepsiCo’s disciplined, long-term debt strategy—maintaining fixed-rate, long-maturity debt with stable disclosure—is a valid inference from the repeated inclusion of the note. The multi-hop synthesis across three years of filings is correctly executed. (4) The only minor shortcoming is the lack of specific exhibit numbers (e.g., Exhibit 4.31 in 2022), which were present in the original answer, but this does not detract from the overall factual correctness. The answer is contextually excellent, directly addressing the evolution and strategic implications of the filing pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 357,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosure about capital returns has been unchanged from 2022 through 2024, with the same wording—“our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock”—appearing in each filing (BK_10k_2022.pdf p5; BK_10k_2023.pdf p4; BK_10k_2024.pdf p4). This consistency indicates that the regulatory constraints on BNY’s capital‑return policy have remained persistent and unchanged over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claim: BNY Mellon consistently cited the same regulatory constraints on capital returns across 2022–2024, including U.S. banking laws, Delaware law, and preferred stock dividend obligations. The specific quote and document references (e.g., BK_10k_2022.pdf p5, etc.) are correctly attributed, supporting quantitative and entity accuracy. There are no numerical errors, and the years and legal frameworks are correctly identified. However, the LLM portrays the disclosure as 'unchanged' in wording and emphasis, while the ground truth notes a subtle evolution—particularly in 2024, where the company emphasized maintaining 'well capitalized' status, indicating a slight expansion in disclosure focus. This nuance is missed by the LLM, which treats the repetition of a key sentence as evidence of complete stasis. While the central regulatory constraints are accurately synthesized across years, the LLM underrepresents the evolving emphasis in BNY Mellon’s narrative around capital planning, which the original answer frames as a progression reflecting ongoing prudential oversight. Thus, while factually sound and contextually relevant, the LLM answer lacks full qualitative depth in capturing the multi-year progression aspect of the question, particularly the incremental shifts in emphasis beyond verbatim repetition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 378,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in 2021 with a 2.300% coupon and a 2028 maturity. The 2023 and 2024 10‑Ks (both page 111) list the same coupon and maturity, indicating no amendments or changes to the terms through 2024. This consistency demonstrates Oracle’s preference for stable, low‑rate fixed‑rate debt and a conservative approach to refinancing, locking in favorable rates and avoiding frequent adjustments to its debt structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key quantitative facts: Oracle issued the 2.300% Notes due 2028 with a fixed coupon and maturity, and there were no changes to these terms in 2023 or 2024, as confirmed by consistent disclosure in the 10-Ks. The dates, percentages, and maturities are all factually accurate, earning a perfect score on quantitative accuracy. (2) However, the LLM omits critical context from the ground truth: the original issuance was governed by an Officers' Certificate dated March 24, 2021 (filed in the 2022 10-K), and Oracle’s broader financing strategy involved issuing higher-yielding notes (e.g., 4.500% Notes due 2028) in 2023, which signals a strategic shift in new issuance rather than refinancing existing low-rate debt. This multi-hop insight—comparing Oracle’s new issuance activity across years to infer strategic behavior in varying rate environments—is underdeveloped in the LLM answer. (3) While the LLM correctly infers that Oracle prefers to lock in low fixed rates and avoid frequent refinancing, it fails to synthesize evidence of Oracle’s active new issuance in higher-rate environments, which is central to understanding the company’s adaptive financing strategy. The reasoning is sound but incomplete. (4) The answer remains contextually relevant and factually correct on surface-level details, but lacks the depth of strategic analysis supported by cross-year, multi-instrument evidence in the ground truth. Hence, correctness and qualitative accuracy are penalized for missing key strategic implications and supporting documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 436,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "In 2022 IBM’s 10‑K did not list client relationships and trust as a principal competitive method (page 6 of 2022). By 2023 the company explicitly added “client relationships and trust” to its competitive methods (page 4 of 2023), and the same emphasis is retained in 2024 (page 4 of 2024). This progression shows IBM is increasingly positioning itself as a trusted partner in the hybrid‑cloud‑and‑AI market, using long‑term client relationships as a key differentiator to leverage its incumbency and deep expertise.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claim that IBM did not explicitly list 'client relationships and trust' as a competitive differentiator in 2022 but added it in 2023 and retained it in 2024, with correct page references. This aligns with the ground truth's broader narrative of increasing strategic emphasis. Quantitative accuracy is perfect: years (2022, 2023, 2024) and document locations (page 6, page 4) are correct, and no numerical calculations are required. Contextual relevance is high—the answer directly addresses the evolution across years and links it to IBM’s strategic positioning in hybrid cloud and AI. However, the qualitative accuracy is slightly lower because the LLM oversimplifies the 2022 stance: while 'client relationships and trust' was not explicitly named, the ground truth notes that trust was part of a broader strategy involving AI/cloud integration and platform modernization, which the LLM omits. Additionally, the 2024 expansion of strategic partnerships (e.g., Palo Alto Networks) and the nuance of 'delivering business value' in the context of trust are missing, weakening the multi-hop synthesis. Thus, while the main trajectory is correct, the answer lacks the full depth of IBM’s evolving, nuanced positioning as described in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 361,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s average yield on foreign‑government bonds and obligations climbed from **3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024** (non‑U.S. taxable investment securities)【176†L1-L10】.  The upward trend reflects a deliberate shift toward higher‑yielding foreign debt as rates tightened, increasing the company’s exposure to interest‑rate risk—an exposure that it actively manages through its derivative‑hedging program (see Note 13)【135†L1-L20】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there is no mention of a 3.5% yield in 2022 or a 6.1% yield in 2024. Instead, the correct yields are: no yield explicitly stated for 2022 (only holdings amount: $630M), 6.45% in 2023, and 5.85% in 2024. The LLM incorrectly reports an increasing trend (3.5% → 5.9% → 6.1%), while the actual data shows a decrease from 6.45% to 5.85% between 2023 and 2024. Additionally, the LLM cites 'non-U.S. taxable investment securities' as the source, but the ground truth specifically refers to 'foreign government bonds and obligations' with detailed maturity breakdowns, which the LLM omits entirely. (2) The dollar amounts and maturity distributions are completely missing in the LLM answer: $630M in 2022, $628M maturing within one year, and the shift in 2024 to include 2.03% maturing between 1–5 years are all unmentioned. These are critical quantitative and structural details. (3) The multi-hop reasoning is flawed. The question asks about the evolution of the yield *profile*, which includes both yield changes and maturity structure shifts. The LLM fails to recognize the strategic shift from ultra-short-duration in 2023 to a more diversified maturity profile in 2024, instead implying a simple yield-chasing strategy. It incorrectly infers increasing yields and rising interest rate risk, while the actual data suggests a deliberate de-risking through maturity diversification despite a yield decline. (4) The contextual relevance is moderate because the answer addresses yield trends and interest rate risk, but the incorrect numbers and missing maturity profile severely undermine the validity of the conclusion. The mention of derivative hedging is contextually relevant but does not compensate for the core factual errors. Overall, the answer misrepresents the data and draws incorrect inferences, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 524,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s capital outlay for diagnostics‑testing technologies has risen sharply, with government grants increasingly offsetting the spend.  In 2022 the company recorded $87 million of PP&E purchases funded by grants (offsetting $49 million of operating costs), which grew to $136 million in 2023 (offsetting $51 million) and $198 million in 2024 (offsetting $43 million)【page_72】【page_68】.  The upward trend in both grant‑assisted capital expenditures and the sustained use of BARDA‑type funding signals that diagnostics testing is a growing strategic pillar within Danaher’s broader health‑care portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core financial figures for government grant funding used to offset capital expenditures in diagnostics testing technologies: $87 million in 2022, $136 million in 2023, and $198 million in 2024 — matching the ground truth exactly. These numbers are presented accurately with acceptable formatting. However, the LLM introduces additional data not present in the original answer — namely, 'offsetting $49 million of operating costs' in 2022, $51 million in 2023, and $43 million in 2024 — which were not part of the ground truth and could misrepresent the nature of the grants (which were specified as offsetting capital expenditures, not operating costs). This is a factual overreach based on the provided context. (2) Quantitative accuracy is high: the primary progression of grant-funded PP&E amounts is correct across all three years, and the trend calculation (increasing from $87M to $198M) is sound. The extraneous operating cost offsets reduce precision slightly but do not contradict the main trend. (3) The multi-hop reasoning is largely sound — the model correctly infers increasing strategic importance from rising grant funding and ties it to BARDA-type support and portfolio strategy. It synthesizes across years and connects funding trends to strategic intent, though the mention of BARDA is an inference not explicitly confirmed in the ground truth. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question — the evolution of investment via grants and the strategic implications — and maintains focus on Danaher’s diagnostics segment within its healthcare portfolio. Despite minor inaccuracies in secondary details, the core facts and interpretation align well with the ground truth, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 496,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across FY 2022, FY 2023, and FY 2024 BNY Mellon continued to disclose that KPMG LLP’s PCAOB firm identification number is **185**. The statement was consistently located in Item 14 – Principal Accountant Fees and Services and incorporated by reference as Item 3 – Ratification of KPMG LLP in the Proxy, with no change in wording or placement (see page 14 of each 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the PCAOB firm identification number is correctly stated as 185 for all three fiscal years (2022, 2023, 2024), which matches the original answer. (2) The disclosure location is accurately described: it appears in Item 14 – Principal Accountant Fees and Services and is incorporated by reference as Item 3 – Ratification of KPMG LLP in the Proxy, consistent across years. The mention of page 14 of each 10-K adds specificity not in the original but does not contradict it. (3) The reasoning is sound—there is correct multi-hop synthesis across years and document sections, showing stable disclosure practices. (4) Minor deduction in qualitative accuracy because the LLM refers to 'BNY Mellon' instead of 'BK', which may cause entity confusion despite likely referring to the same entity (BK is commonly used for BNY Mellon). Otherwise, the answer captures all key elements: consistency in number, placement, structure, and year-over-year stability. Wording is semantically equivalent to the original answer, and contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 321,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "American Express has continued to earn discount revenue from third‑party merchant acquirers by recording the network‑rate fee as discount revenue at the time of each card‑member transaction, a practice that has been unchanged from 2022 through 2024 (Note 3, p. 104).  The contractual framework with merchants has also remained stable—small‑ and mid‑size merchants operate under open‑ended agreements, while large merchants sign fixed 3‑to‑7‑year contracts (2023 p. 104).  By 2024, however, the company’s strategic narrative explicitly foregrounds third‑party acquirers, aggregators and processors as key partners for expanding global merchant coverage and modernizing its authorization platform (2024 p. 93).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of revenue recognition and contractual structures, correctly stating that discount revenue from third-party merchant acquirers has remained consistent from 2022 to 2024, with network-rate fees recorded at transaction time (aligned with ground truth). It accurately notes the stability of contractual frameworks—open-ended for small/mid-size merchants and fixed-term for large ones—with correct citation references. The 2024 strategic shift is also correctly identified: third-party acquirers, aggregators, and processors are highlighted as key to global merchant expansion and platform modernization. However, the LLM omits a key evolution mentioned in the ground truth: the formal integration of third-party acquirers into a broader 'Processed Revenue' model in 2023 that included royalties, fees, and network partnership agreements. This represents a significant qualitative shift from transactional to strategic, which the LLM does not mention. While it notes the 2024 strategic emphasis, it fails to capture the intermediate 2023 structural change in revenue recognition, weakening the multi-hop synthesis across all three years. Quantitatively, no numbers are incorrect—dates, years, and revenue recognition practices are accurately represented. Contextually, the answer is highly relevant and well-structured. The omission of the 2023 revenue model shift prevents a higher score on qualitative accuracy and overall correctness, but core facts remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 415,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital targets—15 % higher representation of women and under‑represented minorities in leadership and a 20 % overall URM increase—were first set in FY 2022 and remained unchanged in FY 2023 and FY 2024 (QCOM_10k_2022, QCOM_10k_2023, QCOM_10k_2024). For each fiscal year, the HR and Compensation Committee linked progress on these diversity goals to executive bonuses, applying a non‑financial performance modifier that can adjust the bonus by a multiple of 0.9 to 1.1 (2022, 2023, 2024). Thus, both the diversity targets and the bonus‑adjustment mechanism stayed consistent across FY 2022‑FY 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 15% increase for women and underrepresented minorities (URM) in leadership, the 20% overall URM representation goal, and the 0.9 to 1.1 non-financial performance modifier affecting executive bonuses are correctly reported for fiscal years 2022–2024. These numbers match the ground truth exactly, and the citation of consistent targets and mechanisms across the three years is supported by the data. However, the LLM answer omits key qualitative developments noted in the original answer, particularly the expansion of global engagement efforts and the emphasis on broader wellness and development programs in FY2024, which indicate a deepening integration of human capital metrics beyond diversity. While the core structure of compensation linkage remained unchanged, the original answer highlights an evolution in scope and strategic integration that the LLM answer does not capture. This omission reduces completeness and nuance in the qualitative reasoning, especially regarding how human capital goals evolved beyond static targets. The multi-hop synthesis across years is sound, and entity accuracy (Qualcomm, FY2022–2024, executive compensation, diversity goals) is correct. The answer is highly contextually relevant and conveys the central continuity in diversity targets and compensation linkage accurately, but lacks the full depth of progression described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 400,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s EMD‑branded products are sold through the same dealer network that distributes all of its machines.  In 2022 the network covered 44 U.S. dealers, 116 outside the U.S., and reached 193 countries 【page_76】, whereas in 2024 it had 41 U.S. dealers, 111 outside the U.S., and served 187 countries 【page_64】.  The modest contraction in dealer count and country reach suggests Caterpillar is streamlining its global distribution, concentrating on core markets and high‑margin opportunities while tightening dealer relationships to improve efficiency and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the geographic reach of Caterpillar's EMD-branded products in 2022 (193 countries) and 2024 (187 countries), matching the ground truth. It also accurately notes a reduction in dealer count in both U.S. and international markets, which supports the country-level decline. Although the 2023 figure (191 countries) is omitted, this does not materially alter the overall trend described. 2) All numeric values (193 in 2022, 187 in 2024, dealer counts) are factually correct and properly cited to document pages. The calculation of a 6-country decline is implicit and accurate. 3) The multi-hop reasoning is sound: the model correctly links EMD distribution to Caterpillar’s broader dealer network and infers strategic intent from network contraction. It synthesizes dealer count changes with country reach to support a conclusion about strategic streamlining. 4) The qualitative interpretation ('streamlining', 'concentrating on core markets', 'improve efficiency and profitability') is logically consistent with the data and aligns semantically with the ground truth’s suggestion of 'strategic refocusing or consolidation'. The only minor omission is the 2023 data point, but the overall trend and strategic implication are correctly conveyed. Thus, the answer is highly accurate, complete in essence, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 378,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "Palmolive’s appearance as a principal global trademark in every 10‑K from 2022 through 2024 shows that it is a core, high‑value brand in Colgate’s Oral, Personal and Home Care segment. The company treats it as a key driver of sales and brand equity, and its continued inclusion signals a strategic focus on maintaining and leveraging this brand as a central pillar of the segment’s portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Palmolive has been consistently included as a principal global trademark in Colgate's 10-K filings from 2022 to 2024, which aligns with the ground truth. All dates and entity names (Palmolive, Colgate, Oral, Personal and Home Care segment) are accurate, and there are no numerical inaccuracies—this earns a perfect quantitative accuracy score. The answer correctly infers that Palmolive is a core, high-value brand and a strategic pillar, which reflects the intended inference from the consistent disclosure. However, it lacks specific contextual details present in the original answer, such as the comparative positioning with other brands (e.g., Ajax, Darlie), the absence of positional dilution, and the explicit mention of product categories like liquid hand soap and dishwashing detergents. These omissions reduce completeness and nuance in the qualitative reasoning, though the core logic and conclusion remain sound. The answer is fully relevant to the question and captures the strategic implication of sustained inclusion. Thus, while not fully detailed, it conveys the essential truth with accurate multi-hop synthesis across years and brand strategy context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 341,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "From fiscal 2022 to 2024 Qualcomm kept edge‑networking as a core part of its IoT strategy, projecting the IoT device base to more than double to 27 billion by 2026 and positioning mobile‑broadband and Wi‑Fi 6/6E access points as key edge‑networking products【page_8】.  The company continued to classify edge‑networking under the IoT revenue stream (consumer, edge‑networking, industrial) in the QCT segment, with equipment sales recognized at a point in time and licensing revenue from QTL recognized over time【page_73】.  Although IoT revenue fell from $7.35 billion in 2022 to $5.94 billion in 2023 and $5.42 billion in 2024, Qualcomm’s strategic emphasis on edge‑networking persisted, reflected in ongoing investment in 5G‑enabled and Wi‑Fi‑based edge solutions【page_71-75】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's strategic continuity in Edge Networking from 2022 to 2024, its role in IoT growth projections (27 billion devices by 2026), and the emphasis on Wi-Fi 6/6E and 5G. It also correctly identifies Edge Networking as part of the IoT category under QCT and notes the revenue recognition structure (equipment sales at a point in time, licensing over time). However, it introduces revenue figures for IoT ($7.35B, $5.94B, $5.42B) that are not present in the original answer and were not part of the ground truth — these numbers, while possibly accurate, are extraneous and not requested in the question, indicating a potential hallucination or unsupported data inclusion. (2) The quantitative accuracy is reduced because while the 27 billion IoT projection is correct, the specific IoT revenue declines are not mentioned in the ground truth and thus cannot be verified as relevant or accurate in this context. The fiscal years are correctly referenced, but the addition of unverified dollar amounts undermines precision. (3) The multi-hop reasoning is mostly sound: the LLM connects Edge Networking to IoT growth, product categorization, and revenue recognition across years. It correctly notes the structural placement within QCT and the persistence of strategy despite revenue declines. However, it misses the key evolution point from the original answer — that in 2023, Edge Networking was formally grouped into a new third revenue category (consumer, industrial, and edge networking), marking a structural shift, not just continuity. This nuance is critical to the 'evolution' aspect of the question and is underemphasized. (4) Contextual relevance is high because the answer addresses all core themes: IoT growth, product categorization, and revenue recognition. The qualitative accuracy is strong due to correct entity identification (Qualcomm, QCT, IoT, Edge Networking, Wi-Fi 6/6E) and logical flow, but the missing structural evolution detail and inclusion of unsupported revenue figures prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 556,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 10‑K filings from 2022 through 2024 consistently note that its global operations expose it to significant currency‑exchange‑rate risk and that it uses hedging instruments to mitigate adverse movements.  In 2022 the risk paragraph (page 22) states that hedging can protect against unfavorable fluctuations but forego potential gains; the 2023 and 2024 disclosures (page 19 in each filing) repeat the same language, underscoring that earnings volatility remains a risk but that the company’s hedging strategy has not materially changed over the period.  Thus, while the exposure from international operations stayed high, Caterpillar’s approach to managing it through hedges remained largely unchanged, balancing volatility reduction against the loss of upside from favorable currency moves.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Caterpillar's consistent use of hedging instruments and the trade-off between reducing downside risk and forgoing upside gains, with correct references to the 10-K page numbers and years (2022–2024), supporting a high quantitative accuracy score. However, it incorrectly states that the disclosures in 2023 and 2024 'repeat the same language' and that the hedging strategy 'has not materially changed,' which contradicts the ground truth. The original answer reveals an evolution in Caterpillar’s risk discussion: in 2023, the company expanded its focus to include exchange controls and currency devaluations in emerging markets, and in 2024 emphasized the limitations of hedging amid intensifying macroeconomic volatility. This reflects a growing caution and broadening of risk awareness that the LLM answer overlooks. Thus, while the LLM captures the stable core hedging approach, it fails to identify the qualitative evolution in risk disclosure and management emphasis, resulting in incomplete multi-hop synthesis and a lower qualitative accuracy score. Contextually, the answer is highly relevant and well-structured, but the omission of key developments in Caterpillar’s risk management evolution limits its overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 359,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive reduced its exposure to U.S. Treasury and agency securities in its pension‑plan fixed‑income portfolio from about **40 % in 2022** to roughly **30 % in 2023**, a level that remained unchanged in 2024 (CL_10k_2022, page 102; CL_10k_2023, page 100; CL_10k_2024, page 99). This downward trend indicates the company is diversifying away from the lowest‑risk Treasury holdings, likely to balance yield and interest‑rate risk while maintaining a conservative risk profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a key inaccuracy in the starting percentage and year. The original answer states that Colgate-Palmolive's allocation was 50% as of December 31, 2020 (reported in the 2022 filing), then dropped to 40% as of December 31, 2021, and further to 30% as of December 31, 2022. However, the LLM claims the reduction was from 'about 40% in 2022' to 30% in 2023, which misrepresents both the timing and magnitude of the decline. The LLM omits the earlier drop from 50% to 40% and incorrectly frames the 40% allocation as occurring in 2022, when it actually applied to the end of 2021. The 30% allocation is correctly reported for 2023 and 2024. (2) Quantitatively, the LLM gets the 30% figure right for 2023 and 2024 and correctly cites the downward trend, but fails to report the full evolution across the period, missing one data point and misassigning another. This affects the accuracy of the trend description. (3) The reasoning is sound in interpreting the reduction as a diversification strategy to balance yield and interest rate risk, which aligns with the ground truth’s interpretation. The mention of maintaining a conservative risk profile is reasonable, though the LLM omits the Level 2 classification and liquidity considerations noted in the original, which adds nuance to the risk management approach. (4) Contextual relevance is high—the answer addresses the evolution of allocation and infers strategic intent regarding interest rate risk. However, due to the incorrect starting point and missing data, the multi-hop synthesis is incomplete. The score reflects mostly correct core facts with significant but not critical omissions in quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 470,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer granted 1,165 Breakthrough Performance Awards (BPAs) in 2022 (see the 2022 10‑K table on page 101) and accounted for them using the intrinsic‑value method at grant date, amortizing the expense over the probable vesting term (Note 13, page 96). By 2023 the company disclosed that no BPAs were granted or outstanding (Note 13, page 97), a position that was repeated in the 2024 filing (Note 13, page 97). Across all three years the valuation methodology remained unchanged—intrinsic value based on the closing price of common stock—while disclosure transparency shifted from a detailed activity table in 2022 to a concise statement in 2023 and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It correctly states that 1,165 thousand BPAs were granted in 2022 (though it omits 'thousand' in stating '1,165 BPAs', which misrepresents the scale). The intrinsic value method is correctly identified, but the LLM fails to mention the weighted average intrinsic value of $38.73 per share or the 859 thousand nonvested shares at year-end 2022—key quantitative details from the original answer. (2) The LLM incorrectly claims that the 'position was repeated in the 2024 filing'—stating no BPAs were granted or outstanding—when in fact the 2024 filing reintroduced BPAs with new valuation and amortization policies. This is a major factual error. The claim that 'valuation methodology remained unchanged' contradicts the ground truth, which states that in 2024 Pfizer introduced a more dynamic framework including adjustments for performance probability and stock price changes. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the evolution from active grants (2022) to suspension (2023) to reintroduction with enhanced transparency (2024). Instead, it incorrectly asserts continuity in disclosure and methodology through 2024, missing the strategic shift entirely. (4) While the LLM correctly cites Note 13 and page numbers, its synthesis across years is inaccurate. The contextual relevance is high because it addresses grant activity, valuation, and disclosure, but the factual and qualitative inaccuracies—especially regarding 2024—severely undermine correctness. Quantitative accuracy is partially correct for 2022 but fails on 2023–2024 details and omits key numbers. Qualitative accuracy is low due to incorrect reasoning about the program’s evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 483,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "From 2022 through 2024, Schwab’s Advisor Services website kept its core interactive tools—such as the free Advisor Portfolio Connect and multi‑year statement archiving—while steadily expanding third‑party integrations. In 2022 the platform added the thinkpipes trading platform and iRebal rebalancing solution (pages 10, 8, 9), and in 2023 it introduced the Schwab Trading Powered by Ameritrade platform, further enhancing real‑time charting and trading for RIAs (pages 7, 8, 9). By 2024 those integrations—thinkpipes, iRebal, and the Ameritrade‑powered trading engine—remained central, broadening portfolio‑management capabilities and third‑party connectivity for independent advisors (pages 5‑9).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unverified third-party integrations not present in the ground truth. (1) Incorrect entities: The LLM claims Schwab integrated 'thinkpipes' and 'iRebal' in 2022 and 'Schwab Trading Powered by Ameritrade' in 2023, but the original answer makes no mention of these platforms—these names appear to be fabricated or hallucinated. (2) Quantitative inaccuracy: The LLM cites specific page numbers (e.g., 'pages 10, 8, 9') which are not part of the provided ground truth and cannot be verified; more critically, the core financial or technological developments described (e.g., real-time charting enhancements) are not supported by the original answer. (3) Reasoning failure: The original answer describes a gradual evolution in usability and platform experience with consistent emphasis on third-party integrations and Schwab Advisor Portfolio Connect, but does not support any specific new integrations year-by-year. The LLM invents a detailed timeline of integrations that contradicts the more general, iterative improvement narrative in the ground truth. (4) Contextual relevance: The answer addresses the right topic—evolution of tools for RIAs, third-party integrations, and portfolio management—and correctly notes the continuity of Advisor Portfolio Connect and document archiving. However, the fabricated details severely undermine factual correctness. While the structure and intent align with the question, the answer fails on core accuracy due to hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 421,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Texas Instruments consistently framed embedded‑processing as a core pillar of its strategy in 2022, 2023 and 2024, with each MD&A stating that its strategic focus is on analog and embedded‑processing products and that it places additional emphasis on industrial and automotive markets (2022 page 18; 2023 page 20; 2024 page 20).  While embedded‑processing revenue rose modestly from $3.26 B in 2022 to $3.37 B in 2023 and then fell to $2.53 B in 2024, the company’s narrative remained unchanged, underscoring its long‑term positioning as a leading analog‑and‑embedded‑processing provider and a key player in high‑margin semiconductor markets (2022 page 18; 2023 page 20; 2024 page 20).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial figures. According to the ground truth, there is no mention of specific embedded processing revenue values for 2022 ($3.26B), 2023 ($3.37B), or 2024 ($2.53B). These numbers are not present in the original answer and cannot be verified from the provided knowledge graph, making their inclusion incorrect and misleading. The drop in 2024 revenue is also not supported by the ground truth, which focuses on strategic framing rather than financial performance. (2) The quantitative accuracy is low because the model fabricates precise revenue figures without grounding in the source data. Even if such data existed elsewhere, the ground truth does not include it, so the LLM fails to align with the provided reference. (3) Qualitatively, the model correctly identifies the consistent strategic emphasis on embedded processing across the three years and links it to TI's broader positioning in analog and embedded markets. It also correctly notes the focus on industrial and automotive segments, which aligns with contextual knowledge, though this detail is not in the ground truth. The reasoning about long-term positioning as a high-margin player is a reasonable inference but goes beyond the original answer’s focus on free cash flow per share and value delivery. (4) Contextually, the response is relevant and addresses the evolution of strategic emphasis over time, citing consistent framing. However, it introduces unsupported financial data that undermines factual correctness. While the narrative synthesis is partially sound, the inclusion of unverified numbers severely impacts overall accuracy, warranting a moderate score of 4 out of 10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 475,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Fleet‑support costs stayed essentially flat, being expensed as incurred and historically about 1 % of total consolidated product and service costs with no material change from 2022 through 2024 (page 40). In contrast, the 787 program accumulated significant abnormal production costs—$2.7 billion through 2023 and an additional $256 million in 2024 (pages 36, 39)—and delivery delays, with production slowed to below five aircraft per month in 2024 because of supply‑chain constraints and business‑class seat issues, leaving 25 aircraft in inventory for rework that are expected to be delivered in 2025 (pages 36, 39).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key factual elements from the ground truth. Fleet support services consistently accounted for about 1% of total consolidated costs with no material change from 2022 to 2024, which matches the original answer. The abnormal production costs for the 787 program are accurately reported: $2.7 billion cumulative through 2023 and $256 million in 2024, both figures matching the ground truth. The expectation to deliver the reworked aircraft in 2025 is also correctly stated. (2) Quantitative accuracy is perfect: all dollar amounts ($2.7 billion, $256 million), timeframes (through 2023, in 2024), and percentages (1%) are correct and properly attributed. There are no calculation errors. (3) The multi-hop reasoning is sound—information is synthesized across years and programs (fleet support vs. 787 program), and the contrast between stable support costs and escalating/resolving abnormal production costs is logically presented. The mention of production slowed to below five aircraft per month and issues with supply chain and business-class seats adds contextual detail consistent with the evolving delivery challenges, though these specifics were not in the ground truth; however, they do not contradict it and may reflect additional filing content. (4) The only minor shortcoming is that the original answer notes that by 2024, rework was completed on *most* of the 25 inventoried aircraft, while the LLM answer states 25 aircraft were in inventory for rework without specifying 'most' were already reworked. This slightly omits a nuance about progress in resolution. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 484,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold its Meridian subsidiary on December 31 2021 for roughly $51 million cash, recording a $167 million loss (2023 10‑K, p. 73).  After the sale, Pfizer and the buyer entered into interim transition‑service agreements and a three‑year manufacturing‑service agreement (with a two‑year extension) to keep a post‑sale relationship; the amounts recorded under those agreements were immaterial in 2022 and 2023 and none were recorded in 2024, indicating the relationship had largely ended (2023 10‑K, p. 73‑74; 2024 10‑K, p. 2‑6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the sale date (December 31, 2021), the $167 million loss (net of tax), and the existence of transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) with a two-year extension option. It accurately states that financial impacts were immaterial in 2022 and 2023 and none were recorded in 2024. However, the mention of a '$51 million cash' sale price is not present in the original answer (ground truth) and cannot be verified from the provided context, making this an unsupported addition. (2) Quantitatively, all dates and the $167 million loss are correct. The $51 million figure lacks corroboration in the ground truth and appears to be extraneous information, possibly from a source outside the knowledge graph. All other numerical assertions (immaterial amounts, no 2024 recordings) align with the diminishing financial impact described in the original. (3) The reasoning is sound: the LLM correctly traces the evolution from ownership to a limited supplier relationship, infers the winding down of the relationship based on the cessation of recorded amounts, and references the contractual framework (TSA and MSA). It correctly synthesizes information across 2023 and 2024 filings to show progression. However, it omits the explicit mention that TSAs ended on December 31, 2023, and does not note Meridian's inclusion in the 2024 glossary as 'Meridian Medical Technologies, Inc.', which supports ongoing recognition due to the MSA. This minor omission affects completeness. (4) The answer is highly contextually relevant, directly addressing financial implications and contractual arrangements over the 2022–2024 period. Despite the unsupported sale price and missing glossary detail, the core multi-hop reasoning and factual backbone are accurate, warranting a high correctness score with minor deductions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 513,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, “hello” is consistently listed as a global trademark within the Oral, Personal and Home Care segment (page 77 of each filing).  The filings contain no mention of a repositioning or strategic shift for the brand relative to the other product lines, indicating that its positioning has remained essentially unchanged over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that 'hello' was consistently listed as a global trademark in the Oral, Personal and Home Care segment across the 2022, 2023, and 2024 10-K filings (page 77 in each), which matches the original answer's claim of sustained strategic emphasis. The LLM correctly infers that the absence of any mention of repositioning implies no significant change in strategic positioning—consistent with the ground truth's conclusion of continued prioritization. All entities (Colgate-Palmolive, 'hello', time period, segment) are correct, and the reasoning is sound. The only minor limitation is that the LLM does not explicitly note the addition of Darlie in 2023 or directly compare 'hello' to other major brands like Colgate and Palmolive as in the original answer, which slightly reduces qualitative depth. However, the core factual content and inference are accurate and semantically equivalent. No numbers or dates are incorrect (quantitative accuracy is perfect), and the response is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 312,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "The Non‑Qualified Defined Benefit Pension Plan has remained unfunded and closed to new participants throughout 2022‑2024.  The U.S. defined‑benefit plan’s funded status, which includes the non‑qualified plan, fell from a $100 million deficit at year‑end 2022 to $87 million in 2023 and slipped to $93 million in 2024, while participant contributions stayed at zero each year【page_45】.  This steady underfunding and lack of employee contributions indicate that Texas Instruments continues to carry significant long‑term pension obligations for the non‑qualified plan and that employee participation in it remains minimal, reflecting the company’s shift toward defined‑contribution options.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 'funded status' of the U.S. defined-benefit plan was a $100 million deficit in 2022, $87 million in 2023, and $93 million in 2024. This data is not present in the ground truth and contradicts it—no such deficits or trends are mentioned. The ground truth emphasizes that the Non-Qualified Defined Benefit Pension Plan is unfunded, but does not provide aggregate funded status deficits for the U.S. defined-benefit plans across years. Additionally, the claim that 'participant contributions stayed at zero' is not supported by the original answer, which does not mention participant contributions to the non-qualified plan. (2) The ground truth focuses on defined contribution plans: the number of TI shares held (6M → 5M → 5M), their value ($940M → $873M → $852M), dividends ($28M → $27M → $26M), and company expenses ($70M → $75M → $76M). None of these key quantitative trends are mentioned in the LLM answer, indicating a failure to report the core data. (3) The multi-hop reasoning is flawed. The original answer infers a strategic shift based on rising defined contribution expenses and declining holdings, but the LLM invents a narrative around funded status deficits and participant contributions not present in the data. It fails to connect the actual dots: decreasing share holdings and dividends alongside increasing company contributions to defined contribution plans. (4) While the LLM correctly notes the non-qualified plan is unfunded and closed to new participants, and correctly infers a shift toward defined contribution plans, these correct qualitative points are outweighed by the fabricated quantitative data and omission of central evidence. Hence, the correctness score is low due to major factual errors, despite partial relevance and some accurate reasoning direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 512,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost declined from **$800 million in 2022** to **$755 million in 2023** and further to **$719 million in 2024** (see 2023 10‑K, p. 86 and 2024 10‑K, p. 83). This steady downward trend indicates a deliberate reduction in the company’s allocation to private‑equity, suggesting a portfolio rebalancing or strategic shift toward other asset classes or liquidity needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million, which is both numerically wrong and reverses the trend for the first year. This error fundamentally undermines the answer’s validity. (2) The quantitative inaccuracies are critical: the $800M figure for 2022 is unsupported by the ground truth and leads to an incorrect 'steady downward trend' narrative. While the 2023 ($755M) and 2024 ($719M) values are correct, the starting point is wrong, invalidating the comparative analysis. Calculations or trends based on incorrect inputs cannot be accurate. (3) The multi-hop reasoning fails because the model misidentifies the initial state of the data. Instead of recognizing a strategic increase in 2023 followed by a partial pullback in 2024, the model asserts a continuous decline, leading to an incorrect conclusion about strategic intent—'deliberate reduction' and 'portfolio rebalancing' contradict the ground truth's indication of a measured, non-linear allocation strategy. (4) Contextual relevance is moderate: the answer addresses the right metric, company, and time frame, and attempts interpretation, so it remains on-topic. However, due to the core numerical error and resulting flawed reasoning, the correctness and qualitative accuracy scores are low. A correct interpretation hinges on accurate data, which is missing here.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 442,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "In 2022, under the 2019 IDA agreement, Schwab could move up to $10 billion of IDA balances each year, but only floating‑rate balances and it had to keep a minimum $50 billion IDA balance and at least 80 % of balances as fixed‑rate through June 2026. The 2023 IDA agreement replaced those terms; Schwab still had a $10 billion annual migration option, but the 80 % fixed‑rate rule was removed and it had to maintain balances above the total of unmatured fixed‑rate obligations with a $30 billion ceiling (and after Sept 10 2025 a $60 billion minimum and $90 billion maximum), with withdrawals limited to customer‑initiated withdrawals until that date. Schwab did not exercise the migration in 2023 or 2024, so the same 2023 constraints applied in both years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. It incorrectly states that in 2022, Schwab could only migrate floating-rate balances and had to maintain a minimum $50 billion IDA balance and 80% fixed-rate requirement through June 2026 — none of which is supported by the ground truth. The original answer makes no mention of a $50 billion minimum or 80% fixed-rate rule in 2022. Additionally, the LLM claims Schwab still had a $10 billion annual migration option under the 2023 agreement, which contradicts the ground truth stating that no migration occurred in 2023 or 2024 due to new constraints replacing the prior annual option. The $30 billion ceiling and post-September 2025 thresholds of $60 billion minimum and $90 billion maximum are not in the original answer; instead, the ground truth specifies a maximum of $30 billion above unmatured fixed-rate obligations through September 10, 2025, with no mention of a $90 billion cap. (2) Quantitative accuracy is low: while the $10 billion figure for 2022 is correct, the $50B, $60B, and $90B figures are fabricated. The 80% fixed-rate requirement and customer-initiated withdrawal limitation until September 10, 2025, are also unsupported. (3) Multi-hop reasoning is partially sound — the model attempts to track changes across years and agreements — but it introduces false constraints and misrepresents the evolution from an annual migration right to a fully constrained framework. The conclusion that no migration occurred in 2023 and 2024 aligns with the ground truth, but the reasoning is flawed. (4) Scores reflect major factual and quantitative errors despite addressing the right context and timeline. The answer is relevant and structured appropriately, but core details about terms and constraints are incorrect, undermining overall reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 506,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments has listed Melaka, Malaysia as an analog‑manufacturing site in every 10‑K for 2022, 2023 and 2024 (see the property tables on page 16 of each filing).  The designation and leased status ( * in 2022/23, ** in 2024 —both indicating a leased facility) remained unchanged, showing a stable, long‑term investment in that location.  This multi‑year consistency signals that Melaka is a strategically important, reliable hub for TI’s analog product production, likely chosen for its cost, talent pool or supply‑chain advantages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitative accuracy: All years (2022, 2023, 2024) are correctly cited, and the evolution of markings (*, **) is accurately reported. The reference to page 16 of each 10-K adds precision, though not required for correctness. (2) Completeness: The answer addresses all parts—multi-year presence in Melaka, involvement in analog manufacturing, designation changes, and strategic implications. The leased status interpretation (* and ** indicating leased) is consistent with TI’s footnote conventions, though the ground truth does not explicitly confirm this detail; however, it does not contradict it either. (3) Entity accuracy: 'Texas Instruments', 'Melaka, Malaysia', and 'analog product manufacturing' are correctly identified across all years. (4) Reasoning: The multi-hop synthesis across three years of 10-K filings is sound. The conclusion about strategic importance due to consistency is logically supported and semantically equivalent to the original answer. The only minor gap is that the LLM implies the * and ** solely denote leasing status without acknowledging the potential signaling of increased emphasis (e.g., expansion), which the ground truth suggests. However, this does not make the answer incorrect—just slightly narrower in interpretation. Overall, the answer is highly accurate, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 394,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Debit Card (RedCard/Target Circle Card) penetration fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024** (RedCard Penetration data, 2024 10‑K p. 27; 2023 10‑K p. 27). This downward trend indicates that fewer purchases are being made with the card, suggesting a modest erosion of its incremental‑sales contribution over time, even though it remains a key driver of Target’s sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rate for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports 18.6% for 2024, which is incorrect—the ground truth value is 17.8%. This is a significant quantitative error that affects the trend interpretation. (2) The calculation of the downward trend is qualitatively correct (declining), but the magnitude of decline is misrepresented due to the incorrect 2024 figure. The actual drop from 2022 to 2024 is 2.7 percentage points, whereas the LLM implies a 1.9-point drop, understating the decline. (3) The reasoning about the card’s diminishing role in driving incremental sales is logically sound and aligns with the downward trend, but the conclusion is based on inaccurate data for 2024. The multi-hop synthesis across years is structurally correct—pulling data from multiple 10-Ks—but the final data point is wrong, suggesting either a misreading of the source or incorrect data retrieval. (4) The contextual relevance is high—the answer addresses both parts of the question (evolution of penetration and implications for sales). The qualitative reasoning is mostly sound, but the quantitative inaccuracy in the key 2024 metric reduces confidence in the conclusion. Hence, correctness is penalized significantly for the wrong percentage, though not fully dismissed due to correct trend direction and partial data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 393,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "From 2022 through 2024 the Texas Instruments 2003 Director Compensation Plan had **zero shares remaining available for future issuance**.  The plan is not listed in the “available for future issuance” column of the equity‑compensation tables for those years (see footnote (c) on pages 59 and 61).  This indicates the plan has been fully utilized and not replenished, and TI has shifted to newer plans—such as the 2018 Director Plan and the 2024 LTIP—to provide future equity incentives to directors.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims zero shares were available from 2022–2024, which directly contradicts the ground truth: 35,385,153 (2022), 25,296,767 (2023), and 24,503,062 (2024). These numbers show a clear, consistent decline—not exhaustion. (2) The LLM incorrectly states the plan is not listed in the 'available for future issuance' column with reference to footnotes on pages 59 and 61, implying the plan is expired or fully utilized. However, the ground truth confirms the plan was still active and being drawn down annually. (3) The reasoning is flawed: the conclusion that Texas Instruments has shifted to newer plans (e.g., 2018 Director Plan, 2024 LTIP) is unsupported by the provided truth, which makes no mention of plan transitions or newer plans replacing the 2003 plan. (4) While the question involves multi-hop reasoning across years and interpretation of trends, the LLM failed to correctly extract or synthesize the actual data. Instead, it made an erroneous inference about plan expiration. (5) The trend in the original answer—consistent use without replenishment—aligns with sustained investment in director incentives; the LLM’s claim of full utilization and plan obsolescence contradicts this. Despite addressing the general topic (equity incentives for directors), the answer is factually wrong and misleading. Minor contextual relevance is retained due to correct identification of the company and topic area.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 416,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In 2022, Visa integrated virtual accounts into its Visa Direct platform via Currencycloud, adding real‑time FX, virtual accounts and liquidity settlement to support cross‑border flows (page_10 2022). In 2023, the company launched Visa+, enabling P2P transfers between apps and further embedding virtual accounts and digital capabilities within Visa Direct (page_10 2023). By 2024, Visa Direct had expanded cross‑border use cases with Visa Treasury as a Service and enhanced Currencycloud features—real‑time FX, virtual accounts, and liquidity settlement—supporting nearly 10 billion transactions across 550 partners (page_10 2024; page_12 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Visa's virtual accounts and digital capabilities across 2022–2024 with generally accurate information, but contains some inaccuracies and omissions compared to the ground truth. In 2022, it correctly identifies the integration of virtual accounts via Currencycloud with real-time FX and liquidity settlement, though it incorrectly states they were integrated into Visa Direct at that stage—the ground truth specifies that virtual accounts were introduced under Visa Treasury as a Service, not directly into Visa Direct until 2023. This is a significant nuance affecting the accuracy of the integration timeline. In 2023, the LLM mentions the launch of 'Visa+' and deeper embedding in Visa Direct, which aligns with the expansion of Visa Direct to include cross-border solutions, though 'Visa+' is not mentioned in the ground truth and may be extraneous or misattributed. The 2024 description is partially accurate: it notes expanded cross-border use cases and enhanced Currencycloud features, but cites 'nearly 10 billion transactions' and '550 partners'—figures not present in the ground truth. Instead, the ground truth emphasizes a network reach of over 11 billion endpoints and a strategic focus on $20 trillion in B2B cross-border opportunities, which the LLM omits entirely. These missing strategic figures reduce completeness and quantitative accuracy. (2) Quantitative accuracy is compromised by the use of unverified numbers (e.g., 10 billion transactions vs. 11 billion endpoints; 550 partners not mentioned in original). The ground truth does not provide transaction volume or partner count, so these appear to be hallucinated or misaligned metrics. (3) The multi-hop reasoning is mostly sound—linking Currencycloud, Visa Direct, and cross-border expansion across years—but the incorrect sequencing of integration (2022 vs. 2023) and inclusion of unsupported metrics weaken the logical fidelity. (4) Despite these issues, the answer remains contextually relevant and conveys a similar narrative of progressive integration and expansion. The core themes—virtual accounts, real-time FX, liquidity, cross-border use cases, and platform evolution—are present and correctly framed, warranting a correctness score of 7. Minor wording differences are acceptable under semantic equivalence, but factual and numerical discrepancies prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 643,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi’s 2023 international sales fell 1 % due to a lower net price, signaling revenue pressure that prompted Pfizer to strengthen its lifecycle‑management strategy.  This investment is reflected in the April 2024 EU approval of Xtandi for the same indication—an indication expansion that extends the product’s market reach—and in the 2022 intangible‑asset carrying amount of $73.3 billion for developed‑technology rights that include Xtandi, underscoring the asset’s valuation within Pfizer’s intangible portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Xtandi's 1% revenue decline in 2023 due to lower net pricing, aligns with the 2022 valuation context, and notes the 2024 indication expansion. However, it introduces a specific dollar figure—$73.3 billion—for Pfizer’s developed-technology rights that is not present in the original answer and cannot be verified from the provided ground truth. This number may be factually accurate but was not part of the knowledge graph’s stated information, making it an unsupported addition. (2) The date of the 2024 approval is correctly contextualized, though the original answer does not specify 'April' or 'EU approval'—these details are plausible but not confirmed in the ground truth. The 1% revenue decline is accurately cited. The $73.3 billion figure is the primary quantitative issue, as it introduces precision not warranted by the source. (3) The multi-hop reasoning is sound: the model connects 2023 revenue pressure to lifecycle management efforts and links this to the 2024 indication expansion and 2022 intangible asset status. It correctly infers strategic investment despite revenue challenges. (4) The answer is contextually excellent and semantically close to the original, with only minor over-precision in numbers and slight additions (EU, April) that don’t contradict but go beyond the ground truth. The core logic and synthesis are correct, warranting a high score, but the unsupported $73.3B figure prevents a 9–10 on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 418,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "From 2022 to 2024 the penetration of Target’s MasterCard‑branded credit card fell from 20.5 % (2022) to 19.8 % (2023) to 18.6 % (2024)【page_27】.  The gradual decline suggests a modest shift in consumer preference away from the MasterCard credit card, even as overall loyalty‑program engagement remains strong (penetration stays above 18 %).  This trend indicates that while Target’s loyalty benefits continue to attract shoppers, customers are increasingly choosing alternative payment methods or cards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. These numbers are cited with proper formatting variations (e.g., 20.5 % vs 20.5%) that do not affect accuracy. 2) All calculations and comparisons are implicit but correct—the downward trend is accurately described as a 'gradual decline' from 20.5% to 18.6% over three years. There are no mathematical or temporal errors. 3) The multi-hop reasoning is sound: the model correctly identifies the card (Target MasterCard, part of RedCards™/Target Circle Cards) and synthesizes the trend to infer implications about consumer preference and loyalty engagement. It appropriately notes that despite declining penetration, engagement remains relatively strong (above 18%), which adds nuance not explicitly in the ground truth but is logically consistent. 4) The only minor deviation from the original answer is the addition of the interpretation that 'overall loyalty-program engagement remains strong'—while plausible and contextually reasonable, this is a slight positive inference not directly supported by the downward trend emphasized in the ground truth. However, it does not contradict it and remains within semantic bounds. All entities (Target, MasterCard, RedCards™, Target Circle Cards), time periods (2022–2024), and metrics (penetration rate) are correctly identified and used. The answer fully addresses both parts of the question: the evolution of penetration and its implications. Therefore, the answer is factually excellent with only minor interpretive expansion, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 455,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In FY 2022, Currencycloud’s virtual accounts were introduced to enable real‑time FX, liquidity and settlement for cross‑border payments, reaching more than 190 countries (page 11). By FY 2023, the platform was fully integrated into Visa Direct, expanding its cross‑border reach to over 195 countries and adding additional real‑time payment schemes (page 10). In FY 2024, the network reach remained at 195+ countries while continuing to provide virtual accounts and real‑time FX, sustaining a $20 trillion cross‑border opportunity (page 10).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies compared to the ground truth. While it correctly identifies the introduction of virtual accounts in FY 2022 with real-time FX, liquidity, and settlement capabilities, it incorrectly states that the reach was 'more than 190 countries'—the original answer does not specify country count in 2022 but instead emphasizes real-time FX and settlement enhancements. In FY 2023, the LLM claims expansion to 'over 195 countries' and integration into Visa Direct, but the ground truth specifies a network reach of 'over 11 billion endpoints' (not countries), including cards, bank accounts, and digital wallets—this is a significant misrepresentation of scale and metric type. The LLM also introduces a '$20 trillion cross-border opportunity' in 2024, which is not mentioned in the original answer and appears to be fabricated or misattributed. (2) Quantitative accuracy is low: country counts (190, 195) are unsupported by the original; the 11 billion endpoints figure is entirely missing; the $20 trillion figure has no basis in the ground truth. These are major quantitative errors. (3) The multi-hop reasoning is partially sound—the LLM traces evolution across years and attempts to show progression in cross-border capabilities—but it fails to accurately synthesize the nature of network reach (endpoints vs. countries) and omits key developments like Visa B2B Connect and optimization across more than 100 countries in 2024. It also misses the strategic deepening in B2B transactions. (4) Despite these issues, the answer remains contextually relevant, addressing the evolution of virtual accounts and cross-border capabilities over time. The structure follows the correct timeline and touches on relevant themes (FX, network expansion, real-time payments), warranting moderate scores for qualitative accuracy and high for contextual relevance. However, the correctness score is limited by major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 536,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 10‑K filings for 2022, 2023 and 2024 all list “difficulties in protecting our intellectual property” as a key risk tied to its global operations, with the risk language unchanged across the three years (2022 page 39; 2023 page 41; 2024 page 42).  The company continues to rely on third‑party wafer foundries in the U.S., Europe and Asia and on manufacturing facilities in China, Malaysia and Taiwan, and the percentage of revenue from international sales has remained high (72 % in 2022, 65 % in 2023, 66 % in 2024).  Thus, AMD’s exposure to IP‑protection risks has persisted without substantive change, while geopolitical and export‑control concerns—particularly around China‑Taiwan tensions—remain highlighted as potential amplifiers of that risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and completeness compared to the ground truth. (1) Quantitatively, the percentages for international sales (72% in 2022, 65% in 2023, 66% in 2024) are accurate and correctly cited, and the references to third-party manufacturing locations (China, Malaysia, Taiwan) align with the original answer—this supports a high quantitative accuracy score. (2) However, the claim that the risk language regarding IP protection was 'unchanged across the three years' is factually incorrect and contradicts the ground truth, which shows an evolution: from a general mention in 2022, to specific linkage with third-party manufacturing and China-Taiwan tensions in 2023, and further expansion in 2024 to include export controls related to Ukraine-Russia and Israel-Hamas conflicts. The LLM fails to capture this progression, misrepresenting the trend as static when it is actually intensifying. (3) This reflects a failure in multi-hop reasoning: the model does not synthesize the increasing specificity and severity of risks over time, which is central to the question about how exposure 'evolved'. Instead, it concludes that exposure 'persisted without substantive change', directly contradicting the ground truth. (4) Contextual relevance is strong because the answer addresses international operations, third-party manufacturing, and geopolitical concerns, but the incorrect characterization of risk evolution undermines qualitative accuracy. The answer omits key developments in 2024 and downplays the growing regulatory dimension, leading to a correctness score of 6—partially correct but with major omissions in the core analytical thread.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 465,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "UNP’s pension plan shifted its corporate‑stock holdings from a largely Level‑2 (with a small Level‑3) portfolio in 2022 ($1.11 B) to a mix dominated by Level‑1 common shares and Level‑2 preferred shares in 2023 ($226 M) and continues to classify common shares as Level‑1 in 2024 (page 56).  The dollar amount of corporate stock fell from $1.11 B in 2022 to $226 M in 2023 and is expected to be lower in 2024 as equity allocation targets drop from 48 % in 2022 to 20‑30 % in 2024 (page 58).  This evolution signals a deliberate de‑risking strategy, reducing equity exposure and market volatility while increasing debt weighting to meet a lower expected return target.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, UNP's Corporate Stock investment was $1,990 million in 2022, not $1.11 billion as stated. The 2023 value was $181 million, not $226 million. Additionally, in 2022, the allocation was overwhelmingly Level 1 ($1,980M), not Level 2 or Level 3 as claimed. The LLM incorrectly states there was a 'small Level-3' component, which is not supported by the ground truth. (2) The dollar amounts are off by hundreds of millions, and the classification across valuation levels is reversed. The LLM claims a shift from Level 2/Level 3 to Level 1, while the truth shows a shift from Level 1 to a much smaller Level 1/Level 2 portfolio. The cited equity allocation targets (48% to 20-30%) and page references (56, 58) are not verifiable from the provided ground truth and appear fabricated. (3) The multi-hop reasoning is partially sound in interpreting the decline as a de-risking strategy, which aligns with the ground truth's interpretation of a strategic shift. However, the reasoning is based on incorrect data, undermining the validity of the conclusion. The mention of continued Level 1 classification for common stock in 2024 matches the ground truth, showing some correct synthesis. (4) The correctness score is low due to major quantitative errors and misrepresentation of valuation levels. The qualitative accuracy is slightly higher because the general direction of interpretation (de-risking, reduced equity exposure) is plausible, though not fully supported by the provided data. Contextual relevance is fair as the answer addresses the question's structure and intent, but with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 463,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott has continued to disclose the 4.75 % Senior Notes due 2043 in the same fashion in each of its 2022, 2023 and 2024 Form 10‑K filings – the note’s form is filed as Exhibit 4.6 and the accompanying officers’ certificate as Exhibit 4.7 (see the exhibit tables on 2022 page 86, 2023 page 86 and 2024 page 86).  This unchanged presentation signals a deliberate emphasis on regulatory‑compliant, transparent disclosure of long‑term debt, underscoring Abbott’s preference for consistency in debt management and clear communication with investors.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Abbott's disclosure strategy. The ground truth states that in 2022, Abbott referenced the notes via legacy St. Jude Medical documentation from 2013, indicating indirect integration. However, the LLM claims that in 2022, the note form was already filed as Exhibit 4.6 to the 10-K, which contradicts the original answer and implies a more current and direct disclosure than actually occurred. The LLM incorrectly asserts that the exhibit structure (Exhibit 4.6 and 4.7) was consistently used across 2022–2024 10-Ks, but the ground truth shows a progression from legacy referencing (2022) to formal inclusion (2023 onward). (2) Quantitatively, the percentage (4.75%) and maturity year (2043) are correct, and the exhibit numbers (4.6, 4.7) align with the 2023–2024 disclosures. However, the claim about their presence in the 2022 10-K is unsupported by the ground truth, which emphasizes legacy referencing rather than current exhibit filing. The page numbers (86) cited are plausible but not verifiable from the provided truth data and are irrelevant since the focus is on the nature of disclosure evolution, not document layout. (3) The multi-hop reasoning is flawed: the question asks about evolution across years, but the LLM incorrectly concludes there was no change, directly contradicting the ground truth’s narrative of a shift from legacy-based to standardized disclosure. This failure to recognize the progression undermines the core of the answer. (4) Contextual relevance is moderate—the response addresses long-term debt communication and investor transparency, which are relevant themes. However, due to the incorrect characterization of the timeline and disclosure evolution, the qualitative accuracy is low. The conclusion about consistency is factually wrong based on the ground truth, which highlights a strategic shift, not stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 526,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The penetration of Target’s branded credit card fell from 20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024【page_27】.  The decline signals a modest slowdown in customer adoption of the RedCard/Target Credit Card, yet Target notes that a meaningful portion of card‑used purchases are incremental sales, so the product still contributes appreciably to revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and trends are accurate. (2) There are no calculations required beyond reporting percentages, and all figures are presented correctly with only minor formatting differences (e.g., use of thin space in '20.5 %'), which do not affect accuracy. (3) The reasoning is sound: the model correctly identifies the downward trend in penetration and links it to customer adoption, noting the continued importance of the card for incremental sales and revenue—consistent with the original answer’s emphasis on the card’s strategic role despite declining usage. The only minor omission is that the LLM does not explicitly mention 'Target Circle Card' or 'credit card profit sharing and customer retention efforts,' which are part of the broader loyalty strategy noted in the ground truth. However, the core multi-hop synthesis—linking declining penetration to adoption trends and then to sales impact—is logically and factually sound. (4) The answer is highly relevant, directly addressing both parts of the question: the evolution of penetration and its implications. The qualitative accuracy is slightly reduced due to the omission of specific program names and retention mechanisms, but the overall meaning and key insights remain aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 395,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s Multiple‑Purpose locomotive fleet shrank by roughly 115 units (from 7,008 units in 2023 to 6,893 units in 2024) and the average age rose by about 0.9 years (from 24.3 years in 2023 to 25.2 years in 2024). This gradual reduction in size coupled with a higher average age indicates a deliberate asset‑management strategy that phases out older locomotives while keeping the fleet lean and efficient.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both fleet size and average age for the years 2022 and 2023. According to the ground truth, in 2022, Union Pacific had 7,242 locomotives with an average age of 22.5 years, but the LLM incorrectly reports data starting from 2023 with 7,008 units and 24.3 years. The correct 2024 figures (6,893 units, 25.2 years) are accurately cited, but the starting point for comparison is wrong, leading to an incorrect change analysis. The claimed reduction of 'roughly 115 units' (from 7,008 to 6,893) is based on incorrect 2023 data and does not reflect the actual 2022–2024 change of 349 units (7,242 – 6,893). Similarly, the reported age increase of 'about 0.9 years' (from 24.3 to 25.2) ignores the actual increase from 22.5 to 25.2, which is 2.7 years. (2) Calculations are internally consistent with the incorrect data the model used, but they do not align with the ground truth. The correct total unit change is -349, not -115; the correct age increase is +2.7 years, not +0.9. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize fleet size and age trends to infer asset management strategy, but it does so on flawed data. The conclusion about a 'lean and efficient' fleet is plausible but contradicts the ground truth interpretation of deferred modernization due to rising average age and larger reduction in fleet size. (4) The contextual relevance is high because the answer addresses all parts of the question—fleet size, age, and strategic implication—and uses appropriate terminology. However, due to major quantitative errors and resulting flawed reasoning, the correctness score is low. The qualitative accuracy is moderate because the logic structure is sound, but entity and data accuracy are poor, especially regarding the years and values for 2022 and 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 507,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell steadily: $590 million at December 31 2022, $555 million at December 31 2023, and $540 million at December 31 2024 (see Note 14, page 70 of the 2023 and 2024 10‑Ks). This gradual decline signals a deliberate shift toward tighter liquidity and risk control while still maintaining a diversified exposure to illiquid alternative assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the downward trend in Abbott Laboratories' unfunded commitments to private real estate funds from 2022 to 2024 and reports the correct values for 2023 ($555 million) and 2024 ($540 million). However, it states the 2022 amount as $590 million, which is incorrect—the ground truth reports $585 million. This $5 million discrepancy affects quantitative accuracy. 2) Calculations: The decline from 2022 to 2023 is reported as $35 million ($590M → $555M) in the LLM answer, but should be $30 million ($585M → $555M); the 2023–2024 decline of $15 million is correct. The total three-year decline is thus overstated. Despite this, the trend direction and final value are accurate. 3) The reasoning is sound: the LLM correctly infers that the declining commitments suggest a strategic tightening of liquidity and risk control while maintaining exposure—this aligns with the ground truth’s interpretation of a 'measured approach' and continued long-term participation. The synthesis across years and implication for investment strategy is logically supported. 4) All entities (Abbott Laboratories, private real estate funds, unfunded commitments, years 2022–2024) are correctly identified. The citation to Note 14, page 70 of the 10-Ks adds contextual credibility. 5) The answer is semantically very close to the original, with only the initial figure incorrect. The conclusion about strategic direction remains valid despite the minor data error. Thus, the answer is mostly correct with a notable but not critical numerical inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 427,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "From FY 2022 to FY 2024, NVIDIA’s 3.50% Notes Due 2050 carried $1.604 billion (FY 2022) → $1.637 billion (FY 2023) → $2.000 billion (FY 2024) 【page_78】【page_67】【page_72】. The modest rise reflects a small increase in the outstanding balance of this long‑term note, but the carrying amount has remained essentially flat, indicating that NVIDIA’s long‑term debt profile has been stable with no significant shift in its debt mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, the carrying value was $2,147 million in FY2022, $1,604 million in FY2023, and $2,000 million in FY2024. However, the LLM incorrectly reports FY2022 as $1.604 billion (should be $2.147 billion) and FY2023 as $1.637 billion (should be $1.604 billion), reversing the correct values and introducing a non-existent increase from FY2022 to FY2023. Only the FY2024 value ($2.000 billion) is correct. (2) These errors invalidate the quantitative analysis: the actual trend is a sharp drop from 2022 to 2023 followed by a partial rebound in 2024, whereas the LLM describes a 'modest rise' and 'essentially flat' profile, which misrepresents the dynamics. The calculation of change across years is therefore incorrect. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and sequence the values across the three fiscal years, leading to an incorrect interpretation. The ground truth emphasizes a fluctuation indicating strategic revaluation or refinancing, while the LLM concludes 'stable' debt with 'no significant shift,' which contradicts the actual volatility in the carrying amount. (4) Contextually, the answer addresses the right metric and time frame and attempts interpretation, so relevance is moderate. However, due to major numerical inaccuracies and resulting flawed reasoning, the correctness score is low. Quantitative accuracy is severely compromised (score 2), qualitative reasoning suffers as a result (score 3), and overall correctness is only 3 out of 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 443,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD has consistently identified the risk of “loss or modification of exemptions for taxes and tariffs” in its 10‑K filings—listed on page 37 of the 2022 filing, page 41 of the 2023 filing, and again on page 41 of the 2024 filing. While the core risk statement remained unchanged, the 2024 disclosure expands the context to include a broader array of sanctions and geopolitical tensions (U.S. sanctions on Russia, Belarus, Ukraine, China‑Taiwan disputes, and Israel‑Hamas conflicts), underscoring a more intricate regulatory landscape. This evolution indicates that AMD’s exposure to tax‑and‑tariff exemption risk is increasingly intertwined with a dynamic, multifaceted global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently disclosed the risk of losing tax and tariff exemptions in its 2022, 2023, and 2024 10-K filings, with increasing contextual detail over time. The page numbers cited (37 in 2022, 41 in 2023 and 2024) are consistent with actual filings and correctly attributed. (2) Quantitative accuracy is perfect—no numerical errors; dates and document locations are precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the risk evolved across years, noting the expansion of geopolitical contexts (Russia, Belarus, Ukraine, China-Taiwan, Israel-Hamas) and links them to regulatory complexity. The only minor shortcoming is that the LLM does not explicitly mention the connection to third-party manufacturing partners in 2024, which is a key element in the ground truth and highlights operational vulnerability. This omission slightly weakens the completeness of the synthesis but does not invalidate the overall conclusion. (4) The answer is contextually excellent—directly addresses the evolution of risk exposure and interprets it correctly as reflecting a more complex global regulatory environment. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 397,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosures in 2022, 2023 and 2024 all repeat the same statement that its ability to return capital—whether through dividends or share repurchases—is subject to board discretion and may be limited by U.S. banking laws and regulations, including capital‑planning rules and Delaware law, and that failure to pay full and timely dividends on preferred stock could restrict these returns. The wording and emphasis have not changed across the three filings, indicating that the company’s exposure to regulatory constraints on dividend payments and share repurchases has remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility remained consistent from 2022 to 2024, with repeated disclosures about constraints from U.S. banking regulations, capital-planning rules, Delaware law, and preferred stock dividend obligations. These elements are present in the original answer and correctly reflected. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense—but all dates (2022, 2023, 2024) are correct and consistently referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years and correctly infers that unchanged language implies stable regulatory exposure. The only minor gap is that the original answer adds detail about 2023 emphasis on credit ratings and Title I/II resolution strategies, and 2024 expansion to include liquidity management and strategic initiatives—nuances not captured in the LLM response. This results in a slightly less complete qualitative picture, hence the 9 instead of 10 for qualitative accuracy. (4) Despite this, the LLM captures the core conclusion—regulatory constraints on capital returns have remained essentially unchanged—and directly addresses the question about evolution (or lack thereof) in exposure. The answer is fully contextually relevant and semantically equivalent in overall meaning, just slightly less detailed in the specifics of evolving disclosure emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 447,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott’s 2.950 % Note due 2025 has been consistently disclosed as **Exhibit 99.6** of the 8‑K filed March 5 2015.  That same reference appears unchanged in the 10‑K Exhibit Tables for 2022, 2023 and 2024, with no new exhibit or updated documentation added in any of those years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the 2.950% Note due 2025 is consistently disclosed as Exhibit 99.6 in the 8-K filing dated March 5, 2015, and this reference is unchanged in 2022, 2023, and 2024. (2) Quantitative elements—interest rate (2.950%), year of note maturity (2025), exhibit number (99.6), and filing date (March 5, 2015)—are all correctly stated with no discrepancies. (3) The multi-hop reasoning across three years of filings is sound: the model correctly infers stability in disclosure practices over time, noting no new exhibits or updates, which aligns with the ground truth's conclusion of a static financial instrument. (4) The answer addresses all parts of the question: evolution of disclosure, inclusion in exhibit filings, and associated documentation across 2022–2024. Wording differs slightly (e.g., 'reiterated' vs 'unchanged'), but meaning is preserved. No omissions or inaccuracies. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 294,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s carrying value of the 1.55% Notes Due 2028 was $1.25 billion at each year‑end for FY 2022, FY 2023, and FY 2024 (page 72 shows $1.25 billion for FY 2024 and FY 2023). The unchanged balance over three years indicates a deliberate long‑term debt strategy of maintaining a stable, low‑interest debt load to fund growth while preserving financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. According to the ground truth, the carrying value was $1,200 million in FY 2022, $1,099 million in FY 2023, and $1,250 million in FY 2024. The LLM incorrectly states that the value was $1.25 billion in all three years, which contradicts the actual fluctuating trend. This misrepresents both the magnitude and direction of change, especially the decrease in FY 2023. (2) The numbers are not accurate: the LLM reports $1.25 billion for all years, while the truth shows a dip to $1.099 billion in FY 2023 before rising to $1.25 billion in FY 2024. Even allowing for format variations (e.g., $1.25B vs $1,250 million), the values for 2022 and 2023 are wrong. (3) The reasoning is flawed because it interprets stability where there is volatility. The ground truth indicates strategic management through fluctuations, while the LLM infers stability due to an incorrect assumption of unchanged balances. This fails the multi-hop synthesis test—correctly tracking changes over time across fiscal years. (4) Contextual relevance is moderate because the answer addresses the right metric and company and attempts to interpret strategy, but the incorrect data undermines the conclusion. The qualitative analysis is reasonable given the assumed data, but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 375,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "AMD’s approach to AIB partners has stayed essentially the same from 2022 through 2024: it continues to supply component‑level graphics and chipset products, and its agreements with AIBs explicitly protect their inventory from price cuts (2022, 2023, 2024).  In each filing the company also stresses that system integrators use discrete graphics solutions to differentiate their board‑level products and add value for customers (2022, 2023, 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and matches the ground truth on key points: AMD maintained inventory protection policies for AIBs from 2022 to 2024, and discrete graphics solutions were consistently highlighted as a means for differentiation. All years (2022, 2023, 2024) are correctly referenced, and there are no numerical or date inaccuracies—thus, quantitative accuracy is perfect. The answer correctly identifies AMD, AIBs, and the role of discrete graphics, satisfying entity accuracy. However, the LLM omits specific details about the 12-month return policy for products removed from the price book (mentioned in 2022) and the evolving emphasis AMD placed over time—particularly the increased focus on market competitiveness in 2023 and the strategic push for differentiation through discrete graphics in 2024. While the LLM notes differentiation, it does not reflect the evolution in emphasis across the years, which is central to the question’s focus on 'how the strategy evolved.' This lack of nuance in capturing the strategic shift reduces qualitative accuracy slightly. Contextual relevance is strong, as the response directly addresses both parts of the question—inventory protection and the role of discrete graphics in differentiation—and synthesizes information across all three years. Overall, the answer is correct but lacks depth in portraying the strategic evolution, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 399,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD first flagged “difficulties in protecting our intellectual property” as a general foreign‑operations risk on page 37 of the 2022 10‑K. By 2023 (page 41) the company still listed IP protection as a risk but added explicit concern over China‑Taiwan tensions and its reliance on third‑party wafer foundries. In the 2024 filing (pages 38–40) the risk was expanded to include sanctions, export‑control revisions and geopolitical conflicts (Russia‑Ukraine, Israel‑Hamas) that could disrupt Taiwan‑, China‑ and Malaysia‑based manufacturing, while noting that 66 % of revenue is international and most assembly/testing occurs in those politically sensitive regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD flagged IP protection risks in 2022, expanded disclosures in 2023 to include China-Taiwan tensions and third-party foundries, and in 2024 added geopolitical conflicts (Russia-Ukraine, Israel-Hamas), sanctions, and export controls. The 66% international revenue figure in 2024 is correctly stated and matches the ground truth (up from 65% in 2023). (2) Quantitative accuracy is perfect: the 66% and 65% revenue figures are correct, and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound—LLM synthesizes risk evolution across three years, connects IP protection to geopolitical tensions, third-party manufacturing, and international revenue growth, and correctly identifies the increasing complexity of the risk. (4) Minor deduction in qualitative accuracy due to omission of the specific mention that international sales increased from an 'unspecified but lower figure' in 2022 (though 65% in 2023 and 66% in 2024 are correctly noted), and slightly less emphasis on the transformation of IP risk into a more regionally concentrated issue. However, the core evolution is accurately captured. Contextual relevance is full—every part of the question (IP protection, international operations, third-party manufacturing, politically sensitive regions) is addressed with precise, evidence-based details from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 402,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "BK continued to award both performance‑share and restricted‑stock units under its 2019 Long‑Term Incentive Plan each year: in 2022 it introduced a 2022 Form of Restricted Stock Unit Agreement (Exhibit 10.19) and a 2022 Form of Performance Share Unit Agreement (Exhibit 10.21) (page 19 of 2022); in 2023 it added a 2023 Form of Performance Share Unit Agreement (Exhibit 10.23) and a 2023 Form of Restricted Stock Unit Agreement (Exhibit 10.24) (page 19 of 2023); and in 2024 it continued the pattern with a 2024 Form of Performance Share Unit Agreement (Exhibit 10.28) and a 2024 Form of Restricted Stock Unit Agreement (Exhibit 10.29) (page 20 of 2024). This steady, year‑over‑year use of both incentive and retention equity under the 2019 LTI Plan indicates a consistent strategy of aligning executive pay with long‑term performance while maintaining a balanced mix of equity awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims BK introduced a 2022 Form of Restricted Stock Unit Agreement and a 2022 Form of PSU Agreement in 2022, but the ground truth states that in 2022, BK referenced the 2019 LTIP alongside the 2021 Form of PSU Agreement—not 2022 forms. Similarly, the LLM asserts the introduction of 2023 and 2024 forms of both PSU and RSU agreements, but the ground truth indicates that in 2023, BK introduced the 2020 Form of PSU Agreement (not 2023), and in 2024, the 2022 Form of PSU Agreement (not 2024). These are significant factual errors in dates and document versions. (2) The quantitative inaccuracies are severe: every year's agreement form is misstated (2022 vs. 2021, 2023 vs. 2020, 2024 vs. 2022), and the LLM fabricates the use of Restricted Stock Unit agreements annually, which are not mentioned in the ground truth. (3) The multi-hop reasoning is flawed: instead of recognizing a layered, continuity-based strategy using older plan frameworks with selectively updated instruments, the LLM invents a pattern of annual updates to both PSU and RSU forms, suggesting a different compensation strategy. (4) While the answer is contextually relevant—discussing executive compensation under the 2019 LTIP and attempting to infer strategy—the factual foundation is incorrect, leading to a misleading conclusion about consistency and balance in equity awards. The ground truth emphasizes continuity with periodic enhancements using legacy forms, whereas the LLM describes a more dynamic, annual refresh model that is not supported by the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 441,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s original cost of diagnostics instruments leased to customers increased from **$3.6 B in 2022 to $3.9 B in 2023** and remained at **$3.9 B in 2024** (net book values rose from $1.6 B to $1.8 B and then held steady)【page_64】【page_62】. This modest, steady growth shows the company is maintaining and slightly expanding its diagnostics equipment base rather than pursuing aggressive capital outlays, indicating a focus on sustaining existing capabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the original cost and net book value figures. According to the ground truth, the original cost was $3.3B in 2022, $3.6B in 2023, and $3.9B in 2024 — but the LLM incorrectly states it increased from $3.6B in 2022 to $3.9B in 2023, reversing the correct trend. Similarly, net book value was $1.4B in 2022, $1.6B in 2023, and $1.6B in 2024, but the LLM reports $1.6B in 2022 and $1.8B in 2023, which is entirely incorrect. These errors affect all years and metrics. (2) The quantitative inaccuracies are severe: the LLM swaps 2022 and 2023 values and invents a non-existent plateau in 2024 based on wrong data. No calculation is required, but the directional trend is misrepresented. (3) The reasoning is partially sound in interpreting the trend as reflecting a strategic capital deployment, but it draws conclusions from incorrect data. The LLM suggests 'modest, steady growth' and 'sustaining existing capabilities', which understates the actual consistent investment increase shown in the ground truth. The correct inference — that Abbott is strategically expanding access to drive reagent sales — is missed. (4) Due to major factual errors in core financial figures, the correctness score is low at 3. Quantitative accuracy is 2 due to complete inversion of data points. Qualitative accuracy is 4 because the general idea of leasing strategy is present but poorly supported. Contextual relevance is 6 because the answer addresses the right topic and time frame, but with wrong numbers and suboptimal interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 438,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Lumentum Holdings is consistently named in NVIDIA’s competitor list as a rival in the interconnect, switch, and cable solutions segment in fiscal 2022 (page 15), 2023 (pages 9‑11), and 2024 (pages 7‑11)【page_15】【page_9】【page_10】【page_11】【page_7】【page_8】【page_9】【page_10】【page_11】. NVIDIA’s strategic shift toward AI‑driven networking and interconnect technologies has amplified the importance of this category, yet Lumentum’s competitive positioning has remained largely unchanged, indicating a stable but increasingly contested landscape as NVIDIA expands its AI networking portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of the years (2022, 2023, 2024) and correctly identifies Lumentum Holdings as a competitor in interconnect, switch, and cable solutions across all three fiscal years, which aligns with the ground truth. It also correctly references NVIDIA's strategic focus on AI-driven networking, satisfying contextual relevance. However, the key shortcoming lies in qualitative accuracy: the LLM claims Lumentum’s competitive positioning has 'remained largely unchanged,' which directly contradicts the ground truth that shows a clear evolution in Lumentum's positioning. According to the original answer, Lumentum moved from a general supplier category in 2022, to a more specialized high-performance interconnect segment in 2023 (aligned with InfiniBand, Ethernet, and proprietary AI technologies), and then received a more specific corporate designation ('Lumentum Holdings Inc.') in 2024—indicating rising prominence and recognition. The LLM fails to capture this progression, instead asserting stability in positioning, which misrepresents the multi-hop synthesis required. While all entities and years are correct, and no numerical inaccuracies exist (hence full quantitative accuracy), the reasoning and conclusion are flawed. The answer misses the nuanced evolution in competitive landscape and thus provides an incomplete and misleading assessment of Lumentum's changing role in NVIDIA's ecosystem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 396,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In 2022 Emerson listed pipe cutters under its Tools & Home Products segment as part of its Professional Tools offering (see the 2022 10‑K “Professional Tools” description on page 9). By 2024 the same product line was positioned in the Safety & Productivity segment, where the 2024 10‑K segment description on page 73 lists pipe‑working tools—including cutters—as part of that segment’s portfolio. This shift shows Emerson consolidating its professional‑tool lineup into a safety‑and‑productivity‑focused segment, underscoring a strategy that frames pipe cutters as essential safety and productivity solutions for professionals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, pipe cutters were part of the Tools & Home Products segment under Professional Tools, citing the correct 2022 10-K page 9. By 2024, it accurately notes the repositioning into the Safety & Productivity segment, referencing the 2024 10-K page 73 and including 'pipe-working tools—including cutters' as part of that segment. These entity and year assignments are correct. (2) There are no numeric values requiring calculation, but all dates (2022, 2024) and document references (page numbers, segment names) are factually accurate—quantitative accuracy is perfect. (3) The reasoning correctly infers a strategic consolidation of professional tools into a segment emphasizing safety and productivity, which matches the ground truth’s interpretation. However, the LLM omits mention of the broader context such as the InSinkErator divestiture and the grouping with battery hydraulic tools, drain cleaners, and diagnostic systems, which weakens the completeness of the multi-hop synthesis slightly. (4) Despite this minor omission, the core shift and strategic implication are correctly interpreted, and the answer remains contextually precise and relevant. The conclusion about framing pipe cutters as safety and productivity tools for professionals is semantically equivalent to the ground truth. Thus, correctness is high but not perfect due to missing contextual linkages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 408,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 to 2024 Schwab’s RIA platform evolved from a basic website that offered account‑servicing, multi‑year archival, document search, and a free, intuitive portfolio‑management tool (Schwab Advisor Portfolio Connect) with interactive tools and educational content【page_7】 to a more integrated ecosystem that added Ameritrade’s thinkpipes trading engine, iRebal rebalancing, and in 2023 the Schwab Trading Powered by Ameritrade platform—providing a full trading and allocation experience for RIAs【page_7】【page_8】. The website continued to provide the same core account‑servicing and third‑party integration capabilities while now supporting the expanded trading and rebalancing features, and advisor‑support offerings (consulting, benchmarking, and thought‑leadership content) remained robust and unchanged in scope【page_7】【page_8】. Thus, the platform’s functionality grew through added trading and rebalancing tools, its integration deepened with Ameritrade’s technology, and its advisor support offerings stayed consistently comprehensive.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth. While it correctly identifies Schwab Advisor Portfolio Connect and the general evolution of tools for RIAs from 2022 to 2024, it introduces incorrect functionality such as 'Ameritrade’s thinkpipes trading engine', 'iRebal rebalancing', and 'Schwab Trading Powered by Ameritrade'—none of which are mentioned or supported in the original answer. These are likely confabulations or misinterpretations not present in the ground truth. Additionally, the LLM claims advisor support offerings 'remained robust and unchanged in scope', which directly contradicts the original answer stating that Schwab expanded educational and consulting services in 2023 and enhanced prospect consulting in 2024. (2) Quantitatively, there are no explicit numbers, dollar amounts, or percentages in either answer, so no calculation errors exist. Dates (2022–2024) are used correctly, earning high marks for quantitative accuracy. (3) The multi-hop reasoning is partially sound—information is synthesized across years and services—but the LLM fails to accurately represent the nature of integration and evolution. The original emphasizes deeper third-party integrations for CRM, portfolio management, compliance data feeds, and document archiving, while the LLM incorrectly frames integration around Ameritrade’s technology, which is not mentioned in the ground truth. This undermines the qualitative accuracy. (4) Contextually, the LLM addresses the question’s focus on functionality, integration, and advisor support, but due to key factual errors and incorrect tool names, the answer is only partially aligned with the truth. The core progression toward a more integrated ecosystem is acknowledged, but the specifics are misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 495,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10‑K (Exhibit 4.16, issued March 24 2021) and treated them as long‑term debt with a fixed 1.650 % coupon maturing in 2026. The 2023 and 2024 10‑K filings (Exhibit 4.14 on page 111 of each) continue to list the same notes unchanged, with no amendments, repayments or conversion. This consistency shows Oracle’s strategy of maintaining a stable, low‑rate long‑term debt base to fund short‑to‑intermediate‑term needs, keeping interest costs predictable and avoiding the volatility of short‑term borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 1.650% interest rate, 2026 maturity, and exhibit numbers (4.16 in 2022, 4.14 in 2023 and 2024) are correct. However, there is a minor error in the issuance date: the LLM states the notes were issued on March 24, 2021, but the original answer and typical 10-K disclosures indicate the note was first reported in the 2022 10-K, which covers fiscal year 2022—this suggests the filing date is 2022, not 2021. This discrepancy affects the timeline but not the core analysis. (2) The answer is complete, addressing the evolution (or lack thereof) from 2022 through 2024 and interpreting Oracle’s financing strategy. (3) Entity accuracy is strong: Oracle, the notes, the correct exhibits, and years are all properly identified. (4) The reasoning is sound—by noting the unchanged treatment across filings and linking it to a stable, low-rate debt strategy, the LLM correctly infers Oracle’s intent to maintain predictable interest costs and avoid refinancing risk. The conclusion that Oracle uses long-term debt for short-to-intermediate-term needs is a reasonable interpretation of the consistent disclosure. (5) Semantic equivalence is high: while the LLM adds slight interpretive nuance (e.g., 'funding short-to-intermediate-term needs'), it does not contradict the ground truth and enhances the strategic insight without introducing error. The minor date inaccuracy prevents a perfect score, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 417,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson moved electrical‑distribution equipment out of its Industrial Solutions segment and into the Discrete Automation portfolio.  In the 2022 10‑K the equipment is described as part of Industrial Solutions (page 76), whereas the 2023 and 2024 10‑Ks list it explicitly within Discrete Automation (page 73).  This shift signals a deliberate focus on electrifying discrete‑manufacturing processes, underscoring the company’s strategy to embed industrial‑electrification solutions into its core automation offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies the repositioning of Electrical Distribution Equipment from Industrial Solutions in 2022 to Discrete Automation in 2023 and 2024, with accurate references to the respective 10-K filings and page numbers (2022: p.76, 2023/2024: p.73), which supports quantitative and entity accuracy. (2) There are no numerical values requiring calculation, but the years and segment names are correct—EMR ticker implied correctly, and time periods (2022–2024) are fully addressed. (3) The reasoning is sound: the model correctly infers a strategic shift toward industrial electrification and smart manufacturing through the re-segmentation, demonstrating proper multi-hop synthesis across three years of filing data. (4) The LLM captures the core strategic implication—embedding electrification into core automation offerings—though it omits the minor detail about the 2024 description being consistent with 2023 (a small completeness gap). However, this does not detract from the overall correctness. Semantic equivalence is strong, and the answer is highly contextually relevant. A score of 9 is justified due to full factual alignment, with only slight omission of the continuity between 2023 and 2024 emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 362,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate funds rose modestly from **$540 million in 2022 to $555 million in 2023** and then fell back to **$540 million in 2024**【page_68】.  The near‑flat trajectory indicates that Abbott is maintaining a steady, cautiously‑managed exposure to illiquid alternative assets within its pension portfolio, balancing diversification benefits with liquidity considerations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and trend. According to the ground truth, Abbott's unfunded commitments decreased from $585M in 2022 to $555M in 2023, then to $540M in 2024. The LLM incorrectly states that the amount was $540M in 2022 and rose to $555M in 2023, reversing the actual trend for the first year. This misrepresents the direction of change and invalidates the core quantitative claim. (2) The numbers are not accurate: the starting value is off by $45 million, and the trend is misrepresented as increasing then decreasing, when in reality it is consistently decreasing. Calculations based on these numbers would be fundamentally flawed. (3) The multi-hop reasoning is unsound because the LLM draws a conclusion about 'near-flat trajectory' and 'steady exposure' based on incorrect data. The ground truth supports a narrative of deliberate de-risking and reduction in illiquid asset exposure, while the LLM suggests stability, which contradicts the actual trend. The synthesis fails because it is based on inverted data. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right company, metric, time frame, and attempts to interpret pension strategy regarding illiquid assets. However, due to the critical error in data direction and magnitude, the correctness and qualitative accuracy scores are low. The answer would lead to an incorrect understanding of Abbott’s strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 412,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle consistently reported the 1.650% Notes due 2026 as part of Exhibit 4.14 in all three filings—2022 (page 111), 2023 (page 109), and 2024 (page 109)—with identical terms and no changes to the maturity or interest rate. The note remains part of the same 2021‑issued series of long‑term notes, indicating Oracle’s preference for a stable, low‑cost debt structure rather than frequent short‑term borrowing. This continuity reflects a short‑term debt strategy that relies on long‑term financing to manage interest costs and maturity risk while preserving liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% interest rate, the 2026 maturity, and the consistent referencing across 2022, 2023, and 2024 filings are accurately reported. The mention of Exhibit 4.14 and specific page numbers (111, 109, 109) adds precision, and while the ground truth does not include page numbers, their inclusion does not detract from accuracy. (2) The LLM correctly identifies that the notes were part of a 2021 issuance, consistent with the original 8-K filing referenced in the ground truth. Although the LLM does not explicitly name the March 24, 2021 8-K filing, it captures the essential fact that the terms originated in 2021 and remained unchanged. (3) The reasoning is sound: the continuity in reporting and lack of modifications support the conclusion that Oracle favors stable, long-term financing to manage short-term debt strategy, which is a valid inference from the data. The LLM correctly interprets this as a strategy to control interest costs and maturity risk. (4) The answer is contextually relevant and fully addresses both parts of the question—evolution (or lack thereof) of the notes and what it reveals about Oracle’s short-term debt strategy. The only minor shortcoming is the lack of explicit mention of the 8-K filing reference in each 10-K, which is a detail present in the ground truth, but the substance of that reference (unchanged terms since 2021) is preserved. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 438,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in 2014, and the same terms are documented in Exhibit 4.09, which is referenced in the 2022 10‑K (page 113) and re‑filed in the 2023 and 2024 10‑Ks (page 110). The repeated appearance of this long‑maturity instrument over three consecutive filing periods shows Oracle’s intent to keep a stable, diversified debt portfolio with predictable, long‑term financing and to provide consistent disclosure to investors.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the issuance date of the 4.30% Note due 2034, claiming it was 'first issued in 2014', which contradicts the ground truth that does not mention an issuance date but focuses on its documentation in 2022–2024 filings. This is a critical quantitative and factual inaccuracy. The exhibit numbers cited (4.09 in 2022, 2023, 2024) partially conflict with the ground truth: the original answer states Exhibit 4.11 was used in 2022 and Exhibit 4.09 in 2023 and 2024, whereas the LLM claims Exhibit 4.09 was used in all three years, including 2022. This misalignment in exhibit numbers reduces quantitative accuracy. (2) The LLM correctly identifies the consistent documentation of the note across three years and links it to Oracle’s long-term debt strategy, which aligns with the ground truth’s conclusion about stable financing and investor disclosure. However, the incorrect issuance date and exhibit references undermine factual precision. (3) The multi-hop reasoning is partially sound—the model correctly infers from repeated filing references that Oracle maintains a stable, diversified debt portfolio. It synthesizes across years and connects documentation patterns to strategic intent, which shows good qualitative reasoning. However, the failure to accurately reflect the exhibit evolution (4.11 → 4.09) and the erroneous 2014 issuance claim indicate flawed data synthesis. (4) Contextual relevance is high because the answer addresses both the evolution across years and the strategic implication. Despite incorrect details, the overall narrative about Oracle’s long-term financing strategy is logically derived and semantically aligned with the ground truth. Thus, correctness is reduced primarily due to key factual inaccuracies, especially the unsupported 2014 issuance claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 503,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab used the 2019 IDA agreement to migrate up to $10 billion of IDA balances to its balance sheet each year, while keeping a minimum $50 billion balance and an 80 % fixed‑rate requirement. In 2023 the new 2023 IDA agreement replaced the 2019 terms; Schwab did not move balances that year, the 80 % fixed‑rate rule was eliminated, and new minimum/maximum balance limits ($30 billion above fixed‑rate amounts until Sept 10 2025, then $60 billion min/$90 billion max) and a $5 billion buy‑down option were introduced, but withdrawal restrictions were imposed. In 2024 Schwab again did not migrate IDA balances, and the contractual constraints remained those of the 2023 agreement, with no further changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details compared to the ground truth. While it correctly states that Schwab had the option to migrate up to $10 billion annually under the 2019 IDA agreement and did not migrate balances in 2023 and 2024, it introduces specific balance thresholds ($30 billion above fixed-rate amounts, $60 billion min/$90 billion max) and a $5 billion buy-down option that are not present in the original answer. These figures are unsupported by the ground truth and represent significant factual additions. Additionally, the mention of a 'minimum $50 billion balance' in 2022 is not mentioned in the original answer and appears to be fabricated. (2) The original answer notes that $10.1 billion had already been moved by December 31, 2021, including $10 billion 'subsequent to that date'—a likely typo or misstatement in the original, but the LLM does not address this nuance. The elimination of the 80% fixed-rate requirement in 2023 is correctly identified. However, the introduction of new balance limits and the buy-down option lacks support. (3) The multi-hop reasoning is partially sound: the model correctly identifies the shift from the 2019 to the 2023 IDA agreement, recognizes the increased contractual flexibility due to the removal of the fixed-rate requirement, and notes the absence of balance migrations in 2023 and 2024. However, the synthesis includes unsupported details, undermining the factual integrity. (4) The contextual relevance is high as the answer addresses the evolution across years and changes in contractual terms. Qualitative accuracy is moderate due to correct high-level structure and entity identification (Schwab, IDA agreements, years), but quantitative accuracy is low due to the inclusion of incorrect dollar amounts and thresholds not present in the ground truth. Correctness score reflects partial accuracy with significant factual overreach in numerical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 530,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Abbott Laboratories continued to file the same Officer’s Certificate (Exhibit 4.18) for its 2.000% Senior Notes due 2018 in each of the 2022, 2023 and 2024 10‑K filings, all of which referenced the original 2017 indenture. No new supplemental indenture, amendment or refinancing of the 2018 notes was disclosed in any of the three years (page 86, 2022; page 86, 2023; page 86, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains key factual discrepancies compared to the ground truth. (1) Quantitatively, the LLM correctly identifies the 2.000% Senior Notes due 2018 and the years 2022–2024, and accurately states no new amendments or refinancing occurred—this aligns with the ground truth’s conclusion of no new actions. However, the LLM incorrectly identifies the exhibit number as 4.18 in all three years, while the ground truth specifies Exhibit 4.21 in 2023 and 2024. Additionally, the LLM references an 'Officer’s Certificate' tied to a 2017 indenture, which contradicts the ground truth stating the notes were governed by the Fifth Supplemental Indenture dated September 23, 2015, related to St. Jude Medical debt. (2) The numbers and dates mentioned (e.g., 2.000%, 2018 maturity) are accurate, but the exhibit numbers and indenture date are incorrect, affecting document-level precision. (3) The reasoning is partially sound—correctly inferring no refinancing from lack of disclosures—but fails the multi-hop synthesis by not connecting Abbott’s continued disclosure to legacy St. Jude Medical debt structure, a key contextual point in the original answer. (4) Contextually, the answer addresses the question’s focus on documentation updates and refinancing, correctly noting no activity, but misrepresents the specific documentation trail. Thus, while the high-level conclusion about inactivity is consistent, the supporting details are factually flawed, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 417,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650% Notes due 2041 in 2021, with the officers’ certificate dated March 24 2021 (exhibit 4.14)【page_111】. The same note series is still listed in the 2023 and 2024 10‑K filings (exhibit 4.14) with no new issuance or amendment, indicating the debt remains on the books for its full 20‑year term【page_111】. This multi‑year pattern shows Oracle’s long‑term debt strategy of issuing long‑dated, fixed‑rate notes to lock in borrowing costs and spread maturities over a multi‑decade horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM Answer is mostly correct in substance but contains a critical factual error in the issuance year: it states the 3.650% Notes due 2041 were issued in 2021, while the ground truth specifies the introduction occurred in 2022. This discrepancy affects quantitative accuracy, as the timeline is central to the question’s focus on 2022–2024 evolution. However, the interest rate (3.650%), maturity year (2041), and continued presence in 2023 and 2024 filings are correctly stated. (2) No calculations are involved, but the date error is significant—Oracle’s 2021 issuance may refer to a different series or an early registration, but the ground truth emphasizes the 2022 introduction as part of the observed multi-year pattern. The LLM’s citation of exhibit 4.14 and page 111 suggests document support, but the interpretation conflicts with the verified timeline. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years (2021, 2023, 2024) and infers Oracle’s long-term debt strategy of using long-dated, fixed-rate debt to lock in costs and extend maturities. This aligns with the ground truth’s conclusion about stable financing and financial flexibility. (4) Despite the incorrect start year, the answer captures the strategic intent and persistence of the notes, making it contextually relevant and qualitatively strong. The core message about Oracle’s long-term debt strategy remains valid, warranting a correctness score of 7 due to the factual inaccuracy in timing but strong overall alignment in reasoning and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 433,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were first issued in 2021 and remained outstanding through 2022, as shown in the 2023 10‑K’s officer certificate (Exhibit 4.14, page_111). In 2023, Oracle issued new 4.500% Notes due 2028 (Exhibit 4.16, page_111), indicating a shift to a higher coupon for the same maturity. By 2024, the 4.500% Notes remained the primary 2028 debt, with no new 2.300% issuance, reflecting a strategy of refinancing existing debt at higher rates to capture favorable market conditions while maintaining a diversified maturity mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2.300% Notes due 2028 were first issued in 2021 and remained outstanding through 2022 as shown in the 2023 10-K’s Exhibit 4.14. However, the ground truth indicates the notes were introduced in 2022 under Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021—meaning the certificate predates the actual issuance. The LLM confuses the certificate date with the issuance date and misattributes the exhibit number (4.14 vs. 4.16). Additionally, the LLM incorrectly claims that by 2024, the 4.500% Notes were the 'primary' 2028 debt and that there was no new 2.300% issuance, which contradicts the ground truth stating that Oracle maintained the same structure for the 2.300% Notes due 2028 in 2024, referencing the original certificate. (2) Quantitative accuracy is low: while the percentages (2.300%, 4.500%) and maturity year (2028) are correct, the issuance timeline and exhibit references are wrong. The fiscal years of issuance and documentation are misrepresented. (3) Multi-hop reasoning is partially sound—the model attempts to track debt evolution across years and infers a refinancing strategy—but it fails to correctly synthesize the continuity of the 2.300% Notes. Instead, it falsely implies replacement with higher-coupon debt, which is not supported by the ground truth. (4) Contextual relevance is fair because the answer addresses Oracle’s debt strategy and cites relevant exhibits, but the incorrect facts undermine the conclusion. The strategy should reflect stability and diversification, not refinancing at higher rates. Thus, the correctness score is 4 due to partial factual alignment but major errors in key details and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 484,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In 2022, Visa integrated virtual accounts into its Currencycloud platform as part of the Visa Direct Platform, adding real‑time FX, virtual accounts and liquidity for cross‑border flows (2022 10‑K, page_10). By 2024, that integration deepened—Visa Direct now incorporated Visa Cross‑Border Solutions and Currencycloud capabilities that support new and existing cross‑border consumer payments, expanding the service to more than 195 countries and processing nearly 10 billion transactions (2024 10‑K, page_10).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Visa's virtual accounts from 2022 to 2024, particularly around integration with Visa Direct and cross-border capabilities. However, it misrepresents the timeline: the original answer states that virtual accounts were introduced in 2022 as part of Treasury as a Service and then fully integrated into Visa Direct in 2023, whereas the LLM answer implies integration into Visa Direct occurred in 2022. This is a significant factual misalignment in the multi-hop timeline. (2) Quantitatively, the LLM introduces a figure of 'nearly 10 billion transactions' and 'more than 195 countries' from the 2024 10-K, which are not present in the ground truth. While these numbers may be factually correct in the actual filing, they are not part of the verified knowledge graph answer and thus introduce unverified data. The ground truth references 'more than 11 billion endpoints' (not transactions), which the LLM omits. (3) The reasoning is partially sound—there is clear synthesis across years and platforms (Currencycloud, Visa Direct, cross-border flows)—but the conflation of 2022 and 2023 integration milestones undermines the multi-hop accuracy. The LLM skips the 2023 milestone entirely, jumping from 2022 to 2024. (4) Contextual relevance is high as the answer addresses virtual accounts, Currencycloud, Visa Direct, and cross-border expansion. However, the omission of the 2023 integration and the introduction of unverified metrics reduce qualitative and quantitative accuracy. The core facts about real-time FX, liquidity, and cross-border support are correctly attributed, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 459,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "From 2022 to 2024 the ME&T dealer network that carries EMD‑branded engines grew from 152 dealers in 187 countries to 160 dealers in 193 countries in 2023, then slightly contracted to 156 dealers in 191 countries in 2024【page_66】【page_65】【page_64】.  This pattern shows Caterpillar’s intent to broaden its global reach for EMD while fine‑tuning dealer coverage to improve efficiency and focus on high‑growth markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key quantitative aspects. According to the ground truth, the number of distributors for EMD-branded products remained stable at 110 in 2022 and 2023, then decreased slightly to 108 in 2024, while the number of countries expanded from 109 to 158. The LLM incorrectly states that the dealer network grew from 152 to 160 to 156 and operated in 187–193 countries, which contradicts the verified data. These numbers are entirely inconsistent with the original answer. (2) The cited figures (e.g., 152 dealers in 187 countries) do not match the ground truth (110 distributors in 109 countries in 2022). There is no mention in the original answer of FG Wilson being part of a 150+ dealer network, nor any reference to 187+ countries. The calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the entity (EMD-branded products via FG Wilson systems) and misrepresents the distribution network evolution. It incorrectly infers a growth strategy from fabricated numbers, whereas the actual data shows a strategy of distribution optimization with expanded geographic reach despite fewer distributors. (4) The contextual relevance is moderate because the answer attempts to interpret strategic intent (broadening global reach, improving efficiency), which aligns with the question’s goal. However, due to completely inaccurate data and misidentification of the distribution network size and scope, the qualitative and quantitative accuracy scores are very low. The answer fabricates numbers not present in the source material, leading to a correctness score of 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 459,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s investment in diagnostics instruments leased to customers grew modestly from 2022 to 2023, with the original cost rising from **$3.6 billion to $3.9 billion** and the net book value climbing from **$1.6 billion to $1.8 billion**.  The figures then held steady through 2024, remaining at **$3.9 billion** for original cost and **$1.8 billion** for net book value (page_64 2022, page_63 2023, page_64 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the starting values for 2022. It claims the original cost rose from $3.6 billion in 2022 to $3.9 billion in 2023, but the ground truth states it was $3.3 billion in 2022, increasing to $3.6 billion in 2023 and then $3.9 billion in 2024. Similarly, the net book value is incorrectly reported as starting at $1.6 billion in 2022, when the correct value is $1.4 billion. These errors misrepresent the trend and magnitude of growth. (2) The quantitative inaccuracies are critical: the LLM swaps the 2022 and 2023 figures, making it appear that investment was flat in 2024 rather than continuing to grow. While the 2023 and 2024 numbers are correct, the misattribution of earlier values undermines the analysis. (3) The reasoning is partially sound in that it identifies a growth trend and correctly notes that values remained at $3.9B and $1.8B in 2024, but it fails the multi-hop synthesis by not accurately tracking the full three-year evolution from 2022 to 2024. The conclusion of 'modest growth' followed by stagnation contradicts the ground truth of consistent annual increases. (4) Contextual relevance is high because the answer addresses the right metric, company, and time frame, and cites appropriate document pages. However, due to major numerical errors in key data points, the correctness and quantitative accuracy scores are low, though not zero because some values (2023–2024) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 408,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "PepsiCo’s 10‑K filings for 2022, 2023 and 2024 all list the 3.450% Senior Note due 2046 in Exhibit 4 (see page 126 of each filing), showing that the note remains an outstanding long‑term debt instrument. This consistent disclosure signals that the company continues to rely on this fixed‑rate, 2046‑maturity note as a core component of its capital‑structure mix, helping to maintain a diversified debt maturity profile and a stable interest‑expense base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth in substance. (1) All key facts are accurate: the 3.450% Senior Note due 2046 is correctly identified, and its consistent disclosure across 2022–2024 is properly noted. The percentage (3.450%), maturity year (2046), and multi-year presence are all correct. (2) Quantitative accuracy is perfect—no calculations are required, but the numeric identifiers (interest rate, year) match exactly. The LLM references 'Exhibit 4' and page 126, which, while not matching the exact exhibit numbers in the ground truth (4.17, 4.16, 4.15), is a reasonable simplification and does not constitute an error—Exhibit 4 typically contains debt instruments, and page 126 consistency across filings is plausible. (3) The reasoning is sound: the LLM correctly infers that the note's ongoing disclosure indicates it remains outstanding and strategically used in the capital structure, supporting long-term funding, interest stability, and maturity diversification—this aligns with the ground truth’s interpretation. (4) The only minor shortcoming is the lack of specific exhibit numbers (4.17, 4.16, 4.15), which were present in the original answer and add precision. However, this omission does not undermine the core conclusion. The LLM captures the strategic implications—fixed-rate, long-term funding—as intended. Thus, the answer is highly accurate, contextually appropriate, and demonstrates correct multi-hop reasoning across years, earning a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 439,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in 2021 as part of a structured debt program (see 2022 10‑K Exhibit 4.16). The same terms and maturity were disclosed unchanged in the 2023 10‑K (Exhibit 4.14) and the 2024 10‑K (Exhibit 4.14)【page_114】【page_111】【page_109】. This continuity across three fiscal years indicates Oracle’s strategy of maintaining a stable, long‑term debt profile with staggered maturities and moderate coupon rates, allowing it to manage refinancing risk and interest costs without frequent restructuring.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the 2.300% Notes due 2028 were issued in 2021, while the ground truth confirms they were first introduced in 2022 in Exhibit 4.16. This misstatement of the issuance year undermines the quantitative accuracy. However, the coupon rate (2.300%), maturity year (2028), and exhibit numbers (4.16 in 2022, 4.14 in 2023 and 2024) are correctly reported, and the continuity of disclosure across years is accurately noted. (2) The numbers and percentages (2.300%, 2028 maturity) are correct, but the incorrect issuance year (2021 vs. 2022) is a significant factual flaw. No calculations are involved, so no computational errors exist, but the temporal accuracy is compromised. (3) The reasoning is partially sound: the LLM correctly infers that Oracle maintains a stable debt profile with staggered maturities, which aligns with the ground truth’s conclusion about consistent referencing of prior instruments. However, it misses the key multi-hop insight that Oracle layered in newer, higher-yielding notes (e.g., 4.500% Notes due 2028) in 2023 and 2024, which the ground truth highlights as evidence of adapting to market conditions. This omission limits the depth of strategic analysis. (4) The answer is contextually relevant and well-structured, addressing both the evolution and strategic implication. While the core observation about stability is valid, the failure to mention concurrent new issuances with higher yields results in an incomplete synthesis of Oracle’s broader financing strategy. Thus, correctness is reduced to 6 due to the incorrect issuance year and missing strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 456,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa has continued to designate its Series B Convertible Participating Preferred Stock in the 2022, 2023, and 2024 10‑K filings, with the certificate of designation appearing unchanged in each report (see Exhibit 4.4 on page_109 and page_114). This consistency indicates that Visa prioritizes a stable, flexible capital structure and keeps convertible preferred equity as a long‑term financing option for future capital needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Visa consistently referenced its Series B Convertible Participating Preferred Stock in its 2022, 2023, and 2024 10-K filings, with no changes to the certificate of designation—consistent with the ground truth's reference to the unamended June 21, 2016 Certificate of Designations. The LLM correctly infers that this continuity reflects a strategic preference for a stable and flexible capital structure, preserving convertible preferred equity as a long-term financing tool. The mention of Exhibit 4.4 on specific pages (page_109, page_114) supports the claim with document-level detail, though the placeholder 'page_' suggests formatting from a source extraction but does not undermine factual accuracy. The answer omits minor contextual details present in the original answer—such as the unchanged Bylaws in 2022 and the 2024 Certificate of Incorporation update—but these omissions do not detract from the core factual correctness or the valid inference about capital structure priorities. All entities (Visa, Series B stock, 10-K filings, certificate of designation) are correctly identified and synthesized across years. No numerical or date inaccuracies are present; the reasoning is sound and logically connects consistent disclosure to strategic capital management. Thus, the answer earns a 9 for correctness and qualitative accuracy due to high fidelity with minor completeness gaps, full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 426,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In 2022 Caterpillar disclosed that its Cat Financial segment had significant LIBOR‑based loans and derivatives and that a cross‑functional team was formed to assess the impact of LIBOR reform and the transition to SOFR. By 2023 the company had begun shifting variable‑rate exposures to SOFR, continued to use currency‑hedging instruments to mitigate exchange‑rate risk, and warned that ineffective hedges could hurt earnings. In 2024 the disclosures reiterated the use of SOFR‑linked instruments and hedging strategies, noting that while hedges protect against adverse currency moves they can also forgo favorable fluctuations and may still be ineffective, underscoring an ongoing focus on managing the transition and associated risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Cat Financial formed a cross-functional team to assess LIBOR transition risks; by 2023, the company shifted variable-rate exposures to SOFR and continued using currency hedging instruments; in 2024, disclosures reiterated SOFR-linked instruments and hedging strategies with emphasis on risks of ineffectiveness and trade-offs. These points match the original answer's timeline and substance. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—dates (2022–2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and connects currency hedging practices with the LIBOR-to-SOFR transition, even though the latter primarily affects interest rate rather than currency risk. It appropriately notes that while currency hedging remained consistent, the broader risk management framework evolved to incorporate SOFR. (4) The only minor shortcoming is that the LLM does not explicitly mention 'match funding' or 'diversified funding'—details included in the 2023 portion of the ground truth—which slightly reduces completeness in qualitative accuracy. However, this omission does not distort the overall message. The LLM captures the core evolution and risk disclosures accurately, making the answer semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 423,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "After the 2021 LTL bankruptcy filing, J&J funded a $2 billion trust and set a matching reserve to cover LTL’s talc liabilities. The bankruptcy was dismissed in 2022, and a second filing was dismissed in 2023, prompting J&J to shift to a consensual pre‑packaged Chapter 11 plan that would resolve 99.75 % of claims for a present‑value $9 billion (including the $2 billion trust) over 25 years. By 2024 the company had increased the plan’s value by $1.75 billion, restructured the debtor into LLT and created new entities (Red River, Pecos River) to isolate specific claim classes while maintaining the $2 billion trust as part of the overall reserve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Incorrect timeline: The original answer states that LTL's bankruptcy was filed in 2022 (not 2021), and the first dismissal occurred in 2023 after the Third Circuit reversal, not in 2022. The LLM incorrectly backdates the initial filing and misrepresents the sequence. (2) Incorrect financial figures: The ground truth mentions a $2 billion trust and reserve, but the LLM introduces a $9 billion pre-packaged Chapter 11 plan and a $1.75 billion increase—figures absent from the original answer and not supported by the provided knowledge. There is no mention of a 'present-value $9 billion' plan or restructuring into 'Red River, Pecos River' entities in the ground truth. (3) Entity error: The LLM refers to 'LLT' as a restructured debtor, reversing the correct name 'LTL Management LLC', and invents new entities not referenced in the original. (4) Mischaracterization of strategy: The original answer describes continued appellate efforts and reliance on the LTL structure through 2024, while the LLM suggests a shift to a consensual pre-packaged plan and structural changes not confirmed in the ground truth. (5) Multi-hop reasoning fails: The LLM does not accurately synthesize the evolution across 2022–2024; instead, it fabricates a resolution path. While it correctly notes the $2 billion trust and its role in funding claims, this single point does not compensate for the extensive inaccuracies. The answer is contextually relevant to J&J’s talc liability strategy but is largely factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 443,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "In 2022, Adobe positioned the Photography Plan as a targeted bundle inside its Creative Cloud subscription, giving photographers access to Photoshop, Lightroom and Lightroom Classic【page_5】. By 2023 the plan remained a focused package but Adobe deepened its appeal by embedding generative‑AI tools—such as Generative Fill/Expand in Photoshop, Firefly integration and other AI‑powered features—across the Creative Cloud suite【page_3】【page_5】. In 2024 the plan was re‑branded as a distinct, more limited cloud‑based offering aimed at photographers and photo enthusiasts, adding AI‑powered tools like Generative Remove in Lightroom and broader Firefly integration across Photoshop and other apps, sharpening its positioning and value for creative professionals【page_10】【page_12】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and strategic evolution of Adobe's Photography Plan from 2022 to 2024. (1) All dates (2022, 2023, 2024) are accurate, and the core components of the Photography Plan—Photoshop, Lightroom, and Lightroom Classic—are correctly identified for 2022. The integration of generative AI tools like Generative Fill and Firefly in 2023 is factually sound and supported by the knowledge base. In 2024, the mention of Generative Remove and expanded Firefly integration reflects actual enhancements. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all temporal references are correct. (3) The multi-hop reasoning is solid: the answer traces the plan’s evolution across three years, synthesizing positioning, feature enhancements, and strategic intent. However, the claim that the plan was 're-branded' in 2024 as a 'distinct, more limited cloud-based offering' introduces a slight inaccuracy not present in the ground truth—the Photography Plan was not rebranded, but rather enhanced with AI features while maintaining its existing identity as a streamlined alternative. The ground truth emphasizes continuity in positioning with enhanced AI capabilities, not a rebranding. (4) Despite this minor overstatement, the answer captures the core strategic shift toward AI integration and the plan’s role within Creative Cloud. Wording differs but semantic meaning is largely equivalent. Contextual relevance is excellent, directly addressing all parts of the question. The correctness score is 8 due to the minor mischaracterization of a 're-branding,' but all key facts and enhancements are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 484,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s specimen certificate for class C common stock has remained unchanged from 2022 through 2024.  In 2022 the certificate appears as Exhibit 4.3 (8‑A, file 000‑53572, filed 1/28/2009)【page_114】, while in 2023 and 2024 it is listed as Exhibit 4.2 with the identical description, form type, and file number【page_109 (2023)】【page_109 (2024)}.  This consistency signals Visa’s deliberate focus on stable, transparent governance and investor communication, reassuring shareholders that its foundational corporate documents remain reliable even as regulatory and market conditions evolve.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Visa's specimen certificate for Class C common stock has remained unchanged from 2022 to 2024 and accurately references the same underlying filing (Exhibit 4.2 or 4.3, 8-A, File Number 000-53572, filed January 28, 2009). However, there is a minor discrepancy in exhibit numbering: the ground truth states that each year cites Exhibit 4.2, while the LLM notes Exhibit 4.3 in 2022 and Exhibit 4.2 in 2023 and 2024. This inconsistency in exhibit number labeling—though referencing the same form and filing—introduces a small factual error, likely due to variation in how exhibits were labeled across annual filings. Despite this, the core fact—that the same specimen certificate document has been referenced throughout—is correct. (2) All dates (January 28, 2009) and file numbers (000-53572) are accurate. No calculations are required, so quantitative accuracy is high, though the exhibit number shift slightly affects precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings and draws a logical inference about corporate governance and investor relations. It appropriately infers that consistency reflects stability and transparency, aligning with the ground truth’s interpretation. However, it omits the contrast with other updated governance documents (e.g., the 2024 Certificate of Incorporation revision), which weakens completeness and depth of analysis. (4) The answer is contextually highly relevant, directly addressing both the documentation consistency and its implications. The correctness score is 8 due to the exhibit number discrepancy and missing comparative context about other updated documents, but the core facts and reasoning remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 485,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1,109 million at December 31, 2022** to **$1,091 million at December 31, 2023** and further to **$993 million at December 31, 2024** – a net decline of $116 million over two years. The reductions were driven by settlements outpacing new guarantees issued (2024: 216 issued vs. 247 settled, 67 other; 2023: 305 issued vs. 308 settled, 15 other; 2022: 264 issued vs. 284 settled, 28 other). This trend indicates that RTX is actively trimming its exposure to future guarantee costs, reflecting more effective risk management and potentially improved product performance in its commercial aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and misidentifies the metric. The ground truth states that RTX's collaboration partners' share of financing guarantees was $140M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM reports total liabilities of $1,109M, $1,091M, and $993M — figures that are over 8x larger and do not match the ground truth metric. These numbers appear to conflate total guarantee liabilities with the partners' share, or refer to a different liability category altogether. (2) Calculations in the LLM answer (e.g., $116M net decline) are mathematically correct based on its own numbers but are irrelevant because the inputs are factually wrong. The ground truth shows a $9M total decline (from $140M to $131M), not $116M. The issuance and settlement data cited (e.g., 216 issued vs. 247 settled) are not present in the ground truth and appear fabricated or misattributed. (3) The multi-hop reasoning fails because the LLM does not correctly identify or synthesize the specific liability metric related to performance and operating cost guarantees as shared with partners. Instead, it discusses a broader or different liability category, undermining the reasoning chain. While the conclusion about risk reduction is directionally similar, it is based on incorrect data. (4) The contextual relevance is moderate because the answer addresses the right topic (liabilities for guarantees and risk management) and attempts to explain trends and drivers. However, due to severe quantitative and entity inaccuracies, the qualitative accuracy is low. The answer does not reflect the actual data from the knowledge graph, resulting in a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 469,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s 10‑K disclosures for FY 2022, 2023 and 2024 all describe free‑rent periods as being recognized on a straight‑line basis over the lease’s original term and any extension options that the Company is reasonably certain to exercise. The lease term is consistently defined as the non‑cancelable period plus such options, and right‑of‑use assets continue to be measured at the present value of discounted minimum lease payments using the incremental borrowing rate. Consequently, there were no material changes in the accounting treatment or disclosure of free‑rent periods or their impact on ROU asset valuations across these fiscal years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core accounting treatment of free-rent periods at Costco across fiscal years 2022–2024, stating the consistent use of straight-line recognition over the lease term (including extension options that are reasonably certain to be exercised) and the use of the incremental borrowing rate to discount lease payments. All entities (Costco, fiscal years 2022–2024, right-of-use assets, lease terms) are accurately identified, and there are no numerical or date inaccuracies—this earns a perfect score on quantitative accuracy. The reasoning is logically sound in asserting that there were no material changes in accounting treatment, which aligns with the ground truth. However, the LLM answer omits key qualitative evolutions in disclosure highlighted in the original answer: (1) the 2023 expansion on variable lease payments tied to indices or sales volume, and (2) the 2024 increased emphasis on impairment evaluation of long-lived assets in the context of lease-related valuations due to facility relocations or closures. These omissions reduce completeness and nuance in the qualitative assessment, though the core facts remain correct. The answer is highly contextually relevant, directly addressing the question’s focus on accounting treatment and disclosure evolution. While the conclusion of 'no material changes' is defensible, the ground truth notes a shift in emphasis and disclosure depth that the LLM overlooks, warranting a slight deduction in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 420,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "Adobe’s AI‑powered document strategy grew from 2022 to 2024, shifting from basic AI tweaks in Acrobat to a full AI‑powered ecosystem. In 2022, Acrobat was enhanced by Sensei‑driven AI and API integration (pages 6‑7). By 2023, Acrobat added Liquid Mode, generative tools under the new “Adobe Firefly” brand, and increased R&D spend to support these capabilities (pages 2‑5). In 2024, Acrobat remains the core AI‑powered engine, now integrated with Sign and Scan and highlighted as “Adobe Acrobat” in the product line, while Firefly continues as the formal brand for generative AI, reflecting deeper AI R&D investment (pages 94‑95).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in entity identification and strategic narrative, particularly around branding and R&D focus. (1) Correct aspects: The mention of AI enhancements in Acrobat using Sensei in 2022 aligns with Adobe's AI use, and the increase in R&D investment by 2023 is plausible and contextually relevant. Liquid Mode and Firefly are correctly identified as AI-related innovations. (2) Quantitative accuracy: No specific dollar amounts or percentages are provided in either answer, so no numeric errors are present. Dates (2022–2024) are used appropriately. (3) Multi-hop reasoning issues: The LLM incorrectly identifies 'Firefly' as the formal brand for generative AI within Acrobat, whereas the ground truth specifies 'Acrobat AI Assistant' as the branded extension in 2024. This misattributes Adobe’s product branding strategy—Firefly is a broader generative AI model platform, not the branded product extension for Acrobat. Additionally, the LLM omits the key evolution from document leadership to AI-powered productivity as a strategic shift, instead framing it as a technical upgrade. (4) The answer is contextually relevant and includes real features and timelines, but fails to accurately reflect the strategic emphasis and formal branding evolution described in the ground truth, which is central to the question. Thus, while some facts are correct, the synthesis and entity accuracy are flawed, leading to a partially correct response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 414,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "From 2022 through 2024 Schwab expanded the amount of client securities it could pledge, with the fair value of securities available to be pledged rising from $120.3 B in 2021 to higher levels in subsequent years, and the fair value of securities actually pledged for margin, short‑sale collateral, and securities‑lending activities increasing from $31.4 B in 2021 to $?? B in 2024 (see the margin‑lending table on page 108). This upward trend reflects a balance‑sheet strategy that leverages client collateral to support margin lending and securities‑lending programs, generating interest income and liquidity while encouraging client leverage (see page 107 and page 78). The continued use of client securities as collateral indicates Schwab’s focus on maintaining liquidity and income generation through securities lending, even as it offers margin facilities that raise the firm’s exposure to client‑driven leverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It cites specific dollar amounts such as $120.3B in 2021 and $31.4B pledged in 2021, but the original answer (ground truth) does not provide any such figures for 2021 or 2022, nor does it quantify the amount of pledged securities in any year. The LLM fabricates a data point of $??B in 2024, indicating missing information, which further undermines accuracy. These numbers are not present in the ground truth, making the quantitative claims unsupported and incorrect. (2) The original answer emphasizes qualitative disclosures and evolving policy transparency from 2022 to 2024, not numerical trends. The LLM incorrectly frames the evolution as a quantifiable increase in pledged securities, introducing data not found in the source. There are no calculations in the ground truth to validate or compare. (3) The multi-hop reasoning is partially sound in that the LLM identifies the connection between client securities, margin lending, and securities lending, and infers a strategic balance sheet motive. However, it fails to accurately reflect the nature of the evolution—increasing disclosure and formalization of use—instead portraying it as a numerical increase in pledged assets. The mention of 'listed option contracts cleared by the Options Clearing Corporation' in 2024, a key factual development in the original answer, is omitted. (4) While the LLM captures the general theme of leveraging client assets for income and liquidity, it distorts the evidence base by introducing false precision through incorrect numerical data. The contextual relevance is high because it addresses margin lending, securities lending, balance sheet strategy, and client leverage behavior as asked, but the factual foundation is flawed. Correctness is penalized heavily due to invented figures and lack of alignment with disclosed non-quantitative progression in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 528,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "In 2022 the 1.375% Senior Notes due June 2027 were recorded as long‑term debt (carrying $1,250) and contributed to a total long‑term debt of $6,590 (excluding a $73 current portion). By 2024 the notes were still classified as long‑term debt at the same $1,250, but total long‑term debt had fallen to $5,919 (excluding a $103 current portion) because the 2.750% Senior Notes were repaid and other long‑term debt rose from $590 to $919, shifting the debt mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.375% Senior Notes due June 2027 remained at $1,250 million in both 2022 and 2024 and were consistently classified as long-term debt, which aligns with the ground truth. However, it provides incorrect total long-term debt figures: $6,590 million in 2022 and $5,919 million in 2024, whereas the ground truth reports $6,484 million in 2022 and $5,794 million in 2024. These discrepancies are significant and affect the accuracy of the debt composition analysis. Additionally, the LLM incorrectly states that the 2.750% Senior Notes were 'repaid' in 2024, while the ground truth specifies they were reclassified from long-term to current portion as maturity approached—not necessarily repaid during that period. The LLM also introduces a claim that 'other long-term debt rose from $590 to $919', which is not supported in the original answer and appears to be an erroneous decomposition. (2) Number verification: $1,250 million for the 1.375% notes is correct across years. But total long-term debt values are off by $106 million in 2022 and $125 million in 2024. The current portion amounts ($73M and $103M) are not present in the ground truth and cannot be verified, suggesting potential hallucination. (3) Multi-hop reasoning: The model attempts to explain the shift in debt composition but misattributes the decline in long-term debt to repayment rather than reclassification, which is a key conceptual error. It also fabricates subcomponents of debt not mentioned in the original, weakening the synthesis. (4) Despite these issues, the core point—that the 1.375% notes remained stable while overall long-term debt decreased due to maturity-related changes—is partially correct, warranting a mid-range score. Contextual relevance is high as the response addresses classification and composition as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 503,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe’s 10‑K filings from 2022 through 2024 consistently list a large catalog of free online self‑service learning on learning.adobe.com as a core element of its Digital Learning Services (page 17). By 2024 the description places this offering squarely within the broader Customer Solutions portfolio—alongside fee‑based training, custom learning, consulting and technical support—highlighting its role in enterprise enablement. The 2024 filing also stresses that solution‑specific skills assessments and custom learning services are used by Customer Success Managers to assess enterprise teams and tailor learning priorities, tightening the link between free self‑service learning and enterprise customer‑success strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe consistently offered free online self-service learning via learning.adobe.com from 2022 to 2024 as part of its Digital Learning Services, and this was positioned within the broader Customer Solutions portfolio by 2024. The integration with enterprise success strategies through skills assessments and custom learning services, guided by Customer Success Managers, is correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), connects free self-service learning to fee-based and custom services, and correctly identifies its evolving role in enterprise enablement. The only minor gap is that the LLM does not explicitly mention the continuity of this strategy in 2023, which the ground truth includes, slightly reducing completeness in the qualitative dimension. (4) The answer is contextually excellent—directly addresses the evolution of positioning and integration with enterprise success, uses correct entities (Adobe, learning.adobe.com, Customer Success Managers), and accurately reflects the strategic maturation. Wording differs slightly but meaning is semantically equivalent. One point deducted from correctness for the slight omission of 2023 reinforcement, but overall a strong, factually correct response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 428,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 were $1,044 million at the end of 2022 (unchanged in 2023) and rose modestly to $1,057 million by the end of 2024, a 1.2 % increase【page_78】【page_67】. The near‑flat exposure over three years shows the company is deliberately keeping long‑term debt levels stable, using its AI‑driven cash‑flow growth to service debt without expanding leverage【page_67】, reflecting a conservative long‑term debt‑management strategy amid rapid revenue acceleration.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for NVIDIA's 2.00% Notes Due 2031. According to the ground truth, the exposure was $1.20 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. The LLM incorrectly states it was $1,044 million in 2022 and unchanged in 2023, then $1,057 million in 2024—misrepresenting all three years. The correct trend is a decrease followed by an increase, but the LLM describes a near-flat trend with a small rise, which contradicts the actual fluctuation. (2) The quantitative inaccuracies are severe: the 2022 figure is off by $156 million, the 2023 figure is wrong (shows no change when there was a $143 million decrease), and the 2024 figure is understated by $193 million. The claimed 1.2% increase is based on incorrect starting and ending values and does not reflect the true 4.2% increase from 2022 to 2024 (or the actual volatility). (3) The multi-hop reasoning is flawed because the LLM fails to correctly synthesize the temporal pattern across the three years. It draws a conclusion about 'stable' debt levels and 'conservative' strategy, which contradicts the ground truth interpretation of a dynamic strategy involving reduction and reinvestment. The LLM’s reasoning is based on false data, leading to an invalid conclusion. (4) While the answer addresses the question's structure and attempts to interpret strategy, the severe numerical errors and resulting incorrect inference about debt management strategy justify a low correctness score. Contextual relevance is moderate because the response engages with the right concept (debt strategy amid AI growth), but factual grounding is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 463,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson’s multi‑year, enterprise‑wide initiative has remained essentially unchanged from 2022 through 2024, consistently describing the same goal of “integrating, simplifying and standardizing processes and systems for HR, IT, procurement, supply chain and finance” to grow its financial shared‑service capabilities and standardize financial systems【2022 page 118】【2023 page 118】【2024 page 118】.  Each filing reiterates the ongoing alignment and streamlining of the financial control environment, underscoring a sustained strategic emphasis on standardizing financial processes and tightening control alignment to support efficient, governed operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of Johnson & Johnson's initiative from 2022 to 2024, accurately stating that the company consistently emphasized integrating, simplifying, and standardizing processes across finance and other functions. It correctly notes that the initiative is enterprise-wide, ongoing, and aimed at enhancing financial shared services and standardization. The answer correctly identifies that each year’s filing reaffirms the alignment and streamlining of the financial control environment. However, the LLM slightly overgeneralizes by including 'HR, IT, procurement, supply chain' as explicitly stated goals in the context of financial shared services, while the ground truth emphasizes finance as the primary domain, with integration across 'key functions including finance'—implying broader applicability but not equal focus. This is a minor contextual drift. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes consistent messaging across three years (2022–2024) from the same page (118) of each filing, correctly inferring sustained strategic focus. It accurately concludes that the initiative reflects a long-term, proactive strategy rather than a reactive one, aligning with the ground truth’s emphasis on non-reactive, efficiency-driven modernization. (4) The answer is semantically very close to the original, with only slight overextension of scope in listing non-finance functions as equally targeted. Otherwise, it matches the ground truth in tone, intent, and factual content. Thus, correctness is high but not perfect due to minor overgeneralization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 481,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 2022 10‑K states that it competes with BJ’s Wholesale Club and that its private‑label brand, Kirkland Signature, “offers lower prices, helps lower costs, differentiates our merchandise offerings, and generally earns higher margins” while the company expects to grow its private‑label sales penetration (page 8). The 2024 filing repeats that same wording, again highlighting Kirkland Signature as a key differentiator and noting the continued focus on increasing private‑label sales (page 8). Across 2022‑2024, Costco’s competitive‑positioning language has remained essentially unchanged, consistently framing Kirkland Signature as the strategic edge against BJ’s in the warehouse‑club market.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of the 10-K language and correctly identifies Costco's competitive positioning against BJ's Wholesale Club with Kirkland Signature as a differentiator. It accurately reports that the same phrase appears in both the 2022 and 2024 filings (e.g., 'offers lower prices, helps lower costs, differentiates our merchandise offerings, and generally earns higher margins'), which aligns with the ground truth's acknowledgment of consistent core strategy. However, the LLM answer incorrectly asserts that the language 'remained essentially unchanged' across 2022–2024, directly contradicting the ground truth's key point about an evolution in tone by 2024—specifically, the stronger emphasis on 'differentiating our merchandise offerings' in competitive metropolitan markets and the introduction of sustainability-linked brand loyalty in 2023. The LLM fails to mention any 2023 developments or the nuanced shift in strategic framing, resulting in a significant omission in the qualitative evolution. While entity accuracy (Costco, BJ's, Kirkland Signature, years) and contextual relevance are strong, and no numeric inaccuracies exist (hence full quantitative accuracy), the failure to capture the evolving tone and added context in 2023–2024 undermines the multi-hop synthesis required to fully answer how the *language evolved*. Thus, the answer is partially correct but misses a critical dimension of the evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 409,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Charles Schwab’s U.S. state‑and‑municipal holdings fell from **$638 million in 2022** (2022 10‑K, page 52) to **$579 million in 2023** (2023 10‑K, page 113) and further to **$100 million in 2024** (2024 10‑K, page 50).  Across all three years the firm repeatedly notes that “substantially all securities in the investment portfolios were rated investment‑grade” (2022 10‑K, page 52; 2024 10‑K, page 48), underscoring a fixed‑income strategy that prioritizes credit quality and capital preservation over higher‑yield, higher‑risk assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the quantitative data. According to the ground truth, Schwab disclosed a $638 million investment in U.S. State and Municipal Securities in 2023, not 2022. The LLM incorrectly states that the amount was $638 million in 2022, then declining to $579 million in 2023 and $100 million in 2024—none of which aligns with the original answer. The ground truth does not provide specific figures for 2022 or 2024, only confirming a $638 million allocation in 2023 and a continued emphasis on investment-grade quality in 2024. Thus, the LLM fabricates or misattributes numbers for 2022 and 2024 and introduces a downward trend that is unsupported. (2) The calculation and comparison of year-over-year declines are therefore entirely incorrect. There is no evidence in the ground truth of a drop to $579M or $100M in subsequent years. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the recurring emphasis on 'substantially all securities' being investment-grade across years (a point supported in both 2022 and 2024 filings), it incorrectly synthesizes this with fabricated quantitative trends. The original answer does not support any numerical decline, nor does it mention 2024 having only $100 million in such securities. (4) While the qualitative insight about Schwab’s strategy favoring credit quality and capital preservation is consistent with the ground truth, the severe quantitative errors—especially the invented figures and false trend—undermine the overall correctness. The contextual relevance is moderate because the answer addresses the right topic and cites appropriate themes (investment-grade focus), but the core numerical claims are false. Correctness score is low due to critical factual errors in financial figures and misrepresentation of temporal data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 504,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum‑potential exposure to commercial‑aerospace customer financing guarantees declined from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024【page_100】.  Correspondingly, the collaboration partners’ share of those guarantees fell from $140 million in 2022 to $135 million in 2023 and to $131 million in 2024【page_100】【page_101】.  This downward trend reflects a deliberate risk‑transfer strategy, with RTX progressively shifting more guarantee liability to partners and reducing its own exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners’ share of guarantees—$140M in 2022, $135M in 2023, and $131M in 2024—which matches the ground truth exactly. However, it introduces an additional metric—RTX’s maximum-potential exposure ($304M, $288M, $274M)—that is not mentioned in the original question or ground truth answer, potentially conflating different aspects of exposure. While this data may be factually present in the source document, it shifts focus from the specific metric highlighted in the question (collaboration partners’ share) to RTX’s total exposure, which changes the analytical framing. (2) The numbers for the collaboration partners’ share are accurate and correctly trend downward. Calculations of year-over-year declines are implied and numerically correct. However, the interpretation of this trend is flawed: the LLM claims the decline reflects a 'deliberate risk-transfer strategy, with RTX progressively shifting more guarantee liability to partners,' which contradicts the ground truth. The original answer states the declining partner share suggests *reduced* reliance on third-party risk sharing, implying RTX may be retaining more risk internally, not transferring more to partners. This is a critical reversal of logic. (3) The multi-hop reasoning fails at the synthesis stage: while the model correctly identifies the trend in partner shares, it misinterprets the direction of risk transfer. A lower partner share means partners are covering less of the risk, not more—thus, risk is being retained by RTX, not transferred to partners. The model incorrectly infers that decreasing partner liability equates to increased risk transfer *to* partners, when in fact it indicates the opposite. (4) Quantitative accuracy is high due to correct numbers and formatting. Contextual relevance is strong as the answer addresses the time frame and domain. However, qualitative accuracy is low due to the flawed causal interpretation, which undermines the core analytical component of the question. Correctness score is moderate because factual data is accurate but the key inference is incorrect, leading to a misleading conclusion about RTX’s strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 589,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "From 2022 through 2024 Adobe’s Frame.io remained positioned as a cloud‑native collaboration hub that supports the same core file types—video, still images, design files and PDFs—and is tightly integrated with the same set of Adobe creative apps (Premiere Pro, After Effects, Photoshop, Lightroom and Workfront). Its role in content‑production workflows stayed consistent, providing real‑time upload, review, frame‑accurate commenting and camera‑to‑cloud capture, and it continues to be embedded in Adobe GenStudio to streamline pre‑production, post‑production and marketing‑campaign workflows. No new file‑type support or app integrations were disclosed, and the platform’s core function as a real‑time collaboration engine remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual evolution from 2022 to 2024, despite being contextually relevant to the topic. (1) It falsely claims that Frame.io had integration with Photoshop, Lightroom, and Workfront from the beginning (2022), while the ground truth states these integrations were added by 2024. This misrepresents the timeline and progression of integration. (2) The answer asserts that 'no new file-type support or app integrations were disclosed,' which directly contradicts the ground truth that Frame.io expanded its integration to include Photoshop, Lightroom, and Workfront by 2024 and broadened its role into casting, location scouting, and marketing—indicating both new integrations and functional expansion. (3) The LLM fails the multi-hop reasoning requirement: it does not correctly synthesize changes over time across years—specifically the evolution from post-production focus in 2023 to end-to-end workflow support in 2024. (4) While the mention of Camera-to-Cloud and core collaboration features aligns with 2023 data, projecting them unchanged back to 2022 and through 2024 ignores the documented expansion. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. However, qualitative accuracy is very low due to incorrect entity relationships and timeline conflation. Contextual relevance is moderate because the answer discusses the right platform and general features, but fails to capture the evolution asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 413,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "RMS’s 2024 10‑K reports that VH‑92A production volume was lower than in 2023, after a period of higher volume in 2023 (VH‑92A is listed among the major helicopter programs in the 2023 10‑K). This shift indicates that while the VH‑92A remains a strategically important Marine One transport helicopter, the segment is reallocating production emphasis toward other helicopter and systems programs, underscoring its continued importance but not as the primary growth driver within RMS. (page_5, page_41)",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces a claim not supported by the ground truth: that VH-92A production volume decreased in 2024 compared to 2023. The original answer (ground truth) does not mention any changes in production volume—it only states that the VH-92A was consistently listed as a major program within RMS from 2022 to 2024, indicating sustained strategic importance. The LLM’s assertion about production volume being 'lower' in 2024 and 'higher' in 2023 is a specific quantitative claim not present in the ground truth and cannot be verified from the provided information, making it factually inaccurate. While the LLM correctly identifies the VH-92A as a strategically important program within RMS and notes its presence in the 2023 and 2024 10-Ks, it misrepresents the trend. The ground truth emphasizes consistency and stability, whereas the LLM implies a decline in production focus. This undermines the qualitative accuracy of the reasoning. However, the answer is contextually relevant and addresses the multi-year evolution and strategic importance, albeit with incorrect specifics. Entity accuracy (Lockheed Martin, RMS, VH-92A, years) is correct, and the mention of other RMS programs like Aegis and LCS is consistent in spirit, though not explicitly tied to the VH-92A comparison in the ground truth. Overall, the answer gets core elements right but fails on key factual and reasoning points, especially the unsupported production volume comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 411,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "MDLZ’s 2022, 2023 and 2024 10‑Ks all describe sales and media‑marketing restrictions—limits on promotions or advertising of products with specified nutrient profiles on certain channels or times—that apply in every jurisdiction where the company operates, including the EU and emerging markets (page_15, page_11, page_11). The filings show no change in the geographic scope or the stringency of these restrictions over the three years; the same regulatory language is repeated in each filing, indicating a consistent regulatory environment (page_11, page_11, page_11).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims there was no change in the geographic scope or regulatory stringency from 2022 to 2024, stating that 'the same regulatory language is repeated'—this directly conflicts with the original answer, which documents a clear expansion: in 2022, over 25 EU countries had EPR policies; by 2023, EPR was spreading to India, Vietnam, and U.S. states, and data privacy emerged as a new marketing constraint; in 2024, the EU adopted the Packaging and Packaging Waste Directive, and Southeast Asia advanced plastic bans. (2) Quantitatively, the LLM fails to report any of the specific developments (e.g., 25+ EU countries, adoption of EU directive in 2024, spread to specific emerging markets), rendering numerical and temporal accuracy nonexistent. (3) The reasoning is flawed: instead of synthesizing evolving regulatory trends across years and regions, the model incorrectly infers stability from repetitive disclosure language in 10-Ks, failing the multi-hop requirement to track changes over time and across jurisdictions. (4) While the answer is contextually relevant—addressing MDLZ, regulations, and geographic regions—it is factually wrong in its core conclusion. The original answer shows increasing scope and stringency; the LLM asserts no change. Thus, despite correct entity identification (MDLZ, EU, emerging markets), the factual and reasoning errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 403,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700% Notes due 2046 are consistently disclosed as part of the Eleventh Supplemental Indenture (Exhibit 4.14) in the 2022, 2023 and 2024 10‑K filings, with no amendments, repayments or new indentures reported in any of the three periods【page_106】.  The unchanged treatment indicates that Microsoft is maintaining these long‑term, fixed‑rate notes within its existing debt structure rather than refinancing or repaying them, reflecting a strategy of preserving a diversified maturity ladder and predictable interest expense over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft's 3.700% Notes due 2046 are consistently referenced in the 2022, 2023, and 2024 10-K filings under the Eleventh Supplemental Indenture (Exhibit 4.14), with no amendments or repayments reported. The percentage (3.700%), maturity year (2046), and indenture date (implied as August 8, 2016, though not explicitly repeated in the LLM answer) are accurate. (2) There are no numerical or date inaccuracies—formatting such as '3.700%' and '2046' matches exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers a strategic rationale—preserving long-term fixed-rate debt for predictable interest expenses and a diversified maturity ladder. This aligns with the ground truth’s conclusion about stable long-dated liabilities and confidence in cash flow. (4) The only minor omission is that the LLM does not explicitly name the Eleventh Supplemental Indenture's execution date (August 8, 2016), though it correctly references the exhibit and its consistent application. This does not detract significantly from the overall accuracy. The answer is contextually excellent, directly addressing both the evolution (no change) and strategic implication. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 403,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft’s Eleventh Supplemental Indenture (4.14) first introduced 2.000 % Notes due 2023 in the 2022 10‑K (page 105) and the same indenture is still listed in the 2023 and 2024 10‑Ks, showing that the 2023 maturity remained unchanged (page 105).  The 2023 10‑K added a Twelfth Supplemental Indenture (4.15) that introduced 2.875 % Notes due 2024 and later maturities, extending the debt ladder while leaving the 2023 notes intact (page 106).  By the 2024 10‑K, the Eleventh Supplemental Indenture still contains the 2.000 % Notes due 2023, and a new Fifteenth Supplemental Indenture (4.18) adds notes due 2025, 2035, 2045, and 2055, further pushing the maturity profile forward without altering the 2023 maturity (page 106).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2.000% Notes due 2023 as being consistently referenced under the Eleventh Supplemental Indenture (Exhibit 4.14) in the 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. It accurately notes that the notes were introduced in the 2022 10-K and remained unchanged through subsequent years. However, the LLM adds details not present in the ground truth—specifically, the introduction of the Twelfth and Fifteenth Supplemental Indentures with new notes due in 2024–2055—which, while plausible, are not mentioned or implied in the original answer and thus introduce unverified information. (2) Quantitatively, all percentages (2.000%, 2.875%), years (2023, 2024, etc.), and exhibit numbers (4.14, 4.15, 4.18) are correctly stated, and there are no calculation errors. Page numbers (e.g., page 105, 106) are included but not verifiable from the ground truth; they do not contradict it but add specificity beyond the source. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity of the 2023 notes across filings, but extends beyond the evidence by interpreting the addition of new indentures as part of the evolution of the 2023 notes’ structure, which the original answer does not support. The ground truth focuses on the persistence of the 2023 notes post-maturity, while the LLM shifts focus to the extension of the debt ladder, missing the key point about post-maturity disclosure implications. (4) The answer is contextually relevant and well-structured, but scores lower on qualitative accuracy due to the introduction of unsupported details about new indentures and their impact, which distracts from the core evolution of the 2023 notes. The correctness score is 7 because the core facts about the 2023 notes are accurate, but the answer includes extraneous, unverified information that affects completeness and reasoning fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 523,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Medtronic’s 2022, 2023 and 2024 10‑K filings all list the same underlying plan for its Non‑Employee Restricted Stock Unit Award Agreements – the Amended and Restated 2013 Stock Award and Incentive Plan (see Exhibit 10.65 in each filing).  The 2022 filing also cites the 2021 Medtronic plc Long‑Term Incentive Plan for other award types (Exhibit 10.78), but the Non‑Employee Restricted Stock Unit Award Agreements themselves did not shift to a newer plan in 2023 or 2024.  Thus, the underlying plan for these agreements remained unchanged across the three years【page_115】【page_114】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core factual claims: it accurately identifies that Medtronic’s Non-Employee Restricted Stock Unit Award Agreements across 2022, 2023, and 2024 consistently referenced the same underlying plan—the Amended and Restated 2013 Stock Award and Incentive Plan. It correctly notes that the 2022 filing also references the 2021 Medtronic plc Long-Term Incentive Plan (Exhibit 10.78), but correctly clarifies that this newer plan was not used for the Non-Employee RSU agreements. The quantitative accuracy is perfect: no numerical errors, and the exhibit numbers (10.65 in each year) are correctly cited. However, there is a minor discrepancy: the original answer states that in 2022, the agreement was listed as Exhibit 10.45, not 10.65. The LLM claims Exhibit 10.65 in all three years, which contradicts the ground truth and suggests a potential error in document referencing. This affects qualitative accuracy, as the exhibit number inconsistency undermines precision in entity identification. Despite this, the overall reasoning is sound—the conclusion that the underlying plan remained stable across years is correct and well-supported. The answer addresses all parts of the question, including the evolution (or lack thereof) in the agreements and the referenced plans. Semantic equivalence is mostly preserved, and the contextual relevance is excellent. The score is reduced slightly due to the exhibit number inaccuracy, which, while not affecting the high-level conclusion, reflects a lapse in multi-hop precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 425,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated **17 %** of assets to buy‑in annuity policies in 2022, **16 %** in 2023, and **17 %** again in 2024【page_105】【page_104】. The modest dip in 2023 followed by a return to the 2022 level indicates that the company maintains a stable target allocation for these contracts while periodically rebalancing to reflect market conditions or plan‑specific needs, underscoring a disciplined liability‑management strategy that keeps international pension obligations adequately covered.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2024 percentage, stating 17% allocation to buy-in annuity policies, whereas the ground truth indicates that the allocation was effectively discontinued by 2024. This contradicts the actual trend of decline and strategic shift. The 2022 (17%) and 2023 (16%) figures are correct, but the 2024 figure is wrong, undermining the core of the answer. (2) Quantitative accuracy fails on the final data point—while 2022 and 2023 are accurate, 2024 is not. The claim of a return to 17% directly conflicts with the discontinuation of the practice. No calculation is involved, but the trend interpretation is based on incorrect data. (3) The multi-hop reasoning is flawed: instead of recognizing the downward trend and eventual discontinuation as a strategic shift toward fair value estimation and direct liability management, the model infers a 'stable target allocation' and 'rebalancing,' which is the opposite of the actual strategy. It fails to synthesize the evolution toward de-risking via methodological change. (4) Contextual relevance is moderate—the answer addresses the right company (MDLZ), metric (non-U.S. pension allocation to buy-in annuities), and time frame (2022–2024), and attempts interpretation of liability management strategy. However, due to the incorrect 2024 data and resulting misinterpretation, the qualitative and overall correctness scores are low. The model appears to have misread or misattributed the 2024 data, leading to an incorrect conclusion that contradicts the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 432,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft issued 2.000 % notes due 2023 under the Eleventh Supplemental Indenture (Exhibit 4.14, filed 8/5/2016).  Those notes were still outstanding through fiscal year 2022, matured and were retired in fiscal year 2023, and no longer appear on the 2024 balance sheet.  This pattern shows Microsoft’s disciplined debt‑maturity strategy: it uses short‑term notes to meet liquidity needs and then retires them as they mature, keeping a balanced long‑term debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the 2.000% Notes due in 2023 'matured and were retired in fiscal year 2023' and 'no longer appear on the 2024 balance sheet.' However, the ground truth states that the notes were still disclosed in the 2024 annual report under Exhibit 4.14, indicating they remained on Microsoft's books through 2024, even as the due date approached. This directly contradicts the LLM's claim of retirement. (2) The date of the Eleventh Supplemental Indenture is incorrect: LLM states '8/5/2016', while the ground truth specifies 'August 8, 2016' — a clear discrepancy. The interest rate (2.000%) and exhibit number (4.14) are correct. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers retirement in 2023 and absence in 2024, which is not supported by the data. The ground truth emphasizes consistency across all three years, revealing a stable long-term debt strategy, whereas the LLM interprets this as a short-term, retiring note strategy — the opposite conclusion. (4) The contextual relevance is moderate because the answer addresses the right topic (debt strategy, notes due 2023, exhibit references), but the core factual error about the note's status in 2023–2024 undermines the entire analysis. The reasoning and conclusion are therefore invalid. Correctness and qualitative accuracy are low due to these critical errors in facts and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 397,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Microsoft’s 4.000 % Notes due 2021 were originally issued under the Third Supplemental Indenture (Feb 8 2011) and were still listed in the 2022 and 2023 10‑Ks (page_104). By the 2024 10‑K the notes had been retired, as they no longer appear in subsequent supplemental indentures (Ninth, Tenth, Eleventh, and Fifteenth) that now cover newer notes with different maturities and coupon rates (page_105 and page_106). This shift shows Microsoft’s debt structure moving away from the older 4.000 % Notes toward newer issues under later supplemental indentures.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) The claim that the 4.000% Notes due 2021 were retired by the 2024 10-K and no longer appear in filings is incorrect. The ground truth states that these notes continued to be listed in Exhibit 4.6 of the 2024 10-K under the Third Supplemental Indenture, indicating they were still reported despite maturity. Companies often continue to disclose matured or repaid debt in supplemental indentures for transparency. (2) The LLM incorrectly infers disappearance from supplemental indentures (Ninth through Fifteenth) as evidence of retirement, but the ground truth clarifies that the 4.000% Notes due 2021 remained under the Third Supplemental Indenture consistently across all years. The introduction of newer notes under later indentures does not imply removal of older ones. (3) Quantitative accuracy is partially correct: the interest rate (4.000%), maturity year (2021), and date of the Third Supplemental Indenture (February 8, 2011) are accurate. However, the conclusion about retirement based on absence in later indentures reflects flawed reasoning. (4) Multi-hop reasoning fails: the model should have recognized consistent inclusion in Exhibit 4.6 across 2022–2024, not assumed removal due to maturity. The original answer emphasizes structural consistency, which the LLM misinterprets as change. (5) Contextual relevance is moderate—the response addresses debt structure evolution and indentures—but draws incorrect conclusions from correct document locations (e.g., page numbers). Overall, core facts are misrepresented, leading to a low correctness score despite some accurate data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 457,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K notes consistently state that its 40,000 authorized Euro Deferred Shares have never been issued or outstanding: in 2022 the filing notes “At April 29, 2022, no Euro Deferred Shares were issued or outstanding” (page 81), in 2023 the same wording appears for “At April 28, 2023” (page 81), and in 2024 the statement is repeated for “At April 26, 2024” (page 81). This unchanged disclosure shows the company does not use Euro Deferred Shares as a financing or dilution tool, instead relying on ordinary shares and its share‑repurchase program, reflecting a conservative, stable capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Medtronic disclosed zero issuance or outstanding Euro Deferred Shares in fiscal years 2022, 2023, and 2024, with accurate citations to the specific dates (April 29, 2022; April 28, 2023; April 26, 2024) and page numbers (81 for each year), which aligns with the ground truth. The authorized amount of 40,000 shares at €1.00 par value is implied by mentioning the authorized but unissued status, though the par value is not explicitly stated—this is a minor omission. (2) All numeric values—number of shares authorized, fiscal year-end dates, and consistent zero balances—are factually correct and match the ground truth. No calculations are required, but the repetition across years is accurately represented. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three fiscal years and draws a logical conclusion about capital structure strategy. It correctly infers that the lack of issuance indicates non-use of this instrument, linking it to reliance on ordinary shares and share repurchases—a reasonable interpretation consistent with the ground truth’s suggestion of strategic preference. (4) The answer is contextually excellent, directly addressing both parts of the question: evolution of disclosures (unchanged) and strategic implication (non-utilization in capital structure). The only reason for not scoring a 10 is the omission of the €1.00 par value detail, which is part of the full factual record but does not undermine the core correctness or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 428,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "On page 104 of each filing, Microsoft lists **Exhibit 4.6 – the Third Supplemental Indenture** that contains the 4.000 % Notes due 2021. The description and indenture details are identical in the 2022, 2023, and 2024 10‑K filings, indicating no restructuring, retirement, or re‑issuance of the note. This consistency shows that Microsoft treats the 4.000 % Notes due 2021 as a stable component of its long‑term debt portfolio throughout the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all details are accurate: the 4.000% Notes due 2021, Exhibit 4.6, the Third Supplemental Indenture, and consistent referencing across 2022–2024 filings are correctly identified. The percentage, note title, and exhibit number match the original answer. (2) The claim that the description and indenture details are identical across filings is consistent with the ground truth assertion of 'no material changes.' (3) The reasoning is sound: the consistency in disclosure is correctly interpreted as indicating no restructuring, retirement, or re-issuance, which aligns with the ground truth's conclusion that the debt was static and likely matured or fully accounted for. (4) However, the LLM answer misses a key nuance: it does not mention that the exhibit is 'incorporated by reference from a prior 8-K filing,' which is a specific procedural detail included in the ground truth and relevant to disclosure practices. Additionally, the LLM implies the notes are still part of the 'long-term debt portfolio,' which is factually incorrect since the notes were due in 2021 and thus should have been settled by the 2022 filing year. This mischaracterization affects the qualitative accuracy, as it misrepresents the current status of the debt. Despite this, the core factual elements and multi-hop synthesis across years are handled correctly, and the answer remains highly relevant and mostly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 409,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s 2021 pension‑risk‑transfer transaction moved $4.9 billion of gross defined‑benefit pension obligations into group annuity contracts (GACs).  The 2022‑through‑2024 filings do not disclose additional transfer amounts, but the company notes that it continues to “evaluate such transactions” and “purchase GACs … for portions of our outstanding defined‑benefit pension obligations.”  This consistent use of risk‑transfer indicates a deliberate strategy to reduce pension‑liability volatility and manage long‑term obligations, even if the exact dollar amounts for each year are not specified in the provided pages.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that a $4.9 billion pension risk transfer occurred in 2021, which is not supported by the ground truth. The original answer states that by 2022, the cumulative amount transferred since December 2018 was $11.6 billion, but does not break down annual transfers or specify a 2021 transaction. The LLM's claim of a $4.9 billion transfer in 2021 is unsupported and contradicts the disclosed cumulative figure. Additionally, the LLM claims no additional transfers were disclosed from 2022–2024, while the ground truth confirms ongoing strategic intent and activity, including public announcements in 2023 and 2024 about continued evaluation and pursuit of transfers. (2) The quantitative inaccuracies are severe: the $4.9 billion figure is fabricated or misattributed, and the timeline is off (2021 vs. cumulative through 2022). The ground truth does not provide annual breakdowns, so asserting a specific amount for 2021 is incorrect. (3) The reasoning is partially sound in interpreting the company’s ongoing strategy—phrases like 'evaluate such transactions' and 'purchase GACs' align with the ground truth’s description of continued interest. However, the model fails to correctly synthesize the multi-hop information: it should have referenced the $11.6 billion cumulative transfer by 2022 and the reaffirmed strategy in 2023–2024, rather than inventing a prior year transaction. (4) The contextual relevance is moderate because the answer addresses pension risk transfers and strategic intent, but the incorrect numbers and misattribution undermine the response. The qualitative accuracy is mid-range because the strategic interpretation is reasonable, but the factual foundation is flawed. Correctness is low due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 501,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "The 2022 10‑K contains no reference to the 0.125% Notes due 2029, indicating the note had not yet been issued (page_134). The 2023 10‑K lists the note in Exhibit 4.4, citing 8‑K filings of 2020 and 2021 (page_136), and the 2024 10‑K likewise cites the same exhibit (page_130). This consistent disclosure and identical coupon‑maturity structure across filings shows Coca‑Cola’s debt‑instrument strategy remains stable and repeatable over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the 2022 10-K contains no reference to the 0.125% Notes due 2029, stating the note had not yet been issued. This directly contradicts the ground truth, which confirms the note was disclosed in the 2022 filing in Exhibits 4.23 and 4.31, citing the same Exhibit 4.4 from 2020 and 2021 Form 8-Ks. The LLM incorrectly asserts the note first appeared in the 2023 10-K, which is false. (2) Quantitative accuracy is low: while the coupon rate (0.125%) and maturity (2029) are correct, the timeline of disclosure is wrong. The claim that the note was absent in 2022 undermines all chronological reasoning. Page numbers (e.g., page_134, page_136) may be accurate to the documents but are used to support an incorrect narrative. (3) Multi-hop reasoning fails: the question requires tracking the disclosure evolution across three years, but the LLM incorrectly identifies the starting point. It misses that the note was consistently disclosed in the same manner across all three years, including 2022. The conclusion about stable strategy is partially aligned with the ground truth but is based on flawed premises. (4) Contextual relevance is moderate—the answer addresses the right topic (debt disclosure consistency) and mentions correct source documents (Exhibit 4.4, 8-K filings), but the core factual error about 2022 disclosure severely undermines correctness. The answer fabricates an evolution (non-existent in 2022 → present in 2023/2024) that contradicts the ground truth of consistent, unchanging disclosure. Thus, the correctness score is low despite some surface-level alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 454,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1,109 million** at the end of 2022 to **$1,091 million** at the end of 2023 and further to **$993 million** at the end of 2024 (a net decline of $116 million over two years). The drop reflects fewer warranties issued and fewer settlements in 2024, indicating a lower expected future cost of long‑term product performance guarantees. While the liability remains sizable, the downward trend suggests a reduced exposure to long‑term product performance risks in RTX’s commercial aerospace business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's liabilities related to performance and operating cost guarantees refer specifically to the collaboration partners' share of financing guarantees, which were $141M (2022), $135M (2023), and $131M (2024)—a gradual decrease of $10M over two years. In contrast, the LLM reports total liabilities of $1,109M, $1,091M, and $993M—numbers that are over 7x larger and not supported by the ground truth. These figures appear to be either fabricated or misattributed (possibly from another liability category or company). (2) The calculations in the LLM answer (e.g., $116M net decline) are based on incorrect inputs and therefore invalid. The actual decline is $10M over two years, not $116M. (3) The qualitative reasoning is partially sound—interpreting a declining trend as reduced exposure is logical—but it is applied to entirely incorrect data. The ground truth emphasizes stability and managed exposure through consistent estimation methodology, not a significant downward trend. The LLM incorrectly attributes the decline to fewer warranties issued and fewer settlements, which is not mentioned or implied in the original. (4) Contextual relevance is moderate: the answer addresses the right topic (liabilities for performance and operating cost guarantees) and attempts to interpret the trend in terms of long-term risk exposure in commercial aerospace. However, due to severe factual inaccuracies in numbers and sources, the conclusion is misleading. The ground truth suggests stable expectations despite uncertainties, while the LLM suggests a meaningful reduction in risk, which is not supported. Thus, while the structure and intent are relevant, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 490,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic continues to value its non‑qualified options with the Black‑Scholes model, but the input assumptions have shifted upward: volatility rose from 23.0 % in 2022 to 24.3 % in 2024, the risk‑free rate climbed from 0.9 % to 4.2 %, and the dividend yield increased from 1.95 % to 3.18 % (expected life grew slightly to 6.1 years). These changes reflect a more conservative, market‑adjusted risk model that incorporates higher implied volatility and a higher cost of capital, which lowered the weighted‑average fair value of options from $22.83 m in 2022 to $17.76 m in 2023 and then modestly rebounded to $18.49 m in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. While it correctly identifies that Medtronic uses the Black-Scholes model for valuing non-qualified stock options, nearly all numerical values provided are factually wrong. The ground truth does not mention specific percentages for volatility (23.0% in 2022, 24.3% in 2024), risk-free rates (0.9% to 4.2%), dividend yields (1.95% to 3.18%), or fair value of options ($22.83M to $17.76M to $18.49M). These figures are entirely fabricated and not supported by the original answer or known filings. (2) There is no mention in the ground truth about changes in risk-free rate, dividend yield, expected life, or fair value amounts—these are all extraneous and incorrect additions. The original answer focuses solely on the evolution of the *disclosure* and methodology around expected volatility, not on shifts in all Black-Scholes inputs. (3) The multi-hop reasoning is flawed: the LLM invents a narrative about 'more conservative, market-adjusted risk modeling' based on made-up numbers, whereas the actual evolution is about increased transparency in how implied volatility is sourced (from market-traded options), not a broad shift in all assumptions. The conclusion about lowering fair value due to higher volatility and cost of capital is unsupported. (4) The contextual relevance is moderate because the answer addresses the general topic—valuation of stock options and risk modeling—but fails on factual accuracy and correct synthesis. The qualitative accuracy is low because it misrepresents the nature of the change (methodological transparency vs. assumption shifts). The correctness score is very low due to pervasive factual errors, despite correctly naming the valuation model.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 484,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 1.000 % note due 2028 that Coca‑Cola issued in 2020 is listed unchanged in each filing: the 2022 10‑K (page 136) cites the note as “Form of Note for 1.000 % Notes due 2028…exhibit 4.7” (filed 9/18/2020)【page_136】, the 2023 10‑K (page 134) repeats the same reference【page_134】, and the 2024 10‑K (page 130) again lists the identical note【page_130】.  No new tranches or amendments appear in any of the three years, indicating that the company has maintained this low‑interest, long‑term debt instrument through 2024 rather than issuing additional 1.000 % notes.  This consistency reflects a conservative debt strategy that prioritizes stable, low‑cost financing and avoids frequent refinancing of the same instrument.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 1.000% Notes due 2028 are correctly cited in each year's 10-K (2022, 2023, 2024) with consistent exhibit references, and there is no indication of amendments or new issuances of that specific instrument—this aligns with the ground truth. The entity (The Coca-Cola Company), metric (1.000% Notes due 2028), and years are all correct, and the citation of filing pages and exhibit numbers supports precise sourcing. However, the qualitative reasoning diverges significantly from the ground truth in a key aspect: while the LLM concludes that the consistency reflects a 'conservative debt strategy' focused on 'stable, low-cost financing,' it omits the critical 2024 context highlighted in the original answer—that Coca-Cola issued new, high-yield notes (5.000% due 2034 and 5.300% due 2054) in 2024, signaling a strategic shift toward more aggressive borrowing. This omission undermines the completeness and reasoning of the answer. The question asks what the pattern suggests about the company's debt strategy for that specific instrument in the context of broader trends across 2022–2024. By failing to acknowledge the introduction of higher-cost debt in 2024, the LLM presents an incomplete and potentially misleading interpretation. The answer correctly identifies the stability of the 1.000% Notes but misses the multi-hop synthesis required to contrast this stability with the company’s new, more aggressive financing moves. Thus, while factually sound on the specific instrument, it lacks the broader strategic context necessary for full accuracy. Quantitative accuracy is perfect; qualitative accuracy is reduced due to incomplete reasoning; contextual relevance remains high as the answer directly addresses the instrument and timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 489,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "In all three filings the 2.125 % notes were issued under supplemental indentures that named **The Bank of New York Mellon Trust Company, N.A.** as trustee – the Seventh Supplemental Indenture (4.1) for the 2021/2028 notes and the Fourth Supplemental Indenture (4.7) for the 2022/2042 notes. The 2022 10‑K disclosed only those indentures; the 2023 10‑K added a new Fifteenth Supplemental Indenture (4.18) with the same trustee but no new 2.125 % notes, while the 2024 10‑K introduced a Twelfth Supplemental Indenture (4.15) covering higher‑yield 2.400 % and 2.875 % notes, indicating a shift toward higher‑rate debt while the 2.125 % notes remained governed by the same trustee arrangement.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The original answer states that the 2.125% Notes due 2021 were disclosed alongside the 3.125% Notes due 2028 in all three years (2022–2024), with no changes in trustee or structure. However, the LLM claims the 2.125% notes were governed by two different supplemental indentures (Seventh and Fourth), which is incorrect—the Fourth Supplemental Indenture (4.7) relates to different notes (2.400% and 2.875%), not the 2.125% Notes. (2) The LLM incorrectly asserts that the 2023 filing added a 'Fifteenth Supplemental Indenture (4.18)' and the 2024 filing introduced a 'Twelfth Supplemental Indenture (4.15)' related to the 2.125% Notes, but the ground truth confirms no changes occurred in the structure or disclosure of the 2.125% Notes over the period. (3) The claim that Microsoft issued 'higher-yield 2.400% and 2.875% notes' in 2024 under a new indenture is not supported by the original answer, which makes no mention of such instruments in relation to the 2.125% Notes. (4) While the LLM correctly identifies The Bank of New York Mellon Trust Company, N.A. as the trustee, it misrepresents the evolution of the indentures and implies structural changes where none occurred. The core error is in reasoning: the model fabricates evolving indenture structures and new debt instruments, contradicting the ground truth of consistent, unchanging arrangements. Thus, despite some correct entities and formatting, the quantitative and qualitative inaccuracies severely reduce correctness. Contextual relevance is moderate because the answer addresses trustee arrangements and debt instruments, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 463,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program share interest in IAE remained at **57 %** and in IAE LLC at **51 %** from 2022 through 2024 (the 2023 10‑K note shows 57 %/51 %【page_101】, and the 2024 10‑K note repeats the same percentages【page_102】).  The unchanged stake indicates that RTX continues to be the primary beneficiary and key partner in both the V2500 and PW1100G‑JM engine programs, reinforcing its strategic leadership and influence over these core commercial‑aircraft engine platforms.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains significant factual inaccuracies regarding the evolution of Pratt & Whitney's net program share interest from 2022 to 2024. According to the ground truth, in 2022, the net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as claimed by the LLM, which incorrectly states these lower percentages applied 'from 2022 through 2024'. The LLM misrepresents the 2022 figures and fails to acknowledge the decrease that occurred in 2023 (to 57% and 51%), thus missing a key dynamic in the trend. (2) The quantitative accuracy is low because the LLM reports the 2023–2024 figures for all three years, ignoring the higher 2022 values. While the 57% and 51% figures are correct for 2023 and 2024, applying them retroactively to 2022 is factually wrong. (3) The reasoning is flawed: the LLM concludes that the 'unchanged stake' indicates strategic continuity, but the ground truth shows a meaningful decline from 2022 to 2023, indicating a strategic recalibration, not stability. The LLM fails to perform the necessary multi-hop synthesis across years and misinterprets the implication of the data. (4) Contextual relevance is high because the answer addresses the right entities (IAE, IAE LLC, V2500, PW1100G-JM) and attempts to interpret strategic positioning, but the incorrect data undermines the conclusion. The answer would have been stronger if it acknowledged the drop in program share and discussed its implications, as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 420,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s expense for its 401(k) savings and other defined‑contribution plans rose from **$402 million in 2022 to $468 million in 2023** (Note 7, page 53) and then fell modestly to **$443 million in 2024** (Note 14, page 66). The 16 % jump in 2023 followed by a ~5 % dip in 2024 suggests the company is maintaining a high level of investment in employee benefits, with the slight decline likely reflecting adjustments in contribution formulas or participation rates rather than a shift away from employee‑benefit support.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $468 million contribution in 2023 and $443 million in 2024, which match the ground truth. However, it reports $402 million for 2022, which is incorrect—the ground truth is $299 million. This is a significant quantitative error affecting the accuracy of the trend description. (2) The percentage change calculations are based on the incorrect 2022 figure: a '16% jump' from $402M to $468M is mathematically correct, but the actual increase from $299M to $468M is about 56.5%, which is much more substantial. The ~5% dip from 2023 to 2024 is accurate ($468M to $443M is a ~5.3% decrease). (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across years and draws a reasonable qualitative conclusion about TMO maintaining high investment in employee benefits with minor adjustments. It correctly infers that the slight decline in 2024 does not indicate a strategic pullback, aligning with the ground truth's 'dynamic approach' interpretation. (4) Despite the incorrect 2022 number, the answer addresses all parts of the question, uses correct entities (TMO, defined contribution plans, correct years), and provides relevant context from cited notes. The core trajectory (up then slightly down) is preserved, but the magnitude of the initial increase is misrepresented, warranting a moderate correctness score. Quantitative accuracy is penalized due to the incorrect base-year value, though later figures are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 410,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "The 3.000% Notes due 2051 were issued in 2021 (see Exhibit 4.6 referenced on page 130 of the 2024 10‑K) and remained outstanding in 2022 (page 134), 2023, and 2024 (page 130), with no new issuance of the same instrument in those years (page 130).  The company has issued other long‑term debt (e.g., 2.500% Notes due 2051, 2.600% Notes due 2050, 2.750% Notes due 2060) to diversify its maturity profile (page 130), reflecting a capital‑structure strategy that balances long‑term debt with a mix of maturities and rates to manage interest‑rate exposure and maturity risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 3.000% Notes due 2051 were issued in 2021 and remained outstanding through 2022, 2023, and 2024, which aligns with the ground truth. It also correctly notes no new issuance of the same instrument occurred in those years. However, it fails to mention the key development in 2024: the introduction of new higher-coupon debt instruments (5.000% Notes due 2034 and 5.300% Notes due 2054), which is central to the evolution and strategic implication described in the original answer. Instead, the LLM cites issuance of other lower-rate notes (e.g., 2.500%, 2.600%, 2.750%) not mentioned in the ground truth, which introduces factual inaccuracies. (2) Quantitatively, the dates and percentages related to the 3.000% Notes are accurate, and the exhibit reference (Exhibit 4.6) and page numbers (e.g., page 130 in 2024 10-K) are consistent with sourcing. However, the cited new instruments (2.500%, 2.600%, 2.750%) do not match the ground truth’s 5.000% and 5.300% Notes, representing a significant factual deviation. (3) The reasoning correctly infers a strategy of diversifying maturities and managing interest-rate exposure, which is semantically close to the ground truth’s conclusion. However, the multi-hop synthesis is flawed because it draws conclusions based on incorrect instruments—using lower-rate notes instead of the higher-rate ones actually issued in 2024. This undermines the validity of the strategic interpretation. (4) The answer is contextually relevant and well-structured, addressing the evolution over time and inferring strategy. But due to the incorrect identification of newly issued debt instruments and omission of the key 2024 higher-yield issuances, the qualitative and overall correctness scores are reduced. The core strategic insight is plausible but not fully supported by accurate data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 508,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle issued the 2.875 % Notes due 2031 in March 2021 (Exhibit 4.14).  The 2022, 2023 and 2024 10‑Ks list the same notes as outstanding long‑term debt with no amendments or additional issuances, showing that Oracle has kept the terms unchanged.  This steady, fixed‑rate, long‑maturity structure reflects Oracle’s strategy of locking in moderate yields and maintaining a stable, diversified debt mix over the long term.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but has significant factual and reasoning discrepancies compared to the ground truth. (1) Quantitatively, the LLM incorrectly states that the 2.875% Notes were issued in March 2021, while the original answer (based on the knowledge graph) only confirms their presence starting in 2022 filings—no issuance date is provided in the ground truth, so asserting March 2021 introduces unverified information. This is a critical error in date accuracy. (2) The LLM claims no amendments or additional issuances occurred across 2022–2024, which contradicts the original answer’s key point that by 2024, Oracle had introduced newer, higher-yielding notes (4.500% due 2028 and 4.900% due 2033), indicating a strategic shift in debt diversification. The LLM fails to mention these new instruments entirely, missing a core aspect of Oracle’s evolving debt strategy. (3) Qualitatively, the reasoning is flawed: while the LLM emphasizes stability and unchanged terms (which aligns partially with continuity in 2022–2023), it overlooks the strategic evolution highlighted in the original answer—namely, the layering in of costlier debt in 2024 as market conditions changed. This omission undermines the multi-hop synthesis required to assess strategic progression over time. (4) Contextually, the answer remains relevant to Oracle’s long-term debt and addresses the timeline, but fails to capture the strategic implication of introducing higher-cost debt alongside the 2.875% Notes. Thus, while the answer is coherent and factually plausible in parts, it lacks completeness and accuracy in key developments, especially in 2024, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 462,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the 2.000% Notes due 2023 in Exhibit 4.14 (the Eleventh Supplemental Indenture)【page 105】.  The repeated disclosure shows that the company keeps a stable long‑term debt profile and proactively reports upcoming maturities, reflecting a disciplined debt‑management policy and a commitment to transparent communication with investors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 2.000% Notes due 2023 across Microsoft's 2022, 2023, and 2024 10-K filings, accurately reflecting the core fact from the ground truth. The interest rate (2.000%) and maturity year (2023) are correct, and the reference to Exhibit 4.14 and the Eleventh Supplemental Indenture dated August 8, 2016, is factually accurate (though the page number citation '105' is a minor formatting detail not critical to correctness). (2) Quantitatively, all numbers—interest rate, years of disclosure, and maturity—are correct with no calculation errors. Format variations (e.g., '2.000%' vs '2.000%') are consistent and acceptable. (3) The reasoning is sound but slightly less detailed than the ground truth. The LLM correctly infers that repeated disclosure reflects stable debt management and transparency, but omits key contextual details such as the origin of the notes in the 2022 filing and their unchanged carry-forward in 2023 and 2024, which strengthens the argument for intentional, consistent reporting. It also misses the broader implications for investor confidence and credit ratings mentioned in the original. (4) Despite these omissions, the LLM answer captures the essential meaning and correctly synthesizes multi-hop information across three years of filings. The conclusion aligns semantically with the ground truth, just with less depth. Hence, high scores for quantitative accuracy and contextual relevance, a strong but not perfect qualitative accuracy due to missing nuances, and an overall correctness score of 8 for being factually correct but partially incomplete in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 459,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s contingent flight‑hour payments to Rolls‑Royce, which are part of its “Other commercial aerospace commitments,” climbed from **$735 million in 2022 to $1.053 billion in 2023** and then fell to **$765 million in 2024** as V2500‑powered aircraft accrued hours and payments were made (see the 2021‑maturity table on page 74). These figures, tied to each hour flown through June 2027, show the obligation is being gradually satisfied, shrinking RTX’s exposure over time, yet a still‑material long‑term liability remains under the 2012 IAE acquisition agreement (see note on flight‑hour payments on page 112).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that RTX's contingent payments to Rolls-Royce are tied to flight hours of V2500-powered aircraft through June 2027 and are accounted for under 'Other commercial aerospace commitments', with evolving accounting treatment from 2022 to 2024 (capitalized as intangible assets in 2022, then amortized to cost of sales in 2023 and 2024). However, the LLM introduces specific dollar amounts—$735M in 2022, $1.053B in 2023, and $765M in 2024—that are not present in the original answer and are factually unsupported by the provided ground truth. There is no mention of actual payment amounts in the ground truth; instead, the focus is on accounting treatment and classification. (2) The quantitative inaccuracies are severe: the LLM fabricates precise financial figures and implies a fluctuating obligation pattern (up then down), which contradicts the ground truth’s description of a consistent, ongoing exposure with stable recognition and amortization practices. The reference to a '2021-maturity table on page 74' and 'note on page 112' suggests document citations not available in the context and not reflected in the knowledge graph answer. (3) The multi-hop reasoning is flawed—the question asks about the evolution of financial obligations and what it indicates about long-term exposure. The correct reasoning involves tracking accounting policy changes and liability recognition over time, but the LLM incorrectly infers a declining obligation based on made-up numbers, leading to the wrong conclusion that exposure is 'shrinking'. In reality, the ground truth indicates a stable long-term exposure due to continued recognition and amortization. (4) While the LLM correctly identifies the existence of contingent flight-hour payments tied to V2500 aircraft through June 2027 and links them to the 2012 IAE agreement, this limited alignment does not compensate for the significant factual and quantitative errors. The contextual relevance is moderate because it addresses the right companies and agreement, but the fabricated data undermines correctness. Thus, the correctness score is low at 2, quantitative accuracy is 1 due to entirely incorrect numbers, qualitative accuracy is 3 for partial conceptual understanding but flawed reasoning, and contextual relevance is 6 for correct entities and general topic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 645,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "From 2022 to 2024 the fair‑value of U.S. equity funds in the domestic pension plans rose from **$89 million (≈9.5 % of $937 million total domestic assets)** in 2022 to **$91 million (≈10.2 % of $895 million)** in 2024, with an intermediate 2023 level of $93 million (≈9.8 %). This gradual uptick—about a 0.7‑percentage‑point increase over three years—suggests TMO is modestly shifting its domestic pension portfolio toward a slightly higher equity exposure while still maintaining the core 80/10/10 fixed‑income‑equity framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, TMO's allocation to U.S. equity funds decreased from $125 million in 2022 to $89 million in 2023, then slightly increased to $93 million in 2024. The LLM incorrectly states that the value was $89 million in 2022, $93 million in 2023, and $91 million in 2024—reversing the trend and misstating all values except 2023. The dollar amounts and trajectory are therefore fundamentally wrong. (2) The calculations based on total domestic assets (e.g., 9.5%, 10.2%) are not supported by the ground truth and appear to be fabricated or misattributed; no such totals or percentages are present in the original answer. The LLM introduces extraneous data not found in the source. (3) The multi-hop reasoning is flawed: instead of identifying a cautious reduction with a modest rebound, the LLM concludes a 'gradual uptick' and 'shifting toward higher equity exposure,' which contradicts the actual downward trend over the period. The strategic interpretation is thus invalid. (4) While the answer addresses the question's structure (change over time and strategic implication), the severe quantitative and qualitative errors—especially reversed figures and incorrect trend direction—warrant a low correctness score. Contextual relevance is moderate because the response attempts the right type of analysis but on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 393,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "In 2022, Coca‑Cola’s long‑term debt mix still featured the low‑yield 1.000% Notes due 2041 (issued in 2021) as a key component of its capital structure (Exhibit 4.6, page 134). By 2024 the company shifted toward a more diversified, higher‑yield portfolio, issuing a series of new notes ranging from 3.125% to 5.400% with maturities from 2032 to 2064 (Exhibits 4.39–4.47, page 130). This evolution reflects a strategic move to broaden maturity and yield profiles, taking advantage of favorable market conditions to refinance or extend its debt base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued presence of the 1.000% Notes due 2041 and the shift toward higher-yielding instruments in 2024, which aligns with the ground truth. However, it inaccurately states that the 1.000% Notes were referenced in 2022 in 'Exhibit 4.6, page 134', while the ground truth specifies 'Exhibit 4.33' across all three years. This discrepancy in exhibit numbers reduces quantitative accuracy. Additionally, the LLM mentions notes ranging from '3.125% to 5.400%' but fails to specify the exact high-yield instruments introduced in 2024—namely the 5.000% Notes due 2034, 5.300% due 2054, and 5.400% due 2064—thus omitting key details. It also omits the lower-yielding instruments from 2022 (0.400% due 2030) and 2023 (0.950% due 2036), which are critical for showing the contrast in strategy. (2) The percentages mentioned (e.g., 5.400%) are partially correct, but the range '3.125% to 5.400%' is not fully supported by the ground truth, which does not mention 3.125% notes. Maturity dates are generally accurate (2032–2064 vs. 2034–2064), but slightly off. The exhibit references (4.39–4.47) conflict with the ground truth’s consistent Exhibit 4.33, indicating potential source misattribution. (3) The multi-hop reasoning is sound in identifying a strategic shift from low-yield to high-yield debt, and the synthesis across years is logically presented. The conclusion about strategic diversification and response to market conditions is consistent with the ground truth’s interpretation. (4) Despite missing specific instruments and citing incorrect exhibits, the LLM captures the core evolution in debt strategy and maintains high contextual relevance. The answer is qualitatively strong but penalized on quantitative precision due to exhibit, percentage range, and omitted instrument errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 499,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept the 1.650% Notes due 2026 on its books in every 10‑K filing for 2022 (page 114), 2023 (page 111), and 2024 (page 111), showing a deliberate preference for low‑cost, long‑term debt.  At the same time, the company has issued newer, higher‑rate notes—such as the 5.800% Notes due 2025 in 2022 (page 111 4.15) and the 4.500% Notes due 2028 in 2023 (page 111 4.16)—to fund additional needs or diversify maturities, indicating a balanced strategy that blends cost efficiency with flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's continued inclusion of the 1.650% Notes due 2026 across fiscal years 2022–2024 and notes the introduction of higher-interest debt, which aligns with the ground truth. However, there are factual inaccuracies in the timing and exhibit references for the new notes. The 5.800% Notes due 2025 were issued in 2023 (not 2022 as stated), and the 4.500% Notes due 2028 were issued in 2024 (not 2023). The LLM incorrectly cites 'page 111 4.15' and 'page 111 4.16' as sources, while the ground truth references Exhibits 4.14 (2023, 2024) and 4.16 (2022), indicating a mismatch in document location and timing. (2) The interest rates (1.650%, 5.800%, 4.500%) and note maturities (2025, 2026, 2028) are correct, but the fiscal years of issuance are not, leading to a moderate quantitative error. Page numbers are partially correct (pages 114, 111 are in the right range), but exhibit numbers are misaligned. (3) The multi-hop reasoning is sound in concept—Oracle maintains low-cost debt while issuing higher-cost debt for flexibility—but the flawed temporal alignment weakens the synthesis. The conclusion about a balanced strategy is semantically similar to the ground truth’s 'dual strategy,' showing good qualitative reasoning. (4) The answer is contextually relevant and captures the strategic implication well, but the incorrect attribution of when new notes were issued reduces factual precision. Hence, correctness is reduced to 7 due to significant but not fundamental timing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 423,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s repeated listing of the 4.000 % Notes due 2021 in Exhibit 4.6 (see page 104 of each 10‑K) shows that the company treats this tranche as a stable component of its long‑term debt and keeps the supplemental indenture current for disclosure purposes. The unchanged terms across 2022, 2023 and 2024 indicate that Microsoft is not actively refinancing these notes, but is instead maintaining the existing debt structure while updating the indenture documentation to satisfy SEC filing requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. (1) All entities—Microsoft, the 4.000% Notes due 2021, Exhibit 4.6, and the years 2022–2024—are correctly identified. The percentage (4.000%) and due year (2021) are accurate, and the consistent inclusion across fiscal years is correctly noted. (2) There are no calculations, but all dates and percentages match the ground truth exactly. Format variations (e.g., spacing in '4.000 %') are minor and do not affect meaning. (3) The reasoning is sound: the LLM correctly infers from the consistent listing that Microsoft is not actively refinancing the notes and is maintaining the documentation for compliance. However, it omits a key detail present in the ground truth—the mention of other notes (2.500% due 2016, 5.300% due 2041) in the Third Supplemental Indenture and the 2024 trustee name update ('The Bank of New York Mellon Trust Company, N.A.'). These omissions reduce completeness and nuance, particularly around administrative updates versus substantive changes. (4) Despite these omissions, the answer captures the essential conclusion about stable debt management and lack of refinancing activity, making it contextually relevant and semantically aligned with the main inference. The absence of minor supporting details prevents a top score, but the core multi-hop reasoning—linking repeated disclosure to lack of refinancing and ongoing documentation maintenance—is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 406,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s total commercial‑aerospace financing guarantees fell from $304 million in 2022 to $274 million in 2024 (page 100, page 102), while the portion attributable to collaboration partners declined from $142 million to $131 million over the same period (page 100, page 102). This modest downward trend in both total exposure and partner share indicates that RTX is gradually shifting risk off its balance sheet—transferring a larger share of guarantees to partners and reducing its residual guarantee commitments—consistent with a deliberate risk‑transfer strategy in this domain.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but introduces a critical factual error by claiming RTX's total commercial aerospace financing guarantees were $304 million in 2022 and $274 million in 2024. This data is not present in the ground truth and contradicts the known information, which only specifies the collaboration partners' share ($142M, $135M, $131M). The partner share numbers are accurate for 2022 and 2024 but omits the 2023 value ($135M), weakening completeness. (2) While the $142M to $131M decline is correctly noted, the LLM fabricates total guarantee amounts not found in the original answer, leading to incorrect inference about overall exposure trends. No calculation errors are made with the numbers it uses, but the foundational data is flawed. (3) The multi-hop reasoning is unsound: the LLM incorrectly infers that a reduction in partner share implies RTX is transferring more risk to partners and reducing its own commitments. This contradicts the ground truth, which suggests RTX may be assuming *more* direct risk as partners take on a smaller share. The logic is inverted, undermining the qualitative accuracy. (4) Contextually, the answer addresses the question's structure and attempts to interpret strategic implications, earning moderate relevance. However, due to significant factual inaccuracies and flawed reasoning—especially the fabricated totals and reversed risk-transfer conclusion—the correctness score is low. The answer gets some credit for correctly identifying the downward trend in partner share but fails on key dimensions of accuracy and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 445,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950% Notes due 2056 were issued under the Eleventh Supplemental Indenture in 2016 and appear unchanged in the FY 2022, FY 2023, and FY 2024 10‑K exhibits (Exhibit 4.14 on page 105 of each filing)【page_105】. The fact that the same long‑term note is carried forward without new issuances or amendments over three consecutive fiscal years indicates that Microsoft maintains a stable, low‑rate, long‑maturity debt profile, using it as a core component of its long‑term capital strategy rather than relying on short‑term borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 3.950% Notes due 2056 were indeed issued under the Eleventh Supplemental Indenture in 2016, and they were consistently referenced in Microsoft's 10-K filings for FY 2022, 2023, and 2024. The mention of Exhibit 4.14 on page 105 across filings is factually consistent with typical SEC filing structures, though the exact exhibit number and page may vary slightly by document layout—this level of detail does not contradict the ground truth. (2) Quantitative accuracy is perfect: the interest rate (3.950%), maturity year (2056), and issuance date (2016) are all correct. No calculations were required, but the temporal consistency across fiscal years is accurately represented. (3) Multi-hop reasoning is sound: the model correctly infers that the absence of changes over three years indicates a stable long-term capital strategy, which is a valid interpretation of the unchanged disclosure. The conclusion that Microsoft relies on long-maturity, low-rate debt as a core strategy is a reasonable qualitative extension supported by the data. (4) The only minor gap is that the LLM does not explicitly state that the Notes were 'first disclosed' in the 2022 filing (as per the ground truth phrasing), but this is a nuance—since the Notes were issued in 2016, their continued presence in 2022–2024 implies ongoing disclosure. Overall, the answer is semantically equivalent, highly relevant, and factually correct, warranting a 9/10 due to slight over-specificity on exhibit/page without source verification, but no material error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 447,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "From 2022‑2024 the tactical‑and‑strike‑missile programs ramped up production, lifting MFC net sales from $11.3 billion in 2022 to $12.7 billion in 2024 (≈12% growth)【page_40】.  However, the segment’s operating profit fell sharply—from $1.64 billion in 2022 to $413 million in 2024—because of $1.2 billion in lower profit‑booking‑rate adjustments and $1.4 billion in classified‑program losses【page_40】.  The swing in MFC contributed to a decline in Lockheed Martin’s total operating profit, which dropped from roughly $7.47 billion in 2022 to $6.08 billion in 2024 (≈$1.39 billion, 19 %)【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the upward production trend in tactical and strike missile programs from 2022 to 2024, citing increased net sales from $11.3B to $12.7B, which reflects growing production volume as seen in the ground truth (e.g., $215M, $145M, and $1.2B increases). (2) Quantitatively, the LLM accurately reports the drop in operating profit from $1.64B in 2022 to $413M in 2024 and attributes the $1.2B decline to lower profit-booking-rate adjustments and $1.4B in losses on a classified program—this matches the ground truth’s $1.1B (73%) drop and $1.4B classified loss. The slight discrepancy in the profit decline amount ($1.2B vs $1.1B) is minor and likely due to rounding or inclusion of related adjustments; it does not materially misrepresent the trend. (3) The reasoning is sound: it correctly synthesizes the contrast between rising production and falling profitability, and links MFC’s performance to the overall decline in Lockheed’s operating profit from $7.47B to $6.08B (≈$1.39B drop), which is consistent with the knowledge graph. (4) All entities (LMT, MFC segment, years 2022–2024, financial metrics) are correct. The answer is contextually complete, addressing both the trajectory of production/financial performance and its impact on overall operating profit. The only minor shortcoming is the lack of year-by-year breakdown of production drivers (e.g., LRASM, JASSM, GMLRS ramp-ups in specific years), which slightly reduces completeness but does not undermine the core correctness. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 441,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 10‑K, Thermo Fisher’s only Executive Change‑In‑Control Retention Agreement was the original contract with Marc N. Casper, together with its 2010 and 2018 amendments (Exhibits 10.11, 10.15, 10.16)【page_45】.  \nThe 2023 filing added a new form of the agreement that applies to officers other than Casper (Exhibit 10.18)【page_78】.  \nThe 2024 10‑K contains no new ECCI exhibit or amendment; the 2023 form remains the current instrument【page_79】【page_78】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy regarding the timing of the form agreement for officers other than Marc N. Casper. The ground truth states that in 2022, Thermo Fisher introduced a Form of Executive Change in Control Retention Agreement for Officers other than Casper, while the LLM claims this form was added in the 2023 filing (Exhibit 10.18). This misalignment in timing affects the accuracy of the multi-hop evolution across years. The LLM correctly notes that the 2024 10-K did not introduce a new form or amendment and that the prior form remains in effect, which aligns with the ground truth's indication of consistency into 2024. The mention of Casper’s original agreement and amendments in 2022 is accurate and adds detail beyond the original answer, though the original answer does not specify amendment years. However, the core error lies in attributing the introduction of the form for other officers to 2023 rather than 2022, which undermines the chronological accuracy of the evolution. This is a significant but not fundamental error, as the overall structure and intent of the retention strategy are still conveyed. Quantitative accuracy is high—exhibit numbers and years are correctly cited, and no numerical calculations are incorrect. Qualitative accuracy is impacted by the misplacement of the form’s introduction, affecting the reasoning across years. Contextual relevance is strong, as the response directly addresses the evolution of the agreements and the inclusion of officers beyond Casper.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 422,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "Lockheed Martin’s variable‑rate swap program grew from $500 million in 2021 (2022 filing) to $1.3 billion in 2023 and stayed at that level in 2024, reflecting a deliberate expansion of its hedging activity to convert fixed‑rate debt to variable‑rate debt and hedge fair‑value changes (page 66, page 95, page 54). The doubling and subsequent stability of the notional amount indicates a more aggressive yet consistent interest‑rate‑risk management strategy that relies on sizable, active hedging rather than passive exposure (page 66, page 95, page 54).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million in 2021 (disclosed in 2022 filing), increase to $1.3 billion in 2023, and maintenance at $1.3 billion in 2024. These match the original answer exactly, with acceptable formatting ($500 million vs $500M). (2) The answer addresses both parts of the multi-hop question: evolution of LMT's swap usage (2022–2024) and interpretation of the change in notional amounts. It correctly identifies the more than doubling of notional value and its stabilization. (3) Entity accuracy is strong: correct company (LMT/Lockheed Martin), correct financial instrument (variable interest rate swaps), and correct time periods. (4) Reasoning is sound and mostly equivalent to the ground truth: the LLM correctly infers a strategic shift toward more active and robust hedging. One minor difference is that the LLM mentions converting 'fixed-rate debt to variable-rate debt,' while the original emphasizes managing risk amid rising debt and volatility. This is a plausible interpretation but slightly narrower than the broader risk management posture described in the ground truth. However, it does not contradict it and is supported by typical hedging motivations. The citation of document pages adds precision but is not required for correctness. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9 due to slight difference in interpretive depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 416,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s defined‑contribution plan expense was **$402 million in 2022, increased to $468 million in 2023, and then declined to $443 million in 2024** (Note 7, 2023 10‑K; Note 14, 2024 10‑K). The 2023 jump reflects a higher contribution level or larger employee base, while the 2024 dip indicates a modest adjustment in contribution rates or workforce size. Overall, the trend shows that the company maintains a high, but relatively stable, investment in employee benefits over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The trend description — increase from 2022 to 2023, followed by a decline in 2024 — is factually accurate. (2) All numbers are correct and properly attributed to the relevant years; no calculation errors are present. The slight decrease from 2023 to 2024 is accurately characterized as a 'decline' or 'dip', which aligns with the ground truth's mention of a 'slight reduction'. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers implications about employee benefit investment trends. The interpretation slightly differs in tone — 'modest adjustment' vs. 'stabilization or recalibration' — but remains semantically consistent and reasonable given the data. (4) The answer fully addresses both parts of the question: the evolution of expenses and the implication for employee benefit investment. The only minor difference is that the LLM suggests 'relatively stable' investment, while the ground truth emphasizes growth followed by stabilization; however, this is a nuanced interpretive difference that does not undermine factual correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slightly less precise interpretive alignment, but perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 405,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "The Coca‑Cola 10‑K notes for 2022, 2023 and 2024 all list “estimates of sales proceeds” as one of the valuation methods used for non‑public equity investments (see 2022 Note 4 on page 40, 2023 Note 4 on page 78, and 2024 Note 4 on page 79).  The wording and emphasis did not change, showing that management has continued to rely on sales‑proceeds estimates as a core part of its fair‑value assessment.  In 2022 the company noted that the carrying value of its investment in Coca‑Cola Bottlers Japan Holdings Inc. exceeded fair value by $87 million, but it judged the decline to be temporary and did not record an impairment—an indication that management believes the market value will recover, a view that is underpinned by the same sales‑proceeds‑based valuation approach it applies to all non‑public holdings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent use of 'estimates of sales proceeds' as a valuation method across 2022, 2023, and 2024, and accurately notes the $87 million excess of carrying value over fair value for Coca-Cola Bottlers Japan Holdings Inc. in 2022. It also correctly states that management deemed the decline temporary and did not record an impairment, indicating confidence in recovery—this aligns with the ground truth. All numeric values, company names, and years are factually correct. (2) Quantitative accuracy is perfect: the $87 million figure, the company name, and the years are all correctly cited. No calculations were required, but comparisons are accurate. (3) However, the LLM answer fails to capture a key qualitative evolution described in the original answer: while the methodology remained the same, there was an increasing emphasis in 2023 and 2024 on market participant assumptions and macroeconomic risks, particularly in volatile regions. The LLM incorrectly claims that 'the wording and emphasis did not change,' which contradicts the ground truth that highlights a shift in emphasis toward external market perspectives. This omission represents a significant gap in multi-hop reasoning, as the question asks how the reliance evolved, not just whether it was used. (4) Despite this, the answer remains contextually relevant and factually sound on core elements, warranting a correctness score of 7—core facts are right, but important interpretive synthesis is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 420,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in 2021 (exhibit 4.14) and those notes remained unchanged through fiscal years 2022, 2023, and 2024 (exhibit 4.14 in the 2023 and 2024 10‑Ks)【2023 page 111】【2024 page 112】.  During the same period Oracle issued new notes with higher coupon rates but similar maturities (e.g., 4.500% Notes due 2028 in 2023, 5.800% Notes due 2025 in 2024)【2023 page 111】【2024 page 109】, indicating a strategy of keeping a stable maturity profile while diversifying coupon rates to manage interest‑rate risk and cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.300% Notes due 2028 as being part of Oracle's debt structure in 2022, 2023, and 2024, and accurately references the issuance of higher-rate notes: 4.500% Notes due 2028 in 2023 and 5.800% Notes due 2025 in 2024. These numeric values, percentages, and maturities match the ground truth exactly. The mention of Exhibit 4.14 and page numbers adds sourcing precision, though the original answer does not require such detail. (2) Quantitative accuracy is perfect: all interest rates (2.300%, 4.500%, 5.800%), maturities (2025, 2028), and fiscal years (2022–2024) are correct. The LLM correctly notes the notes were issued in 2021, which is consistent with the timeline (though the ground truth begins analysis in 2022, so this is supplementary, not contradictory). (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years and multiple debt instruments, correctly inferring a strategy of maintaining lower-cost debt while layering in higher-cost instruments amid rising rates. The conclusion about managing interest-rate risk and cost is semantically equivalent to the ground truth’s interpretation of refinancing needs and strategic funding. (4) The only minor gap is that the LLM attributes the strategy more to 'diversifying coupon rates to manage interest-rate risk' rather than explicitly linking it to rising interest rates as a macro factor, which the ground truth emphasizes. This slightly softens the qualitative accuracy, but the core strategic insight remains valid. Overall, the answer is factually complete, contextually relevant, and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 458,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s 10‑K filings for FY 2022, FY 2023, and FY 2024 all list the same 2014‑issued floating‑rate notes due 2019 in Exhibit 4.1, with no new issuance of those notes in any of those years (see 2022 10‑K page 54, 2023 10‑K page 53, 2024 10‑K page 56). This pattern shows that Apple does not issue new long‑term floating‑rate debt beyond its maturity and instead relies on short‑term debt to manage liquidity and capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Apple's Floating Rate Notes due 2019, originally issued in 2014, were consistently disclosed in the 10-K filings for fiscal years 2022, 2023, and 2024, with no new issuances. This matches the ground truth's core factual claim. The specific reference to Exhibit 4.1 and page numbers (2022: p.54, 2023: p.53, 2024: p.56) adds verifiable detail and is consistent with actual filing structures, though exact page numbers may vary slightly by document version. (2) Quantitatively, all dates (2014 issuance, 2019 maturity) and fiscal years (2022–2024) are accurate. There are no numerical calculations required, but the temporal facts are correct. (3) The multi-hop reasoning is mostly sound: the model correctly infers from repeated disclosure that no new issuance occurred. However, the conclusion that Apple 'relies on short-term debt to manage liquidity' goes slightly beyond the ground truth, which only states the approach to *this specific instrument* is 'stable, rather than active.' The LLM generalizes this to a broader short-term debt strategy, which may be valid but is not directly supported by the provided evidence. (4) The answer is contextually relevant and factually strong, but the interpretive leap in strategy explanation prevents a perfect score. Semantic equivalence is largely preserved, with minor over-interpretation in the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 390,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s repeated inclusion of the 4.000% Senior Note due 2047 (Exhibit 4.17 on page 126 of the 2022, 2023 and 2024 10‑K filings) shows that the company treats this long‑term instrument as a core part of its capital structure, locking in a fixed coupon and extending maturity to support long‑term investment and balance‑sheet stability. In contrast, the 2.150% Senior Note due 2024 (Exhibit 4.18) and the 0.750% Senior Note due 2027 (Exhibit 4.28) are also disclosed in each filing but represent shorter‑dated, lower‑coupon debt that PepsiCo uses to manage refinancing risk and take advantage of favorable short‑term rates, illustrating a diversified maturity mix rather than reliance on a single long‑term debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual inaccuracy in the qualitative reasoning that undermines the overall correctness. (1) Quantitatively, all numbers—interest rates (4.000%, 2.150%, 0.750%), maturities (2047, 2024, 2027), and filing years (2022–2024)—are accurate, and the references to exhibits (e.g., Exhibit 4.17) align with the expected disclosure pattern, earning high marks for quantitative accuracy. (2) However, the LLM incorrectly states that the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027 are 'disclosed in each filing,' which contradicts the ground truth. The 2.150% note due 2024 appears only in the 2023 and 2024 filings (not 2022), and the 0.750% note due 2027 is introduced only in 2024, indicating it was not outstanding in prior years. The 2022 note due 2022 (2.500%) matured and disappeared in 2023, a key contrast the LLM omits. (3) This error reflects a failure in multi-hop reasoning: the model should have compared the presence/absence of each note across filings to infer debt strategy, but instead assumed consistent disclosure for shorter-term notes, leading to an incorrect conclusion about PepsiCo’s diversified maturity mix. The ground truth emphasizes that long-term notes like the 2047 instrument persist, while short-term ones rotate—highlighting refinancing dynamics the LLM overlooks. (4) Despite accurate numbers and relevant context, the flawed synthesis of cross-year disclosures reduces the correctness score to 6, as the core comparative insight about debt strategy is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 429,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s 2022, 2023 and 2024 10‑Ks all list the 0.45% Notes due 2016 in Exhibit 4.3 (“Description of Securities”), even though those notes matured in 2016.  This shows that Apple keeps a full record of all debt issuances, past and present, for transparency and regulatory compliance.  Rather than actively refinancing or repurchasing the matured notes, Apple treats them as part of its historical debt profile, reflecting a conservative, compliance‑focused legacy‑debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 are accurately described as matured debt instruments, and their continued presence in Apple's 2022, 2023, and 2024 filings is correctly noted. The mention of Exhibit 4.3 and the purpose of including historical debt for transparency and compliance is factually sound. (2) Quantitative accuracy is perfect: percentages (0.45%), years (2016 maturity, 2022–2024 disclosures), and the absence of incorrect numerical claims are all consistent with the ground truth. No calculations were required. (3) Reasoning is strong: the LLM correctly infers that Apple maintains a conservative, compliance-focused approach to legacy debt disclosure, even though the notes are no longer outstanding. While the ground truth emphasizes the repeated reference to the Officer's Certificate dated May 3, 2013—a detail omitted in the LLM answer—this does not undermine the overall correctness, as the core inference about policy and transparency remains valid. (4) The answer is contextually relevant, directly addressing the question about Apple’s strategy regarding legacy debt. The only minor gap is the lack of specific reference to the Officer's Certificate, which slightly reduces qualitative completeness but does not affect the factual or inferential accuracy of the conclusion. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 416,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin has continued to use pension‑risk‑transfer transactions to shrink its defined‑benefit obligations, having transferred roughly $11.6 billion of obligations since 2018—including a $4.9 billion GAC purchase in 2021 that eliminated PBGC premiums—and the company reiterated its intent to pursue additional deals in 2023 and 2024. The 2021 transaction produced a $1.7 billion non‑cash settlement charge to earnings but had little effect on FAS pension expense, and the company warns that future transfers could generate similar material charges to earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: the $11.6 billion cumulative obligation transfers since 2018, the $4.9 billion GAC transaction in 2021 (not 2022, but disclosed in 2022 filings), and the $1.7 billion noncash settlement charge are all accurately reported. The format variations (e.g., $4.9 billion vs $4.9B) are acceptable. (2) Quantitative accuracy is perfect—no calculation errors, and all dollar amounts and timeframes match the ground truth. The mention of eliminating PBGC premiums, while not in the original answer, is a plausible detail and does not contradict the truth. (3) The multi-hop reasoning is sound: the answer synthesizes data across years (2021 transaction disclosed in 2022, continued strategy in 2023–2024) and correctly links pension transfers to financial impacts on earnings. (4) The only minor shortcoming is that the original answer emphasizes the ongoing nature of the strategy through 2024 with explicit mention of continued reductions and expected future actions, which the LLM summarizes but with slightly less emphasis on the forward-looking 2024 posture. However, the core message of continued evaluation and potential for future charges is preserved. Wording differs but semantic equivalence is maintained. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 374,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "In the 2022 Form 10‑K the only Executive Change‑In‑Control Retention Agreement listed was the one with CEO Marc N. Casper (Exhibit 10.12).  Beginning with the 2023 filing, Thermo Fisher added a separate retention agreement for other officers (Exhibit 10.17, filed with the April 2023 10‑Q).  The 2024 10‑K continues to include that officer‑retention form, showing the company’s shift from a single‑person agreement to a broader framework that covers officers beyond Casper.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution of Thermo Fisher Scientific's Executive Change In Control Retention Agreements from 2022 to 2024. It correctly notes that in 2022, only Marc N. Casper's agreement was listed (Exhibit 10.12), and that beginning in 2023, a new form for other officers was introduced (Exhibit 10.17, filed with the April 2023 10-Q), which was carried forward into the 2024 10-K. This reflects the core progression described in the ground truth: a shift from a CEO-specific agreement to a broader framework for officers beyond Casper. However, the LLM omits specific details about the prior form dated March 16, 2018, and does not mention that the 2023 form (April 1, 2023) was a new version replacing an older one—this nuance about the revision of an existing structure for non-Casper officers is missing. While the LLM correctly infers a strategic shift, it presents the 2023 introduction as entirely new, rather than an update to a pre-existing form for other officers. Dates and exhibits are accurately cited, and the multi-hop reasoning across years and filings is sound. The answer is contextually relevant and semantically close to the ground truth, but lacks full completeness regarding the prior existence of non-Casper forms, leading to a slightly simplified narrative. Hence, minor deductions in quantitative and qualitative accuracy, but high correctness and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 393,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2.750% Senior Note due 2051 is consistently listed in the board‑resolution exhibits of its 2022 and 2024 Form 10‑Ks (page 130) and cited in the 2023 10‑K as part of the 8‑K exhibit (page 129). By issuing this long‑term, fixed‑rate note at a relatively low 2.75 % coupon, the company locks in financing costs while keeping a diversified debt mix that also includes floating‑rate notes—an approach that lets it hedge against rising rates while securing stable, long‑term capital.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2.750% Senior Note due 2051 and its consistent treatment across 2022–2024 filings, aligning with the ground truth. The coupon rate (2.75%) and maturity year (2051) are accurate. However, the LLM incorrectly states that the note is listed on 'page 130' in both 2022 and 2024, while the ground truth specifies page 135 for 2022 and page 129 for 2024 (with 2023 on page 128). These page number discrepancies are minor but factually incorrect. (2) Quantitatively, all financial terms—2.750% coupon, 2051 maturity—are correct. No calculations are required, so numerical accuracy is high. Format variations (e.g., 2.75% vs 2.750%) are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly infers that maintaining a fixed-rate, long-term note in a rising rate environment allows PepsiCo to lock in low financing costs and diversify its debt structure. It appropriately connects the consistent disclosure of the note to a broader strategy of rate hedging and capital stability, even though it does not explicitly mention the introduction of higher-yielding notes like the 5.250% due 2054, which the ground truth uses to strengthen the argument. This omission slightly weakens the multi-hop synthesis but does not invalidate the conclusion. (4) The answer is contextually highly relevant, directly addressing PepsiCo’s long-term debt strategy in a rising rate environment. The core insight—that PepsiCo preserves access to fixed-rate, long-dated debt—is consistent with the ground truth. The qualitative accuracy is slightly reduced due to the lack of reference to newer, higher-yielding debt issues, which would have demonstrated a more complete cross-year comparison. Overall, the answer is factually strong and logically coherent, meriting a high correctness score with minor deductions for precision and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 513,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 were first issued in 2014 and are listed in Exhibit 4.4 of Apple’s 2022, 2023, and 2024 Form 10‑Ks, with no new issuances or amendments disclosed through 2024 [page_58] [page_53] [page_58]. The unchanged presence of this long‑term, fixed‑rate debt over three consecutive years underscores Apple’s strategy of locking in low‑cost, long‑maturity financing to support its liquidity and capital‑allocation plans over a multi‑decade horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.45% Notes due 2044, their inclusion in Apple's 10-K filings for 2022, 2023, and 2024, and the absence of new issuances or amendments through 2024. The reference to Exhibit 4.4 and the Officer's Certificate (implied via context) aligns with the ground truth. The issuance date (2014) is accurate. All numeric values—interest rate (4.45%), maturity year (2044), and filing years—are correct. (2) Quantitative accuracy is perfect: percentages, years, and document references (Exhibit 4.4) are factually sound and consistent with the knowledge graph. No calculations were required, but the temporal consistency across three years is correctly observed. (3) The multi-hop reasoning is strong: the model synthesizes data across three years of filings and infers Apple’s strategic intent—locking in low-cost, long-term financing—based on the unchanged status of the debt. This aligns with the ground truth’s conclusion about financial flexibility and fixed-rate retention. The only minor gap is the lack of explicit mention of the May 6, 2014 Officer's Certificate, which is part of the original answer but not strictly necessary for semantic completeness. (4) The answer is contextually relevant, fully addressing the evolution (or lack thereof) of the debt instrument and its implications for Apple’s capital strategy. Wording differs slightly but conveys equivalent meaning. A score of 9 is justified due to high factual accuracy and strong reasoning, with only a minor omission in documentary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 427,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan reduced its allocation to Collective Trust and Other Funds from **$622 million in 2022 to $382 million in 2023**—a decline of roughly $240 million. The 2024 filing explains that these commingled funds are valued at **net asset value (NAV) using the underlying publicly traded assets’ prices**, indicating that the plan relies on NAV‑based, independent pricing rather than direct market quotes to manage and monitor these investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 allocation amount—stating $622 million instead of the correct $756 million from the ground truth. This is a significant factual inaccuracy affecting the core quantitative claim. The 2023 figure ($382 million) is correct. The implied reduction of $240 million is close to the actual reduction of $374 million ($756M - $382M), but the incorrect base year value undermines the accuracy of the comparison. (2) Calculations: The stated decline of $240 million is inconsistent with both the LLM's own numbers (a true difference of $240M would require a 2022 value of $622M, which is wrong) and the ground truth difference of $374M. Thus, both the input numbers and the implied calculation are flawed. (3) Multi-hop reasoning: The LLM correctly identifies the two-year trend (decrease from 2022 to 2023) and appropriately references the 2024 filing’s disclosure on valuation methodology (NAV based on underlying assets). It draws a reasonable inference about reliance on NAV for monitoring, though it misses the ground truth’s deeper insight that the valuation method remained consistent, so the drop likely reflects portfolio rebalancing rather than methodological change. (4) Despite accurate mention of NAV and commingled funds, the major numerical error in the 2022 allocation reduces confidence in the answer’s factual foundation. The reasoning and relevance are strong, but the quantitative inaccuracy severely impacts overall correctness. Hence, correctness_score is 6 (partially correct with significant error), quantitative_accuracy is 5 (half credit due to one major number wrong), qualitative_accuracy is 7 (sound logic where facts are correct), and contextual relevance is 9 (fully addresses the question’s scope and intent).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 488,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple lists the Officer’s Certificate for the 1.05% Notes due 2017 as Exhibit 4.4 in every annual report – the 2022 filing (page 58) and the 2024 filing (page 58) both show the certificate, and the 2023 filing likewise lists Exhibit 4.4. By continuing to attach the original certificate for a note that has already matured, Apple demonstrates a deliberate policy of retaining full documentation for all debt issuances, ensuring that the historical capital‑structure information remains available for investors and regulators and supporting a consistent, auditable record of its financing history.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple included the Officer’s Certificate for the 1.05% Notes due 2017 as Exhibit 4.4 in its 10-K filings for 2022, 2023, and 2024, despite the notes maturing in 2017. The dates, percentages, and exhibit numbers are accurately represented. (2) Quantitative elements—specifically the 1.05% interest rate, the 2017 maturity date, and the consistent citation across fiscal years 2022–2024—are factually correct and match the original answer. Minor formatting differences (e.g., '2024 filing (page 58)' vs. general reference) do not affect accuracy. (3) The reasoning correctly infers that this reflects a deliberate documentation retention policy emphasizing transparency, historical continuity, and auditability—directly mirroring the original answer’s conclusion. The multi-hop synthesis—linking repeated inclusion of a matured debt exhibit to broader disclosure practices—is sound. (4) The only reason for not scoring a perfect 10 is the omission of the specific date of the Officer’s Certificate (May 6, 2014), which was included in the ground truth and adds minor but relevant detail. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 357,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan cut its corporate‑stock holdings sharply: from $1.11 billion in 2022 (≈37 % of plan assets) to $226 million in 2023 (≈7 %) and $181 million in 2024 (≈5 %)【page_58】. This decline mirrors the plan’s equity‑allocation targets, which fell from 48 % in 2022 to 24 % in 2023 and 20‑30 % in 2024, indicating a deliberate de‑risking strategy that reduces equity exposure in favor of higher‑quality debt and other assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dollar amounts and direction of change. The original answer states Union Pacific's allocation was $1,990 million in 2022, dropped to $181 million in 2023, then increased to $1,116 million in 2024. The LLM incorrectly reports $1.11 billion in 2022 (should be $1,990 million), $226 million in 2023 (should be $181 million), and $181 million in 2024 (should be $1,116 million) — reversing the trend in 2024. This misrepresents the evolution as a continued decline when it was actually a partial rebound. (2) Percentage allocations (37%, 7%, 5%) and equity targets (48%, 24%, 20-30%) are not present in the ground truth and appear fabricated or misattributed; no such percentages are in the original answer. (3) The reasoning about de-risking and shifting to fixed income aligns qualitatively with the original conclusion, showing some correct multi-hop synthesis regarding investment strategy. However, due to incorrect data, the logic is based on false premises. (4) The contextual relevance is moderate because the answer addresses pension plan allocation and investment strategy, but quantitative inaccuracy severely undermines correctness. Minor formatting variations like $1.11 billion vs $1,116 million are acceptable, but the sequence and values are fundamentally wrong. Thus, correctness and quantitative accuracy scores are low; qualitative reasoning receives partial credit for strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 408,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "MRK’s Prevymis sales climbed from **$428 million in 2022** to **$605 million in 2023** and **$785 million in 2024** (U.S. + international).  The roughly 40 % year‑over‑year jump in 2023 followed by a 30 % jump in 2024 signals growing uptake by transplant centers and hospitals, underscoring Prevymis’s rising strategic importance within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all sales figures are accurate: $428 million in 2022, $605 million in 2023, and $785 million in 2024. The percentage growth calculations are also correct—2023 represents a ~41.36% increase from 2022 (approximated as 'roughly 40%'), and 2024 shows a ~29.75% increase from 2023 (rounded to '30%'), which is reasonable for qualitative reporting. (2) The answer is complete, addressing both the sales evolution over the three years and interpreting the trajectory in terms of market adoption and strategic importance in the Hospital Acute Care segment. (3) Entity accuracy is perfect: MRK (Merck), product name Prevymis, correct time periods (2022–2024), and correct business segment are all correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model infers increasing market adoption from consistent growth and explicitly links it to strategic importance, aligning with the ground truth. The addition of 'U.S. + international' provides helpful context without contradicting the source. (5) Semantic equivalence is strong—the LLM conveys the same core message with enhanced analytical insight (growth percentages) while preserving factual integrity. No errors or omissions; the response exceeds expectations in clarity and depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 376,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "In each of PepsiCo’s 2022, 2023 and 2024 Form 10‑Ks the 3.000% Senior Note due 2027 is listed as Exhibit 4.3 and described simply as a “3.000% Senior Note due 2027.”  The description and exhibit reference remain unchanged across the three filings, showing that the note is still an active, long‑term debt instrument in the company’s portfolio.  This consistency underscores PepsiCo’s strategy of maintaining a stable, diversified mix of fixed‑rate senior notes to manage interest‑rate risk and preserve financing flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies and omits critical multi-hop analysis required by the question. (1) QUANTITATIVE ACCURACY: The interest rate (3.000%) and maturity year (2027) are correct, but the exhibit number is wrong—the note was listed as Exhibit 4.22 in 2022, 4.19 in 2023, and 4.17 in 2024, not consistently as Exhibit 4.3 across all years. This misrepresentation undermines factual reliability. (2) COMPLETENESS: The answer fails to address the evolution of the note’s characterization across filings—specifically, how its contextual presentation alongside other debt instruments changed over time. The original answer highlights that in 2022 it was grouped with medium-term notes, in 2023 with long-dated instruments, and in 2024 alongside newer short-term notes, indicating a strategic layering of maturities. This key insight is entirely missing. (3) ENTITY ACCURACY: While PepsiCo and the note details are correct, the exhibit references are inaccurate, suggesting possible confusion with different document versions or sources. (4) REASONING: The LLM concludes that the consistency in description reflects a stable debt strategy, which is partially valid, but it fails to recognize the nuanced evolution in context that reveals an adaptive strategy—maintaining fixed-rate liabilities while introducing lower-rate instruments. This multi-hop synthesis across years and associated debt instruments is absent. (5) SEMANTIC EQUIVALENCE: The answer captures the basic fact that the note remained active but misses the deeper strategic implications derived from its changing context. Thus, while it is relevant and conveys a plausible high-level interpretation, it lacks the detailed, evidence-based reasoning supported by exhibit-specific and cross-year comparisons. Correctness score is 4 due to major omissions in analysis and factual errors in exhibit numbers, despite correct identification of the note’s basic terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 531,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "In 2022, Frame.io was positioned as a cloud‑native collaboration platform that offered real‑time upload, review, approval, frame‑accurate commenting, annotations, camera‑to‑cloud, and support for still images, design files and PDFs, but was integrated only with Premiere Pro and After Effects [2022 page 12]. The same core capabilities and two‑app integration were carried forward into 2023 [2023 page 12]. By 2024, Adobe expanded Frame.io’s integration depth to include Photoshop, Lightroom and Workfront (in addition to Premiere Pro and After Effects), positioning it as a core component of Adobe GenStudio for scalable content production while preserving its original collaboration features [2024 page 12].",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct in terms of dates, features, and integration progression, with accurate entity and year references. It correctly identifies Frame.io's integration with Premiere Pro and After Effects in 2022 and 2023, and the expansion to Photoshop, Lightroom, and Workfront in 2024. It also accurately notes Frame.io's positioning within Adobe GenStudio for scalable content production. However, there is a significant factual discrepancy in the 2022 description: the original answer states that in 2022, Frame.io was only listed in Adobe's trademark portfolio—indicating formal branding alignment post-acquisition—but does not confirm functional capabilities or integrations at that time. The LLM incorrectly attributes detailed functional capabilities (real-time upload, review, approval, frame-accurate commenting, etc.) and integration with Premiere Pro and After Effects to 2022, which the ground truth only confirms for 2023. This misrepresents the evolution timeline and overstates 2022's integration depth. The 2023 and 2024 descriptions are largely consistent with the ground truth. Quantitative accuracy is perfect—no numbers or dates are incorrect. Contextual relevance is strong, addressing all aspects of the question. The reasoning is mostly sound but flawed in the multi-hop synthesis of the 2022 status, where it conflates later capabilities with earlier branding alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 388,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple disclosed its 2.40% Notes due 2023 in the 2022 Form 10‑K as part of the description of securities (Exhibit 4.3) and in the notes to the financial statements (page 58). The 2023 Form 10‑K continued to list the same notes in Exhibit 4.3, indicating they were still outstanding and due in 2023 (page 54). By the 2024 Form 10‑K, the 2.40% Notes no longer appear in the notes to the financial statements, implying they had been repaid or refinanced before the due date—showing Apple’s proactive strategy of refinancing or paying down maturing debt to keep its balance‑sheet profile strong (page 58).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 2.40% Notes due 2023 are correctly referenced in Apple's 2022 and 2023 10-K filings (Exhibit 4.3 and specified pages), and their absence in the 2024 10-K is accurately noted. All dates, percentages, and document references (e.g., Form 10-K, exhibit numbers, page numbers) are consistent with the ground truth, warranting a perfect quantitative accuracy score. Contextual relevance is high, as the answer directly addresses the evolution of disclosure from 2022 to 2024 and draws a conclusion about Apple's debt strategy. However, the qualitative accuracy is lower due to a critical misinterpretation in reasoning: while the ground truth concludes that Apple held the debt to maturity—indicating a 'hold-to-maturity' strategy—the LLM interprets the disappearance of the notes by 2024 as evidence of 'proactive refinancing or paying down before the due date,' implying early action. This contradicts the ground truth, which emphasizes no early retirement occurred in 2022 or 2023 and suggests repayment occurred at maturity. The LLM incorrectly infers proactive refinancing rather than recognizing the natural payoff at maturity, which reflects a flaw in multi-hop reasoning and strategic interpretation. Thus, while the facts are correct, the synthesis and conclusion are partially misaligned, leading to a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 387,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet stayed roughly the same size in 2022‑23 (7,008 units – 5,971 owned, 1,037 leased – with an average age of 24.3 years【page_19 (2023)】) but fell to 6,893 units (5,973 owned, 920 leased) and the average age rose to 25.2 years in 2024【page_19 (2024)】. The slight contraction in fleet size coupled with a modest increase in age over the three‑year span signals a deliberate asset‑management strategy that prioritizes replacing older locomotives with newer, more efficient units while maintaining a leaner, more productive fleet.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Union Pacific had 7,242 total Multiple Purpose Locomotives in 2022 (6,204 owned + 1,038 leased), but the LLM incorrectly reports 7,008 units (5,971 owned, 1,037 leased) for 2022, which misrepresents both total and component numbers. The 2024 numbers (6,893 total, 5,973 owned, 920 leased) are correct in the LLM answer. However, the average age in 2022 was 22.5 years (not mentioned in LLM), and in 2023 it was 24.3 years — the LLM incorrectly applies the 24.3-year age to 2022–2023 without specifying 2022 data and omits the 2023 data point entirely. Instead, it implies 24.3 years was the age in both 2022 and 2023, which is factually incorrect. (2) Calculations: The LLM fails to report the correct 2022 fleet size and age, and misattributes the 24.3-year average age to a two-year span rather than correctly assigning 22.5 (2022), 24.3 (2023), and 25.2 (2024). This undermines the multi-year progression. (3) Multi-hop reasoning is partially sound — the LLM recognizes a trend of declining fleet size and increasing age — but draws an incorrect conclusion. The ground truth suggests a conservative strategy with lack of new investment, while the LLM claims a strategy of replacing older units with newer, more efficient ones, which contradicts the aging trend and fleet reduction. This misinterpretation stems from incorrect data synthesis. (4) Scores justified: Correctness is 5 due to partial accuracy in 2024 data but major errors in 2022–2023 figures and trend description. Quantitative accuracy is 5 because half the numbers are wrong. Qualitative accuracy is 5 due to flawed reasoning based on incorrect data. Contextual relevance is 8 because the answer addresses the right topic and structure, even if facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 498,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "Merck’s MK‑8591A program entered Phase 3 in 2023, but a clinical hold imposed by the FDA in December 2021—triggered by observed decreases in lymphocyte and CD4⁺ T‑cell counts—kept enrollment in both Phase 2 and Phase 3 studies paused through 2022 and 2023 (page_21, page_23, page_24). After addressing the FDA’s safety concerns, the agency lifted the hold on December 4 2024, allowing the program to resume (page_26).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It states that MK-8591A entered Phase 3 in 2023, but the ground truth indicates it entered Phase 3 in February 2020. This is a major error in timeline accuracy. The FDA clinical hold was correctly attributed to safety concerns (lymphocyte and CD4+ T-cell decreases), but the LLM incorrectly states the hold was lifted on December 4, 2024—while the original answer confirms the hold was lifted in 2024, no specific date is given, and only a partial hold remained for higher doses. The LLM omits the key development of MK-8591D entering Phase 3 in October 2024, which reflects a strategic shift and is a critical part of Merck’s evolving trajectory. (2) Quantitatively, the dates are partially correct: the hold was indeed imposed in December 2021 and lifted in 2024, but the exact December 4, 2024 date is not in the ground truth and appears to be over-specified. The entry into Phase 3 is misdated (2023 vs. 2020), which is a significant error. (3) The reasoning is partially sound in linking the clinical hold to paused enrollment, but fails to capture the multi-hop synthesis required: the persistence of Phase 3 status from 2022–2023, the lack of regulatory advancement, and the strategic pivot with MK-8591D. The answer focuses narrowly on the hold and its lifting without addressing the broader developmental evolution. (4) Contextual relevance is high—the answer addresses clinical phases and FDA interactions as asked—but due to factual and completeness gaps, especially the omission of MK-8591D and incorrect Phase 3 start, the overall correctness is significantly reduced. Minor point: citing 'page_21, page_23' etc. suggests document retrieval but does not affect factual scoring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 478,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "In 2022, Merck listed MK‑1308A (quavonlimab + pembrolizumab) as a combination for advanced solid tumors, with no specific renal‑cell carcinoma (RCC) indication (MRK_10k_2022, p. 25). By 2024, the company repositioned the co‑formulation as a dedicated RCC therapy, describing it as “being evaluated for the treatment of RCC” within its immuno‑oncology portfolio (MRK_10k_2024, p. 50). This shift from a broad solid‑tumor focus to a specific RCC indication underscores Merck’s intensified strategy to expand its RCC pipeline with novel combination immunotherapies and highlights the company’s growing emphasis on RCC treatment innovation.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies MK-1308A as a co-formulation of quavonlimab and pembrolizumab and notes its evaluation in RCC by 2024, which aligns with the ground truth. However, it inaccurately claims that in 2022, MK-1308A was listed for 'advanced solid tumors' with no specific RCC indication, directly contradicting the ground truth that Merck already listed it under Phase 3 programs for RCC in 2022 with an entry date of April 2021. This misrepresents the timeline and strategic positioning. Additionally, the LLM introduces a 'shift from broad solid tumor to RCC-specific' narrative not supported by the original answer, which instead describes consistent RCC focus since 2022. (2) Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) to verify, but the years (2022, 2024) are correctly used as reference points. The document citations (MRK_10k_2022, MRK_10k_2024) are plausible but not verifiable here; their use does not contradict the evaluation. (3) The multi-hop reasoning is flawed: the model fails to recognize that Merck’s focus on RCC with MK-1308A began in 2022, not 2024, undermining the synthesis across years. The conclusion about a strategic 'repositioning' is therefore based on incorrect premise. (4) Despite the incorrect trajectory narrative, the answer captures Merck’s growing emphasis on RCC and combination immunotherapies, giving it partial credit for thematic relevance. Hence, correctness is scored mid-range due to significant factual error in the evolution timeline, even though the general direction of strategic focus is plausibly interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 459,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023, and 2024 all list the 4.000% Notes due 2021 as part of Exhibit 4.6 (the Third Supplemental Indenture dated February 8, 2011) and the description remains unchanged across the three filings [page_104]. The unchanged disclosure indicates that the note, which matured in 2021, is retained only for historical reference, and that Microsoft’s long‑term debt structure is stable, with a conservative refinancing strategy that focuses on long‑term planning rather than frequent restructuring [page_104]. This consistency suggests that Microsoft prioritizes long‑term debt stability and does not routinely refinance older maturities, instead issuing new debt with longer maturities to manage its capital structure [page_104].",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Microsoft's 4.000% Notes due 2021 were consistently disclosed in the 2022, 2023, and 2024 10-K filings under Exhibit 4.6 (Third Supplemental Indenture), which aligns with the ground truth. However, the LLM incorrectly states that the Third Supplemental Indenture is dated February 8, 2011, while the ground truth clarifies that the 8-K filing on that date is referenced in the disclosure — not that the indenture itself was dated then. The original Indenture is correctly noted as May 18, 2009, in the ground truth, but this nuance is missing in the LLM answer. (2) Quantitatively, the percentage (4.000%), maturity year (2021), exhibit number (4.6), and referenced 8-K date (February 8, 2011) are all accurate. The error lies in misattributing the February 8, 2011 date to the Supplemental Indenture’s execution rather than correctly identifying it as a filing date for disclosure purposes. This is a factual misrepresentation, though not a numerical inaccuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that unchanged disclosures suggest no refinancing or restructuring, and it reasonably concludes that Microsoft maintains a stable long-term debt structure. However, the interpretation that the note is retained 'for historical reference' goes beyond the ground truth, which does not speculate on the purpose of retention. The claim about a 'conservative refinancing strategy' and 'issuing new debt with longer maturities' introduces assumptions not supported by the provided ground truth, which only states there were no material changes. (4) The correctness score is 7 because core facts (exhibit, note terms, consistency) are accurate, but there is a meaningful misstatement about the indenture date and unsupported strategic interpretations. Quantitative accuracy is 8 due to correct numbers but a minor contextual error in date usage. Qualitative accuracy is 7 due to correct synthesis but overinterpretation. Contextual relevance is 9 — the answer directly addresses the question and remains focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 563,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s 2022 10‑K positioned the company as a key player in automotive connectivity, digital cockpit and ADAS/AD, reporting $1.509 B in automotive revenue (which includes digital‑cockpit products). That segment grew to $1.872 B in 2023 and to $2.910 B in 2024—an almost 93 % increase—highlighting a shift from a chip‑centric supplier to a comprehensive digital‑cockpit and software‑defined vehicle platform provider, and signaling Qualcomm’s broader transformation toward OTA‑enabled, software‑centric automotive solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative domain. The ground truth does not provide specific revenue figures for Qualcomm's automotive segment in 2022, 2023, or 2024, nor does it mention a $1.509B, $1.872B, or $2.910B revenue in any year. These numbers are fabricated or hallucinated. The 93% increase cited is therefore also incorrect, as it is based on false inputs. (2) There is no mention in the original answer of OTA-enabled solutions or software-centric platforms as explicit strategic shifts, though the general direction toward software-defined vehicles is aligned. The original answer emphasizes structural and reporting changes (e.g., digital cockpit becoming a distinct revenue stream in 2023, integration into QCT in 2024), which the LLM answer omits entirely. (3) The multi-hop reasoning is partially sound in that the LLM attempts to trace a strategic evolution, but it fails to accurately reflect the actual progression described in the ground truth: the key milestones are organizational and reporting-related (e.g., formal categorization in 2023, operationalization in 2024), not revenue growth-driven. The LLM incorrectly bases its conclusion on financial growth that is not present in the source. (4) While the general theme of transformation toward digital cockpit and software-defined vehicles is contextually relevant and captures the spirit of the question, the reliance on incorrect data severely undermines factual correctness. The answer substitutes real strategic indicators (reporting structure, product line maturity) with invented financial metrics, leading to a misleading narrative. Thus, despite contextual relevance and some qualitative alignment, the answer scores low on quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 491,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT’s variable‑rate swap activity grew markedly after 2022.  The company’s 2023 and 2024 10‑Ks report an aggregate notional amount of $1.3 billion for outstanding interest‑rate swaps, a jump from the $500 million noted for 2021 (the 2022 filing does not list a separate figure, implying a modest or no swap position that year)【page_52】【page_66】.  The steady $1.3 billion level in 2024 shows that LMT has adopted a consistent, active hedging strategy—converting fixed‑rate debt to variable‑rate exposure to manage fair‑value risk—rather than a one‑off or fluctuating approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline: it states that the $500 million notional amount was reported for 2021, not 2022 as per the ground truth. This misalignment undermines the quantitative accuracy and distorts the trend analysis. The ground truth clearly states that LMT had $500M in 2022, rising to $1.3B in 2023 and holding steady in 2024. The LLM incorrectly claims the 2022 filing 'does not list a separate figure,' which contradicts the original answer and implies a gap that isn't present. (2) The dollar amounts themselves ($500 million and $1.3 billion) are correct in value but misattributed to the wrong years. The calculation of a 'jump' is directionally correct but based on flawed year assignments. The fourfold increase from 2022 to 2023 is accurate in the original (from $500M to $1.3B ≈ 2.6x, though 'fourfold' is an overstatement), but the LLM does not quantify the change and instead relies on vague 'markedly grew' language. (3) The reasoning about LMT adopting a consistent hedging strategy by converting fixed-rate debt to variable-rate exposure is semantically aligned with the original and reflects sound qualitative understanding of interest rate risk management. The conclusion that the stable 2024 amount indicates a new baseline is correct and well-reasoned. However, the multi-hop synthesis fails due to incorrect temporal grounding—using 2021 instead of 2022 breaks the causal chain. (4) The contextual relevance is high because the answer addresses both parts of the question: evolution over time and strategic implications. Despite the factual error, the explanation of risk management strategy is coherent and relevant. Correctness score is 6 due to significant but not total factual inaccuracy in the time series; qualitative reasoning and strategic interpretation remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 502,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft consistently reported the 3.950% Notes due 2056 as part of its long‑term debt in the 2022, 2023, and 2024 10‑K filings (Exhibit 4.14).  The notes were not marked as retired or refinanced in any filing, indicating that Microsoft keeps this instrument on its balance sheet and plans to manage the maturity through future refinancing or repayment rather than early retirement.  This reflects a deliberate long‑term debt‑maturity strategy that extends maturities into the 2050s while maintaining a cautious refinancing approach (page_105).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are correctly identified, and their consistent presence in the 2022, 2023, and 2024 10-K filings is accurately noted. The maturity date (2056), interest rate (3.950%), and lack of refinancing or retirement are all factually sound. The reference to Exhibit 4.14 (though not in the ground truth) is plausible and does not contradict. (2) Quantitative elements—interest rate and maturity year—are exact matches; no calculations were required. (3) The reasoning is strong: the LLM correctly infers that Microsoft is maintaining long-term debt without early redemption, reflecting a strategy of long-duration financing. It appropriately contrasts this with other notes (though less explicitly than the ground truth, which names specific other tranches like the 2.000% Notes due 2023). The conclusion about future refinancing or repayment is logically sound. (4) The answer is contextually relevant and directly addresses the question about debt maturity management and refinancing strategy. The only minor shortcoming is the lack of reference to the Eleventh Supplemental Indenture (August 8, 2016), which adds specificity to the debt's origin and supports the multi-hop synthesis in the ground truth. While not critical to the core insight, its omission slightly reduces qualitative completeness. Overall, the answer captures the strategic implication accurately and is semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 422,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all cite the Eleventh Supplemental Indenture (dated August 8 2016) because it is the legal framework that governs the 3.700 % Notes due 2046 (and other long‑term notes).  The repeated reference shows that Microsoft has not amended or replaced that indenture, so the 2046 notes remain subject to the same covenants and terms, underscoring a stable, long‑term debt structure and a consistent pattern of financial‑obligation disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is dated August 8, 2016, it governs the 3.700% Notes due 2046, and it is consistently referenced in Microsoft's 2022, 2023, and 2024 filings. These dates, percentages, and document titles match the original answer exactly. (2) Quantitative accuracy is perfect: the percentage (3.700%), year (2046), and date (August 8, 2016) are all correctly stated with no calculation errors. (3) The reasoning is sound: the LLM correctly infers that the repeated reference indicates no amendments or replacements, reflecting stability in Microsoft's long-term debt structure. It captures the multi-hop logic—linking consistent disclosure across years to ongoing obligations under a stable legal framework. (4) While the LLM answer is concise, it omits a minor but relevant detail from the ground truth: the base Indenture dated May 18, 2009, and the broader layered financing structure. This contextual depth enhances understanding of the debt hierarchy but is not essential to the core conclusion. Despite this slight omission, the answer conveys semantic equivalence and reflects accurate, relevant, and logically sound reasoning. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 360,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft disclosed the 2.125% Notes due 2021 in its FY 2022 and FY 2023 10‑Ks as part of its debt schedule (Exhibit 4.1 – “Seventh Supplemental Indenture for 2.125% Notes due 2021 and 3.125% Notes due 2028”)【page_104】.  By FY 2024 the notes were no longer reported as outstanding, indicating they had been repaid or refinanced【page_104】.  This change shows Microsoft is actively managing its debt portfolio by retiring or refinancing older, higher‑rate notes to reduce interest expense and improve leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The key error is the claim that the 2.125% Notes due 2021 were 'no longer reported as outstanding' in FY2024, which directly contradicts the ground truth: the notes were still referenced in Exhibit 4.1 of the FY2024 10-K (page 104), indicating continued disclosure. The LLM incorrectly infers repayment or refinancing based on absence, but the ground truth states the instrument remained listed across all three years. (2) Quantitative accuracy is partially correct—the note's interest rate (2.125%) and maturity year (2021) are accurate, and the exhibit number (4.1) and page (104) are correctly cited for 2023 and 2024. However, the LLM misrepresents the content of the FY2024 filing, making a critical factual error. (3) Reasoning is flawed: the conclusion that Microsoft 'retired or refinanced' the notes is unsupported by the evidence provided in the ground truth, which explicitly states the continued listing raises questions about refinancing or reporting lags. The LLM fails to acknowledge the ambiguity or alternative explanations (e.g., disclosure requirements for historical instruments). (4) Contextual relevance is moderate—the response addresses the question's structure and attempts to interpret debt management strategy, but the incorrect premise leads to a misleading conclusion. Overall, the answer fails on core factual accuracy despite correct citation formatting and partial entity recognition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 413,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft issued the 2.000 % Notes due 2023 in the Eleventh Supplemental Indenture dated August 8 2016 (Exhibit 4.14).  The notes remained on the balance sheet through FY 2022 and FY 2023, maturing in 2023, and were no longer outstanding in FY 2024, showing that the company uses long‑term, low‑interest debt and systematically retires it as it matures to keep leverage and refinancing risk low. (Exhibit 4.14, page 105)",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of the 2.000% Notes due 2023 under the Eleventh Supplemental Indenture on August 8, 2016, matching the ground truth. It accurately states that the notes were present in FY 2022 and FY 2023 and were no longer outstanding in FY 2024, which aligns with the maturity in 2023. All dates, percentages, and fiscal years are factually correct. (2) Quantitative accuracy is perfect: the interest rate (2.000%), issuance date (August 8, 2016), and maturity (2023) are all correct, and the fiscal year references (2022, 2023, 2024) are consistent with the timeline. (3) The multi-hop reasoning is mostly sound—correctly inferring that the debt was retired upon maturity. However, the ground truth emphasizes that the *continued referencing* of the same indenture across filings indicates stability and lack of early refinancing, while the LLM interprets this as a strategy of systematic retirement to reduce refinancing risk. This is a reasonable inference but slightly overreaches the evidence; the filings show consistency in disclosure, not necessarily an intentional low-leverage strategy. The original answer does not mention refinancing risk, so this addition, while plausible, is not directly supported. (4) The answer is contextually relevant and addresses all parts of the question—evolution across years and strategic implication—though the strategic interpretation is slightly more speculative than the ground truth. Hence, minor deduction in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 427,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "From 2022 through 2024 Lockheed Martin kept the same overall scale of pension‑risk‑transfer activity – roughly $11.6 billion of defined‑benefit obligations have been transferred since 2018, covering about 95,000 retirees, with the most recent large transfer being the 2021 GAC purchase of $4.9 billion that generated a $1.7 billion non‑cash settlement charge. No new large transfer or settlement charge was disclosed in 2024, so the financial impact has remained essentially unchanged. The company’s stated strategy is to continue evaluating additional GAC purchases to reduce pension volatility and PBGC premiums, while acknowledging that future transactions could trigger further non‑cash settlement charges and additional contributions to the pension trust.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its factual content but contains a minor inaccuracy regarding the timeline and evolution of Lockheed Martin's pension risk transfer strategy. It correctly states that $11.6 billion in obligations have been transferred since December 2018 and references the August 2021 transaction of $4.9 billion with a $1.7 billion noncash charge. However, it incorrectly implies no new transfers occurred in 2024, while the ground truth indicates that by 2024, the company had continued the strategy and reaffirmed intent to pursue further transactions—though no specific new dollar amount was disclosed. The LLM interprets lack of disclosure as no activity, which may misrepresent the continuity of the strategy. (2) Quantitatively, all numbers are accurate: $11.6 billion total transferred, $4.9 billion in 2021, $1.7 billion charge, and correct linkage to PBGC premium reduction (implied via context). The 95,000 retirees figure is not in the original answer but may come from external knowledge; since it doesn't contradict and is plausible, it doesn't penalize heavily. (3) The multi-hop reasoning is sound—LLM synthesizes info across years and connects GACs to financial impacts and strategic intent. However, it underemphasizes the evolution: the original answer highlights increasing clarity and consistency in strategy through 2024, which the LLM downplays by stating 'no new large transfer...disclosed in 2024' without acknowledging ongoing evaluation and reaffirmation as part of strategic continuity. (4) Scores reflect high accuracy in numbers and relevance, with slight deduction in correctness and qualitative reasoning for missing the nuance of strategic progression and overinterpreting silence on new transactions as lack of evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 486,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s 10‑K filings consistently list the Floating Rate Notes due 2019 in the officer’s certificate of securities (see page 56 of each filing).  This shows the debt is still outstanding and remains part of Apple’s long‑term debt mix, indicating a strategy that includes floating‑rate instruments to manage interest‑rate exposure.  The repeated reference also signals a disciplined maturity‑management approach, with Apple likely planning to refinance or repay the 2019 notes when they mature, taking advantage of favorable market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error: it claims the Floating Rate Notes due 2019 are still 'outstanding' and 'remain part of Apple’s long-term debt mix' as of 2022–2024 filings. This contradicts the ground truth, which clarifies that the notes matured in 2019 but were still referenced in later filings for transparency or disclosure continuity. The LLM incorrectly infers ongoing outstanding status, which is factually wrong—debt due in 2019 cannot remain outstanding through 2024. (2) Quantitatively, the years (2019, 2022–2024) are correctly cited, and no numerical calculations are required, so the score is acceptable on dates. However, the misinterpretation of the debt's status undermines factual accuracy. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that continued disclosure does not imply continued outstanding debt. The correct inference (per ground truth) is that Apple maintains transparency about past debt instruments as part of a refinancing or rollover strategy, not that the debt is still active. The LLM instead assumes the debt remains on the books, leading to an incorrect conclusion about Apple’s use of floating-rate instruments in its current capital structure. (4) Contextual relevance is high—the response addresses capital structure, refinancing strategy, and interest rate management—but the core factual misunderstanding severely limits correctness. The qualitative reasoning is thus partially sound but built on a false premise, resulting in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 427,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft lists the 4.000 % Notes due 2021 in Exhibit 4.6 (the Third Supplemental Indenture) in each of its 2022, 2023, and 2024 10‑K filings [page_104]. The description and placement of the note remain unchanged across the three years, indicating that the instrument has not been retired or repaid and continues to be a material component of Microsoft’s debt portfolio [page_104]. This persistence underscores the ongoing relevance of the 4.000 % Notes due 2021 in the company’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the 4.000% interest rate, the 2021 maturity date, and the consistent inclusion in Exhibit 4.6 across 2022, 2023, and 2024 filings are factually accurate. The reference to page 104 is acceptable as a formatting or source detail and does not affect factual correctness. (2) The answer correctly identifies that the notes were still referenced post-maturity, which matches the ground truth assertion that they remained in disclosures despite maturity. (3) The reasoning is sound: the LLM infers ongoing materiality and structural relevance from the consistent inclusion, which is logically supported by the evidence. The only minor shortcoming is that it states the notes 'have not been retired or repaid' with more certainty than the ground truth, which cautiously suggests 'likely still outstanding or held ongoing legal or structural relevance.' The ground truth allows for the possibility of post-maturity structural relevance (e.g., covenants), whereas the LLM leans toward the note still being an active debt instrument. This is a subtle but important distinction in financial disclosures. (4) Despite this nuance, the answer captures the core insight about ongoing relevance in Microsoft's capital structure and exhibits strong multi-hop reasoning by synthesizing exhibit data across three years. Wording differs but semantic meaning is equivalent. All entities (Microsoft, 4.000% Notes due 2021, 10-K filings, Exhibit 4.6) are correct. Thus, the answer earns a 9 for correctness and qualitative accuracy, 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 457,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "In 2022 UPS listed the 7.620 % debentures only with principal, maturity and the note that the rate had been cut to 7.620 % in 2020 (page 118).  By 2023 the company expanded the disclosure to include full redemption terms—redeemable at option at the greater of principal + accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus 5 bps—and stated that interest was paid semi‑annually with no sinking‑fund requirement (page 105).  The 2024 filing repeated those same terms unchanged (page 108) and the debentures remained a small, stable component of UPS’s debt, carrying about $280 million within a $22.5 billion total debt load and $18.9 billion long‑term debt (pages 106 and 103).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 7.620% debentures, $276 million principal (approximated as $280 million book value in 2023 and 2024), maturity in 2030 (implied), redemption terms (greater of principal plus accrued interest or present value at treasury yield plus 5 bps), and semi-annual interest payments with no sinking fund. The dollar amounts are consistent with the original answer—$280 million book value in 2023 and 2024 matches the ground truth. The mention of a $22.5 billion total debt and $18.9 billion long-term debt in 2024 adds contextual detail not in the original but is factually appropriate and enhances positioning. (2) Quantitative accuracy is perfect: percentages, redemption mechanics, and financial figures are correctly reported. The $280 million book value is accurately carried across years. (3) The multi-hop reasoning is sound—LLM correctly traces the evolution of disclosure from minimal (2022) to expanded (2023) to stable (2024), capturing the shift in focus from historical rate change to structural details. It correctly identifies the increasing detail in disclosure, though it does not explicitly note the 2024 emphasis on comparative treatment within international debt (e.g., Pound Sterling, Euro notes), which is a minor omission. (4) Contextual relevance is excellent—the answer directly addresses redemption terms, interest structure, and debt positioning across all three years. The only reason for not scoring 10 is the slight lack of emphasis on the 2024 contextual shift toward global debt portfolio integration, which was highlighted in the original answer. Overall, the LLM answer is factually robust, well-structured, and semantically equivalent to the ground truth with minor qualitative nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 493,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "Vraylar, launched in 2020, generated $2.68 million in 2022 (page 62) and grew 35 % to $2.76 million in 2023, driven by market‑share gains and FDA approval as an adjunctive therapy for major depressive disorder (page 44). The 2024 10‑K continues to list Vraylar as a core neuroscience product and outlines AbbVie’s ongoing marketing and distribution strategy through its global commercial network (page 8), underscoring the company’s commitment to expanding this asset. This steady revenue growth and sustained investment signal that Vraylar is a strategically important growth lever within AbbVie’s neuroscience portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states Vraylar generated $2.68 million in 2022 and $2.76 million in 2023, which is off by a factor of 1,000—the correct figures are $2,759 million (i.e., $2.759 billion) in 2023 with a 35.4% year-over-year increase. The LLM incorrectly reports millions instead of billions, a critical error in financial context. While the 35% growth figure is approximately correct (aligned with 35.4%), the base numbers are wildly inaccurate. (2) The LLM incorrectly claims Vraylar generated $2.68 million in 2022, but the ground truth does not provide 2022 revenue—only 2023 revenue and growth rate. From the 35.4% growth, 2022 revenue should be approximately $2,038 million, not $2.68 million. This suggests the model misread or misreported the data. (3) Qualitatively, the LLM correctly identifies Vraylar’s strategic importance, its indications (including adjunctive use in MDD), and AbbVie’s ongoing commercial commitment. It appropriately infers that revenue growth and sustained investment reflect strategic importance. However, it omits key 2022 clinical trial results (one positive, one not statistically significant) that were central to the product’s development trajectory. (4) Contextually, the answer addresses the evolution and strategic importance, but fails to fully synthesize the multi-hop elements—linking clinical results in 2022 to commercial performance in 2023 and strategic positioning in 2024. The reasoning is partially sound but undermined by severe numerical errors. The mention of 'page 62' and 'page 44' suggests reliance on document excerpts but with critical misinterpretation of units. Overall, core strategic interpretation is valid, but factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 480,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023, and 2024 all list the 0.45% Notes due 2016 in the Officer’s Certificate (see page 56 in each filing).  The repeated disclosure shows that the company’s long‑term debt portfolio still contains legacy instruments that are tracked and reported, and that Apple follows a disciplined disclosure policy that includes every outstanding maturity—regardless of age—to keep investors fully informed.  This consistency signals a diversified debt structure and a commitment to transparent reporting of all legacy debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.45% Notes due 2016 and their inclusion in Apple's 10-K filings for 2022, 2023, and 2024, as well as referencing the Officer's Certificate, which aligns with the ground truth. The quantitative elements—interest rate (0.45%), maturity year (2016), and filing years (2022–2024)—are all accurate, warranting a high quantitative accuracy score. (2) However, the LLM incorrectly implies that these notes are still part of Apple's 'outstanding' or 'active' long-term debt portfolio, stating that 'the company’s long-term debt portfolio still contains legacy instruments' and that disclosures include 'every outstanding maturity.' This is factually wrong: the notes matured in 2016 and are no longer outstanding. The ground truth emphasizes that their inclusion is for historical transparency, not because they remain active obligations. (3) The multi-hop reasoning is partially sound—linking repeated disclosure to transparency and investor communication—but flawed in interpretation. The LLM fails to recognize that the persistence of the exhibit is due to static legal documentation (Exhibit 4.3 being retained for record-keeping) rather than an indication of current debt structure. It misattributes the reason for disclosure, suggesting ongoing tracking of 'outstanding' maturities when in fact the instrument is retired. (4) Despite this key factual misinterpretation, the answer captures Apple’s consistent disclosure strategy and intent to inform investors, which is contextually relevant and partially aligned with the ground truth. Hence, correctness is reduced due to a significant qualitative error in reasoning, even though core facts (dates, percentages, exhibit reference) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 476,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "UPS SurePost has remained a residential‑ground service for non‑urgent, lightweight shipments throughout 2022‑24, using UPS’s ground fleet for pickup and sorting and relying on the U.S. Postal Service for final delivery.  In each filing it is positioned as a low‑cost, residential option within the U.S. Domestic Package segment, and UPS reaffirmed that it would insource the service in 2025 to gain greater control over the delivery process【page_5 (2022)】【page_5 (2023)】【page_5 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of UPS SurePost from 2022 to 2024. (1) It correctly states that UPS SurePost remained a residential ground service for non-urgent, lightweight shipments throughout the period, using UPS for initial transport and USPS for final delivery—consistent with the ground truth for 2022 and 2023. It accurately notes the 2025 insourcing shift announced in 2024, which marks a strategic change in delivery methodology. (2) Quantitatively, all dates (2022–2024, 2025 effective date) are correct, and no numerical inaccuracies are present. The format of referencing the insourcing announcement aligns with the original answer. (3) The multi-hop reasoning is sound: the model synthesizes consistent descriptions across three years and correctly identifies the strategic shift announced in the 2024 filing. The only minor omission is that the original answer explicitly frames the 2024 announcement as a 'strategic transformation' and links it to service quality and differentiation, which the LLM implies but does not fully elaborate. (4) Contextual relevance is excellent—the response directly addresses delivery methodology and strategic positioning within the U.S. Domestic Package business as required. Wording differs slightly but maintains semantic equivalence. No factual errors; minor depth difference in strategic interpretation prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 390,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 were first issued in 2014 as part of a global notes offering (see Exhibit 4.4 in the 2022 10‑K).  The 2024 10‑K continues to list the same 4.45 % Notes as outstanding long‑term debt, with no new issuances or repurchases reported in the 2022, 2023 or 2024 filings (see Exhibit 4.4 in the 2024 10‑K).  The steady, unchanged presence of these long‑dated, fixed‑rate notes over multiple years signals Apple’s long‑term capital strategy of maintaining a stable, low‑cost debt base to support operations, share‑repurchase and dividend programs while preserving financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were issued in 2014 (via the Officer's Certificate referenced in filings), and they remained outstanding in 2022, 2023, and 2024 with no reported repurchases or new issuances during that period. The mention of Exhibit 4.4 in both the 2022 and 2024 10-Ks is consistent with SEC filing practices. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance year (2014)—are all accurate. No calculations were required, but the temporal consistency across years is correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer a strategic pattern—stable long-term debt usage—despite no explicit statement of strategy in any single filing. The conclusion about maintaining a 'stable, low-cost debt base' and supporting share repurchases/dividends aligns with Apple's known capital allocation strategy, even if slightly more detailed than the original answer; however, this added context is reasonable and consistent with public knowledge. (4) The only minor gap is that the LLM answer does not explicitly reference the repeated inclusion of the Officer's Certificate as evidence of continuity, which is a nuance highlighted in the ground truth. However, the core reasoning and factual content are substantively equivalent. Overall, the answer is highly accurate, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 419,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle’s 2.875% notes due 2031 were first disclosed in the 2022 10‑K as part of Exhibit 4.16, a set of notes with varying maturities【page 114】.  In the 2023 and 2024 10‑Ks the same notes appear in Exhibit 4.14, a different grouping that also contains the 1.650% and 2.300% notes due 2026 and 2028【page 111】.  This shift and the continued placement in Exhibit 4.14 demonstrate Oracle’s deliberate, stable debt‑management approach—grouping similar long‑term notes together to maintain a predictable maturity profile and interest‑rate exposure over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) QUANTITATIVE/ENTITY INACCURACY: The LLM incorrectly states that the 2.875% Notes due 2031 were listed as Exhibit 4.16 in the 2022 10-K, whereas the ground truth confirms they were consistently Exhibit 4.14 across 2022, 2023, and 2024. This misstatement of exhibit numbers—critical identifiers in SEC filings—is a major factual error. Additionally, the claim that the 2022 filing grouped the notes in Exhibit 4.16 with 'varying maturities' is unsupported and contradicts the ground truth of consistent positioning. (2) REASONING FLAW: The LLM infers a 'shift' in exhibit numbering as evidence of a deliberate strategy, but this shift did not occur. The reasoning is therefore based on a false premise. The ground truth emphasizes the *lack* of change as indicative of stability, while the LLM constructs a narrative around a non-existent reorganization. (3) COMPLETENESS: While the answer attempts to address Oracle's debt strategy, it misses the key point that the Notes' terms were unchanged and originally established in March 2021 under an Officers' Certificate—a critical detail in the original answer that supports the stability narrative. (4) SEMANTIC EQUIVALENCE: The LLM’s conclusion about a 'stable debt-management approach' aligns thematically with the ground truth, but it is derived from incorrect data, making the conclusion invalid. The contextual relevance is moderate because the answer discusses the right topic (debt strategy, exhibit grouping), but the factual foundation is flawed. Overall, the answer fails on core factual accuracy despite some surface-level plausibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 456,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement increased benefit rates for Teamsters employees in the UPS/IBT Full‑Time Employee Pension Plan, raising pension benefit accruals and resulting in a net periodic benefit cost of $1,212 million for 2023 versus a negative cost in 2022 (page 82–83). In 2024 UPS continues to accrue benefits under the same plan, with a 5.88 % discount rate and a 7.17 % expected return on plan assets (page 86–88), indicating that the company’s long‑term pension obligations remain sizable and are driven by collective‑bargaining‑based benefit adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims a 'net periodic benefit cost of $1,212 million for 2023 versus a negative cost in 2022,' which is not supported by the ground truth. The original answer does not mention any specific dollar amounts or net periodic benefit costs, nor does it reference a negative cost in 2022. These figures and comparisons are fabricated or misattributed, severely undermining factual accuracy. (2) The percentages cited—5.88% discount rate and 7.17% expected return on plan assets—are not mentioned in the ground truth and cannot be verified as correct based on the provided information. While such metrics may appear in actual disclosures, their inclusion here introduces unverified specifics that were not part of the known facts. (3) Qualitatively, the LLM correctly identifies that the 2023 Teamsters agreement increased benefit rates and impacted pension accruals under the UPS/IBT Full-Time Employee Pension Plan, and that these changes influence long-term obligations. It also correctly infers that UPS continues to operate under the same plan structure in 2024, aligning with the ground truth’s point about no structural changes. This shows sound multi-hop reasoning in connecting collective bargaining outcomes to pension accruals and long-term liabilities. (4) Contextually, the response is highly relevant, addressing both parts of the question: the impact of the 2023 agreement on accruals and what this reveals about long-term obligations. However, the addition of unsourced numerical data reduces overall correctness despite accurate conceptual framing. The core reasoning is valid, but the inclusion of unsupported quantitative details results in a partially incorrect answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 479,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023, and 2024 all list the 1.05% Notes due 2017 in the Officer’s Certificate (May 6 2014) section (see 2022 p. 56, 2023 p. 53, 2024 p. 56) with no change to the description or status. This unchanged disclosure shows that Apple treats all short‑term debt issued under the 2014 certificate as part of its long‑term debt reporting framework, maintaining consistent transparency and regulatory compliance even after the notes have matured or been repaid.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Apple's disclosure of the 1.05% Notes due 2017 remained unchanged across the 2022, 2023, and 2024 10-K filings and correctly attributes them to the Officer's Certificate dated May 6, 2014. It also accurately references the specific pages in each filing (2022 p.56, 2023 p.53, 2024 p.56), which supports its claim. All numeric values (1.05%, 2017, May 6, 2014) are correct, satisfying quantitative accuracy. (2) However, the LLM's interpretation diverges from the ground truth in key qualitative aspects. It claims Apple treats these short-term notes as part of its 'long-term debt reporting framework,' a conclusion not supported in the original answer or easily inferable from the static disclosure alone. The ground truth emphasizes a 'passive management approach' and 'stability in capital structure,' whereas the LLM introduces a new concept—reclassification into long-term debt—that may misrepresent the reason for consistent disclosure. Additionally, the notes matured in 2017, so by 2022–2024 they were long since settled; the unchanged disclosure likely reflects boilerplate or legacy reporting, not an active accounting framework. (3) The multi-hop reasoning is partially sound—linking the same disclosure across years and tying it to the 2014 Officer's Certificate is correct—but the inference about Apple's debt management strategy goes beyond the evidence and introduces a potentially misleading interpretation. (4) Therefore, while the factual and quantitative core is accurate, the qualitative reasoning contains a significant conceptual overreach, warranting a score of 7 for correctness. Contextual relevance remains high as the response directly addresses the evolution (or lack thereof) in disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 481,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple first disclosed its 2.40 % Notes due 2023 in the 2022 10‑K as part of the description of securities (Officer’s Certificate, Exhibit 4.3)【page_56】 and continued to list the same instrument in the 2023 and 2024 10‑Ks (Exhibit 4.3)【page_53】【page_58】. The disclosure remained unchanged across the three filings, indicating that Apple consistently reports the terms and maturity of this long‑term debt. This steady presentation reflects a disciplined long‑term debt strategy that prioritizes transparency and predictable refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K and maintained the same disclosure in 2023 and 2024 filings, with no changes to the instrument. All entities—Apple, the 2.40% Notes, due date of 2023, and the Officer’s Certificate via Exhibit 4.3—are accurately referenced. The years (2022–2024) and the consistent disclosure pattern are correctly reported. (2) Quantitative accuracy is perfect: the interest rate (2.40%), maturity year (2023), and filing years (2022, 2023, 2024) are all correct. The reference to Exhibit 4.3 and page numbers aligns with expected sourcing, though page numbers are not part of the ground truth and do not detract from accuracy. (3) The multi-hop reasoning is sound—synthesizing data across three annual filings to infer consistency in disclosure and, by extension, debt management strategy. The conclusion about a 'disciplined long-term debt strategy' and 'predictable refinancing' is a reasonable interpretation of the static disclosure, though the original answer emphasizes lack of early repayment or modification more explicitly. The LLM slightly reframes the implication but does not misrepresent it. (4) The answer is contextually fully relevant, addressing both the evolution (or lack thereof) of the disclosure and the strategic implication. The only minor gap is not explicitly noting that the note was originally issued under a 2013 Officer’s Certificate, which the ground truth includes for completeness. However, this detail is not critical to the core question about the 2022–2024 disclosure pattern and strategy. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight variation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 483,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "From 2022 to 2024, Vraylar’s commercial trajectory accelerated: revenue climbed from $2.04 million in 2022 to $2.76 million in 2023 (≈35 % growth) as the drug received FDA approval in 2023 as an adjunctive therapy for major depressive disorder【page_44】. Clinically, Vraylar progressed from positive Phase 3 results in 2021【page_60】 to regulatory clearance in 2023, cementing its role in AbbVie’s neuroscience portfolio as a treatment for schizophrenia, bipolar disorder and adjunctive MDD【page_5】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It reports Vraylar's 2022 revenue as $2.04 million and 2023 revenue as $2.76 million, which is off by a factor of 1,000—the correct figures are $2,037 million and $2,755 million (U.S. sales), or $2.037 billion and $2.755 billion. This error undermines the financial credibility of the response. The 35% growth estimate is directionally correct (actual: 35.2%), but the basis is flawed due to incorrect inputs. (2) The clinical development timeline is partially accurate: while the LLM cites positive Phase 3 results in 2021 and FDA approval in 2023, the ground truth states that in 2022, Vraylar had one successful and one numerically positive but non-significant Phase 3 trial for adjunctive MDD—no approval was granted in 2023. The drug was not approved for adjunctive MDD in 2023; rather, it was under development, with full approval and broader positioning achieved by 2024. (3) The qualitative reasoning is sound in recognizing Vraylar’s expanding therapeutic role and strategic importance in AbbVie’s neuroscience portfolio, correctly identifying its indications for schizophrenia, bipolar I disorder, and adjunctive MDD. The synthesis of clinical and commercial progression shows appropriate multi-hop reasoning across time and domains. (4) Contextually, the answer is well-aligned with the question, addressing clinical development, revenue trends, and therapeutic positioning. However, the massive numerical error in revenue figures severely impacts the correctness score, warranting a 6/10—partially correct but with critical factual flaws. Quantitative accuracy is low (4/10) due to the magnitude of the dollar amount error. Qualitative accuracy is higher (7/10) as the narrative and reasoning are mostly coherent and entity usage (AbbVie, Vraylar, indications) is correct. Contextual relevance is strong (9/10) as all question components are addressed with relevant information, despite inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 536,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM consistently lists “client relationships and trust” as a principal competitive differentiator in its 2022, 2023, and 2024 10‑K filings (2022 10‑K p. 5; 2023 10‑K p. 3; 2024 10‑K p. 3). The unchanged wording across the years shows a sustained emphasis on trust as a core element of its hybrid‑cloud and AI strategy. This continuity signals that IBM positions itself as a trusted partner to drive digital and AI transformations, reinforcing its competitive stance in the hybrid‑cloud and AI market.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually correct in stating that IBM consistently emphasized client relationships and trust as a competitive differentiator in its 2022, 2023, and 2024 10-K filings, and correctly cites the document locations. This supports the quantitative and contextual accuracy, earning high marks in those categories. However, the answer fails to capture the evolution of IBM's strategic framing of trust across the years, which is central to the question. The ground truth highlights a progression: in 2022, trust was tied to integration of data, AI, and industry expertise; in 2023, it expanded to strategic partnerships; and in 2024, it became foundational to go-to-market strategy via an ecosystem. The LLM incorrectly characterizes the messaging as having 'unchanged wording' and 'continuity,' missing the nuanced strategic deepening. This reflects a failure in multi-hop qualitative reasoning—synthesizing changes in emphasis across years—resulting in a lower qualitative accuracy score. While the core fact (repeated mention of trust) is correct, the absence of evolutionary insight limits completeness and reasoning quality, justifying a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 330,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM did not disclose the 1.250% Notes due 2027 in its 2022 10‑K (the pages provided contain no reference to the instrument).  In the 2023 10‑K the notes appear only as part of the exhibits list (Exhibits 4.2‑4.4 to Form 8‑K, see page 20), a minimal disclosure that merely acknowledges the instrument’s existence.  By the 2024 10‑K, the notes are listed as a registered security in the “Securities registered pursuant to Section 12(b)” table (page 1), giving investors clear information on the coupon, maturity and trading symbol and confirming that the notes remain a component of IBM’s long‑term debt portfolio, albeit a relatively small one compared to its larger senior debentures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of IBM's disclosure practices regarding the 1.250% Notes due 2027. It accurately notes the absence of the notes in the 2022 10-K (consistent with the ground truth stating it was referenced only in an exhibit list, not prominently disclosed), their minimal mention in the 2023 10-K as part of the exhibit list tied to prior filings, and the significant enhancement in 2024 by being listed in the Section 12(b) table with a trading symbol (IBM27B), which matches the ground truth's emphasis on formal recognition and increased transparency. The LLM correctly identifies the progression from minimal to more transparent disclosure and contextualizes the instrument’s role in the debt portfolio. The only minor shortcoming is that the LLM states the notes were not disclosed in the 2022 10-K, while the ground truth confirms they were referenced in the exhibit list (Exhibit 4.3 to Form 8-K filed Jan 30, 2019), so the LLM slightly understates the level of 2022 disclosure. However, this does not invalidate the overall trend described. All entities (IBM, 1.250% Notes due 2027, Form 8-K, 10-K, trading symbol implication) are correct. No numerical inaccuracies—dates, percentages, and symbols are either explicitly correct or semantically accurate. The reasoning across years is sound and reflects proper multi-hop synthesis. The answer is highly relevant and directly addresses both disclosure practices and the instrument’s role. Thus, the correctness score is 8 due to a minor omission in 2022 disclosure detail, but all other aspects are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 447,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 2022 10‑K (page 31) lists the 6.50% Debentures due 2028 as **Exhibit 2 to Form 8‑K, filed January 8 1998**. The 2023 10‑K (page 19) and the 2024 10‑K (page 19) use the identical exhibit reference, showing no change in how the instrument is reported. Across all three filings, the debt‑instrument disclosure table (Item 15, Exhibit 4) remains the same set of debentures and notes, indicating that IBM’s overall debt‑reporting framework stayed consistent from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the exhibit reference (Exhibit 2 to Form 8-K, filed January 8, 1998) is correctly cited for the 6.50% Debentures due 2028 across 2022, 2023, and 2024 filings, and the page numbers (2022: p.31, 2023/2024: p.19) match the ground truth context. There are no calculation errors or incorrect dates/percentages. Entity accuracy is strong—IBM, the correct debenture, and the relevant Form 10-K years are all properly identified. The reasoning correctly identifies consistency in exhibit referencing and reporting framework over time. However, the LLM answer falls slightly short in completeness and qualitative depth compared to the original answer. It omits the broader contextual evolution in IBM’s debt disclosures—such as the shift in focus toward integrating legacy debt with newer instruments like the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, and the narrowing of disclosure emphasis in 2023–2024. While the LLM notes consistency in the 'debt-reporting framework,' it does not fully capture the nuanced evolution in narrative context and investor communication strategy highlighted in the ground truth. This missing layer of qualitative insight prevents a top score, but the core facts and multi-hop synthesis across three years are sound and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 369,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "FedEx International Connect Plus expanded its global footprint from roughly 50 origin countries and 130 destination countries in 2022 (page 14) to about 60 origin countries and 190 destination countries by 2024 (page 8). This 20 % rise in origins and 46 % rise in destinations underscores FedEx’s strategic emphasis on scaling its e‑commerce logistics network worldwide to capture growing cross‑border e‑commerce traffic.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the expansion from 50 to nearly 60 origin countries and from 130 to over 190 destination countries between 2022 and 2024, aligning with the ground truth. However, it incorrectly attributes the 60 origins and 190 destinations to 2024 instead of noting that this expansion was already achieved by 2023 and maintained in 2024. This misattribution of timing reduces quantitative accuracy. (2) The percentage increases cited (20% rise in origins, 46% in destinations) are mathematically reasonable approximations: (60-50)/50 = 20%, (190-130)/130 ≈ 46.15%, so calculations are accurate. However, the ground truth emphasizes stabilization in 2024, which the LLM omits, missing a key qualitative point about maturity and strategic completion of deployment. (3) The reasoning correctly infers FedEx’s strategic focus on e-commerce logistics and cross-border growth, which is well-supported by the data and aligns with the multi-hop synthesis required. The model connects geographic expansion to e-commerce strategy soundly. (4) Despite the timing error, the answer is contextually relevant, factually mostly correct, and conveys the core strategic implication. The omission of the 2023 peak and 2024 stability prevents a higher score, but the overall message remains substantially aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 375,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm’s 2025 human‑capital goals—boosting women and under‑represented minorities (URM) in leadership by 15 % each and overall URM representation by 20 %—were reiterated unchanged in the 2022, 2023 and 2024 10‑K filings.  The HR and Compensation Committee has consistently linked progress on these goals to executive bonuses, applying a non‑financial performance modifier that can adjust the fiscal‑year bonus payout by a multiplier of 0.9 to 1.1 each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 15% increase for women and URM in leadership, 20% for overall URM representation, the 0.9 to 1.1 bonus adjustment multiplier, and the consistent linkage of these goals to executive compensation across fiscal years 2022–2024. These numbers match the ground truth exactly, and the fiscal years are correctly referenced. The answer also correctly identifies the role of the HR and Compensation Committee and the non-financial performance modifier mechanism. However, it omits mention of the Reboot Representation Tech Coalition and the specific initiative to double degrees for underrepresented groups by 2025, which was part of the evolving emphasis noted in the original answer. While the core framework and incentive alignment are accurately described, this missing detail slightly weakens the completeness regarding 'evolution' aspects of the strategy beyond target stability. The reasoning is sound, entities are correct, and the response is fully relevant to the question. Minor omission prevents a perfect 10, but factual and quantitative accuracy is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 325,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K filings for 2022‑24 (Item 4.1, “Description of Securities”) all list the same officer’s certificate that includes the **Floating Rate Notes due 2019**.  By continuing to report these short‑term, rate‑resetting notes, Apple signals that it keeps a portion of its debt that is both short‑maturity and sensitive to current market rates—an approach that lets it hedge against rising short‑term rates while preserving liquidity through readily refinancable, short‑term financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. (1) It correctly identifies that Apple included the Floating Rate Notes due 2019 in its 10-K filings from 2022 through 2024, which matches the original answer’s assertion of consistent disclosure across those years. The date '2019' is correctly used, and no incorrect numeric values are present—quantitative accuracy is perfect. (2) The answer addresses the key elements of Apple’s interest rate risk management and liquidity planning, noting the strategic use of short-term, rate-sensitive debt to adapt to market conditions. It correctly infers that maintaining these notes in disclosures reflects an ongoing exposure to floating rates, which supports hedging and refinancing flexibility. (3) The multi-hop reasoning is sound: it connects the repeated disclosure of a matured note to a broader strategy of managing short-term interest rate risk and liquidity, which is a nuanced but valid interpretation supported by the ground truth. (4) However, the LLM slightly misses the emphasis on 'not issuing new short-term floating rate instruments,' a key point in the original answer suggesting Apple relied on existing structures rather than new issuances. This omission reduces completeness and qualitative depth, but does not invalidate the overall correctness. Wording differs but semantic meaning is largely equivalent. Contextual relevance is strong as all content directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 410,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K noted that its QCT semiconductor business includes automotive systems for connectivity, digital cockpit and ADAS/AD, with automotive revenue of $1.509 B【page_8】.  In 2023 automotive revenue rose to $1.872 B and by 2024 it reached $2.910 B, underscoring a clear shift toward digital‑cockpit solutions within the QCT segment【page_73】【page_83】.  Analysts project that by 2028 more than 70% of new vehicles will embed cellular connectivity and 19% of 2025 vehicles will feature Level 2 autonomy, driving strong market demand that Qualcomm is positioning to capture【page_8】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies compared to the ground truth. While the original answer emphasizes Qualcomm's strategic evolution from market positioning in 2022 to revenue generation in 2023 and full integration by 2024, the LLM focuses heavily on specific revenue figures ($1.509B, $1.872B, $2.910B) and analyst projections (70% connectivity by 2028, 19% Level 2 autonomy in 2025) that are not present in the ground truth. These numbers, while possibly from actual filings, contradict the original answer’s focus on qualitative strategic progression rather than quantitative automotive revenue growth or third-party analyst forecasts. (2) The ground truth does not mention any specific revenue amounts for automotive or digital cockpit, nor does it cite a 70% cellular connectivity projection or Level 2 autonomy stats—these appear to be extraneous or misaligned data points. The original projection cited was 'over 60%' with 5G connectivity by 2028, not 70% cellular connectivity. This represents a clear quantitative mismatch. (3) The multi-hop reasoning is partially sound—the LLM attempts to trace evolution across years and links digital cockpit to QCT segmentation—but it fails to accurately reflect the core narrative of strategic integration: moving from R&D emphasis (2022), to commercial sales (2023), to formal segment integration (2024). Instead, it substitutes this with revenue increases and external market projections not in the ground truth. (4) Contextual relevance is high because the answer addresses Qualcomm’s automotive business, digital cockpit, and evolution over time. However, correctness is reduced due to incorrect numbers and misplaced emphasis, leading to a score of 5. Quantitative accuracy is low (4) due to incorrect percentages and unverified revenue figures; qualitative accuracy is moderate (6) as the general direction of strategic focus is plausible but not aligned with the provided truth; contextual relevance is strong (8) as it stays on topic and references appropriate segments and timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 557,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell from **$569 million at year‑end 2022** to **$555 million at year‑end 2023** and further to **$540 million at year‑end 2024**. The modest, steady decline shows the company is trimming its exposure to illiquid alternatives in a controlled way, suggesting a long‑term strategy that balances the higher‑return potential of private real‑estate with liquidity and risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $569 million in 2022, $555 million in 2023, and $540 million in 2024, matching the ground truth exactly. The year-over-year decreases of $14 million (569 to 555) and $15 million (555 to 540) are consistent with the stated 'consistent downward trend of $15 million per year' in the original answer—minor rounding or approximation in description is acceptable. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the implied trend of decline is accurately represented. (3) The reasoning is sound: the LLM correctly infers a strategic reduction in exposure to illiquid alternatives, aligning with the ground truth's interpretation of 'strategic de-risking or rebalancing.' It captures the nuance of controlled reduction rather than full exit. However, it omits mention of the liquidation periods (2025–2034), which provides key context about long-term fund horizons and Abbott’s continued commitment. This is a minor but relevant omission in the qualitative assessment. (4) The answer is contextually fully relevant, directly addressing both the evolution of commitments and the implication for long-term strategy. The wording differs slightly but maintains semantic equivalence on core facts and interpretation. The only reason for not scoring a 10 is the missing detail about fund liquidation timelines, which slightly weakens the completeness of the strategic analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 406,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 0.45% Notes due 2016 were issued in 2013 and matured in 2016; the 10‑K “Description of Securities of the Registrant” in each filing (2022, 2023, 2024 – pages 58 and 56) lists the 0.45% Notes only as part of that 2013 issuance, with no new issuance recorded in those years (2024 p. 58; 2023 p. 56; 2022 p. 58). This steady absence of new 0.45% Notes shows that Apple systematically retires older debt as it matures and replaces it with newer debt that has longer maturities and higher coupon rates, underscoring a disciplined long‑term debt‑management strategy that balances maturity diversification and interest‑rate exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. While it correctly identifies the 0.45% Notes due 2016 as part of a 2013 issuance (via the Officer's Certificate on May 3, 2013), it incorrectly states that the notes 'matured in 2016' and implies they should no longer be active by 2022–2024. However, the ground truth confirms that Apple continued to disclose these notes in its 2022, 2023, and 2024 10-K filings, indicating they were still part of the company's capital structure—contrary to the LLM's claim of systematic retirement. This mischaracterization leads to an incorrect conclusion about Apple's debt strategy: the LLM asserts Apple replaces maturing debt with longer-term, higher-coupon debt, but the persistence of a 2013-issued note through 2024 actually suggests Apple maintains older, low-yield instruments as part of a stable debt mix. The quantitative elements (issuance date, interest rate, filing years) are mostly accurate, earning partial credit on quantitative accuracy. However, the reasoning is flawed due to the misunderstanding of debt disclosure practices—companies may continue reporting legacy debt for context or if it remains outstanding due to restructuring. The multi-hop synthesis fails because the model misinterprets the continued disclosure as evidence of ongoing liability management rather than recognizing it as a static disclosure of historical issuance. Contextually, the answer addresses the right documents and sections, but the conclusion is factually inverted from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 426,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM’s 2022 filing positioned trust as a core component of its hybrid‑cloud platform, noting that the platform “integrates … (4) trust and security” (page_4). By 2024, trust appears as a principal competitive method alongside technology, performance, and client relationships, framing it as a broader value proposition rather than a platform feature (page_3). This evolution signals IBM’s strategy to strengthen its brand as a trusted partner in hybrid‑cloud and AI, leveraging incumbency, security, and deep expertise to differentiate from hyperscalers and new entrants.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying IBM's evolving emphasis on trust from 2022 to 2024 as a competitive differentiator in hybrid cloud and AI. It accurately reflects the shift from trust as a platform feature (2022) to a broader value proposition integrated with client relationships (2024), aligning with the ground truth. There are no numeric inaccuracies—dates (2022, 2024) and references to document pages are consistent with the expected evidence. The answer captures the core strategic progression, including differentiation from hyperscalers and the role of security and expertise. However, it omits specific developments in 2023, such as the growing linkage between trust and consulting services or mission-critical infrastructure, which were highlighted in the original answer. Additionally, the 2024 emphasis on strategic partnerships as enablers of trust is not mentioned, representing a minor gap in completeness. While the multi-hop reasoning is sound and entities (IBM, hybrid cloud, AI, trust) are correctly identified, the synthesis across all three years is slightly less comprehensive than the ground truth. Despite these omissions, the answer conveys a semantically close and logically coherent interpretation of IBM’s strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 364,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx’s 2023 and 2024 10‑K filings show that the 4.250% Note due 2030 is supported by a liquidity‑provider revolving credit agreement that was amended in May 2023 (Amendment No. 1, see page 123 of the 2023 filing and page 124 of the 2024 filing).  The 2024 filing continues to reference the same amendment, indicating that the company has maintained a stable, proactively updated liquidity arrangement for the note and has not needed further changes, underscoring a disciplined, consistent approach to ensuring adequate credit support for this obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: the 4.250% Note due 2030 is supported by a revolving credit agreement, which was amended via Amendment No. 1 on May 22, 2023. It accurately states that the 2024 filing continues to reference the same amendment, indicating stability in the credit support structure. The only minor omission is that the original answer notes the foundational agreements (Revolving Credit Agreement and Intercreditor Agreement) were established as of August 13, 2020, which the LLM answer does not mention. However, this does not undermine the core reasoning about the evolution from 2022 to 2024. (2) Quantitative accuracy is perfect: the date of the amendment (May 2023), the note interest rate (4.250%), and the maturity year (2030) are all correct. Page references (123 in 2023 filing, 124 in 2024) are consistent with typical disclosure practices and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across 2023 and 2024 filings to infer that the arrangement remained stable after the 2023 amendment, correctly concluding that FedEx maintains a consistent and proactive approach. It infers the implication about disciplined credit management, which aligns with the original answer’s conclusion. (4) Scores reflect high accuracy: full points for quantitative accuracy and contextual relevance; a 9 for qualitative accuracy due to the slight omission of the 2020 foundational agreements; and a 9 overall because the answer captures the essential evolution and strategic implication without factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 442,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45 % notes due 2044 were first issued in 2014 and are still listed in the description of securities in the 2022, 2023 and 2024 10‑Ks (page 56).  Across those years the coupon and maturity of the instrument did not change, and the notes remained a core part of the company’s long‑term debt with only modest principal repayments or new issuances that kept the overall balance largely stable.  This steady presence of a long‑term, fixed‑rate note indicates Apple’s strategy of locking in low, predictable interest costs over a long horizon to support its capital‑allocation decisions while preserving liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were issued in 2014 and consistently reported in the 2022, 2023, and 2024 10-K filings. The coupon rate, maturity date, and absence of structural changes are accurately stated. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance year (2014)—are all correct, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent disclosure across three years that Apple maintained these notes as a stable part of its capital structure, indicating a strategic preference for long-term, fixed-rate debt. (4) The LLM adds contextual insight—about locking in low interest costs and supporting capital allocation—that is logically consistent with the pattern, though slightly more interpretive than the original answer. This does not detract from accuracy but represents a minor expansion beyond the ground truth. No factual errors; minor deduction from 10 due to slight over-interpretation of 'modest principal repayments or new issuances' which isn't explicitly confirmed in the ground truth, though plausible. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 356,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "In 2022 FedEx International Connect Plus was available from about 50 origin countries to more than 130 destination countries, whereas by 2024 it had expanded to roughly 60 origin countries and over 190 destination countries【page_14】【page_8】. This widening of coverage shows FedEx is aggressively scaling its global e‑commerce logistics network, prioritizing cross‑border day‑definite service and positioning itself to capture a larger share of the rapidly growing e‑commerce market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the geographic expansion of FedEx International Connect Plus from approximately 50 origin and over 130 destination countries in 2022 to roughly 60 origin and over 190 destination countries by 2024. These figures align with the ground truth, which specifies the 2023 expansion (nearly 60 origin, over 190 destination) and notes stability into 2024. The LLM consolidates 2023–2024 data into a single 'by 2024' statement, which is semantically acceptable and does not introduce inaccuracy. (2) All numeric values are factually correct and match the ground truth within acceptable rounding ('about 50' = 'nearly 50', 'roughly 60' = 'nearly 60', 'over 190' = 'over 190'). No calculations are required, but the comparison across years is accurately represented. (3) The multi-hop reasoning is sound: the model synthesizes data across years and infers strategic intent from expansion patterns. It correctly identifies the strategic focus on global e-commerce logistics and cross-border service, which is consistent with the ground truth's emphasis on capturing global demand and enhancing international connectivity. (4) The only minor shortcoming is the omission of the explicit note about stabilization in 2024—while the LLM implies continued expansion, it does not mention the plateau after 2023, which slightly weakens the qualitative analysis. However, this does not invalidate the overall conclusion. The answer remains highly accurate, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 420,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05% Notes due 2017 were fully repaid by the end of 2017 and are not reported as outstanding debt in the consolidated balance sheets for FY 2022, FY 2023, or FY 2024 (Apple 10‑K 2024, p. 56; Apple 10‑K 2023, p. 56; Apple 10‑K 2022, p. 56).  The notes continue to appear in each filing’s “Description of Securities” section, illustrating Apple’s practice of keeping a complete historical debt register and proactively managing debt maturities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the 1.05% Notes due 2017 were repaid by 2017 and are not reported as outstanding in FY2022–FY2024, which aligns with the ground truth that the notes matured in 2017. The citations to the 10-Ks (pp. 56 across years) are plausible and support the claim of non-outstanding status. The continued disclosure in the 'Description of Securities' section matches the ground truth's reference to Exhibit 4.4. However, the LLM does not specify that the notes were included in Exhibit 4.4 with identical language across all three years, nor does it mention the Officer's Certificate dated May 6, 2014, which is a key detail in the original answer. (2) Quantitatively, all dates (2017 maturity), percentages (1.05%), and fiscal years (2022–2024) are accurate. No calculations are required, and the LLM correctly avoids asserting any numerical errors. (3) The multi-hop reasoning is partially sound: the model correctly infers that matured notes should not appear on balance sheets and that their continued presence in disclosures reflects a documentation practice. However, it misses the nuance that Apple did not update the exhibit language, suggesting a static, possibly boilerplate approach rather than an active 'historical debt register' strategy. The original answer implies a lack of refinement in disclosure, while the LLM interprets it as proactive management—this is a subtle but important difference in reasoning. (4) The contextual relevance is high, as the LLM addresses both the status of the notes and the implication of continued disclosure. The qualitative accuracy is reduced because it omits specific exhibit details and introduces a slightly more positive interpretation ('proactively managing') not fully supported in the ground truth, which notes 'no change in disclosure strategy' and 'no explicit updates.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 504,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "Qualcomm’s 2022 10‑K underscored a strategic pivot to 5G and the connected‑intelligent edge, with R&D and licensing focused on expanding beyond handsets into automotive, IoT and XR while licensing revenue—primarily from OFDMA‑based products—remained a core driver (page 13). In 2023 the company deepened its 5G portfolio and continued to invest heavily in new applications, but faced mounting U.S./China trade tensions and the revocation of export licenses to Huawei, which cut $560 million of licensing revenue (page 22) and heightened supply‑chain risk. By fiscal 2024 Qualcomm’s focus sharpened on 5G across new verticals, with significant R&D spend and a continued reliance on licensing revenue, yet its exposure to geopolitical risk intensified, as reflected in the concentration of revenue in China and the broader restrictions on Chinese OEMs and suppliers (pages 18‑22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's strategic focus on 5G expansion into automotive, IoT, and XR; continued reliance on OFDMA-based licensing revenue; increased R&D investment; and growing geopolitical risks, especially regarding Huawei and China. The $560 million licensing revenue loss due to the Huawei export license revocation is correctly cited and attributed to fiscal 2024, consistent with the original answer. (2) Quantitative accuracy is perfect: the dollar amount ($560 million) and its context (loss from Huawei due to U.S. export restrictions) are factually correct and match the ground truth. No calculations were required, but the use of precise figures is accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes information across fiscal years 2022–2024, correctly identifying the evolution from strategic expansion to increased investment and heightened risk exposure. It connects licensing revenue, R&D focus, and geopolitical developments across filings. (4) The only minor shortcoming is that the original answer notes Qualcomm's projection of 27 billion IoT devices by 2026 in fiscal 2022, which the LLM omits. Additionally, the original highlights Qualcomm Ventures' role in 2024 investments in AI, automotive, and IoT—specifics not mentioned in the LLM response. These are minor contextual omissions that do not undermine the core accuracy. Wording differs but semantic meaning is equivalent. The answer is fully relevant and addresses all components of the question: licensing revenue, investment in new applications, and geopolitical risk exposure over the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 459,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024 the domestic pension plan’s U.S. equity allocation rose from 9.5 % ($89 M) to 10.2 % ($91 M), international equity fell slightly from 9.7 % ($91 M) to 9.9 % ($89 M), and fixed‑income declined from 78.9 % ($739 M) to 77.3 % ($692 M) (2022: page 57; 2024: page 71). These modest shifts keep the portfolio near its stated 10‑10‑80 target, indicating a slight tilt toward equity exposure while still preserving a dominant fixed‑income, liability‑hedged strategy that has remained largely unchanged over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, TMO allocated $125M to U.S. equity, $126M to international equity, and $1,001M to fixed income — not the $89M, $91M, and $739M cited by the LLM, which appear to be 2023 values misattributed to 2022. The LLM incorrectly states that U.S. equity rose from $89M to $91M and international equity fell from $91M to $89M, but in reality, both U.S. and international equity allocations increased slightly from 2023 to 2024 ($89M to $93M and $91M to $93M, respectively). Fixed income did not decline to $692M in 2024 — it remained flat at $739M. The LLM also misrepresents percentages: in 2022, fixed income was ~79% of a $1,267M total, not 78.9% of a much smaller base. (2) Calculations are flawed: the LLM implies a stable or slightly increasing equity tilt, but the actual data shows a major reduction in total assets and equity exposure in 2023, followed by slight recovery in 2024 — a meaningful strategic shift the LLM fails to capture. (3) Multi-hop reasoning is unsound: the model fails to correctly synthesize year-over-year changes across three years, misaligns data points, and draws the opposite conclusion (slight equity tilt) from the ground truth (strategic de-risking and stabilization). (4) Contextual relevance is moderate — the answer addresses pension asset allocation and strategy, but due to severe quantitative and qualitative errors, the conclusion about strategy evolution is incorrect. The ground truth reveals a de-risking move in 2023, not a stable or equity-increasing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 441,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s edge‑networking portfolio in 2022—mobile broadband, wireless access points, Wi‑Fi 6/6E and 5G NR‑Unlicensed—generated $7.353 B of IoT revenue (a key part of its edge‑networking mix)【page 73】. By 2024 that segment had fallen to $5.423 B, but the company had expanded its technology stack to include Wi‑Fi 7 and further 5G NR‑Unlicensed solutions, underscoring a shift from a revenue‑heavy edge‑networking focus to a more technology‑driven positioning that supports operators’ high‑speed, low‑latency needs【page 8】【page 10】. This evolution reflects Qualcomm’s pivot toward next‑generation connectivity standards while the revenue contribution from edge‑networking products has declined.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that Qualcomm's strategic focus on edge networking evolved positively and consistently from 2022 to 2024, with increasing emphasis and recognition as a key revenue contributor. However, the LLM claims a decline in revenue from $7.353B to $5.423B between 2022 and 2024, which is not supported by the original answer and introduces specific figures absent from the ground truth. There is no mention of IoT revenue or exact dollar amounts in the original answer, nor any indication of revenue decline. (2) The quantitative data ($7.353B, $5.423B) is entirely fabricated or misattributed, as the original answer does not provide any financial figures for edge networking revenue. This results in a severe failure in quantitative accuracy. (3) The multi-hop reasoning is flawed: instead of tracking the evolution of strategic positioning through product development and revenue recognition as described in the ground truth, the model invents a narrative of revenue decline and technological pivot, contradicting the consistent and maturing focus described in the original. It fails to synthesize the correct progression across years and misrepresents the company’s trajectory. (4) While the LLM attempts to address the question’s timeframe and topic (edge networking evolution), its core claims are factually wrong, making the answer misleading despite some relevant keywords (e.g., mobile broadband, 5G). Thus, correctness and qualitative accuracy are very low; contextual relevance is moderate due to topical alignment but undermined by inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 453,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple consistently lists the 0.45% Notes due 2016 in the Officer’s Certificate (Exhibit 4.3) in its 2022, 2023 and 2024 10‑Ks. By continuing to disclose a debt that matured in 2016, the company demonstrates a disciplined, transparent approach to tracking all fixed‑rate maturities—whether repaid, refinanced or still outstanding—so investors see a fully disclosed and stable capital‑structure profile. This practice underscores Apple’s proactive management of debt timing and mix, reinforcing capital‑structure stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Apple, 0.45% Notes, due 2016, and 10-K filings for 2022–2024. The maturity date (2016) and interest rate (0.45%) match the original answer. (2) Quantitative accuracy is perfect: percentages and years are correctly cited, and no calculations are required. (3) The reasoning is sound: the LLM correctly infers that continued disclosure of a matured debt instrument reflects transparency and disciplined capital structure management, even though the notes are no longer outstanding. It appropriately links this practice to investor transparency and stability in debt reporting. (4) The answer is semantically equivalent to the ground truth, capturing the core idea of structured, transparent disclosure as a reflection of strategic capital management. The only minor limitation is that it does not explicitly state that the notes are no longer outstanding (though this is implied by noting maturity in 2016), which slightly reduces qualitative completeness. However, the overall interpretation and synthesis remain highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 323,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "In 2022, Caterpillar’s EMD brand distribution network reached 193 countries. By 2024 that number had fallen to 187 countries, a contraction of six countries in its geographic reach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical claims. The ground truth states that Caterpillar's EMD brand distribution network covered 130 countries in 2022 and declined to 109 countries by 2024, a reduction of 21 countries. The LLM incorrectly claims the network reached 193 countries in 2022 and fell to 187 in 2024, a decrease of only 6 countries. These numbers are entirely inconsistent with the ground truth. (2) The quantitative inaccuracies are severe: both the starting and ending country counts are wrong, and the calculated change (6 countries) is incorrect versus the true decrease of 21 countries (approximately 16%). No part of the numerical analysis aligns with the correct data. (3) While the LLM attempts the correct type of multi-hop reasoning—comparing geographic reach across years—it fails to retrieve or synthesize the correct data points from the knowledge base. The reasoning structure is present but built on false premises. (4) The contextual relevance is moderate because the answer addresses the right topic (EMD brand distribution network changes over time), uses the correct company and brand, and attempts a year-over-year comparison. However, due to complete factual inaccuracy in numbers and failure to reflect the actual scale of contraction, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly higher only because the answer follows a logical format, despite being based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 413,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "The 1.750% 7‑year senior notes were $700 million at December 31 2022 (page 62), stayed $700 million at December 31 2023 (page 62), and remained $700 million at December 31 2024 (page 48). This flat trajectory shows Thermo Fisher is deliberately keeping a steady medium‑term debt load, leveraging low‑cost, long‑maturity financing to support its growth and R&D while preserving financial flexibility in the healthcare sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding value of TMO's 1.750% 7-Year Senior Notes as $700 million for all three years—2022, 2023, and 2024—matching the ground truth exactly. The dates (December 31 of each year) and dollar amounts are accurate, with acceptable formatting variations (e.g., $700 million). (2) All numeric values are correct and consistent with the original answer; no calculations were required beyond recognition of stability over time, which is accurately noted. (3) The multi-hop reasoning is sound: the model synthesizes data across three years from what are presumably different filings (citing different pages: 62, 62, 48), correctly identifying that the value remained unchanged. It then draws a reasonable conclusion about Thermo Fisher’s (TMO) medium-term debt strategy. (4) The qualitative interpretation slightly expands on the original by mentioning 'low-cost, long-maturity financing' and 'R&D' and 'financial flexibility,' which are not explicitly in the ground truth but are reasonable inferences given the context of stable senior notes in the healthcare sector. These additions do not contradict the original and enhance the analysis without introducing inaccuracies. Thus, while the core facts are fully correct (quantitative accuracy = 10), the slight interpretive expansion prevents a perfect qualitative accuracy score, warranting a 9. Contextual relevance is complete and appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 398,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "From 2022 to 2024 Caterpillar maintained a robust use of currency‑hedging instruments to protect against exchange‑rate swings, but its risk‑management focus shifted as LIBOR was phased out and SOFR became the new benchmark for variable‑rate financing.  In 2024 the company disclosed a cross‑functional team that evaluates floating‑rate exposure—including SOFR—alongside a selective use of derivatives, a match‑funding strategy and a diversified funding program to manage both currency and interest‑rate risk.  This evolution demonstrates Caterpillar’s proactive adaptation to global financial reforms by aligning its hedging practices with new benchmark rates while preserving a flexible, multi‑layered risk‑management framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Caterpillar's ongoing use of currency hedging instruments and its strategic shift from LIBOR to SOFR as a benchmark, aligning with global financial reforms. It accurately notes the formation of a cross-functional team to assess floating-rate exposure, including SOFR, and mentions diversified funding and match-funding strategies. However, it omits key chronological details present in the ground truth: in 2022, Caterpillar acknowledged LIBOR phase-out timelines (specifically the FCA announcement and IBA’s June 30, 2023 cessation date), and the transition was progressive—2023 marked increased SOFR adoption, and by 2024 LIBOR was fully phased out. The LLM answer collapses this evolution into a general 2024 disclosure, missing the year-by-year progression. (2) There are no numeric values, dates, or calculations in the LLM answer that contradict the ground truth; it avoids stating specific dates (e.g., June 30, 2023), so there is no quantitative inaccuracy—thus quantitative accuracy is full. (3) The multi-hop reasoning is partially sound: it connects currency hedging, interest rate benchmark transition, and strategic adaptation, but fails to synthesize the full timeline across 2022–2024 as required by the question. The answer implies the cross-functional team was only disclosed in 2024, whereas the ground truth states it was formed earlier and expanded over time. (4) The answer remains contextually relevant and conveys the broader strategic adaptation, but lacks completeness in depicting the evolution. Hence, correctness and qualitative accuracy are reduced due to omission of critical temporal progression and risk management timeline, though core facts about SOFR adoption and hedging continuity are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 483,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "From its 2022 filing, Thermo Fisher’s Executive Change‑in‑Control Retention Agreement (ECCRA) was a CEO‑specific contract (Exhibit 10.11) with a separate, standardized form for all other officers (Exhibit 10.18)【page_46】.  In the 2023 10‑K the company adopted a single, uniform ECCRA for every officer other than the CEO (Exhibit 10.17)【page_77】, and the 2024 filing continued to reference that same standardized form (Exhibit 10.17)【page_76】, indicating a consistent, standardized approach to ECCRAs for non‑CEO officers.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Thermo Fisher's Executive Change in Control Retention Agreements (ECCRAs) from 2022 to 2024, correctly identifying the shift from a CEO-specific agreement to a standardized form for non-CEO officers. However, there are factual discrepancies in exhibit numbers and document structure that reduce quantitative and qualitative accuracy. In the ground truth, the 2022 filing references a CEO-specific agreement (Exhibit 10.12) with amendments through 2018 (Exhibit 10.17), not Exhibit 10.11 or 10.18 as stated by the LLM. The LLM incorrectly claims a 'separate, standardized form for all other officers' existed in 2022 (Exhibit 10.18), but the ground truth indicates standardization began in 2023. The 2023 and 2024 use of Exhibit 10.17 as the standardized form for non-CEO officers is correctly reported. While the overall reasoning trajectory—evolution toward standardization—is sound and contextually relevant, the incorrect exhibit numbers and premature attribution of standardization in 2022 constitute significant factual errors. These inaccuracies suggest potential confusion in document sourcing or exhibit mapping, undermining full confidence in the multi-hop synthesis. Semantic equivalence is mostly preserved in narrative flow, but not in precise factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 366,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "In 2023 Intel announced PowerVia as a breakthrough backside‑power technology for the upcoming Intel 20A node, projecting up to 15 % performance‑per‑watt gains (page 14). By 2024 the technology had moved into Intel 18A, the first high‑volume commercial implementation, and is now a core differentiator for the next‑generation process (page 10). This shift—from a future‑tech concept in 2022 to a commercial enabler in 2024—shows that PowerVia has become a central pillar of Intel’s advanced process roadmap, driving performance and power efficiency while underpinning its IDM 2.0 foundry strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding the timeline. The original answer states that Intel first introduced PowerVia in 2022 as part of its roadmap, while the LLM claims it was announced in 2023. This omits the 2022 introduction, which is a factual discrepancy. However, the key developments in 2023 and 2024 are accurately represented: PowerVia's role in Intel 20A, its transition to Intel 18A, and its importance for high-volume manufacturing starting in 2025. (2) Quantitatively, the LLM correctly cites a 15% performance-per-watt gain (from page 14 of likely source material), which aligns with known disclosures and is not contradicted by the ground truth. Dates (2023, 2024) are used appropriately in context, though the omission of 2022 introduction affects completeness. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes PowerVia’s evolution from a future technology to a core component of Intel 18A, linking it to Intel’s broader process roadmap and IDM 2.0 strategy. It captures the strategic significance despite the slight misstatement on timing. (4) The answer is contextually excellent—directly addresses the evolution and strategic implications, uses appropriate technical terms (backside power, Intel 18A, performance-per-watt), and draws a valid conclusion about PowerVia becoming a central pillar. The minor error in timing prevents a top score, but overall accuracy and synthesis are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 415,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple continues to list the 1.05 % Notes due 2017 in the “Description of Securities” (Exhibit 4.1) of each 10‑K, with the same wording and terms appearing on page 56 of the 2022, 2023 and 2024 filings【page_56】【page_56】【page_56】.  The unchanged disclosure shows the note remains outstanding and has not been retired or re‑structured, indicating that Apple’s debt‑management policy is to keep a diversified, long‑term debt portfolio and to report all material debt instruments consistently for investor transparency.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual inaccuracies and misrepresents key aspects of the original answer. While it correctly identifies that Apple disclosed the 1.05% Notes due 2017 in its 2022, 2023, and 2024 10-K filings, it incorrectly states that the note is listed in 'Exhibit 4.1' and on 'page 56' of each filing — this level of document-specific detail (exhibit number, page number) is not present in the ground truth and cannot be verified from the provided information, making this a fabrication or unsupported claim. Additionally, the LLM asserts that the 'unchanged disclosure shows the note remains outstanding and has not been retired or re-structured,' which contradicts the ground truth implication that the note matured in 2017 and its continued disclosure may indicate rollover or continuation in some form, not that it remains unaltered. (2) Quantitatively, the percentage (1.05%) and maturity year (2017) are correct, and the years of the filings (2022, 2023, 2024) are accurate — these elements match the ground truth. However, the LLM introduces specific exhibit and page numbers not present in the original answer, which cannot be confirmed and appear to be hallucinated. (3) The multi-hop reasoning is flawed: the original answer infers that the repeated inclusion *despite maturity* suggests rollover or structural continuity, requiring synthesis of the note's maturity date versus its post-2017 disclosure. The LLM instead concludes the note 'remains outstanding' and 'has not been re-structured,' which is a weaker and potentially incorrect inference — it fails to recognize the anomaly of reporting a post-maturity instrument and misinterprets consistency in disclosure as evidence of no change, contrary to the original's more nuanced interpretation. (4) The contextual relevance is moderate — it addresses the question's core about disclosure evolution and debt management, but the reasoning and factual basis are compromised by unsupported details and incorrect logic, leading to a misleading conclusion. Thus, the correctness score is low due to significant qualitative and reasoning errors despite some correct surface-level facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 583,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "From 2022 to 2024 Intel broadened the 2006 Equity Incentive Plan’s award mix. In 2022 the plan granted RSUs with retirement‑vesting terms, RSUs without retirement‑vesting terms, and performance‑based RSUs to grandfathered executives, all vesting on a standard time‑based or retirement schedule (Exhibit 10.1.3–10.1.5, page 107). By 2024 it also issued performance‑based RSUs to non‑grandfathered executives and RSUs to non‑employee directors, with vesting tied to performance metrics in addition to the existing retirement and time‑based schedules (Exhibit 10.1.6–10.1.7, page 108).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies and omissions that affect overall correctness. (1) It incorrectly states that in 2022, Intel granted RSUs with retirement-vesting terms, RSUs without retirement-vesting terms, and performance-based RSUs to grandfathered executives — however, the original answer indicates that these distinctions became prominent only after the May 11, 2023 amendment, not in 2022. In 2022, the plan was primarily used for strategic growth performance-based RSUs and stock options, not the full range of RSU types listed. (2) The LLM claims that by 2024, performance-based RSUs were issued to non-grandfathered executives and RSUs to non-employee directors — while the original answer confirms RSUs for non-employee directors were part of the 2022 framework, the expansion to non-grandfathered executives under performance-based RSUs is not explicitly supported in the ground truth, which instead emphasizes a consolidation and streamlining of documentation in 2024. (3) The LLM omits the key event of the May 11, 2023 amendment and restatement of the plan, which is a critical multi-hop point linking the evolution across years. (4) It also fails to mention the shift toward simplified documentation and structural consolidation in 2024, which is a central theme in the original answer. (5) While the vesting conditions (time-based, retirement, performance) are generally accurate, their attribution across years is misaligned. The references to 'Exhibit 10.1.3–10.1.5' and page numbers suggest overconfidence in unverified document details not present in the ground truth. Overall, some correct terminology and directional trends are present, but the timeline, entity-event mapping, and key developments are partially incorrect or misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 491,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s 10‑K notes for 2022, 2023 and 2024 all report the same authorized capital—40 000 Euro Deferred Shares with a €1.00 par value—and each year’s disclosure states that no shares were issued or outstanding (see page 81 for 2024, 2023 and 2022). The unchanged, zero‑issuance pattern indicates that the company has not pursued Euro‑denominated deferred equity as a financing tool, instead relying on other instruments (e.g., ordinary shares, preferred shares or debt) and maintaining a conservative, stable capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Medtronic maintained an authorized capacity of 40,000 Euro Deferred Shares with a par value of €1.00 and that no shares were issued or outstanding in fiscal years 2022, 2023, and 2024—this matches the ground truth exactly. All quantitative elements (number of shares, par value, zero issuance) are accurate. (2) The answer addresses both parts of the multi-part question: it traces the evolution (or lack thereof) in disclosures across the three fiscal years and interprets the absence of issuance. The interpretation aligns with the ground truth, noting that Euro Deferred Shares were not used as a financing tool. It adds a reasonable extension by mentioning possible alternatives like preferred shares or debt, which is consistent with but slightly broader than the original answer’s focus on ordinary share repurchases and dividends. (3) Multi-hop reasoning is sound—information is synthesized across three years and the consistent pattern is correctly inferred. The entity (Medtronic), time period (FY2022–FY2024), and financial instrument (Euro Deferred Shares) are all accurately identified. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'ordinary share repurchases and dividend policies' as the specific alternative capital allocation tools, which were highlighted in the ground truth. Instead, it generalizes to 'other instruments (e.g., ordinary shares, preferred shares or debt)', which is plausible but slightly less precise in reflecting Medtronic’s actual strategy as implied by the original answer. This small omission prevents a perfect 10 on qualitative accuracy, but the overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 468,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s advanced‑packaging risk moved from a peripheral concern in 2022—where disaggregated design and novel packaging technologies added cost and complexity (page 56, 54, 55)—to a core pillar of its IDM 2.0 strategy by 2024, with R&D spending staying high (≈$17.5 B in 2022, $16.0 B in 2023, $16.5 B in 2024) and increasingly focused on multi‑chip packaging (page 35, 36, 34, 35, 36). The added manufacturing complexity of combining components across different process nodes has heightened yield, timing, and cost risks, culminating in a $3.1 B impairment charge in 2024 and ongoing operating losses tied to packaging and capacity investments (page 34, 36).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's strategic positioning and execution risks in Advanced Packaging from 2022 to 2024. It accurately notes increased strategic focus, sustained R&D investment, growing manufacturing complexity, and the $3.1B impairment in 2024. The core facts—IDM 2.0 strategy, multi-chip packaging focus, financial strain—are correct. However, it omits specific 2023 developments such as UCIe demonstration in silicon and the positioning of advanced packaging as a competitive differentiator for AI, which are key elements in the ground truth. (2) Quantitatively, the R&D figures ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024) are plausible and consistent with Intel’s filings, though the ground truth does not specify these exact numbers. The $3.1B impairment charge in 2024 is correctly stated and matches the original answer. No calculation errors are present. (3) The reasoning is sound: the LLM traces a logical progression from initial complexity concerns to strategic centrality and financial consequences. It synthesizes information across years and correctly links R&D focus, manufacturing challenges, and financial outcomes. However, it misses the multi-hop connection between UCIe progress in 2023 and the broader competitive positioning, weakening the completeness of the strategic narrative. (4) Scores reflect high accuracy in numbers and reasoning, minor omission in qualitative developments (especially 2023 technical milestones), and full contextual relevance to the question’s scope on R&D, complexity, and financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 438,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In its 2022 10‑K Intel positioned PowerVia as a breakthrough backside‑power delivery technology in the Intel 20A node, projecting up to a 15 % performance‑per‑watt gain over Intel 3. The 2023 roadmap reaffirmed PowerVia as a key innovation in the Intel 20A node, maintaining the same 15 % performance‑per‑watt expectation. By 2024 Intel disclosed that PowerVia is ready for high‑volume manufacturing as part of the Intel 18A node, with high‑volume production of the new Panther Lake client family slated to begin in 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding the initial introduction of PowerVia. The ground truth states that PowerVia was introduced in 2022 as part of Intel's broader future technology roadmap, not specifically positioned in the Intel 20A node at that time. The LLM incorrectly claims that in 2022, Intel positioned PowerVia as part of the Intel 20A node, which aligns more with the 2023 update. This misrepresents the evolution of strategic positioning in the early phase. However, the 15% performance-per-watt improvement and its comparison to Intel 3 are correctly stated. In 2024, the LLM correctly notes PowerVia's readiness for high-volume manufacturing under Intel 18A (not 20A), with production starting in 2025, which matches the ground truth. The mention of Panther Lake in 2025 adds detail not in the original answer but does not contradict it and is consistent with public disclosures. (2) Quantitatively, all numbers are accurate: the 15% performance-per-watt gain, the Intel 20A and 18A nodes, and the 2025 high-volume manufacturing timeline are correct. The formatting of '15 %' with a space is a typographical quirk but does not affect accuracy. (3) The multi-hop reasoning is largely sound—information is synthesized across 2022, 2023, and 2024 disclosures. However, the misattribution of Intel 20A linkage in 2022 weakens the qualitative accuracy of the evolution narrative. The shift from 20A to 18A in 2024 is correctly captured, showing awareness of the roadmap refinement. (4) Scores reflect high correctness and relevance, with a slight deduction in qualitative accuracy due to the early-stage positioning error. The answer remains semantically close to the ground truth and conveys the core evolution accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 485,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s U.S. employee Restricted Stock Unit (RSU) agreement has not been revised between FY 2022 and FY 2024.  The 2024 10‑K (page 112) lists the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (Exhibit 10.3) that appears in the 2022 10‑K (page 114) and the 2023 10‑K (page 112).  This lack of change suggests a deliberate, stable equity‑compensation strategy that prioritizes continuity and long‑term alignment over frequent plan adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Medtronic did not update its U.S. employee RSU agreements between FY2022 and FY2024, matching the original answer's claim of consistency across the three-year period. (2) The LLM correctly references the same document title and plan (Form of Restricted Stock Unit Award Agreement under the 2013 Stock Award and Incentive Plan) and implicitly confirms no changes by citing identical exhibit numbers (Exhibit 10.3) across all three 10-Ks, though it does not repeat the August 27, 2013 filing date or File No. 001-07707—minor omissions that do not affect factual accuracy. (3) The reasoning is sound: the lack of revisions is correctly interpreted as evidence of a stable, consistent equity compensation strategy focused on long-term alignment, which aligns with the original answer’s conclusion. (4) All entities—Medtronic, U.S. employees, RSU agreements, 2013 Plan, and fiscal years 2022–2024—are correctly identified and synthesized across filings. The answer addresses both parts of the question: the absence of updates and the strategic implication. Minor differences in wording (e.g., 'deliberate, stable equity-compensation strategy' vs 'stable and consistent equity compensation strategy') do not affect meaning. All scores are 10 due to full factual correctness, accurate reasoning, and complete responsiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 394,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "In 2022, Intel’s 2006 Equity Incentive Plan was used to award performance‑based RSUs to executives under a single grant agreement, as reflected in the plan’s definition in the 2022 filing (page 113). By 2024, the plan had been refined to issue separate grant agreements: one specifically for performance‑based RSUs granted to non‑grandfathered executives (and another for grandfathered executives) and distinct agreements for RSUs with and without retirement‑vesting terms (page 108). This shift shows a move toward a more granular, differentiated structuring of RSU grants under the plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and misrepresentations in the evolution of Intel's use of the 2006 Equity Incentive Plan from 2022 to 2024. (1) Correctly identifies that the 2006 Equity Incentive Plan was used for performance-based RSUs in 2022 and references the correct context (2022 10-K, page 113). It also correctly notes a structural refinement by 2024 involving separate agreements for grandfathered vs. non-grandfathered executives and retirement-vesting terms (citing 2024 filing, page 108). However, it skips any mention of 2023 — a critical year in the multi-hop timeline — where Intel continued using the plan with differentiated agreements, as confirmed in the 2023 10-K. This omission breaks the longitudinal analysis required by the question. (2) Quantitatively, there are no numerical errors per se, as the answer avoids specific figures (e.g., grant sizes, financial values), so accuracy is high on available data. Dates like 'September 26, 2023' (S-8 filing) and 'May 11, 2023' (amended plan) are not mentioned in the LLM answer, but since they weren't included in the response, this is an omission rather than an inaccuracy. (3) The reasoning is partially sound: the observation about increased granularity in grant structuring by 2024 aligns with the ground truth. However, the LLM incorrectly implies that the split into separate agreements (grandfathered vs. non-grandfathered) occurred *by 2024*, when in fact it was already in place in 2023. Thus, the evolution is misrepresented — the change happened earlier than suggested. (4) Contextual relevance is strong: the answer focuses on the right plan, the right type of award (performance-based RSUs), and executive compensation structure. But due to missing the 2023 continuity and mis-timing the structural changes, the multi-hop synthesis across all three years is incomplete. The ground truth emphasizes consistency and reaffirmation across 2022–2024, while the LLM overemphasizes a 2024 shift that was already underway. Therefore, while factually plausible in parts, the answer does not fully or accurately reflect the evolution as documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 578,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s 2022 filing (pages 52‑56) does not emphasize advanced‑packaging, but the 2023 filing (page 35) reports a surge in activity—five new AI‑centric design wins and a growing IFS accelerator ecosystem—indicating a ramp‑up of capital and focus on chip‑let packaging. By 2024, Intel continues to invest heavily in advanced packaging as a core element of its disaggregated‑design strategy, yet the filing (pages 35‑36) also highlights significant R&D and manufacturing risks and the need for new packaging technologies. This trajectory shows Intel is aggressively pursuing chip‑let packaging to compete in AI workloads, but the persistent risks reveal that execution remains challenging and will require sustained investment to achieve market leadership.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of Intel's increasing focus on advanced packaging from 2022 to 2024 and correctly identifies it as part of its disaggregated design strategy and AI competitiveness. However, it omits key quantitative and factual details from the ground truth. Most critically, it fails to mention the $16.5 billion R&D investment in 2024 and the $3.1 billion in non-cash impairment charges related to manufacturing assets, including Intel 7, which are central to the financial and execution risks highlighted in the original answer. These omissions significantly affect quantitative accuracy. (2) The LLM introduces unverified claims not present in the ground truth, such as 'five new AI-centric design wins' and 'growing IFS accelerator ecosystem,' with no corresponding data in the original answer. These appear to be fabrications or misattributions, further reducing factual reliability. No numeric values from the ground truth (e.g., $16.5B, $3.1B) are accurately reflected. (3) The multi-hop reasoning is partially sound—linking advanced packaging to disaggregated design and AI competition—but lacks the critical synthesis of financial performance and technical progress that defines the original answer’s conclusion about 'persistent execution challenges and high financial stakes.' The reasoning is plausible but incomplete without the impairment charges and R&D figures. (4) Contextual relevance is high because the answer addresses the evolution over time and ties packaging to strategy and competition. However, the absence of key financial data and introduction of unsupported specifics reduce correctness. The answer conveys a similar narrative but lacks the evidentiary foundation required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 479,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel amended its 2006 Equity Incentive Plan in 2022 to authorize RSU awards to non‑employee directors, as evidenced by the grant agreement dated May 12 2022 (Exhibit 10.1.7, page 108). In 2023 the plan continued to be used for RSU awards to executives, with a performance‑based RSU grant agreement dated January 30 2019 (Exhibit 10.1.6, page 108). By 2024 the plan remained unchanged but was still employed for both non‑employee director and executive RSU awards, with no new amendments disclosed (Exhibits 10.1, 10.1.6, 10.1.7 on pages 107‑108).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents key aspects of the evolution of Intel's 2006 Equity Incentive Plan. (1) It incorrectly states that Intel amended the plan in 2022 to authorize RSU awards to non-employee directors. The ground truth does not mention a 2022 amendment; instead, the major amendment occurred in 2023, specifically on May 11, 2023, when the plan was formally amended and restated. This is a significant error in both timing and event type. (2) The LLM references a performance-based RSU grant agreement dated January 30, 2019, as evidence of 2023 usage, which is misleading—using a 2019 agreement in 2023 filings does not imply the plan evolved in 2023, and the ground truth emphasizes the 2023 amendment and updated grant agreements, not reuse of old ones. (3) The claim that the plan 'remained unchanged' in 2024 contradicts the ground truth, which notes ongoing use of standardized agreements but follows a 2023 amendment—so the plan was not unchanged. (4) The LLM omits the key detail about retirement vesting terms and performance-based RSUs introduced or emphasized in 2023, reducing completeness. (5) While the LLM correctly identifies that the plan was still in use in 2024 for executives and non-employee directors, this is only partially accurate and lacks the nuance of sustained reliance despite the plan's age, as highlighted in the original answer. (6) The citation of specific exhibits and pages may lend false precision, as the answer uses them to support incorrect claims. Quantitative accuracy is moderate because no numerical values (e.g., dollar amounts) are present, but dates are misapplied. Qualitative accuracy is low due to flawed reasoning—failing to recognize that the 2023 amendment was the key evolutionary step and misattributing plan changes to 2022. Contextual relevance is high because the answer addresses the right plan, time frame, and types of awards, but with incorrect details. Overall, the answer captures surface-level continuity but fails on critical multi-hop reasoning: correctly sequencing amendments and linking them to grant agreement updates across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 574,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm has kept the same accounting treatment for wireless‑access‑point revenue, reporting it under the QCT “IoT” stream that is defined as edge networking (mobile broadband + wireless access points) in both the 2022 10‑K (page 7) and the 2024 10‑K (page 73).  The 2024 filing, however, stresses edge‑networking as a strategic growth focus, highlighting the company’s role in mobile‑broadband and Wi‑Fi (Wi‑Fi 6/6E) access‑point markets and positioning Qualcomm as a leading supplier of edge‑computing infrastructure (page 73).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that wireless access point revenue has been consistently classified under the edge networking segment (within QCT IoT) in both 2022 and 2024, aligning with the ground truth. It accurately notes the continued financial categorization and highlights Qualcomm's strategic emphasis on edge networking in 2024, particularly in mobile broadband and Wi-Fi access points. However, the LLM omits the specific 2022 projection of IoT devices doubling to over 27 billion by 2026, which was a key part of the strategic rationale in the original answer. Additionally, while the LLM mentions the 2022 and 2024 10-Ks, it does not reference 2023, where the formal classification was explicitly confirmed — a gap in completeness across the full 2022–2024 timeline. (2) There are no numerical inaccuracies; the answer avoids stating specific revenue figures, which is appropriate since none are disclosed in the ground truth. Dates and document references (e.g., 2022 and 2024 10-K pages) are cited plausibly and support the claims. (3) The multi-hop reasoning is mostly sound: the model connects financial categorization across years and infers strategic emphasis from disclosure language. However, it misses the incremental confirmation in 2023, weakening the longitudinal synthesis slightly. (4) The answer is contextually highly relevant, directly addressing revenue classification and strategic positioning. The omission of the IoT growth projection and 2023 confirmation prevents a top score, but core facts and reasoning remain accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 438,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales rose from **$428 million in 2022 to $605 million in 2023 and $785 million in 2024** (all figures in millions of dollars)【page_130】. The steady year‑over‑year growth signals that the drug is consolidating its role as a leading CMV‑prophylaxis in the Hospital Acute Care segment, indicating increasing adoption by hospitals and a strengthening market position for Merck in that niche.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures. According to the ground truth, MRK's Prevymis sales were $370 million in 2022 and $428 million in 2023, but the LLM incorrectly reports $428 million in 2022 and $605 million in 2023. Only the 2024 figure ($785 million) is correct. This misrepresentation leads to an inaccurate growth trajectory. (2) The quantitative inaccuracies are severe: the LLM overstates 2022 sales by $58 million and 2023 sales by $177 million. The compound growth rate cannot be verified from the LLM's numbers, but based on ground truth, the actual CAGR is ~46%, which the LLM fails to mention. (3) The reasoning about market positioning is partially sound—increasing adoption and strengthening market position in Hospital Acute Care for CMV prophylaxis aligns with the ground truth—but it is based on incorrect data, weakening the validity of the conclusion. The multi-hop synthesis (linking sales growth to market positioning) is conceptually correct but undermined by faulty inputs. (4) Contextually, the answer addresses both parts of the question—sales evolution and market positioning—and uses appropriate terminology. However, due to major numerical errors, the correctness score is low despite relevant framing. Minor formatting like 'million' is acceptable, but core data must match.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 379,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "Intel’s IDM 2.0 strategy has shifted from a 2022 focus on “risk‑laden” R&D and limited manufacturing history for advanced packaging (page 56, page 54) to a 2023 period where packaging revenue rose sharply and new design wins and a silicon‑demonstrated interconnect standard underscored tangible progress (page 38, page 37, page 36, page 35). By 2024 the company still lists advanced packaging as a “unique advantage” while continuing large, long‑term capital outlays and acknowledging ongoing delays and inventory write‑downs (page 34, page 36), revealing that Intel is committed to IDM 2.0 but must still overcome significant execution risk from manufacturing lag and constrained cash flow.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the multi-year evolution of Intel's advanced packaging strategy and its connection to IDM 2.0, aligning well with the ground truth in terms of narrative and strategic trajectory. It accurately reflects the increasing strategic emphasis on packaging from 2022 to 2024, acknowledges execution risks, manufacturing delays, and capital constraints. However, it omits specific quantitative details present in the original answer, notably the $16.5 billion R&D investment in 2024 and the $3.1 billion non-cash impairment in Q3 2024. These are critical financial indicators of capital constraints and execution challenges, and their absence reduces quantitative accuracy. (2) While the LLM mentions 'large, long-term capital outlays,' it does not specify amounts or impairments, making it impossible to verify precision. The ground truth includes two exact figures that are missing in the LLM response, which affects numeric completeness. (3) The multi-hop reasoning is sound: the model synthesizes information across years, connects packaging advancements to IDM 2.0, references UCIe (implied via 'silicon-demonstrated interconnect standard'), and correctly identifies delays and financial strain as ongoing issues. The use of document page references suggests grounding in source material. (4) Despite missing key numbers, the LLM conveys the core qualitative insight—that Intel advanced its packaging capabilities strategically but struggled with execution and capital efficiency—making the answer largely correct in substance. Contextual relevance is perfect, as all content directly addresses the question’s focus on strategic evolution and execution challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 466,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM’s 10‑K filings for 2022, 2023 and 2024 all list “client relationships and trust” as a core competitive differentiator, with the same wording and placement in the competition section (2022 p.6; 2023 p.3; 2024 p.3). The unchanged emphasis signals that IBM is positioning its hybrid‑cloud and AI strategy around trusted, long‑term client relationships, using that trust to differentiate from hyperscalers and other competitors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that IBM consistently listed 'client relationships and trust' as a competitive differentiator in its 10-K filings from 2022 to 2024, with identical wording and placement. This aligns with the ground truth and demonstrates accurate entity and date identification (IBM, 2022–2024, 10-K filings), earning full marks for quantitative accuracy. However, the LLM answer lacks the nuanced evolution described in the original answer: it does not mention how the framing of trust evolved—from integration with hybrid cloud and AI in 2022, to broader competitive methods in 2023, to expanded strategic partnerships (e.g., Palo Alto Networks) in 2024. This missing progression weakens the qualitative accuracy, as the multi-hop synthesis across years to show strategic deepening is incomplete. While the core fact of consistency is correct, the answer omits key contextual developments that explain *how* the emphasis evolved and what it indicates about IBM’s strategy. The reasoning is sound but superficial, and the conclusion about differentiation from hyperscalers, while plausible, is not explicitly supported in the ground truth. Contextual relevance is high as the response directly addresses the question’s focus on trust and strategy positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 359,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "From 2022 to 2023, IBM disclosed the 0.950% Notes due 2025 only as part of the instrument definition (Exhibit 4.1/4.2) incorporated by reference (pages 30 of the 2022 10‑K and 20 of the 2023 10‑K), indicating the notes were already outstanding and not newly issued. In 2024 the notes appear as a registered security (IBM25B) in the 10‑K (page 1), reflecting a more explicit disclosure of the instrument as part of IBM’s debt portfolio. This progression signals IBM’s focus on maintaining a stable, low‑coupon, long‑term debt mix while consistently and transparently reporting its existing debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 0.950% Notes due 2025 were disclosed via Exhibit 4.1 (and possibly 4.2) in both 2022 and 2023 10-Ks, and in 2024 the notes were explicitly listed as a registered security under symbol IBM25B. The years, percentages, and exhibit references are accurate. (2) The LLM correctly identifies the evolution: from incorporation by reference in 2022–2023 to more prominent disclosure in 2024, which matches the ground truth's emphasis on increasing visibility and transparency. (3) The reasoning is sound: the model infers that the notes were outstanding (not newly issued), which is consistent with referencing historical filings (e.g., 2017 Form 8-K), and correctly interprets the 2024 listing on NYSE as a sign of active trading and transparency. (4) The broader conclusion about IBM’s stable, transparent debt management strategy is semantically equivalent to the original answer, though slightly less explicit about 'regulatory continuity'—a minor omission. The LLM adds value by characterizing the debt as 'low-coupon, long-term,' which is reasonable given the 0.950% rate and 2025 maturity, but this characterization is not in the ground truth and could be seen as mild extrapolation. However, it does not detract from accuracy. All multi-hop elements (tracking disclosure changes across years, linking to exchange listing, inferring strategy) are correctly synthesized. No calculation errors. One point deducted from correctness and qualitative accuracy for slight over-interpretation of 'low-coupon' without benchmarking, though contextually justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 456,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "In 2022 Intel announced PowerVia as a breakthrough backside‑power delivery technology for its next‑generation Intel 20A node (see 2022 10‑K, pages 5‑9).  By 2023 the company reiterated PowerVia’s role—describing it as an industry‑first that would be introduced in 20A and slated for high‑volume manufacturing in 2025 (2023 10‑K, page 14).  In 2024 Intel moved PowerVia to the earlier Intel 18A node, with high‑volume production of PowerVia‑enabled Panther Lake processors expected in 2025 (2024 10‑K, page 10), underscoring a roadmap that accelerates backside power delivery across successive advanced nodes as part of its IDM 2.0 strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, reaffirmed in 2023 for high-volume manufacturing in 2025, and in 2024 shifted to Intel 18A for 2025 production. The dates, node names (20A, 18A), and timeline (2025 HVM) match the original answer. (2) Quantitative accuracy is perfect: no numerical errors; years and production timelines are correctly cited. (3) Multi-hop reasoning is sound—information is synthesized across three years of 10-K filings, showing evolution from announcement to deployment. The only minor gap is that the LLM answer does not explicitly frame the shift from 20A to 18A as a 'cancellation' of 20A productization, which is a subtle but important strategic nuance mentioned in the ground truth. Instead, it states PowerVia was 'moved' to 18A, which is semantically close but slightly less precise. (4) Contextual relevance is excellent—the answer directly addresses the evolution of PowerVia and what it reveals about Intel's roadmap, tying it to IDM 2.0 strategy. Overall, the answer is factually correct, well-structured, and only slightly less detailed in strategic interpretation, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 350,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 2022‑2024 10‑K filings all reference the same 2021 Medtronic plc Long‑Term Incentive Plan for Restricted Stock Unit (RSU) awards, with identical vesting schedules (100 % at the third anniversary and ratably over four years)【page 116 of 2024】【page 116 of 2023】【page 116 of 2022】.  The unchanged plan and vesting structure across three years indicates a stable U.S. equity‑compensation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right question and demonstrating relevant reasoning intent. (1) The LLM incorrectly states that Medtronic's 2022–2024 filings reference the '2021 Medtronic plc Long-Term Incentive Plan' for RSU awards. The ground truth confirms that the Restricted Stock Unit Award Agreement (Exhibit 10.54) consistently referenced an August 27, 2013 filing, not a 2021 plan. This is a critical entity and date error. (2) The vesting schedules cited (100% at third anniversary and ratably over four years) are not corroborated in the ground truth, which makes no mention of specific vesting terms—this introduces unverified quantitative details. (3) While the LLM correctly infers strategic stability from the consistency of the plan documentation across years, this reasoning is based on incorrect underlying facts. The multi-hop synthesis is logically structured—comparing filings across years to assess stability—but rests on a false premise. (4) The answer is contextually relevant and interprets the intent of the question well, earning high marks for relevance. However, due to the incorrect plan name, date, and unverified vesting details, the quantitative and qualitative accuracy scores are moderate. The conclusion about stability aligns with the ground truth, but the factual foundation is flawed, resulting in a partial correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 398,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "From 2022‑24 Intel positioned advanced packaging as a core differentiator of its IDM‑2.0 strategy, with packaging revenue rising from $469 million in 2022 to $952 million in 2023 and continuing into 2024 (pages 38–39, 2023 10‑K; page 38, 2024 10‑K).  However, execution lagged: delays in 10 nm, Intel 4 (7 nm) and the 4th‑Gen Xeon launch, plus capital‑intensive facility expansions that were postponed or scaled back (pages 34–36, 2024 10‑K), constrained the pace of new‑node and packaging roll‑outs; the disaggregated design approach added further complexity and risk, with potential delays in component integration and packaging (pages 53–56, 2022 10‑K and pages 35–36, 2024 10‑K).  Consequently, while advanced packaging helped offset some margin pressure, the combination of delayed process nodes, capital constraints, and the nascent disaggregated design strategy continued to challenge Intel’s ability to deliver timely, high‑margin products.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The claim that 'packaging revenue rose from $469 million in 2022 to $952 million in 2023' is not supported by the ground truth and introduces specific figures absent from the original answer; no such revenue numbers appear in the provided ground truth, making this a significant fabrication or misattribution. Additionally, the mention of delays in '10 nm' and '4th-Gen Xeon launch' adds details not present in the ground truth, which focuses on Intel 4 (7nm) delays and advanced packaging execution issues. (2) The quantitative inaccuracies are critical: the revenue figures are unsupported, and no financial metrics related to packaging revenue were mentioned in the ground truth. The $3.1 billion impairment charge in 2024 — a key factual anchor in the original answer — is entirely omitted. This severely undermines the quantitative accuracy score. (3) Qualitatively, the LLM captures the general multi-hop narrative: Intel's strategic emphasis on advanced packaging as part of its IDM 2.0 strategy, the complexity of disaggregated design, execution challenges, and capital constraints. It correctly links delays in process nodes (Intel 4) to impacts on packaging rollouts and references UCIe-adjacent concepts like chiplet integration. However, it fails to mention UCIe explicitly or Intel’s strategic positioning around it in 2023, a key differentiator highlighted in the ground truth. The 2024 challenges are underdeveloped, missing the specific impairment charge and underutilized assets that are central to the original answer. (4) Contextual relevance is high because the response addresses the evolution of Intel’s strategic positioning and execution challenges across 2022–2024, engages with advanced packaging, capital constraints, and disaggregated design, and attempts to synthesize across years. However, the inclusion of unverified financial figures and omission of key facts like the $3.1B impairment reduce correctness. Overall, the answer is partially correct with plausible reasoning but undermined by significant factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 581,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s target mix for non‑U.S. defined‑benefit plans moved from 21 % equity and 50 % debt in FY 2022 to 27 % equity and 48 % debt in FY 2023, then eased to 23 % equity and 42 % debt in FY 2024 (U.S. plans remained 100 % debt throughout). This gradual tilt toward higher‑return equities and lower‑duration fixed income shows a deliberate, market‑responsive strategy that seeks to enhance risk‑adjusted returns while still matching liability duration.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the ground truth. (1) Quantitatively, the percentages provided (e.g., 21% equity, 50% debt in FY2022) are fabricated and not supported by the original answer, which does not provide specific numerical allocations for any fiscal year. The claim that U.S. plans remained 100% debt is also not mentioned in the ground truth. (2) The original answer describes a qualitative evolution in strategy—focusing on duration matching, flexibility, and risk-adjusted returns—but contains no numerical breakdowns of asset allocation. The LLM invents precise percentages for three years and differentiates between U.S. and non-U.S. plans, which is a significant hallucination. (3) While the LLM attempts multi-hop reasoning by inferring a strategic shift toward equities and lower-duration debt, this interpretation is based on false data. The ground truth notes a consistent balance between fixed income and equities with increasing flexibility, not a measurable 'tilt' toward equities. (4) Contextually, the answer addresses the question's theme—evolution of asset allocation and risk-adjusted returns—but fails on factual accuracy. The invented numbers severely undermine correctness. The qualitative reasoning about market responsiveness has partial alignment with the original's mention of flexibility, but this is overshadowed by factual errors. Thus, the correctness and quantitative accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 400,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s repeated mention of the 1.05% Notes due 2017 (see Exhibit 4.4, page 54) shows the company’s commitment to fully disclose all outstanding debt, even older maturities, underscoring a consistent, transparent debt‑reporting policy. By contrast, Apple’s debt‑issuance activity during 2022–2024 has focused on new, higher‑coupon, longer‑term notes (e.g., 4.421% Notes due 2026, 4.000% Notes due 2028, etc., see Exhibit 4.28, page 58), reflecting a strategy to diversify maturities and capture favorable market rates for financing and share‑repurchase programs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's transparent disclosure approach and contrasts it with its active debt issuance strategy, which aligns with the ground truth. However, there are key quantitative inaccuracies: the LLM cites '4.421% Notes due 2026' and '4.000% Notes due 2028' as examples from 2022–2024, but the ground truth references 'Floating Rate Notes due 2020', '2.15% Notes due 2022', and '3.45% Notes due 2024'—different instruments with different coupons and maturities. These discrepancies affect factual precision. (2) The dates and percentages in the LLM answer do not match the original answer; for instance, the ground truth does not mention any notes due in 2026 or 2028, nor does it reference a 4.421% or 4.000% coupon. This indicates a failure in accurately retrieving or synthesizing the specific debt instruments issued during 2022–2024. (3) The multi-hop reasoning is sound in structure—comparing continued disclosure of matured debt with current issuance strategy—but relies on incorrect specific entities, weakening the factual foundation. The logic that Apple maintains transparency while actively managing its debt portfolio is valid and well-synthesized. (4) Despite incorrect specific instruments, the overall qualitative interpretation and intent of the answer are aligned with the ground truth, warranting a score of 7 for correctness. Quantitative accuracy is penalized due to mismatched percentages and maturities, but contextual relevance and reasoning quality remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 420,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12,180,917 shares for $4.1 million, and the board added $3.0 billion in additional authority, raising total outstanding authority to $6.129 billion (page_94, page_95). In fiscal 2024 the company bought 2,072,563 shares for $605 million under its open‑market program and approved $4.0 billion in new authority, bringing total outstanding authority to $6.694 billion (page_39). The steady use of the repurchase program coupled with incremental increases in available authorization over these years signals a disciplined, flexible capital‑return strategy that balances regular shareholder payouts with a sizable pool of repurchase capacity for future market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims Accenture repurchased 12,180,917 shares for $4.1 million in fiscal 2022, which is factually incorrect — $4.1 million for over 12 million shares implies an implausible share price of ~$0.33. The ground truth does not specify the number of shares or dollar amount repurchased in 2022, only that the available authorization was $3.13 billion. The LLM fabricates specific repurchase figures not present in the original answer. Additionally, the LLM states that $3.0 billion in new authority was added in 2022, but the ground truth does not mention a 2022 board addition — instead, the $4.0 billion increase occurred in September 2024. The total outstanding authority in 2022 is incorrectly stated as $6.129 billion, which is unsupported. (2) The only correct quantitative elements are: $605 million in share purchases in fiscal 2024 and the $4.0 billion new authority approved in 2024, leading to a total outstanding authority of ~$6.69 billion (LLM says $6.694B, close enough). However, the evolution from 2022 to 2024 is misrepresented due to incorrect inputs. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a disciplined capital return strategy from sustained repurchases and renewed authorizations — but the synthesis is based on incorrect data for 2022, undermining the validity of the trend. The original answer emphasizes a decrease in available authorization from $3.13B to $2.69B despite new approvals, indicating active usage; this nuance is missing. (4) Contextual relevance is high — the answer addresses share repurchases, authorization changes, and strategic implications — but factual errors in key numbers severely reduce correctness. The conclusion about a flexible, disciplined strategy aligns semantically with the original, but rests on flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 509,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Bristol‑Myers Squibb issued $1 billion of 4.350 % senior notes due 2047 in each of the 2022, 2023, and 2024 10‑Ks (2022 10‑K p. 137; 2023 10‑K p. 133; 2024 10‑K p. 136). The consistent issuance of the same coupon and maturity each year shows a deliberate strategy of maintaining a stable, long‑term debt profile—using moderate‑rate, long‑dated notes to finance growth and acquisitions while preserving predictable interest costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims BMY issued $1 billion of the 4.350% Senior Notes due 2047 in each of 2022, 2023, and 2024, which is incorrect. The ground truth states that the notes were *referenced* or *listed* as part of the outstanding debt portfolio each year, not that they were newly issued annually. This misrepresents the nature of the debt instrument, implying repeated issuance of the same note, which did not occur. (2) The dollar amount ($1 billion) and the frequency (annual issuance) are unsupported by the ground truth, which does not specify the original principal amount of the 4.350% notes or any reissuance. The LLM fabricates page numbers and implies active issuance where only continuity in disclosure exists. (3) The reasoning is partially sound in interpreting the strategic intent—maintaining long-term debt with predictable costs—but fails the multi-hop synthesis by not acknowledging that the 2047 notes were issued earlier (under the 2019 indenture) and remained on the books, while newer debt (e.g., 2032, 2052, 2049 notes) was layered on top. The model misses the key point about debt diversification with staggered maturities and overemphasizes repetition of issuance. (4) While the general direction of the conclusion (stable long-term financing) aligns with the ground truth, the factual foundation is flawed. Quantitative accuracy is very low due to invented figures; qualitative accuracy is moderate due to correct identification of BMY and the note terms, and some valid strategic interpretation; contextual relevance is high as the response addresses the question’s focus on evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 458,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple consistently listed the 2.40% Notes due 2023 in the “Description of Securities” section of each filing.  The 2022 filing (page 56) and the 2023 filing (page 53) both include the note, and the 2024 filing (page 56) continues to list it, showing no change in the level of detail or presentation as the notes approached maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Apple consistently disclosed the 2.40% Notes due 2023 across the 2022, 2023, and 2024 filings with no change in presentation or level of detail. The specific page numbers (2022: p.56, 2023: p.53, 2024: p.56) and section ('Description of Securities') align with the expected disclosure pattern and support the conclusion of a stable approach. All entities (Apple, 2.40% Notes due 2023) and years are accurate, and there are no numerical or date inaccuracies—quantitative accuracy is perfect. The reasoning correctly infers consistency in disclosure despite the notes maturing in 2023, which addresses the core of the multi-hop question. However, the LLM omits key details present in the ground truth: it does not mention Exhibit 4.3 or the Officer's Certificate dated May 3, 2013, which are central to the original answer and demonstrate deeper document-level precision. While the semantic meaning is largely equivalent—both emphasize unchanged disclosure—the absence of these specific exhibit and document references reduces completeness and qualitative depth. Thus, while the answer is contextually relevant and quantitatively sound, it falls slightly short of full qualitative accuracy due to missing granular sourcing details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 356,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "Accenture authorized 127 million Class A shares for the Amended 2010 Share Incentive Plan in FY 2022 (page 91). By FY 2024 that authorization had risen to 141 million shares (page 98), a 14 million‑share increase. The upward trend reflects a deliberate expansion of the share‑based compensation pool to better align employee incentives with shareholder value and support long‑term talent retention.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the share authorization numbers for FY 2022 (127 million) and FY 2024 (141 million), and notes the 14 million increase, which aligns with the ground truth (127M → 141M). However, it omits the explicit FY 2023 value (141 million), which is a key data point in the progression. While the increase is accurately described, the absence of confirmation that the number remained stable in FY 2024 slightly undermines completeness. (2) The numbers themselves are quantitatively accurate—127 million and 141 million are correct, and the 14 million difference is accurate. The fiscal years are correctly referenced, though the answer skips stating that the increase occurred in FY 2023 and then held steady. (3) The reasoning is sound in interpreting the increase as a strategic expansion of the compensation pool to support incentives and talent retention, which is consistent with the ground truth’s interpretation. However, the LLM misses the nuance that the pool stabilized in FY 2024, which the original answer highlights as evidence that the new level became sufficient—this reflects a minor gap in multi-hop synthesis across all three years. (4) The answer is highly relevant and addresses the core of the question—evolution of shares and strategic implications—with accurate entities (Accenture plc, Amended 2010 SIP, Class A ordinary shares) and correct fiscal context. The omission of the FY 2023 data point prevents a perfect score, but the overall factual and interpretive content is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 423,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "In 2022 Intel’s 10‑K did not reference PowerVia, indicating the technology was still in early research stages (page 9, 2022). By the 2023 filing, PowerVia was announced as a breakthrough backside‑power delivery feature for the Intel 20A node, projected to deliver up to a 15 % performance‑per‑watt improvement over Intel 3 (page 14, 2023). In the 2024 filing, Intel positioned PowerVia as a core component of the next‑generation Intel 18A node and continued to develop it for the 14A roadmap, underscoring its growing centrality to power‑efficiency and signal‑integrity goals in Intel’s advanced process strategy (page 10, 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its portrayal of PowerVia's evolution, but contains a minor factual inaccuracy regarding the 2022 10-K not referencing PowerVia. While the 2022 10-K may not have mentioned PowerVia explicitly, the ground truth states that Intel introduced PowerVia in 2022 as part of its updated technology roadmaps, which is a matter of public record beyond the 10-K. Thus, claiming it was absent from the 10-K does not negate its 2022 introduction and misrepresents the timeline slightly. The 15% performance-per-watt improvement cited in the LLM answer is plausible and consistent with Intel’s messaging, though this specific figure is not in the ground truth and cannot be fully verified; this introduces a small risk of hallucination. (2) Quantitatively, the 15% improvement is the only number provided; while not contradicted by the ground truth, it is an addition not present in the original answer and lacks corroboration. Dates (2022–2024) and node names (20A, 18A, 14A) are accurate, though the mention of '14A roadmap' in 2024 is an expansion beyond the ground truth, which only confirms PowerVia in 18A with Panther Lake. (3) The multi-hop reasoning is sound—LLM correctly traces PowerVia’s progression across years and nodes, linking it to strategic goals like power efficiency and signal integrity. However, it omits the key detail that Intel 20A was canceled in favor of 18A, a significant strategic shift highlighted in the ground truth. Instead, it implies continuity into 14A, which goes beyond available information. (4) Despite missing the cancellation of 20A and adding unverified details (15%, 14A), the LLM captures the core narrative: PowerVia evolved from a new concept to a central feature in Intel’s advanced nodes, reflecting its strategic importance. Wording differs but meaning is largely aligned, warranting a 7 for correctness. Contextual relevance is high as it directly addresses the evolution and strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 536,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s pension‑plan assets in mutual‑fund equity securities fell from **$239,293** in 2022 to **$196,226** in 2023, then rose sharply to **$273,699** in 2024.  The dip in 2023 followed by the rebound in 2024 signals a deliberate, flexible asset‑allocation strategy: the company reduced equity exposure amid market volatility, then increased it when conditions improved, underscoring a long‑term focus on equity‑based growth within its pension‑plan portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly reports the $239,293 million allocation in 2022 and $196,226 million in 2023, it falsely claims the amount rose to $273,699 million in 2024, whereas the ground truth states it remained unchanged at $196,226 million. This error completely misrepresents the trend. (2) Quantitative accuracy is severely compromised: the 2024 figure is incorrect, and no such rebound occurred. The numbers do not support the claimed 'sharp rise' or 'rebound'. Calculations or comparisons based on these numbers are invalid. (3) The reasoning is flawed due to incorrect data. The LLM infers a 'flexible asset-allocation strategy' with a dip and rebound, but the actual trajectory shows a reduction followed by stability—indicating a strategic pullback, not tactical re-entry. The multi-hop synthesis fails because it misreads the 2024 data point, leading to an incorrect conclusion about strategic intent. (4) Contextual relevance is moderate: the answer addresses the right topic (Accenture's mutual fund equity allocation over three years) and attempts to interpret strategic positioning, but the conclusion is unsupported due to factual errors. The mention of 'pension-plan assets' adds specificity not in the original question but may be contextually accurate; however, this does not offset the core numerical and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 389,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck’s treatment of Dificid has been largely consistent but has shown modest financial growth.  The intangible asset net value recorded at acquisition was $145 million in 2021 (page 115) and no impairment charge or write‑down has been reported for 2022‑2024, indicating a stable asset valuation.  Therapeutically, Dificid remains a targeted antibiotic for Clostridioides difficile‑associated diarrhea and continues to be positioned within the Hospital Acute Care segment (page 4) without any noted repositioning.  Its global revenue contribution has risen steadily—from $263 million in 2022 to $302 million in 2023 and $340 million in 2024 (U.S. $303 m/37 m, $274 m/28 m, $241 m/22 m respectively) (page 130), increasing its share of the $1,685 million (2022‑23) to $1,764 million (2024) hospital‑acute‑care sales.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly states that Dificid had a $145 million intangible asset value (matching the ground truth for 2022), it incorrectly attributes this to 2021 and fails to note that this valuation was reported in 2022. More critically, the revenue figures for 2022 ($263M) and 2023 ($302M) are not supported by the ground truth, which does not provide 2022 or 2023 revenue—only 2024 revenue of $340M. The LLM fabricates a trend of increasing revenue from 2022 to 2024 with specific breakdowns ($241M U.S. in 2022, etc.), which contradicts the original answer that only reports 2024 figures. Additionally, the claim that Hospital Acute Care sales were $1,685M (2022–23) and $1,764M (2024) is unsupported and introduces data not present in the ground truth. (2) The calculation of U.S. and international revenue is inconsistent: for 2024, the LLM reports $303M U.S. and $37M international, which matches the ground truth, but incorrectly extends this breakdown to prior years. The sum of $274M/$28M and $241M/$22M also does not align with the stated totals of $302M and $263M. (3) The qualitative reasoning is partially sound: the LLM correctly identifies Dificid’s therapeutic indication and its placement in the Hospital Acute Care segment, and notes the absence of impairment, suggesting stable valuation. However, it misses the strategic evolution emphasized in the ground truth—i.e., Dificid’s growing recognition from a modest asset in 2022 to a strategically highlighted product in 2023 and a measurable revenue contributor in 2024. Instead, it frames the treatment as 'largely consistent,' which underrepresents the strategic shift. (4) Contextual relevance is high—the answer addresses all dimensions of the question (valuation, positioning, revenue)—but the inclusion of fabricated revenue data and incorrect years significantly undermines factual correctness. The model synthesizes across time points but invents data to fill gaps, failing the multi-hop accuracy standard. Quantitative accuracy is low due to unsupported numbers; qualitative accuracy is moderate due to correct entity and segment identification; correctness score is mid-range because core elements are present but key facts are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 620,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "Intel has kept advanced packaging as a cornerstone of its IDM 2.0 strategy, investing roughly $17 B in R&D in 2022, $16 B in 2023, and $16.5 B in 2024 (page 34).  Yet execution lag persisted— the 4th‑Gen Xeon launch was delayed in 2022, disaggregated‑design setbacks stalled packaging roll‑outs, and a $922 M inventory charge for Gaudi AI accelerators appeared in 2024 (page 35).  Financial risk has risen as penalties ($755 M) for Ireland construction delays and a $3.1 B impairment of Intel 7 assets were recorded in 2024, underscoring the cost of delayed packaging and process‑node implementation (page 36).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Intel's advanced packaging strategy from 2022 to 2024 with correct qualitative trends—strategic emphasis, execution delays, and rising financial risks. However, several key quantitative inaccuracies undermine full correctness. The R&D figures ($17B, $16B, $16.5B) are not present in the ground truth and are likely fabricated or misattributed, as the original answer does not specify R&D dollar amounts. The $922M inventory charge for Gaudi AI accelerators and $755M penalty for Ireland construction delays are not mentioned in the ground truth and represent unsupported additions. The $3.1B impairment charge is correctly cited and aligns with the original answer. (2) While the $3.1B impairment is accurate, other financial figures lack corroboration in the ground truth and introduce factual errors. The absence of R&D numbers in the original makes their inclusion here a significant quantitative deviation. (3) The multi-hop reasoning is sound in structure—tying R&D investment, execution delays, and financial risks across years—but relies on unsupported data points. The synthesis of strategic intent with operational setbacks and financial consequences mirrors the original’s logic, but with embellished specifics. (4) The contextual relevance is high, as the answer directly addresses all facets of the question (strategy, R&D, delays, financial risk) and maintains a coherent narrative across 2022–2024. The qualitative accuracy is strong due to correct identification of Intel, IDM 2.0, advanced packaging, and the trajectory from optimism to strain, despite numerical inaccuracies. Correctness score is 7 due to accurate overall narrative but significant quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 475,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "Merck’s HIV‑1 candidate MK‑8591A entered Phase 3 in 2022 but was stalled by an FDA clinical hold that cited lymphocyte‑count reductions (2022 10‑K, p. 23). The hold remained through 2023 while a Phase 2 study ended enrollment, and the program stayed in Phase 3 (2023 10‑K, pp. 22‑23). In 2024 the FDA lifted the hold on December 4, 2024, allowing new studies and the addition of a related combination (MK‑8591D) into development, underscoring Merck’s long‑term strategy to expand its HIV portfolio with novel once‑daily therapies (2024 10‑K, pp. 23‑24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and events are correct: MK-8591A was in Phase 3 in 2022 and 2023, and the FDA lifted the clinical hold on December 4, 2024—this matches the original answer exactly. The mention of the Phase 2 study ending enrollment is additional context not contradicted by the ground truth. (2) The LLM correctly identifies the reason for the clinical hold (lymphocyte-count reductions), which is consistent with regulatory concerns mentioned in the original answer, though not explicitly detailed. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years of 10-K filings, correctly tracking the regulatory and developmental status over time. (4) The conclusion about Merck’s long-term strategy—expanding its HIV portfolio with novel once-daily therapies—is a valid inference supported by the persistence in development despite setbacks. The only minor gap is that the original answer notes a partial clinical hold remains for higher doses, which the LLM omits. However, this does not undermine the overall correctness, as the lifting of the full hold is the primary regulatory update. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 392,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "Merck’s strategy for MK‑1308A has shifted from a broad advanced‑solid‑tumor portfolio in 2022 (colorectal, hepatocellular, melanoma, small‑cell lung) to a single, Phase 3 program focused on renal cell carcinoma (RCC) in 2023–24, still as a co‑formulation of the investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab (Keytruda) (page 25, page 18, page 50).  The combination therapy remains the core of the program, and regulatory progress has kept the drug in Phase 3 clinical development with no approvals yet, but the program is actively pursued under Merck’s immuno‑oncology pillar (page 50).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy in claiming that in 2022, MK-1308A was being developed for a 'broad advanced-solid-tumor portfolio' including colorectal, hepatocellular, melanoma, and small-cell lung cancers. The ground truth states that as early as 2022, MK-1308A was specifically listed for renal cell carcinoma (RCC) and in Phase 3 development with pembrolizumab—there is no mention of a broader tumor focus. This misrepresents the clinical focus evolution and contradicts the ground truth of a consistent RCC emphasis. However, the LLM correctly identifies that by 2023–2024, the program was focused on RCC and remained in Phase 3 with no approval. It also accurately describes MK-1308A as a coformulation of quavonlimab and pembrolizumab, which aligns with the 2023 ground truth. (2) Quantitatively, the years (2022–2024), phase of development (Phase 3), and lack of regulatory approval are correct. There are no numerical calculations, but temporal and developmental stage data are accurate except for the misleading implication of a 'shift' in focus. (3) The multi-hop reasoning is partially sound—information is synthesized across years and correctly identifies continuity in combination therapy and development phase. However, the core reasoning about strategic evolution is flawed due to the incorrect premise of a broad initial focus. The model fails to reflect the ground truth that the strategy showed consistency in RCC focus with increasing specificity in formulation, not a narrowing of indication. (4) Contextually, the answer is highly relevant, citing appropriate details like immuno-oncology focus and combination therapy. The qualitative accuracy is reduced due to the major error in clinical focus evolution, which is central to the question. Correctness score is 6 due to partially correct facts but significant error in the narrative of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 519,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture’s share‑repurchase activity jumped from $4.1 million in fiscal 2022 (total purchases of $4.111 million, including $3.152 million in open‑market buys) to $4.5 billion in fiscal 2024 (share purchases of $4.5 billion, per the 2024 key metrics) while its available authorization grew from $3.1 million at the end of 2022 to $2.694 billion after a $4 billion boost in 2024 (aggregate available authorization of $2.694 billion and total outstanding authority of $6.694 billion, page 39). This multi‑year trend shows Accenture is aggressively expanding its buy‑back program, underscoring a capital‑return strategy that increasingly relies on share repurchases to reward shareholders. (page 94, page 93, page 41, page 39)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that Accenture's share repurchase activity was $4.1 million in fiscal 2022, when the ground truth shows no such amount was reported for total purchases—instead, $3.13 billion was the remaining authorization, not the amount repurchased. Similarly, it claims $4.5 billion was spent on repurchases in fiscal 2024, but the actual amount spent was $605 million, not billions. The LLM confuses repurchase amounts with authorization levels. (2) Number verification: The available authorization at the end of fiscal 2022 is correctly cited as ~$3.13 billion (LLM says $3.1 million—off by a factor of 1,000). The $4 billion additional authorization in September 2024 and resulting total outstanding authority of $6.694 billion are correctly mentioned in the LLM answer, as is the $2.694 billion remaining available authorization. However, the LLM misrepresents these as growth in authorization from $3.1 million to $2.694 billion, again confusing millions with billions and misrepresenting trends. (3) Multi-hop reasoning is flawed: The LLM fails to correctly synthesize the evolution of repurchase activity and authorization over time. It invents repurchase figures not present in the ground truth (e.g., $4.1 million in 2022, $4.5 billion in 2024) and draws an incorrect conclusion about an 'aggressively expanding' buyback program, when the actual pattern shows measured, modest repurchases ($605M in 2024) with periodic replenishment of authority. The ground truth emphasizes a 'sustained but measured' strategy; the LLM mischaracterizes this as aggressive. (4) Scores justified: Correctness is low (3/10) due to pervasive numerical and conceptual errors. Quantitative accuracy is very poor (2/10) because most dollar figures are off by orders of magnitude or misattributed. Qualitative accuracy is low (3/10) due to incorrect reasoning and misinterpretation of strategy. Contextual relevance is moderate (6/10) because the answer addresses the right topic and cites relevant concepts (authorization, repurchases), but with serious inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 572,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol‑Myers Squibb has kept the $750 million 2.350% senior notes due 2040 on its books in the 12th, 13th and 14th Supplemental Indentures disclosed in the 2022, 2023 and 2024 10‑Ks (page 136 of each filing).  By retaining this long‑term, fixed‑rate instrument rather than refinancing or retiring it, BMS signals a deliberate strategy to lock in a low coupon for a 20‑year horizon, provide predictable interest expense and reduce refinancing risk as rates rise.  The persistence of the note therefore reflects BMS’s preference for a stable, diversified debt mix that supports its long‑term growth and acquisition plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million 2.350% Notes due 2040 are correctly identified, and their presence in the 2022, 2023, and 2024 filings is accurately noted. The dollar amount ($750,000,000 = $750 million) and interest rate (2.350%) match exactly. The reference to Supplemental Indentures in the 10-Ks, while more specific than the original answer, is consistent with typical disclosure practices and does not contradict the ground truth. (2) Quantitative accuracy is perfect: all numbers, percentages, and dates are correct and properly formatted. (3) The reasoning is sound: the LLM correctly infers that retaining the notes reflects a strategic choice to lock in low fixed rates, ensure predictable interest expenses, and avoid refinancing risk—key elements of long-term debt management. It appropriately connects the persistence of the debt instrument to broader strategic goals like growth and acquisitions. (4) The answer is contextually excellent, directly addressing how the continued inclusion of the notes reflects BMS's strategy. The only minor shortcoming is that it does not explicitly mention 'interest rate risk management' using those exact terms, though the concept is clearly implied. Overall, the answer demonstrates strong multi-hop reasoning across years and filings, with full factual alignment and high semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 395,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Bristol‑Myers Squibb has kept the coupon on its Senior Notes due 2047 fixed at 4.350 % in every recent filing.  The 4.350% Senior Notes are referenced in the 2024 10‑K (Exhibit 4.19 – page 134), the 2024 10‑K (page 136), and the 2024 10‑K (page 137), and the same rate appears in the 2022 10‑K (page 137).  The unchanged rate across filings signals a deliberate, stable long‑term debt strategy that relies on predictable, moderate financing costs to support the company’s capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fixed interest rate of 4.350% for the Senior Notes due 2047 across recent filings, which matches the ground truth. However, it inaccurately cites exhibit and page numbers—specifically, referencing Exhibit 4.19 and pages 134–137 in the 2024 10-K and repeating '2024 10-K' three times without mentioning the 2023 or 2022 exhibit details correctly. The ground truth specifies Exhibit 4bbb in 2022, Exhibit 4ff in 2023 under the Fourteenth Supplemental Indenture, and incorporation by reference to a Form 8-K from 2019 in 2024, none of which are accurately reflected in the LLM answer. (2) Quantitatively, the 4.350% rate is correct and consistently reported, satisfying the core numerical accuracy requirement. Dates and indenture names (e.g., November 13, 2023, Fourteenth Supplemental Indenture) are omitted or misstated, but no incorrect percentages or dollar amounts are present. (3) The reasoning is sound in concluding that the stable rate reflects a deliberate long-term debt strategy with predictable financing costs, aligning with the ground truth’s interpretation. However, the multi-hop synthesis across years and documents is weakened by incorrect exhibit references and omission of key legal documents (e.g., Supplemental Indentures), reducing qualitative accuracy. (4) Despite citation inaccuracies, the LLM captures the essential pattern—unchanged interest rate commitment—and draws a valid strategic inference, warranting high scores for contextual relevance and overall correctness, with a moderate deduction for lack of precision in sourcing details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 442,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "In FY 2022 Nike listed FlyEase as one of many “innovative technologies” in its product research and development section, noting it as part of the company’s broader technology portfolio. By FY 2024 the same technology is still mentioned in that section, but the filing now adds manufacturing data that shows FlyEase is produced at scale—Nike’s footwear is made by 15 contract manufacturers operating 96 finished‑goods factories worldwide (with 50 % of production in Vietnam, 27 % in Indonesia and 18 % in China) and apparel by 68 contract manufacturers in 285 factories—demonstrating its integration into the global supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Nike's reporting on FlyEase from FY2022 to FY2024. In FY2022, FlyEase is accurately described as part of Nike’s broader innovative technologies in R&D. By FY2024, the persistence of the mention and integration into manufacturing is correctly noted. The quantitative evidence about production scale—50% in Vietnam, 27% in Indonesia, and 18% in China—is factually correct and matches the ground truth. However, the LLM incorrectly attributes this geographic breakdown specifically to FlyEase production, while the original answer clarifies that these percentages refer to total Nike Brand footwear, which *includes* FlyEase-integrated products. This is a subtle but important distinction: the data demonstrates integration into the global supply chain but does not isolate FlyEase-specific production. (2) All numbers are accurate: 50%, 27%, 18% match the ground truth; the additional details about 15 contract manufacturers, 96 factories, and 68 apparel manufacturers are contextually plausible but not present in the original answer and not directly tied to FlyEase—this adds extraneous detail without error but slightly misdirects focus. (3) The multi-hop reasoning is mostly sound: the model connects FlyEase’s mention over time and infers integration via manufacturing footprint. However, it overreaches slightly by implying the production split is specific to FlyEase rather than the broader footwear line, weakening the logical precision. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in correctness and qualitative accuracy due to the misattribution of production data specificity. Wording differences are acceptable under semantic equivalence, but the conflation of general footwear manufacturing with FlyEase-specific output is a meaningful nuance in financial/operational reporting context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 513,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "RedCard penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024 (the 2024 figure is the most recent year‑end data)【page_27】. The decline of roughly 1.9 percentage points over two years indicates that the loyalty‑driven payment strategy is losing traction, suggesting the 5 % discount incentive and card offerings are becoming less effective at driving incremental purchases and may need to be re‑evaluated.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it incorrectly reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This is a significant factual error affecting the quantitative accuracy. (2) The calculation of a 1.9 percentage point decline is approximately correct between 2022 and 2024 using the LLM's numbers (20.5% to 18.6% = 1.9 pp), but using the correct numbers (20.5% to 17.8%) yields a 2.7 pp decline, making the LLM's characterization of the trend misleadingly mild. (3) The reasoning about the weakening effectiveness of Target's loyalty-driven payment strategy is sound and aligns with the downward trend; however, the conclusion is based on inaccurate data. The multi-hop synthesis—linking declining penetration to strategic effectiveness—is appropriate and contextually valid. (4) The contextual relevance is high because the answer addresses both parts of the question: the evolution of penetration and its strategic implication. The qualitative reasoning is strong but undermined by the incorrect 2024 figure. Thus, while the structure and intent are correct, the factual inaccuracy in a key data point reduces the overall correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 361,
        "total_tokens": 1590
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 798,
    "successful_evaluations": 798,
    "failed_evaluations": 0,
    "average_correctness_score": 6.48,
    "average_quantitative_accuracy": 7.15,
    "average_qualitative_accuracy": 6.76,
    "average_contextual_relevance": 8.69,
    "score_distribution": {
      "excellent": 272,
      "good": 166,
      "fair": 219,
      "poor": 141
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 798,
    "failed": 2,
    "elapsed_seconds": 37944.25,
    "timestamp": "2026-02-03T11:36:18.533329"
  }
}